-DOCSTART- -X- N

lomustine NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
control VB Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
or CC None
the DT Pharmocological
8-drugs-in-1-day JJ Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
experimental JJ Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
; : None
-DOCSTART- -X- N

Alvimopan NNP Pharmocological
alvimopan NN Pharmocological
Alvimopan NNP Pharmocological
alvimopan RB Pharmocological
( ( None
alvimopan NN Pharmocological
placebo NN Control
( ( None
alvimopan NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

multiplane NN Other
probe NN Other
biplane NN Other
probe NN Other
multiplane NN Other
probe NN Other
biplane NN Other
probe NN Other
transesophageal JJ Physical
echocardiography NN Physical
with IN None
either DT None
probe NN None
. . None
multiplane NN Other
and CC Other
biplane NN Other
probes NNS Other
multiplane NN Other
probe NN Other
multiplane NN Other
probe NN Other
. . None
-DOCSTART- -X- N

Methylphenidate NNP Pharmocological
0.3 CD Pharmocological
and CC Pharmocological
0.6 CD Pharmocological
mg/kg NN Pharmocological
methylphenidate NN Pharmocological
placebo-controlled JJ Control
methylphenidate NN Pharmocological
-DOCSTART- -X- N

movement NN Physical
selection NN Physical
and CC Physical
initiation NN Physical
( ( Physical
initiate NN Physical
) ) Physical
, , Physical
synchronisation NN Physical
of IN Physical
finger NN Physical
tapping VBG Physical
with IN Physical
an DT Physical
external JJ Physical
auditory NN Physical
cue NN Physical
( ( Physical
synchronise NN Physical
) ) Physical
continued VBD Physical
tapping VBG Physical
in IN Physical
absence NN Physical
of IN Physical
the DT Physical
auditory JJ Physical
pacer NN Physical
continuation NN Physical
synchronisation NN Physical
-DOCSTART- -X- N

pioglitazone NN Pharmocological
oral JJ Pharmocological
pioglitazone NN Pharmocological
titrated VBD Pharmocological
from IN Pharmocological
15 CD Pharmocological
mg NNS Pharmocological
to TO Pharmocological
45 CD Pharmocological
mg NN Pharmocological
or CC None
matching VBG None
placebo NN Control
in IN Pharmocological
addition NN Pharmocological
to TO Pharmocological
their PRP$ Pharmocological
glucose-lowering JJ Pharmocological
drugs NNS Pharmocological
and CC Pharmocological
other JJ Pharmocological
medications NNS Pharmocological
. . None
-DOCSTART- -X- N

conventional JJ Physical
physical JJ Physical
therapy NN Physical
alone RB Physical
with IN None
a DT None
specialised JJ Educational
balance NN Educational
retraining VBG Educational
program NN Educational
physical JJ Physical
therapy NN Physical
therapy NN Physical
and CC Physical
retraining NN Physical
conventional JJ Control
therapy NN Control
therapy NN Physical
combined VBN Physical
with IN Physical
standing VBG Physical
balance NN Physical
training NN Physical
by IN Physical
biofeedback NN Physical
( ( Physical
BPM NNP Physical
Monitor NNP Physical
) ) Physical
conventional JJ Physical
therapy NN Physical
-DOCSTART- -X- N

Calcium NNP Pharmocological
chloride NN Pharmocological
before IN Pharmocological
i.v NN Pharmocological
. . None
diltiazem NN Pharmocological
Diltiazem NNP Pharmocological
calcium JJ Pharmocological
chloride NN Pharmocological
( ( Pharmocological
CaCl NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
diltiazem NN Pharmocological
CaCl NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
placebo NN Control
. . None
diltiazem NN Pharmocological
placebo NN Pharmocological
diltiazem NN Pharmocological
placebo JJ Pharmocological
CaCl NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

laryngeal JJ Surgical
tube-S JJ Surgical
Proseal NNP Surgical
laryngeal JJ Surgical
mask NN Surgical
Laryngeal NNP Physical
Tube NNP Physical
Sonda NNP Physical
( ( Physical
LTS NNP Physical
) ) Physical
ProSeal NNP Physical
Laryngeal NNP Physical
Mask NNP Physical
Airway NNP Physical
( ( Physical
PLMA NNP Physical
) ) Physical
LTS NNP Surgical
PLMA NNP Surgical
-DOCSTART- -X- N

pulsed JJ Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
Pulsed VBD Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
( ( Physical
300 CD Physical
to TO Physical
600 CD Physical
microA NN Physical
) ) Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
pulsed VBD Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
Pulsed VBD Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
pulsed JJ Physical
low-intensity NN Physical
direct JJ Physical
current JJ Physical
-DOCSTART- -X- N

CBT NNP Educational
approach NN Educational
with IN Educational
conjoint JJ Educational
family NN Educational
therapy NN Educational
and CC Educational
an DT Educational
eclectic JJ Educational
approach NN Educational
. . Educational
CBT NNP Educational
naturalistic JJ Educational
follow-up JJ Educational
design NN None
. . None
-DOCSTART- -X- N

cerivastatin NN Pharmocological
cerivastatin NN Pharmocological
cerivastatin NN Pharmocological
placebo NN Control
cerivastatin NN Pharmocological
. . Pharmocological
placebo NN Control
-DOCSTART- -X- N

anticholinergic NN Pharmocological
and CC Pharmocological
beta VB Pharmocological
2-agonist JJ Pharmocological
and CC None
combination NN Pharmocological
therapy NN Pharmocological
inhaled JJ Pharmocological
bronchodilators NNS Pharmocological
ipratropium JJ Pharmocological
bromide NN Pharmocological
fenoterol JJ Pharmocological
hydrobromide NN Pharmocological
a DT None
combination NN Pharmocological
of IN Pharmocological
40 CD Pharmocological
micrograms NNS Pharmocological
ipratropium NN Pharmocological
and CC Pharmocological
100 CD Pharmocological
micrograms NNS Pharmocological
fenoterol VBP Pharmocological
-DOCSTART- -X- N

One CD Pharmocological
quadrant JJ Pharmocological
sub-Tenon NN Pharmocological
's POS Pharmocological
capsule NN Pharmocological
anesthesia NN Pharmocological
Sub-Tenon NNP Pharmocological
's POS Pharmocological
capsule NN Pharmocological
anesthesia NN Pharmocological
retrobulbar NN None
sub-Tenon NN Pharmocological
's POS Pharmocological
retrobulbar NN Pharmocological
anesthesia NN Pharmocological
. . Pharmocological
sub-Tenon NN Pharmocological
's POS Pharmocological
or CC Pharmocological
retrobulbar NN Pharmocological
anesthesia NN Pharmocological
; : None
Retrobulbar NNP Pharmocological
anesthesia NN Pharmocological
lidocaine NN Pharmocological
without IN Pharmocological
epinephrine NN Pharmocological
and CC Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
bupivacaine NN Pharmocological
. . None
Sub-Tenon NNP Pharmocological
's POS Pharmocological
anesthesia NN Pharmocological
1-QST CD Pharmocological
retrobulbar VB Pharmocological
anesthesia NN Pharmocological
; : None
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
1-QST JJ Pharmocological
1-QST JJ Pharmocological
1-QST JJ Pharmocological
retrobulbar NN Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

customized JJ Educational
letters NNS Educational
customized JJ Educational
letters NNS Educational
control NN Control
form-letter JJ Other
customizing VBG Educational
reminder NN Educational
letters NNS Educational
. . Educational
-DOCSTART- -X- N

electrothermal JJ Surgical
bipolar JJ Surgical
vessel NN Surgical
system NN Surgical
( ( Surgical
EBVS NNP Surgical
) ) Surgical
electrothermal JJ Surgical
bipolar JJ Surgical
vessel NN Surgical
sealing NN Surgical
( ( Surgical
EBVS NNP Surgical
) ) Surgical
EBVS NNP Surgical
( ( Physical
25 CD Physical
pts NNS Physical
, , Physical
group NN Physical
A NNP Physical
) ) Physical
versus IN Physical
the DT Physical
UltraSonic NNP Physical
Shears NNP Physical
( ( Physical
USS NNP Physical
) ) Physical
device NN Physical
-DOCSTART- -X- N

racemic JJ Pharmocological
warfarin NN Pharmocological
25 CD Pharmocological
mg NN Pharmocological
single JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
and CC Pharmocological
chronically RB Pharmocological
administered VBD Pharmocological
ketorolac NN Pharmocological
Ketorolac NNP Pharmocological
Ketorolac NNP Pharmocological
Ketorolac NNP Pharmocological
ketorolac NN Pharmocological
warfarin NN Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
Risperidone NN Pharmocological
-DOCSTART- -X- N

diclofenac NN Pharmocological
diclofenac NN Pharmocological
diclofenac VB Pharmocological
control NN Control
cyclopentolate NN Pharmocological
phenylephrine JJ Pharmocological
hydrochloride NN Pharmocological
diclofenac NN Pharmocological
diclofenac NNS Pharmocological
diclofenac NN Pharmocological
diclofenac NN Pharmocological
-DOCSTART- -X- N

hypnotized VBN Psychological
and CC None
read VB None
a DT None
passage NN None
while IN None
in IN None
hypnosis NN Psychological
. . None
post-hypnotic JJ Psychological
suggestion NN Psychological
hypnosis NN Psychological
-DOCSTART- -X- N

propranolol NN Pharmocological
or CC None
a DT None
placebo NN Control
-DOCSTART- -X- N

terfenadine NN Pharmocological
placebo NN Control
terfenadine NN Pharmocological
placebo NN Control
reference NN Pharmocological
drug NN Pharmocological
placebo NN Control
Terfenadine NNP Pharmocological
-DOCSTART- -X- N

Warfarin NNP Pharmocological
aspirin NN Pharmocological
Warfarin NNP Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
warfarin NN Pharmocological
aspirin $ Pharmocological
325 CD Pharmocological
mg JJ Pharmocological
daily RB Pharmocological
warfarin NNS Pharmocological
aspirin NN Pharmocological
warfarin NNS Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
warfarin NNS Pharmocological
warfarin NN Pharmocological
aspirin NN Pharmocological
aspirin NN None
warfarin NN None
Warfarin NNP None
aspirin NN None
warfarin NN None
aspirin NN None
. . None
-DOCSTART- -X- N

groups NNS None
; : None
one CD None
was VBD None
cultured VBN None
at IN None
37?C CD None
and CC None
the DT None
other JJ None
at IN None
36?C CD None
from IN None
of IN None
ICSI NNP None
to TO None
time NN None
of IN None
embryo NN None
transfer NN None
or CC None
vitrification NN None
. . None
Paired NNP None
group NN None
. . None
DNA NN None
fingerprinting NN None
was VBD None
-DOCSTART- -X- N

2-Chloroprocaine JJ Pharmocological
2-Chloroprocaine JJ Pharmocological
( ( Pharmocological
2-CP JJ Pharmocological
) ) Pharmocological
morphine NN Pharmocological
( ( Pharmocological
EM NNP Pharmocological
) ) Pharmocological
EM NNP Pharmocological
2-CP JJ Pharmocological
. . None
2-CP JJ Pharmocological
, , None
2-CP JJ Pharmocological
+ NN Pharmocological
epinephrine NN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
( ( Pharmocological
Lido NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
Epi NNP Pharmocological
EM NNP Pharmocological
PCA NNP Pharmocological
morphine NN Pharmocological
2-CP JJ Pharmocological
, , None
2-CP+Epi JJ Pharmocological
Lido+Epi NNP None
2-CP JJ Pharmocological
2-CP JJ Pharmocological
EM NNP Pharmocological
2-CP JJ Pharmocological
Lido NNP Pharmocological
+ NNP Pharmocological
Epi NNP Pharmocological
-DOCSTART- -X- N

Gabapentin NNP Pharmocological
Gabapentin NNP Pharmocological
Gabapentin NNP Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
oxazepam NN Pharmocological
( ( Pharmocological
active JJ Control
placebo NN Control
) ) Pharmocological
Gabapentin NNP Pharmocological
placebo NN Control
gabapentin-treated JJ Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
oxazepam NN Pharmocological
gabapentin NN Pharmocological
. . None
-DOCSTART- -X- N

tamoxifen NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

imidafenacin JJ Pharmocological
versus NN Pharmocological
fesoterodine NN Pharmocological
imidafenacin NN Pharmocological
fesoterodine NN Pharmocological
fesoterodine-controlled JJ Control
twice-daily JJ None
0.1 CD None
mg NN None
imidafenacin NN None
with IN None
placebo NN None
, , None
or CC None
4 CD None
mg NNS None
fesoterodine JJ None
with IN None
placebo NN None
were VBD None
non-inferior JJ None
to TO None
fesoterodine VB None
, , None
and CC None
CONCLUSIONS NNP None
Imidafenacin NNP None
was VBD None
non-inferior JJ None
to TO None
fesoterodine VB None
in IN None
terms NNS None
-DOCSTART- -X- N

haptic JJ Psychological
decomposition NN Psychological
of IN Psychological
complex JJ Psychological
movements NNS Psychological
robot-assisted JJ Educational
Training VBG Psychological
with IN Psychological
haptic JJ Psychological
guidance NN Psychological
haptic JJ Psychological
feedback NN Psychological
from IN Psychological
a DT Psychological
robotic JJ Psychological
exoskeleton NN Psychological
, , None
but CC None
experienced VBD None
the DT None
simpler NN None
, , None
anatomically-isolated JJ None
motions NNS None
-DOCSTART- -X- N

recombinant NN Pharmocological
adenoassociated VBN Pharmocological
vector NN Pharmocological
containing VBG Pharmocological
a DT Pharmocological
tumour JJ Pharmocological
necrosis NN Pharmocological
factor NN Pharmocological
alpha IN Pharmocological
antagonist JJ Pharmocological
gene NN Pharmocological
rAAV2-TNFR NN Pharmocological
: : Pharmocological
Fc NNP Pharmocological
, , Pharmocological
an DT Pharmocological
adenoassociated JJ Pharmocological
virus NN Pharmocological
serotype NN Pharmocological
2 CD Pharmocological
vector NN Pharmocological
containing VBG Pharmocological
the DT Pharmocological
cDNA NN Pharmocological
placebo-controlled JJ Control
rAAV2-TNFR NN Pharmocological
: : Pharmocological
Fc NN Pharmocological
or CC Control
placebo NN Control
-DOCSTART- -X- N

HPV16 NNP Physical
( ( Physical
and CC Physical
HPV18 NNP Physical
) ) Physical
-DOCSTART- -X- N

placebo JJ Psychological
placebo-informed JJ Psychological
instructions NNS Psychological
individuals NNS Psychological
informed VBD Psychological
of IN Psychological
the DT Psychological
placebo NN Psychological
) ) None
placebo-uninformed JJ Psychological
instructions NNS Psychological
individuals NNS Educational
informed VBD Educational
they PRP Educational
are VBP Educational
taking VBG Educational
an DT Educational
active JJ Educational
stimulant NN Educational
) ) Educational
caffeine NN Pharmocological
caffeine NN Pharmocological
-DOCSTART- -X- N

Ondansetron NNP Pharmocological
Ondansetron NNP Pharmocological
ondansetron NN Pharmocological
vs NN Pharmocological
placebo NN Control
. . None
ondansetron NN Pharmocological
ondansetron NN Pharmocological
-DOCSTART- -X- N

splinting VBG Physical
teeth NNS Physical
periodontal JJ Surgical
reconstructive JJ Surgical
surgery NN Surgical
splinted VBN Surgical
to TO Surgical
at IN Surgical
least JJS Surgical
two CD Surgical
rigid JJ Surgical
teeth NNS Surgical
before IN Surgical
surgery NN Surgical
splinted VBN Physical
at IN Physical
suture NN Physical
removal NN Physical
treated JJ Physical
teeth NNS Physical
were VBD Physical
not RB Physical
splinted VBN Physical
at IN Physical
all DT Physical
. . None
-DOCSTART- -X- N

Clobazam NNP Pharmocological
benzodiazepine NN Pharmocological
, , Pharmocological
clobazam NN Pharmocological
. . Pharmocological
placebo NN Control
clobazam NN Pharmocological
placebo VB Control
Clobazam NNP Pharmocological
-DOCSTART- -X- N

doxepin NN Pharmocological
bupropion NN Pharmocological
bupropion NN Pharmocological
doxepin VB Pharmocological
placebo NN Control
Doxepin NNP Pharmocological
bupropion NN Pharmocological
doxepin NN Pharmocological
bupropion NN Pharmocological
Doxepin NNP Pharmocological
bupropion NN Pharmocological
doxepin NN Pharmocological
bupropion NN Pharmocological
-DOCSTART- -X- N

captopril NN Pharmocological
enalapril NN Pharmocological
Captopril NNP Pharmocological
enalapril NNS Pharmocological
captopril NN Pharmocological
enalapril $ Pharmocological
Captopril NNP Pharmocological
placebo NN Control
. . None
Enalapril NNP Pharmocological
captopril JJ Pharmocological
enalapril NNS Pharmocological
captopril NN Pharmocological
enalapril NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
estrogen NN Pharmocological
transdermal JJ Pharmocological
estrogen NN Pharmocological
oral JJ Pharmocological
or CC Pharmocological
transdermal JJ Pharmocological
estrogen NN Pharmocological
estrogen NN Pharmocological
treatment NN None
transdermal JJ Pharmocological
treatment NN Pharmocological
. . None
estrogen NN Pharmocological
GH NNP Pharmocological
Oral JJ Pharmocological
estrogen NN Pharmocological
Estrogen NNP Pharmocological
replacement NN Pharmocological
-DOCSTART- -X- N

donepezil NN Pharmocological
placebo-controlled JJ Control
cholinesterase NN Pharmocological
inhibitors NNS Pharmocological
. . None
donepezil NN Pharmocological
donepezil JJ Pharmocological
donepezil $ Pharmocological
placebo NN Control
donepezil NN Pharmocological
placebo NN None
donepezil NN Pharmocological
donepezil VBZ Pharmocological
placebo NN None
donepezil JJ Pharmocological
Donepezil-treated JJ None
placebo NN None
donepezil NN None
donepezil VBZ None
Donepezil NNP None
( ( None
placebo NN None
donepezil CC None
donepezil CC None
placebo NN None
) ) None
-DOCSTART- -X- N

Human NNP Physical
recombinant JJ Physical
GM-CSF NNP Physical
for IN None
14 CD None
days NNS None
after IN None
allogeneic JJ None
matched VBD None
sibling VBG None
bone NN None
marrow NN None
transplantation NN None
. . None
GM NNP Physical
CSF NNP Physical
GM-CSF NNP Pharmocological
placebo NN Control
GM-CSF NNP Pharmocological
GM NNP Pharmocological
CSF NNP Pharmocological
-DOCSTART- -X- N

Left NNP Surgical
thoracoabdominal JJ Surgical
approach NN Surgical
abdominal-transhiatal JJ Surgical
approach NN Surgical
left JJ Surgical
thoracoabdominal JJ Surgical
approach NN Surgical
( ( Physical
LTA NNP Physical
) ) Physical
LTA NNP Surgical
with IN Surgical
the DT Surgical
abdominal-transhiatal JJ Surgical
approach NN Surgical
( ( Physical
TH NNP Physical
) ) Physical
in IN Physical
the DT Physical
treatment NN Physical
-DOCSTART- -X- N

Creon NNP Pharmocological
10,000 CD Pharmocological
Minimicrospheres NNP Pharmocological
vs. FW None
Creon NNP Pharmocological
8,000 CD Pharmocological
microspheres NNS Pharmocological
-- : None
an DT None
Creon NNP Pharmocological
10,000 CD Pharmocological
Minimicrospherestrade NNP Pharmocological
mark NN Pharmocological
( ( Pharmocological
Creon NNP Pharmocological
) ) Pharmocological
10,000 CD Pharmocological
MMS NNP Pharmocological
) ) Pharmocological
microspheres NNS Pharmocological
( ( Pharmocological
Creon NNP Pharmocological
) ) Pharmocological
8,000 CD Pharmocological
) ) Pharmocological
. . Pharmocological
28 CD None
days NNS None
of IN None
Creon NNP Pharmocological
8,000 CD Pharmocological
ms NN Pharmocological
followed VBN None
by IN None
28 CD None
days NNS None
of IN None
Creon NNP Pharmocological
10,000 CD Pharmocological
MMS NNP Pharmocological
, , None
or CC None
vice NN None
versa NN None
. . None
( ( None
Creon JJ Pharmocological
Creon NNP Pharmocological
-DOCSTART- -X- N

Stapled JJ None
mucosectomy NN None
conventional JJ None
haemorrhoidectomy NN None
. . None
Stapled NNP Surgical
mucosectomy NN Surgical
conventional JJ Physical
haemorrhoidectomy NN Physical
conventional JJ Surgical
procedure NN Surgical
conventional JJ Physical
Milligan-Morgan JJ Physical
haemorrhoidectomy NN Physical
and CC Physical
stapled VBD Physical
mucosectomy NN Physical
stapled VBN Educational
group NN Educational
conventional JJ Educational
group NN Educational
stapled VBN None
group NN None
Stapled VBD None
mucosectomy NN None
conventional JJ None
procedure NN None
. . None
-DOCSTART- -X- N

adjuvant VB Physical
therapy NN Physical
. . None
postoperative JJ Physical
radiotherapy NN Physical
with IN Pharmocological
50 CD Pharmocological
Gy NNP Pharmocological
cytotoxic JJ Pharmocological
therapy NN Pharmocological
( ( None
cyclophosphamide NN Pharmocological
, , Pharmocological
methotrexate NN Pharmocological
, , Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
) ) None
tamoxifen NN Pharmocological
. . None
Cytotoxic NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

acupuncture NN Physical
acupuncture NN Physical
acupuncture NN Pharmocological
at IN Pharmocological
Dicang NNP Pharmocological
( ( Pharmocological
ST NNP Pharmocological
4 CD Pharmocological
) ) Pharmocological
, , None
Jiache NNP Pharmocological
( ( Pharmocological
ST NNP Pharmocological
6 CD Pharmocological
) ) Pharmocological
, , None
Yangbai NNP Pharmocological
( ( Pharmocological
GB NNP Pharmocological
14 CD Pharmocological
) ) Pharmocological
, , None
etc. FW None
with IN Control
less JJR Control
than IN Control
4 CD Control
points NNS Control
selected VBN Control
on IN Control
the DT Control
face NN Control
and CC Control
with IN Control
shallow JJ Control
puncture NN Control
, , Control
and CC Control
10 CD Control
days NNS Control
later RB Control
electroacupuncture VBP Control
were VBD Control
added VBN Control
at IN Control
acupoints NNS Control
selected VBN Control
routinely RB Control
; : Control
the DT Control
control NN Control
group NN Control
were VBD Control
treated VBN Control
with IN Control
the DT Control
same JJ Control
methods NNS Control
as IN Control
the DT Control
treatment NN Control
group NN Control
but CC Control
acupuncture NN Control
was VBD Control
not RB Control
given VBN Control
at IN Control
the DT Control
acute JJ Control
stage NN Control
. . None
acupuncture NN Physical
-DOCSTART- -X- N

risperidone NN Pharmocological
plus CC Pharmocological
topiramate NN Pharmocological
topiramate NN Pharmocological
plus CC Pharmocological
risperidone NN Pharmocological
topiramate+risperidone VB Pharmocological
( ( None
Group NNP None
A NNP None
) ) None
or CC None
placebo+risperidone NN Pharmocological
( ( None
Group NNP None
B NNP None
) ) None
risperidone NN Pharmocological
topiramate NN Pharmocological
topiramate NN Pharmocological
topiramate NN Pharmocological
-DOCSTART- -X- N

Diclofenac NNP Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
( ( Pharmocological
NSAIDs NNP Pharmocological
) ) Pharmocological
diclofenac NN Pharmocological
or CC Pharmocological
placebo NN Control
diclofenac NN Pharmocological
placebo NN Control
placebo NN Control
diclofenac NN Pharmocological
Diclofenac NNP Pharmocological
-DOCSTART- -X- N

Radiotherapy NNP Pharmocological
CCNU NNP Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
1- JJ Pharmocological
( ( Pharmocological
2-chloroethyl JJ Pharmocological
) ) Pharmocological
-3-cyclohexyl-1-nitrosourea FW Pharmocological
CCNU NNP Pharmocological
) ) Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
plus CC Pharmocological
CCNU NNP Pharmocological
CCNU NNP Pharmocological
-DOCSTART- -X- N

xenogenic JJ Pharmocological
( ( Pharmocological
porcine NN Pharmocological
) ) Pharmocological
acellular NN Pharmocological
dermal JJ Pharmocological
matrix NN Pharmocological
xenogenic NNP Pharmocological
( ( Pharmocological
porcine NN Pharmocological
) ) Pharmocological
acellular NN Pharmocological
dermal JJ Pharmocological
matrix NN Pharmocological
xenogenic NNP Pharmocological
( ( Pharmocological
porcine NN Pharmocological
) ) Pharmocological
acellular NN Pharmocological
dermal JJ Pharmocological
matrix NN Pharmocological
-DOCSTART- -X- N

rofecoxib NN None
indomethacin NN None
indomethacin NN Pharmocological
COX-2 NNP Pharmocological
selective JJ Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
-- : None
has VBZ None
COX-2 NNP Pharmocological
selective NN Pharmocological
indomethacin NN Pharmocological
rofecoxib NN Pharmocological
rofecoxib NN Pharmocological
indomethacin NN Pharmocological
-DOCSTART- -X- N

continuous JJ Physical
glucose JJ Physical
monitoring NN Physical
( ( Physical
CGM NNP Physical
) ) Physical
-DOCSTART- -X- N

combined VBN Educational
treatment NN Educational
( ( Educational
COMB NNP Educational
) ) Educational
with IN None
risperidone NN Pharmocological
and CC Pharmocological
parent NN Pharmocological
training NN Pharmocological
( ( Pharmocological
PT NNP Pharmocological
) ) Pharmocological
risperidone JJ Pharmocological
monotherapy NN Pharmocological
aripiprazole VB Pharmocological
risperidone NN Pharmocological
COMB NNP Educational
Final NNP None
CONCLUSIONS NNP None
Medication NNP None
plus CC None
PT NNP None
-DOCSTART- -X- N

oral JJ Physical
hygiene NN Physical
measures NNS Physical
oral JJ Physical
hygiene NN Physical
measures NNS Physical
professional JJ Physical
mechanical JJ Physical
tooth-cleaning NN Physical
, , Educational
tongue-scraping NN Physical
, , Educational
chlorhexidine NN Control
treatment NN Control
, , Educational
and CC Educational
oral JJ Educational
hygiene NN Educational
instructions NNS Educational
oral JJ Educational
hygiene NN Educational
instructions NNS Educational
preventive JJ Educational
program NN Educational
provided VBN Educational
by IN Educational
the DT Educational
local JJ Educational
Dental NNP Educational
Health NNP Educational
Office NNP Educational
mechanical JJ Physical
plaque NN Physical
control NN Physical
topical JJ Pharmocological
use NN Pharmocological
of IN Pharmocological
fluorides NNS Pharmocological
and CC Pharmocological
chlorhexidine NN Pharmocological
-DOCSTART- -X- N

serum NN Physical
vancomycin NN Physical
concentration NN None
monitoring NN None
vancomycin NN Pharmocological
serum NN None
concentration NN None
monitoring NN None
control NN Control
group NN None
patient JJ None
follow-up NN None
by IN None
a DT None
clinical JJ None
pharmacist NN None
to TO None
obtain VB None
and CC None
pharmacokinetically RB None
interpret JJ None
serum NN None
vancomycin NN Physical
concentrations NNS None
for IN None
dosage NN None
individualization NN None
. . None
vancomycin JJ Pharmocological
vancomycin NN Pharmocological
vancomycin NN Pharmocological
-DOCSTART- -X- N

salbutamol NN Pharmocological
and CC Pharmocological
terbutaline NN Pharmocological
beta2-adrenergic JJ Pharmocological
salbutamol NN Pharmocological
inhaled VBN Pharmocological
terbutaline NN Pharmocological
. . None
salbutamol NN Pharmocological
terbutaline NN Pharmocological
salbutamol NN Pharmocological
terbutaline JJ Pharmocological
Acute NNP Pharmocological
salbutamol NN Pharmocological
and CC Pharmocological
terbutaline JJ Pharmocological
inhalation NN Pharmocological
-DOCSTART- -X- N

Photodynamic NNP Physical
therapy NN Physical
with IN None
5-aminolaevulinic JJ Pharmocological
acid NN Pharmocological
or CC None
placebo NN Control
Photodynamic NNP Pharmocological
therapy NN Pharmocological
( ( Pharmocological
PDT NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
topical JJ Pharmocological
5-aminolaevulinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ALA NNP Pharmocological
) ) Pharmocological
followed VBN Pharmocological
by IN Pharmocological
irradiation NN Pharmocological
with IN Pharmocological
incoherent JJ Pharmocological
light NN Pharmocological
( ( Pharmocological
ALA-PDT NNP Pharmocological
) ) Pharmocological
ALA-PDT NNP Pharmocological
or CC None
placebo-PDT JJ Control
interventions NNS None
combined VBN None
with IN None
standard JJ None
treatment NN None
encompassing VBG None
paring VBG None
followed VBN None
by IN None
a DT None
keratolytic JJ None
( ( None
Verucid NNP None
) ) None
. . None
ALA-PDT NNP Pharmocological
placebo-PDT NN Control
. . None
ALA-PDT NNP Pharmocological
ALA-PDT NNP Pharmocological
placebo-PDT JJ Control
ALA-PDT JJ Pharmocological
placebo-PDT JJ Control
placebo-PDT NN Control
-DOCSTART- -X- N

polymeric JJ Surgical
surgical JJ Surgical
sealant NN Surgical
( ( Surgical
CoSeal NNP Surgical
) ) Surgical
compared VBN None
to TO None
Gelfoam/thrombin NNP Surgical
for IN None
Each DT Surgical
treatment NN Surgical
was VBD Surgical
directly RB Surgical
applied VBN Surgical
to TO Surgical
the DT Surgical
suture NN Surgical
line NN Surgical
after IN Surgical
confirmation NN Surgical
of IN Surgical
anastomotic JJ Surgical
bleeding NN Surgical
. . Surgical
polymeric JJ Surgical
sealant NN Surgical
CoSeal NNP Surgical
polymeric JJ Surgical
sealant NN Surgical
-DOCSTART- -X- N

hydroxyzine NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
doxepin NN Pharmocological
at IN Pharmocological
night NN Pharmocological
, , None
pentoxifylline NN Pharmocological
, , None
indomethacin NN Pharmocological
and CC Pharmocological
topical JJ Pharmocological
moisturization NN Pharmocological
with IN Pharmocological
medium-strength JJ Pharmocological
topical JJ Pharmocological
steroids NNS Pharmocological
. . None
-DOCSTART- -X- N

schedules NNS Other
of IN Other
antenatal JJ Other
visits NNS Other
: : None
antenatal JJ Educational
care NN Educational
( ( Educational
traditional JJ Educational
care NN Educational
) ) Educational
( ( Educational
new JJ Educational
style NN Educational
care NN Educational
) ) Educational
antenatal JJ Educational
care NN Educational
antenatal JJ Educational
care NN Educational
visits NNS Other
reduced JJ Other
visit NN Other
schedules NNS Other
-DOCSTART- -X- N

Postal NNP Other
Group NNP Other
, , None
( ( None
2 CD None
) ) None
Telephone CD Other
Group NNP Other
, , None
and CC None
( ( None
3 CD None
) ) None
Face-to-face NN Other
Group NNP Other
. . None
mail NN Other
survey NN Other
-DOCSTART- -X- N

training NN Educational
strength NN Physical
aerobic JJ Pharmocological
( ( None
serial JJ Physical
CE NNP Physical
integrated VBN Physical
CE NNP Physical
) ) None
CE NNP Educational
program NN Educational
CE NNP Educational
training NN Educational
Integrated VBN Physical
CE NNP Physical
Integrated VBN Physical
CE NNP Physical
-DOCSTART- -X- N

nizatidine-controlled JJ Pharmocological
release NN Pharmocological
nizatidine NN Pharmocological
nizatidine NN Pharmocological
controlled VBN Pharmocological
release NN Pharmocological
( ( Pharmocological
CR NNP Pharmocological
) ) Pharmocological
nizatidine JJ Pharmocological
CR NNP Pharmocological
. . Pharmocological
single-blind JJ Pharmocological
placebo NN Pharmocological
baseline NN Pharmocological
was VBD Pharmocological
followed VBN Pharmocological
by IN Pharmocological
double-blind JJ Pharmocological
nizatidine JJ Pharmocological
CR NNP Pharmocological
( ( Pharmocological
150 CD Pharmocological
and CC Pharmocological
300 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
in IN Pharmocological
randomized VBN Pharmocological
sequence NN Pharmocological
, , Pharmocological
2 CD Pharmocological
to TO Pharmocological
5 CD Pharmocological
days NNS Pharmocological
apart RB Pharmocological
. . Pharmocological
Each DT Physical
dose NN Physical
was VBD Physical
followed VBN Physical
1 CD Physical
hour NN Physical
later RB Physical
by IN Physical
an DT Physical
egg-beater JJ Physical
meal NN Physical
, , Physical
labeled VBN Physical
with IN Physical
Tc99m NNP Physical
. . Physical
were VBD Physical
obtained VBN Physical
at IN Physical
meal JJ Physical
completion NN Physical
, , Physical
1- JJ Physical
, , Physical
2- JJ Physical
, , Physical
3- JJ Physical
and CC Physical
4-hour JJ Physical
postmeal NN Physical
. . Physical
placebo NN Control
nizatidine JJ Pharmocological
CR NNP Pharmocological
Nizatidine NNP Pharmocological
CR NNP Pharmocological
-DOCSTART- -X- N

sodium NN Pharmocological
( ( None
Na NNP None
) ) None
400 CD None
mmol/d NN None
Na NNP Pharmocological
as IN Pharmocological
the DT Pharmocological
chloride NN Pharmocological
salt NN Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
Na NNP Pharmocological
-DOCSTART- -X- N

Riluzole NNP Pharmocological
risperidone VB Pharmocological
placebo-controlled JJ Control
Riluzole NNP Pharmocological
riluzole NN Pharmocological
received VBD None
riluzole JJ None
( ( None
titrated VBN None
bodyweight NN None
) ) None
or CC None
placebo NN None
in IN None
addition NN None
to TO None
risperidone VB None
( ( None
titrated VBN None
by IN None
the DT None
riluzole-treated JJ None
with IN None
the DT None
placebo NN None
group NN None
the DT None
riluzole NN None
group NN None
the DT None
riluzole NN None
group NN None
placebo NN None
group NN None
the DT None
riluzole NN None
in IN None
the DT None
placebo NN None
Riluzole NNP None
add-on JJ None
add-on JJ None
to TO None
risperidone VB None
also RB None
-DOCSTART- -X- N

Dipyridamole NNP Pharmocological
dipyridamole NN Pharmocological
dipyridamole NN Pharmocological
modified JJ Pharmocological
release NN Pharmocological
dipyridamole NN Pharmocological
corresponding VBG None
placebo NN Control
conventional JJ Pharmocological
antianginal JJ Pharmocological
therapy NN Pharmocological
withdrawal NN Pharmocological
of IN Pharmocological
standard JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
calcium NN Pharmocological
antagonists NNS Pharmocological
and/or VBP Pharmocological
beta-blockers NNS Pharmocological
and/or JJ Pharmocological
long-acting JJ Pharmocological
( ( Pharmocological
prophylactic JJ Pharmocological
) ) Pharmocological
nitrates NNS Pharmocological
. . None
dipyridamole VB Pharmocological
placebo VB Control
dipyridamole NN None
-DOCSTART- -X- N

penbutolol NN Pharmocological
placebo NN Control
penbutolol NN Pharmocological
placebo VB Control
treated VBN None
with IN None
penbutolol NN Pharmocological
and CC None
placebo NN Control
for IN None
a DT None
period NN None
of IN None
three CD None
days NNS None
, , None
and CC None
then RB None
were VBD None
examined VBN None
with IN None
the DT None
help NN None
of IN None
the DT None
glucose-controlled JJ Physical
insulin NN Physical
infusion NN Physical
system NN Physical
. . None
-DOCSTART- -X- N

propranolol JJ Pharmocological
80 CD Pharmocological
mg NN Pharmocological
b.i.d. NN Pharmocological
atenolol RB Pharmocological
50 CD Pharmocological
mg NN Pharmocological
b.i.d NN Pharmocological
. . Pharmocological
and CC Control
placebo JJ Control
b.i.d NN Control
. . Control
propranolol NN Pharmocological
atenolol NN Pharmocological
placebo VB Control
Propranolol NNP Pharmocological
-DOCSTART- -X- N

antiepileptic JJ Pharmocological
drug NN Pharmocological
antiepileptic JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
AED NNP Pharmocological
) ) Pharmocological
treatment NN Pharmocological
implementation NN None
intention NN None
intervention NN None
self-administered JJ Educational
questionnaire NN Educational
intention NN None
of IN None
taking VBG None
medication NN None
with IN None
a DT None
particular JJ None
time NN None
, , None
place NN None
, , None
and CC None
other JJ None
activity NN None
AED NNP Pharmocological
Intervention NN None
intention NN Pharmocological
intervention NN Pharmocological
AED NNP Pharmocological
-DOCSTART- -X- N

Low JJ Physical
protein NN Physical
provision NN Physical
Low JJ Physical
protein NN Physical
low JJ Physical
protein NN Physical
provision NN Physical
low JJ Physical
protein NN Physical
( ( Physical
LP NNP Physical
) ) Physical
provision NN Physical
low JJ Physical
protein NNS Physical
in IN Physical
low JJ Physical
protein NN Physical
provision NN Physical
-DOCSTART- -X- N

Torasemide NNP Pharmocological
furosemide NN Pharmocological
torasemide NN Pharmocological
furosemide NN Pharmocological
spironolactone NN Pharmocological
torasemide NN Pharmocological
furosemide NN Pharmocological
. . None
Torasemide VB Pharmocological
furosemide NN Pharmocological
torasemide NN Pharmocological
torasemide NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Carbon NNP Pharmocological
dioxide NN Pharmocological
laser NN Pharmocological
treatment NN Pharmocological
carbon NN Pharmocological
dioxide NN Pharmocological
laser NN Pharmocological
did VBD Control
not RB Control
receive VB Control
any DT Control
specific JJ Control
treatment NN Control
carbon NN Pharmocological
dioxide NN Pharmocological
laser NN Pharmocological
-DOCSTART- -X- N

transdermal JJ Pharmocological
glyceryl NN Pharmocological
trinitrate NN Pharmocological
glyceryl JJ Pharmocological
trinitrate NN Pharmocological
placebo NN Control
patches NNS Control
glyceryl NN Pharmocological
trinitrate NN Pharmocological
placebo JJ Control
patches NNS Control
. . None
analgesics NNS None
. . None
-DOCSTART- -X- N

Topical JJ Pharmocological
PUVA NNP Pharmocological
, , Pharmocological
etretinate NN Pharmocological
combined VBN Pharmocological
PUVA NNP Pharmocological
and CC Pharmocological
etretinate VB Pharmocological
topical JJ Pharmocological
PUVA NNP Pharmocological
, , Pharmocological
oral JJ Pharmocological
etretinate NN Pharmocological
( ( Pharmocological
Re NNP Pharmocological
) ) Pharmocological
combined VBN Pharmocological
PUVA NNP Pharmocological
and CC Pharmocological
etretinate VB Pharmocological
( ( Pharmocological
Re-PUVA NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Dietary NNP Other
Approaches NNP Other
to TO Other
Stop VB Other
Hypertension NNP Other
( ( Other
DASH NNP Other
) ) Other
diet NN Other
reduced JJ Physical
sodium NN Physical
intake NN Physical
DASH NNP Educational
diet NN Educational
or CC None
a DT None
typical JJ Control
American NNP Control
( ( Control
control NN Control
) ) Control
diet NN Control
, , None
consuming VBG None
three CD None
different JJ None
sodium NN None
intakes NNS None
control/lower NN Control
sodium NN Control
diet NN Control
DASH/lower NNP Educational
sodium NN Educational
diet NN Educational
. . None
-DOCSTART- -X- N

Ligaclip NNP Surgical
lymphadenectomy NN Surgical
in IN None
1 CD None
side NN None
of IN None
the DT None
pelvis NN None
using VBG None
the DT None
Ligaclip NNP Surgical
bipolar JJ Surgical
coagulation NN Surgical
to TO Surgical
seal VB Surgical
lymphatic JJ Surgical
vessels NNS Surgical
-DOCSTART- -X- N

Antibiotic JJ Pharmocological
strategy NN Pharmocological
Empiric JJ Pharmocological
broad-spectrum JJ Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
antibiotic JJ Pharmocological
therapy NN Pharmocological
impact NN None
of IN None
a DT None
set NN None
of IN None
rules NNS None
that WDT None
evolved VBD None
during IN None
the DT None
first JJ None
randomized JJ None
trials NNS None
. . None
Evaluation NN None
of IN None
Treatment NNP None
was VBD None
modified VBN None
antibiotic JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

20 CD Pharmocological
ml NNS Pharmocological
of IN Pharmocological
bupivacaine NN Pharmocological
( ( Pharmocological
100 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
, , None
ropivacaine NN Pharmocological
( ( Pharmocological
150 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
saline JJ Pharmocological
as IN Pharmocological
control NN Pharmocological
group NN Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NN Pharmocological
10 CD Pharmocological
in IN Pharmocological
each DT Pharmocological
group NN Pharmocological
) ) Pharmocological
single JJ None
administration NN None
of IN None
plain JJ None
bupivacaine NN Pharmocological
( ( None
100 CD None
mg NN None
) ) None
and CC None
bupivacaine NN Pharmocological
( ( None
500 CD None
mg NN None
) ) None
-loaded VBD None
microspheres NNS None
. . None
morphine NN Pharmocological
. . None
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
. . None
ropivacaine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
anaesthetic-loaded JJ Pharmocological
microspheres NNS Pharmocological
-DOCSTART- -X- N

nonexercising JJ Control
control NN Control
group NN Control
, , Control
a DT Physical
cycle NN Physical
training NN Physical
group NN Physical
( ( Physical
cycle NN Physical
) ) Physical
, , Control
or CC Physical
one CD Physical
of IN Physical
the DT Physical
two CD Physical
HCT NNP Physical
groups NNS Physical
. . None
Training VBG Educational
groups NNS Educational
participated VBN Educational
in IN Educational
a DT Educational
9 CD Educational
wk NN Educational
program NN Educational
, , Educational
3 CD Educational
d.wk-1 NN Educational
. . None
Subjects NNS Physical
assigned VBD Physical
to TO Physical
HCT NNP Physical
exercised VBN Physical
on IN Physical
a DT Physical
9 CD Physical
station NN Physical
circuit NN Physical
, , Physical
completing VBG Physical
3 CD Physical
circuits.d-1 JJ Physical
. . None
-DOCSTART- -X- N

L-5-HTP NNP Physical
placebo NN Control
) ) None
] NN None
L-5-HTP NNP Physical
placebo NN Control
placebo NN Control
- : None
L-5-HTP NNP Pharmocological
L-5-HTP NNP Pharmocological
- : None
placebo NN Control
L-5-HTP NNP Physical
-DOCSTART- -X- N

5-aminosalicylic JJ Pharmocological
acid NN Pharmocological
prednisolone JJ Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
5-aminosalicylic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
5-ASA JJ Pharmocological
) ) Pharmocological
prednisolone NN Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
( ( Pharmocological
PP NNP Pharmocological
) ) Pharmocological
5-ASA JJ Pharmocological
PP NNP Pharmocological
-DOCSTART- -X- N

full JJ Physical
orthodontic JJ Physical
appliances NNS Physical
. . None
-DOCSTART- -X- N

S-1+paclitaxel JJ Pharmocological
S-1+cisplatin NNP Pharmocological
S-1 NNP Pharmocological
cisplatin NN Pharmocological
S-1+paclitaxel NNP Pharmocological
S-1+cisplatin NNP Pharmocological
S-1+cisplatin NNP Pharmocological
. . None
S-1+cisplatin NNP Pharmocological
. . None
S-1+paclitaxel NNP Pharmocological
non-platinum-based JJ None
regimen NNS None
-DOCSTART- -X- N

-DOCSTART- -X- N

cessation NN Pharmocological
interventions NNS Pharmocological
INDEPENDENT NNP None
VARIABLE NNP None
type NN None
of IN None
intervention NN None
. . None
Minimal NNP Pharmocological
Intervention NNP Pharmocological
Advanced NNP Pharmocological
Intervention NNP Pharmocological
-DOCSTART- -X- N

original JJ Other
Qigong NNP Other
massage NN Other
methodology NN Other
. . None
Cignolini NNP Other
methodology NN Other
, , Physical
an DT Physical
original JJ Other
Qigong NNP Other
massage NN Other
methodology NN Other
-DOCSTART- -X- N

psychotherapy NN Psychological
alone RB Psychological
, , None
drug NN Pharmocological
alone RB Pharmocological
, , None
psychotherapy JJ Psychological
plus CC Psychological
drug NN Psychological
, , None
electroconvulsive JJ Physical
therapy NN Physical
( ( Physical
ECT NNP Physical
, , Physical
and CC Physical
milieu NN Physical
. . None
-DOCSTART- -X- N

Carbenicillin-trimethoprim/sulfamethoxazole JJ Pharmocological
versus NN Pharmocological
carbenicillin-gentamicin NN Pharmocological
carbenicillin JJ Pharmocological
plus CC Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
( ( Pharmocological
C-T/S NNP Pharmocological
) ) Pharmocological
were VBD Pharmocological
compared VBN Pharmocological
to TO Pharmocological
those DT Pharmocological
obtained VBN Pharmocological
with IN Pharmocological
carbenicillin JJ Pharmocological
plus CC Pharmocological
gentamicin JJ Pharmocological
( ( Pharmocological
C-G NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

echocardiography NN Physical
at IN None
24-48 JJ None
hours NNS None
from IN None
symptom JJ None
onset NN None
-DOCSTART- -X- N

clinician JJ Other
feedback NN Other
patient JJ Educational
feedback NN Educational
a DT Other
letter NN Other
bimonthly JJ Other
telephone NN Other
call NN Other
to TO Educational
collect VB Educational
clinical JJ Educational
information NN Educational
about IN Educational
the DT Educational
child NN Educational
's POS Educational
asthma NN Educational
. . None
bimonthly RB Other
computer-generated JJ Other
letters NNS Other
Asthma NNP Pharmocological
medications NNS Pharmocological
control NN Control
Patient-specific JJ Other
feedback NN Other
-DOCSTART- -X- N

pulsed JJ Physical
Doppler NNP Physical
echocardiography NN Physical
] NNP None
Doppler NNP Physical
echocardiography NN Physical
pulsed JJ Physical
Doppler NNP Physical
-DOCSTART- -X- N

flurbiprofen JJ Pharmocological
sodium NN Pharmocological
0.03 CD Pharmocological
% NN Pharmocological
flurbiprofen NN Pharmocological
flurbiprofen NN Pharmocological
Flurbiprofen NNP Pharmocological
flurbiprofen NN Pharmocological
flurbiprofen NN Pharmocological
-DOCSTART- -X- N

Conservative NNP Pharmocological
fluid NN Pharmocological
management NN Pharmocological
mechanical JJ Physical
ventilation NN Physical
. . None
-DOCSTART- -X- N

cefotaxime NN Pharmocological
and CC None
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
or CC None
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole JJ Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
cefotaxime NN Pharmocological
cephamandole NN Pharmocological
. . None
cefotaxime JJ Pharmocological
-DOCSTART- -X- N

usual JJ Physical
pain NN Physical
management NN Physical
( ( Physical
n JJ Physical
= NNP Physical
132 CD Physical
) ) Physical
was VBD Physical
compared VBN Physical
to TO Physical
a DT Physical
multifactorial JJ Physical
strategy NN Physical
( ( Physical
n JJ Physical
= NNP Physical
107 CD Physical
) ) Physical
associating VBG Physical
preliminary JJ Physical
application NN Physical
of IN Physical
an DT Physical
anesthesic JJ Physical
patch NN Physical
, , Physical
preferential JJ Physical
use NN Physical
of IN Physical
specified JJ Physical
vaccines NNS Physical
, , None
child JJ Educational
education NN Educational
by IN Educational
the DT Educational
parents NNS Educational
and CC Educational
the DT Educational
doctor NN Educational
, , Educational
parental JJ Educational
accompaniment NN Educational
and CC Educational
child JJ Educational
distraction NN Educational
with IN Educational
soap NN Educational
bubbles NNS Educational
during IN Educational
the DT Educational
procedure NN Educational
. . None
-DOCSTART- -X- N

occupational JJ Educational
physiotherapy JJ Psychological
specialist JJ Psychological
therapy NN Psychological
-DOCSTART- -X- N

brief NN Psychological
alcohol NN Psychological
interventions NNS Psychological
brief VB Psychological
intervention NN Psychological
or CC Pharmocological
treatment NN Control
as IN Control
usual JJ Control
. . None
-DOCSTART- -X- N

Nizatidine NNP Pharmocological
ranitidine NN Pharmocological
nizatidine NN Pharmocological
ranitidine NN Pharmocological
nizatidine VB Pharmocological
300 CD Pharmocological
mg NN Pharmocological
nocte NN Pharmocological
, , Pharmocological
150 CD Pharmocological
mg NN Pharmocological
b.d NN Pharmocological
. . Pharmocological
or CC Pharmocological
ranitidine VB Pharmocological
150 CD Pharmocological
mg NN Pharmocological
nizatidine VB Pharmocological
300 CD Pharmocological
mg JJ Pharmocological
nocte NN Pharmocological
or CC Pharmocological
ranitidine VB Pharmocological
300 CD Pharmocological
mg NN Pharmocological
nocte NN Pharmocological
. . Pharmocological
Nizatidine NNP Pharmocological
ranitidine NN Pharmocological
-DOCSTART- -X- N

regular JJ Physical
health NN Physical
checks NNS Physical
to TO None
health NN Physical
checks NNS Physical
control NN Control
intervention NN None
health NN Physical
check NN Physical
which WDT Physical
included VBD Physical
being VBG Physical
screened VBN Physical
for IN Physical
cardiovascular JJ Physical
risk NN Physical
factors NNS Physical
, , Physical
lung NN Physical
and CC Physical
liver NN Physical
function NN Physical
, , Physical
fitness NN Physical
, , Physical
sight NN Physical
and CC Physical
hearing NN Physical
and CC Physical
an DT Physical
optional JJ Physical
test NN Physical
for IN Physical
the DT Physical
human JJ Physical
immunodeficiency NN Physical
virus NN Physical
( ( Physical
HIV NNP Physical
) ) Physical
; : Physical
this DT Physical
group NN Physical
received VBD Physical
written VBN Physical
feedback RB Physical
from IN Physical
the DT Physical
general JJ Physical
practitioner NN Physical
. . Physical
health NN Physical
check NN Physical
and CC Physical
written VBN Other
feedback NN Other
; : Physical
in IN Physical
addition NN Physical
, , Physical
they PRP Physical
were VBD Physical
given VBN Physical
the DT Physical
opportunity NN Physical
to TO Physical
attend VB Physical
their PRP$ Physical
general JJ Physical
practitioner NN Physical
to TO Physical
discuss VB Physical
preventive JJ Physical
health NN Physical
. . Physical
health NN Physical
checks NNS Physical
-DOCSTART- -X- N

vincristine NN Pharmocological
, , Pharmocological
corticosteroids NNS Pharmocological
, , Pharmocological
and CC Pharmocological
anthracyclines NNS Pharmocological
intensified VBN Pharmocological
with IN Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
asparaginase NN Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
. . None
cytarabine JJ Pharmocological
mitoxantrone NN Pharmocological
4-drug JJ Pharmocological
induction NN Pharmocological
( ( Pharmocological
the DT Pharmocological
L-20 NNP Pharmocological
regimen NNS Pharmocological
) ) Pharmocological
. . Pharmocological
consolidation NN Pharmocological
, , Pharmocological
maintenance NN Pharmocological
therapy NN Pharmocological
, , Pharmocological
and CC Pharmocological
central JJ Pharmocological
nervous JJ Pharmocological
system NN Pharmocological
prophylaxis NN Pharmocological
. . None
-DOCSTART- -X- N

Simvastatin JJ Pharmocological
statins NNS Pharmocological
placebo-controlled JJ Control
simvastatin NN Pharmocological
or CC None
placebo NN Control
Statin NNP Pharmocological
simvastatin NN Pharmocological
Simvastatin NNP Pharmocological
-DOCSTART- -X- N

FRF NNP Physical
model NN Physical
functional JJ Physical
( ( Physical
f JJ Physical
) ) Physical
MRI-adaptation NN Physical
protocol NN Physical
-DOCSTART- -X- N

sumatriptan VB Pharmocological
5-HT1d JJ Pharmocological
receptor NN Pharmocological
agonist NN Pharmocological
sumatriptan NN Pharmocological
single JJ Pharmocological
dose JJ Pharmocological
sumatriptan NN Pharmocological
( ( Pharmocological
6 CD Pharmocological
mg RB Pharmocological
SQ NNP Pharmocological
) ) Pharmocological
and CC None
placebo NN Control
challenges NNS Control
, , None
separated VBN None
by IN None
a DT None
1-week JJ None
interval NN None
, , None
and CC None
was VBD Pharmocological
measured VBN Pharmocological
before IN Pharmocological
and CC Pharmocological
during IN Pharmocological
the DT Pharmocological
challenges NNS Pharmocological
. . None
sumatriptan VB Pharmocological
-DOCSTART- -X- N

horizontally RB Other
moving VBG Other
sound NN Other
500-Hz JJ Other
low-pass JJ Other
noise NN Other
or CC None
a DT None
6300-Hz JJ Other
high-pass NN Other
noise NN Other
moving NN Other
probe NN Other
-DOCSTART- -X- N

angiotensin NN Pharmocological
II NNP Pharmocological
antagonism NN Pharmocological
antagonistic JJ Pharmocological
agonistic JJ Pharmocological
saralasin NN Pharmocological
renin-angiotensin JJ Pharmocological
axis NN Pharmocological
-DOCSTART- -X- N

randomly RB None
allocated VBN None
to TO None
the DT None
intervention NN None
condition NN None
and CC None
all DT None
remaining VBG None
students NNS None
were VBD None
either RB None
allocated VBN None
to TO None
the DT None
no-intervention JJ None
peer NN None
or CC None
no-intervention JJ None
non-peer JJ None
condition NN None
. . None
-DOCSTART- -X- N

versus JJ Surgical
conventional JJ Physical
hybrid JJ Surgical
prosthesis NN Surgical
. . Surgical
MOM NNP Physical
hip NN Physical
resurfacing VBG Physical
system NN Physical
( ( Physical
ReCap NNP Physical
) ) Physical
standard JJ Physical
MOP NNP Physical
total JJ Physical
hip NN Physical
arthoplasty NN Physical
( ( Physical
Mallory NNP Physical
Head/Exeter NNP Physical
) ) Physical
. . Surgical
MOM NNP Physical
MOM NNP Physical
-DOCSTART- -X- N

bupivacaine NN Pharmocological
sufentanil NN Pharmocological
: : None
combined VBN None
spinal-epidural JJ Pharmocological
vs. FW Pharmocological
epidural JJ Pharmocological
initiated VBN None
with IN None
intrathecal JJ None
bupivacaine NN Pharmocological
0.25 CD Pharmocological
% NN Pharmocological
1 CD Pharmocological
mL NN Pharmocological
+ NNP None
sufentanil VBD Pharmocological
5 CD Pharmocological
microg NN Pharmocological
in IN None
the DT None
combined JJ None
spinal-epidural JJ None
group NN None
( ( None
n JJ None
= NNP None
54 CD None
) ) None
, , None
and CC None
with IN None
bupivacaine JJ Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
+ JJ None
epinephrine NN Pharmocological
2.5 CD Pharmocological
microg NN Pharmocological
mL NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
+ VBD None
sufentanil $ Pharmocological
7.5 CD Pharmocological
microg NN Pharmocological
in IN None
the DT None
epidural JJ None
group NN None
( ( None
n JJ None
= NNP None
59 CD None
) ) None
. . None
In IN Pharmocological
both DT Pharmocological
cases NNS Pharmocological
this DT Pharmocological
was VBD Pharmocological
followed VBN Pharmocological
by IN Pharmocological
patient-controlled JJ Pharmocological
epidural JJ Pharmocological
analgesia NN Pharmocological
with IN Pharmocological
bupivacaine JJ Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
( ( None
+ JJ None
sufentanil NN Pharmocological
0.25 CD Pharmocological
microg NN Pharmocological
mL NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
digoxin NN Pharmocological
given VBN Educational
postcards NNS Educational
at IN Educational
their PRP$ Educational
final JJ Educational
study NN Educational
visit NN Educational
to TO Educational
be VB Educational
completed VBN Educational
and CC Educational
mailed VBN Educational
on IN Educational
or CC Educational
after IN Educational
January NNP Educational
1 CD Educational
, , Educational
1996 CD Educational
. . None
-DOCSTART- -X- N

dietary JJ Pharmocological
threonine NN Pharmocological
and CC None
purified JJ Pharmocological
fiber NN Pharmocological
supplemental JJ Pharmocological
dietary JJ Pharmocological
Thr NNP Pharmocological
and CC None
purified VBD Pharmocological
fiber NN Pharmocological
Thr-deficient JJ Pharmocological
basal NN Pharmocological
70 CD Control
g/kg NN Control
of IN Control
silica NN Control
sand NN Control
( ( Control
control NN Control
) ) Control
or CC None
high-methoxy JJ Pharmocological
pectin NN Pharmocological
and CC Pharmocological
1 CD Pharmocological
of IN Pharmocological
2 CD Pharmocological
concentrations NNS Pharmocological
of IN Pharmocological
Thr NNP Pharmocological
0.5 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
distilled JJ Pharmocological
water NN Pharmocological
or CC None
an DT None
acute JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
Eimeria NNP Pharmocological
maxima NNP Pharmocological
infection NN None
or CC None
Thr NNP None
supplementation NN None
for IN None
-DOCSTART- -X- N

rocuronium NN Pharmocological
N2O/O2-fentanyl NNP Pharmocological
or CC Pharmocological
N2O/O2-sevoflurane NNP Pharmocological
( ( None
one CD None
MAC NNP None
) ) None
anesthesia NN None
. . None
electromyographically RB Physical
. . None
rocuronium NN Pharmocological
-DOCSTART- -X- N

Home NNP Physical
monitoring NN Physical
: : None
Home NNP Physical
blood NN Physical
pressure NN Physical
monitoring NN Physical
home NN Educational
blood NN Educational
pressure NN Educational
monitoring NN Educational
home NN Physical
monitoring NN Physical
Home NNP Physical
blood NN Physical
pressure NN Physical
monitoring NN Physical
non-pharmacologic JJ Physical
means NNS Physical
. . None
-DOCSTART- -X- N

sound-producing JJ Other
voice NN Other
prosthesis NN Other
. . None
pneumatic JJ Other
sound NN Other
source NN Other
sound-producing JJ Other
voice NN Other
prosthesis NN Other
-DOCSTART- -X- N

community NN Educational
pharmacists NNS Educational
intensive JJ Educational
skill NN Educational
development NN Educational
program NN Educational
community NN Educational
pharmacists VBZ Educational
-DOCSTART- -X- N

Thrombolysis NN Pharmocological
thrombolysis NN Pharmocological
-DOCSTART- -X- N

placebo NN Control
citalopram NN Pharmocological
hydrobromide NN Pharmocological
citalopram VB Pharmocological
placebo NN Control
citalopram NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

cutting VBG Surgical
balloon NN Surgical
angioplasty JJ Surgical
high-pressure NN Surgical
balloon NN Surgical
angioplasty NN Surgical
cutting VBG Surgical
balloon NN Surgical
angioplasty NN Surgical
( ( Surgical
CBA NNP Surgical
) ) Surgical
versus IN Surgical
high-pressure NN Surgical
balloon NN Surgical
angioplasty NN Surgical
( ( Surgical
HPBA NNP Surgical
) ) Surgical
CBA NNP Surgical
HPBA NNP Surgical
CBA NNP Physical
CBA NNP Physical
HPBA NNP Physical
CBA NNP Physical
HPBA NNP Physical
CBA NNP Physical
. . None
HPBA NNP Physical
CBA NNP Physical
HPBA NNP Physical
CBA NNP Physical
-DOCSTART- -X- N

calcium NN Pharmocological
hydroxide NN Pharmocological
sealers NNS Pharmocological
. . None
apical JJ Physical
seal NN Physical
root NN Pharmocological
canal JJ Pharmocological
sealers NNS Pharmocological
. . None
gutta-percha JJ Pharmocological
sealers NNS Physical
canal NN Physical
was VBD Physical
filled VBN Physical
with IN Physical
gutta-percha JJ Physical
along IN Physical
with IN Physical
either DT Physical
Roth NNP Physical
's POS Physical
sealer NN Physical
, , Physical
AH26 NNP Physical
, , Physical
Sealapex NNP Physical
, , Physical
CRCS NNP Physical
, , Physical
or CC Physical
Nogenol NNP Physical
sealer NN Physical
, , Physical
respectively RB Physical
. . None
filled VBN Control
with IN Control
gutta-percha JJ Control
and CC Control
without IN Control
sealer NN Control
to TO None
serve VB None
as IN None
a DT None
control NN None
. . None
amalgam NN Pharmocological
. . None
-DOCSTART- -X- N

skeletal JJ Physical
myoblast NN Physical
implantation NN Physical
myoblasts NNS Physical
placebo NN Control
myoblasts NNS Pharmocological
placebo NN Control
myoblast-treated JJ Pharmocological
placebo NN Control
myoblast-treated JJ Pharmocological
myoblasts NNS None
myoblast JJ None
myoblast JJ None
-DOCSTART- -X- N

syncope NN Physical
unit NN Physical
evaluation NN Physical
and CC None
standard NN Control
care NN Control
. . None
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
curative JJ Surgical
resection NN Surgical
Adjuvant NNP Pharmocological
locoregional JJ Pharmocological
chemotherapy NN Pharmocological
cisplatin/lipiodol NN Pharmocological
Adjuvant NNP Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

auditory JJ Educational
selective JJ Educational
attention NN Educational
task NN Educational
( ( Educational
SAT NNP Educational
) ) Educational
-DOCSTART- -X- N

trial-and-error JJ Educational
discrimination NN Educational
task NN Educational
two CD Educational
, , Educational
two-element JJ Educational
stimuli NNS Educational
over-selected JJ Educational
-DOCSTART- -X- N

cyclosporin VB Pharmocological
A DT Pharmocological
or CC None
methotrexate NN Pharmocological
cyclosporin VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CSA NNP Pharmocological
) ) Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
CSA NNP Pharmocological
and CC None
MTX NNP Pharmocological
in IN None
combination NN None
single-agent JJ None
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
MTX NNP Pharmocological
CSA NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
. . Pharmocological
-DOCSTART- -X- N

maintenance NN None
treatment NN None
regimens NNS None
either DT None
induction NN Physical
intrathecal JJ Physical
chemotherapy NN Physical
( ( Pharmocological
ITC NNP Pharmocological
) ) Pharmocological
and CC None
cranial JJ Physical
irradiation NN Physical
( ( Physical
CRT NNP Physical
) ) Physical
plus CC Pharmocological
maintenance NN Physical
ITC NNP Physical
, , None
or CC None
induction NN Physical
ITC NNP Physical
and CC Pharmocological
craniospinal JJ Pharmocological
irradiation NN Pharmocological
( ( Pharmocological
CSpRT NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
no DT Pharmocological
maintenance NN Pharmocological
ITC NNP Pharmocological
. . None
methotrexate NN Pharmocological
, , None
hydrocortisone NN Pharmocological
, , None
and CC None
arabinosylcytosine NN Pharmocological
. . None
intensification NN Physical
of IN Physical
systemic JJ Physical
induction NN Physical
and CC None
maintenance NN Physical
chemotherapy NN Physical
CRT NNP Physical
+ NNP Pharmocological
ITC NNP Physical
CRT NNP Physical
ITC NNP Physical
Craniospinal JJ Physical
irradiation NN Physical
consisted VBD Physical
of IN Physical
CRT NNP Physical
-DOCSTART- -X- N

ziprasidone NN Pharmocological
: : None
placebo-controlled JJ Control
ziprasidone NN Pharmocological
or CC None
placebo NN Pharmocological
-DOCSTART- -X- N

person-centred JJ Educational
dementia NN Educational
care NN Educational
Dementia NNP Educational
Care NNP Educational
Mapping NNP Educational
( ( Educational
DCM NNP Educational
) ) Educational
VIPS NNP Educational
practice NN Educational
model NN Educational
( ( Educational
VPM NNP Educational
) ) Educational
dementia NN None
DCM NNP Educational
VPM NNP Educational
-DOCSTART- -X- N

Oral JJ Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
sildenafil NN Pharmocological
-DOCSTART- -X- N

either DT None
conventional JJ Control
chemotherapy NN Control
with IN Control
CEOP-Bleo NNP Control
( ( Control
cyclophosphamide VB Control
750 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
vincristine JJ Control
1.4 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
prednisone RB Control
40 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
epirubicin $ Control
70 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
, , Control
and CC Control
bleomycin $ Control
10 CD Control
mg/m NN Control
( ( Control
2 CD Control
) ) Control
) ) Control
or CC None
mega JJ Pharmocological
CEOP-Bleo NNP Pharmocological
( ( Pharmocological
cyclophosphamide JJ Pharmocological
1000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
, , Pharmocological
epirubicin $ Pharmocological
120 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
prednisone NN Pharmocological
, , Pharmocological
and CC Pharmocological
bleomycin NN Pharmocological
at IN Pharmocological
the DT Pharmocological
same JJ Pharmocological
doses NNS Pharmocological
) ) Pharmocological
every DT None
21 CD None
days NNS None
for IN None
six CD None
cycles NNS None
, , None
followed VBN None
by IN None
radiotherapy NN Physical
to TO Physical
the DT Physical
mediastinum NN Physical
with IN Physical
the DT Physical
mantle NN Physical
technique NN Physical
( ( Physical
35-45 JJ Physical
Gy NNP Physical
, , Physical
mean VBP Physical
38 CD Physical
Gy NNP Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
, , Pharmocological
adriamycin NN Pharmocological
, , Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
CAF NNP Pharmocological
) ) Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
Adriamycin NNP Pharmocological
( ( Pharmocological
doxorubicin NN Pharmocological
) ) Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
CAF NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

collaborative JJ Other
care NN Other
PD NNP Pharmocological
pharmacotherapy NN Pharmocological
embedded VBD None
in IN None
a DT None
disease NN None
management NN None
framework NN None
of IN None
collaborative JJ None
care NN None
( ( None
CC NNP None
) ) None
. . None
CC NNP Educational
usual JJ None
care NN None
( ( None
UC NNP None
) ) None
. . None
educational JJ Educational
videotapes NNS Educational
and CC Educational
pamphlets NNS Educational
; : None
pharmacotherapy NN Pharmocological
with IN Pharmocological
the DT Pharmocological
selective JJ Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
paroxetine NN Pharmocological
; : None
2 CD Educational
psychiatrist NN Educational
visits NNS Educational
and CC None
2 CD None
telephone NN None
calls NNS None
telephone NN None
calls NNS None
-DOCSTART- -X- N

formoterol NN Pharmocological
salbutamol JJ Pharmocological
formoterol NN Pharmocological
salbutamol NN Pharmocological
formoterol NN Pharmocological
formoterol NN Pharmocological
9 CD Pharmocological
microg NN Pharmocological
or CC None
salbutamol VB Pharmocological
100 CD Pharmocological
microg NN Pharmocological
( ( Pharmocological
group NN Pharmocological
A NNP Pharmocological
) ) Pharmocological
or CC None
formoterol $ Pharmocological
18 CD Pharmocological
microg NN Pharmocological
or CC None
salbutamol VB Pharmocological
200 CD Pharmocological
microg NN Pharmocological
( ( None
group NN None
B NNP None
) ) None
. . None
Formoterol NNP Pharmocological
salbutamol NN Pharmocological
-DOCSTART- -X- N

amantadine NN Pharmocological
and CC None
desipramine NN Pharmocological
psychotherapy NN Psychological
placebo-controlled JJ Control
desipramine JJ Pharmocological
hydrochloride NN Pharmocological
and CC None
amantadine JJ Pharmocological
hydrochloride NN Pharmocological
desipramine NN Pharmocological
amantadine-placebo JJ Pharmocological
placebo NN Control
desipramine NN Pharmocological
desipramine NN Pharmocological
desipramine NN Pharmocological
-DOCSTART- -X- N

dorsal NN Physical
and CC Physical
volar JJ Physical
resting NN Physical
hand NN Physical
splints NNS Physical
dorsal NN Physical
and CC Physical
volar JJ Physical
resting NN Physical
hand NN Physical
splints NNS Physical
dorsal NN Physical
splints NNS Physical
volar JJ Physical
splints NNS Physical
. . None
volar NN Physical
and CC Physical
dorsal NN Physical
splints NNS Physical
-DOCSTART- -X- N

ketazolam NN Pharmocological
, , None
diazepam NN Pharmocological
and CC None
placebo NN Control
ketazolam NNP Pharmocological
diazepam NN Pharmocological
and CC None
placebo VB Control
diazepam JJ Pharmocological
ketazolam NN Pharmocological
-DOCSTART- -X- N

Ketoconazole NNP Pharmocological
tretinoin CC Pharmocological
cream NN Pharmocological
Adapalene NNP Pharmocological
gel NN Pharmocological
adapalene NN Pharmocological
gel NN Pharmocological
adapalene NN Pharmocological
gel NN Pharmocological
adapalene JJ Pharmocological
gel NNS Pharmocological
and CC None
2 CD Pharmocological
% NN Pharmocological
ketoconazole JJ Pharmocological
cream NN Pharmocological
2 CD Pharmocological
% NN Pharmocological
ketoconazole JJ Pharmocological
cream NN Pharmocological
adapalene JJ Pharmocological
gel NN Pharmocological
Adapalene NNP Pharmocological
adapalene NN Pharmocological
-DOCSTART- -X- N

topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
( ( Pharmocological
pennsaid NN Pharmocological
) ) Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
plus CC None
placebo JJ Control
oral JJ Control
capsules NNS Control
placebo VB Control
topical JJ Control
solution NN Control
plus CC None
oral JJ Pharmocological
diclofenac NN Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
topical JJ Pharmocological
diclofenac NN Pharmocological
solution NN Pharmocological
oral JJ Pharmocological
diclofenac NN Pharmocological
-DOCSTART- -X- N

school NN Educational
dental JJ Educational
screening VBG Educational
programme NN Educational
school NN None
dental JJ None
screening NN None
programme NN None
school NN Educational
dental JJ Educational
screening NN Educational
standard JJ Educational
school NN Educational
dental JJ Educational
screening NN Educational
group NN Educational
children NNS Educational
were VBD Educational
not RB Educational
, , Educational
at IN Educational
this DT Educational
stage NN Educational
, , Educational
screened VBD Educational
same JJ None
questionnaire NN None
assessing VBG None
over IN None
the DT None
2-month JJ None
period NN None
. . None
control NN None
-DOCSTART- -X- N

Palliative JJ Physical
brachytherapy NN Physical
with IN Surgical
or CC Surgical
without IN Surgical
primary JJ Surgical
stent JJ Surgical
placement NN Surgical
combination NN Physical
of IN Physical
self-expanding JJ Surgical
metal NN Surgical
stent NN Surgical
( ( Surgical
SEMS NNP Surgical
) ) Surgical
and CC Physical
brachytherapy NN Physical
SEMS NNP None
followed VBN None
by IN None
brachytherapy NN None
, , None
8 CD None
Gy?3 NNP None
( ( None
n=21 NN None
) ) None
or CC None
brachytherapy VB None
alone RB None
, , None
8 CD None
Gy?3 NNP None
( ( None
receiving VBG None
SEMS NNP None
followed VBN None
by IN None
brachytherapy NN None
had VBD None
receiving VBG None
brachytherapy NN None
alone RB None
( ( None
dysphagia NN None
, , None
SEMS NNP None
followed VBN None
brachytherapy NN None
is VBZ None
while IN None
brachytherapy NN None
with IN None
or CC None
without IN None
preceding VBG None
SEMS NNP None
provides VBZ None
-DOCSTART- -X- N

carbamazepine VB Pharmocological
sustained-release JJ Pharmocological
morphine NN Pharmocological
carbamazepine NN Pharmocological
( ( Pharmocological
CMZ NNP Pharmocological
) ) Pharmocological
opioids NNS Pharmocological
placebo-controlled JJ Control
CMZ NNP Pharmocological
( ( Pharmocological
600 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
CMZ NNP Pharmocological
sustained-release JJ Pharmocological
morphine NN Pharmocological
( ( Pharmocological
90 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
SCS NNP Pharmocological
. . Pharmocological
CMZ NNP None
placebo NN None
morphine NN Pharmocological
CMZ JJ None
morphine NN None
SCS NNP None
. . None
CMZ NNP Pharmocological
Morphine NNP None
-DOCSTART- -X- N

atropine NN Pharmocological
and CC None
metoclopramide NN Pharmocological
atropine NN Pharmocological
and CC Pharmocological
metoclopramide NN Pharmocological
Atropine NNP Pharmocological
Metoclopramide NNP Pharmocological
atropine NN Pharmocological
-DOCSTART- -X- N

dan NN Pharmocological
shao NN Pharmocological
tang NN Pharmocological
Dan NNP Pharmocological
Shao NNP Pharmocological
Tang NNP Pharmocological
( ( Pharmocological
DST NNP Pharmocological
) ) Pharmocological
DST NNP Pharmocological
and CC None
western JJ Pharmocological
medicine NN Pharmocological
only RB None
with IN Pharmocological
western JJ Pharmocological
medicine NN Pharmocological
. . None
DST NNP Pharmocological
-DOCSTART- -X- N

estramustine JJ Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
Estracyt NNP Pharmocological
) ) Pharmocological
or CC None
conventional JJ Pharmocological
estrogen NN Pharmocological
. . None
-DOCSTART- -X- N

clinical JJ Educational
pharmacy NN Educational
services NNS Educational
clinical JJ Educational
pharmacist NN Educational
received VBD Educational
clinical JJ Educational
pharmacy NN Educational
services NNS Educational
that WDT Educational
included VBD Educational
a DT Educational
clinical JJ Educational
pharmacist NN Educational
performing VBG Educational
patient JJ Educational
medication NN Educational
reviews NNS Educational
, , Educational
with IN Educational
emphasis NN Educational
on IN Educational
preventing VBG Educational
or CC Educational
resolving VBG Educational
medication-related JJ Educational
problems NNS Educational
and CC Educational
providing VBG Educational
medication NN Educational
recommendations NNS Educational
. . Educational
received VBD Educational
routine JJ Control
clinic NN Control
services NNS Control
, , Educational
but CC Educational
had VBD Educational
no DT Control
clinical JJ Control
pharmacist NN Control
interaction NN Control
. . Educational
-DOCSTART- -X- N

Recombinant NNP Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
administered VBN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NN Pharmocological
Radioiodine NNP Pharmocological
WBS NNP Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
administration NN Pharmocological
thyroid JJ Pharmocological
hormone NN Pharmocological
therapy NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
thyroid JJ Pharmocological
hormone NN Pharmocological
withdrawal NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
TSH NNP Pharmocological
administration NN Pharmocological
-DOCSTART- -X- N

standard JJ Educational
direct-mailed JJ Educational
procedures NNS Educational
( ( Educational
X1 NNP Educational
) ) Educational
, , Educational
X1 NNP Educational
plus CC Educational
culturally RB Educational
tailored JJ Educational
materials NNS Educational
( ( Educational
X2 NNP Educational
) ) Educational
X2 NNP Educational
plus CC Educational
interpersonal JJ Educational
phone NN Educational
contact NN Educational
( ( Educational
X3 NNP Educational
) ) Educational
Interpersonal NNP Educational
communication NN Educational
-DOCSTART- -X- N

HOXB13 NNP Physical
G84E NNP Physical
mutation NN Physical
G84E NNP Physical
in IN Physical
HOXB13 NNP Physical
G84E NNP Physical
mutation NN Physical
Genotyping VBG Physical
-DOCSTART- -X- N

indobufen NN Pharmocological
( ( Pharmocological
K NNP Pharmocological
3920 CD Pharmocological
) ) Pharmocological
. . Pharmocological
indobufen NN Pharmocological
indobufen NN Pharmocological
Indobufen NNP Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
control NN Control
chemotherapy NN Pharmocological
Vincristine NNP Pharmocological
1 CD None
mg NN None
, , None
cyclophosphamide RB Pharmocological
600 CD None
mg NNS None
and CC None
5-fluorouracil JJ Pharmocological
500 CD None
mg NN None
IV NNP None
Pingyangmycin NNP Pharmocological
Bleomycin NNP Pharmocological
A5 NNP Pharmocological
chemotherapy NN Pharmocological
surgical JJ Surgical
resection NN Surgical
chemotherapy NN Pharmocological
. . None
chemotherapy NN None
chemotherapy NN Pharmocological
-DOCSTART- -X- N

biofeedback NN Psychological
treatment NN Psychological
biofeedback NN Psychological
treatment NN Psychological
( ( Psychological
BF NNP Psychological
) ) Psychological
BF NNP Psychological
group NN None
B NNP None
visited VBD Other
the DT Other
clinic NN Other
only RB None
BF NNP Other
. . None
BF NNP Other
. . None
BF NNP None
BF NNP Other
-DOCSTART- -X- N

paromomycin NN Pharmocological
placebo-controlled JJ Control
paromomycin NN Pharmocological
sulfate NN Pharmocological
placebo NN Pharmocological
paromomycin NN Pharmocological
placebo NN Control
paromomycin NN Pharmocological
placebo NN Control
paromomycin NN Pharmocological
placebo NN Control
paromomycin JJ Pharmocological
paromomycin NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
fluconazole JJ Pharmocological
fluconazole NN Pharmocological
or CC None
placebo NN Control
fluconazole NN Pharmocological
placebo VB Control
fluconazole VB Pharmocological
placebo NN Control
fluconazole JJ Pharmocological
fluconazole JJ Pharmocological
treatment NN Pharmocological
fluconazole NN Pharmocological
-DOCSTART- -X- N

nonspecific JJ Pharmocological
inhalation NN Pharmocological
provocation NN Pharmocological
-DOCSTART- -X- N

ticlopidine NN Pharmocological
cyclosporin NN Pharmocological
ticlopidine NN Pharmocological
cyclosporin NN Pharmocological
cyclosporin NN Pharmocological
A NNP Pharmocological
and CC Pharmocological
ticlopidine NN Pharmocological
cyclosporin NN Pharmocological
ticlopidine JJ Pharmocological
ticlopidine NN Pharmocological
. . None
ticlopidine NN Pharmocological
placebo NN Pharmocological
placebo NN Pharmocological
ticlopidine NN Pharmocological
ticlopidine NN Pharmocological
. . None
cyclosporin NN Pharmocological
ticlopidine NN Pharmocological
. . None
-DOCSTART- -X- N

perioperative JJ Pharmocological
blood NN Pharmocological
transfusion NN Pharmocological
Perioperative NNP Pharmocological
red VBD Pharmocological
blood NN Pharmocological
cell NN Pharmocological
( ( Pharmocological
RBC NNP Pharmocological
) ) Pharmocological
transfusion NN Pharmocological
transfusion NN Pharmocological
with IN Pharmocological
LD NNP Pharmocological
versus IN Pharmocological
non-LD JJ Physical
RBC NNP Physical
transfusions NNS Physical
. . None
-DOCSTART- -X- N

neutral-pH JJ Pharmocological
bicarbonate JJ Pharmocological
dialysis NN Pharmocological
solution NN Pharmocological
novel JJ Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
buffered VBD Pharmocological
with IN Pharmocological
34 CD Pharmocological
mM NNS Pharmocological
pure JJ Pharmocological
bicarbonate NN Pharmocological
at IN Pharmocological
neutral JJ Pharmocological
pH NN Pharmocological
conventional JJ Pharmocological
, , Pharmocological
acidic JJ Pharmocological
, , Pharmocological
35 CD Pharmocological
mM NN Pharmocological
lactate NN Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
neutral-pH JJ Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
with IN Pharmocological
reduced VBN Pharmocological
glucose JJ Pharmocological
degradation NN Pharmocological
product NN Pharmocological
content NN Pharmocological
. . None
, , Pharmocological
neutral-pH JJ Pharmocological
, , Pharmocological
bicarbonate-buffered JJ Pharmocological
PD NNP Pharmocological
fluid NN Pharmocological
conventional JJ Pharmocological
, , Pharmocological
acidic JJ Pharmocological
, , Pharmocological
lactate-based JJ Pharmocological
fluids NNS Pharmocological
. . None
-DOCSTART- -X- N

progressive JJ Educational
muscle NN Educational
relaxation NN Educational
training NN Educational
progressive JJ Educational
muscle NN Educational
relaxation NN Educational
training NN Educational
( ( Educational
PMRT NNP Educational
) ) Educational
PMRT NNP Educational
-DOCSTART- -X- N

hyperfractionated VBN Physical
chest JJS Physical
wall NN Physical
irradiation NN Physical
versus IN None
once-daily RB Physical
chest JJS Physical
wall NN Physical
irradiation NN Physical
after IN Physical
chemotherapy NN Pharmocological
hyperfractionated JJ Physical
radiotherapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
hyperfractionated VBN Physical
( ( Physical
twice-daily JJ Physical
, , Physical
b.i.d NN Physical
. . Physical
) ) Physical
chest JJS Physical
wall NN Physical
RT NNP Physical
q.d NN Physical
. . Physical
arm NN None
b.i.d NN Physical
. . Physical
arm NN None
b.i.d NN Physical
. . Physical
arm NN None
q.d NN Physical
. . Physical
arm NN None
postmastectomy NN Physical
RT NNP Physical
-DOCSTART- -X- N

Olanzapine NNP Pharmocological
versus NN None
haloperidol NN Pharmocological
neuroleptics NNS Pharmocological
Atypical JJ Pharmocological
neuroleptics NNS Pharmocological
olanzapine NN Pharmocological
haloperidol NN Pharmocological
open JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
olanzapine NN Pharmocological
or CC None
haloperidol NN Pharmocological
. . None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
. . None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
olanzapine NN Pharmocological
olanzapine NN Pharmocological
-DOCSTART- -X- N

transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
TENS NN Physical
placebo NN Control
TENS NNP Control
, , None
or CC None
( ( None
3 CD None
) ) None
control NN Control
treatments NNS Control
TENS NNP Physical
-DOCSTART- -X- N

family NN Pharmocological
therapy NN Pharmocological
family NN Pharmocological
therapy NN Pharmocological
family NN Physical
therapy NN Physical
or CC None
the DT None
control NN Control
treatment NN Control
( ( Control
individual JJ Control
supportive JJ Control
therapy NN Control
) ) None
-DOCSTART- -X- N

Catheter NNP Physical
ablation NN Physical
of IN Physical
stable JJ Physical
implantable JJ Surgical
cardioverter NN Surgical
defibrillator NN Surgical
( ( Surgical
ICD NNP Surgical
) ) Surgical
catheter NN Physical
ablation NN Physical
receive VB Physical
catheter NN Physical
ablation NN Physical
and CC Physical
an DT Physical
ICD NNP Physical
( ( Physical
ablation NN Physical
group NN Physical
, , Physical
n=54 RB Physical
) ) Physical
or CC None
ICD NNP Control
alone RB Control
( ( Control
control NN Control
group NN Control
, , Control
n=56 RB Control
) ) Control
. . None
ablation NN Physical
group NN Physical
control NN Control
group NN Control
ablation NN Physical
group NN Physical
control NN Control
group NN Control
( ( None
ablation NN Physical
group NN Physical
control NN Control
group NN Control
Prophylactic NNP Physical
VT NNP Physical
ablation NN Physical
defibrillator NN Surgical
implantation NN Surgical
Prophylactic NNP Physical
catheter NN Physical
ablation NN Physical
cardioverter NN Surgical
defibrillator NN Surgical
-DOCSTART- -X- N

ophthalmic JJ Physical
insert NN Physical
Mydriasert NNP Physical
Mydriasert NNP None
( ( None
ophthalmic JJ None
insert NN None
containing VBG None
tropicamide NN None
and CC None
phenylephrine NN None
) ) None
Mydriasert NNP Pharmocological
Mydriasert NNP Pharmocological
-DOCSTART- -X- N

potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
and CC None
bipolar JJ Surgical
radiofrequency NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
with IN None
those DT None
of IN None
bipolar JJ Surgical
radiofrequency NN Surgical
techniques NNS Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
laser NN Surgical
tonsillectomy NN Surgical
and CC None
bipolar JJ Surgical
radiofrequency NN Surgical
tonsillectomy NN Surgical
. . None
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
group NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
bipolar JJ Surgical
radiofrequency NN Surgical
group NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate NN Surgical
and CC None
the DT None
bipolar JJ Surgical
radiofrequency NN Surgical
techniques NNS Surgical
Potassium NNP Surgical
titanyl JJ Surgical
phosphate NN Surgical
laser NN Surgical
potassium NN Surgical
titanyl NN Surgical
phosphate VBP Surgical
laser NN Surgical
-DOCSTART- -X- N

total JJ None
knee NN Surgical
arthroplasty NN Surgical
custom-fit JJ Physical
magnetic JJ Physical
resonance NN Physical
imaging NN Physical
( ( Physical
MRI NNP Physical
) ) Physical
-based VBD Physical
pin NN Physical
guides NNS Physical
intramedullary JJ Physical
alignment NN Physical
jigs NNS Physical
custom-fit JJ Physical
MRI-based JJ Physical
pin NN Physical
guides NNS Physical
cemented VBD Surgical
posterior-stabilized JJ Surgical
implant NN Surgical
custom-fit JJ Physical
custom-fit JJ None
custom-fit JJ None
pin NN None
guides NNS None
-DOCSTART- -X- N

flunarizine NN Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
. . None
blocker NN Pharmocological
Flunarizine NNP Pharmocological
( ( Pharmocological
Sibelium NNP Pharmocological
) ) Pharmocological
Acetylsalicylic NNP Pharmocological
acid NN Pharmocological
( ( Pharmocological
ASS NNP Pharmocological
) ) Pharmocological
ASS NNP Pharmocological
Flunarizine NNP Pharmocological
. . None
Flunarizine NNP Pharmocological
-DOCSTART- -X- N

bed NN Physical
rest NN Physical
bed NN Physical
rest NN Physical
-DOCSTART- -X- N

ApoA-I JJ Pharmocological
apolipoprotein RB Pharmocological
A-I NNP Pharmocological
Apolipoprotein NNP Pharmocological
A-I NNP Pharmocological
Stimulation NNP Pharmocological
apoA-I JJ Pharmocological
inducer NN Pharmocological
( ( Pharmocological
RVX-208 NNP Pharmocological
) ) Pharmocological
Intravascular NNP None
Ultrasound NNP None
RVX-208 NNP Pharmocological
placebo NN Control
RVX-208 NNP Pharmocological
placebo NN Control
RVX-208 NNP Pharmocological
ApoA-I NNP Pharmocological
RVX-208 NNP Pharmocological
-DOCSTART- -X- N

Intravesical JJ Physical
seeding NN Physical
of IN Physical
upper JJ Physical
urinary JJ Physical
tract NN Physical
urothelial JJ Physical
carcinoma NN Physical
cells NNS Physical
pirarubicin NN Pharmocological
intravesical JJ Physical
seeding NN Physical
of IN Physical
cancer NN Physical
cells NNS Physical
. . None
pirarubicin JJ None
instillation NN None
Intravesical NNP Pharmocological
instillation NN Pharmocological
of IN Pharmocological
pirarubicin NN Pharmocological
nephroureterectomy NN Pharmocological
-DOCSTART- -X- N

low-dose JJ Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
: : None
multiphasic JJ Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
( ( Pharmocological
OCs NNP Pharmocological
) ) Pharmocological
multiphasic JJ Pharmocological
pill NN Pharmocological
, , None
a DT Pharmocological
lower-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
a DT None
higher-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
or CC None
nonsteroidal JJ Pharmocological
contraception NN Pharmocological
. . None
monophasic NN Pharmocological
pill NN Pharmocological
multiphasic NN Pharmocological
pill NN Pharmocological
multiphasic NN Pharmocological
pill NN Pharmocological
multiphasic JJ Pharmocological
pill NN Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
-DOCSTART- -X- N

Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
. . None
Ringer NNP Pharmocological
's POS Pharmocological
acetate JJ Pharmocological
solution NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
infusion NN Pharmocological
of IN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
-DOCSTART- -X- N

atenolol NN Pharmocological
atenolol NN Pharmocological
placebo NN Control
. . None
Atenolol NNP Pharmocological
-DOCSTART- -X- N

prepackaged VBN Pharmocological
, , Pharmocological
low JJ Pharmocological
residual JJ Pharmocological
test NN Pharmocological
meals NNS Pharmocological
with IN Pharmocological
4L CD Pharmocological
polyethylene NN Pharmocological
glycol NN Pharmocological
versus IN None
a DT None
clear JJ Pharmocological
liquid NN Pharmocological
diet NN Pharmocological
with IN Pharmocological
4L CD Pharmocological
polyethylene NN Pharmocological
glycol NN Pharmocological
bowel NN Pharmocological
preparation NN Pharmocological
: : None
low JJ Pharmocological
residue JJ Pharmocological
diet NN Pharmocological
4L CD Pharmocological
polyethylene NN Pharmocological
glycol NN Pharmocological
( ( Pharmocological
PEG NNP Pharmocological
) ) Pharmocological
solution NN Pharmocological
traditional JJ Pharmocological
liquid NN Pharmocological
diet NN Pharmocological
and CC Pharmocological
the DT Pharmocological
PEG NNP Pharmocological
4L CD Pharmocological
lavage NN Pharmocological
. . None
clear JJ Pharmocological
liquid NN Pharmocological
diet NN Pharmocological
and CC Pharmocological
the DT Pharmocological
PEG NNP Pharmocological
4L CD Pharmocological
regimen NNS Pharmocological
low JJ Pharmocological
residue JJ Pharmocological
test NN Pharmocological
meals NNS Pharmocological
and CC Pharmocological
the DT Pharmocological
PEG NNP Pharmocological
4L CD Pharmocological
regimen NNS Pharmocological
( ( Pharmocological
TM-PEG JJ Pharmocological
-DOCSTART- -X- N

bupivacaine NN Pharmocological
morphine NN Pharmocological
opioid NN None
bupivacaine NN Pharmocological
and CC None
morphine NN Pharmocological
physiological JJ Pharmocological
saline NN Pharmocological
bupivacaine VBP Pharmocological
bupivacaine VBP Pharmocological
plus CC Pharmocological
morphine JJ Pharmocological
morphine NN Pharmocological
saline NN Pharmocological
saline NN Pharmocological
bupivacaine NN Pharmocological
morphine NN Pharmocological
morphine JJ Pharmocological
bupivacaine JJ Pharmocological
bupivacaine JJ Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

heat NN Physical
and CC Physical
cold NN Physical
episiotomy/laceration NN Physical
heat NN Physical
and CC Physical
cold NN Physical
-DOCSTART- -X- N

COX-2 NNP Pharmocological
selective JJ Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
versus NN None
placebo NN Control
placebo-controlled JJ Control
rofecoxib JJ Pharmocological
or CC None
placebo NN Control
. . None
hydrocodone NN Pharmocological
bitartrate NN Pharmocological
-DOCSTART- -X- N

insulin NN Pharmocological
1-2 JJ Pharmocological
units NNS Pharmocological
insulin/kg VBP Pharmocological
body NN Pharmocological
weight/24 JJ Pharmocological
h NN Pharmocological
with IN Pharmocological
their PRP$ Pharmocological
feed NN Pharmocological
received VBD Control
the DT Control
feed NN Control
only RB Control
. . None
15N-glycine JJ Pharmocological
insulin NN Pharmocological
insulin NN Pharmocological
insulin NN Pharmocological
insulin NN Pharmocological
. . None
insulin NN Pharmocological
. . None
insulin NN Pharmocological
-DOCSTART- -X- N

desflurane NN Pharmocological
versus IN None
isoflurane NN Pharmocological
. . None
desflurane NN Pharmocological
( ( None
D NNP None
) ) None
or CC None
isoflurane NN Pharmocological
( ( None
I PRP None
) ) None
for IN None
-DOCSTART- -X- N

Home NN Educational
based VBN Educational
management NN Educational
Home NNP Educational
based VBN Educational
medical JJ Educational
care NN Educational
multidisciplinary JJ Educational
home NN Educational
based VBN Educational
care NN Educational
Comprehensive NNP Educational
planning NN Educational
of IN Educational
home NN Educational
based VBN Educational
intervention NN Educational
-DOCSTART- -X- N

Divalproex NNP Pharmocological
sodium NN Pharmocological
vs NN None
placebo NN Control
divalproex NN Pharmocological
sodium NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
divalproex JJ Pharmocological
placebo JJ Control
divalproex NN Pharmocological
-DOCSTART- -X- N

Anxiolytics NNS Pharmocological
anxiolytic JJ Pharmocological
analgesic JJ Physical
Midazolam NNP Pharmocological
( ( Pharmocological
Mi NNP Pharmocological
) ) Pharmocological
+Morphine NN Pharmocological
( ( Pharmocological
Mo NNP Pharmocological
) ) Pharmocological
and CC None
Mo NNP Control
alone RB Control
. . None
Mi+Mo NNP None
and CC None
Mo NNP None
alone RB None
Mi+Mo NNP None
and CC None
anxiolytics NNS None
and CC None
analgesics NNS None
as IN None
-DOCSTART- -X- N

high-protein JJ Pharmocological
, , Pharmocological
energy-restricted JJ Pharmocological
diet NN Pharmocological
energy NN Other
restriction NN Other
energy NN Other
balance NN Other
high-protein NN Pharmocological
( ( Pharmocological
HP NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
lower-protein JJ Pharmocological
( ( Pharmocological
LP NNP Pharmocological
) ) Pharmocological
diet NN Pharmocological
HP NNP Other
LP NNP Other
HP NNP Physical
LP NNP Physical
-DOCSTART- -X- N

meal NN Educational
plan NN Educational
of IN Educational
'eating VBG Educational
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
' '' Educational
exchange-based JJ Educational
meal NN Educational
plan NN Educational
'eat VB Educational
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
' '' None
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
exchange-based JJ Educational
meal NN Educational
plan NN Educational
meal NN Educational
plan NN Educational
of IN Educational
'eating VBG Educational
vegetables NNS Educational
before IN Educational
carbohydrate NN Educational
' '' Educational
-DOCSTART- -X- N

relaxation NN Physical
training NN Physical
effects NNS Physical
. . None
45-item JJ Educational
questionnaire NN Educational
relaxation NN Psychological
training NN Psychological
, , None
tension NN Psychological
inducement NN Psychological
, , None
pre-postcontrol NN Psychological
, , Psychological
or CC Psychological
postcontrol NN Psychological
. . None
relaxation NN Psychological
training NN Psychological
. . None
-DOCSTART- -X- N

motivational JJ Educational
music NN Educational
motivational JJ Educational
music NN Educational
( ( Educational
music NN Educational
that WDT Educational
stimulates VBZ Educational
or CC Educational
inspires VBZ Educational
physical JJ Educational
activity NN Educational
) ) Educational
6-minute JJ None
run NN None
at IN None
peak NN None
oxygen NN None
consumption NN None
speed NN None
and CC None
without IN None
music NN None
. . None
-DOCSTART- -X- N

Echocardiography NN Physical
natriuretic JJ None
peptide NN None
Carvedilol NN Pharmocological
-DOCSTART- -X- N

selamectin NN Pharmocological
selamectin NN Pharmocological
Selamectin NNP Pharmocological
selamectin NN Pharmocological
-DOCSTART- -X- N

homeopathic JJ Pharmocological
preparation NN Pharmocological
Galphimia NNP Pharmocological
potentiation NN Pharmocological
D6 NNP Pharmocological
, , None
Galphimia NNP Pharmocological
dilution NN Pharmocological
10 CD Pharmocological
( ( Pharmocological
-6 NN Pharmocological
) ) Pharmocological
and CC None
placebo NN Control
homeopathic JJ Pharmocological
drugs NNS Pharmocological
ethanol NN Pharmocological
) ) None
D6 NNP Pharmocological
Galphimia NNP Pharmocological
D6 NNP Pharmocological
, , None
a DT None
conventional JJ None
Galphimia NNP Pharmocological
dilution NN Pharmocological
placebo NN Control
placebo NN Control
. . None
homeopathic JJ Pharmocological
drugs NNS Pharmocological
-DOCSTART- -X- N

Lithium NN Pharmocological
lithium NN Pharmocological
carbonate NN Pharmocological
, , Pharmocological
300 CD Pharmocological
mg NN Pharmocological
t.i.d. NN Pharmocological
or CC None
no DT Pharmocological
lithium NN Pharmocological
. . None
lithium NN Pharmocological
no-lithium JJ Pharmocological
lithium NN Pharmocological
lithium NN Pharmocological
lithium VB Pharmocological
-DOCSTART- -X- N

COMPASS NNP Other
web-based JJ Other
face-to-face JJ Educational
teacher NN Educational
coaching NN Educational
Collaborative NNP Educational
Model NNP Educational
for IN Educational
Promoting VBG Educational
Competence NNP Educational
and CC Educational
Success NNP Educational
( ( Educational
COMPASS NNP Educational
; : None
1 CD None
of IN None
3 CD None
groups NNS None
: : None
( ( None
1 CD None
) ) None
a DT None
placebo NN Control
control NN None
( ( None
PBO NNP None
) ) None
group NN None
, , None
( ( None
2 CD None
) ) None
COMPASS NN Educational
followed VBN Educational
by IN Educational
face-to-face NN Educational
( ( Educational
FF NNP Educational
) ) Educational
coaching NN Educational
sessions NNS Educational
, , None
and CC None
( ( None
3 CD None
) ) None
COMPASS NN Educational
followed VBN Educational
by IN Educational
web-based JJ Educational
( ( Educational
WEB NNP Educational
) ) Educational
coaching NN Educational
sessions NNS Educational
. . None
Three CD None
individualized JJ None
goals NNS None
( ( None
social JJ Educational
, , Educational
communication NN Educational
, , Educational
and CC Educational
independence NN Educational
skills NNS Educational
) ) None
COMPASS NNP Other
-DOCSTART- -X- N

induction NN Pharmocological
chemotherapy NN Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
followed VBN None
by IN None
maintenance NN Pharmocological
chemotherapy NN Pharmocological
etoposide NN Pharmocological
vindesine NN Pharmocological
-DOCSTART- -X- N

Anabolic JJ Pharmocological
steroids NNS Pharmocological
methandienone NN Pharmocological
methandienone NN Pharmocological
placebo NN Control
; : None
Methandienone NNP Pharmocological
Anabolic JJ Pharmocological
steroids NNS Pharmocological
-DOCSTART- -X- N

Cognitive JJ Educational
behavioral JJ Educational
therapy NN Educational
modular JJ None
cognitive JJ Educational
behavioral JJ Educational
therapy NN Educational
( ( Educational
CBT NNP Educational
) ) Educational
CBT NNP Educational
CBT NNP Educational
3-month JJ Educational
waitlist NN Educational
CBT NNP Educational
CBT NNP Educational
waitlist NN Educational
CBT NNP Educational
waitlist NN Educational
CBT NNP Educational
-DOCSTART- -X- N

metoclopramide RB Pharmocological
either DT Pharmocological
5 CD Pharmocological
% NN Pharmocological
D-glucose NNP Pharmocological
( ( Pharmocological
placebo NN Control
) ) Pharmocological
or CC Pharmocological
ANF NNP Pharmocological
pmol JJ Pharmocological
Metoclopramide NNP Pharmocological
ANF NNP Pharmocological
3 CD Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
single JJ None
dose NN None
of IN None
100 CD None
mg JJ None
ACT-178882 NNP Pharmocological
and CC None
treatment NN None
B NNP None
of IN None
diltiazem NN Pharmocological
300 CD None
mg NN None
once RB None
a DT None
day NN None
for IN None
13 CD None
days NNS None
and CC None
a DT None
single JJ None
dose NN None
of IN None
100 CD None
mg JJ None
ACT-178882 JJ None
on IN None
day NN None
4 CD None
. . None
-DOCSTART- -X- N

health NN Educational
counseling NN Educational
intervention NN Educational
group NN Educational
control NN Control
group NN Control
. . Control
counselled VBN Educational
exercise NN Educational
group NN Educational
aerobics NNS Educational
exercise VBP Educational
diet JJ Educational
group NN Educational
reduce VB Educational
the DT Educational
intake NN Educational
of IN Educational
saturated JJ Educational
fat NN Educational
and CC Educational
increase VB Educational
fish JJ Educational
products NNS Educational
stop VB Educational
smoking NN Educational
. . Educational
one CD Educational
or CC Educational
more JJR Educational
behavioural JJ Educational
changes NNS Educational
Individual NNP Educational
counselling VBG Educational
diet JJ Educational
and CC Educational
smoking VBG Educational
counselling VBG Educational
models NNS Educational
-DOCSTART- -X- N

Iron NNP Pharmocological
Iron NNP Pharmocological
Dietary NNP Pharmocological
iron NN Pharmocological
iron NN Pharmocological
iron NN Pharmocological
-DOCSTART- -X- N

MEC NNP Pharmocological
( ( None
methotrexate NN Pharmocological
, , None
epirubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
) ) None
MEC NNP Pharmocological
M-VAC NNP Pharmocological
( ( None
methotrexate NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
doxorubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
) ) None
methotrexate NN Pharmocological
, , None
epirubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
chemotherapy NN None
group NN None
( ( None
arm JJ None
1 CD None
: : None
S-MEC JJ None
therapy NN None
; : None
n CC None
= VB None
29 CD None
) ) None
, , None
a DT None
dose-intensified JJ None
MEC NNP Pharmocological
therapy NN Pharmocological
combined VBN None
with IN None
G-CSF NNP Pharmocological
group NN None
( ( None
arm JJ None
2 CD None
: : None
I-MEC JJ None
therapy NN None
; : None
n CC None
= VB None
30 CD None
) ) None
or CC None
a DT None
methotrexate NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
doxorubicin NN Pharmocological
and CC None
cisplatin NN Pharmocological
chemotherapy NN None
( ( None
arm JJ None
3 CD None
: : None
M-VAC JJ Pharmocological
therapy NN Pharmocological
; : None
n CC None
= VB None
30 CD None
) ) None
. . None
S-MEC NNP Pharmocological
therapy NN Pharmocological
I-MEC NNP Pharmocological
S-MEC NNP Pharmocological
therapy NN Pharmocological
I-MEC NNP Pharmocological
M-VAC NNP Pharmocological
M-VAC NNP Pharmocological
MEC NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

prophylactic JJ Pharmocological
fentanyl NN Pharmocological
fentanyl NN Pharmocological
fentanyl NN Pharmocological
-DOCSTART- -X- N

systemic JJ Pharmocological
penicillin NN Pharmocological
penicillin NN Pharmocological
received VBD None
a DT None
7-day JJ None
oral JJ None
dose NN None
( ( None
28 CD None
capsules NNS None
, , None
500 CD None
mg NN None
each DT None
, , None
to TO None
be VB None
taken VBN None
every DT None
6 CD None
hours NNS None
) ) None
of IN None
either DT None
penicillin NN Pharmocological
or CC None
a DT None
placebo NN Control
control NN None
in IN None
a DT None
double-blind JJ None
manner NN None
. . None
ibuprofen NNS Pharmocological
; : None
acetaminophen VBZ Pharmocological
with IN Pharmocological
codeine NN Pharmocological
( ( None
30 CD None
mg NN None
) ) None
; : None
and CC None
a DT None
penicillin NN Pharmocological
-DOCSTART- -X- N

object-based JJ Educational
positive JJ Educational
and CC Educational
negative JJ Educational
priming NN Educational
tasks NNS Educational
visual JJ Educational
search NN Educational
procedure NN Educational
. . Educational
visual JJ Educational
search NN Educational
task NN Educational
performance NN Educational
-DOCSTART- -X- N

manidipine/delapril NN Pharmocological
losartan/hydrochlorothiazide NN Pharmocological
fixed-dose JJ Pharmocological
manidipine/delapril NN Pharmocological
losartan/hydrochlorothiazide JJ Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
manidipine/delapril NN Pharmocological
losartan/HCTZ NN Pharmocological
manidipine/delapril NN Pharmocological
manidipine/delapril NN Pharmocological
losartan/HCTZ NN Pharmocological
manidipine/delapril NN Pharmocological
-DOCSTART- -X- N

pantoprazole NN Pharmocological
and CC Pharmocological
digoxin NN Pharmocological
Substituted JJ Pharmocological
benzimidazole JJ Pharmocological
inhibitors NNS Pharmocological
pantoprazole JJ Pharmocological
digoxin NN Pharmocological
. . None
digoxin NN Pharmocological
pantoprazole NN Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
pantoprazole NN Pharmocological
( ( Pharmocological
40 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
and CC None
serum JJ None
concentrations NNS None
beta-acetyldigoxin NN Pharmocological
concomitant JJ Pharmocological
oral JJ Pharmocological
pantoprazole NN Pharmocological
placebo JJ Control
pantoprazole NN Pharmocological
and CC None
digoxin NN Pharmocological
pantoprazole NN Pharmocological
) ) None
pantoprazole JJ Pharmocological
( ( None
with IN None
and CC None
without IN None
digoxin NN Pharmocological
) ) None
Pantoprazole NNP Pharmocological
pantoprazole NN Pharmocological
and CC None
digoxin NN Pharmocological
-DOCSTART- -X- N

aldose JJ Pharmocological
reductase NN Pharmocological
tolrestat NN Pharmocological
tolrestat NN Pharmocological
placebo NN Control
placebo NN Control
tolrestat NN Pharmocological
tolrestat NN Pharmocological
tolrestat NN Pharmocological
-DOCSTART- -X- N

propofol JJ Pharmocological
with IN Pharmocological
and CC Pharmocological
without IN Pharmocological
EDTA NNP Pharmocological
EDTA NNP Pharmocological
to TO Pharmocological
propofol VB Pharmocological
induction NN Pharmocological
of IN Pharmocological
anesthesia NN Pharmocological
with IN Pharmocological
halothane NN Pharmocological
received VBD None
propofol NN Pharmocological
without IN Pharmocological
EDTA NNP Pharmocological
( ( None
n JJ None
= NNP None
33 CD None
) ) None
or CC None
propofol NN Pharmocological
with IN Pharmocological
EDTA NNP Pharmocological
Propofol NNP Pharmocological
with IN Pharmocological
EDTA NNP Pharmocological
Propofol NNP Pharmocological
and CC None
propofol JJ Pharmocological
EDTA NNP Pharmocological
EDTA NNP Pharmocological
EDTA NNP Pharmocological
, , None
propofol NN Pharmocological
-DOCSTART- -X- N

decision NN Educational
aid NN Educational
( ( Educational
DA NNP Educational
) ) Educational
immediate JJ Educational
or CC Educational
delayed JJ Educational
access NN Educational
to TO Educational
the DT Educational
online NN Educational
DA NNP Educational
control NN Control
-DOCSTART- -X- N

Transdermal NNP None
scopolamine NN Pharmocological
patch NN None
ondansetron VB Pharmocological
transdermal JJ None
scopolamine NN Pharmocological
ondansetron VB Pharmocological
transdermal JJ None
scopolamine NN Pharmocological
( ( None
TDS NNP None
) ) None
patch NN None
a DT None
placebo JJ Control
patch NN None
scopolamine NN Pharmocological
-DOCSTART- -X- N

chloroquine VB Pharmocological
sulfadoxine-pyrimethamine VB Pharmocological
chloroquine NN Pharmocological
sulfadoxine-pyrimethamine JJ Pharmocological
CQ-treated JJ Pharmocological
CQ NNP Pharmocological
CQ NNP Pharmocological
-DOCSTART- -X- N

an DT None
ion NN Physical
exchange NN Physical
membrane NN Physical
with IN Physical
30-microgram JJ Physical
dexamethasone NN Physical
elution NN Physical
in IN Physical
a DT Physical
contoured JJ Physical
activated JJ Physical
carbon NN Physical
tip NN Physical
lead NN Physical
the DT Educational
same JJ Physical
lead NN Physical
design NN Physical
without IN Physical
steroid NN Physical
the DT Educational
same JJ Physical
lead NN Physical
design NN Physical
without IN Physical
steroid NN Physical
or CC Physical
membrane NN Physical
ion NN Physical
exchange NN Physical
membrane NN Physical
-DOCSTART- -X- N

short-term JJ Control
cognitive JJ Control
group NN Control
treatment NN Control
program NN Control
cognitive JJ Control
short-term JJ Control
weight NN Control
reducing VBG Control
treatment NN Control
program NN Control
control NN Control
10-week JJ Control
( ( Control
30 CD Control
hours NNS Control
) ) Control
cognitive VBP Control
group NN Control
treatment NN Control
program NN Control
. . None
post-treatment JJ None
treatment NN None
cognitive JJ None
group NN None
treatment NN None
program NN None
treatment NN Control
controls NNS None
-DOCSTART- -X- N

immunotherapy NN Pharmocological
interleukin-2 JJ Pharmocological
and CC None
interferon-alpha JJ Pharmocological
subcutaneous JJ Pharmocological
low JJ Pharmocological
doses NNS Pharmocological
IL-2 NNP Pharmocological
+ NNP Pharmocological
IFN NNP Pharmocological
chemotherapy NN Pharmocological
Chronic JJ Pharmocological
maintenance NN Pharmocological
immunotherapy NN Pharmocological
-DOCSTART- -X- N

secretin NN Physical
secretin NN None
or CC None
placebo NN Control
secretin NN Physical
placebo JJ Control
-DOCSTART- -X- N

Hypnosis NNP Psychological
treatment NN Psychological
Hypnosis NNP Psychological
biweekly JJ Psychological
hypnosis NN Psychological
sessions NNS Psychological
and CC Psychological
used VBD Psychological
hypnosis NN Psychological
audiotapes NNS Psychological
hypnosis NN Educational
-DOCSTART- -X- N

gonadotropin-releasing JJ Pharmocological
hormone NN Pharmocological
agonists NNS Pharmocological
antagonists NNS Pharmocological
versus NN None
GnRH NNP Pharmocological
antagonist NN Pharmocological
protocols NNS None
GnRH NNP Pharmocological
antagonist NN Pharmocological
( ( Pharmocological
cetrorelix NN Pharmocological
) ) Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
( ( Pharmocological
buserelin NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

pressure- JJ None
and CC None
volume-limited JJ None
full JJ None
face NN None
mask NN None
and CC None
an DT None
artificial JJ None
leak NN None
in IN None
the DT None
ventilatory NN None
circuit NN None
either RB None
without IN None
leakage NN None
( ( None
setting VBG None
I PRP None
) ) None
, , None
with IN None
leakage NN None
during IN None
inspiration NN None
only RB None
( ( None
setting VBG None
II NNP None
) ) None
, , None
and CC None
with IN None
leakage NN None
during IN None
inspiration NN None
and CC None
expiration NN None
( ( None
setting VBG None
III NNP None
) ) None
. . None
-DOCSTART- -X- N

citalopram VB Pharmocological
and CC Pharmocological
reboxetine VB Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
SSRI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
citalopram NN Pharmocological
, , Pharmocological
and CC Pharmocological
a DT Pharmocological
noradrenaline JJ Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
NARI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
reboxetine NN Pharmocological
citalopram NN Pharmocological
reboxetine NN Pharmocological
. . None
citalopram NN Pharmocological
reboxetine NN Pharmocological
reboxetine NN Pharmocological
Citalopram NNP Pharmocological
reboxetine NN Pharmocological
-DOCSTART- -X- N

serial JJ Physical
CPAP NNP Physical
therapy NN Physical
or CC None
high-flow JJ Control
face NN Control
mask NN Control
oxygen NN Control
therapy NN Control
without IN Control
CPAP NNP Control
( ( Control
control NN Control
) ) Control
-DOCSTART- -X- N

capecitabine JJ Pharmocological
plus CC None
docetaxel JJ Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
Docetaxel NNP Pharmocological
and CC None
capecitabine NN Pharmocological
capecitabine/docetaxel JJ Pharmocological
therapy NN Pharmocological
single-agent JJ Pharmocological
docetaxel NN Pharmocological
capecitabine NN Pharmocological
docetaxel JJ Pharmocological
docetaxel VB Pharmocological
Capecitabine/docetaxel NNP Pharmocological
docetaxel NN Pharmocological
. . None
combination NN Pharmocological
therapy NN Pharmocological
single-agent JJ Pharmocological
docetaxel NN Pharmocological
. . None
combination NN None
therapy NN None
docetaxel NN Pharmocological
addition NN Pharmocological
of IN Pharmocological
capecitabine NN Pharmocological
to TO Pharmocological
docetaxel VB Pharmocological
combination NN None
single-agent JJ Pharmocological
docetaxel NN Pharmocological
Docetaxel/capecitabine NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Screening VBG Physical
, , Physical
brief JJ Physical
intervention NN Physical
, , Physical
and CC Physical
referral JJ Physical
to TO Physical
treatment NN Physical
( ( Physical
SBIRT NNP Physical
) ) Physical
screening NN Physical
, , Physical
brief JJ Physical
intervention NN Physical
, , Physical
and CC Physical
referral JJ Physical
to TO Physical
treatment NN Physical
( ( Physical
SBIRT NNP Physical
) ) Physical
screened VBN Physical
only RB Physical
assessed VBN Educational
received VBN Physical
intervention NN Physical
assessment NN None
intervention NN Physical
intervention NN Other
assessment JJ Educational
intervention NN Physical
-DOCSTART- -X- N

Bevacizumab NNP Pharmocological
macular JJ Physical
laser NN Physical
grid JJ Physical
photocoagulation NN Physical
intravitreal JJ Pharmocological
injections NNS Pharmocological
of IN Pharmocological
bevacizumab NN Pharmocological
and CC None
macular JJ Physical
grid NN Physical
laser NN Physical
photocoagulation NN Physical
( ( Physical
GLP NNP Physical
) ) Physical
GLP NNP Physical
group NN None
intravitreal VB Pharmocological
bevacizumab NN Pharmocological
( ( Pharmocological
IB NNP Pharmocological
) ) Pharmocological
GLP NNP Physical
IB NNP Pharmocological
GLP NNP Physical
IB NNP Pharmocological
GLP NNP Physical
IB NNP Pharmocological
bevacizumab NN Pharmocological
bevacizumab NN Pharmocological
bevacizumab JJ Pharmocological
-DOCSTART- -X- N

joint JJ Educational
attention NN Educational
or CC Educational
symbolic JJ Educational
play NN Educational
-DOCSTART- -X- N

histatin-containing JJ Pharmocological
mouthrinse NN Pharmocological
P-113 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
12 CD Pharmocological
amino NN Pharmocological
acid JJ Pharmocological
histatin-based JJ Pharmocological
peptide NN Pharmocological
mouthrinse NN Pharmocological
formulation NN Pharmocological
self-administered JJ Pharmocological
either DT Pharmocological
0.005 CD Pharmocological
% NN Pharmocological
, , Pharmocological
0.01 CD Pharmocological
% NN Pharmocological
, , Pharmocological
0.05 CD Pharmocological
% NN Pharmocological
P-113 NNP Pharmocological
or CC None
placebo NN Control
mouthrinse NN None
formulations NNS None
twice RB None
daily RB None
over IN None
a DT None
four CD None
week NN None
treatment NN None
period NN None
. . None
P-113 JJ Pharmocological
mouthrinse NN Pharmocological
. . None
P-113 NNP Pharmocological
P-113 NNP Pharmocological
mouthrinse NN Pharmocological
-DOCSTART- -X- N

biopsychosocial JJ Psychological
therapy NN Psychological
( ( Psychological
BT NNP Psychological
) ) Psychological
with IN None
a DT None
conventional JJ Pharmocological
biomedical JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
MT NNP Pharmocological
) ) Pharmocological
biopsychosocial JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
a DT Pharmocological
solely JJ Pharmocological
conventional JJ Pharmocological
biomedical JJ Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
biomedical JJ Pharmocological
therapy NN Pharmocological
biopsychosocial JJ Psychological
therapy NN Psychological
-DOCSTART- -X- N

Cholesterol-lowering JJ Physical
therapy NN Physical
cholesterol-lowering JJ None
therapy NN None
lovastatin NN Pharmocological
, , Pharmocological
an DT Pharmocological
HMG NNP Pharmocological
CoA NNP Pharmocological
reductase NN Pharmocological
inhibitor NN Pharmocological
placebo NN Control
Lovastatin NNP Pharmocological
placebo NN None
lovastatin-treated JJ Pharmocological
placebo-treated JJ None
lovastatin NN Pharmocological
Lovastatin NNP Pharmocological
-DOCSTART- -X- N

receive VB Educational
the DT Educational
decision NN Educational
aid NN Educational
or CC Educational
a DT Educational
control JJ Educational
pamphlet NN Educational
at IN Educational
the DT Educational
end NN Educational
of IN Educational
their PRP$ Educational
first JJ Educational
genetic JJ Educational
counseling NN Educational
consultation NN Educational
. . None
decision NN Educational
aid NN Educational
control NN Control
pamphlet NN Control
. . None
decision NN Educational
aid NN Educational
control NN Control
pamphlet NN Control
decision NN Educational
aid NN Educational
-DOCSTART- -X- N

hypertonic JJ Pharmocological
saline NN Pharmocological
and CC Pharmocological
dextran NN Pharmocological
( ( Pharmocological
HSD NNP Pharmocological
) ) Pharmocological
with IN None
normal JJ Pharmocological
saline NN Pharmocological
( ( Pharmocological
NS NNP Pharmocological
) ) None
250 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
HSD NNP Pharmocological
vs FW None
NS NNP Pharmocological
-DOCSTART- -X- N

two-filter JJ Other
model NN Other
two-filter JJ Other
model NN Other
six CD Other
frequencies NNS Other
( ( Other
from IN Other
0.25 CD Other
to TO Other
8 CD Other
kHz NN Other
) ) Other
-DOCSTART- -X- N

Pre-operative JJ Physical
short-term JJ Physical
pulmonary JJ Physical
rehabilitation NN Physical
for IN Physical
pre-operative JJ Physical
short-term JJ Physical
pulmonary JJ Physical
rehabilitation NN Physical
short-term JJ Physical
pulmonary JJ Physical
rehabilitation NN Physical
or CC None
no DT Control
such JJ Control
programme NN Control
-DOCSTART- -X- N

contrast NN Physical
Meglumine NNP Pharmocological
iothalamate NN Pharmocological
( ( Pharmocological
Conray NNP Pharmocological
Meglumin NNP Pharmocological
) ) Pharmocological
, , None
sodium-calcium-meglumine JJ Pharmocological
metrizoate NN Pharmocological
( ( Pharmocological
Isopaque NNP Pharmocological
Cerebral NNP Pharmocological
) ) Pharmocological
and CC None
dimeglumine JJ Pharmocological
iocarmate NN Pharmocological
( ( Pharmocological
Dimerex NNP Pharmocological
) ) Pharmocological
Conray NNP Pharmocological
Meglumin NNP Pharmocological
Isopaque NNP Pharmocological
Cerebral NNP Pharmocological
and CC None
Conray NNP Pharmocological
Meglumin NNP Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
or CC None
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
risperidone NN Pharmocological
Risperidone NNP Pharmocological
-DOCSTART- -X- N

intravesical JJ Pharmocological
BCG NNP Pharmocological
mitomycin JJ Pharmocological
C NNP Pharmocological
plus CC Pharmocological
doxorubicin JJ Pharmocological
sequential JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

indomethacin NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
oral JJ Pharmocological
cilazapril NN Pharmocological
oral JJ Pharmocological
indomethacin NN Pharmocological
Cilazapril NNP Pharmocological
Indomethacin NNP Pharmocological
cilazapril NN Pharmocological
. . None
indomethacin JJ Control
plus CC Control
placebo NN Control
cilazapril NN Pharmocological
cilazapril JJ Control
plus CC Control
placebo NN Control
indomethacin NN Pharmocological
. . None
indomethacin NN Pharmocological
cilazapril NN Pharmocological
-DOCSTART- -X- N

Levamisole NNP Psychological
versus NN None
placebo NN Control
levamisole JJ Pharmocological
( ( None
150 CD None
mg NNS None
daily RB None
during IN None
three CD None
consecutive JJ None
days NNS None
, , None
every DT None
fortnight NN None
) ) None
or CC None
placebo NN None
-DOCSTART- -X- N

Rehabilitation NN Educational
including VBG Educational
Social NNP Educational
and CC Educational
Physical NNP Educational
activity NN Educational
and CC Educational
Education NN Educational
multimodal JJ Educational
intervention NN Educational
program NN Educational
, , Educational
including VBG Educational
ambassador-facilitated JJ Educational
educational JJ Educational
, , Educational
physical JJ Educational
, , Educational
and CC Educational
social JJ Educational
interventions NNS Educational
. . Educational
educational JJ Educational
intervention NN Educational
educational JJ Educational
program NN Educational
visit VBP Pharmocological
the DT Pharmocological
and CC None
participate VB None
in IN None
the DT None
intervention NN None
program NN None
. . None
physical JJ None
and CC None
social JJ None
intervention NN None
educational JJ None
, , None
physical JJ None
, , None
and CC None
social JJ None
intervention NN None
programs NNS None
. . None
classmates NNS Physical
as IN Physical
ambassadors NNS Physical
-DOCSTART- -X- N

ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
ciprofloxacin NN Pharmocological
ceftriaxone NN Pharmocological
-DOCSTART- -X- N

surgical JJ Surgical
staging NN Surgical
adjuvant JJ Physical
therapy NN Physical
. . None
intraperitoneal JJ Pharmocological
radioactive JJ Pharmocological
phosphorus NN Pharmocological
or CC None
oral JJ Pharmocological
melphalan NN Pharmocological
. . None
-DOCSTART- -X- N

Allopurinol NNP Pharmocological
blood NN Physical
samples NNS Physical
allopurinol NN Pharmocological
placebo NN None
-DOCSTART- -X- N

Cognitive-behavioral JJ Psychological
therapy NN Psychological
cognitive-behavioral JJ Psychological
therapy NN Psychological
( ( None
CBT NNP Psychological
) ) None
and CC None
standard JJ Pharmocological
medical JJ Pharmocological
care NN Pharmocological
( ( Pharmocological
SMC NNP Pharmocological
) ) Pharmocological
CBT NNP Psychological
SMC NNP Pharmocological
CBT NNP Educational
SMC NNP Pharmocological
) ) None
SMC NNP Pharmocological
CBT NNP Educational
cognitive-behavioral JJ Psychological
therapy NN Psychological
CBT NNP Educational
SMC NNP Pharmocological
SMC NNP Pharmocological
-DOCSTART- -X- N

placebo NN Control
oral JJ Pharmocological
vaccine NN Pharmocological
prepared VBN Pharmocological
from IN Pharmocological
insect JJ Pharmocological
saliva NN Pharmocological
placebo NN Control
( ( Control
stable JJ Control
vaccine NN Control
solvent NN Control
) ) Control
. . Control
Vaccine NNP Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

Endurance NNP Physical
physical JJ Physical
activity NN Physical
, , Physical
diet JJ Other
long-term JJ Physical
, , Physical
heavy JJ Physical
exercise NN Physical
14-day JJ Physical
skiing NN Physical
tour NN Physical
through IN Physical
the DT Physical
Swedish JJ Physical
mountains NNS Physical
, , Physical
carrying VBG Physical
a DT Physical
pack NN Physical
load NN Physical
of IN Physical
30 CD Physical
kg NNS Physical
, , Physical
and CC Physical
spending VBG Physical
each DT Physical
night NN Physical
in IN Physical
self-dug JJ Physical
igloos NN Physical
( ( Physical
ambient JJ Physical
temp NN Physical
-10 NN Physical
degrees NNS Physical
to TO Physical
-25 VB Physical
degrees NNS Physical
C NNP Physical
) ) Physical
, , None
and CC None
were VBD None
randomized VBN None
to TO None
2 CD Other
food NN Other
regimens NNS Other
having VBG Other
30 CD Other
or CC Other
40 CD Other
energy NN Other
percent NN Other
of IN Other
fat NN Other
. . None
Individual JJ Educational
records NNS Educational
were VBD Educational
kept VBN Educational
of IN Educational
all DT Educational
consumed VBN Educational
food NN Educational
. . None
was VBD Physical
obtained VBN Physical
before IN Physical
and CC Physical
after IN Physical
1 CD Physical
and CC Physical
2 CD Physical
weeks NNS Physical
of IN Physical
exercise NN Physical
: : Physical
was VBD Physical
assessed VBN Physical
by IN Physical
a DT Physical
10 CD Physical
min NN Physical
venous JJ Physical
occlusion NN Physical
( ( Physical
VO NNP Physical
) ) Physical
test NN Physical
. . None
endurance JJ Physical
physical JJ Physical
activity NN Physical
-DOCSTART- -X- N

Mechanical NNP Physical
autotransfusion NN Physical
systems NNS Physical
controlled VBN Other
autotransfusion NN Physical
system NN Physical
WSB NNP Physical
was VBD Physical
retransfused VBN Physical
after IN Physical
processing VBG Physical
. . None
regular JJ Physical
drain NN Physical
without IN Physical
suction NN Physical
was VBD Physical
used VBN Physical
. . None
-DOCSTART- -X- N

Competitive JJ Psychological
memory NN Psychological
training NN Psychological
( ( Psychological
COMET NNP Psychological
) ) Psychological
COMET NNP Psychological
COMET NNP Psychological
in IN Physical
addition NN Physical
to TO Physical
their PRP$ Physical
regular JJ Psychological
therapy NN Psychological
( ( Physical
COMET NNP Psychological
+ NNP Physical
therapy NN Psychological
as IN Psychological
usual JJ Psychological
[ NNP Psychological
TAU NNP Psychological
] NN Psychological
: : None
of IN None
ongoing VBG Control
regular JJ Control
therapy NN Control
( ( Control
TAU NNP Control
only RB Control
: : None
COMET NNP Psychological
TAU NNP Psychological
COMET NNP Psychological
TAU NNP Physical
COMET NNP Psychological
+ NNP None
TAU NNP Psychological
COMET NNP Psychological
+ NNP None
TAU NNP Psychological
COMET NNP Psychological
-DOCSTART- -X- N

standard JJ Pharmocological
danazol NN Pharmocological
and CC None
modified VBD Pharmocological
triptorelin NN Pharmocological
regimens NNS Pharmocological
danazol NN Pharmocological
and CC None
triptorelin NN Pharmocological
danazol NN Pharmocological
or CC None
triptorelin NN Pharmocological
danazol NN Pharmocological
triptorelin NN Pharmocological
triptorelin NN Pharmocological
. . Pharmocological
danazol NN Pharmocological
triptorelin NN Pharmocological
triptorelin JJ Pharmocological
triptorelin NN Pharmocological
danazol NN Pharmocological
. . Pharmocological
triptorelin JJ Pharmocological
-DOCSTART- -X- N

Faux NNP Educational
pas CC Educational
detection NN Educational
faux JJ Educational
pas NN Educational
task NN Educational
, , Educational
an DT Educational
advanced JJ Educational
test NN Educational
of IN Educational
theory NN Educational
of IN Educational
mind NN Educational
faux JJ Educational
pas NN Educational
-DOCSTART- -X- N

Tinzaparin NNP Pharmocological
versus NN None
dalteparin NN Pharmocological
Low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
( ( Pharmocological
LMWH NNP Pharmocological
) ) Pharmocological
tinzaparin NN Pharmocological
dalteparin VB Pharmocological
warfarin JJ Pharmocological
therapy NN Pharmocological
3 CD Pharmocological
daily JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
tinzaparin NN Pharmocological
( ( Pharmocological
175 CD Pharmocological
IU/kg NNP Pharmocological
) ) Pharmocological
or CC None
dalteparin NN Pharmocological
tinzaparin JJ Pharmocological
dalteparin JJ Pharmocological
. . None
for IN None
tinzaparin NN None
for IN None
dalteparin NN Pharmocological
( ( None
the DT None
tinzaparin NN None
arm NN None
thrombosis NN None
[ NNP None
dalteparin NN None
group NN None
CONCLUSIONS NNP None
Dalteparin NNP None
and CC None
tinzaparin VB None
significantly RB None
warfarin NN None
therapy NN None
has VBZ None
intravenous JJ None
heparin NN None
, , None
-DOCSTART- -X- N

indomethacin JJ Pharmocological
phonophoresis NN Pharmocological
indomethacin JJ Pharmocological
phonophoresis NN Pharmocological
placebo-controlled JJ Control
indomethacin JJ Pharmocological
placebo NN Control
indomethacin JJ Pharmocological
phonophoresis NN Pharmocological
-DOCSTART- -X- N

randomized VBD None
controlled VBN None
trial NN None
in IN None
. . None
receive VB Physical
full-dose JJ Pharmocological
thrombolysis NN Pharmocological
, , None
preferably RB None
pre-hospital JJ None
, , None
and CC None
then RB None
be VB None
randomized VBN None
to TO None
either DT None
strategy NN None
. . None
-DOCSTART- -X- N

trimetazidine NN Pharmocological
trimetazidine NN Pharmocological
-DOCSTART- -X- N

Heparin NNP Pharmocological
plus CC Pharmocological
dipyridamole NN Pharmocological
heparin NN Pharmocological
and CC Pharmocological
dipyridamole NN Pharmocological
or CC Pharmocological
with IN Pharmocological
supportive JJ Pharmocological
management NN Pharmocological
only RB Pharmocological
. . Pharmocological
treatment NN None
with IN None
-DOCSTART- -X- N

immunohistochemical JJ Physical
analysis NN Physical
of IN Physical
bone NN Physical
marrow NN Physical
biopsies NNS Physical
induction NN Pharmocological
chemotherapy VBD Pharmocological
antiangiogenic JJ Other
antileukemic JJ None
treatment NN None
-DOCSTART- -X- N

adrenaline NN Pharmocological
racemic JJ Pharmocological
adrenaline NN Pharmocological
( ( Pharmocological
RA NNP Pharmocological
) ) Pharmocological
topical JJ Pharmocological
gauze NN Pharmocological
sponges NNS Pharmocological
soaked VBN Pharmocological
in IN Pharmocological
either DT Pharmocological
1:500 CD Pharmocological
RA NNP Pharmocological
or CC None
0.9 CD Control
% NN Control
sodium NN Pharmocological
chloride NN Pharmocological
( ( Pharmocological
physiological JJ Pharmocological
saline NN Pharmocological
) ) Pharmocological
for IN None
3 CD None
min NN None
after IN None
adenoidectomy NN Surgical
. . None
Adrenaline NNP Pharmocological
adrenaline NN Pharmocological
adrenaline NN Pharmocological
adrenaline NN Pharmocological
-DOCSTART- -X- N

[ JJ Pharmocological
Local NNP Pharmocological
therapy NN Pharmocological
of IN Pharmocological
combination NN Pharmocological
preparation NN Pharmocological
with IN Pharmocological
standardized JJ Pharmocological
blood NN Pharmocological
leech NN Pharmocological
extract NN Pharmocological
] NNP Pharmocological
topical JJ Pharmocological
combination NN Pharmocological
preparation NN Pharmocological
containing VBG Pharmocological
standardized VBN Pharmocological
leech JJ Pharmocological
extract NN Pharmocological
, , Pharmocological
polidocanol NN Pharmocological
and CC Pharmocological
allantoin NN Pharmocological
. . Pharmocological
Placebo-controlled NNP Control
test NN Educational
preparation NN Educational
placebo NN None
. . None
preparation NN None
placebo NN None
topical JJ Pharmocological
therapeutic JJ Pharmocological
preparation NN Pharmocological
-DOCSTART- -X- N

low-intensity NN Physical
back RB Physical
exercise NN Physical
home-based JJ Physical
, , Physical
simple JJ Physical
, , Physical
low-intensity JJ Physical
exercise NN Physical
. . None
Low-intensity JJ Physical
back-strengthening JJ Physical
exercise NN Physical
-DOCSTART- -X- N

drug NN Physical
infusions NNS Physical
at IN Physical
the DT Physical
bedside NN Physical
pre-filled JJ Pharmocological
syringes NNS Pharmocological
. . None
Vasopressor NNP Pharmocological
infusions NNS Pharmocological
diluting VBG Pharmocological
concentrated VBN Pharmocological
drugs NNS Pharmocological
from IN Pharmocological
ampoules NNS Pharmocological
syringes NNS Pharmocological
pre-filled JJ Pharmocological
pre-filled JJ Pharmocological
syringes NNS Pharmocological
epinephrine NN Pharmocological
; : None
pre-filled JJ Pharmocological
syringes NNS Pharmocological
infusions NNS Pharmocological
norepinephrine NN Pharmocological
epinephrine NN Pharmocological
) ) None
drug NN Pharmocological
infusions NNS Pharmocological
pre-filled VBN Pharmocological
-DOCSTART- -X- N

continuous JJ Pharmocological
infusion NN Pharmocological
fluorouracil NN Pharmocological
versus NN None
fluorouracil NN Pharmocological
plus CC Pharmocological
cisplatin NN Pharmocological
infusional JJ Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
FU NNP Pharmocological
) ) Pharmocological
versus NN None
cisplatin NN Pharmocological
( ( Pharmocological
CDDP NNP Pharmocological
) ) Pharmocological
and CC None
FU NNP Pharmocological
. . None
CDDP/FU NNP Pharmocological
CDDP NNP Pharmocological
CDDP/FU NNP Pharmocological
FU NNP Pharmocological
CDDP/FU NNP Pharmocological
FU NNP Pharmocological
CDDP/FU NNP Pharmocological
FU NNP Pharmocological
FU NNP Pharmocological
CDDP/FU NNP Pharmocological
CDDP/FU NNP Pharmocological
-DOCSTART- -X- N

Alternating VBG Physical
chemotherapy NN Physical
rapid JJ Pharmocological
cyclic JJ Pharmocological
alternating VBG Pharmocological
chemotherapy NN Pharmocological
initial JJ Pharmocological
common JJ Pharmocological
continuous JJ Pharmocological
therapy NN Pharmocological
. . None
continuous JJ Physical
standard NN Physical
therapy NN Physical
based VBN Physical
on IN Physical
the DT Physical
CAV- NNP Pharmocological
or CC Pharmocological
CMC-protocol NNP Pharmocological
with IN Pharmocological
an DT Pharmocological
alternating VBG Pharmocological
schedule NN Pharmocological
often RB Pharmocological
consisting VBG Pharmocological
of IN Pharmocological
the DT Pharmocological
CAV- NNP Pharmocological
or CC Pharmocological
CMC-derived JJ Pharmocological
combinations NNS Pharmocological
and CC None
a DT None
second JJ Pharmocological
regimen NN Pharmocological
including VBG Pharmocological
cisplatinum NN Pharmocological
and/or NN Pharmocological
etoposide NN Pharmocological
. . None
-DOCSTART- -X- N

diltiazem NN Pharmocological
placebo NN Control
diltiazem NN Pharmocological
. . None
-DOCSTART- -X- N

galantamine NN Pharmocological
and CC None
risperidone NN Pharmocological
galantamine NN Pharmocological
and CC None
risperidone NN Pharmocological
risperidone NN Pharmocological
galantamine NN Pharmocological
galantamine NN Pharmocological
risperidone NN Pharmocological
( ( None
risperidone JJ Pharmocological
plus CC Pharmocological
9-hydroxyrisperidone CD Pharmocological
) ) None
risperidone NN Pharmocological
galantamine JJ Pharmocological
risperidone NN Pharmocological
9-hydroxyrisperidone CD Pharmocological
risperidone NN Pharmocological
) ) None
Galantamine NNP Pharmocological
and CC None
risperidone NN None
risperidone NN Pharmocological
orgalantamine NN Pharmocological
-DOCSTART- -X- N

hydrotalcite JJ Pharmocological
esomeprazole NN Pharmocological
hydrotalcite NN Pharmocological
esomeprazole VB Pharmocological
hydrotalcite NN Pharmocological
or CC None
esomeprazole NN Pharmocological
hydrotalcite NN Pharmocological
esomeprazole JJ Pharmocological
of IN None
hydrotalcite NN None
to TO None
of IN None
esomeprazole NN None
( ( None
per IN None
CONCLUSION NNP None
Hydrotalcite NNP None
is VBZ None
-DOCSTART- -X- N

tetracycline NN Pharmocological
. . None
placebo-controlled JJ Control
bronchodilators NNS Pharmocological
, , None
corticosteroids NNS Pharmocological
tetracycline NN Pharmocological
or CC None
placebo NN Control
placebo NN Control
. . None
-DOCSTART- -X- N

verapamil NN Pharmocological
. . None
verapamil NN Pharmocological
calcium-antagonist JJ Pharmocological
drug NN Pharmocological
oral JJ Pharmocological
verapamil NN Pharmocological
480 CD Pharmocological
mg/day NN Pharmocological
and CC None
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

encapsulated JJ Pharmocological
juice NN Pharmocological
powder NN Pharmocological
concentrate NN Pharmocological
Phytonutrients NNS Pharmocological
from IN Pharmocological
plant NN Pharmocological
foods NNS Pharmocological
commercially RB Pharmocological
available JJ Pharmocological
encapsulated JJ Pharmocological
juice NN Pharmocological
powder NN Pharmocological
concentrate NN Pharmocological
( ( Pharmocological
JPC NNP Pharmocological
) ) Pharmocological
JPC NNP Pharmocological
or CC Control
placebo NN Control
We PRP None
collected VBD None
plasma NN None
at IN None
baseline NN None
and CC None
study NN None
wk VBP None
4 CD None
, , None
8 CD None
, , None
16 CD None
, , None
and CC None
28 CD None
for IN None
analysis NN None
of IN None
JPC NNP Pharmocological
JPC NNP Pharmocological
placebo NN Control
placebo NN Control
JPC NNP Pharmocological
JPC NNP Pharmocological
-DOCSTART- -X- N

Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Physical
absorbable JJ Physical
adhesion NN Physical
barrier NN Physical
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Physical
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) Pharmocological
Interceed NNP Physical
( ( Physical
TC7 NNP Physical
) ) None
other JJ Educational
was VBD Educational
left VBN Educational
uncovered JJ Educational
. . None
laparotomy NN Physical
. . None
Interceed NNP Pharmocological
( ( Pharmocological
TC7 NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Risperidone NNP Pharmocological
versus NN None
haloperidol NN Pharmocological
risperidone NN Pharmocological
with IN None
haloperidol NN Pharmocological
-DOCSTART- -X- N

[ RB None
Dexmedetomidine NNP Pharmocological
with IN None
trimeperidine NN Pharmocological
and CC None
dexmedetomidine NN Pharmocological
sedation NN None
hypokinetic JJ None
type NN None
of IN None
haemodynamics NNS None
dexmedetomidine NN Pharmocological
trimeperidine NN Pharmocological
Dexmedetomidine NNP Pharmocological
-DOCSTART- -X- N

Selaginella NNP Pharmocological
radiotherapy NN Physical
group NN None
A NNP None
received VBD None
radiotherapy NN Physical
alone RB Physical
, , None
those DT None
in IN None
group NN None
B NNP None
were VBD None
given VBN None
daily JJ Pharmocological
Selaginella NNP Pharmocological
( ( Pharmocological
30 CD Pharmocological
g NN Pharmocological
) ) Pharmocological
prepared VBD Pharmocological
into IN Pharmocological
50 CD Pharmocological
ml JJ Pharmocological
decoction NN Pharmocological
during IN Pharmocological
the DT Pharmocological
entire JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
radiotherapy NN Pharmocological
group NN Pharmocological
C NNP Pharmocological
had VBD Pharmocological
Selaginella NNP Pharmocological
30 CD Pharmocological
g JJ Pharmocological
daily RB Pharmocological
in IN None
the DT None
late JJ None
course NN None
of IN None
radiotherapy NN Pharmocological
. . None
Selaginella NNP Pharmocological
-DOCSTART- -X- N

meloxicam NN Pharmocological
and CC Pharmocological
a DT Pharmocological
glucosamine-chondroitin JJ Pharmocological
supplement NN Pharmocological
meloxicam NN Pharmocological
and CC None
a DT None
glucosamine-chondroitin JJ Pharmocological
( ( Pharmocological
Glu-Ch NNP Pharmocological
) ) Pharmocological
supplement NN Pharmocological
Glu-Ch NNP Pharmocological
or CC Pharmocological
meloxicam NN Pharmocological
placebo NN Control
meloxicam NN Pharmocological
meloxicam NN Pharmocological
meloxicam NN Pharmocological
placebo NN None
meloxicam NN Pharmocological
meloxicam NN Pharmocological
placebo NN None
meloxicam NN Pharmocological
-DOCSTART- -X- N

lorazepam JJ Pharmocological
0.5 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
1 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
2 CD Pharmocological
mg NN Pharmocological
, , None
sertraline VBP Pharmocological
50 CD Pharmocological
mg NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

placebo-controlled JJ Control
D-cycloserine NNP Pharmocological
D-cycloserine NNP Pharmocological
D-cycloserine NNP Pharmocological
placebo NN Control
D-cycloserine NNP Pharmocological
placebo NN Control
D-cycloserine NNP Pharmocological
placebo NN Control
D-cycloserine NNP Pharmocological
-DOCSTART- -X- N

integrated VBN Psychological
, , Psychological
community-based JJ Psychological
package NN Psychological
for IN Psychological
-DOCSTART- -X- N

Heparan NNP Pharmocological
sulfate NN Pharmocological
randomly RB None
assigned VBN None
to TO None
heparan VB Pharmocological
sulfate NN Pharmocological
( ( Pharmocological
40 CD Pharmocological
mg NN Pharmocological
orally RB Pharmocological
twice RB Pharmocological
a DT Pharmocological
day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
for IN None
6 CD None
months NNS None
. . None
heparan NN Pharmocological
sulfate NN Pharmocological
-DOCSTART- -X- N

granisetron NN Pharmocological
cisplatin-based JJ Pharmocological
chemotherapy NN Pharmocological
. . None
granisetron NN Pharmocological
Granisetron NNP Pharmocological
chemotherapy NN Pharmocological
granisetron NN Pharmocological
granisetron VBZ Pharmocological
-DOCSTART- -X- N

sensorimotor NN Physical
enrichment NN Physical
group NN Physical
olfactory/tactile JJ Physical
stimulation NN Physical
along IN None
with IN None
exercises NNS Physical
that WDT None
stimulated VBD None
other JJ None
paired JJ None
sensory JJ None
modalities NNS None
, , None
or CC None
to TO None
a DT None
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

GS-9620 NNP Pharmocological
GS-9620 NNP Pharmocological
placebo-controlled JJ Control
GS-9620 NNP Pharmocological
single JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
GS-9620 NNP Pharmocological
( ( Pharmocological
0.3 CD Pharmocological
, , Pharmocological
1 CD Pharmocological
, , Pharmocological
2 CD Pharmocological
, , Pharmocological
4 CD Pharmocological
, , Pharmocological
6 CD Pharmocological
, , Pharmocological
8 CD Pharmocological
or CC Pharmocological
12 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
GS-9620 NNP Pharmocological
GS-9620 NNP None
doses NNS None
CONCLUSIONS NNP None
GS-9620 NNP None
-DOCSTART- -X- N

chemotherapy NN None
-DOCSTART- -X- N

colloidal JJ Pharmocological
bismuth NN Pharmocological
subcitrate NN Pharmocological
coated VBD Pharmocological
tablets NNS Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
coated VBD Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
coated VBD Pharmocological
tablets NNS Pharmocological
CBS NNP Pharmocological
coated VBD Pharmocological
tablet NN Pharmocological
chewing VBG Pharmocological
tablets NNS Pharmocological
. . None
-DOCSTART- -X- N

Videotaped NNP Educational
training NN Educational
in IN Educational
alcohol NN Educational
counseling NN Educational
videotaped JJ Educational
training NN Educational
for IN Educational
in IN Educational
motivational JJ Educational
interviewing NN Educational
skills NNS Educational
20-minute JJ Educational
videotape NN Educational
motivational JJ Educational
interviewing NN Educational
videotape NN Educational
. . None
Control NNP Pharmocological
20-minute JJ Pharmocological
docudrama NN Pharmocological
training NN Educational
video NN Educational
videotaped JJ Educational
instruction NN Educational
in IN Educational
motivational JJ Educational
interviewing NN Educational
. . Educational
motivational JJ Educational
interviewing NN Educational
-DOCSTART- -X- N

echis JJ Pharmocological
antivenom NN Pharmocological
made VBD Pharmocological
either CC Pharmocological
by IN Pharmocological
the DT Pharmocological
South JJ Pharmocological
African NNP Pharmocological
Institute NNP Pharmocological
for IN Pharmocological
Medical NNP Pharmocological
Research NNP Pharmocological
( ( Pharmocological
S.A.I.M.R NNP Pharmocological
. . Pharmocological
) ) Pharmocological
( ( None
North NNP None
and CC None
West NNP None
African NNP None
polyvalent NN None
antivenom NN None
) ) None
S.A.I.M.R NNP Pharmocological
. . Pharmocological
antivenom RB None
Behringwerke NNP Pharmocological
antivenom VBP Pharmocological
Behringwerke NNP Pharmocological
antivenom NN Pharmocological
-DOCSTART- -X- N

face NN Other
gaze NN Other
Bubbles NNP Other
method NN Other
-DOCSTART- -X- N

toothpastes NNS Physical
abrasivity NN Physical
. . None
five-treatment JJ None
cross-over NN None
design NN None
Drinking NN Physical
water NN Physical
brushing NN Physical
toothpaste NN None
Drinking VBG None
orange NN Physical
juice NN Physical
. . None
orange NN Physical
juice NN Physical
and CC None
brushing VBG Physical
with IN Physical
toothpaste NN Physical
-DOCSTART- -X- N

resistance NN Physical
exercise NN Physical
eccentric JJ Educational
( ( Physical
ECC NNP Physical
) ) Physical
or CC Physical
concentric JJ Physical
( ( Physical
CONC NNP Physical
) ) Physical
contractions NNS Physical
exercise NN Physical
ECC NNP Physical
exercise NN Physical
. . None
CONC NNP Physical
exercise NN Physical
acute VB Physical
exercise NN Physical
accumulated JJ Educational
training NN Educational
-DOCSTART- -X- N

chiropractic JJ Pharmocological
and CC None
medical JJ Educational
care NN Educational
medical JJ Educational
and CC Educational
chiropractic JJ Educational
care NN Educational
for IN Educational
physical JJ Physical
therapy NN Physical
chiropractic VB Physical
with IN Physical
or CC Physical
without IN Physical
physical JJ Physical
modalities NNS Physical
, , None
or CC None
medical JJ Physical
care NN Physical
with IN Physical
or CC Physical
without IN Physical
physical JJ Physical
therapy NN Physical
physical JJ Physical
therapy NN Physical
chiropractic JJ Educational
care NN Educational
chiropractic JJ Educational
medical JJ Educational
and CC Educational
chiropractic JJ Educational
care NN Educational
Physical JJ Physical
therapy NN Physical
-DOCSTART- -X- N

laser-powered JJ Surgical
hydrokinetic JJ Surgical
system NN Surgical
Laser NNP Surgical
systems NNS Surgical
Er NNP Surgical
, , Surgical
Cr NNP Surgical
: : Surgical
YSGG NN Surgical
, , Surgical
laser NN Surgical
system NN Surgical
resin NN Physical
restorations NNS Physical
Er NNP Surgical
, , Surgical
Cr NNP Surgical
: : Surgical
YSGG NNP Surgical
laser NN Surgical
system NN Surgical
Er NNP Surgical
, , Surgical
Cr NNP Surgical
: : Surgical
YSGG NNP Surgical
laser NN Surgical
-DOCSTART- -X- N

repetitive JJ Surgical
transcranial JJ Surgical
magnetic JJ Surgical
stimulation NN Surgical
( ( Surgical
rTMS NN Surgical
) ) Surgical
repetitive JJ Surgical
transcranial JJ Surgical
magnetic JJ Surgical
stimulation NN Surgical
( ( Surgical
rTMS NN Surgical
) ) None
10 CD Surgical
Hz NNP Surgical
rTMS NN Surgical
sham NN None
sham JJ Control
stimulation NN Control
. . None
-DOCSTART- -X- N

interleukin-2 NN Pharmocological
( ( Pharmocological
IS-IL-2 NNP Pharmocological
) ) Pharmocological
continuous JJ None
infusion NN None
with IN None
low JJ Pharmocological
dose JJ Pharmocological
recombinant NN Pharmocological
of IN Pharmocological
IL-2 NNP Pharmocological
-DOCSTART- -X- N

glycoPEGylated JJ None
recombinant NN None
activated VBD None
factor NN None
VII NNP None
derivative NN None
: : None
is VBZ None
glycoPEGylation NN None
, , None
rFVIIa NN None
derivative JJ None
( ( None
N7-GP NNP None
) ) None
of IN None
N7-GP NNP None
placebo NN None
( ( None
-DOCSTART- -X- N

root NN Physical
planing VBG Physical
Ultrasonic JJ Physical
and CC Physical
power-driven JJ Physical
instrumentation NN Physical
Various JJ Educational
ultrasonic JJ Physical
scalers NNS Physical
, , Educational
hand NN Physical
instruments NNS Physical
and CC Educational
two CD Physical
power-driven JJ Physical
systems NNS Physical
ultrasonic JJ Physical
scaler NN Physical
and CC Physical
Periopolisher NNP Physical
diamond-coated JJ Physical
inserts NNS Physical
( ( Physical
US-POL NNP Physical
) ) Physical
, , Educational
hand NN Physical
instruments NNS Physical
( ( Physical
MANUAL NNP Physical
) ) Physical
, , Educational
Perioplaner-Periopolisher NNP Physical
system NN Physical
( ( Physical
PPL-POL NNP Physical
) ) Physical
and CC Educational
Periokit NNP Physical
ultrasonic-designed JJ Physical
scalers NNS Physical
( ( Physical
PERIOKIT NNP Physical
) ) Physical
. . Educational
ultrasonic JJ Physical
scaler NN Physical
alone RB Other
and CC Other
hand NN Physical
instruments NNS Physical
-DOCSTART- -X- N

fish JJ Pharmocological
oil NN Pharmocological
corn NN Pharmocological
oil NN Pharmocological
. . None
fish JJ Pharmocological
oil NN Pharmocological
corn NN Pharmocological
oil NN Pharmocological
cyclosporin-treated JJ Pharmocological
oil NN Pharmocological
. . None
cyclosporin NN Pharmocological
oil NN Pharmocological
cyclosporin-induced JJ Pharmocological
-DOCSTART- -X- N

Ambulation NN Physical
an DT None
ambulant JJ Physical
group NN None
and CC None
half NN None
to TO None
a DT None
recumbent NN Control
group NN None
. . None
Ambulation NNP Physical
-DOCSTART- -X- N

tamoxifen NN Pharmocological
surgical JJ Surgical
oophorectomy NN Surgical
tamoxifen NN Pharmocological
undergo VB Surgical
a DT Surgical
surgical JJ Surgical
oophorectomy NN Surgical
. . Surgical
. . None
tamoxifen NN Pharmocological
surgical JJ Surgical
oophorectomy NN Surgical
tamoxifen EX Pharmocological
surgical JJ Surgical
oophorectomy NN Surgical
. . None
-DOCSTART- -X- N

panitumumab NN Pharmocological
( ( Pharmocological
Vectibix NNP Pharmocological
) ) Pharmocological
panitumumab VB Pharmocological
( ( Pharmocological
Vectibix NNP Pharmocological
; : Pharmocological
panitumumab JJ Pharmocological
chemotherapy NN Pharmocological
and CC None
bevacizumab NN Pharmocological
with IN Pharmocological
and CC Pharmocological
without IN Pharmocological
panitumumab NN Pharmocological
bevacizumab NN Pharmocological
and CC Pharmocological
chemotherapy NN Pharmocological
panitumumab NN Pharmocological
panitumumab-treated JJ Pharmocological
panitumumab NN Pharmocological
to TO Pharmocological
bevacizumab VB Pharmocological
and CC Pharmocological
chemotherapy VB Pharmocological
bevacizumab NN Pharmocological
and CC Pharmocological
chemotherapy NN Pharmocological
alone RB Pharmocological
. . None
panitumumab NN Pharmocological
-DOCSTART- -X- N

higher JJR None
imatinib NN Pharmocological
doses NNS None
imatinib NN Pharmocological
dose NN None
imatinib JJ Pharmocological
400 CD Pharmocological
-DOCSTART- -X- N

micronutrient NN Pharmocological
supplement NN Pharmocological
supplementation NN None
with IN None
a DT None
micronutrient-fortified JJ Pharmocological
beverage NN Pharmocological
micronutrient-enriched JJ Pharmocological
beverage NN Pharmocological
or CC None
a DT None
placebo NN Control
without IN Control
added JJ Control
micronutrients NNS Control
. . None
micronutrient-enriched JJ Pharmocological
beverage NN Pharmocological
. . None
micronutrients NNS Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

Promoting VBG Other
social JJ Other
skill NN Other
development NN Other
social JJ Educational
skills NNS Educational
intervention NN Educational
group NN Educational
intervention NN Educational
designed VBN Educational
to TO Educational
teach VB Educational
appropriate JJ Educational
social JJ Educational
behavior NN Educational
. . None
social JJ Educational
skills NNS Educational
intervention NN Educational
. . Educational
-DOCSTART- -X- N

Low-dose JJ Pharmocological
growth NN Pharmocological
hormone NN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
diet JJ Pharmocological
restriction NN Pharmocological
Growth NNP Pharmocological
hormone NN Pharmocological
diet NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
GH NNP Pharmocological
placebo NN Control
GH NNP Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
injections NNS Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

interdental JJ Educational
hygiene NN Educational
structural JJ Educational
equation NN Educational
modeling NN Educational
pre-curved JJ Educational
interdental JJ Educational
brushes NNS Educational
and CC Educational
flossing VBG Educational
-DOCSTART- -X- N

hydrochlorothiazide NN Pharmocological
therapy NN Pharmocological
hydrochlorothiazide NN Pharmocological
therapy NN Pharmocological
patients NNS None
were VBD None
treated VBN None
with IN None
placebo NN Control
followed VBN None
by IN None
hydrochlorothiazide NN Pharmocological
. . None
hydrochlorothiazide JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
placebo NN Control
hydrochlorothiazide NN Pharmocological
. . Pharmocological
hydrochlorothiazide NN Pharmocological
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
methylprednisolone NN Pharmocological
methylprednisolone NN Pharmocological
cyclophosphamide NN Pharmocological
IV NNP Pharmocological
MP NNP Pharmocological
bimonthly RB Pharmocological
-DOCSTART- -X- N

hip NN Surgical
fracture NN Surgical
surgery NN Surgical
hip NN Surgical
fracture NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

pill NN Pharmocological
containing VBG Pharmocological
drospirenone NN Pharmocological
with IN None
those DT None
of IN None
a DT None
combined JJ Pharmocological
contraceptive JJ Pharmocological
vaginal JJ Pharmocological
ring NN Pharmocological
on IN None
drospirenone+ethinylestradiol VB Pharmocological
or CC None
combined VBN Pharmocological
contraceptive JJ Pharmocological
vaginal JJ Pharmocological
ring NN Pharmocological
therapy NN Pharmocological
. . None
6 CD None
months NNS None
of IN None
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

Whole-body JJ Other
CT NNP Other
screening NN Other
: : None
scan JJ None
delay NN None
and CC None
contrast NN Pharmocological
injection NN Pharmocological
contrast-enhanced JJ Other
whole-body NN Other
computed VBN Other
tomography NN Other
( ( Other
CT NNP Other
) ) Other
. . Other
protocol NN None
A-scan JJ None
delay NN None
of IN None
65 CD None
s NNS None
after IN None
starting VBG None
contrast NN Pharmocological
injection NN Pharmocological
over IN None
30 CD None
s NNS None
; : None
protocol CC None
B-105 NNP None
and CC None
70 CD None
s NN None
; : None
and CC None
protocol VB None
C-145 NNP None
and CC None
110 CD None
s NN None
protocol NN None
C NNP None
whole-body JJ Other
CT NNP Other
. . Other
-DOCSTART- -X- N

complementary JJ Pharmocological
foods NNS Pharmocological
complementary JJ Educational
feeding NN Educational
continued VBN Other
full JJ Other
breast-feeding NN Other
until IN Other
6 CD Other
mo NNS Other
introduction NN Other
of IN Other
complementary JJ Other
foods NNS Other
at IN Other
4 CD Other
mo NN Other
with IN Other
ad NN Other
libitum NN Other
breast-feeding NN Other
from IN Other
4 CD Other
to TO Other
6 CD Other
mo NN Other
introduction NN Psychological
of IN Psychological
complementary JJ Psychological
foods NNS Psychological
at IN Psychological
4 CD Psychological
mo NN Psychological
with IN Psychological
maintenance NN Psychological
of IN Psychological
baseline JJ Psychological
breast-feeding JJ Psychological
frequency NN Psychological
from IN Psychological
4 CD Psychological
to TO Psychological
6 CD Psychological
mo NNS Psychological
complementary JJ Pharmocological
foods NNS Pharmocological
-DOCSTART- -X- N

telephone NN Educational
videophone NN Other
telephone NN Educational
videophone VB Other
. . None
telephone NN Educational
videophone NN Other
. . None
videophone NN Other
videophone NN Other
. . None
videophone NN Other
telephone NN Educational
. . None
videophone NN Other
-DOCSTART- -X- N

ischaemic JJ Physical
preconditioning NN Physical
, , None
cardiopulmonary JJ Surgical
bypass NN Surgical
and CC None
myocardial JJ Surgical
ischaemic/reperfusion NN Surgical
ischaemic JJ Physical
preconditioning NN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
ischaemic JJ Physical
preconditioning NN Physical
. . Surgical
ischaemic JJ Physical
preconditioning NN Physical
control NN None
group NN None
. . None
ischaemic JJ Physical
preconditioning NN Physical
two CD None
cycles NNS None
of IN None
2-min JJ None
ischaemia NN Physical
followed VBN None
by IN None
3-min JJ None
reperfusion NN Physical
. . None
ischaemic JJ Physical
preconditioning NN Physical
ischaemic JJ Physical
preconditioning NN Physical
ischaemic JJ Physical
preconditioning NN Physical
. . Surgical
ischaemic JJ Physical
preconditioning NN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
ischaemic JJ Physical
preconditioning NN Physical
-DOCSTART- -X- N

behavioral JJ Psychological
training NN Psychological
therapy NN Psychological
behavioral JJ Educational
program NN Educational
. . None
-DOCSTART- -X- N

wet JJ Other
corn NN Other
gluten NNS Other
feed VBP Other
( ( Other
WCGF NNP Other
) ) Other
control NN Physical
-- : Physical
WCGF NNP Physical
not RB Physical
fed RB Physical
( ( None
n JJ None
= NNP None
27 CD None
) ) None
; : None
2 CD None
) ) None
WCGF-L-cows NNP None
received VBD None
diets NNS Other
containing VBG Other
WCGF NNP Other
( ( None
38 CD None
% NN None
DM NNP None
basis NN None
) ) None
during IN None
lactation NN None
( ( None
n JJ None
= NNP None
23 CD None
) ) None
; : None
and CC None
3 CD None
) ) None
WCGF-DL NNP None
-- : None
cows VBZ None
received VBN None
diets NNS Other
containing VBG Other
WCGF NNP Other
( ( None
38 CD None
% NN None
DM NNP None
basis NN None
) ) None
during IN None
the DT None
dry JJ None
period NN None
and CC None
lactation NN None
( ( None
n JJ None
= NNP None
26 CD None
) ) None
. . None
-DOCSTART- -X- N

telcagepant NN Pharmocological
Telcagepant NNP Pharmocological
oral JJ Physical
calcitonin NN Physical
gene-related JJ Physical
peptide NN Physical
receptor NN Physical
oral JJ Pharmocological
triptans NNS Pharmocological
. . Pharmocological
telcagepant NN Pharmocological
. . None
telcagepant NN Pharmocological
( ( Pharmocological
150 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
300 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
zolmitriptan VBZ Pharmocological
5 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
or CC Pharmocological
placebo NN Pharmocological
For IN None
zolmitriptan JJ None
, , None
for IN None
telcagepant JJ None
and CC None
placebo NN None
receiving VBG None
telcagepant JJ None
receiving VBG None
zolmitriptan NN None
for IN None
telcagepant JJ None
from IN None
zolmitriptan NN None
to TO None
triptans NNS None
or CC None
telcagepant JJ None
-DOCSTART- -X- N

FemCap NNP Physical
, , Physical
a DT Physical
new JJ Physical
vaginal JJ Physical
barrier NN Physical
contraceptive NN Physical
Ortho NNP Pharmocological
All-Flex NNP Pharmocological
diaphragm NN Pharmocological
. . None
FemCap NNP Physical
FemCap NNP Pharmocological
or CC Pharmocological
Ortho NNP Pharmocological
All-Flex NNP Pharmocological
contraceptive NN Pharmocological
diaphragm NN Pharmocological
, , Pharmocological
both DT Pharmocological
with IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
nonoxynol-9 JJ Pharmocological
spermicide NN Pharmocological
FemCap NNP Pharmocological
diaphragm NN Physical
FemCap NNP Pharmocological
diaphragm JJ Pharmocological
FemCap NNP Pharmocological
diaphragm JJ Pharmocological
FemCap NNP Pharmocological
FemCap NNP Pharmocological
diaphragm NN Pharmocological
diaphragm JJ Pharmocological
FemCap NNP Pharmocological
FemCap NNP Pharmocological
-DOCSTART- -X- N

cicloxilic JJ Pharmocological
acid NN Pharmocological
cicloxilic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

marine NN Pharmocological
lipid JJ Pharmocological
suppositories NNS Pharmocological
suppositories NNS Pharmocological
and CC Pharmocological
ointment NN Pharmocological
with IN Pharmocological
30 CD Pharmocological
% NN Pharmocological
free JJ Pharmocological
fatty JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
FFA NNP Pharmocological
) ) Pharmocological
extract NN Pharmocological
from IN Pharmocological
omega-3 JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
. . None
FFA NNP Pharmocological
suppositories NNS Pharmocological
FFA NNP Pharmocological
ointment NN Pharmocological
placebo NN Control
suppositories NNS Control
-DOCSTART- -X- N

eye-tracking JJ Educational
eye-tracking VBG Educational
Eye-tracking JJ Educational
methodology NN Educational
-DOCSTART- -X- N

rabeprazole NN Pharmocological
rabeprazole JJ Pharmocological
placebo-controlled JJ Control
rabeprazole JJ Pharmocological
placebo NN Control
. . None
rabeprazole JJ Pharmocological
placebo NN Control
rabeprazole NN Pharmocological
placebo NN Control
rabeprazole NN Pharmocological
Rabeprazole NNP Pharmocological
-DOCSTART- -X- N

ganciclovir NN Pharmocological
valacyclovir NN Pharmocological
ganciclovir NN Pharmocological
and CC None
valacyclovir NN Pharmocological
ganciclovir NN Pharmocological
and CC None
valacyclovir NN Pharmocological
no DT Control
prophylaxis NN Control
. . None
-DOCSTART- -X- N

FAM NNP Pharmocological
5-FU JJ Pharmocological
plus JJ Pharmocological
BCNU NNP Pharmocological
. . None
chemotherapy NN Pharmocological
( ( None
FAM NNP Pharmocological
versus IN None
5-FU JJ Pharmocological
plus CC Pharmocological
BCNU NNP Pharmocological
) ) Pharmocological
FAM NNP Pharmocological
FAM NNP Pharmocological
FAM NNP Pharmocological
5-FU JJ Pharmocological
plus CC Pharmocological
BCNU JJ Pharmocological
-DOCSTART- -X- N

demonstration NN Educational
physician JJ Educational
intervention NN Educational
-DOCSTART- -X- N

Topical JJ None
therapy NN None
with IN None
beta-antagonists NNS None
timolol NNS Pharmocological
carteolol NN Pharmocological
betaxolol NN Pharmocological
betaxolol VB Pharmocological
carteolol NN Pharmocological
timolol NNS Pharmocological
-DOCSTART- -X- N

enoxaparin NN Pharmocological
and CC None
standard JJ Pharmocological
heparin NN Pharmocological
enoxaparin NN Pharmocological
standard NN Pharmocological
heparin NN Pharmocological
( ( Pharmocological
SH NNP Pharmocological
) ) Pharmocological
2,500 CD Pharmocological
IU NNP Pharmocological
enoxaparin NN Pharmocological
once RB None
daily JJ None
and CC None
SH NNP Pharmocological
in IN None
a DT None
dose NN None
of IN None
5,000 CD None
IU NNP None
three CD None
times NNS None
daily RB None
. . None
enoxaparin/day NN Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
before IN None
chemotherapeutic JJ None
treatment NN None
as RB None
well RB None
chemotherapy NN None
and CC None
chemotherapy NN None
for IN None
before IN None
chemotherapy NN None
and CC None
chemotherapy NN None
( ( None
p JJ None
< NNP None
0.005 CD None
DISCUSSION NNP None
Chemotherapy NNP None
significantly RB None
-DOCSTART- -X- N

mizolastine JJ Pharmocological
placebo-controlled JJ Control
loratadine NN Pharmocological
Mizolastine NNP Pharmocological
mizolastine NN Pharmocological
with IN Pharmocological
loratadine NN Pharmocological
and CC None
placebo NN Control
placebo NN Control
mizolastine NN Pharmocological
loratadine NN Pharmocological
placebo NN Control
Mizolastine NNP Pharmocological
loratadine VB Pharmocological
mizolastine NN Pharmocological
and CC Pharmocological
loratadine NN Pharmocological
placebo NN Control
( ( None
mizolastine NN Pharmocological
: : None
loratadine NN Pharmocological
: : None
placebo NN Control
: : None
placebo NN Control
( ( None
mizolastine NN Pharmocological
: : None
loratadine NN Pharmocological
: : None
placebo NN Control
: : None
mizolastine NN Pharmocological
loratadine NN Pharmocological
placebo NN Control
placebo VB Control
mizolastine NN Pharmocological
or CC Pharmocological
loratadine NN Pharmocological
. . None
Mizolastine NNP Pharmocological
placebo VB Control
Mizolastine NNP Pharmocological
loratadine NN Pharmocological
-DOCSTART- -X- N

sham JJ Pharmocological
intravitreal JJ Pharmocological
injections NNS Pharmocological
. . None
sham NN Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
prompt JJ Physical
laser NN Physical
, , None
intravitreal JJ Pharmocological
ranibizumab NN Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
prompt JJ Physical
laser NN Physical
, , None
intravitreal JJ Pharmocological
ranibizumab NN Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
deferred JJ Physical
laser NN Physical
, , None
or CC None
intravitreal VB Pharmocological
triamcinolone JJ Pharmocological
acetonide JJ Pharmocological
injections NNS Pharmocological
plus CC Pharmocological
prompt NN Physical
laser NN Physical
sham VB Physical
plus JJ Physical
prompt JJ Physical
laser NN Physical
real JJ Pharmocological
injection NN Pharmocological
Laser NNP Physical
treatment NN Physical
sham NN Physical
sometimes RB Physical
real JJ Physical
and CC Physical
sometimes RB Physical
sham JJ Physical
. . None
sham NN Physical
plus CC Physical
prompt JJ Physical
laser NN Physical
ranibizumab NN Physical
plus CC Physical
prompt JJ Physical
laser NN Physical
ranibizumab NN Physical
plus CC Physical
deferred JJ Physical
laser NN Physical
triamcinolone NN Pharmocological
plus CC Pharmocological
prompt JJ Pharmocological
laser NN Pharmocological
sham NN Pharmocological
injection NN Pharmocological
real JJ Pharmocological
injection NN Pharmocological
-DOCSTART- -X- N

enamel JJ Pharmocological
preparation NN Pharmocological
method NN Pharmocological
Er NNP Physical
: : Physical
YAG NNP Physical
laser NN Physical
diamond-bur JJ Physical
conventional JJ Physical
technique NN Physical
. . Educational
high-speed JJ Pharmocological
handpiece NN Pharmocological
+ VBD None
37 CD Pharmocological
% NN Pharmocological
phosphoric JJ Pharmocological
acid NN Pharmocological
; : Pharmocological
Er NN Pharmocological
: : Pharmocological
YAG NNP Pharmocological
laser NN Pharmocological
( ( Pharmocological
350 CD Pharmocological
mJ NN Pharmocological
, , None
4 CD None
Hz NNP None
and CC None
112 CD None
J/cm NNP None
( ( None
2 CD None
) ) None
) ) None
+ $ None
37 CD Pharmocological
% NN Pharmocological
phosphoric JJ Pharmocological
acid NN Pharmocological
; : None
Er NN Pharmocological
: : Pharmocological
YAG NNP Pharmocological
laser NN Pharmocological
( ( Pharmocological
350 CD Pharmocological
mJ NN Pharmocological
, , None
4 CD None
Hz NNP None
and CC None
112 CD None
J/cm NNP None
( ( None
2 CD None
) ) None
) ) None
+ FW None
Er NNP Pharmocological
: : Pharmocological
YAG NNP Pharmocological
laser NN Pharmocological
( ( Pharmocological
80 CD Pharmocological
mJ NN Pharmocological
, , Pharmocological
4 CD Pharmocological
Hz NNP Pharmocological
, , Pharmocological
and CC Pharmocological
25 CD Pharmocological
mJ/cm NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
thermal VB Physical
cycling NN Physical
silver NN Pharmocological
nitrate JJ Pharmocological
solutions NNS Pharmocological
enamel NN Pharmocological
preparation NN Pharmocological
Er NNP Physical
: : Physical
YAG NNP Physical
laser NN Physical
-DOCSTART- -X- N

imiquimod JJ Pharmocological
cream NN Pharmocological
imiquimod JJ None
5 CD None
% NN None
imiquimod JJ Pharmocological
cream NN Pharmocological
or CC None
vehicle NN None
to TO None
3 CD None
times NNS None
per IN None
week NN None
for IN None
a DT None
maximum NN None
of IN None
12 CD None
weeks NNS None
or CC None
until IN None
lesions NNS None
had VBD None
resolved VBN None
. . None
imiquimod NN Pharmocological
imiquimod JJ Pharmocological
cream NN Pharmocological
imiquimod NN Pharmocological
imiquimod NN None
imiquimod NN Pharmocological
imiquimod JJ Pharmocological
cream NN Pharmocological
-DOCSTART- -X- N

Hexetidine NNP Pharmocological
( ( Pharmocological
'Oraldene NNP Pharmocological
' POS Pharmocological
) ) Pharmocological
: : None
0.1 CD Pharmocological
% NN Pharmocological
solution NN Pharmocological
of IN Pharmocological
hexetidine NN Pharmocological
with IN None
that DT None
of IN None
placebo NN Control
. . None
hexetidine NN Pharmocological
or CC None
placebo NN Control
Hexetidine NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

-DOCSTART- -X- N

Sivelestat NNP Pharmocological
sodium NN Pharmocological
hydrate NN Pharmocological
Sivelestat NNP Pharmocological
sodium NN Pharmocological
hydrate NN Pharmocological
( ( Pharmocological
sivelestat NN Pharmocological
) ) Pharmocological
sivelestat NNS Pharmocological
sivelestat NN Pharmocological
sivelestat NN Pharmocological
-DOCSTART- -X- N

addition NN Pharmocological
of IN Pharmocological
adriamycin NN Control
( ( Control
ADR NNP Control
) ) Control
or CC Control
bilateral JJ Physical
pulmonary JJ Physical
radiotherapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
to TO Control
vincristine VB Control
, , Control
dactinomycin NN Control
, , Control
and CC Control
cyclophosphamide NN Control
( ( Control
VAC NNP Control
therapy NN Control
) ) Control
RT NNP None
ADR NNP None
VAC NNP None
-DOCSTART- -X- N

cyclosporine JJ Pharmocological
reduction NN None
sirolimus NN Pharmocological
, , Pharmocological
corticosteroid NN Pharmocological
, , Pharmocological
and CC Pharmocological
cyclosporine VB Pharmocological
reduction NN None
standard-dose JJ Pharmocological
cyclosporine NN Pharmocological
( ( None
sCsA NN None
reduced-dose JJ Pharmocological
cyclosporine NN Pharmocological
( ( None
rCsA NN None
sirolimus JJ Pharmocological
and CC None
corticosteroids NNS Pharmocological
. . None
-DOCSTART- -X- N

synthetic JJ Pharmocological
appeasing VBG Pharmocological
pheromone NN Pharmocological
synthetic JJ Pharmocological
, , Pharmocological
dog-appeasing JJ Pharmocological
pheromone NN Pharmocological
( ( Pharmocological
sDAP NN Pharmocological
) ) Pharmocological
sDAP JJ Physical
solution NN Physical
or CC None
sham NN Control
treated VBN Control
with IN Control
the DT Control
carrier NN Control
used VBN None
in IN None
the DT None
solution NN None
20 CD None
minutes NNS None
prior RB None
to TO None
use VB None
. . None
sDAP NN Physical
sham JJ Control
treatment NN Control
sDAP NN Pharmocological
-DOCSTART- -X- N

electro-acupuncture NN Physical
electro-acupuncture NN Physical
Electro-acupuncture NN Physical
chemotherapy NN Pharmocological
electro-acupuncture NN Physical
chemotherapy NN Pharmocological
electro-acupuncture NN Physical
Electro-acupuncture NN Physical
chemotherapy NN Pharmocological
-DOCSTART- -X- N

endogenous JJ Pharmocological
estrogen NN Pharmocological
concentrations NNS Pharmocological
serum NN Pharmocological
cholesteryl NN Pharmocological
ester NN Pharmocological
were VBD None
determined VBN None
in IN None
-DOCSTART- -X- N

epanolol NN Pharmocological
Epanolol NNP Pharmocological
epanolol JJ Pharmocological
epanolol NN Pharmocological
atenolol NN Pharmocological
epanolol NN Pharmocological
-DOCSTART- -X- N

Bacterial NNP Pharmocological
ribosomal JJ Pharmocological
immunostimulants NNS Pharmocological
D53 NNP Pharmocological
( ( Pharmocological
Ribomunyl NNP Pharmocological
) ) Pharmocological
, , Pharmocological
a DT Pharmocological
composite JJ Pharmocological
bacterial JJ Pharmocological
ribosomal NN Pharmocological
immunostimulant NN Pharmocological
D53 NNP Pharmocological
D53 NNP Pharmocological
placebo NN Control
D53-treated NNP Pharmocological
D53-treated NNP Pharmocological
placebo NN None
D53-treated NNP Pharmocological
D53 NNP Pharmocological
immunostimulant NN Pharmocological
D53 NNP Pharmocological
immunostimulant NN Pharmocological
-DOCSTART- -X- N

Use NNP Educational
of IN Educational
an DT Educational
Internet NNP Educational
portal NN Educational
quality NN Educational
improvement NN Educational
program NN Educational
training NN Educational
, , Educational
including VBG Educational
didactic JJ Educational
lectures NNS Educational
and CC Educational
office NN Educational
flow NN Educational
modification NN Educational
workshops NNS Educational
. . Educational
ADHD NNP Educational
Internet NNP Educational
portal NN Educational
control NN Control
A DT Educational
quality NN Educational
improvement NN Educational
intervention NN Educational
Internet-based JJ Educational
information NN Educational
technology NN Educational
-DOCSTART- -X- N

pentoxifylline NN Pharmocological
phosphodiesterase NN Pharmocological
( ( Pharmocological
PDE NNP Pharmocological
) ) Pharmocological
inhibitor NN Pharmocological
pentoxifylline NN Pharmocological
PDE NNP Pharmocological
inhibitor NN Pharmocological
PDE NNP Pharmocological
inhibitor NN Pharmocological
pentoxifylline NN Pharmocological
randomly RB None
assigned VBN None
to TO None
either DT None
pentoxifylline NN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
or CC None
placebo NN Pharmocological
3 CD None
times NNS None
daily RB None
for IN None
14 CD None
days NNS None
. . None
placebo NN Control
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
-DOCSTART- -X- N

2-chloroprocaine JJ Pharmocological
: : None
clonidine NN Pharmocological
. . None
2-chloroprocaine JJ Pharmocological
( ( Pharmocological
2-CP JJ Pharmocological
) ) Pharmocological
Clonidine NNP Pharmocological
2-CP JJ Pharmocological
. . None
clonidine NN Pharmocological
clonidine NN Pharmocological
Clonidine NNP Pharmocological
clonidine NN Pharmocological
-DOCSTART- -X- N

Lightwand NNP Surgical
or CC Physical
GlideScope NNP Surgical
to TO Physical
Macintosh NNP Surgical
laryngoscopy NN Surgical
, , Physical
with IN Physical
in-line JJ Surgical
stabilization NN Surgical
. . None
manual JJ Physical
ventilation NN Physical
via IN Physical
bag-mask NN Physical
, , Physical
laryngoscopy NN Surgical
, , Physical
and CC Physical
intubation NN Surgical
. . None
-DOCSTART- -X- N

whole-body JJ Physical
mild-cold JJ Physical
exposure NN Physical
whole-body JJ Educational
mild-cold JJ Educational
12 CD None
?C NNS None
( ( None
mild-cold JJ None
) ) None
and CC None
21 CD None
?C NNP None
( ( None
control NN None
) ) None
on IN None
mild-cold JJ None
and CC None
mild-cold JJ None
exposure NN None
-DOCSTART- -X- N

language NN Educational
and CC Educational
speech-language JJ Educational
intervention NN Educational
. . None
direct JJ Educational
and CC Educational
indirect JJ Educational
intervention NN Educational
receiving VBG None
both DT None
direct JJ None
and CC None
indirect JJ None
intervention NN None
( ( None
TG NNP None
) ) None
, , None
receiving VBG None
indirect JJ None
intervention NN None
exclusively RB None
the DT None
OG NNP None
-DOCSTART- -X- N

mecamylamine NN Pharmocological
nicotinic JJ Pharmocological
acetylcholine NN Pharmocological
receptor NN Pharmocological
( ( Pharmocological
nAChR JJ Pharmocological
) ) Pharmocological
agent NN Pharmocological
Mecamylamine NNP None
, , None
because IN None
placebo VB None
( ( None
n=8 NN None
mecamylamine NN None
( ( None
n=12 JJ None
placebo NN None
group NN None
placebo NN None
. . None
Of IN None
continued JJ None
mecamylamine NN None
at IN None
their PRP$ None
CONCLUSION NNP None
Mecamylamine NNP None
appeared VBD None
specific JJ None
?4?2 NNP None
nAChR JJ None
agonist NN None
, , None
such JJ None
as IN None
varenicline NN None
. . None
-DOCSTART- -X- N

tobacco JJ Pharmocological
abstinent JJ Pharmocological
approximately RB None
1-2mg JJ Pharmocological
of IN Pharmocological
nasal JJ Pharmocological
nicotine JJ Pharmocological
spray NN Pharmocological
and CC None
after IN Control
an DT Control
equivalent JJ Control
volume NN Control
of IN Control
an DT Control
active JJ Control
placebo NN Control
spray NN Control
of IN Control
oleoresin NN Control
of IN Control
pepper NN Control
Nicotine NNP Pharmocological
nicotine NN Pharmocological
nicotine NN Pharmocological
. . None
-DOCSTART- -X- N

pulsed-dye JJ Surgical
laser NN Surgical
pulsed-dye JJ Surgical
laser NN Surgical
( ( Surgical
PDL NNP Surgical
) ) Surgical
PDL NNP Surgical
C/BPO NNP Surgical
alone RB Surgical
or CC Surgical
in IN Surgical
combination NN Surgical
with IN Surgical
PDL NNP Surgical
treatment NN Surgical
( ( None
C/BPO NNP Surgical
) ) None
( ( None
C/BPO NNP Surgical
+ NNP Surgical
laser NN Surgical
) ) None
PDL NNP Surgical
-DOCSTART- -X- N

-DOCSTART- -X- N

ipilimumab JJ Pharmocological
were VBD None
randomized VBN None
to TO None
receive VB None
concomitant NN None
blinded VBN None
prophylactic JJ None
oral JJ None
budesonide NN None
( ( None
9 CD None
mg/d NN None
with IN None
gradual JJ None
taper NN None
through IN None
week NN None
16 CD None
) ) None
or CC None
placebo NN None
. . None
Outcome NNP None
resulted VBD None
Prophylactic NNP None
budesonide NN None
did VBD None
-DOCSTART- -X- N

emergency NN Physical
coronary JJ Physical
angioplasty NN Physical
intracoronary JJ Physical
streptokinase NN Physical
. . None
emergency NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
and CC None
intracoronary JJ Physical
streptokinase NN Physical
intracoronary JJ Physical
streptokinase NN Physical
. . None
Recatheterization NN Physical
and CC Physical
submaximal JJ Physical
exercise NN Physical
thallium-201 JJ Physical
single JJ Physical
photon NN Physical
emission NN Physical
computed VBD Physical
tomography NN Physical
emergency NN Physical
angioplasty NN Physical
streptokinase NN Physical
streptokinase NN Physical
. . None
coronary JJ Physical
angioplasty NN Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
streptokinase NN Pharmocological
angioplasty JJ Physical
versus NN Physical
lone NN Physical
angioplasty JJ Physical
therapy NN Physical
thrombolytic JJ Pharmocological
agents NNS Pharmocological
percutaneous JJ Physical
transluminal JJ Physical
coronary NN Physical
angioplasty NN Physical
( ( Physical
PTCA NNP Physical
) ) Physical
therapy NN Physical
intravenous JJ Pharmocological
heparin NNS Pharmocological
oral JJ Pharmocological
aspirin NN Pharmocological
placebo NN Control
or CC None
streptokinase NN Pharmocological
PTCA NNP None
. . None
PTCA NNP None
placebo NN Control
streptokinase NNP Pharmocological
Angioplasty NNP None
placebo NN None
streptokinase NNP Pharmocological
placebo NN None
and CC None
streptokinase NN Pharmocological
placebo NN None
and CC None
streptokinase NN Pharmocological
streptokinase NN Pharmocological
streptokinase NN Pharmocological
therapy NN Pharmocological
PTCA NNP None
therapy NN None
PTCA NNP None
therapy NN None
streptokinase NN Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

medication NN Pharmocological
parent NN Educational
training NN Educational
risperidone NN Pharmocological
structured JJ Educational
parent NN Educational
training NN Educational
risperidone VB Pharmocological
-DOCSTART- -X- N

modified VBN None
starch NN None
hydrophilic NN None
matrix NN None
for IN None
the DT None
sustained JJ None
release NN None
of IN None
theophylline NN Pharmocological
theophylline NN Pharmocological
with IN Pharmocological
a DT Pharmocological
hydrophilic JJ Pharmocological
starch NN Pharmocological
matrix NN Pharmocological
Theo-dur NN Pharmocological
Theo-dur NNP Pharmocological
theophylline NN None
with IN None
70 CD None
% NN None
drum-dried JJ None
corn NN None
starch NN None
as IN None
the DT None
sustained-release JJ None
agent NN None
( ( None
DDCS-70 NNP None
) ) None
Theo-dur NNP Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

DMSA NNP Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
dimercapto NN Pharmocological
succinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DMSA NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
DMSA NNP Pharmocological
or CC None
placebo NN Control
. . None
DMSA NNP Pharmocological
DMSA NNP Pharmocological
-DOCSTART- -X- N

omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
fenofibrate NN Pharmocological
Omega-3 NNP Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
fenofibrate NN Pharmocological
placebo NNS Control
, , None
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
2 CD None
g NN None
fenofibrate VB Pharmocological
160 CD Pharmocological
mg NN Pharmocological
Omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
therapy NN Pharmocological
Fenofibrate NNP Pharmocological
therapy NN Pharmocological
placebo NN Control
and CC None
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
, , None
fenofibrate JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Growth NNP Pharmocological
hormone NN Pharmocological
treatment NN Pharmocological
GH NNP Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
GH NNP Pharmocological
therapy NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

arrow NN Physical
localization NN Physical
of IN Physical
a DT Physical
target NN Physical
that WDT None
appeared VBD None
to TO None
the DT None
left NN None
or CC None
right NN None
of IN None
the DT None
fixation NN None
point NN None
. . None
the DT None
participant NN None
's POS None
attention NN None
was VBD None
cued VBN None
to TO None
the DT None
left NN None
or CC None
right NN None
by IN None
either DT None
an DT None
arrow NN Physical
or CC None
the DT None
direction NN Physical
of IN Physical
eye NN Physical
gaze NN Physical
on IN Physical
a DT Physical
computerized JJ Physical
face NN Physical
. . None
-DOCSTART- -X- N

alcohol NN Pharmocological
morphine NN Pharmocological
sulfate NN Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
opioids NNS Pharmocological
Morphine NNP Pharmocological
sulfate NN Pharmocological
and CC Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
extended VBD Pharmocological
release NN Pharmocological
capsules NNS Pharmocological
( ( Pharmocological
MS-sNT NNP Pharmocological
) ) Pharmocological
MS-sNT NNP Pharmocological
alcohol NN Pharmocological
-DOCSTART- -X- N

individual-level JJ Educational
responses NNS Educational
-DOCSTART- -X- N

plastic NN Physical
cast NN Physical
fixation NN Physical
plaster NN Physical
cast NN Physical
wrist NN Physical
was VBD Physical
immobilized VBN Physical
in IN Physical
neutral JJ Physical
flexion-extension NN Physical
. . None
dorsiflexed JJ Physical
20 CD Physical
degrees NNS Physical
, , Physical
while IN Physical
the DT Physical
carpus NN Physical
was VBD Physical
pushed VBN Physical
in IN Physical
a DT Physical
volar JJ Physical
direction NN Physical
by IN Physical
an DT Physical
impression NN Physical
in IN Physical
the DT Physical
plaster NN Physical
cast NN Physical
. . None
-DOCSTART- -X- N

generalized JJ Other
estimating NN Other
equations NNS Other
( ( Other
GEE NNP Other
) ) Other
GEE-independent NNP Physical
GEE-independent JJ Physical
-DOCSTART- -X- N

prajmalium NN Pharmocological
bitartrate NN Pharmocological
prajmalium NN Pharmocological
bitartrate NN Pharmocological
tablet NN Pharmocological
( ( None
Neo-Gilurytmal JJ Pharmocological
, , Pharmocological
CAS NNP Pharmocological
2589-47-1 CD Pharmocological
) ) None
compared VBN None
to TO None
an DT None
oral JJ Pharmocological
solution NN Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
enalapril NN Pharmocological
or CC None
matched VBN None
placebo JJ Control
-DOCSTART- -X- N

holmium NN Surgical
laser NN Surgical
enucleation NN Surgical
transurethral JJ Surgical
resection NN Surgical
holmium NN Surgical
laser JJR Surgical
enucleation NN Surgical
of IN Surgical
the DT Surgical
prostate NN Surgical
( ( Surgical
HoLEP NNP Surgical
) ) Surgical
transurethral JJ Surgical
resection NN Surgical
of IN Surgical
the DT Surgical
prostate NN Surgical
( ( Surgical
TURP NNP Surgical
) ) Surgical
HoLEP NNP Surgical
TURP NNP Surgical
. . Surgical
TURP NNP Physical
HoLEP NNP Physical
HoLEP NNP Physical
HoLEP NNP Physical
TURP NNP Physical
HoLEP NNP Physical
TURP NNP Physical
HoLEP NNP Physical
TURP NNP Physical
. . None
-DOCSTART- -X- N

naloxone NN Pharmocological
placebo NN Control
. . None
naloxone JJ Pharmocological
-DOCSTART- -X- N

recombinant JJ Physical
human JJ Physical
granulocyte NN Physical
colony-stimulating NN Physical
factor NN Physical
chemotherapy JJ Physical
recombinant JJ Physical
human JJ Physical
granulocyte NN Physical
colony-stimulating NN Physical
factor NN Physical
( ( Physical
[ JJ Physical
G-CSF NNP Physical
] NNP Physical
lenogastrim NN Physical
) ) None
consolidation NN Physical
chemotherapy NN Physical
chemotherapy NN Physical
; : None
combination NN None
of IN None
high-dose JJ Pharmocological
cytarabine NN Pharmocological
, , None
etoposide RB Pharmocological
, , None
and CC None
dexamethasone NN Pharmocological
( ( None
R3 NNP None
) ) None
vincristine NN Pharmocological
, , None
prednisone NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
doxorubicin NN Pharmocological
, , None
and CC None
methotrexate NN Pharmocological
( ( None
COPADM NNP None
) ) None
. . None
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
non-G-CSF JJ Pharmocological
G-CSF NNP Pharmocological
post-COPADM JJ Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
administration NN Pharmocological
. . None
-DOCSTART- -X- N

prostaglandin NN Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
intraumbilical JJ Pharmocological
prostaglandin NN Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
( ( None
Hembate NNP Pharmocological
, , None
Upjohn NNP Pharmocological
) ) None
oxytocin JJ Pharmocological
injection NN Pharmocological
Prostaglandin NNP Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
, , None
20 CD None
mg NN None
, , None
diluted VBD Pharmocological
to TO Pharmocological
20 CD Pharmocological
ml NNS Pharmocological
in IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
30 CD Pharmocological
IU NNP Pharmocological
of IN Pharmocological
oxytocin NN Pharmocological
, , None
diluted VBD Pharmocological
to TO Pharmocological
20 CD Pharmocological
ml NNS Pharmocological
in IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
20 CD Pharmocological
ml NNS Pharmocological
of IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
alone RB Pharmocological
prostaglandin NN Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
Oxytocin CC Pharmocological
-DOCSTART- -X- N

general-practitioner-based JJ Educational
interventions NNS Educational
identifying VBG Educational
depression NN Educational
and CC Educational
offering VBG Educational
an DT Educational
evidence-based JJ Educational
intervention NN Educational
multidisciplinary JJ Educational
telephone NN Educational
case NN Educational
conferencing NN Educational
-DOCSTART- -X- N

monophasic JJ Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
containing VBG None
gestodene NN Pharmocological
or CC None
desogestrel NN Pharmocological
OC NNP Pharmocological
gestodene NN Pharmocological
( ( Pharmocological
GTD NNP Pharmocological
) ) Pharmocological
ethinyl VBP Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
EE NNP Pharmocological
) ) Pharmocological
OC NNP Pharmocological
desogestrel NN Pharmocological
( ( Pharmocological
DSG NNP Pharmocological
) ) Pharmocological
EE NNP None
. . None
OC NNP Pharmocological
-DOCSTART- -X- N

canalith NN Surgical
repositioning NN Surgical
procedure NN Surgical
. . None
modified JJ Surgical
CRP NNP Surgical
technique NN Surgical
CRP NNP Surgical
CRP NNP Surgical
CRP NNP Surgical
CRP NNP Surgical
CRP NNP Surgical
-DOCSTART- -X- N

reamed VBN Surgical
and CC Surgical
unreamed JJ Surgical
nailing NN Surgical
Stabilization NNP Surgical
of IN Surgical
tibial JJ Surgical
fractures NNS Surgical
either CC Surgical
with IN Surgical
a DT Surgical
slotted VBN Surgical
, , Surgical
stainless JJ Surgical
steel NN Surgical
reamed VBD Surgical
nail JJ Surgical
or CC Surgical
a DT Surgical
solid JJ Surgical
, , Surgical
titanium NN Surgical
unreamed JJ Surgical
nail NN Surgical
. . Surgical
reamed VBN Physical
unreamed JJ Physical
unreamed JJ Physical
nail NN Physical
reamed VBD Physical
reamed VBN None
unreamed JJ None
Unreamed VBD None
nailing VBG None
in IN None
reamed JJ Physical
nailing NN Physical
. . Physical
unreamed JJ None
nails NNS None
. . None
-DOCSTART- -X- N

ranitidine NN Pharmocological
or CC None
omeprazole NN Pharmocological
ranitidine NN Pharmocological
omeprazole JJ Pharmocological
-DOCSTART- -X- N

laparoscopic NN Surgical
open JJ Surgical
surgery NN Surgical
laparoscopic NN Surgical
treatment NN Surgical
laparoscopic NN Surgical
neoadjuvant JJ Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
capecitabine NN Pharmocological
and CC None
50-54 JJ Physical
Gy NNP Physical
external JJ Physical
beam NN Physical
radiotherapy NN Physical
. . None
Sphincter-preserving JJ Surgical
surgery NN Surgical
open JJ Surgical
open JJ Surgical
surgery NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
open JJ Surgical
surgery NN Surgical
. . None
laparoscopic NN Surgical
Laparoscopic NNP Surgical
surgery NN Surgical
open VB Surgical
surgery NN Surgical
-DOCSTART- -X- N

300 CD Pharmocological
microg NNS Pharmocological
( ( Pharmocological
1.2 CD Pharmocological
micromol NN Pharmocological
) ) Pharmocological
biotin/d NN Pharmocological
or CC Pharmocological
placebo NN Control
. . Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
timolol NN Pharmocological
hydrochlorothiazide JJ Pharmocological
plus CC Pharmocological
amiloride JJ Pharmocological
hydrochlorothiazide JJ Pharmocological
amiloride NN Pharmocological
enalapril NN Pharmocological
timolol JJ Pharmocological
-DOCSTART- -X- N

barrier NN Physical
cream NN Physical
and CC None
its PRP$ Physical
vehicle NN Physical
barrier NN Pharmocological
creams NNS Pharmocological
barrier NN Pharmocological
cream NN Pharmocological
moisturizing NN Pharmocological
vehicle NN Pharmocological
( ( None
verum NN Physical
or CC Physical
vehicle NN Physical
) ) Physical
over IN Physical
a DT Physical
period NN Physical
of IN Physical
4 CD Physical
weeks NNS Physical
. . None
barrier NN Pharmocological
cream NN Pharmocological
vehicle NN Physical
. . None
vehicle NN Pharmocological
-DOCSTART- -X- N

tyrosine JJ Pharmocological
kinase NN Pharmocological
inhibitors NNS Pharmocological
everolimus NN Pharmocological
tyrosine JJ Pharmocological
kinase NN Pharmocological
inhibitors NNS Pharmocological
( ( Pharmocological
TKI NNP Pharmocological
) ) Pharmocological
sunitinib NN Pharmocological
or CC None
sorafenib NN Pharmocological
. . None
TKI NNP Pharmocological
TKI NNP Pharmocological
everolimus NN Pharmocological
: : None
sunitinib NN Pharmocological
sorafenib NN Pharmocological
dovitinib NN Pharmocological
TKI NNP Pharmocological
TKI-everolimus-TKI NNP Pharmocological
everolimus NN Pharmocological
TKI NNP Pharmocological
TKI-everolimus-TKI JJ Pharmocological
sequence NN Pharmocological
-DOCSTART- -X- N

traditional JJ Physical
bone NN Physical
setting NN Physical
and CC Physical
conventional JJ Physical
physical JJ Physical
therapy NN Physical
. . None
traditional JJ Physical
bone NN Physical
setting NN Physical
and CC Physical
physical JJ Physical
therapy NN Physical
. . None
traditional JJ Physical
bone NN Physical
setting NN Physical
and CC Physical
physical JJ Physical
therapy NN Physical
. . None
Active NNP Physical
back RB Physical
exercise NN Physical
at IN Physical
home NN Physical
treatments NNS Control
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN None
risperidone NN None
risperidone NN None
risperidone NN None
-DOCSTART- -X- N

smoking VBG Educational
cessation NN Educational
smoking VBG Educational
cessation NN Educational
programs NNS Educational
smoking NN Educational
cessation NN Educational
smoking VBG Educational
cessation NN Educational
interventions NNS Educational
-DOCSTART- -X- N

lasalocid NN Pharmocological
lasalocid NN Pharmocological
lasalocid NN Pharmocological
lasalocid NN Pharmocological
lasalocid JJ Pharmocological
lasalocid NN Pharmocological
-DOCSTART- -X- N

D-myo-inositol-1,2,6-trisphosphate NNP Pharmocological
D-myo-inositol-1,2,6-trisphosphate NNP Pharmocological
( ( Pharmocological
1,2,6-IP3 CD Pharmocological
) ) Pharmocological
1,2,6-IP3 JJ Pharmocological
isotonic JJ Pharmocological
saline NN Pharmocological
. . None
inositol-1,2,6-trisphosphate JJ Pharmocological
-DOCSTART- -X- N

bifidobacterium NN Pharmocological
breve VBP Pharmocological
Bifidobacterium NNP Pharmocological
breve NN Pharmocological
( ( Pharmocological
B. NNP Pharmocological
breve VBP Pharmocological
) ) Pharmocological
supplements NNS Pharmocological
three CD None
groups NNS None
: : None
Group NNP None
A NNP None
and CC None
B NNP None
received VBD None
a DT None
dose NN None
of IN None
1.6 CD None
x NNS None
10 CD None
( ( None
8 CD None
) ) None
cells NNS None
of IN None
B. NNP None
breve VBP None
supplement NN None
twice RB None
a DT None
day NN None
, , None
commencing VBG None
either CC None
from IN None
several JJ None
hours NNS None
after IN None
birth NN None
( ( None
group NN None
A NNP None
) ) None
or CC None
24 CD None
h NN None
after IN None
birth NN None
( ( None
group NN None
B NNP None
) ) None
. . None
control NN Control
group NN Control
no DT None
supplement NN None
. . None
-DOCSTART- -X- N

group NN Psychological
versus FW Psychological
individual JJ Psychological
cognitive JJ Psychological
behavioural JJ Psychological
therapy NN Psychological
group NN Psychological
and CC Psychological
individual JJ Psychological
cognitive JJ Psychological
behaviour NN Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
group NN Psychological
CBT NNP Psychological
or CC None
individual JJ Psychological
CBT NNP Psychological
. . None
group NN Psychological
vs. FW Psychological
individual JJ Psychological
CBT NNP Psychological
CBT NNP Psychological
group NN Educational
format NN Educational
of IN Educational
CBT NNP Educational
CBT NNP Psychological
. . None
-DOCSTART- -X- N

Financial JJ None
and CC None
quality-of-life JJ None
burden NN None
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
burden NN Educational
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
burden NN Educational
; : None
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
burden NN Educational
. . None
financial JJ Educational
and CC Educational
quality-of-life JJ Educational
effects NNS Educational
-DOCSTART- -X- N

angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blocker NN Pharmocological
therapy NN Pharmocological
( ( None
olmesartan JJ Pharmocological
or CC None
valsartan NN Pharmocological
) ) None
( ( None
olmesartan NN Pharmocological
or CC None
valsartan NN Pharmocological
olmesartan NN Pharmocological
valsartan NN Pharmocological
olmesartan PRP None
or CC None
valsartan VB None
for IN None
6 CD None
months NNS None
-DOCSTART- -X- N

asimadoline NN Pharmocological
asimadoline NN Pharmocological
placebo-controlled JJ Control
1 CD Pharmocological
, , Pharmocological
5 CD Pharmocological
, , Pharmocological
and CC Pharmocological
10 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
asimadoline NN Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
Asimadoline NNP Pharmocological
-DOCSTART- -X- N

one CD Physical
vs NN Physical
two CD Physical
daily JJ Physical
bouts NNS Physical
of IN Physical
walking VBG Physical
walked VBD Educational
5 CD Physical
d/week NN Physical
for IN Physical
15 CD Physical
weeks NNS Physical
at IN Physical
65 CD Physical
% NN Physical
of IN Physical
their PRP$ Physical
maximal NN Physical
aerobic JJ Physical
power NN Physical
expending VBG Physical
300 CD Physical
kcal JJ Physical
( ( None
1255 CD None
kJ NN None
) ) None
in IN None
exercise NN Educational
in IN None
one CD None
( ( None
Group NNP None
S1 NNP None
) ) None
or CC None
two CD None
daily JJ None
sessions NNS None
( ( None
Group NNP None
S2 NNP None
) ) None
. . None
was VBD None
measured VBN None
in IN None
a DT None
direct JJ Physical
maximal NN Physical
treadmill NN Physical
test NN Physical
. . None
was VBD None
calculated VBN None
and CC None
the DT None
percentage NN None
of IN None
body NN None
fat NN None
( ( None
fat JJ None
% NN None
) ) None
estimated VBN None
using VBG None
skinfold JJ None
measurements NNS None
. . None
walking NN Physical
-DOCSTART- -X- N

two CD None
communication NN None
interventions NNS None
2 CD Educational
communication NN Educational
interventions NNS Educational
( ( Educational
Responsive JJ Educational
Education NN Educational
and CC Educational
Prelinguistic NNP Educational
Milieu NNP Educational
Teaching NNP Educational
[ NNP Educational
RPMT NNP Educational
] NNP Educational
and CC Educational
the DT Educational
Picture NNP Educational
Exchange NNP Educational
Communication NNP Educational
System NNP Educational
[ NNP Educational
PECS NNP Educational
] NNP Educational
) ) None
RPMT NNP Educational
PECS NNP Pharmocological
-DOCSTART- -X- N

Speech NN Educational
following VBG Educational
sign JJ Educational
language NN Educational
training NN Educational
language NN Educational
training NN Educational
Sign NNP Educational
Alone NNP Educational
-DOCSTART- -X- N

Angio-Seal NNP Physical
( ( Physical
AS NNP Physical
) ) Physical
and CC None
StarClose NNP Physical
( ( Physical
SC NNP Physical
) ) Physical
and CC None
manual JJ Physical
compression NN Physical
( ( Physical
MC NNP Physical
) ) Physical
In IN None
a DT None
prospective JJ None
trial NN None
were VBD None
randomized VBN None
to TO None
AS NNP Physical
, , None
SC NNP Physical
, , None
or CC None
MC NNP Physical
. . None
Patients NNS None
were VBD None
mobilized VBN None
1 CD None
to TO None
2 CD None
hr NN None
after IN None
device NN None
placement NN None
, , None
and CC None
6 CD None
hr NN None
after IN None
MC NNP Physical
. . None
-DOCSTART- -X- N

olopatadine JJ Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
ketorolac NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
olopatadine JJ Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
ketorolac NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
Olopatadine NNP Pharmocological
Ketorolac NNP Pharmocological
olopatadine NN Pharmocological
placebo NN Control
ketorolac NN Pharmocological
placebo NN Control
alternate NN Pharmocological
treatment NN Pharmocological
placebo NN Control
Olopatadine NNP Pharmocological
placebo VB Control
Ketorolac NNP Pharmocological
placebo VB Control
. . None
Olopatadine NNP Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
olopatadine NN Pharmocological
ketorolac NN Pharmocological
. . None
-DOCSTART- -X- N

Infliximab NNP Pharmocological
methotrexate NN Pharmocological
Methotrexate NNP Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
infliximab JJ Pharmocological
infliximab NN Pharmocological
MTX NNP Pharmocological
on IN Pharmocological
infliximab NN Pharmocological
infliximab NN Pharmocological
alone RB Pharmocological
or CC Pharmocological
infliximab JJ Pharmocological
combined VBN Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
infliximab NN Pharmocological
+ NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Educational
and CC Educational
infliximab NN Educational
infliximab JJ Educational
-DOCSTART- -X- N

pronase NN Pharmocological
ultrasonography NN Physical
. . None
proteolytic JJ Pharmocological
enzyme NN Pharmocological
, , None
pronase NN Pharmocological
endoscopic JJ Physical
ultrasonography NN Physical
. . None
pronase NN Pharmocological
C NNP None
) ) None
pronase NN Pharmocological
treatments NNS None
A DT None
and CC None
B NNP None
) ) None
pronase NN Pharmocological
pronase NN Pharmocological
( ( None
treatment NN None
C NNP None
) ) None
treatments NNS None
A NNP None
and CC None
B NNP None
. . None
pronase NN Pharmocological
-DOCSTART- -X- N

somatostatin NN Pharmocological
( ( Pharmocological
octreotide JJ Pharmocological
) ) Pharmocological
Somatostatin NNP Pharmocological
somatostatin NN Pharmocological
saline NN Pharmocological
octreotide NN Pharmocological
( ( Pharmocological
Sandostatin NNP Pharmocological
octreotide RB Pharmocological
saline NN Pharmocological
octreotide RB Pharmocological
octreotide JJ Pharmocological
saline NN Pharmocological
octreotide NN Pharmocological
saline NN Pharmocological
octreotide NN Pharmocological
octreotide JJ Pharmocological
saline NN Control
octreotide NN Pharmocological
somatostatin NN Pharmocological
somatostatin NN Pharmocological
octreotide NN Pharmocological
somatostatin NN Pharmocological
-DOCSTART- -X- N

guided JJ Physical
imagery NN Physical
. . None
guided JJ Other
imagery NN Other
modality NN Other
. . Educational
and CC None
control NN Control
groups NNS Control
a DT None
4-day JJ None
period NN None
of IN None
time NN None
. . None
Guided VBN Physical
imagery NN Physical
-DOCSTART- -X- N

epothilone NN None
B NNP None
analog NN None
ixabepilone NN None
( ( None
BMS-247550 NNP None
) ) None
with IN None
or CC None
without IN None
estramustine JJ None
phosphate NN None
epothilone NN Pharmocological
B NNP Pharmocological
analog NN Pharmocological
, , Pharmocological
ixabepilone NN Pharmocological
, , Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
estramustine JJ Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
EMP NNP Pharmocological
) ) Pharmocological
ixabepilone NN Pharmocological
intravenous JJ None
infusion NN None
every DT None
3 CD None
weeks NNS None
with IN None
or CC None
without IN None
EMP NNP Pharmocological
280 CD None
mg NN None
orally RB None
Ixabepilone NNP Pharmocological
estramustine JJ Pharmocological
phosphate NN Pharmocological
-DOCSTART- -X- N

active JJ Surgical
pectoral JJ Surgical
pulse NN Surgical
generator NN Surgical
active JJ Surgical
pectoral JJ Surgical
electrode NN Surgical
( ( Surgical
active JJ Surgical
can MD Surgical
) ) Surgical
active JJ Physical
pectoral NN Physical
can MD Physical
comparison NN Educational
of IN Educational
two CD Educational
shock NN Educational
configurations NNS Educational
dual-coil JJ Surgical
transvenous JJ Surgical
defibrillation NN Surgical
lead NN None
with IN None
a DT None
left JJ Surgical
pectoral JJ Surgical
pulse NN Surgical
generator NN Surgical
emulator NN Surgical
right JJ None
ventricular NN None
coil NN None
and CC None
proximal JJ None
atrial JJ None
coil NN None
( ( None
lead JJ None
) ) None
or CC None
between IN None
the DT None
right JJ None
ventricular NN None
coil NN None
and CC None
an DT None
active JJ None
can MD None
in IN None
common JJ None
with IN None
the DT None
atrial JJ None
coil NN None
active JJ Surgical
can MD Surgical
active JJ Surgical
can MD Surgical
active JJ Surgical
can MD Surgical
active JJ Surgical
pectoral JJ Surgical
electrode NN Surgical
-DOCSTART- -X- N

risperidone NN Pharmocological
placebo NN Control
risperidone NN None
placebo-controlled JJ None
risperidone NN None
. . None
placebo NN None
risperidone NN None
. . None
Risperidone NNP None
placebo VB None
risperidone NN None
-DOCSTART- -X- N

transfusion NN Physical
of IN Physical
residual JJ Physical
blood NN Physical
centrifugation NN Physical
and CC Physical
multiple-pass NN Physical
hemoconcentration NN Physical
. . Physical
methods NNS None
of IN None
centrifugation NN None
( ( None
CF NNP None
) ) None
and CC None
multiple-pass JJ None
hemoconcentration NN None
( ( None
MPH NNP None
) ) None
centrifugation NN Physical
or CC None
multiple-pass NN Physical
hemoconcentration NN Physical
method NN Physical
centrifugation NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
centrifugation NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
centrifugation NN Physical
multiple-pass JJ Physical
hemoconcentration NN Physical
centrifugation NN Physical
CF NNP Physical
method NN Physical
heparin NN Pharmocological
MPH NNP Physical
method NN Physical
-DOCSTART- -X- N

Liposome-entrapped JJ Pharmocological
D. NNP Pharmocological
pteronyssinus NN Pharmocological
vaccination NN Pharmocological
placebo-controlled JJ Control
liposome-entrapped JJ Pharmocological
D. NNP Pharmocological
pteronyssinus NN Pharmocological
vaccine NN Pharmocological
methacholine NN Pharmocological
-DOCSTART- -X- N

psychological JJ Educational
intervention NN Educational
psychological JJ Psychological
intervention NN Psychological
psychological JJ Psychological
intervention NN Psychological
( ( Psychological
weekly JJ Psychological
cognitive VBP Psychological
individual JJ Psychological
psychotherapy NN Psychological
and CC Psychological
bimonthly JJ Psychological
family NN Psychological
counselling VBG Psychological
) ) Psychological
standard JJ Control
follow-up NN Control
. . None
-DOCSTART- -X- N

imaging VBG Physical
intraperitoneal JJ Physical
distribution NN Physical
imaging NN Physical
( ( Physical
IDI NNP Physical
) ) Physical
. . None
IDI NNP Physical
normal JJ Pharmocological
saline NN Pharmocological
and CC None
1 CD Pharmocological
mCi NN Pharmocological
of IN Pharmocological
Tc-99m NNP Pharmocological
SC NNP Pharmocological
IDI NNP Physical
. . None
normal JJ Pharmocological
saline NN Pharmocological
Tc-99m NNP Pharmocological
SC NNP Pharmocological
. . None
-DOCSTART- -X- N

Osteoporosis NN Pharmocological
timed VBN None
up RP None
and CC None
go VB None
, , None
chair NN None
stand NN None
, , None
single JJ None
leg NN None
stand NN None
step VB Other
test NN Other
. . None
-DOCSTART- -X- N

pharmacy NN Other
discharge NN Other
plan NN Other
hospital NN Other
pharmacist NN Other
developed VBD Other
discharge NN Other
plans NNS Other
discharged VBN Other
from IN Other
hospital NN Other
following VBG Other
standard JJ Other
procedures NNS Other
community NN Other
pharmacy NN Other
care NN Other
discharge NN Other
plans NNS Other
-DOCSTART- -X- N

amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

iron NN Pharmocological
formula NN Control
milk NN Control
with IN Control
no DT Control
added JJ Control
iron NN Control
against IN None
the DT None
same JJ Pharmocological
formula NN Pharmocological
milk NN Pharmocological
containing VBG Pharmocological
1.2 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
iron NN Pharmocological
per IN Pharmocological
100 CD Pharmocological
ml NN Pharmocological
. . None
iron NN Pharmocological
iron NN Pharmocological
-DOCSTART- -X- N

antisecretory JJ Pharmocological
treatment NN Pharmocological
antisecretory NN Pharmocological
treatment NN Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
( ( Pharmocological
PPIs NNP Pharmocological
) ) Pharmocological
or CC None
histamine JJ Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
-receptor NN Pharmocological
antagonists NNS Pharmocological
( ( Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNPS Pharmocological
) ) Pharmocological
PPIs NNP Pharmocological
( ( Pharmocological
omeprazole JJ Pharmocological
; : None
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNP Pharmocological
( ( Pharmocological
ranitidine NN Pharmocological
; : None
PPI-treated JJ Pharmocological
PPI NNP Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNPS Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNP Pharmocological
PPIs NNP Pharmocological
. . None
Antisecretory NNP Pharmocological
reflux JJ Pharmocological
treatment NN Pharmocological
PPIs NNP Pharmocological
H NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
RAs NNPS Pharmocological
-DOCSTART- -X- N

Transdermal NNP Pharmocological
nitroglycerin NN Pharmocological
transdermal JJ Pharmocological
nitroglycerin JJ Pharmocological
transdermal JJ Pharmocological
nitroglycerin NN Pharmocological
in IN Pharmocological
placebo NN Control
transdermal JJ Pharmocological
nitroglycerin NN Pharmocological
-DOCSTART- -X- N

audiotapes NNS Educational
audiotapes NNS Educational
audiotaped VBN Educational
. . None
copy NN Educational
of IN Educational
the DT Educational
tape NN Educational
to TO Educational
play VB Educational
at IN Educational
home NN Educational
or CC Educational
not RB Educational
( ( Educational
control VB Educational
group NN Educational
) ) Educational
. . None
audiotape NN Educational
audiotapes NNS Educational
-DOCSTART- -X- N

appliance NN Physical
therapy NN Physical
stabilization NN Physical
appliance NN Physical
control NN Physical
appliance NN Physical
stabilization NN Physical
appliance NN Physical
stabilization NN Physical
appliance NN Physical
stabilization NN Physical
appliance NN Physical
-DOCSTART- -X- N

group NN Physical
exercise NN Physical
class NN Physical
, , None
individual JJ Physical
physiotherapy NN Physical
, , None
and CC None
home NN Physical
exercises NNS Physical
alone RB Physical
. . None
hospital-based JJ Physical
exercise NN Physical
class NN Physical
-DOCSTART- -X- N

explicit JJ Educational
instruction NN Educational
on IN Educational
Japanese JJ Educational
Verbal NNP Educational
Learning NNP Educational
Test NNP Educational
explicit NN Educational
or CC Educational
normal JJ Educational
instruction NN Educational
Japanese JJ Educational
Verbal NNP Educational
Learning NNP Educational
Test NNP Educational
-DOCSTART- -X- N

Amisulpride NNP Pharmocological
bromocriptine NN Pharmocological
DA NNP Pharmocological
antagonist NN Pharmocological
( ( Pharmocological
amisulpride IN Pharmocological
) ) Pharmocological
DA NNP Pharmocological
agonist NN Pharmocological
( ( Pharmocological
bromocriptine NN Pharmocological
) ) Pharmocological
Amisulpride NNP Pharmocological
bromocriptine JJ Pharmocological
DA NNP Pharmocological
agonists NNS Pharmocological
DA NNP Pharmocological
antagonists NNS Pharmocological
benzamides NNS Pharmocological
. . None
-DOCSTART- -X- N

statins NNS Pharmocological
statins NNS Pharmocological
statins NNS Pharmocological
simvastatin NN Pharmocological
placebo NN Control
simvastatin $ Pharmocological
placebo NN Control
placebo NN Control
simvastatin JJ Pharmocological
-DOCSTART- -X- N

ketorolac NN Pharmocological
pethidine NN Pharmocological
. . None
thiopentone NN Pharmocological
and CC Pharmocological
suxamethonium NN Pharmocological
and CC Pharmocological
maintained VBD Pharmocological
with IN Pharmocological
atracurium NN Pharmocological
, , Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
and CC Pharmocological
isoflurane NN Pharmocological
. . None
Intravenous JJ Pharmocological
fentanyl JJ Pharmocological
100 CD None
micrograms NN None
was VBD None
given VBN None
after IN None
delivery NN None
of IN None
the DT None
neonate NN None
. . None
-DOCSTART- -X- N

temporary JJ Surgical
clamping NN Surgical
of IN Surgical
drains NNS Surgical
immediate JJ Surgical
drain NN Surgical
opening NN Surgical
( ( None
n JJ None
= NNP None
45 CD None
) ) None
or CC None
drains NNS Surgical
opened VBN Surgical
at IN Surgical
2 CD Surgical
h NN Surgical
clamping VBG Surgical
drains NNS Surgical
drains NNS Surgical
-DOCSTART- -X- N

were VBD None
divided VBN None
into IN None
4 CD None
groups NNS None
randomly RB None
, , None
and CC None
boosted VBD None
3 CD None
dose NN None
of IN None
4 CD None
different JJ None
types NNS None
of IN None
HepB NNP Pharmocological
at IN None
0 CD None
, , None
1 CD None
, , None
6 CD None
months NNS None
. . None
revaccination NN Pharmocological
HepB-Y NNP Pharmocological
HepB-Y NNP Pharmocological
HepB-CHO NNP Pharmocological
HepB-HY NNP Pharmocological
-DOCSTART- -X- N

ketamine NN Pharmocological
opioids NNS Pharmocological
ketamine NN Pharmocological
opioids NNS Pharmocological
placebo NN Pharmocological
opioids NNS Pharmocological
plus CC Pharmocological
ketamine NN Pharmocological
regular JJ Pharmocological
opioids NNS Pharmocological
plus CC Pharmocological
placebo NN Pharmocological
. . Pharmocological
opioid JJ Pharmocological
analgesia NN Pharmocological
-DOCSTART- -X- N

Tubeless NNP Surgical
percutaneous JJ Surgical
nephrolithotomy NN Surgical
: : None
tubeless NN Surgical
percutaneous JJ Surgical
nephrolithotomy NN Surgical
( ( Surgical
PCNL NNP Surgical
) ) Surgical
( ( Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
) ) Pharmocological
Tubeless NNP Surgical
PCNL NNP Surgical
-DOCSTART- -X- N

doxorubicin NN Pharmocological
epirubicin NN Pharmocological
40 CD Pharmocological
mg NNS Pharmocological
doxorubicin VBD Pharmocological
or CC None
40 CD Physical
mg NNS Physical
epirubicin VBP Physical
with IN None
no DT None
instillation NN None
after IN None
transurethral JJ None
resection NN None
of IN None
tumor NN None
( ( None
s NN None
) ) None
doxorubicin NN Pharmocological
epirubicin JJ Pharmocological
-DOCSTART- -X- N

Epimedium NNP Pharmocological
brevicornum NN Pharmocological
Epimedium NNP Pharmocological
brevicornum NN Pharmocological
( ( Pharmocological
EB NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Moclobemide NNP None
, , None
imipramine NN None
and CC None
placebo NN None
Moclobemide NNP Pharmocological
imipramine NN Pharmocological
placebo NN Control
was VBD Pharmocological
300 CD Pharmocological
mg JJ Pharmocological
daily RB Pharmocological
for IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
5 CD Pharmocological
days NNS Pharmocological
, , Pharmocological
after IN Pharmocological
which WDT Pharmocological
it PRP Pharmocological
could MD Pharmocological
be VB Pharmocological
increased VBN Pharmocological
to TO Pharmocological
600 CD Pharmocological
mg. NNS Pharmocological
was VBD Pharmocological
given VBN Pharmocological
in IN Pharmocological
a DT Pharmocological
dosage NN Pharmocological
starting VBG Pharmocological
with IN Pharmocological
33 CD Pharmocological
mg NNS Pharmocological
and CC Pharmocological
gradually RB Pharmocological
increased VBD Pharmocological
to TO Pharmocological
100 CD Pharmocological
mg/day NN Pharmocological
in IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
5 CD Pharmocological
days NNS Pharmocological
placebo NN Control
. . Control
Moclobemide NNP Pharmocological
imipramine NN Pharmocological
-DOCSTART- -X- N

enoximone NN Pharmocological
Gallopamil NNP Pharmocological
Enoximone NNP Pharmocological
Gallopamil NNP Pharmocological
Enoximone NNP Pharmocological
. . None
-DOCSTART- -X- N

3M CD Surgical
Steri-Strip JJ Surgical
S NNP Surgical
Surgical NNP Surgical
Skin NNP Surgical
Closure NNP Surgical
versus IN Surgical
subcuticular JJ Surgical
closure NN Surgical
. . None
new JJ Surgical
coaptive JJ Surgical
film NN Surgical
device NN Surgical
, , None
3M CD Surgical
Steri-Strip JJ Surgical
S NNP Surgical
Surgical NNP Surgical
Skin NNP Surgical
Closure NNP Surgical
, , Surgical
on IN Surgical
linear JJ Surgical
incisions NNS Surgical
. . None
Steri-Strip NNP Physical
S NNP Physical
or CC Physical
suture JJ Physical
closure NN Physical
. . None
new JJ Physical
scar NN Physical
evaluation NN Physical
tool NN Physical
Steri-Strip NNP Physical
S NNP Physical
suture NN Physical
closure NN Physical
Steri-Strip NNP Pharmocological
S NNP Pharmocological
suture NN Physical
. . None
-DOCSTART- -X- N

pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
pyridostigmine NN Pharmocological
on IN None
the DT None
night NN None
before IN None
surgery NN None
morning NN None
dose NN None
of IN None
the DT None
drug NN None
on IN None
the DT None
day NN None
of IN None
surgery NN None
. . None
Neostigmine NNP Pharmocological
Vecuronium NNP Pharmocological
trans-sternal JJ Surgical
thymectomy NN Surgical
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
pyridostigmine NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
vecuronium NN Pharmocological
vecuronium NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

mecamylamine NN Pharmocological
oral JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
mecamylamine NN Pharmocological
( ( Pharmocological
2.5 CD Pharmocological
, , Pharmocological
5.0 CD Pharmocological
, , Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC Pharmocological
placebo NN Pharmocological
. . None
placebo NN Pharmocological
Mecamylamine NNP Pharmocological
Mecamylamine NNP Pharmocological
mecamylamine NN Pharmocological
Mecamylamine NNP Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
Fleet NNP Pharmocological
Phospho-Soda NNP Pharmocological
) ) Pharmocological
, , None
lemon-flavored JJ Pharmocological
castor NN Pharmocological
oil NN Pharmocological
( ( Pharmocological
Purge NNP Pharmocological
) ) Pharmocological
, , None
or CC None
standard JJ Pharmocological
polyethylene NN Pharmocological
glycol-based JJ Pharmocological
lavage NN Pharmocological
solution NN Pharmocological
( ( Pharmocological
GoLYTELY NNP Pharmocological
) ) Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
castor JJ Pharmocological
oil NN Pharmocological
. . None
sodium NN Pharmocological
phosphate NN Pharmocological
castor NN Pharmocological
oil NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
sodium NN Pharmocological
phosphate NN Pharmocological
polyethylene JJ Pharmocological
glycol-electrolyte JJ Pharmocological
lavage NN Pharmocological
solution NN Pharmocological
or CC None
castor NN Pharmocological
oil NN Pharmocological
. . None
-DOCSTART- -X- N

clomipramine VB Pharmocological
desipramine VB Pharmocological
. . None
clomipramine NN Pharmocological
and CC None
desipramine NN Pharmocological
placebo JJ Control
-DOCSTART- -X- N

chelation NN Pharmocological
therapy NN Pharmocological
EDTA NNP Pharmocological
chelation NN Pharmocological
therapy NN Pharmocological
treatment NN None
and CC None
control NN None
groups NNS None
. . None
INTERVENTION NNP None
weekly JJ None
chelation NN None
therapy NN None
for IN None
received VBD None
placebo NN None
for IN None
-DOCSTART- -X- N

seven CD Pharmocological
plant NN Pharmocological
extracts NNS Pharmocological
placebo-controlled JJ Control
seven CD Pharmocological
medical JJ Pharmocological
plant NN Pharmocological
extracts NNS Pharmocological
placebo-controlled JJ Control
1.5 CD Pharmocological
fold JJ Pharmocological
UV-B NNP Pharmocological
minimal NN Pharmocological
erythema NN Pharmocological
dose NN Pharmocological
Aloe NNP Pharmocological
vera NN Pharmocological
, , None
Chamomilla NNP Pharmocological
recutita NN Pharmocological
, , None
Hamamelis NNP Pharmocological
virginiana NN Pharmocological
, , None
Melissa NNP Pharmocological
officinalis NN Pharmocological
, , None
Mentha NNP Pharmocological
arvensis NN Pharmocological
, , None
Melaleuca NNP Pharmocological
alternifolia NN Pharmocological
, , None
Coriandrum NNP Pharmocological
sativum NN Pharmocological
as RB None
well RB None
as IN None
1 CD Pharmocological
% NN Pharmocological
hydrocortisone NN Pharmocological
acetate NN Pharmocological
and CC None
0.1 CD Pharmocological
% NN Pharmocological
betamethasone NN Pharmocological
valerate NN Pharmocological
unguentum JJ Pharmocological
leniens NNS Pharmocological
RESULTS NNP None
Aloe NNP None
vera NN None
, , None
Chamomilla NNP None
recutita NN None
, , None
Melissa NNP None
officinalis NN None
, , None
Melaleuca NNP None
alternifolia NN None
and CC None
Coriandrum NNP None
sativum NN None
showed VBD None
CONCLUSION NNP None
Aloe NNP None
vera NN None
possesses VBZ None
-DOCSTART- -X- N

Gemcitabine NNP Pharmocological
paclitaxel NN Pharmocological
docetaxel NN Pharmocological
split-dose JJ Pharmocological
paclitaxel NN Pharmocological
or CC None
docetaxel NN Pharmocological
in IN None
combination NN Pharmocological
with IN Pharmocological
gemcitabine NN Pharmocological
gemcitabine NN Pharmocological
1,250 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
Days VBZ Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
and CC Pharmocological
paclitaxel VB Pharmocological
175 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
as IN Pharmocological
a DT Pharmocological
3-h JJ Pharmocological
infusion NN Pharmocological
on IN Pharmocological
Day NNP Pharmocological
1 CD Pharmocological
( ( Pharmocological
GP1 NNP Pharmocological
) ) Pharmocological
; : None
gemcitabine $ Pharmocological
1,000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
Days VBZ Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
and CC Pharmocological
paclitaxel VB Pharmocological
100 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
as IN Pharmocological
a DT Pharmocological
1-h JJ Pharmocological
infusion NN Pharmocological
on IN Pharmocological
Days NNP Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
( ( Pharmocological
GP2 NNP Pharmocological
) ) Pharmocological
; : None
gemcitabine $ Pharmocological
1,000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
Days VBZ Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
and CC Pharmocological
docetaxel VB Pharmocological
40 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
as IN Pharmocological
a DT Pharmocological
1-h JJ Pharmocological
infusion NN Pharmocological
on IN Pharmocological
Days NNP Pharmocological
1 CD Pharmocological
and CC Pharmocological
8 CD Pharmocological
( ( Pharmocological
GD NNP Pharmocological
) ) None
gemcitabine-taxane JJ Pharmocological
combinations NNS Pharmocological
paclitaxel NN Pharmocological
docetaxel NN Pharmocological
paclitaxel NN Pharmocological
combinations NNS Pharmocological
-DOCSTART- -X- N

high-intensity NN Physical
aerobic JJ Physical
exercise NN Physical
exhaustive JJ Physical
cycling NN Physical
exercise NN Physical
-DOCSTART- -X- N

Domperidone NN None
, , None
metoclopramide NN None
, , None
and CC None
placebo NN None
. . None
gastric JJ Pharmocological
prokinetic JJ Pharmocological
drugs NNS Pharmocological
metoclopramide RB None
domperidone NN Pharmocological
or CC None
placebo NN None
metoclopramide NN None
domperidone NN None
placebo NN None
placebo NN None
, , None
domperidone NN None
metoclopramide RB Pharmocological
-DOCSTART- -X- N

melodic NNS Psychological
based VBN Psychological
communication NN Psychological
therapy NN Psychological
melodic NNS Psychological
based VBN Psychological
communication NN Psychological
therapy NN Psychological
( ( Psychological
MBCT NNP Psychological
) ) Psychological
to TO None
traditional JJ Psychological
speech NN Psychological
and CC Psychological
language NN Psychological
therapy NN Psychological
MBCT NNP Psychological
MBCT NNP Psychological
MBCT NNP Educational
-DOCSTART- -X- N

exogenous JJ Physical
subclinical JJ Physical
hyperthyroidism NN Physical
two-dimensional JJ Physical
speckle NN Physical
tracking VBG Physical
echocardiography NN Physical
imaging NN Physical
( ( Physical
2D-STE JJ Physical
) ) Physical
TSH-suppressive JJ Pharmocological
l-T NN Pharmocological
( ( Pharmocological
4 CD Pharmocological
) ) Pharmocological
substitution NN Pharmocological
restoration NN Pharmocological
of IN Pharmocological
euthyroidism NN Pharmocological
. . None
Prolonged NNP Physical
subclinical JJ Physical
hyperthyroidism NN Physical
-DOCSTART- -X- N

Long-term JJ None
oral JJ Pharmocological
branched-chain NN Pharmocological
amino NN Pharmocological
acid NN Pharmocological
treatment NN None
branched-chain JJ Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
placebo NN Control
( ( Control
casein NN Control
) ) Control
active JJ Pharmocological
treatment NN Pharmocological
casein NN Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
casein NN Pharmocological
alternative JJ Pharmocological
treatment NN Pharmocological
amino JJ Pharmocological
acid-treated JJ Pharmocological
oral JJ Pharmocological
branched-chain NN Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
casein VB Pharmocological
-DOCSTART- -X- N

MSLT NNP Physical
multiple JJ Physical
sleep JJ Physical
latency NN Physical
test NN Physical
( ( Physical
MSLT NNP Physical
) ) Physical
nocturnal JJ Physical
polysomnograms NNS Physical
( ( Physical
NPSG NNP Physical
) ) Physical
MSLT NNP Physical
zolpidem NN Pharmocological
placebo NN Control
MSLTs NNP Physical
MSLT NNP Physical
. . None
MSLT NNP Physical
MSLTs NNP Physical
-DOCSTART- -X- N

veno-venous JJ Physical
continuous JJ Physical
renal JJ Physical
replacement NN Physical
therapy NN Physical
veno-venous JJ Physical
continuous JJ Physical
renal JJ Physical
replacement NN Physical
therapy NN Physical
( ( Physical
CRRT NNP Physical
) ) Physical
CRRT NNP Physical
Control NNP Control
conventional JJ Physical
therapy NN Physical
Veno-venous JJ Physical
CRRT NNP Physical
CRRT NNP None
-DOCSTART- -X- N

etidronate NN Pharmocological
therapy NN Pharmocological
etidronate NN Pharmocological
etidronate NN Pharmocological
placebo NN Control
etidronate NN Pharmocological
placebo NN Control
placebo NN Control
etidronate NN Pharmocological
etidronate NN Pharmocological
-DOCSTART- -X- N

high-dose JJ Pharmocological
chemotherapy NN Pharmocological
: : None
Chemotherapy NNP Pharmocological
and CC Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
parenteral JJ Pharmocological
nutrition NN Pharmocological
( ( Pharmocological
PN NNP Pharmocological
) ) Pharmocological
bone NN Surgical
marrow NN Surgical
transplantation NN Surgical
( ( Surgical
BMT NNP Surgical
) ) Surgical
high-dose JJ Pharmocological
chemotherapy NN Pharmocological
PN NNP Pharmocological
PN NNP Pharmocological
standard JJ Pharmocological
PN NNP Pharmocological
containing VBG Pharmocological
conventional JJ Pharmocological
amounts NNS Pharmocological
of IN Pharmocological
dextrose NN Pharmocological
, , Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
, , Pharmocological
micronutrients NNS Pharmocological
, , Pharmocological
and CC Pharmocological
lipid JJ Pharmocological
solution NN Physical
containing VBG Physical
only JJ Physical
micronutrients NNS Physical
chemotherapy NN Pharmocological
and CC None
BMT NNP Surgical
. . None
BMT NNP Surgical
-DOCSTART- -X- N

oral JJ Pharmocological
ganciclovir NN Pharmocological
Ganciclovir NNP Pharmocological
oral JJ Pharmocological
ganciclovir NN Pharmocological
oral JJ Pharmocological
ganciclovir NN Pharmocological
1000 CD Pharmocological
placebo NN Control
ganciclovir NN Pharmocological
placebo NN Control
ganciclovir NN Pharmocological
placebo NN None
ganciclovir NN Pharmocological
( ( None
placebo JJ None
ganciclovir CC Pharmocological
placebo NN Control
ganciclovir NN Pharmocological
-DOCSTART- -X- N

play NN Educational
and CC Educational
joint JJ Educational
attention NN Educational
intervention NN Educational
symbolic NN Educational
play NN Educational
then RB Educational
joint JJ Educational
attention NN Educational
intervention NN Educational
joint NN Educational
attention NN Educational
then RB Educational
symbolic JJ Educational
intervention NN Educational
wait-list NN Control
control NN Control
period NN Control
then RB Control
further RB Control
randomized VBN Control
to TO Control
either DT Control
group NN Control
1 CD Control
or CC Control
group NN Control
2 CD Control
. . Control
-DOCSTART- -X- N

( ( Other
13 CD Other
) ) Other
C-octanoic NNP Other
-DOCSTART- -X- N

anesthesia NN Physical
anesthesia JJ Physical
clove NN None
solution NN None
-DOCSTART- -X- N

Nasotracheal JJ None
intubation NN None
under IN None
curve-tipped JJ None
suction NN None
catheter NN None
Nasotracheal NNP None
intubation NN None
( ( None
NTI NNP None
) ) None
curve-tipped JJ Physical
suction NN Physical
catheter NN Physical
( ( Physical
CTSC NNP Physical
) ) Physical
to TO None
NTI NN None
without IN None
CTSC NNP None
guidance NN None
Nasotracheal NNP None
intubation NN None
under IN None
CTSC NNP None
guidance NN None
-DOCSTART- -X- N

amifostine NN Pharmocological
to TO None
carboplatin VB Pharmocological
and CC None
paclitaxel VB Pharmocological
based VBN None
chemoradiation NN Physical
amifostine NN Pharmocological
paclitaxel NN Pharmocological
carboplatin JJ Pharmocological
paclitaxel NN Pharmocological
carboplatin NN Pharmocological
hyperfractionated VBN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
amifostine VB Pharmocological
regimen NNS None
of IN None
carboplatin NN None
and CC None
paclitaxel NN None
produced VBN None
regimens NNS None
. . None
Amifostine NNP None
did VBD None
not RB None
-DOCSTART- -X- N

Epidural JJ Pharmocological
morphine NN Pharmocological
epidurally RB Pharmocological
administered VBN Pharmocological
morphine NN Pharmocological
epidural JJ Pharmocological
morphine NN Pharmocological
intramuscular JJ Pharmocological
regime NN Pharmocological
. . None
morphine NN Pharmocological
-DOCSTART- -X- N

labetalol NN Pharmocological
labetalol NN Pharmocological
Labetalol NNP Pharmocological
Labetalol NNP Pharmocological
labetalol NN Pharmocological
. . None
labetalol JJ Pharmocological
-DOCSTART- -X- N

bare-metal JJ Physical
stent JJ Physical
implantation NN Physical
with IN Physical
sirolimus-eluting JJ Physical
stent NN Physical
implantation NN Physical
sirolimus-eluting JJ Surgical
Cypher NNP Surgical
stents NNS Surgical
( ( Surgical
SESs NNP Surgical
) ) Surgical
SESs NNP None
BMSs NNP None
-DOCSTART- -X- N

Ciprofloxacin/dexamethasone NNP Pharmocological
ciprofloxacin JJ Pharmocological
0.3 CD Pharmocological
% NN Pharmocological
/dexamethasone CD Pharmocological
Ciprodex NNP Pharmocological
or CC None
no DT Control
treatment NN Control
for IN Control
5 CD Control
days NNS Control
post-operatively RB Control
-DOCSTART- -X- N

growth NN Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GH NNP Pharmocological
) ) Pharmocological
treatment NN Pharmocological
GH NNP Pharmocological
treatment NN Pharmocological
placebo-controlled JJ Control
Recombinant JJ Pharmocological
human JJ Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

mesalamine NN Pharmocological
mesalamine NN Pharmocological
( ( None
mesalazine NN Pharmocological
) ) None
granules NNS None
( ( None
MG NNP None
) ) None
. . None
MG NNP None
placebo NN None
( ( None
78.9 CD None
favouring VBG None
MG NNP None
were VBD None
Once-daily JJ None
mesalamine NN None
( ( None
mesalazine NN None
) ) None
was VBD None
effective JJ None
-DOCSTART- -X- N

once-daily JJ Pharmocological
monotherapy NN Pharmocological
new JJ Pharmocological
sustained-release NN Pharmocological
( ( Pharmocological
SR NNP Pharmocological
) ) Pharmocological
formulation NN Pharmocological
of IN Pharmocological
nifedipine JJ Pharmocological
placebo NN Control
placebo NN Pharmocological
or CC Pharmocological
nifedipine JJ Pharmocological
nifedipine JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

Vector NNP Physical
system NN Physical
. . None
Vector NNP Physical
system NN Physical
Vector NNP Physical
system NN Physical
carbon NN Other
fiber NN Other
curette NN Other
. . None
Vector-treated NNP Physical
sites NNS Physical
Vector NNP Physical
system NN Physical
-DOCSTART- -X- N

thrombolytic JJ Physical
coronary JJ Physical
reperfusion NN Physical
: : Physical
streptokinase NN Physical
anistreplase NN Physical
. . Physical
intravenous JJ Physical
anistreplase NN Physical
( ( Physical
Eminase NNP Physical
) ) Physical
, , Physical
also RB Physical
known VBN Physical
as IN Physical
anisoylated JJ Physical
plasminogen NN Physical
streptokinase JJ Physical
activator NN Physical
complex NN Physical
( ( Physical
APSAC NNP Physical
) ) Physical
streptokinase NN Physical
. . None
anistreplase NN Physical
streptokinase NN Physical
. . None
reperfusion NN Psychological
therapy NN Psychological
thrombolytic JJ Psychological
therapy NN Psychological
. . None
thrombolytic JJ Pharmocological
drug NN Pharmocological
-DOCSTART- -X- N

Unopposed VBN Pharmocological
estrogen NN Pharmocological
placebo-controlled JJ Control
Estrogen NNP Pharmocological
therapy NN Pharmocological
unopposed JJ Pharmocological
estrogen NN Pharmocological
placebo VB Control
oral JJ Pharmocological
17beta-estradiol JJ Pharmocological
unopposed JJ Pharmocological
estrogen NN Pharmocological
replacement NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

naltrexone NN Pharmocological
. . None
naltrexone NN Pharmocological
( ( Pharmocological
NAL NNP Pharmocological
) ) Pharmocological
. . None
double-blind JJ None
crossover NN None
study NN None
with IN None
NAL NNP Pharmocological
at IN None
the DT None
doses NNS None
of IN None
0.5 CD None
, , None
1.0 CD None
and CC None
1.5 CD None
mg/kg NN None
every DT None
48 CD None
hours NNS None
. . None
The DT None
behavioural JJ None
evaluation NN None
was VBD None
conducted VBN None
using VBG None
the DT None
specific JJ None
NAL NNP Pharmocological
treatment NN None
produced VBD None
a DT None
significant JJ None
reduction NN None
of IN None
the DT None
in IN None
seven CD None
( ( None
responders NNS None
) ) None
out IN None
of IN None
12 CD None
pharmacological JJ None
therapy NN None
with IN None
opiate JJ Pharmocological
antagonists NNS Pharmocological
. . None
-DOCSTART- -X- N

diet JJ Other
and CC None
Aspergillus NNP Other
oryzae VBP Other
extract NN Other
or CC None
Saccharomyces NNS Other
cervisiae VBP Other
diet JJ Physical
and CC Physical
feed JJ Physical
additive NN Physical
Aspergillus NNP None
oryzae NNP None
extract NN None
, , None
Amaferm NNP None
( ( None
AMF NNP None
) ) None
supplementation NN None
( ( None
% NN None
concentrate NN None
diet NN None
on IN None
of IN None
Saccaromyces NNP None
cervisiae NN None
boulardii NN None
CNCM NNP None
1079-Levucell CD None
SB NNP None
( ( None
LEV NNP None
) ) None
, , None
or CC None
of IN None
AMF NNP None
sources NNS None
, , None
dry JJ None
whole-shelled JJ None
corn NN None
or CC None
high JJ None
moisture NN None
corn NN None
, , None
on IN None
of IN None
LEV NNP None
addition NN None
of IN None
AMF NNP None
AMF NNP None
-DOCSTART- -X- N

FK506 NNP Pharmocological
( ( Pharmocological
tacrolimus NN Pharmocological
) ) Pharmocological
and CC None
cyclosporin NN Pharmocological
cyclosporin NN Pharmocological
. . None
cyclosporin NN Pharmocological
tacrolimus NN Pharmocological
. . None
nifedipine NN Pharmocological
tacrolimus NN Pharmocological
Tacrolimus NNP Pharmocological
cyclosporin NN Pharmocological
-DOCSTART- -X- N

unpaced JJ Physical
finger NN Physical
tapping NN Physical
synchronization-continuation NN Psychological
task NN Psychological
with IN Psychological
intertap JJ Psychological
intervals NNS Psychological
( ( Psychological
ITI NNP Psychological
) ) Psychological
-DOCSTART- -X- N

PRO NNP Physical
discharge NN Physical
screens NNS Physical
Multivariate NNP Other
logistic JJ Other
regression NN Other
analysis NN Other
Generic NNP Other
discharge NN Other
screens NNS Other
-DOCSTART- -X- N

Angiotensin-converting NNP Physical
enzyme NN Physical
inhibitor NN Physical
therapy NN Physical
placebo NN Pharmocological
, , None
quinapril RB Pharmocological
losartan JJ Pharmocological
quinapril NN Pharmocological
placebo VB Control
losartan VB Pharmocological
-DOCSTART- -X- N

antibiotics NNS Pharmocological
antibiotics NNS Pharmocological
. . None
amoxicillin NN Pharmocological
, , Pharmocological
clarithromycin NN Pharmocological
and CC Pharmocological
rabeprazole NN Pharmocological
; : None
tinidazole NN Pharmocological
, , Pharmocological
clarithromycin NN Pharmocological
and CC Pharmocological
ranitidine NN Pharmocological
bismuth NN Pharmocological
citrate NN Pharmocological
; : None
tinidazole NN Pharmocological
, , Pharmocological
clarithromycin NN Pharmocological
and CC Pharmocological
rabeprazole JJ Pharmocological
tinidazole NN Pharmocological
, , Pharmocological
tetracycline NN Pharmocological
, , Pharmocological
bismuth NN Pharmocological
and CC Pharmocological
rabeprazole NN Pharmocological
. . None
tinidazole NN Pharmocological
, , Pharmocological
tetracycline NN Pharmocological
, , Pharmocological
bismuth NN Pharmocological
rabeprazole JJ Pharmocological
triple JJ Pharmocological
rabeprazole-based JJ Pharmocological
eradicating NN Pharmocological
regimens NNS Pharmocological
Quadruple JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
to TO Pharmocological
bradykinin VB Pharmocological
( ( Pharmocological
BK NNP Pharmocological
) ) Pharmocological
, , None
substance NN Pharmocological
P NNP Pharmocological
( ( Pharmocological
SP NNP Pharmocological
) ) Pharmocological
and CC None
citric JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
consisting NN Pharmocological
of IN Pharmocological
doxorubicin NN Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
or CC Pharmocological
equal JJ Pharmocological
to TO Pharmocological
550 CD Pharmocological
mg/m2 NN Pharmocological
) ) Pharmocological
, , None
cyclophosphamide RB Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
or CC Pharmocological
equal JJ Pharmocological
to TO Pharmocological
5500 CD Pharmocological
mg/m2 NN Pharmocological
) ) Pharmocological
, , None
and CC None
methotrexate NN Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
or CC Pharmocological
equal JJ Pharmocological
to TO Pharmocological
1000 CD Pharmocological
mg/kg NN Pharmocological
) ) None
chemotherapy NN Pharmocological
no-chemotherapy JJ Control
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
serotonin2A-dopamine JJ Pharmocological
D2 NNP Pharmocological
antagonist NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
. . None
risperidone NN Pharmocological
placebo NN Control
Risperidone NN Pharmocological
placebo VB Control
placebo NN Control
Risperidone NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

cognitive-behavioral JJ Educational
therapy NN Educational
Cognitive-Behavioral JJ Psychological
Therapy NNP Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
program NN Educational
and CC None
a DT None
Social NNP Psychological
Recreational NNP Psychological
( ( Psychological
SR NNP Psychological
) ) Psychological
program NN Psychological
( ( None
CBT NNP Educational
) ) None
regular JJ None
sessions NNS None
in IN None
a DT None
structured JJ None
setting NN None
, , None
consistent JJ None
therapists NNS None
, , None
social JJ None
exposure NN None
autism-friendly JJ Educational
strategies NNS Educational
-DOCSTART- -X- N

oral JJ Surgical
surgery NN Surgical
local JJ Pharmocological
anesthesia NN Pharmocological
midazolam NNS Pharmocological
: : None
local JJ Pharmocological
anesthetics NNS Pharmocological
. . None
epinephrine-free JJ Pharmocological
and CC Pharmocological
epinephrine-containing JJ Pharmocological
local JJ Pharmocological
anesthetic JJ Pharmocological
4.4 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
with IN Pharmocological
1:80,000 CD Pharmocological
epinephrine NN Pharmocological
as IN Pharmocological
a DT Pharmocological
local JJ Pharmocological
anesthetic NN Pharmocological
and CC None
10 CD None
were VBD None
given VBN None
4.4 CD Pharmocological
mL NN Pharmocological
of IN Pharmocological
3 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
with IN Pharmocological
0.03 CD Pharmocological
IU/mL NNP Pharmocological
felypressin NN Pharmocological
. . None
epinephrine-free JJ Pharmocological
solution NN Pharmocological
. . None
epinephrine-free JJ Pharmocological
epinephrine-containing JJ Pharmocological
local JJ Pharmocological
anesthetics NNS Pharmocological
midazolam JJ Pharmocological
sedation NN Pharmocological
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
lower JJR Educational
fat JJ Educational
challenge NN Educational
vehicle NN Educational
. . None
lower JJR Other
fat NN Other
recipe NN Other
peanut NN Other
-DOCSTART- -X- N

Rapid-sequence JJ Physical
intubation NN Physical
pancuronium NN Pharmocological
minidose JJ Pharmocological
succinylcholine NN Pharmocological
. . None
succinylcholine JJ Pharmocological
administration NN Pharmocological
. . None
succinylcholine NN Pharmocological
rapid-sequence NN Physical
intubation NN Physical
maneuvers NNS Physical
lidocaine NN Pharmocological
minidose JJ Pharmocological
succinylcholine NN Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
mg/kg NN Pharmocological
) ) Pharmocological
or CC None
pancuronium NN Pharmocological
full JJ Pharmocological
paralytic JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
succinylcholine NN Pharmocological
pancuronium NN Pharmocological
succinylcholine NN Pharmocological
succinylcholine JJ Pharmocological
pancuronium NN Pharmocological
succinylcholine NN Pharmocological
-DOCSTART- -X- N

Stepwise NNP Physical
hook NN Physical
extension NN Physical
technique NN Physical
stepwise NN Physical
hook NN Physical
extension NN Physical
technique NN Physical
for IN Physical
radiofrequency NN Physical
ablation NN Physical
( ( Physical
RFA NNP Physical
) ) Physical
therapy NN Physical
RFA NNP Physical
stepwise NN Physical
hook NN Physical
extension NN Physical
technique NN Physical
full JJ Physical
extension NN Physical
method NN Physical
10-hook JJ Other
electrode NN Other
of IN Other
LeVeen NNP Other
needle NN Other
-DOCSTART- -X- N

Vitamin JJ Pharmocological
supplements NNS Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
-DOCSTART- -X- N

culture-specific JJ Educational
education NN Educational
program NN Educational
to TO Educational
promote VB Educational
language NN Educational
and CC Educational
culture NN Educational
specific JJ Educational
education NN Educational
-DOCSTART- -X- N

Low NNP None
Energy NNP None
Safety NNP None
Study NNP None
( ( None
LESS NNP None
) ) None
: : None
Low NNP None
Energy NNP None
Safety NNP None
Study NNP None
( ( None
LESS NNP None
) ) None
initial JJ Physical
2 CD Physical
shocks NNS Physical
for IN Physical
ventricular JJ Physical
fibrillation NN Physical
conversion NN Physical
programmed VBD Physical
at IN Physical
2 CD Physical
energy NN Physical
steps NNS Physical
above IN Physical
DFT++ NNP Physical
( ( Physical
typically RB Physical
4-6 JJ Physical
J NNP Physical
, , Physical
maximum JJ Physical
10 CD Physical
J NNP Physical
) ) Physical
with IN Physical
subsequent JJ Physical
shocks NNS Physical
at IN Physical
maximum JJ Physical
energy NN Physical
all DT Physical
shocks NNS Physical
programmed VBN Physical
at IN Physical
maximum JJ Physical
energy NN Physical
. . None
DFT++ NNP Physical
LESS NNP None
-DOCSTART- -X- N

flosequinan NN Pharmocological
flosequinan NN Pharmocological
flosequinan NN Pharmocological
placebo NN Control
Flosequinan NNP Pharmocological
flosequinan JJ Pharmocological
flosequinan NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
folic JJ Pharmocological
acid-supplementation NN Pharmocological
folic JJ Pharmocological
acid DT Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
folic JJ Pharmocological
acid-supplementation NN Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
or CC None
placebo NN Control
. . None
placebo NN Control
folic JJ Pharmocological
acid JJ Pharmocological
folic JJ Pharmocological
acid DT Pharmocological
-DOCSTART- -X- N

Cognitive-behavioural JJ Educational
stress NN Educational
management NN Educational
group-based JJ Educational
cognitive-behavioural JJ Educational
stress NN Educational
management NN Educational
( ( Educational
CBSM NNP Educational
) ) Educational
intervention NN Educational
wait-list NN Control
control NN Control
condition NN Control
CBSM NNP Educational
intervention NN Educational
battery NN None
of IN None
administered VBN None
by IN None
a DT None
research NN None
assistant NN None
at IN None
baseline NN None
, , None
immediately RB None
following VBG None
the DT None
10-week JJ Educational
CBSM NNP Educational
intervention NN Educational
period NN None
, , None
and CC None
at IN None
a DT None
6-month JJ None
follow-up NN None
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
tamoxifen NN Pharmocological
-DOCSTART- -X- N

gluten-free JJ Physical
, , Physical
casein-free JJ Physical
diet NN Physical
gluten-free JJ Other
and CC Other
casein-free JJ Other
( ( Other
GFCF NNP Other
) ) Other
diet NN Other
GFCF NNP Physical
diet NN Physical
-DOCSTART- -X- N

gemcitabine NN Pharmocological
plus CC None
tipifarnib NN Pharmocological
gemcitabine JJ Pharmocological
plus CC None
placebo NN Control
tipifarnib NN Pharmocological
gemcitabine JJ Pharmocological
+ NNP Pharmocological
tipifarnib NN Pharmocological
gemcitabine NN None
+ NNP None
placebo NN None
Tipifarnib NNP Pharmocological
was VBD Pharmocological
given VBN Pharmocological
at IN Pharmocological
200 CD Pharmocological
mg NNS Pharmocological
bid VBD Pharmocological
orally RB Pharmocological
continuously RB Pharmocological
; : Pharmocological
gemcitabine NN Pharmocological
was VBD Pharmocological
given VBN Pharmocological
at IN Pharmocological
1,000 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
intravenously RB Pharmocological
weekly JJ Pharmocological
x NN Pharmocological
7 CD Pharmocological
for IN Pharmocological
8 CD Pharmocological
weeks NNS Pharmocological
, , Pharmocological
then RB Pharmocological
weekly JJ Pharmocological
x NN Pharmocological
3 CD Pharmocological
every DT Pharmocological
4 CD Pharmocological
weeks NNS Pharmocological
. . Pharmocological
gemcitabine NN Pharmocological
and CC Pharmocological
tipifarnib NN Pharmocological
-DOCSTART- -X- N

EEG NNP Physical
EEGs NNP Physical
-DOCSTART- -X- N

Acamprosate NNP Pharmocological
placebo-controlled JJ Control
Acamprosate NNP Pharmocological
( ( None
calcium NN Pharmocological
acetylhomotaurinate NN Pharmocological
( ( Pharmocological
CA NNP Pharmocological
) ) Pharmocological
, , None
1.3 CD None
g/day NN None
) ) None
CA NNP Pharmocological
CA NNP Pharmocological
placebo NN Control
. . None
CA NNP Pharmocological
placebo NN Control
CA NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

special-effect JJ Physical
contact NN Physical
lenses NNS Physical
( ( Physical
Crazy NNP Physical
Lenses NNP Physical
) ) Physical
Special-effect JJ Physical
contact NN Physical
lenses NNS Physical
A DT Physical
clear JJ Physical
soft JJ Physical
contact NN Physical
lens NNS Physical
and CC None
a DT Physical
special-effect JJ Physical
soft JJ Physical
contact NN Physical
lens NNS Physical
( ( Physical
Crazy NNP Physical
lens VBZ Physical
, , Physical
) ) Physical
clear JJ Physical
lens NNS Physical
special-effect JJ Physical
lenses NNS Physical
Special-effect JJ Physical
contact NN Physical
lenses NNS Physical
-DOCSTART- -X- N

epigallocatechin-3-gallate NN Pharmocological
Epigallocatechin-3-gallate NNP Pharmocological
( ( Pharmocological
EGCG NNP Pharmocological
) ) Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
w/w NN Pharmocological
of IN Pharmocological
EGCG NNP Pharmocological
. . Pharmocological
EGCG NNP Pharmocological
cream NN Pharmocological
vehicle NN Pharmocological
control NN Pharmocological
cream NN Pharmocological
EGCG NNP Pharmocological
vehicle NN Other
treated VBN Other
EGCG NNP None
treated VBD None
EGCG NNP None
treated VBD None
EGCG NNP None
vs. FW None
vehicle-treated JJ None
skin NN None
< NNP None
0.005 CD None
) ) None
. . None
EGCG NNP None
topical JJ None
-DOCSTART- -X- N

B-vitamins NNS Pharmocological
B NNP Pharmocological
vitamins NNS Pharmocological
2mg CD Pharmocological
of IN Pharmocological
folate NN Pharmocological
, , None
plus CC Pharmocological
25mg CD Pharmocological
of IN Pharmocological
B6 NNP Pharmocological
and CC None
400 CD Pharmocological
microg NN Pharmocological
of IN Pharmocological
B12 NNP Pharmocological
, , None
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

levocarnitine NN Pharmocological
L-carnitine NNP Pharmocological
standardized JJ Pharmocological
regimen NN Pharmocological
( ( Pharmocological
50 CD Pharmocological
mg RB Pharmocological
L-carnitine/kg NNP Pharmocological
bodyweight/day NN Pharmocological
) ) Pharmocological
of IN Pharmocological
liquid JJ Pharmocological
L-carnitine NNP Pharmocological
( ( Pharmocological
n=19 NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
( ( Control
n=11 JJ Control
) ) Control
for IN Control
3-months JJ Control
. . Pharmocological
L-carnitine JJ Pharmocological
therapy NN Pharmocological
L-carnitine JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

diet-controlled JJ Educational
crossover NN Educational
intervention NN Educational
caffeine NN Pharmocological
placebo NN Control
. . None
caffeine NN Pharmocological
-DOCSTART- -X- N

triage NN None
room NN None
or CC None
the DT None
standard JJ None
care NN None
labor NN None
room NN None
. . None
standing VBG Physical
orders NNS Physical
in IN Physical
common JJ Physical
obstetric JJ Physical
problems NNS Physical
-DOCSTART- -X- N

High-pressure NN Physical
, , Physical
rapid-inflation NN Physical
pneumatic JJ Physical
compression NN Physical
duplex JJ Physical
ultrasound NN Physical
scanning NN Physical
Three CD Physical
high-pressure NN Physical
, , Physical
rapid-compression NN Physical
devices NNS Physical
and CC Physical
two CD Physical
standard NN Physical
, , Physical
low-pressure JJ Physical
, , None
slow-inflation JJ Physical
compression NN Physical
devices NNS Physical
-DOCSTART- -X- N

pre-counselling VBG Educational
. . Educational
-DOCSTART- -X- N

new JJ Pharmocological
3.3 CD Pharmocological
g NN Pharmocological
b.i.d NN Pharmocological
. . Pharmocological
tablet NN Pharmocological
formulation NN Pharmocological
balsalazide NN Pharmocological
disodium NN Pharmocological
1.1 CD Pharmocological
g NN Pharmocological
tablet NN Pharmocological
balsalazide NN Pharmocological
or CC None
placebo NN Pharmocological
balsalazide NN Pharmocological
placebo NN Control
placebo NN Control
Balsalazide NNP Pharmocological
disodium NN Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

peginterferon NN Pharmocological
alfa-2a NN Pharmocological
peginterferon NN Pharmocological
alfa-2a NN Pharmocological
peginterferon JJ Pharmocological
alfa-2a NN Pharmocological
peginterferon JJ Pharmocological
alfa-2a JJ Pharmocological
peginterferon VB Pharmocological
alfa-2a JJ Pharmocological
peginterferon NN Pharmocological
alfa-2a JJ Pharmocological
plus CC Pharmocological
lamivudine JJ Pharmocological
. . Pharmocological
peginterferon NN Pharmocological
alfa-2a NN Pharmocological
pegylated JJ Pharmocological
interferon NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Transthoracic NNP Physical
versus NN None
transesophageal NN Surgical
cardioversion NN Surgical
of IN Surgical
atrial JJ Surgical
fibrillation NN Surgical
under IN None
light JJ None
sedation NN None
: : None
intravenous JJ Pharmocological
midazolam NNS Pharmocological
. . None
-DOCSTART- -X- N

adrenocorticotrophic JJ Pharmocological
hormone NN Pharmocological
( ( Pharmocological
4-9 JJ Pharmocological
) ) Pharmocological
analog NN Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
neuropeptide NN Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
ORG JJ Pharmocological
2766 CD Pharmocological
treatment NN Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
ORG NNP Pharmocological
2766 CD Pharmocological
-DOCSTART- -X- N

Oxaprozin NNP Pharmocological
diclofenac NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
receive VB None
either RB None
oxaprozin JJ Pharmocological
1200 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
( ( None
n JJ None
= NNP None
49 CD None
) ) None
or CC None
diclofenac $ Pharmocological
50 CD Pharmocological
mg NN Pharmocological
three CD None
times NNS None
daily RB None
( ( None
n JJ None
= NNP None
47 CD None
) ) None
. . None
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
. . None
oxaprozin NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
diclofenac NN Pharmocological
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
Oxaprozin NNP Pharmocological
diclofenac VB Pharmocological
diclofenac NN Pharmocological
. . None
oxaprozin NN Pharmocological
diclofenac NN Pharmocological
. . None
oxaprozin JJ Pharmocological
diclofenac NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Alendronate NNP Pharmocological
Bisphosphonates NNS Pharmocological
alendronate NN Pharmocological
10mg/day CD Pharmocological
: : None
alendronate NN Pharmocological
70 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
a DT Pharmocological
week NN Pharmocological
: : Pharmocological
enteric JJ Pharmocological
alendronate NN Pharmocological
70 CD Pharmocological
mg NN Pharmocological
per IN Pharmocological
week NN Pharmocological
. . None
alendronate NN Pharmocological
Enteric JJ Pharmocological
alendronate NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

High-dose JJ Physical
weekly JJ Physical
fractionation NN Physical
radiotherapy NN Physical
-DOCSTART- -X- N

auditory JJ Educational
stimuli NNS Educational
Stimuli NNP Educational
were VBD Educational
presented VBN Educational
via IN Educational
headphones NNS Educational
and CC Educational
consisted VBN Educational
of IN Educational
common JJ Educational
facts NNS Educational
or CC None
familiar JJ Educational
or CC Educational
unfamiliar JJ Educational
full JJ Educational
names NNS Educational
of IN Educational
fictitious JJ Educational
people NNS Educational
-DOCSTART- -X- N

albumin JJ Pharmocological
Autologous JJ Pharmocological
technetium-99m NN Pharmocological
( ( Pharmocological
99mTc CD Pharmocological
) ) Pharmocological
-labeled VBD Pharmocological
red JJ Pharmocological
blood NN Pharmocological
cells NNS Pharmocological
and CC None
indium-oxine NN Pharmocological
( ( Pharmocological
( ( Pharmocological
111 CD Pharmocological
) ) Pharmocological
In IN Pharmocological
) ) Pharmocological
-labeled VBD Pharmocological
human JJ Pharmocological
serum NN Pharmocological
albumin NN Pharmocological
were VBD Pharmocological
injected VBN Pharmocological
intravenously RB Pharmocological
-DOCSTART- -X- N

CDP571 NNP Pharmocological
placebo-controlled JJ Control
CDP571 NNP Pharmocological
placebo-controlled JJ Control
intravenous JJ None
CDP571 NNP Control
10 CD None
mg/kg NN None
or CC None
placebo NN None
CDP571 NNP Pharmocological
placebo NN Control
CDP571 NNP Pharmocological
CDP571 NNP Pharmocological
-DOCSTART- -X- N

cytokines NNS Pharmocological
Combined VBN Pharmocological
therapy NN Pharmocological
with IN Pharmocological
antibiotics NNS Pharmocological
and CC Pharmocological
superlimf NN Pharmocological
monotherapy NN Control
with IN Control
antibiotics NNS Control
. . None
superlimf NN Pharmocological
-DOCSTART- -X- N

warfarin NN Pharmocological
aspirin NN Pharmocological
receive VB None
warfarin NN Pharmocological
( ( None
target VB None
international JJ None
normalized JJ None
ratio NN None
, , None
2.0 CD None
to TO None
3.0 CD None
) ) None
or CC None
aspirin NN Pharmocological
( ( None
1300 CD None
mg NN None
per IN None
day NN None
) ) None
in IN None
a DT None
double-blind NN None
, , None
multicenter RB None
clinical JJ None
trial NN None
. . None
aspirin NN Pharmocological
aspirin JJ Pharmocological
warfarin VB Pharmocological
Warfarin NNP Pharmocological
Aspirin NNP Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
contraceptives NNS Pharmocological
ethinyl NN Pharmocological
estradiol $ Pharmocological
drospirenone NN Pharmocological
or CC None
desogestrel NN Pharmocological
ethinyl NN Pharmocological
estradiol NN Pharmocological
20 CD Pharmocological
microg/drospirenone NN Pharmocological
3 CD Pharmocological
mg NN Pharmocological
ethinyl JJ Pharmocological
estradiol NN Pharmocological
20 CD Pharmocological
microg/desogestrel NN Pharmocological
-DOCSTART- -X- N

inflation NN None
of IN None
400 CD None
ml NN None
of IN None
air NN None
. . None
-DOCSTART- -X- N

treatment NN None
-- : None
cyclophosphamide NN Pharmocological
ifosfamide NN Pharmocological
etoposide NN Pharmocological
cyclophosphamide NN Pharmocological
ifosfamide NN Pharmocological
etoposide JJ Pharmocological
vincristine NN Pharmocological
, , Pharmocological
dactinomycin NN Pharmocological
, , Pharmocological
ifosfamide NN Pharmocological
, , Pharmocological
and CC Pharmocological
doxorubicin NN Pharmocological
( ( Pharmocological
VAIA NNP Pharmocological
) ) Pharmocological
induction NN Pharmocological
therapy NN Pharmocological
VAIA NNP Pharmocological
or CC Pharmocological
vincristine NN Pharmocological
, , Pharmocological
dactinomycin NN Pharmocological
, , Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
and CC Pharmocological
doxorubicin NN Pharmocological
( ( None
VACA NNP None
; : None
cyclophosphamide NN None
replacing VBG None
ifosfamide NN None
) ) None
VAIA NNP Pharmocological
VAIA NNP Pharmocological
plus CC None
etoposide NN Pharmocological
( ( Pharmocological
EVAIA NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
Clonidine NNP Pharmocological
Clonidine NNP Pharmocological
clonidine NN Pharmocological
propofol NN Pharmocological
propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
. . Pharmocological
propofol NN Pharmocological
Nothing NN Control
was VBD Control
administered VBN Control
to TO Control
the DT Control
Control NNP Control
group NN Control
. . Control
Clonidine NNP Pharmocological
Clonidine NNP Pharmocological
propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
Clonidine NNP Pharmocological
Clonidine NNP Pharmocological
propofol NN Pharmocological
and CC Pharmocological
clonidine NN Pharmocological
clonidine NN Pharmocological
propofol JJ Pharmocological
-DOCSTART- -X- N

combination NN None
of IN None
ketamine NN Pharmocological
and CC None
propofol NN Pharmocological
, , None
propofol VB Pharmocological
alone RB None
, , None
or CC None
a DT None
combination NN None
of IN None
ketamine NN Pharmocological
and CC None
diazepam NN Pharmocological
before IN None
and CC None
after IN None
induction NN Pharmocological
of IN Pharmocological
propofol NN Pharmocological
ketamine JJ Pharmocological
hydrochloride NN Pharmocological
and CC Pharmocological
propofol NN Pharmocological
ketamine VB Pharmocological
hydrochloride NN Pharmocological
diazepam NN Pharmocological
anesthesia NN Pharmocological
anesthetized VBN Pharmocological
with IN Pharmocological
isoflurane NN Pharmocological
. . None
acepromazine NN Pharmocological
oxymorphone NN Pharmocological
propofol NN Pharmocological
, , Pharmocological
K-P NNP Pharmocological
, , Pharmocological
or CC Pharmocological
K-D. NNP Pharmocological
K-P NNP Pharmocological
K-D NNP Pharmocological
K-P NNP Pharmocological
K-P NNP Pharmocological
K-D NNP Pharmocological
-DOCSTART- -X- N

patient JJ Educational
involvement NN Educational
support VB Educational
self-care NN Educational
mediate VB Educational
doctor/patient JJ Educational
interaction NN Educational
Semi-structured JJ Educational
interviews NNS Educational
-DOCSTART- -X- N

video NN Surgical
assisted VBN Surgical
thoracic NN Surgical
surgery NN Surgical
insertion NN Surgical
of IN Surgical
a DT Surgical
chest NN Surgical
tube NN Surgical
( ( Surgical
ICT NNP Surgical
) ) Surgical
video NN Surgical
assisted VBN Surgical
thoracoscopy NN Surgical
( ( Surgical
VATS NNP Surgical
) ) Surgical
ICT NNP Surgical
or CC None
VATS NNP Surgical
. . None
ICT JJ Surgical
VATS NNP Surgical
ICT JJ Surgical
VATS NNP Surgical
ICT NNP Surgical
VATS NNP Surgical
VATS NNP Surgical
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
morphine JJ Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

levetiracetam NN Pharmocological
-DOCSTART- -X- N

EPI-NO NNP Other
EPI-NO NNP Other
EPI-NO NNP Other
EPI-NO NNP Other
EPI-NO NNP Physical
-DOCSTART- -X- N

perioperative JJ Pharmocological
enterococcus NN Pharmocological
and CC Pharmocological
bacteroides NNS Pharmocological
therapy NN Pharmocological
. . None
Perioperative JJ Pharmocological
antibiotics NNS Pharmocological
cefoxitin NN Pharmocological
or CC None
ampicillin/sulbactam NN Pharmocological
-DOCSTART- -X- N

antiplatelet NN Pharmocological
agents NNS Pharmocological
aspirin NN Pharmocological
dipyridamole NN Pharmocological
aspirin JJ Pharmocological
plus CC Pharmocological
dipyridamole JJ Pharmocological
versus NN None
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

acylaminopenicillins NNS Pharmocological
. . None
nondepolarizing VBG Pharmocological
muscle NN Pharmocological
relaxants NNS Pharmocological
and CC None
acylaminopenicillins NNS Pharmocological
apalcillin JJ Pharmocological
, , Pharmocological
azlocillin NN Pharmocological
, , Pharmocological
mezlocillin NN Pharmocological
or CC Pharmocological
piperacillin NN Pharmocological
acylaminopenicillins NNS Pharmocological
-DOCSTART- -X- N

isoprenaline NN Pharmocological
and CC None
glyceryl NN Pharmocological
trinitrate NN Pharmocological
glyceryl JJ Pharmocological
trinitrate JJ Pharmocological
isoprenaline JJ Pharmocological
glyceryl JJ Pharmocological
trinitrate NN Pharmocological
head-up NN Pharmocological
tilt NN Pharmocological
and CC None
isoprenaline JJ Pharmocological
head-up NN Pharmocological
tilt NN Pharmocological
Glyceryl NNP Pharmocological
trinitrate VB Pharmocological
head-up JJ Pharmocological
tilt NN Pharmocological
isoprenaline JJ Pharmocological
head-up JJ Pharmocological
tilt NN Pharmocological
-DOCSTART- -X- N

pneumatic JJ Physical
otoscopy NN Physical
, , None
supplemented VBN Physical
by IN Physical
tympanometry NN Physical
we PRP None
treated VBD None
children NNS None
for IN None
otitis NN Physical
media NNS Physical
according VBG None
to TO None
specified VBN None
guidelines NNS None
. . None
tympanostomy JJ Surgical
tube NN Surgical
placement NN Surgical
-DOCSTART- -X- N

school-based JJ Educational
physical-activity NN Educational
intervention NN Educational
. . Educational
Lifestyle NNP Educational
Education NNP Educational
for IN Educational
Activity NNP Educational
Program NNP Educational
( ( Educational
LEAP NNP Educational
) ) Educational
intervention NN Educational
LEAP NNP Educational
PE NNP Educational
component NN Educational
with IN Educational
core NN Educational
objectives NNS Educational
LEAP NNP Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

RRR-alpha-tocopheryl NNP Pharmocological
acetate NN Pharmocological
and CC None
fish JJ Pharmocological
oil NN Pharmocological
RRR-alpha-tocpheryl NNP Pharmocological
acetate NN Pharmocological
( ( Pharmocological
alpha-tocopheryl JJ Pharmocological
acetate NN Pharmocological
) ) Pharmocological
and CC None
hormone-replacement JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
( ( None
placebo NN Control
) ) None
alpha-tocopheryl JJ Pharmocological
acetate JJ Pharmocological
placebo NN Control
alpha-tocopheryl JJ Pharmocological
-DOCSTART- -X- N

pegvisomant NN Pharmocological
pegvisomant NN Pharmocological
pegvisomant NN Pharmocological
placebo NN Control
pegvisomant JJ Pharmocological
pegvisomant NN Pharmocological
-DOCSTART- -X- N

pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
Pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
Pioglitazone-treated JJ Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
pioglitazone-induced JJ Other
pioglitazone NN Pharmocological
-DOCSTART- -X- N

control NN Control
group NN Control
or CC None
an DT None
added JJ None
treatment NN None
group NN None
( ( None
doxazosin JJ Pharmocological
1-4 JJ Pharmocological
mg NN Pharmocological
and CC None
atenolol NN Pharmocological
when WRB None
needed VBN None
) ) None
. . None
atenolol NN Pharmocological
antiadrenergic JJ Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

cervical JJ Physical
spine NN Physical
manipulative JJ Physical
therapy NN Physical
cervical JJ Physical
spinal JJ Physical
manipulative JJ Physical
therapy NN Physical
( ( Physical
SMT NNP Physical
) ) Physical
chiropractic JJ Physical
SMT NNP Physical
and CC None
sham NN Control
. . None
chiropractic JJ Physical
SMT NNP Physical
-DOCSTART- -X- N

[ NNS None
Sublingually RB Pharmocological
administered VBN Pharmocological
captopril NN Pharmocological
versus NN None
nifedipine NN Pharmocological
sublingual JJ Pharmocological
captopril NN Pharmocological
( ( Pharmocological
SLC NNP Pharmocological
) ) Pharmocological
sublingual JJ Pharmocological
nifedipine NN Pharmocological
( ( Pharmocological
SLN NNP Pharmocological
) ) Pharmocological
SLN NNP Pharmocological
SLC NNP Pharmocological
SLN NNP Pharmocological
SLC NNP Pharmocological
SLN NNP Pharmocological
; : None
SLC NNP Pharmocological
SLN NNP Pharmocological
; : None
SLC NNP Pharmocological
SLN NNP Pharmocological
-DOCSTART- -X- N

Single NNP Physical
negative JJ Physical
colposcopy NN Physical
: : None
-DOCSTART- -X- N

Lanoxin NNP Pharmocological
from IN Pharmocological
an DT Pharmocological
oral JJ Pharmocological
solution NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

methadone NN Pharmocological
methadone NN Pharmocological
Methadone NNP Pharmocological
hydrochloride NN Pharmocological
Liquid NNP Physical
Chromatography-Electrospray NNP Physical
Ionization-Tandem NNP Physical
Mass NNP Physical
Spectrometry NNP Physical
and CC None
radioimmunoassay VB Physical
methadone NN Pharmocological
. . None
methadone NN Pharmocological
methadone NN Pharmocological
methadone NN Pharmocological
methadone NN Pharmocological
-DOCSTART- -X- N

leuprolide JJ Pharmocological
acetate JJ Pharmocological
3-month JJ Pharmocological
3-month JJ Pharmocological
leuprolide NN Pharmocological
depot NN Pharmocological
11.25- JJ Pharmocological
leuprolide JJ Pharmocological
acetate JJ Pharmocological
3-month JJ Pharmocological
Leuprolide NNP Pharmocological
acetate NN Pharmocological
depot NN Pharmocological
leuprolide JJ Pharmocological
acetate JJ Pharmocological
-DOCSTART- -X- N

brushings NNS Physical
before IN Physical
and CC Physical
after IN Physical
biopsy NN Physical
endoscopic JJ Physical
brushings NNS Physical
brushings NNS Surgical
undergo VB Physical
brushing VBG Physical
either CC Physical
before IN Physical
or CC Physical
after IN Physical
forceps JJ Physical
biopsy NN Physical
. . Physical
brushing NN None
-DOCSTART- -X- N

intravenous JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
gamma JJ Pharmocological
globulin NN Pharmocological
( ( Pharmocological
IVGG NNP Pharmocological
) ) Pharmocological
plus CC None
aspirin JJ Pharmocological
versus NN None
aspirin NN Pharmocological
alone RB Pharmocological
IVGG NNP Pharmocological
-DOCSTART- -X- N

Lancet NNP Educational
puncture NN Educational
to TO Educational
the DT Educational
side NN Educational
of IN Educational
the DT Educational
thumb NN Educational
lancet JJ Educational
puncture NN Educational
to TO Educational
the DT Educational
finger NN Educational
or CC Educational
venepuncture NN Educational
at IN Educational
the DT Educational
elbow NN Educational
. . Educational
-DOCSTART- -X- N

allergen-specific JJ Physical
immunotherapy NN Physical
Epicutaneous NNP None
allergen NN None
receive VB None
placebo NN None
or CC None
3 CD None
different JJ None
doses NNS None
of IN None
allergen NN None
. . None
Epicutaneous NNP None
immunotherapy NN None
-DOCSTART- -X- N

Amphotericin NNP Pharmocological
pentamidine NN Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
pentamidine JJ Pharmocological
isethionate NN Pharmocological
pentamidine NN Pharmocological
amphotericin JJ Pharmocological
pentamidine VBP Pharmocological
amphotericin NN Pharmocological
Amphotericin NNP Pharmocological
-DOCSTART- -X- N

antiarrhythmic-drug JJ Pharmocological
therapy NN Pharmocological
with IN None
implantable JJ Physical
defibrillators NNS Physical
Antiarrhythmics NNPS Pharmocological
Implantable JJ Physical
Defibrillators NNS Physical
implantable JJ Physical
cardioverter-defibrillator NN Physical
antiarrhythmic JJ Pharmocological
drugs NNS Pharmocological
implantation NN Physical
of IN Physical
a DT Physical
cardioverter-defibrillator NN Physical
; : Physical
class NN Pharmocological
III NNP Pharmocological
antiarrhythmic JJ Pharmocological
drugs NNS Pharmocological
, , None
primarily RB None
amiodarone NN Pharmocological
implantable JJ Physical
defibrillator NN Physical
antiarrhythmic-drug JJ Pharmocological
implantable JJ Physical
defibrillator NN Physical
implantable JJ Physical
cardioverter-defibrillator NN Physical
antiarrhythmic VB Pharmocological
drugs NNS Pharmocological
-DOCSTART- -X- N

occupation NN Educational
based VBN Educational
physical JJ Educational
activity NN Educational
intervention NN Educational
program NN Educational
: : Educational
occupation NN Educational
based VBN Educational
health NN Educational
and CC Educational
fitness NN Educational
program NN Educational
. . Educational
( ( Educational
implemented VBN Educational
the DT Educational
intervention NN Educational
) ) Educational
( ( Control
continued VBN Control
usual JJ Control
training NN Control
) ) Control
occupational JJ Educational
approach NN Educational
-DOCSTART- -X- N

diuresis NN Physical
extracorporeal JJ Physical
shockwave JJ Physical
lithotripsy NN Physical
( ( Physical
ESWL NNP Physical
) ) Physical
ESWL NNP Surgical
Siemens NNP None
Lithostar NNP None
2 CD None
machine NN None
. . None
standard JJ Surgical
ESWL NNP Surgical
ESWL NNP Surgical
with IN Surgical
diuresis NN Surgical
during IN Surgical
the DT Surgical
ESWL NNP Surgical
session NN Surgical
. . None
-DOCSTART- -X- N

intraoperative JJ Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
placebo NN Control
intraoperative JJ Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
excision NN None
, , None
with IN None
or CC None
without IN None
a DT None
single JJ None
intraoperative JJ Pharmocological
application NN Pharmocological
of IN Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
-DOCSTART- -X- N

binary JJ Educational
logistic JJ Educational
regression NN Educational
physician JJ Educational
counseling NN Educational
and CC Educational
improvements NNS Educational
-DOCSTART- -X- N

chemotherapy NN None
radiation NN None
therapy NN None
breast-conserving JJ Pharmocological
therapy NN Pharmocological
and CC None
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
. . None
chemotherapy NN Pharmocological
and CC None
radiation NN Pharmocological
therapy NN Pharmocological
12-week JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
chemotherapy NN Pharmocological
either CC Pharmocological
before IN Pharmocological
or CC Pharmocological
after IN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
. . None
radiotherapy-first JJ Pharmocological
chemotherapy-first JJ Pharmocological
radiotherapy-first JJ Pharmocological
and CC None
chemotherapy-first JJ Pharmocological
chemotherapy NN None
radiation NN Pharmocological
therapy NN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
chemotherapy NN Pharmocological
. . None
-DOCSTART- -X- N

entecavir NN Pharmocological
prophylaxis NN Pharmocological
antiviral JJ Pharmocological
prophylaxis NN Pharmocological
rituximab-based JJ Pharmocological
chemotherapy NN Pharmocological
prophylactic JJ Pharmocological
entecavir NN Pharmocological
( ( Pharmocological
ETV NNP Pharmocological
) ) Physical
before IN Physical
chemotherapy NN Pharmocological
to TO Physical
3 CD Physical
months NNS Physical
after IN Physical
completing VBG Physical
chemotherapy NN Pharmocological
( ( Physical
ETV NNP Physical
prophylactic JJ Physical
group NN Physical
, , Physical
n RB Physical
= VBZ Physical
41 CD Physical
) ) Physical
or CC None
to TO None
receive VB Physical
therapeutic JJ Physical
ETV NNP Physical
at IN Physical
the DT Physical
time NN Physical
of IN Physical
HBV NNP Physical
reactivation NN Physical
and CC Physical
hepatitis NN Physical
B NNP Physical
surface NN Physical
antigen NN Physical
( ( Physical
HBsAg NNP Physical
) ) Physical
reverse NN Physical
seroconversion NN Physical
since IN Physical
chemotherapy NN Physical
( ( Physical
control NN Physical
group NN Physical
, , Physical
n RB Physical
= VBZ Physical
39 CD Physical
) ) Physical
. . None
ETV NNP Physical
Antiviral NNP Pharmocological
prophylaxis NN Pharmocological
-DOCSTART- -X- N

after-school JJ Educational
exercise NN Educational
program NN Educational
. . None
exercise NN Physical
intervention NN Physical
instructor-led JJ None
after-school JJ None
program NN None
every DT None
Tractography NN None
was VBD None
the DT None
exercise NN None
intervention NN None
, , None
the DT None
control NN None
intervention NN None
, , None
exercise NN None
-DOCSTART- -X- N

early JJ Physical
developmental JJ Physical
intervention NN Physical
early JJ Physical
developmental NN Physical
intervention NN Physical
parent-implemented JJ Physical
EDI NNP Physical
health NN Educational
and CC Educational
safety NN Educational
counseling NN Educational
-DOCSTART- -X- N

whole JJ Pharmocological
pelvic JJ Pharmocological
conventional JJ Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
intensity NN Pharmocological
modulated VBN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
to TO None
receive VB None
50.4 CD None
Gy NNP None
in IN None
28 CD None
fractions NNS None
delivered VBN None
via IN None
either DT None
WP-CRT JJ Physical
or CC None
WP-IMRT JJ Physical
with IN None
concurrent JJ None
weekly JJ None
cisplatin NN None
40 CD None
mg/m NN None
( ( None
2 CD None
) ) None
. . None
was VBD None
graded VBN None
according VBG None
to TO None
the DT None
WP-CRT NNP Pharmocological
WP-IMRT NNP Pharmocological
. . None
WP-CRT JJ Pharmocological
IMRT NNP Pharmocological
WP-CRT NNP Pharmocological
WP-IMRT NNP Pharmocological
CONCLUSION NNP None
WP-IMRT NNP None
is VBZ None
WP-CRT NNP None
and CC None
-DOCSTART- -X- N

m-chlorophenylpiperazine NN Pharmocological
m-chlorophenylpiperazine NN Pharmocological
( ( Pharmocological
m-CPP JJ Pharmocological
) ) Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

knee NN Physical
position NN Physical
knee JJ Physical
position NN Physical
leg NN None
elevated VBD None
30? CD None
at IN None
the DT None
hip NN None
over IN None
an DT None
inactive JJ None
CPM NNP None
for IN None
72 CD None
h NN None
postoperatively RB None
. . None
the DT None
knee NN None
flexed VBD None
to TO None
30? CD None
during IN None
this DT None
period NN None
. . None
the DT None
knee NN None
extended VBD None
that IN None
flexion NN None
of IN None
the DT None
knee NN None
to TO None
-DOCSTART- -X- N

monofluorophosphate NN Pharmocological
trimetaphosphate NN Pharmocological
: : None
a DT Pharmocological
low JJ Pharmocological
abrasion NN Pharmocological
paste NN Pharmocological
containing VBG Pharmocological
0.8 CD Pharmocological
% NN Pharmocological
sodium NN Pharmocological
monofluorophosphate NN Pharmocological
( ( Pharmocological
MFP NNP Pharmocological
) ) Pharmocological
a DT Pharmocological
paste NN Pharmocological
containing VBG Pharmocological
3 CD Pharmocological
% NN Pharmocological
sodium NN Pharmocological
trimetaphosphate NN Pharmocological
( ( Pharmocological
TMP NNP Pharmocological
) ) Pharmocological
. . None
conventional JJ Pharmocological
, , Pharmocological
moderately RB Pharmocological
abrasive JJ Pharmocological
paste NN Pharmocological
containing VBG Pharmocological
0.8 CD Pharmocological
% NN Pharmocological
sodium NN Pharmocological
monofluorophosphate NN Pharmocological
. . None
MFP NNP Control
control NN Control
-DOCSTART- -X- N

nicotine NN Pharmocological
nicotine NN Pharmocological
chewing VBG Pharmocological
gum NN Pharmocological
nicotine NN Pharmocological
nicotine JJ Pharmocological
gum NN Pharmocological
( ( Pharmocological
4 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
echocardiograms JJ Physical
and CC Physical
signal-averaged JJ Physical
electrocardiograms NNS Physical
nicotine JJ Pharmocological
gum NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Memantine NNP Pharmocological
risperidone VB Pharmocological
placebo-controlled JJ Control
memantine NN Pharmocological
plus CC Pharmocological
risperidone NN Pharmocological
risperidone VB Pharmocological
plus JJ Pharmocological
memantine NN Pharmocological
placebo NN Control
plus CC Control
risperidone NN Control
risperidone NN Pharmocological
and CC None
memantine NN None
received VBD None
memantine NN None
had VBD None
that IN None
memantine NN None
may MD None
-DOCSTART- -X- N

Motion NNP Physical
style NN Physical
acupuncture NN Physical
treatment NN Physical
( ( Physical
MSAT NNP Physical
) ) Physical
Motion NNP Physical
style NN Physical
acupuncture NN Physical
treatment NN Physical
( ( Physical
MSAT NNP Physical
) ) Physical
acupuncture NN Physical
group NN None
and CC None
the DT None
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
injection NN Pharmocological
group NN Pharmocological
. . None
MSAT NNP Physical
and CC None
the DT None
NSAID NNP Pharmocological
injection NN Pharmocological
group NN Pharmocological
diclofenac NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

formoterol VB Pharmocological
, , None
ipratropium NN Pharmocological
, , None
and CC None
their PRP$ None
combination NN Pharmocological
placebo-controlled JJ Control
ipratropium NN Pharmocological
bromide NN Pharmocological
( ( Pharmocological
Atrovent NNP Pharmocological
MDI NNP Pharmocological
, , Pharmocological
20 CD Pharmocological
micrograms/puff NN Pharmocological
) ) Pharmocological
plus CC None
2 CD Control
puffs NNS Control
placebo NN Control
; : None
formoterol JJ Pharmocological
fumarate NN Pharmocological
( ( Pharmocological
Foradil NNP Pharmocological
MDI NNP Pharmocological
, , Pharmocological
12 CD Pharmocological
micrograms/puff NN Pharmocological
) ) Pharmocological
plus CC None
3 CD Control
puffs NNS Control
placebo VBP Control
; : None
80 CD Pharmocological
micrograms NNS Pharmocological
ipratropium NN Pharmocological
; : None
D. NNP None
24 CD Pharmocological
micrograms NNS Pharmocological
formoterol JJ Pharmocological
plus CC Pharmocological
2 CD Pharmocological
puffs NNS Pharmocological
placebo VBP Pharmocological
; : None
E. NNP None
12 CD Pharmocological
micrograms NNS Pharmocological
formoterol JJ Pharmocological
plus CC None
40 CD Pharmocological
micrograms NNS Pharmocological
ipratropium JJ Pharmocological
plus CC None
1 CD Control
puff NN Control
placebo NN Control
; : None
4 CD Control
puffs NNS Control
placebo NN Control
. . None
ipratropium NN Pharmocological
and CC None
formoterol NN Pharmocological
ipratropium NN Pharmocological
-DOCSTART- -X- N

low-dose JJ None
monoethylglycinexylidide JJ None
test NN None
: : None
lidocaine NN Pharmocological
monoethylglycinexylidide NN Pharmocological
( ( Pharmocological
MEG-X NNP Pharmocological
) ) Pharmocological
MEG-X NNP Pharmocological
lidocaine-induced JJ Pharmocological
MEG-X NNP Pharmocological
lidocaine JJ None
( ( None
MEG-X NNP Pharmocological
lidocaine NN Pharmocological
[ JJ None
MEG-X30min NNP Pharmocological
] NNP None
MEG-X NNP Pharmocological
MEG-X NNP None
MEG-X JJ None
MEG-X JJ None
MEG-X NNP None
-DOCSTART- -X- N

Pimecrolimus NNP Pharmocological
cream VBZ Pharmocological
betamethasone CD Pharmocological
17-valerate JJ Pharmocological
Pimecrolimus NNP Pharmocological
pimecrolimus NN Pharmocological
corticosteroid NN Pharmocological
( ( Pharmocological
betamethasone CD Pharmocological
17-valerate NN Pharmocological
) ) Pharmocological
pimecrolimus FW Pharmocological
betamethasone NN Pharmocological
Betamethasone NNP Pharmocological
pimecrolimus NN Pharmocological
betamethasone NN Pharmocological
pimecrolimus NN Pharmocological
. . None
pimecrolimus NN Pharmocological
betamethasone NN Pharmocological
pimecrolimus NN Pharmocological
-DOCSTART- -X- N

n-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
group NN Pharmocological
, , Pharmocological
receiving VBG Pharmocological
4 CD Pharmocological
g/day NN Pharmocological
of IN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
concentrate NN Pharmocological
, , Pharmocological
or CC Pharmocological
to TO Pharmocological
a DT Pharmocological
control NN Control
group NN Control
. . Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
n-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

two CD None
alternative JJ None
therapeutic JJ Pharmocological
regimens NNS Pharmocological
for IN None
MAC NNP None
. . None
-DOCSTART- -X- N

individual VBP Psychological
diet JJ Psychological
and CC Psychological
anti-smoking JJ Psychological
counselling NN Psychological
-DOCSTART- -X- N

Acustimulation NNP Physical
wrist NN Physical
bands NNS Physical
acustimulation NN Physical
wrist NN Physical
band NN Physical
( ( None
active JJ Physical
acustimulation NN Physical
, , None
sham JJ Physical
acustimulation NN Physical
no DT Physical
acustimulation NN Physical
) ) None
acustimulation NN Physical
bands NNS Physical
-DOCSTART- -X- N

strategies NNS None
: : None
ETT NNP None
or CC None
exercise NN None
MPI NNP None
. . None
ETT NNP None
or CC None
exercise NN None
MPI NNP None
. . None
-DOCSTART- -X- N

lamivudine NN Pharmocological
, , Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
zidovudine NN Pharmocological
and CC Pharmocological
efavirenz NN Pharmocological
3TC CD Pharmocological
3TC CD Pharmocological
-DOCSTART- -X- N

multifaceted JJ Educational
guideline NN Educational
implementation NN Educational
intervention NN Educational
guideline JJ Educational
education NN Educational
and CC Educational
individual JJ Educational
feedback NN Educational
, , Educational
supporting VBG Educational
patient JJ Educational
education NN Educational
materials NNS Educational
, , Educational
both DT Educational
neither RB Control
. . None
Guideline NNP Educational
implementation NN Educational
patient JJ Educational
education NN Educational
component NN Educational
included VBD Educational
written VBN Educational
and CC Educational
videotaped VBN Educational
materials NNS Educational
on IN Educational
the DT Educational
care NN Educational
of IN Educational
low JJ Educational
back RB Educational
pain NN Educational
. . None
intervention NN Educational
-DOCSTART- -X- N

-DOCSTART- -X- N

tetanus CC Pharmocological
immune VB Pharmocological
globulin NN Pharmocological
tetanus-diphtheria JJ Pharmocological
vaccine NN Pharmocological
tetanus-diphtheria NN Pharmocological
( ( Pharmocological
Td NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
tetanus JJ Pharmocological
immune JJ Pharmocological
globulin NN Pharmocological
( ( Pharmocological
TIG NNP Pharmocological
) ) Pharmocological
. . None
was VBD None
assessed VBN None
after IN None
4 CD None
weeks NNS None
and CC None
4 CD None
months NNS None
. . None
-DOCSTART- -X- N

trained VBN Educational
to TO Educational
match VB Educational
probes NNS Educational
to TO Educational
targets NNS Educational
induction NN Physical
test NN Physical
behavioral JJ Educational
task NN Educational
explicit JJ Educational
questions NNS Educational
. . None
training VBG Educational
modified JJ Educational
training NN Educational
protocol NN Educational
-DOCSTART- -X- N

orthotic JJ Physical
heel NN Physical
lifts NNS Physical
orthotic JJ Physical
heel NN Physical
lifts NNS Physical
Therefore RB None
, , None
heel NN None
lifts NNS None
-DOCSTART- -X- N

pentavalent NN Pharmocological
diphtheria NN Pharmocological
, , None
tetanus NN Pharmocological
, , None
acellular JJ Pharmocological
pertussis NN Pharmocological
, , None
inactivated VBN Pharmocological
poliovirus NN Pharmocological
and CC Pharmocological
Haemophilus NNP Pharmocological
influenzae VBP Pharmocological
type JJ Pharmocological
b-tetanus JJ Pharmocological
conjugate NN Pharmocological
vaccine NN Pharmocological
whole JJ Pharmocological
cell NN Pharmocological
pertussis NN Pharmocological
pentavalent NN Pharmocological
vaccine NN Pharmocological
. . None
combined JJ Pharmocological
diphtheria-tetanus-pertussis-inactivated JJ Pharmocological
poliovirus NN Pharmocological
vaccines NNS Pharmocological
containing VBG Pharmocological
either CC Pharmocological
acellular JJ Pharmocological
( ( None
Pa NNP Pharmocological
, , Pharmocological
SmithKline NNP Pharmocological
Beecham NNP Pharmocological
Biologicals NNP Pharmocological
) ) None
or CC None
whole JJ Pharmocological
cell NN Pharmocological
( ( Pharmocological
Pw NNP Pharmocological
, , Pharmocological
Pasteur NNP Pharmocological
Merieux NNP Pharmocological
Connaught NNP Pharmocological
) ) Pharmocological
pertussis NN Pharmocological
components NNS Pharmocological
, , None
mixed JJ Pharmocological
with IN Pharmocological
a DT Pharmocological
Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
b NN Pharmocological
polysaccharide NN Pharmocological
polyribosylribitol IN Pharmocological
phosphate-tetanus JJ Pharmocological
conjugate NN Pharmocological
vaccine NN Pharmocological
tetanus VB Pharmocological
toxoid JJ Pharmocological
combination NN Pharmocological
diphtheria NN None
, , None
tetanus NN None
, , None
whole JJ None
cell NN None
pertussis-H. JJ None
influenzae NN None
b NN None
vaccine NN None
conjugated VBN None
to TO None
tetanus VB None
toxoid JJ None
combination NN None
-DOCSTART- -X- N

80-kilovoltage NN Physical
( ( Physical
kV NN Physical
) ) Physical
tube NN Physical
voltage NN Physical
coronary JJ Physical
computed VBD Physical
tomographic JJ Physical
angiography NN Physical
( ( Physical
CCTA NNP Physical
) ) Physical
[ VBD Educational
standard-tube JJ Educational
voltage NN Educational
( ( Educational
120-kV JJ Educational
) ) Educational
vs. FW None
low-tube JJ Physical
voltage NN Physical
( ( Physical
80-kV JJ Physical
) ) Physical
] NN Physical
80-kV JJ None
The DT None
80-kV JJ None
protocol NN None
-DOCSTART- -X- N

enoxaparin NN Pharmocological
warfarin NN Pharmocological
. . Pharmocological
fixed-dose JJ Pharmocological
enoxaparin NN Pharmocological
adjusted VBD Pharmocological
dose JJ Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg NN Pharmocological
subcutaneously RB Pharmocological
every DT Pharmocological
12 CD Pharmocological
hours NNS Pharmocological
) ) Pharmocological
or CC Pharmocological
adjusted-dose JJ Pharmocological
warfarin NN Pharmocological
( ( Pharmocological
international JJ Pharmocological
normalized VBN Pharmocological
ratio NN Pharmocological
, , Pharmocological
2.0 CD Pharmocological
to TO Pharmocological
3.0 CD Pharmocological
) ) Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
warfarin NN Pharmocological
enoxaparin NN Pharmocological
warfarin NN Pharmocological
-DOCSTART- -X- N

Margarines NNS None
fortified VBN None
with IN None
?-linolenic JJ None
acid NN None
, , None
eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
, , None
or CC None
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
of IN None
?-linolenic JJ None
acid NN None
( ( None
ALA NNP None
) ) None
, , None
EPA NNP None
, , None
or CC None
DHA NNP None
incorporated VBN None
which WDT None
margarines NNS None
fortified VBD None
with IN None
either DT None
10 CD None
weight NN None
percent NN None
ALA NNP None
, , None
EPA NNP None
, , None
or CC None
DHA NNP None
ethyl VBP None
esters NNS None
replaced VBD None
-DOCSTART- -X- N

bupivacaine NN Pharmocological
placebo NN Control
20cc CD None
saline NN Control
without IN Control
bupivacaine NN Control
bupivacaine NN Pharmocological
0.5 CD None
% NN None
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
-DOCSTART- -X- N

conventional JJ Physical
outpatient NN Physical
dermatology NN Physical
care NN Physical
telemedicine JJ Educational
consultation NN Educational
conventional JJ Physical
hospital NN Physical
outpatient JJ Physical
consultation NN Physical
. . None
telemedicine NN Pharmocological
conventionally RB Physical
. . None
realtime NN Physical
teledermatology NN Physical
consultation NN Physical
conventional JJ Physical
consultation NN Physical
conventional JJ Physical
care NN Physical
telemedicine NN Pharmocological
conventional JJ Physical
consultations NNS Physical
telemedicine NN Physical
consultation NN Physical
conventional JJ Physical
consultation NN Physical
. . None
-DOCSTART- -X- N

Angiotensin-converting JJ Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
inhibitor NN Pharmocological
) ) Pharmocological
captopril NN Pharmocological
ACE NNP Pharmocological
inhibitor NN Pharmocological
. . Pharmocological
captopril JJ Pharmocological
captopril NN Pharmocological
ACE NNP Pharmocological
inhibitor NN Pharmocological
ACE NNP Pharmocological
inhibitor JJ Pharmocological
administration NN Physical
ACE NNP Pharmocological
inhibitor NN Pharmocological
-DOCSTART- -X- N

two CD Physical
different JJ Physical
testosterone NN Physical
undecanoate JJ Physical
formulations NNS Physical
two CD Physical
different JJ Physical
preparations NNS Physical
of IN Physical
testosterone NN Physical
undecanoate NN Physical
( ( Physical
TU NNP Physical
) ) Physical
transdermal JJ Control
placebo NN Control
gel NN Control
TU NNP Pharmocological
] NNP None
oral JJ Pharmocological
TU NNP Pharmocological
P NNP Control
im JJ Pharmocological
TU NNP Pharmocological
TU NNP Pharmocological
im JJ Pharmocological
TU NNP Pharmocological
TU NNP Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

ultrasound NN Physical
-DOCSTART- -X- N

more RBR None
intensive JJ Pharmocological
( ( Pharmocological
MI NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
less RBR Pharmocological
intensive JJ Pharmocological
( ( Pharmocological
LI NNP Pharmocological
) ) Pharmocological
belatacept IN Pharmocological
immunosuppression NN Pharmocological
regimen NNS Pharmocological
, , None
or CC None
cyclosporine VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

ketorolac NN Pharmocological
tromethamine NN Pharmocological
ketorolac NN Pharmocological
tromethamine NN Pharmocological
placebo VB Control
ketorolac NN Pharmocological
tromethamine NN Pharmocological
placebo JJ Control
ketorolac $ Pharmocological
-DOCSTART- -X- N

Calcium NN Pharmocological
acetate NN Pharmocological
calcium NN Pharmocological
carbonate NN Pharmocological
CA NNP Pharmocological
CC NNP Pharmocological
-DOCSTART- -X- N

Standardized JJ Psychological
Psychological JJ Psychological
tests NNS Psychological
-DOCSTART- -X- N

prelinguistic JJ Educational
milieu NN Educational
teaching NN Educational
and CC Educational
parent NN Educational
responsivity NN Educational
education NN Educational
facilitating VBG Educational
prelinguistic JJ Educational
communication NN Educational
Responsivity NNP Educational
education NN Educational
for IN Educational
the DT Educational
RPMT NNP Educational
control NN Control
group NN Control
. . Control
RPMT NNP Educational
RPMT NNP Educational
RPMT NNP Educational
RPMT NNP Educational
PMT NNP Educational
-DOCSTART- -X- N

latanoprost NN Pharmocological
combination NN Pharmocological
with IN Pharmocological
timolol NN Pharmocological
. . None
latanoprost NN Pharmocological
0.5 CD None
% NN None
timolol JJ Pharmocological
maleate NN Pharmocological
. . None
timolol NN Pharmocological
treatment NN None
3 CD None
weeks NNS None
before IN None
the DT None
beginning NN None
of IN None
the DT None
study NN None
. . None
latanoprost NN Pharmocological
) ) None
( ( None
placebo NN Control
) ) None
latanoprost NN Pharmocological
timolol NN Pharmocological
. . None
-DOCSTART- -X- N

ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
UDCA NNP Pharmocological
) ) Pharmocological
UDCA NNP Pharmocological
UDCA NNP Pharmocological
-DOCSTART- -X- N

saliva VB Physical
salivary JJ Physical
erosive JJ Physical
challenges NNS Physical
salivary JJ Physical
-DOCSTART- -X- N

A NNP Physical
targeted JJ Physical
, , Physical
multi-component JJ Physical
disability NN Educational
prevention NN Educational
and CC Educational
disease JJ Educational
self-management JJ Educational
program NN Educational
led VBN Physical
by IN Physical
a DT Physical
geriatric JJ Physical
nurse NN Physical
practitioner NN Physical
( ( Physical
GNP NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

behavioral JJ Educational
intervention NN Educational
receive VB Educational
the DT Educational
ESDM NNP Educational
or CC None
referral JJ Other
to TO Other
community NN Other
intervention NN Other
for IN Educational
2 CD Educational
years NNS Educational
. . None
was VBD None
measured VBN None
during IN None
the DT None
presentation NN None
of IN None
faces VBZ None
versus JJ None
objects NNS None
. . None
ESDM NNP Educational
-DOCSTART- -X- N

Sorafenib NNP Pharmocological
vascular JJ Physical
endothelial JJ Physical
growth NN Physical
factor NN Physical
( ( Physical
VEGF NNP Physical
) ) Physical
sorafenib NN Pharmocological
sorafenib NN None
concentrations NNS None
-DOCSTART- -X- N

outside-the-boot JJ Physical
braces NNS Physical
. . None
-DOCSTART- -X- N

isosorbide JJ Pharmocological
dinitrate NN Pharmocological
and CC None
nitroglycerin NN Pharmocological
. . None
Nitroglycerin NNP Pharmocological
( ( Pharmocological
NTG NNP Pharmocological
) ) Pharmocological
nitrate NN Pharmocological
, , None
isosorbide JJ Pharmocological
dinitrate NN Pharmocological
( ( Pharmocological
ISDN NNP Pharmocological
) ) Pharmocological
ISDN NNP Pharmocological
NTG NNP Pharmocological
ISDN NNP Pharmocological
ISDN NNP Pharmocological
NTG NNP Pharmocological
ISDN NNP Pharmocological
NTG NNP Pharmocological
ISDN NNP Pharmocological
-DOCSTART- -X- N

strontium NN Pharmocological
strontium NN Pharmocological
. . None
strontium NN Pharmocological
SrRan NNP Pharmocological
placebo NN Control
SrRan NNP Pharmocological
. . None
-DOCSTART- -X- N

Cys NNP Physical
LT1 NNP Physical
receptor NN Physical
blockade NN Physical
leukotriene NN Pharmocological
receptor NN Pharmocological
antagonist NN Pharmocological
, , Pharmocological
MK-571 NNP Pharmocological
placebo-controlled JJ Control
8-hour JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
MK-571 NNP Pharmocological
or CC None
placebo NN Pharmocological
histamine NN Pharmocological
MK-571 NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

hydrocodone NN Pharmocological
and CC Pharmocological
ibuprofen JJ Pharmocological
codeine NN Pharmocological
and CC Pharmocological
acetaminophen NN Pharmocological
hydrocodone NN Pharmocological
ibuprofen $ Pharmocological
codeine NN Pharmocological
acetaminophen $ Pharmocological
Hydrocodone NNP Pharmocological
ibuprofen JJ Pharmocological
combination NN Pharmocological
hydrocodone NN Pharmocological
7.5 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
ibuprofen $ Pharmocological
200 CD Pharmocological
mg NN Pharmocological
2-tablet JJ None
dose NN None
codeine NN Pharmocological
30 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
acetaminophen $ Pharmocological
300 CD Pharmocological
mg NN Pharmocological
HI1 NNP None
CA NNP None
HI1 NNP None
CA NNP None
HI2 NNP None
HI1 NNP None
hydrocodone NN Pharmocological
and CC None
ibuprofen $ Pharmocological
codeine NN Pharmocological
and CC None
acetaminophen $ Pharmocological
combination NN Pharmocological
hydrocodone NN Pharmocological
7.5 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
ibuprofen $ Pharmocological
codeine NN Pharmocological
and CC None
acetaminophen $ Pharmocological
-DOCSTART- -X- N

Intravenous JJ Pharmocological
flecainide NN Pharmocological
versus NN None
verapamil NN Pharmocological
intravenous JJ Pharmocological
flecainide NN Pharmocological
versus VBP None
verapamil NN Pharmocological
verapamil NN Pharmocological
verapamil NNS Pharmocological
flecainide NN Pharmocological
flecainide EX Pharmocological
Verapamil NNP Pharmocological
-DOCSTART- -X- N

remifentanil NN Pharmocological
propofol NN Pharmocological
fentanyl NN Pharmocological
midazolam NN Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
propofol NN Pharmocological
midazolam NN Pharmocological
fentanyl NN Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
propofol NN Pharmocological
fentanyl NN Pharmocological
midazolam FW Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
propofol NN Pharmocological
-DOCSTART- -X- N

intervention NN Educational
adult NN Educational
intervention NN Educational
( ( None
low JJ Educational
, , Educational
medium NN Educational
, , Educational
high JJ Educational
intervention NN Educational
, , None
or CC None
no-intervention JJ Physical
control NN None
) ) None
systematically RB None
varying VBG None
the DT None
manner NN Educational
and CC Educational
frequency NN Educational
with IN Educational
which WDT Educational
objects NNS Educational
were VBD Educational
presented VBN Educational
, , None
the DT None
extent NN Educational
to TO Educational
which WDT Educational
the DT Educational
experimenter NN Educational
talked VBD Educational
to TO Educational
the DT Educational
infant NN Educational
, , None
and CC None
physical JJ Educational
proximity NN Educational
. . None
intervention NN Educational
-DOCSTART- -X- N

Abdominoperineal NNP Physical
resection NN Physical
anterior JJ Physical
resection NN Physical
adjuvant VB Physical
preoperative JJ Physical
radiotherapy NN Physical
. . None
radiotherapy NN Physical
Sphincter-saving JJ Educational
procedures NNS Educational
-DOCSTART- -X- N

Trace NNP Pharmocological
element NN Pharmocological
supplementation NN Pharmocological
TE NNP Pharmocological
supplements NNS Pharmocological
placebo-controlled JJ Control
Intravenous JJ Pharmocological
copper NN Pharmocological
, , Pharmocological
selenium NN Pharmocological
, , Pharmocological
and CC Pharmocological
zinc NN Pharmocological
( ( Pharmocological
TE NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
or CC None
vehicle NN Pharmocological
TE NNP Pharmocological
-DOCSTART- -X- N

cytarabine NN Pharmocological
versus NN None
amsacrine NN Pharmocological
cytarabine NN Pharmocological
amsacrine NN Pharmocological
-DOCSTART- -X- N

[ JJ Pharmocological
Bupivacaine-CO2 NNP Pharmocological
and CC Pharmocological
bupivacaine-HCl NN Pharmocological
peridural JJ Pharmocological
anesthesia NN Pharmocological
carbonated JJ Pharmocological
anesthetics NNS Pharmocological
epidural JJ Pharmocological
anesthesia NN Pharmocological
bupivacaine-CO2 JJ Pharmocological
bupivacaine-HCl NN Pharmocological
bupivacaine-CO2 NN Pharmocological
bupivacaine-HCl NN Pharmocological
Epidural JJ Pharmocological
anesthesia NN Pharmocological
18-gauge JJ Physical
Tuohy NNP Physical
bupivacaine NN Pharmocological
with IN Pharmocological
adrenaline JJ Pharmocological
bupivacaine-CO2 JJ Pharmocological
-HCl NN Pharmocological
-DOCSTART- -X- N

GH-releasing NNP Physical
hormone NN Physical
alone RB Physical
combined VBN Physical
with IN Physical
arginine NN Physical
GHRH NNP Pharmocological
injection NN Pharmocological
alone RB Pharmocological
combined VBN None
with IN None
an DT None
infusion NN None
of IN None
the DT None
functional JJ None
somatostatin NN None
antagonist NN None
, , None
arginine NN None
. . None
arginine NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
g NN Pharmocological
) ) Pharmocological
was VBD None
infused VBN None
from IN None
-30 NN None
to TO None
0 CD None
min NN None
, , None
and CC None
GHRH NNP Pharmocological
( ( Pharmocological
100 CD Pharmocological
microg NN Pharmocological
) ) Pharmocological
was VBD None
injected VBN None
as IN None
a DT None
bolus NN None
at IN None
0 CD None
min NNS None
serum NN Physical
GH NNP Physical
[ NNP Physical
immunoradiometric JJ Physical
assay NN Physical
( ( Physical
IRMA NNP Physical
) ) Physical
] VBP Physical
Plasma NNP Physical
IGF-I NNP Physical
( ( Physical
RIA NNP Physical
after IN Physical
acid-ethanol JJ Physical
extraction NN Physical
) ) Physical
GHRH NNP Pharmocological
plus CC Pharmocological
arginine NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

self-report JJ Educational
methods NNS Educational
illicit JJ None
drug NN None
use NN None
: : None
1 CD None
) ) None
Individual NNP Educational
interview NN Educational
in IN Educational
the DT Educational
workplace NN Educational
, , None
2 CD None
) ) None
group-administered JJ Educational
questionnaire NN Educational
in IN Educational
the DT Educational
workplace NN Educational
, , None
3 CD None
) ) None
telephone NN Educational
interview NN Educational
, , None
and CC None
4 CD None
) ) None
individual JJ Educational
interview NN Educational
off IN Educational
the DT Educational
worksite NN Educational
. . None
-DOCSTART- -X- N

intermittent NN Pharmocological
or CC Pharmocological
continuous JJ Pharmocological
methotrexate JJ Pharmocological
plus CC None
6-mercaptopurine JJ Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
PRD NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
vincristine JJ Pharmocological
( ( Pharmocological
VCR NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
vindesine NN Pharmocological
( ( Pharmocological
VDS NNP Pharmocological
) ) Pharmocological
. . None
18 CD Physical
Gy NNP Physical
cranial JJ Physical
irradiation NN Physical
intrathecal JJ Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
PRD NNP Pharmocological
plus CC Pharmocological
6-mercaptopurine JJ Pharmocological
( ( Pharmocological
6MP CD Pharmocological
) ) Pharmocological
plus CC Pharmocological
VCR NNP Pharmocological
( ( Pharmocological
2.0 CD Pharmocological
alternating VBG None
biweekly NN Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
6MP CD Pharmocological
plus CC Pharmocological
MTX NNP Pharmocological
combined VBN Pharmocological
with IN Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
-DOCSTART- -X- N

L-carnitine NNP Pharmocological
. . None
L-carnitine JJ Pharmocological
placebo-controlled JJ Control
L-carnitine NNP Pharmocological
placebo NN Control
and CC None
L-carnitine NNP Pharmocological
. . None
L-carnitine NNP Pharmocological
placebo NN Control
L-carnitine NNP Pharmocological
L-carnitine NNP Pharmocological
L-carnitine NNP Pharmocological
-DOCSTART- -X- N

Levobunolol NNP Pharmocological
timolol NN Pharmocological
levobunolol NN Pharmocological
levobunolol NN Pharmocological
timolol NN Pharmocological
Levobunolol NNP Pharmocological
timolol NN Pharmocological
levobunolol NNS Pharmocological
timolol NN Pharmocological
-DOCSTART- -X- N

eptifibatide NN Pharmocological
platelet NN Pharmocological
glycoprotein NN Pharmocological
IIb/IIIa NNP Pharmocological
inhibitor NN Pharmocological
therapy NN Pharmocological
eptifibatide JJ Pharmocological
therapy NN Pharmocological
as IN None
an DT None
adjunct NN None
to TO None
stent VB None
implantation NN None
( ( None
1,755 CD None
with IN None
CrCl NNP None
> NNP None
or CC None
=60 NNP None
ml/min NN None
and CC None
289 CD None
with IN None
CrCl NNP None
< NNP None
60 CD None
ml/min NN None
) ) None
eptifibatide NN Pharmocological
eptifibatide NN Pharmocological
-DOCSTART- -X- N

budesonide NN None
( ( None
Pulmicort? NNP None
Turbuhaler NNP None
) ) None
inhaled JJ None
budesonide NN None
nebulised JJ None
budesonide NN None
or CC None
saline NN None
. . None
Budesonide NNP None
the DT None
budesonide NN None
Budesonide NNP None
budesonide NN None
may MD None
-DOCSTART- -X- N

ginger NN Pharmocological
root NN Pharmocological
extract NN Pharmocological
ginger NN Pharmocological
2.0 CD Pharmocological
g/d NN Pharmocological
ginger NN Pharmocological
or CC Pharmocological
placebo NN Control
liquid JJ Physical
chromatography NN Physical
mass NN Physical
spectrometry NN Physical
method NN Physical
Ginger NNP Pharmocological
-DOCSTART- -X- N

hypertonic JJ Pharmocological
saline NN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
and CC Pharmocological
with IN Pharmocological
isotonic JJ Pharmocological
lactated VBN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
prehydrated VBN Pharmocological
with IN Pharmocological
isotonic JJ Pharmocological
lactated VBN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
at IN Pharmocological
7 CD Pharmocological
mg/kg NN Pharmocological
prehydration NN Pharmocological
with IN Pharmocological
3 CD Pharmocological
% NN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
at IN Pharmocological
7 CD Pharmocological
ml/kg NN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
-DOCSTART- -X- N

pravastatin NN Pharmocological
pravastatin NN Pharmocological
pravastatin NN Pharmocological
40 CD Pharmocological
mg/day NN Pharmocological
placebo NN Control
Pravastatin NNP Pharmocological
Pravastatin NNP Pharmocological
-DOCSTART- -X- N

Endoscopic NNP Physical
sphincterotomy NN Physical
pure-cut JJ Physical
electrosurgical JJ Physical
current JJ Physical
sphincterotomy NN Physical
pure-cut JJ Physical
current JJ Physical
sphincterotomy NN Surgical
over IN Physical
a DT Physical
non-conductive JJ Physical
guidewire NN Physical
with IN Physical
30 CD Physical
W/sec NNP Physical
pure-cut JJ Physical
current JJ Physical
or CC Physical
30 CD Physical
W/sec JJ Physical
blend-2 JJ Physical
current JJ Physical
by IN Physical
a DT Physical
blinded JJ Physical
endoscopist NN Physical
. . None
current JJ Physical
endoscopic RB Physical
sphincterotomy NN Physical
electrosurgical JJ Physical
current JJ Physical
endoscopic NN Physical
sphincterotomy NN Physical
-DOCSTART- -X- N

Haloperidol NNP Pharmocological
haloperidol NN Pharmocological
( ( Pharmocological
HAL NNP Pharmocological
) ) Pharmocological
: : None
haloperidol NN Pharmocological
haloperidol NN Pharmocological
haloperidol NN Pharmocological
-DOCSTART- -X- N

peer NN Educational
counseling VBG Educational
peer NN Educational
counseling VBG Educational
intervention NN Educational
peer-led JJ Educational
smoking NN Educational
cessation NN Educational
program NN Educational
or CC Educational
to TO Educational
usual JJ Educational
care NN Educational
. . None
usual JJ Educational
care NN Educational
, , Educational
peer NN Educational
counseling NN Educational
peer NN Educational
counseling VBG Educational
intervention NN Educational
programs NNS Educational
-DOCSTART- -X- N

synthetic JJ Pharmocological
zeaxanthin NN Pharmocological
. . None
Zeaxanthin NNP Pharmocological
zeaxanthin NN Pharmocological
zeaxanthin JJ Pharmocological
zeaxanthin NN Pharmocological
all-E-zeaxanthin JJ Pharmocological
. . None
Zeaxanthin NNP Pharmocological
zeaxanthin NN Pharmocological
zeaxanthin NN Pharmocological
-DOCSTART- -X- N

polyfrequency NN Physical
oscillation NN Physical
method NN Physical
bodyplethysmograph NN Physical
transcutaneous JJ Pharmocological
oxygen NN Pharmocological
pressure NN Pharmocological
bodyplethysmography NN Physical
polyfrequent JJ Physical
oscillation NN Physical
method NN Physical
-DOCSTART- -X- N

sertraline NN Pharmocological
GnRH NNP Pharmocological
agonist JJ Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ None
sertraline NN Pharmocological
sertraline NN Pharmocological
GnRH NNP Pharmocological
agonist JJ Pharmocological
therapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
cisplatin JJ Pharmocological
chemo-radiotherapy NN Pharmocological
adding VBG Pharmocological
chemotherapy NN Pharmocological
to TO Pharmocological
radiotherapy VB Pharmocological
in IN None
RT NNP Physical
group NN Physical
received VBD Physical
50 CD Physical
Gy/25 NNP Physical
fx/5 JJ Physical
weeks NNS Physical
of IN Physical
teletherapy NN Physical
followed VBD Physical
1-2 JJ Physical
weeks NNS Physical
later RB Physical
with IN Physical
12 CD Physical
Gy/2 NNP Physical
fx NN Physical
of IN Physical
high-dose-rate JJ Physical
intra-lumenal JJ Physical
brachytherapy NN Physical
spaced VBD Physical
a DT Physical
week NN Physical
apart RB Physical
. . Physical
brachytherapy NN Pharmocological
received VBD Pharmocological
identical JJ Pharmocological
radiotherapy NN Pharmocological
with IN Pharmocological
concurrent JJ Pharmocological
weekly JJ Pharmocological
cisplatin NN Pharmocological
at IN Pharmocological
35 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
for IN Pharmocological
6-7 JJ Pharmocological
cycles NNS Pharmocological
. . None
cisplatin NN Pharmocological
radiotherapy VB Pharmocological
-DOCSTART- -X- N

computer-controlled JJ Pharmocological
articaine NN Pharmocological
+ NNP Pharmocological
epinephrine NN Pharmocological
delivery NN Pharmocological
: : Pharmocological
intraseptal JJ Pharmocological
anesthesia NN Pharmocological
( ( Pharmocological
ISA NNP Pharmocological
) ) Pharmocological
periodontal JJ Pharmocological
ligament NN Pharmocological
anesthesia NN Pharmocological
( ( Pharmocological
PLA NNP Pharmocological
) ) Pharmocological
articaine NN Pharmocological
epinephrine NN Pharmocological
( ( Pharmocological
Ar NNP Pharmocological
+ NNP Pharmocological
Ep NNP Pharmocological
) ) Pharmocological
computer-controlled JJ Pharmocological
local JJ Pharmocological
anesthetic JJ Pharmocological
delivery NN Pharmocological
system NN Pharmocological
( ( Pharmocological
CCLADS NNP Pharmocological
) ) Pharmocological
. . None
receive VB None
16 CD None
mg NN None
+ VBD None
4 CD None
?g NNP None
, , None
24 CD None
mg NN None
+ VBD None
6 CD None
?g NN None
, , None
and CC None
32 CD None
mg NN None
+ VBD None
8 CD None
?g NN None
of IN None
Ar NNP None
+ NNP None
Ep NNP None
, , None
obtained VBN None
with IN None
different JJ None
volumes NNS None
( ( None
0.4 CD None
, , None
0.6 CD None
, , None
and CC None
0.8 CD None
ml NN None
, , None
respectively RB None
) ) None
, , None
for IN None
the DT None
ISA NNP None
and CC None
PLA NNP None
evaluated VBN None
by IN None
the DT None
the DT None
recorded VBN None
using VBG None
the DT None
ISA NNP None
Ar NNP None
Ep NNP None
-DOCSTART- -X- N

satisfaction NN Educational
questionnaire NN Educational
questionnaire NN Educational
-DOCSTART- -X- N

intra-arterial JJ Pharmocological
intravenous JJ Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
randomized VBN None
to TO None
an DT None
intravenous JJ Pharmocological
group NN None
( ( None
n JJ None
= NNP None
250 CD None
) ) None
, , None
receiving VBG None
50 CD None
U/kg NNP None
of IN None
unfractionated JJ None
heparin NN Pharmocological
( ( None
maximal JJ None
dose VBP None
5,000 CD None
U NNP None
) ) None
intravenously RB None
, , None
and CC None
an DT None
intra-arterial JJ Pharmocological
group NN Pharmocological
( ( None
n JJ None
= NNP None
250 CD None
) ) None
receiving VBG None
the DT None
same JJ None
dose JJ None
intra-arterially RB None
. . None
vasodilator NN None
cocktail NN None
intra-arterially RB Pharmocological
and CC None
underwent JJ None
cardiac JJ Physical
catheterization NN Physical
using VBG None
a DT None
5F CD None
introducer NN None
sheath NN None
and CC None
catheters NNS None
. . None
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
chemoendocrine NN Pharmocological
treatment NN Pharmocological
with IN None
that DT None
of IN None
endocrine NN Pharmocological
treatment NN Pharmocological
( ( Pharmocological
ET NNP Pharmocological
) ) Pharmocological
alone RB None
chemotherapy NN Pharmocological
or CC None
endocrine JJ Pharmocological
therapy NN Pharmocological
or CC None
combined VBN Pharmocological
chemoendocrine JJ Pharmocological
treatment NN Pharmocological
. . None
chemotherapy NN Pharmocological
ET NNP Pharmocological
Chemotherapy NNP Pharmocological
-DOCSTART- -X- N

Aerobic NNP Educational
and CC Educational
strength NN Educational
training NN Educational
nutrition NN Pharmocological
combination NN Educational
of IN Educational
aerobic JJ Educational
and CC Educational
strength NN Educational
training NN Educational
( ( Educational
CAST NNP Educational
) ) Educational
nutrition NN Pharmocological
CAST NNP Educational
nutrition NN Pharmocological
only RB None
nutrition NN Pharmocological
strength NN Physical
training NN Physical
C NNP Pharmocological
N NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
ST NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
modified JJ Pharmocological
carbohydrate NN Pharmocological
nutrition NN Pharmocological
classes NNS Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
ST NNP Pharmocological
received VBD Educational
strength NN Educational
training NN Educational
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
a DT None
combination NN Educational
of IN Educational
strength NN Educational
and CC Educational
aerobic JJ Educational
training NN Educational
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
ST NNP Pharmocological
N NNP Pharmocological
N NNP Pharmocological
+ NNP Pharmocological
CAST NNP Pharmocological
CAST NNP Pharmocological
nutrition NN Pharmocological
nutrition JJ Pharmocological
strength NN Educational
training NN Educational
-DOCSTART- -X- N

epinephrine NN Pharmocological
epinephrine NN Pharmocological
. . None
epinephrine-induced JJ Pharmocological
-DOCSTART- -X- N

Risperidone NN Pharmocological
Risperidone NN Pharmocological
risperidone NN Pharmocological
haloperidol NN Pharmocological
, , None
perphenazine NN Pharmocological
or CC None
zuclopenthixol NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
haloperidol NN Pharmocological
, , None
perphenazine NN Pharmocological
or CC None
zuclopenthixol NN Pharmocological
. . None
-DOCSTART- -X- N

losartan JJ Pharmocological
versus NN None
atenolol NN Pharmocological
losartan NN Pharmocological
and CC None
atenolol NN Pharmocological
losartan JJ Pharmocological
versus NN None
atenolol NN Pharmocological
. . None
losartan-treated JJ Pharmocological
atenolol-treated JJ Pharmocological
losartan JJ Pharmocological
atenolol NN Pharmocological
losartan NN Pharmocological
Losartan NNP Pharmocological
atenolol VB Pharmocological
. . None
-DOCSTART- -X- N

electroacununcture NN Physical
of IN None
electroacupuncture NN None
( ( None
EA NNP None
) ) None
EA NNP None
and CC None
into IN None
medication NN None
group NN None
and CC None
acupuncture NN None
group NN None
acupuncture NN None
group NN None
were VBD None
treated VBN None
with IN None
EA NNP None
( ( None
80 CD None
Hz NNP None
, , None
2.5 CD None
mA NN None
) ) None
of IN None
Shenshu NNP None
( ( None
BL NNP None
23 CD None
) ) None
, , None
Taixi NNP None
( ( None
KI NNP None
3 CD None
) ) None
, , None
Hegu NNP None
( ( None
LI NNP None
4 CD None
) ) None
, , None
etc FW None
. . None
for IN None
30 CD None
min NN None
, , None
once RB None
every DT None
other JJ None
day NN None
, , None
and CC None
those DT None
of IN None
medication NN None
group NN None
were VBD None
treated VBN None
with IN None
oral JJ None
administration NN None
of IN None
hydroxyl-chloroquine JJ None
( ( None
6 CD None
mg/kg NNS None
per IN None
day NN None
) ) None
, , None
oral JJ None
transfer NN None
agent NN None
liquid NN None
, , None
Vit NNP None
B1 NNP None
, , None
Vit NNP None
B2 NNP None
, , None
Vit NNP None
C NNP None
, , None
fish-liver JJ None
oil NN None
, , None
one CD None
tablet/time NN None
, , None
t.i.d. NN None
, , None
and CC None
pilocarpine NN None
( ( None
20 CD None
mg/d NN None
) ) None
, , None
continuously RB None
for IN None
2 CD None
months NNS None
. . None
using VBG None
electro-chemiluminescent JJ None
immunoassay NN None
( ( None
CLIA NNP None
) ) None
. . None
CONCLUSION NNP None
EA NNP None
can MD None
EA NNP None
medication NN None
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

Ciprofloxacin NNP Pharmocological
, , None
lomefloxacin NN Pharmocological
, , None
or CC None
levofloxacin CC Pharmocological
oral JJ Pharmocological
fluoroquinolones NNS Pharmocological
( ( None
lomefloxacin NN Pharmocological
, , None
levofloxacin NN Pharmocological
, , None
and CC None
ciprofloxacin NN Pharmocological
) ) None
either DT None
lomefloxacin NN Pharmocological
, , None
levofloxacin NN Pharmocological
, , None
or CC None
ciprofloxacin NN Pharmocological
. . None
-DOCSTART- -X- N

omeprazole NN Pharmocological
amoxycillin NN Pharmocological
omeprazole JJ Pharmocological
amoxycillin NN Pharmocological
omeprazole JJ Pharmocological
placebo VB None
omeprazole JJ Pharmocological
plus CC Pharmocological
amoxycillin JJ Pharmocological
omeprazole JJ Pharmocological
plus CC Pharmocological
amoxycillin JJ Pharmocological
omeprazole JJ None
placebo NN None
omeprazole JJ None
amoxycillin NN None
-DOCSTART- -X- N

low-level JJ Physical
laser NN Physical
and CC Physical
plyometric JJ Physical
exercises NNS Physical
laser NN Physical
with IN Physical
plyometric JJ Physical
exercises NNS Physical
placebo NN Control
laser NN Control
with IN Control
the DT Control
same JJ Control
program NN Control
low-level JJ Physical
laser NN Physical
plyometric JJ Physical
exercises NNS Physical
904 CD Physical
Ga-As NNP Physical
laser NN Physical
CW NNP Physical
plus CC Physical
plyometric JJ Physical
exercises NNS Physical
placebo NNS Physical
laser RBR Physical
plus CC Physical
the DT Physical
same JJ Physical
plyometric JJ Physical
exercises NNS Physical
. . Physical
laser NN Physical
or CC Physical
placebo NN Control
combination NN Physical
of IN Physical
laser NN Physical
with IN Physical
plyometric JJ Physical
exercises NNS Physical
placebo FW Control
laser NN Control
with IN Control
the DT Control
same JJ Control
plyometric JJ Control
exercises NNS Control
-DOCSTART- -X- N

physical JJ None
activity NN None
monitoring NN None
and CC None
distance NN None
counselling NN None
lifestyle JJ Educational
intervention NN Educational
control NN Control
daily JJ Educational
activity NN Educational
monitoring NN Educational
and CC Educational
distance NN Educational
counselling NN Educational
. . Educational
daily JJ None
physical JJ None
activity NN None
monitoring NN None
and CC None
distance NN None
counselling NN None
-DOCSTART- -X- N

ropivacaine/fentanyl NN Pharmocological
Ropivacaine NNP Pharmocological
fentanyl JJ Pharmocological
ropivacaine-fentanyl NN Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
ropivacaine-4 JJ Pharmocological
microg NN Pharmocological
fentanyl VBD Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
ropivacaine-2 JJ Pharmocological
microg NN Pharmocological
fentanyl NN Pharmocological
, , None
or CC None
0.05 CD Pharmocological
% NN Pharmocological
ropivacaine-1 JJ Pharmocological
microg NN Pharmocological
fentanyl NN Pharmocological
ropivacaine-4 JJ Pharmocological
ropivacaine-2 JJ None
ropivacaine NN Pharmocological
fentanyl JJ Pharmocological
-DOCSTART- -X- N

Risperidone NNP Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
) ) None
Risperidone CD Pharmocological
-DOCSTART- -X- N

nifedipine NN Pharmocological
nitrendipine NN Pharmocological
nitrendipine NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
b.i.d NN Pharmocological
. . Pharmocological
; : Pharmocological
nitrendipine NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
; : Pharmocological
or CC Pharmocological
placebo VB Control
-DOCSTART- -X- N

fenfluramine VB Pharmocological
treatment NN Pharmocological
fenfluramine VB Pharmocological
: : None
fenfluramine NN Pharmocological
-DOCSTART- -X- N

5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
2 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
and CC None
2 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
two CD Pharmocological
groups NNS Pharmocological
to TO Pharmocological
receive VB Pharmocological
5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
n JJ Pharmocological
= NNP Pharmocological
27 CD Pharmocological
) ) Pharmocological
or CC None
2 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
( ( Pharmocological
0.8 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
n JJ Pharmocological
= NNP Pharmocological
30 CD Pharmocological
) ) Pharmocological
We PRP Surgical
collected VBD Surgical
data NNS Surgical
on IN Surgical
after IN Surgical
surgery NN Surgical
. . None
prilocaine NN Pharmocological
mepivacaine NN Pharmocological
) ) None
-DOCSTART- -X- N

Sodium NN Pharmocological
bicarbonate NN Pharmocological
( ( None
Bicarb NNP None
, , None
1 CD None
M NNP None
; : None
350-500 CD None
ml NN None
) ) None
or CC None
an DT None
equal JJ None
volume NN None
of IN None
normal JJ Pharmocological
saline NN Pharmocological
( ( None
Sal NNP None
) ) None
was VBD None
infused VBN None
intravenously RB None
at IN None
a DT None
constant JJ None
rate NN None
during IN None
a DT None
'2000 CD None
m NN None
' '' None
maximal JJ None
ergometer NN Pharmocological
row NN Pharmocological
infusion NN None
of IN None
Bicarb NNP None
-DOCSTART- -X- N

antibiotic JJ Pharmocological
cefotiam NN Pharmocological
. . Pharmocological
cefotiam NN Pharmocological
cefotiam NN Pharmocological
antibiotic NN Pharmocological
anaesthesia NN Pharmocological
. . Pharmocological
cefotiam NN Pharmocological
-DOCSTART- -X- N

continuous JJ Physical
infusion NN Physical
continuous JJ Physical
and CC Physical
intermittent JJ Physical
insulin NN Physical
delivery NN Physical
saline NN Pharmocological
or CC None
continuous JJ Pharmocological
or CC None
pulsatile NN Pharmocological
human JJ None
insulin NN None
saline NN Pharmocological
smaller JJR Physical
amount NN Physical
of IN Physical
insulin NN Physical
delivered VBN Physical
continuously RB Physical
or CC None
in IN Pharmocological
a DT Pharmocological
pulsatile JJ Physical
manner NN Pharmocological
arginine NN Pharmocological
-DOCSTART- -X- N

oxygen NN Other
and CC None
hypoxic NN Other
gas NN Other
arterial JJ None
oxygen NN None
saturations NNS None
( ( None
SaO2 NNP None
) ) None
100 CD Other
percent NN Other
oxygen NN Other
room NN Other
air NN Other
-DOCSTART- -X- N

, , None
to TO None
-DOCSTART- -X- N

simulators NNS Other
simulator-based JJ Other
OSCE NNP Other
. . None
simulator-based JJ Other
OSCE NNP Other
-DOCSTART- -X- N

Letrozole NNP Pharmocological
Neoadjuvant JJ Pharmocological
chemotherapy NN Pharmocological
Preoperative JJ Pharmocological
endocrine NN Pharmocological
therapy NN Pharmocological
aromatase NN Pharmocological
inhibitors NNS Pharmocological
tamoxifen NN Pharmocological
AI NNP Pharmocological
tamoxifen NN Pharmocological
letrozole NN Pharmocological
tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
letrozole NN Pharmocological
letrozole NN Pharmocological
letrozole NN Pharmocological
letrozole NN Pharmocological
tamoxifen VB Pharmocological
-DOCSTART- -X- N

descriptive JJ Educational
( ( Educational
AUT-D NNP Educational
) ) Educational
descriptive JJ Educational
and CC Educational
explanatory JJ Educational
information NN Educational
( ( Educational
AUT-D NNP Educational
+ NNP Educational
E NNP Educational
) ) Educational
descriptive JJ Educational
and CC Educational
explanatory JJ Educational
information NN Educational
-DOCSTART- -X- N

loteprednol JJ Pharmocological
etabonate JJ Pharmocological
loteprednol JJ Pharmocological
etabonate NN Pharmocological
( ( Pharmocological
LE NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
LE NNP Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

idarubicin NN Pharmocological
and CC Pharmocological
daunorubicin NN Pharmocological
-DOCSTART- -X- N

Cisplatin NNP Pharmocological
, , Pharmocological
epirubicin NN Pharmocological
, , Pharmocological
leucovorin NN Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
PELF NNP Pharmocological
) ) Pharmocological
5-fluorouracil JJ Pharmocological
, , Pharmocological
doxorubicin JJ Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
FAMTX NNP Pharmocological
) ) Pharmocological
5-Fluorouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
FAMTX NNP Pharmocological
) ) Pharmocological
and CC None
cisplatin NN Pharmocological
, , Pharmocological
epirubicin NN Pharmocological
, , Pharmocological
leucovorin NN Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
( ( Pharmocological
PELF NNP Pharmocological
) ) Pharmocological
FAMTX NNP Pharmocological
. . None
PELF NNP Pharmocological
or CC None
FAMTX NNP Pharmocological
FAMTX NNP Pharmocological
PELF NNP Pharmocological
FAMTX NNP Pharmocological
-DOCSTART- -X- N

Standard NNP Physical
extended VBD Surgical
lymphadenectomy NN Surgical
extended VBD Surgical
lymphadenectomy NN Surgical
standard JJ Surgical
lymphadenectomy NN Surgical
. . Surgical
-DOCSTART- -X- N

fenfluramine NN Pharmocological
fenfluramine NN Pharmocological
fenfluramine NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
fenfluramine NN Pharmocological
's POS Pharmocological
-DOCSTART- -X- N

exercise NN Physical
, , Physical
training NN Physical
glycogen NN Physical
availability NN Physical
exercise NN Physical
exercise NN Physical
, , Physical
training NN Physical
, , None
and CC None
glycogen NN Physical
availability NN Physical
10 CD Physical
wk NN Physical
of IN Physical
training VBG Physical
with IN Physical
an DT Physical
acute JJ Physical
exercise NN Physical
bout NN Physical
before IN Physical
and CC Physical
after IN Physical
the DT Physical
training NN Physical
period NN Physical
, , None
or CC None
a DT None
low-glycogen JJ Pharmocological
vs. NN None
normal-glycogen JJ Physical
acute NN Physical
exercise NN Physical
trial NN Physical
. . None
-DOCSTART- -X- N

Tecnis NNP Physical
Z9000 NNP Physical
intraocular JJ Physical
lens NNS Physical
( ( Physical
Pharmacia NNP Physical
) ) Physical
or CC None
the DT Physical
AMO NNP Physical
AR40e NNP Physical
Opti-Edge NNP Physical
intraocular JJ Physical
lens NNS Physical
-DOCSTART- -X- N

zidovudine NN Pharmocological
and CC Pharmocological
zalcitabine NN Pharmocological
placebo NN Control
zidovudine NN Pharmocological
zalcitabine NN Pharmocological
ZDV NNP Pharmocological
ddC VB Pharmocological
SH NNP Pharmocological
a DT Pharmocological
combination NN Pharmocological
of IN Pharmocological
ZDV NNP Pharmocological
200 CD Pharmocological
mg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
, , Pharmocological
ddC VB Pharmocological
0.75 CD Pharmocological
mg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
, , Pharmocological
and CC Pharmocological
placebo VBZ Control
SH NNP Pharmocological
SH NNP Pharmocological
-DOCSTART- -X- N

ultrasound-guided JJ Surgical
laser NN Surgical
photocoagulation NN Surgical
percutaneous JJ Surgical
ultrasound NN Surgical
( ( Surgical
US NNP Surgical
) ) Surgical
-guided VBD Surgical
laser NN Surgical
photocoagulation NN Surgical
( ( Surgical
PLP NNP Surgical
) ) Surgical
-DOCSTART- -X- N

nicorandil NNS Pharmocological
: : Pharmocological
nifedipine NN Pharmocological
. . Pharmocological
nicorandil NN Pharmocological
nifedipine NN Pharmocological
placebo-controlled JJ Physical
active JJ Pharmocological
drugs NNS Pharmocological
placebo NN Pharmocological
nicorandil NN Pharmocological
nifedipine NN Pharmocological
placebo NN Pharmocological
. . None
Methergin NNP Pharmocological
( ( Pharmocological
ergometrine NN Pharmocological
) ) Pharmocological
placebo NN Pharmocological
ergometrine NN Pharmocological
nicorandil NN Pharmocological
ergometrine NN Pharmocological
placebo NN Pharmocological
) ) Pharmocological
nifedipine NN Pharmocological
ergometrine NN Pharmocological
placebo NN Pharmocological
) ) None
Nifedipine NNP Pharmocological
nicorandil NNS Pharmocological
Nicorandil NNP Pharmocological
-DOCSTART- -X- N

valaciclovir NN Pharmocological
polymerase NN None
chain NN None
reaction NN None
valaciclovir NN Pharmocological
valaciclovir NN Pharmocological
-DOCSTART- -X- N

Specific JJ Physical
immunoglobulin NN Physical
Immunoglobulin NNP Physical
immunoglobulins NNS Physical
placebo-controlled JJ Control
monocomponent NN Pharmocological
pertussis NN Pharmocological
toxoid JJ Pharmocological
vaccine NN Pharmocological
; : None
( ( None
b NN None
) ) None
two-component NN Pharmocological
acellular JJ Pharmocological
vaccine NN Pharmocological
also RB Pharmocological
containing VBG Pharmocological
filamentous JJ Pharmocological
haemagglutinin NN Pharmocological
; : None
or CC None
( ( None
c NN None
) ) None
20 CD Control
% NN Control
albumin JJ Pharmocological
solution NN Pharmocological
( ( Control
placebo NN Control
) ) Control
. . None
immunoglobulins NNS Physical
immunoglobulin NN Physical
placebo NN Control
immunoglobulin NN Physical
-DOCSTART- -X- N

training NN Educational
laryngeal NN Physical
mask NN Physical
airway NN Physical
: : None
emergency NN Physical
technique NN Physical
of IN Physical
insertion NN Physical
of IN Physical
an DT Physical
LMA NNP Physical
. . None
LMA NNP Physical
LMA NNP Physical
LMA NNP Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

ferumoxytol NN Pharmocological
iron NN Pharmocological
replacement NN Pharmocological
therapies NNS Pharmocological
Ferumoxytol NNP Pharmocological
ferumoxytol NN Pharmocological
placebo-controlled JJ Control
ferumoxytol JJ Pharmocological
versus NN None
saline NN Control
as IN Pharmocological
placebo NN Pharmocological
. . None
IV NNP Pharmocological
injection NN Pharmocological
ferumoxytol NN Pharmocological
or CC None
saline NN Control
placebo NN Pharmocological
ferumoxytol NN Pharmocological
placebo NN Control
. . None
ferumoxytol NN Pharmocological
placebo NN Control
. . None
ferumoxytol NN Pharmocological
or CC None
placebo NN Control
. . None
Ferumoxytol NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

Granulocyte-macrophage JJ Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
influenza JJ Pharmocological
vaccination NN Pharmocological
granulocyte-macrophage JJ Physical
colony-stimulating JJ Physical
factor NN Physical
( ( Physical
GM-CSF NNP Physical
) ) Physical
influenza JJ Pharmocological
vaccination NN Pharmocological
GM-CSF NNP Physical
GM-CSF JJ Pharmocological
-DOCSTART- -X- N

olanzapine NN Pharmocological
haloperidol NN Pharmocological
olanzapine NN Pharmocological
haloperidol NN Pharmocological
-DOCSTART- -X- N

Bisphosphonate JJ Pharmocological
infusions NNS Pharmocological
: : None
pamidronate NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
or CC None
zoledronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
Z NNP Pharmocological
) ) Pharmocological
P NNP Pharmocological
and CC Pharmocological
Z NNP Pharmocological
infusions NNS Pharmocological
. . None
infusions NNS Pharmocological
of IN Pharmocological
Z NNP Pharmocological
Z NNP Pharmocological
then RB Pharmocological
P NNP Pharmocological
or CC None
P NNP None
then RB None
Z NNP None
Z NNP Pharmocological
infusions NNS Pharmocological
Z NNP Pharmocological
and CC Pharmocological
P NNP Pharmocological
infusions NNS Pharmocological
Z NNP Pharmocological
to TO Pharmocological
P VB Pharmocological
Z NNP Pharmocological
4 CD Pharmocological
mg NN Pharmocological
infusions NNS Pharmocological
Z NNP Pharmocological
rather RB Pharmocological
than IN Pharmocological
P NNP Pharmocological
-DOCSTART- -X- N

behavioral JJ Psychological
intervention NN Psychological
social-cognitive JJ Psychological
theory-based JJ Psychological
intervention NN Psychological
or CC Physical
control NN Control
comparison NN Control
. . None
-DOCSTART- -X- N

RRR-alpha-tocopherol NNP Pharmocological
and CC Pharmocological
all-racemic JJ Pharmocological
alpha-tocopherol NN Pharmocological
alpha-tocopherol NN Pharmocological
RRR-AT NNP Pharmocological
and CC Pharmocological
all-rac-AT NN Pharmocological
-DOCSTART- -X- N

Positive NNP Educational
Action NNP Educational
Positive JJ Educational
Action NNP Educational
( ( Educational
PA NNP Educational
) ) Educational
school-based JJ Educational
social-emotional JJ Educational
learning NN Educational
and CC Educational
health NN Educational
promotion NN Educational
program NN Educational
PA NNP Educational
control NN None
universal JJ None
, , None
school-based JJ None
programs NNS None
can MD None
benefit VB None
-DOCSTART- -X- N

photodynamic JJ Pharmocological
therapy NN Pharmocological
, , None
imiquimod JJ Pharmocological
immunotherapy NN Pharmocological
and CC None
combination NN Pharmocological
of IN Pharmocological
both DT Pharmocological
therapies NNS Pharmocological
5-aminolevulinic JJ Pharmocological
acid JJ Pharmocological
photodynamic JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
PDT NNP Pharmocological
) ) Pharmocological
, , None
5 CD Pharmocological
% NN Pharmocological
imiquimod JJ Pharmocological
cream NN Pharmocological
and CC None
combination NN Pharmocological
of IN Pharmocological
both DT Pharmocological
therapies NNS Pharmocological
Combination NNP None
therapy NN None
while IN None
PDT NNP None
and CC None
imiquimod JJ None
therapy NN None
of IN None
PDT NNP None
or CC None
imiquimod JJ None
therapy NN None
. . None
either DT None
PDT NNP None
or CC None
imiquimod JJ None
monotherapy NN None
. . None
However RB None
with IN None
combination NN None
therapy NN None
, , None
which WDT None
-DOCSTART- -X- N

blood NN Physical
purifying VBG Physical
technologies NNS Physical
polymyxin NN None
B NNP None
immobilized VBD None
fiber NN None
, , None
charcoal NN None
hemoperfusion NN None
plasma NN Physical
or CC Physical
whole JJ Physical
blood NN Physical
exchange NN Physical
. . None
polymyxin NN None
B NNP None
immobilized JJ None
fiber NN None
-DOCSTART- -X- N

Beliefs NNP Educational
belief JJ Educational
basis NN Educational
of IN Educational
the DT Educational
theory NN Educational
of IN Educational
planned VBN Educational
behavior NN Educational
( ( Educational
TPB NNP Educational
) ) Educational
targeting VBG Educational
different JJ Educational
beliefs NNS Educational
messages NNS Educational
-DOCSTART- -X- N

screening VBG Physical
screening VBG Physical
Breast NNP Physical
cancer NN Physical
screening VBG Physical
-DOCSTART- -X- N

experiments NNS Educational
standard JJ Educational
duration NN Educational
( ( None
between IN None
or CC None
within IN None
subjects NNS None
) ) None
, , None
presentations NNS Educational
of IN Educational
the DT Educational
standard NN Educational
-DOCSTART- -X- N

beta-endorphin NN Pharmocological
beta-endorphin NN Pharmocological
1-h JJ Pharmocological
iv JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
beta-endorphin JJ Pharmocological
( ( Pharmocological
250 CD Pharmocological
mug/h NN Pharmocological
) ) Pharmocological
and CC None
, , None
on IN None
another DT None
occasion NN None
, , None
the DT None
same JJ None
infusion NN None
protocol NN None
preceded VBN None
by IN None
the DT None
opioid JJ Pharmocological
antagonist NN Pharmocological
naloxone NN Pharmocological
( ( Pharmocological
8 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
. . None
beta-endorphin JJ Pharmocological
beta-endorphin JJ Pharmocological
-DOCSTART- -X- N

snowshoeing VBG Physical
. . None
snowshoe JJ Physical
training NN Physical
program NN Physical
run RP Control
training VBG Control
program NN Control
. . None
-DOCSTART- -X- N

Family RB Educational
education NN Educational
family NN Educational
treatments NNS Educational
patient NN Educational
and CC Educational
family NN Educational
education NN Educational
family NN Educational
education NN Educational
control NN Control
group NN None
. . None
Family NNP Educational
education NN Educational
-DOCSTART- -X- N

prophylactic JJ Physical
transluminal JJ Physical
balloon NN Physical
angioplasty NN Physical
Prophylactic JJ Physical
Transluminal NNP Physical
Balloon NNP Physical
Angioplasty NNP Physical
( ( Physical
pTBA NN Physical
) ) Physical
pTBA NN Physical
pTBA NN None
angioplasty NN Physical
pTBA NN None
pTBA NN None
-DOCSTART- -X- N

granulocyte JJ None
colony-stimulating JJ None
factor NN None
G-CSF NNP Pharmocological
PBSCT NNP Pharmocological
) ) None
control NN Control
group NN Control
high-dose JJ Pharmocological
regimens NNS Pharmocological
without IN Pharmocological
total JJ Pharmocological
body NN Pharmocological
irradiation NN Pharmocological
consisted VBD Pharmocological
of IN Pharmocological
the DT Pharmocological
MCVAC NNP Pharmocological
regimen NNS Pharmocological
using VBG Pharmocological
ranimustine NN Pharmocological
( ( Pharmocological
MCNU NNP Pharmocological
, , Pharmocological
450 CD Pharmocological
mg/m2 NN Pharmocological
) ) Pharmocological
, , Pharmocological
cytosine JJ Pharmocological
arabinoside NN Pharmocological
( ( Pharmocological
16 CD Pharmocological
g/m2 NN Pharmocological
) ) Pharmocological
, , Pharmocological
etoposide RB Pharmocological
( ( Pharmocological
1.6 CD Pharmocological
g/m2 NN Pharmocological
) ) Pharmocological
, , Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
Hi-MEC NNP Pharmocological
regimen NNS Pharmocological
using VBG Pharmocological
melphalan NN Pharmocological
etoposide RB Pharmocological
carboplatinum NN Pharmocological
-DOCSTART- -X- N

cognitive JJ Pharmocological
rehabilitation NN Pharmocological
intervention NN Pharmocological
. . None
calendar/notebook NN Physical
rehabilitation NN Physical
intervention NN Physical
Memory NNP Educational
support NN Educational
system NN Educational
training NN Educational
-DOCSTART- -X- N

troxerutin NN Pharmocological
and CC Pharmocological
carbazochrome JJ Pharmocological
combination NN Pharmocological
troxerutin NN Pharmocological
troxerutin $ Pharmocological
carbazochrome VB Pharmocological
troxerutin NN Pharmocological
150 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
carbazochrome VB Pharmocological
1.5 CD Pharmocological
mg NN Pharmocological
placebo NN Control
combination NN Pharmocological
of IN Pharmocological
troxerutin $ Pharmocological
and CC None
carbazochrome VB Pharmocological
placebo VB Control
-DOCSTART- -X- N

clear JJ Physical
liquid NN Physical
diet NN Physical
( ( Physical
CLD NNP Physical
) ) Physical
oral JJ Physical
nutrition NN Physical
with IN Physical
a DT Physical
low-fat JJ Physical
solid JJ Physical
diet NN Physical
( ( Physical
LFSD NNP Physical
) ) Physical
CLD NNP Physical
or CC None
LFSD NNP Physical
-DOCSTART- -X- N

Locomoting-to-reach NN Physical
: : None
Locomoting-to-reach NNP Physical
locomotion-to-reach JJ Physical
task NN Physical
. . None
-DOCSTART- -X- N

non-ionic JJ Pharmocological
dimer NN Pharmocological
, , None
iodixanol NN Pharmocological
a DT Pharmocological
non-ionic JJ Pharmocological
monomer NN Pharmocological
, , Pharmocological
iohexol NN Pharmocological
non-ionic JJ Pharmocological
contrast NN Pharmocological
medium NN Pharmocological
iodixanol NN Pharmocological
monomeric NN Pharmocological
, , Pharmocological
non-ionic JJ Pharmocological
iohexol NN Pharmocological
. . None
iodixanol JJ Pharmocological
or CC Pharmocological
iohexol JJ Pharmocological
iodine NN Pharmocological
Iodixanol NN Pharmocological
Iohexol NNP Pharmocological
iohexol JJ Pharmocological
Iodixanol NNP Pharmocological
iohexol NN Pharmocological
. . Pharmocological
Iodixanol NNP Pharmocological
iohexol NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

risedronate NN Pharmocological
received VBD None
risedronate JJ Pharmocological
2.5 CD Pharmocological
or CC Pharmocological
5 CD Pharmocological
mg/day NN Pharmocological
or CC None
placebo NN Control
; : None
all DT None
subjects NNS None
also RB None
received VBD None
elemental JJ Pharmocological
calcium NN Pharmocological
1000 CD Pharmocological
mg/day NN Pharmocological
, , None
and CC None
up RB None
to TO None
500 CD Pharmocological
IU/day NNP Pharmocological
vitamin FW Pharmocological
D NNP Pharmocological
if IN None
baseline NN None
levels NNS None
were VBD None
low JJ None
. . None
the DT None
2.5 CD None
mg NN None
group NN None
was VBD None
discontinued VBN None
by IN None
protocol NN None
amendment NN None
after IN None
2 CD None
years NNS None
. . None
-DOCSTART- -X- N

intraglomerular JJ Pharmocological
metastases NNS Pharmocological
intraglomerular JJ Pharmocological
metastases NNS Pharmocological
examined VBN Educational
-DOCSTART- -X- N

lexical JJ Educational
information NN Educational
lexically RB Educational
induced VBN Educational
conversational JJ Educational
speech NN Educational
( ( Educational
Experiment NNP Educational
clear JJ Educational
speech NN Educational
noise NN Physical
two CD Educational
cognitive JJ Educational
loads NNS Educational
optimal JJ Educational
conditions NNS Educational
cognitive JJ Educational
load NN Educational
conditions NNS Educational
noise NN Educational
condition NN Educational
. . None
-DOCSTART- -X- N

( ( Pharmocological
cometidine NN Pharmocological
, , Pharmocological
omeprazole NN Pharmocological
, , Pharmocological
colloidal JJ Pharmocological
bismuth NN Pharmocological
subcitrate NN Pharmocological
( ( Pharmocological
CBS NNP Pharmocological
) ) Pharmocological
, , Pharmocological
CBS NNP Pharmocological
and CC Pharmocological
metronidazole JJ Pharmocological
double JJ Pharmocological
therapy NN Pharmocological
, , Pharmocological
CBS NNP Pharmocological
, , Pharmocological
metronidazole NN Pharmocological
and CC Pharmocological
amoxicillin JJ Pharmocological
triple JJ Pharmocological
therapy NN Pharmocological
) ) Pharmocological
cimetidine NN Pharmocological
omeprazole NN Pharmocological
CBS NNP None
double JJ Pharmocological
therapy NN Pharmocological
triple JJ None
therapy NN None
-DOCSTART- -X- N

Dexamethasone NN Pharmocological
dexamethasone NN Pharmocological
placebo NN Control
or CC None
4 CD None
mg/day NN None
of IN None
oral JJ Pharmocological
dexamethasone NN Pharmocological
for IN None
4 CD None
days NNS None
. . None
dexamethasone NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

Exemestane NN Pharmocological
placebo-controlled JJ Control
exemestane NN Pharmocological
exemestane NN Pharmocological
or CC None
placebo NN Control
. . None
exemestane NN Pharmocological
placebo NNS Control
placebo NN Control
Exemestane NNP Pharmocological
-DOCSTART- -X- N

S-phase JJ Pharmocological
kinase-associated JJ Pharmocological
protein NN Pharmocological
S-phase JJ Pharmocological
kinase-associated JJ Pharmocological
protein NN Pharmocological
( ( None
Skp2 NNP Pharmocological
) ) None
Skp2 NNP Pharmocological
Skp2 NNP Pharmocological
immunohistochemical JJ Physical
study NN Physical
. . Educational
Skp2 NNP Pharmocological
Skp2 NNP Pharmocological
Skp2 NNP Pharmocological
-DOCSTART- -X- N

Prolonged NNP Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
and CC None
add-back JJ Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
; : None
norethindrone NN Pharmocological
acetate NN Pharmocological
C-daily NNP Pharmocological
norethindrone NN Pharmocological
acetate NN Pharmocological
conjugated VBD Pharmocological
equine NN Pharmocological
estrogens VBZ Pharmocological
norethindrone NN Pharmocological
acetate NN Pharmocological
conjugated VBD Pharmocological
equine NN Pharmocological
estrogens VBZ Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
norethindrone JJ Pharmocological
acetate NN Pharmocological
alone RB Pharmocological
low-dose JJ Pharmocological
conjugated JJ Pharmocological
equine NN Pharmocological
estrogens NNS Pharmocological
-DOCSTART- -X- N

gonadotropin-releasing NN Pharmocological
hormone NN Pharmocological
analog NN Pharmocological
( ( Pharmocological
Diphereline NNP Pharmocological
) ) Pharmocological
Cabergoline NNP Pharmocological
( ( Pharmocological
Dostinex NNP Pharmocological
) ) Pharmocological
cabergoline NN Pharmocological
( ( Pharmocological
Dostinex NNP Pharmocological
, , Pharmocological
a DT Pharmocological
dopamine JJ Pharmocological
agonist NN Pharmocological
) ) Pharmocological
Diphereline NNP Pharmocological
( ( Pharmocological
a DT Pharmocological
gonadotropin-releasing NN Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
) ) Pharmocological
. . Pharmocological
Diphereline NNP Pharmocological
Cabergoline NNP Pharmocological
. . Pharmocological
Diphereline NNP Pharmocological
Cabergoline NNP Pharmocological
Cabergoline NNP Pharmocological
gonadotropin NN Pharmocological
releasing VBG Pharmocological
hormone JJ Pharmocological
agonist NN Pharmocological
dopamine NN Pharmocological
agonists NNS Pharmocological
-DOCSTART- -X- N

glucocorticoids NNS Pharmocological
glucocorticoid JJ Pharmocological
glucocorticoid VB Pharmocological
( ( Pharmocological
methylprednisolone NN Pharmocological
, , Pharmocological
METH NNP Pharmocological
; : Pharmocological
placebo NN Control
( ( Control
PLAC NNP Control
; : Control
-DOCSTART- -X- N

Moderate NNP Pharmocological
sodium NN Pharmocological
restriction NN Pharmocological
, , None
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibition NN Pharmocological
, , None
and CC None
thiazide RB Pharmocological
diuretic JJ Pharmocological
in IN None
Dietary NNP Physical
sodium JJ Physical
restriction NN Physical
sodium JJ Physical
Angiotensin NNP Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
( ( Pharmocological
ACE NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
The DT None
combination NN None
of IN None
dietary JJ Pharmocological
sodium NN Pharmocological
restriction NN Pharmocological
with IN None
blockade NN None
of IN None
the DT None
renin NN None
system NN None
by IN None
an DT None
ACE NNP Pharmocological
inhibitor NN Pharmocological
thiazide JJ Pharmocological
diuretic NN Pharmocological
-DOCSTART- -X- N

ambient JJ Physical
transitional JJ Physical
prism NN Physical
lenses NNS Physical
. . Educational
wearing VBG Physical
ambient JJ Physical
lenses NNS Physical
placebo NN Control
ambient JJ Physical
lenses NNS Physical
-DOCSTART- -X- N

Ketorolac NNP Pharmocological
versus NN Pharmocological
fentanyl NN Pharmocological
fentanyl NN Pharmocological
ketorolac NN Pharmocological
Fentanyl NNP Pharmocological
ketorolac NN Pharmocological
propofol NN Pharmocological
, , None
nitrous JJ Pharmocological
oxide NN Pharmocological
and CC None
enflurane NN Pharmocological
. . None
-DOCSTART- -X- N

monoiodoacetate NN Pharmocological
. . None
monoiodoacetate NN Pharmocological
( ( Pharmocological
MIA NNP Pharmocological
) ) Pharmocological
MIA NNP Pharmocological
phenylbutazone NN Pharmocological
, , None
butorphanol NN Pharmocological
, , None
and CC None
abaxial JJ Pharmocological
sesamoidean NN Pharmocological
nerve NN Physical
blocks NNS Physical
non-exercised JJ None
exercised JJ None
Exercise NNP Physical
-DOCSTART- -X- N

esmolol NN Pharmocological
placebo NN Control
Esmolol NNP Pharmocological
vs NN None
Placebo NNP Pharmocological
esmolol NN Pharmocological
placebo NN Control
esmolol NN Pharmocological
placebo NN Control
esmolol VB Pharmocological
esmolol JJ Pharmocological
esmolol JJ Pharmocological
esmolol JJ Pharmocological
esmolol NN Pharmocological
-DOCSTART- -X- N

cimetidine NN Pharmocological
antacid NN Pharmocological
. . Pharmocological
cimetidine NN Pharmocological
or CC None
antacid NN Pharmocological
. . None
cimetidine NN Pharmocological
or CC None
Mylanta NNP Pharmocological
II NNP Pharmocological
antacid NN Pharmocological
cimetidine NN Pharmocological
antacid JJ Physical
therapy NN None
cimetidine JJ Pharmocological
therapy NN None
. . None
-DOCSTART- -X- N

read VB Educational
the DT Educational
same JJ Educational
question NN Educational
, , Educational
relating VBG Educational
to TO Educational
either DT Educational
physical JJ Educational
or CC Educational
social JJ Educational
world NN Educational
knowledge NN Educational
, , Educational
when WRB Educational
it PRP Educational
was VBD Educational
either CC Educational
relevant JJ Educational
or CC Educational
irrelevant JJ Educational
to TO Educational
the DT Educational
bridging NN Educational
inference NN Educational
evoked VBN Educational
by IN Educational
a DT Educational
preceding VBG Educational
two-sentence NN Educational
vignette NN Educational
. . None
-DOCSTART- -X- N

stage-of-change NN Educational
oriented VBN Educational
smoking VBG Educational
cessation NN Educational
intervention NN Educational
stage-of-change NN Educational
oriented VBN Educational
smoking VBG Educational
cessation NN Educational
intervention NN Educational
three CD Educational
to TO Educational
five CD Educational
minute NN Educational
scripted VBN Educational
intervention NN Educational
and CC Educational
booklet NN Educational
specific NN Educational
to TO Educational
the DT Educational
woman NN Educational
's POS Educational
stage-of-change NN Educational
in IN Educational
the DT Educational
smoking NN Educational
continuum NN Educational
, , Educational
versus JJ Educational
standard NN Other
of IN Other
care NN Other
. . None
Exhaled VBN Physical
carbon-monoxide NN Physical
( ( Physical
CO NNP Physical
) ) Physical
monitoring NN None
-DOCSTART- -X- N

human JJ Pharmocological
brain NN Pharmocological
natriuretic JJ Pharmocological
peptide NN Pharmocological
Human NNP Pharmocological
brain NN Pharmocological
natriuretic JJ Pharmocological
peptide NN Pharmocological
( ( Pharmocological
hBNP NN Pharmocological
) ) Pharmocological
hBNP NNS Pharmocological
hBNP NN Pharmocological
placebo-controlled JJ Control
placebo JJ Control
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
placebo VB Control
hBNP VB Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP NN Pharmocological
hBNP JJ Pharmocological
hBNP NN Pharmocological
-DOCSTART- -X- N

natriuretic JJ Pharmocological
peptide NN Pharmocological
oxidative JJ Educational
natriuretic JJ Pharmocological
peptide NN Pharmocological
oxidative JJ None
stress NN None
-DOCSTART- -X- N

pindolol NN Pharmocological
and CC None
clopamide NN Pharmocological
clopamide NN Pharmocological
, , None
pindolol NN Pharmocological
and CC None
its PRP$ None
combination NN Pharmocological
on IN Pharmocological
plasma JJ Pharmocological
lipids NNS Pharmocological
-DOCSTART- -X- N

CGM NNP Other
control NN Control
standard JJ Control
home NN Control
blood NN Control
glucose JJ Control
monitoring NN Control
CGM NNP Other
-DOCSTART- -X- N

bilastine NN Pharmocological
bilastine NN Pharmocological
bilastine NN Pharmocological
bilastine NN Pharmocological
bilastine NN Pharmocological
-DOCSTART- -X- N

Behavioral NNP Psychological
Family NNP Psychological
Systems NNP Psychological
Therapy NNP Psychological
Behavioral NNP Psychological
Family NNP Psychological
Systems NNP Psychological
Therapy NNP Psychological
for IN Psychological
Diabetes NNP Psychological
( ( Psychological
BFST-D NNP Psychological
) ) Psychological
intervention NN Psychological
standard VB Educational
care NN Educational
( ( Educational
SC NNP Educational
) ) Educational
or CC Educational
to TO Educational
6 CD Educational
months NNS Educational
of IN Educational
an DT Educational
educational JJ Educational
support NN Educational
group NN Educational
( ( Educational
ES NNP Educational
) ) Educational
or CC Educational
BFST-D. JJ Educational
BFST-D NNP Psychological
BFST-D NNP Educational
BFST-D NNP Educational
-DOCSTART- -X- N

extended JJ Surgical
radical JJ Surgical
radical JJ Surgical
mastectomy NN Surgical
. . None
standard NN Surgical
Halsted NNP Surgical
radical NN Surgical
( ( Surgical
RDL NNP Surgical
) ) Surgical
operation NN Surgical
complete JJ Surgical
extended JJ Surgical
radical NN Surgical
( ( Surgical
EXT NNP Surgical
) ) Surgical
mastectomy NN Surgical
-DOCSTART- -X- N

3D CD Other
finite JJ Other
element NN Other
2D CD Physical
radiographs NN Physical
. . None
Finite NNP Other
element NN Other
( ( Other
FE NNP Other
) ) Other
modelling NN Other
patient-specific JJ Other
FE NNP Other
models NNS Other
computed JJ Other
tomography NN Other
create VB Other
personalised VBD Other
3D CD Other
models NNS Other
from IN Other
standard JJ Other
2D CD Other
hip NN Other
radiographs NN Other
. . None
3D CD Physical
femoral JJ Physical
shape NN Physical
obtained VBN Physical
from IN Physical
CT NNP Physical
FE NNP Other
models NNS Other
from IN None
standard JJ None
2D CD None
radiographs NN None
-DOCSTART- -X- N

recombinant JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
vaccine NN Pharmocological
] NN Pharmocological
placebo NN Control
) ) Control
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
IFN NNP Pharmocological
alpha VBP Pharmocological
1b CD Pharmocological
50 CD Pharmocological
micrograms NNS Pharmocological
with IN Pharmocological
3 CD Pharmocological
times NNS Pharmocological
a DT Pharmocological
week NN Pharmocological
for IN Pharmocological
24 CD Pharmocological
weeks NNS Pharmocological
. . None
recombinant JJ Pharmocological
hepatitis NN Pharmocological
B NNP Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

neurohormones NNS None
-DOCSTART- -X- N

Left NNP Surgical
internal JJ Surgical
thoracic NN Surgical
artery-radial JJ Surgical
artery NN Surgical
composite JJ Surgical
grafts NNS Surgical
left JJ Surgical
internal JJ Surgical
thoracic NN Surgical
artery-radial JJ Surgical
artery NN Surgical
composite JJ Surgical
grafts NNS Surgical
conventional JJ Surgical
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
grafts NNS Surgical
composite JJ Surgical
Y-graft NN Surgical
. . None
-DOCSTART- -X- N

MMX NNP None
( ( None
? . None
) ) None
mesalamine NN None
with IN None
mesalamine NN None
MMX NNP None
( ( None
? . None
) ) None
mesalamine NN Pharmocological
( ( None
Lialda NNP None
; : None
Shire NNP None
Pharmaceuticals NNP None
LLC NNP None
, , None
Wayne NNP None
, , None
PA NNP None
) ) None
, , None
once-daily JJ None
MMX NNP None
mesalamine NN None
compared VBN None
twice-daily JJ None
delayed-release JJ None
mesalamine NN None
( ( None
Asacol NNP Pharmocological
; : None
Warner NNP None
Chilcott NNP None
, , None
Dublin NNP None
, , None
Ireland NNP None
) ) None
for IN None
once-daily JJ None
MMX NNP None
mesalamine NN None
2.4 CD None
with IN None
twice-daily JJ None
delayed-release JJ None
mesalamine NN None
at IN None
a DT None
total JJ None
daily JJ None
dose NN None
of IN None
1.6 CD None
g/day NN None
in IN None
-DOCSTART- -X- N

verbal JJ Psychological
responsiveness NN Psychological
verbal JJ Psychological
responsiveness NN Psychological
Parent NNP Psychological
verbal JJ Psychological
utterances NNS Psychological
videotapes NNS Educational
of IN Educational
naturalistic JJ Educational
parent-child JJ Educational
play NN Educational
sessions NNS Educational
interval JJ None
event-based JJ Educational
coding NN Educational
. . None
Parent NNP Psychological
verbal JJ Psychological
utterances NNS Psychological
-DOCSTART- -X- N

Herpes NNP Pharmocological
simplex JJ Pharmocological
virus NN Pharmocological
vaccine NN Pharmocological
antiherpetic JJ Pharmocological
vaccine NN Pharmocological
specific JJ Pharmocological
vaccination NN Pharmocological
with IN Pharmocological
heat NN Pharmocological
shock-inactivated JJ Pharmocological
herpes NNS Pharmocological
simplex JJ Pharmocological
virus NN Pharmocological
type NN Pharmocological
1 CD Pharmocological
observed VBN None
as IN None
controls NNS Control
vaccination NN Pharmocological
-DOCSTART- -X- N

conventional JJ Control
PCNL NNP Control
and CC None
two CD None
modifications NNS None
to TO None
standard JJ None
procedure NN None
. . None
conventional JJ Control
nephrostomy JJ Physical
tube NN Physical
( ( Physical
NT NNP Physical
) ) Physical
and CC None
temporary JJ Physical
ureteral JJ Physical
catheter NN Physical
( ( Physical
TU NNP Physical
) ) Physical
only RB Physical
TU NNP Physical
only RB Physical
indwelling VBG Physical
ureteral JJ Physical
catheter NN Physical
( ( Physical
IU NNP Physical
) ) Physical
PCNL NNP Surgical
Tubeless NNP Surgical
PCNL NNP Surgical
-DOCSTART- -X- N

botulinum NN Pharmocological
toxin NN Pharmocological
type NN Pharmocological
A NNP Pharmocological
. . Pharmocological
botulinum NN Pharmocological
toxin NN Pharmocological
type NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
BoNT-A NNP Pharmocological
) ) Pharmocological
injected VBN Pharmocological
with IN Pharmocological
BoNT-A NNP Pharmocological
or CC None
placebo NN Control
placebo NN Control
BoNT-A NNP Pharmocological
-DOCSTART- -X- N

lisinopril NN Pharmocological
captopril NN Pharmocological
captopril NN Pharmocological
lisinopril NN Pharmocological
captopril NN Pharmocological
lisinopril NN Pharmocological
antihypertensive JJ Pharmocological
regimen NNS Pharmocological
-DOCSTART- -X- N

primaquine NN Pharmocological
regimens NNS Pharmocological
Fansidar NNP Pharmocological
( ( None
F. NNP None
Hoffmann-La NNP Other
Roche NNP Other
Ltd. NNP Other
Basel NNP Other
Switzerland NNP Other
) ) Other
( ( None
pyrimethamine NN Pharmocological
and CC None
sulfadoxine NN Pharmocological
) ) None
, , None
primaquine NN Pharmocological
artesunate NN Pharmocological
Fansidar NNP Pharmocological
pyrimethamine NN Pharmocological
and CC None
1,500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
sulfadoxine NN Pharmocological
Fansidar NNP None
( ( None
3 CD None
tablets NNS None
, , None
75 CD None
mg NN None
of IN None
pyrimethamine NN None
and CC None
1,500 CD None
mg NN None
of IN None
sulfadoxine NN None
primaquine NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg NN Pharmocological
a DT Pharmocological
day NN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
received VBN Pharmocological
primaquine NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg NN Pharmocological
a DT Pharmocological
day NN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
received VBN None
artesunate NN Pharmocological
primaquine VB Pharmocological
-DOCSTART- -X- N

individual JJ Psychological
peer NN Psychological
support NN Psychological
Peer NNP Pharmocological
support NN Pharmocological
-DOCSTART- -X- N

cognitive-behavioral JJ Psychological
therapy NN Psychological
treatment NN Control
as IN Control
usual JJ Control
cognitive-behavioral JJ Psychological
therapy NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
treatment NN Control
as IN Control
usual JJ Control
( ( None
TAU NNP None
) ) None
CBT NNP Educational
TAU NNP Control
CBT NNP Control
TAU VB Control
CBT NNP Educational
TAU NNP Control
CBT NNP Control
CBT NNP Educational
CBT NNP Educational
-DOCSTART- -X- N

standard NN Educational
wound NN Educational
care NN Educational
adjunctive JJ Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
( ( Physical
HBOT NNP Physical
) ) Physical
adjunctive JJ Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
plus CC Physical
standard NN Physical
wound NN Physical
care NN Physical
standard NN Physical
wound NN Physical
care NN Physical
hyperbaric JJ Physical
oxygen NN Physical
therapy NN Physical
ongoing VBG Educational
wound NN Educational
care NN Educational
hyperbaric JJ None
oxygen NN None
therapy NN None
hyperbaric JJ None
oxygen NN None
therapy NN None
-DOCSTART- -X- N

SQ29,852 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
new JJ Pharmocological
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibitor NN Pharmocological
atenolol NN Pharmocological
. . None
SQ29,852 NNP Pharmocological
angiotensin NN Pharmocological
converting VBG Pharmocological
enzyme JJ Pharmocological
inhibitor NN Pharmocological
atenolol NN Pharmocological
SQ29,852 NNP Pharmocological
atenolol $ Pharmocological
SQ29,852 NNP Pharmocological
atenolol RB Pharmocological
. . None
SQ29,852 NNP Pharmocological
-DOCSTART- -X- N

Theory-driven JJ Educational
intervention NN Educational
osteoporosis JJ Educational
education NN Educational
program NN Educational
( ( None
wait-list JJ Educational
control NN Educational
group NN Educational
) ) None
6 CD Educational
weekly JJ Educational
education NN Educational
program NN Educational
sessions NNS Educational
baseline NN Educational
assessment NN Educational
educational JJ Educational
program NN Educational
-DOCSTART- -X- N

estramustine NN Pharmocological
and CC Pharmocological
vinblastine JJ Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
vs JJ None
estramustine NN Pharmocological
alone RB Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
estramustine JJ Pharmocological
phosphate NN Pharmocological
( ( Pharmocological
EMP NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
vinblastine NN Pharmocological
( ( Pharmocological
VBL NNP Pharmocological
) ) Pharmocological
oral JJ Pharmocological
EMP NNP Pharmocological
( ( Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
kg JJ Pharmocological
day NN Pharmocological
continuously RB Pharmocological
) ) Pharmocological
or CC Pharmocological
oral JJ Pharmocological
EMP NNP Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
intravenous JJ Pharmocological
VBL NNP Pharmocological
EMP/VBL NNP Pharmocological
EMP NNP Pharmocological
VBL NNP Pharmocological
-DOCSTART- -X- N

cisplatin NN Pharmocological
with IN Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
cisplatin NN Pharmocological
75 CD Pharmocological
mg/m2 NN Pharmocological
or CC Pharmocological
cisplatin NN Pharmocological
50 CD Pharmocological
mg/m2 NN Pharmocological
and CC Pharmocological
cyclophosphamide VB Pharmocological
500 CD Pharmocological
mg/m2 NN Pharmocological
CP NNP Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
CP NNP Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
CP NNP Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
carboplatin NN Pharmocological
or CC Pharmocological
cisplatin NN Pharmocological
platinum-containing JJ Pharmocological
chemotherapy NN Pharmocological
platinum-containing JJ Pharmocological
platinum-free JJ Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
CP NNP Pharmocological
. . Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
CP NNP None
. . None
CP NNP Pharmocological
cisplatin NN Pharmocological
. . Pharmocological
platinum-containing JJ Physical
therapy NN Physical
. . None
-DOCSTART- -X- N

closed JJ Physical
suctioning VBG Physical
open JJ Physical
suctioning NN Physical
: : Physical
Closed VBN Physical
( ( Physical
CS NNP Physical
) ) Physical
open JJ Physical
suction NN Physical
( ( Physical
OS NNP Physical
) ) Physical
and CC None
CS NNP Physical
CS NNP Physical
OS NNP Physical
CS NNP Physical
OS NNP Physical
. . None
Closed VBD Physical
suctioning VBG Physical
OS NNP Physical
. . None
CS NNP Physical
-DOCSTART- -X- N

problem-solving JJ Educational
education NN Educational
( ( Educational
PSE NNP Educational
) ) Educational
PSE NNP Educational
usual JJ Control
care NN Control
. . None
Problem-solving JJ Educational
education NN Educational
30-minute JJ Educational
individualized VBN Educational
sessions NNS Educational
by IN Educational
existing VBG Educational
staff NN Educational
research NN None
staff NN None
without IN None
formal JJ None
mental JJ None
health NN None
training NN None
PSE NNP None
usual JJ Control
care NN Control
. . None
PSE NNP None
PSE NNP None
PSE NNP None
-DOCSTART- -X- N

conventional JJ Physical
and CC Physical
accelerated JJ Physical
radiotherapy NN Physical
. . None
assessed VBN Physical
by IN Physical
Ki-67 NNP Physical
staining NN Physical
accelerated VBN Physical
radiotherapy NN Physical
. . None
-DOCSTART- -X- N

fluticasone NN Pharmocological
placebo-controlled JJ Control
fluticasone NN Pharmocological
placebo NN Control
or CC None
fluticasone NN Pharmocological
-DOCSTART- -X- N

Rapeseed NNP Other
and CC Other
soybean NN Other
products NNS Other
rapeseed NN Other
meal NN Other
and CC Other
cake NN Other
and CC Other
soybean NN Other
meal NN Other
and CC Other
cake NN Other
rapeseed NN Other
feeding VBG Other
soybean JJ Other
products NNS Other
. . Pharmocological
soybean JJ Other
meal NN Other
rapeseed VB Other
meal NN Other
soybean JJ Other
cake NN Other
rapeseed VB Other
cake NN Other
. . None
rapeseed NN Other
-DOCSTART- -X- N

Fluorouracil NNP Surgical
Filtering NNP Surgical
Surgery NNP Surgical
Fluorouracil NNP Surgical
Filtering NNP Surgical
Surgery NNP Surgical
Study NNP None
subconjunctival JJ Pharmocological
5- JJ Pharmocological
fluorouracil NN Pharmocological
injections NNS Pharmocological
trabeculectomy NN Physical
alone RB Pharmocological
or CC Pharmocological
trabeculectomy VB Physical
with IN Pharmocological
postoperative JJ Pharmocological
subconjunctival JJ Pharmocological
5-fluorouracil JJ Pharmocological
injections NNS Pharmocological
. . Pharmocological
5-fluorouracil JJ Pharmocological
5-fluorouracil JJ Pharmocological
subconjunctival JJ Pharmocological
5-fluorouracil JJ Pharmocological
-DOCSTART- -X- N

intravenous JJ Pharmocological
synthetic JJ Pharmocological
human NN Pharmocological
secretin NN Pharmocological
intravenous JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
2 CD Pharmocological
IU/kg NNP Pharmocological
of IN Pharmocological
intravenous JJ Pharmocological
synthetic JJ Pharmocological
human NN Pharmocological
secretin NN Pharmocological
intravenous JJ Control
saline NN Control
placebo NN Control
-DOCSTART- -X- N

Dofequidar NNP Pharmocological
fumarate NN Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
dofequidar NN Pharmocological
plus CC Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
CAF NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
CAF NNP Pharmocological
alone RB Pharmocological
placebo-controlled JJ Control
CAF NNP Pharmocological
therapy NN Pharmocological
: : None
days/cycle NN None
, , None
with IN None
doxorubicin NN Pharmocological
( ( None
25 CD None
mg/m2 NN None
) ) None
and CC None
fluorouracil NN Pharmocological
( ( None
500 CD None
mg/m2 NN None
) ) None
administered VBN None
on IN None
days NNS None
1 CD None
and CC None
8 CD None
and CC None
cyclophosphamide NN Pharmocological
( ( None
100 CD None
mg NN None
orally RB None
[ NNP None
PO NNP None
] NNP None
) ) None
administered VBD None
on IN None
day NN None
1 CD None
through IN None
14 CD None
. . None
dofequidar NN Pharmocological
( ( Pharmocological
900 CD Pharmocological
mg RB Pharmocological
PO NNP Pharmocological
) ) Pharmocological
doxorubicin NN Pharmocological
. . None
CAF NNP Pharmocological
dofequidar NN Pharmocological
+ NNP Pharmocological
CAF NNP Pharmocological
dofequidar NN Pharmocological
Dofequidar NNP Pharmocological
+ NNP Pharmocological
CAF NNP Pharmocological
-DOCSTART- -X- N

Low-dose JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
low-dose JJ Pharmocological
aspirin NN Pharmocological
placebo-controlled JJ Control
aspirin NN Pharmocological
and CC None
beta NN Pharmocological
carotene NN Pharmocological
. . None
aspirin NN Pharmocological
and CC None
placebo NN Control
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

antirheumatic JJ Pharmocological
drug NN Pharmocological
therapy NN Pharmocological
combination NN None
of IN None
methotrexate NN Pharmocological
, , None
sulfasalazine NN Pharmocological
, , None
and CC None
hydroxychloroquine NN Pharmocological
with IN Pharmocological
prednisolone NN Pharmocological
( ( Pharmocological
FIN-RACo NNP Pharmocological
) ) Pharmocological
, , None
or CC None
treatment NN None
with IN None
a DT None
single JJ Pharmocological
DMARD NNP Pharmocological
( ( Pharmocological
initially RB Pharmocological
, , Pharmocological
sulfasalazine NN Pharmocological
) ) Pharmocological
with IN None
or CC None
without IN None
prednisolone NN Pharmocological
( ( Pharmocological
SINGLE NNP Pharmocological
) ) Pharmocological
. . None
FIN-RACo NNP Pharmocological
SINGLE NNP Pharmocological
FIN-RACo NNP Pharmocological
SINGLE NNP Pharmocological
combination NN Pharmocological
of IN Pharmocological
DMARDs NNP Pharmocological
DMARD NNP Pharmocological
monotherapy NN Pharmocological
. . None
-DOCSTART- -X- N

Alkalinized NNP Pharmocological
lidocaine NN Pharmocological
and CC Pharmocological
heparin NN Pharmocological
alkalinized JJ Pharmocological
lidocaine NN Pharmocological
and CC Pharmocological
heparin NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

Clonidine NNP Pharmocological
clonidine NN None
low-dose JJ Pharmocological
clonidine NN Pharmocological
versus NN Pharmocological
placebo NN Control
and CC Pharmocological
low-dose JJ Pharmocological
aspirin NN Pharmocological
versus NN Pharmocological
placebo NN Pharmocological
clonidine NN Pharmocological
with IN Pharmocological
placebo NN Pharmocological
clonidine NN None
or CC None
placebo VB None
-DOCSTART- -X- N

intense JJ Educational
quality NN Educational
assurance NN Educational
program NN Educational
dummy JJ Physical
run NN Physical
( ( Physical
DR NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

mometasone NN Pharmocological
furoate NN Pharmocological
mometasone NN Pharmocological
furoate NN Pharmocological
MF-DPI NNP Pharmocological
400 CD Pharmocological
microg NN Pharmocological
once-daily RB Pharmocological
in IN Pharmocological
the DT Pharmocological
evening NN Pharmocological
or CC None
MF-DPI JJ Pharmocological
200 CD Pharmocological
microg JJ Pharmocological
twice-daily RB Pharmocological
. . None
MF-DPI NNP Pharmocological
-DOCSTART- -X- N

Hydrogen NNP Pharmocological
peroxide NN Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
: : None
hydrogen NN Pharmocological
peroxide NN Pharmocological
( ( Pharmocological
H2O2 NNP Pharmocological
) ) Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
control NN Control
H2O2 NNP Pharmocological
or CC None
the DT None
group NN Control
. . None
H2O2 NNP Pharmocological
mouth NN Pharmocological
rinse NN Pharmocological
-DOCSTART- -X- N

Transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
plus CC Pharmocological
conservative JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
ibuprofen JJ Pharmocological
, , None
bite JJ Pharmocological
plate NN Pharmocological
, , None
self-physiotherapy NN Physical
) ) None
TENS NNP Physical
TENS NNP Physical
. . None
Subthreshold NNP Physical
TENS NNP Physical
-DOCSTART- -X- N

Direct JJ Surgical
aortic JJ Surgical
cannulation NN Surgical
minimally RB Surgical
invasive JJ Surgical
Port-Access NNP Surgical
femoral JJ Surgical
arterial JJ Surgical
cannulation NN Surgical
direct JJ Surgical
aortic JJ Surgical
cannulation NN Surgical
direct JJ Surgical
aortic JJ Surgical
cannulation NN Surgical
standard JJ Surgical
femoral JJ Surgical
artery NN Surgical
cannulation NN Surgical
. . None
-DOCSTART- -X- N

risperidone NN Pharmocological
placebo-controlled JJ Control
risperidone NN Pharmocological
placebo NN None
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Pharmocological
( ( None
placebo NN None
risperidone NN Pharmocological
risperidone NN Pharmocological
; : Pharmocological
placebo NN None
) ) None
placebo NN None
risperidone NN Pharmocological
placebo NN None
) ) None
-DOCSTART- -X- N

Acute NNP None
prolactin NN Pharmocological
and CC None
oxytocin JJ Pharmocological
-DOCSTART- -X- N

Pre-operative JJ Physical
radiochemotherapy NN Physical
pre-operative JJ Physical
vs. FW None
postoperative JJ Physical
radiochemotherapy NN Physical
pre-operative JJ Physical
radiochemotherapy NN Physical
postoperative JJ Physical
radiochemotherapy NN Physical
pre-operative JJ Physical
( ( Physical
PRE NNP Physical
) ) Physical
postoperative JJ Physical
( ( Physical
POST NNP Physical
) ) Physical
radiochemotherapy NN Physical
radiotherapy NN Physical
. . None
PRE NNP Physical
POST NNP Physical
pre-operative JJ Physical
radiotherapy NN Physical
postoperative JJ Physical
radiotherapy NN Physical
. . None
-DOCSTART- -X- N

surgery NN Surgical
operated VBN Surgical
on IN None
local JJ Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

conventional JJ None
and CC None
a DT None
new JJ None
sampling NN Physical
device NN Physical
. . None
PapCone? NNP None
versus IN None
the DT None
conventional JJ None
sampling NN None
method NN None
( ( None
Ayre NNP None
's POS None
spatula NN None
plus CC None
cytobrush NN None
) ) None
-DOCSTART- -X- N

esomeprazole NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

who WP Educational
received VBD Educational
the DT Educational
same JJ Educational
short-term JJ Educational
intervention NN Educational
types NNS Educational
( ( Educational
6 CD Educational
weeks NNS Educational
with IN Educational
the DT Educational
mother NN Educational
and CC Educational
6 CD Educational
weeks NNS Educational
with IN Educational
the DT Educational
support NN Educational
of IN Educational
an DT Educational
educational JJ Educational
software NN Educational
program NN Educational
) ) Educational
. . None
The DT Educational
intervention NN Educational
process NN Educational
was VBD Educational
conducted VBN Educational
by IN Educational
speech-language JJ Educational
pathologists NNS Educational
who WP Educational
were VBD Educational
part NN Educational
of IN Educational
a DT Educational
graduate NN Educational
program NN Educational
in IN Educational
this DT Educational
area NN Educational
. . None
-DOCSTART- -X- N

noninvasive JJ Physical
and CC Educational
invasive JJ Surgical
approaches NNS Educational
. . Educational
noninvasive JJ Physical
( ( None
suppression NN None
of IN None
ventricular JJ None
arrhythmias NNS None
detected VBN None
by IN None
ambulatory JJ None
monitoring NN None
) ) None
invasive JJ Surgical
( ( None
suppression NN None
of IN None
arrhythmias NNS None
induced VBN None
by IN None
programmed JJ None
stimulation NN None
) ) None
invasive JJ Surgical
approach NN Surgical
noninvasive JJ Physical
approach NN Physical
noninvasive JJ Physical
invasive JJ Surgical
invasive JJ Surgical
approach NN Surgical
-DOCSTART- -X- N

Escort NNP Pharmocological
spirometer NN Pharmocological
Micromed NNP Pharmocological
turbine NN Pharmocological
spirometer NN Pharmocological
mini-Wright JJ Pharmocological
peak NN Pharmocological
flow NN Pharmocological
meter NN Pharmocological
. . Pharmocological
spirometer NN Pharmocological
new JJ Physical
portable JJ Physical
Fleisch NNP Physical
pneumotachograph NN Pharmocological
spirometer NN Pharmocological
( ( None
known VBN None
as IN None
the DT None
Escort NNP None
) ) None
mini-Wright JJ Pharmocological
peak NN Pharmocological
flow NN Pharmocological
meter NN Pharmocological
Micromed NNP Pharmocological
Pocket NNP Pharmocological
turbine NN Pharmocological
spirometer NN Pharmocological
. . Pharmocological
new JJ Pharmocological
spirometer NN Pharmocological
mini-Wright JJ Physical
peak NN Physical
flow NN Physical
meter NN Physical
new JJ Pharmocological
spirometer NN Pharmocological
turbine NN Pharmocological
spirometer NN Pharmocological
. . Pharmocological
mini-Wright JJ None
turbine JJ None
mini-Wright JJ Physical
meter NN Physical
new JJ None
meter NN None
-DOCSTART- -X- N

structural JJ Educational
equation NN Educational
modeling NN Educational
( ( Educational
SEM NNP Educational
) ) Educational
( ( None
BL NNP Physical
) ) None
-DOCSTART- -X- N

Acute NNP None
reduction NN None
of IN None
arterial JJ None
blood NN None
pressure NN None
acute JJ None
reduction NN None
in IN None
arterial JJ None
blood NN None
pressure NN None
slow JJ None
intravenous JJ None
injection NN None
clonidine NN Pharmocological
saline NN Pharmocological
Clonidine NNP Pharmocological
clonidine JJ Pharmocological
clonidine JJ Pharmocological
-DOCSTART- -X- N

to TO Pharmocological
receive VB Pharmocological
( ( Pharmocological
group NN Pharmocological
S NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
not RB Pharmocological
( ( Pharmocological
group NN Pharmocological
C NNP Pharmocological
) ) Pharmocological
sevoflurane NN Pharmocological
Transoesophageal NNP Physical
Tissue NNP Physical
Doppler NNP Physical
echocardiographic JJ Physical
examination NN Physical
of IN Physical
myocardial JJ Physical
systolic NN Physical
and CC None
early JJ Surgical
diastolic NN Surgical
velocities NNS Surgical
in IN Surgical
both DT Surgical
groups NNS Surgical
basally RB Surgical
and CC Surgical
60 CD Surgical
s NN Surgical
after IN Surgical
coronary JJ Surgical
occlusion NN Surgical
by IN Surgical
the DT Surgical
surgeon NN Surgical
. . None
-DOCSTART- -X- N

etch-and-rinse JJ Physical
adhesive JJ Physical
systems NNS Physical
and CC Physical
a DT Physical
self-etching JJ Physical
system NN Physical
posts NNS Physical
used VBD Physical
for IN Physical
luting VBG Physical
were VBD Physical
duplicated VBN Physical
with IN Physical
dual JJ Physical
resin NN Physical
cement NN Physical
( ( Physical
Duo-link NNP Physical
) ) Physical
inside IN Physical
Aestheti NNP Physical
Plus NNP Physical
# # Physical
2 CD Physical
molds NNS Physical
. . None
All-Bond JJ Other
2 CD Other
( ( Other
TE3 NNP Other
) ) Other
+ VBP Other
resin JJ Other
cement NN Other
post NN Other
( ( Other
rcp NN Other
) ) Other
+ VBZ Other
Duo-link NNP Other
( ( Other
Dl NNP Other
) ) Other
; : None
One-Step JJ Other
Plus NNP Other
( ( Other
TE2 NNP Other
) ) Other
+ VBP Other
rcp JJ Other
+ NNP Other
Dl NNP Other
; : Other
Tyrian/One-Step JJ Other
Plus NNP Other
( ( Other
SE NNP Other
) ) Other
+ VBP Other
rcp JJ Other
+ NNP Other
Dl NNP Other
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

surgical JJ Surgical
adjuvant NN Surgical
chemotherapy NN Surgical
using VBG None
5-fluorouracil JJ Pharmocological
and CC Pharmocological
dl-leucovorin JJ Pharmocological
with IN Pharmocological
CDDP NNP Pharmocological
5-FU JJ Pharmocological
and CC Pharmocological
dl-leucovorin JJ Pharmocological
surgical JJ Surgical
adjuvant NN Surgical
chemotherapy NN Surgical
dl-leucovorin JJ Pharmocological
( ( Pharmocological
dl-LV JJ Pharmocological
) ) Pharmocological
and CC Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
( ( Pharmocological
FL-therapy NNP Pharmocological
) ) Pharmocological
with IN Pharmocological
CDDP NNP Pharmocological
, , Pharmocological
5-FU JJ Pharmocological
, , Pharmocological
and CC Pharmocological
dl-LV JJ Pharmocological
( ( Pharmocological
PFL-therapy NNP Pharmocological
) ) Pharmocological
CDDP NNP Pharmocological
5-FU JJ Pharmocological
dl-LV NN Pharmocological
5-FU JJ Pharmocological
dl-LV NN Pharmocological
dl-LV JJ Pharmocological
5-FU JJ Pharmocological
PFL-therapy NNP None
FL-therapy NNP None
surgical JJ Surgical
adjuvant NN Surgical
therapies NNS Surgical
-DOCSTART- -X- N

risperidone-associated JJ Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
-DOCSTART- -X- N

medroxyprogesterone NN Pharmocological
megestrol NN Pharmocological
Estrogen NNP Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
i.m NN None
. . None
injection NN None
of IN None
depot NN Pharmocological
MPA NNP Pharmocological
500 CD None
mg NN None
on IN None
days NNS None
1 CD None
, , None
14 CD None
and CC None
28 CD None
, , None
or CC None
oral JJ Pharmocological
megestrol NN Pharmocological
acetate VBP Pharmocological
40 CD None
mg JJ None
daily RB None
for IN None
6 CD None
weeks NNS None
. . None
MPA NN Pharmocological
: : None
megestrol NN Pharmocological
MPA NNP Pharmocological
megestrol NN Pharmocological
. . None
-DOCSTART- -X- N

Tolfenamic NNP Pharmocological
acid NN Pharmocological
and CC Pharmocological
caffeine NN Pharmocological
: : None
Tolfenamic NNP Pharmocological
acid NN Pharmocological
caffeine NN Pharmocological
, , None
metoclopramide NN Pharmocological
and CC None
pyridoxine NN Pharmocological
tolfenamic VB Pharmocological
acid NN Pharmocological
tolfenamic JJ Pharmocological
acid NN Pharmocological
either DT None
caffeine NN Pharmocological
metoclopramide RB Pharmocological
or CC None
pyridoxine NN Pharmocological
tolfenamic JJ Pharmocological
acid-caffeine JJ Pharmocological
combination NN Pharmocological
Metoclopramide NNP Pharmocological
pyridoxine NN Pharmocological
-DOCSTART- -X- N

Dexamethasone NNP Pharmocological
versus NN None
prednisone NN Pharmocological
intravenous JJ Pharmocological
mercaptopurine NN Pharmocological
Conventional NNP Pharmocological
therapy NN Pharmocological
prednisone NN Pharmocological
and CC None
oral JJ None
6-mercaptopurine JJ Pharmocological
. . None
dexamethasone NN Pharmocological
over IN None
prednisone NN Pharmocological
and CC None
for IN None
intravenous JJ Pharmocological
( ( Pharmocological
IV NNP Pharmocological
) ) Pharmocological
over IN None
oral JJ Pharmocological
6-mercaptopurine CD Pharmocological
dexamethasone NN Pharmocological
and CC None
IV NNP Pharmocological
6-mercaptopurine JJ Pharmocological
. . None
dexamethasone NN None
plus CC Other
taper NN Other
prednisone NN Pharmocological
IV NNP Pharmocological
6-mercaptopurine NN Pharmocological
oral JJ Pharmocological
6-mercaptopurine JJ Pharmocological
. . None
dexamethasone JJ Pharmocological
with IN Other
taper NN Other
. . None
Intrathecal NNP Pharmocological
( ( Pharmocological
IT NNP Pharmocological
) ) Pharmocological
methotrexate NN Pharmocological
dexamethasone NN Pharmocological
prednisone NN Pharmocological
dexamethasone NN Pharmocological
. . None
dexamethasone NN Pharmocological
prednisone NN Pharmocological
oral JJ Pharmocological
or CC Pharmocological
IV JJ Pharmocological
6-mercaptopurine JJ Pharmocological
; : None
IV NNP Pharmocological
6-mercaptopurine JJ Pharmocological
-DOCSTART- -X- N

whey JJ Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
whey JJ Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
immunized VBN Pharmocological
against IN Pharmocological
Clostridium NNP Pharmocological
difficile NN Pharmocological
( ( None
C. NNP None
difficile NN Pharmocological
) ) Pharmocological
and CC Pharmocological
its PRP$ Pharmocological
toxins NNS Pharmocological
, , Pharmocological
toxin NN Pharmocological
A NNP Pharmocological
and CC Pharmocological
toxin NN Pharmocological
B NNP Pharmocological
anti-C. JJ None
difficile NN Pharmocological
whey NN Pharmocological
protein VBP Pharmocological
concentrate NN Pharmocological
( ( Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
) ) Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
regular JJ Pharmocological
whey NN Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
anti-CD JJ Pharmocological
WPC NNP Pharmocological
-DOCSTART- -X- N

iron NN Pharmocological
Paracetamol NNP Pharmocological
iron NN Pharmocological
. . None
Paracetamol NNP Pharmocological
alone RB None
or CC None
( ( None
300 CD None
mg NN None
) ) None
ferrous JJ Pharmocological
sulphate NN Pharmocological
ferrous JJ Pharmocological
sulphate NN Pharmocological
and CC None
paracetamol NN Pharmocological
iron NN Pharmocological
and CC None
paracetamol JJ Pharmocological
-DOCSTART- -X- N

Breast NNP Surgical
reduction NN Surgical
reduction NN Surgical
mammaplasty NN Surgical
reduction NN Surgical
mammaplasty RB Surgical
mammaplasty NN Surgical
-DOCSTART- -X- N

ascorbic JJ Pharmocological
acid NN Pharmocological
. . None
placebo-controlled JJ Control
ascorbic JJ Pharmocological
acid NN Pharmocological
ascorbic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
, , None
chemotherapy NN Pharmocological
( ( Pharmocological
cyclophosphamide NN Pharmocological
) ) Pharmocological
and CC None
placebo JJ Control
treatment NN None
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
placebo NN Control
. . None
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
placebo NN Control
. . None
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
placebo NN Control
. . None
placebo NN Control
radiotherapy NN Physical
radiotherapy NN Physical
cyclophosphamide NN Pharmocological
radiotherapy NN Physical
-DOCSTART- -X- N

sumatriptan VB Pharmocological
5-HT JJ Pharmocological
1d CD Pharmocological
agonist NN Pharmocological
, , Pharmocological
sumatriptan NN Pharmocological
sumatriptan NN Pharmocological
placebo NN Control
sumatriptan VB Pharmocological
. . Pharmocological
5-HT JJ Pharmocological
1d CD Pharmocological
receptor NN Pharmocological
-DOCSTART- -X- N

treatment NN Pharmocological
as IN Pharmocological
usual JJ Pharmocological
control NN Control
treatment NN Control
Computer NNP Other
generated VBD Other
block NN Other
randomization NN Other
Stratified NNP None
block NN None
randomization NN None
-DOCSTART- -X- N

synbiotic JJ Pharmocological
formulation NN Pharmocological
containing VBG Pharmocological
Lactobacillus NNP Pharmocological
paracasei NN Pharmocological
B21060 NNP Pharmocological
plus CC Pharmocological
arabinogalactan JJ Pharmocological
and CC Pharmocological
xilooligosaccharides NNS Pharmocological
synbiotic JJ Pharmocological
formulation NN Pharmocological
containing VBG Pharmocological
Lactobacillus NNP Pharmocological
paracasei NN Pharmocological
B21060 NNP Pharmocological
, , Pharmocological
arabinogalactan NN Pharmocological
and CC Pharmocological
xilooligosaccharides NNS Pharmocological
placebo VB None
or CC None
synbiotic JJ None
group NN None
. . None
placebo VB Control
placebo VB Control
synbiotic JJ Pharmocological
formulation NN Pharmocological
-DOCSTART- -X- N

entacapone NN Pharmocological
Entacapone NNP Pharmocological
( ( Pharmocological
OR-611 NNP Pharmocological
) ) Pharmocological
, , None
a DT None
novel JJ Pharmocological
COMT NNP Pharmocological
inhibitor NN Pharmocological
levodopa/50 JJ Pharmocological
carbidopa NN Pharmocological
placebo NN Control
entacapone NN Pharmocological
. . None
-DOCSTART- -X- N

sterile JJ Pharmocological
water NN Pharmocological
injection NN Pharmocological
technique NN Pharmocological
sterile JJ Pharmocological
water NN Pharmocological
injections NNS Pharmocological
( ( Pharmocological
SWI NNP Pharmocological
) ) Pharmocological
SWI NNP Pharmocological
SWI NNP Pharmocological
intradermal JJ Pharmocological
needle JJ Pharmocological
SWI NNP Pharmocological
technique NN Pharmocological
. . None
intradermal JJ None
SWI NNP None
technique NN None
requesting VBG None
SWI NNP None
during IN None
-DOCSTART- -X- N

natural JJ Pharmocological
beta-carotene JJ Pharmocological
beta-carotene JJ Pharmocological
preparation NN Pharmocological
beta-carotene-rich JJ Pharmocological
algae NN Pharmocological
60 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
the DT Pharmocological
beta-carotene JJ Pharmocological
preparation NN Pharmocological
-DOCSTART- -X- N

Defibrotide NNP Pharmocological
calcium NN Pharmocological
heparin NN Pharmocological
Defibrotide NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
b.i.d NN Pharmocological
. . None
i.v NN Pharmocological
. . None
in IN Pharmocological
50 CD Pharmocological
ml JJ Pharmocological
phleboclysis NN Pharmocological
in IN Pharmocological
5 CD Pharmocological
minutes NNS Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
108 CD Pharmocological
) ) Pharmocological
; : None
2 CD None
) ) None
calcium NN Pharmocological
heparin NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
5000 CD Pharmocological
IU NNP Pharmocological
t.i.d NN Pharmocological
. . Pharmocological
subcutaneously RB Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
103 CD Pharmocological
) ) Pharmocological
The DT Control
treatment NN Control
began VBD Control
the DT Control
day NN Control
before IN Control
operation NN Control
and CC Control
continued VBN Control
on IN Control
average NN Control
up RB Control
to TO Control
the DT Control
eighth JJ Control
day NN Control
for IN Control
the DT Control
Defibrotide NNP Control
group NN Control
. . None
Defibrotide NNP Pharmocological
Defibrotide NNP Pharmocological
Defibrotide VB Pharmocological
-DOCSTART- -X- N

remaxol NN Pharmocological
remaxol JJ Pharmocological
infusion NN Pharmocological
solution NN Pharmocological
remaxol NNS Pharmocological
placebo NN Control
. . None
remaxol NN Pharmocological
vs NN None
placebo NN Control
remaxol JJ Pharmocological
-DOCSTART- -X- N

Virtual NNP Educational
Dolphinarium NNP Educational
virtual JJ Educational
reality NN Educational
( ( Educational
VR NNP Educational
) ) Educational
technology NN Educational
applications NNS Educational
Dolphin-assisted JJ Psychological
therapy NN Psychological
Virtual NNP Educational
Dolphinarium NNP Educational
Immersive JJ Educational
visualization NN Educational
gesture-based JJ Educational
interaction NN Educational
the DT None
virtual JJ None
dolphin NN None
interaction NN None
. . None
-DOCSTART- -X- N

Unpleasant NNP Educational
, , Educational
pleasant NN Educational
, , Educational
and CC Educational
neutral JJ Educational
words NNS Educational
were VBD Educational
randomly RB Educational
presented VBN Educational
to TO Educational
one CD Educational
in IN Educational
which WDT Educational
they PRP Educational
decided VBD Educational
whether IN Educational
a DT Educational
letter NN Educational
string NN Educational
was VBD Educational
a DT Educational
word NN Educational
or CC Educational
a DT Educational
non-word JJ Educational
( ( Educational
lexical JJ Educational
decision NN Educational
) ) Educational
and CC Educational
two CD Educational
affective JJ Educational
classification NN Educational
tasks NNS Educational
neutral NN Educational
or CC Educational
unpleasant JJ Educational
neutral NN Educational
or CC Educational
pleasant NN Educational
. . None
-DOCSTART- -X- N

ME-609 NNP Pharmocological
ME-609 NNP Pharmocological
( ( Pharmocological
Xerese JJ Pharmocological
, , Pharmocological
Xerclear NNP Pharmocological
) ) Pharmocological
acyclovir NN Pharmocological
hydrocortisone NN Pharmocological
randomized VBN Pharmocological
to TO Pharmocological
self-initiate JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
ME-609 NNP Pharmocological
, , None
5 CD Pharmocological
% NN Pharmocological
acyclovir NN Pharmocological
in IN Pharmocological
ME-609 NNP Pharmocological
vehicle NN Pharmocological
, , None
or CC None
ME-609 JJ Physical
vehicle NN Physical
( ( Physical
placebo NN Physical
) ) Physical
at IN None
the DT None
earliest JJS None
sign NN None
of IN None
a DT None
cold JJ None
sore NN None
recurrence NN None
. . None
Cream NNP Pharmocological
was VBD Pharmocological
applied VBN Pharmocological
5 CD Pharmocological
times/d NN Pharmocological
for IN Pharmocological
5 CD Pharmocological
days NNS Pharmocological
. . None
ME-609 NNP Pharmocological
acyclovir FW Pharmocological
placebo NN Control
acyclovir NN Pharmocological
in IN Pharmocological
ME-609 NNP Pharmocological
vehicle NN Pharmocological
-DOCSTART- -X- N

of IN None
nonintensive JJ None
parent NN None
training VBG None
plus CC None
care-as-usual JJ None
and CC None
care-as-usual JJ None
alone NN None
. . None
The DT None
training NN None
focused VBD None
on IN None
stimulating VBG None
joint JJ None
attention NN None
and CC None
language NN None
skills NNS None
and CC None
was VBD None
based VBN None
on IN None
the DT None
intervention NN None
described VBN None
by IN None
Drew NNP None
et CC None
al NN None
. . None
-DOCSTART- -X- N

Primary JJ Surgical
deep JJ Surgical
sclerectomy NN Surgical
primary JJ Surgical
deep JJ Surgical
sclerectomy NN Surgical
with IN Surgical
the DT Surgical
use NN Surgical
of IN Surgical
mitomycin NN Surgical
C NNP Surgical
deep JJ Surgical
sclerectomy NN Surgical
without IN Surgical
the DT Surgical
use NN Surgical
of IN Surgical
mitomycin NN Surgical
C NNP Surgical
( ( Surgical
DS NNP Surgical
group NN Surgical
) ) Surgical
and CC None
deep JJ Surgical
sclerectomy NN Surgical
with IN Surgical
the DT Surgical
application NN Surgical
of IN Surgical
mitomycin NN Surgical
C NNP Surgical
( ( Surgical
DSMMC NNP Surgical
group NN Surgical
) ) Surgical
-DOCSTART- -X- N

Continuous NNP Pharmocological
infusion NN Pharmocological
of IN Pharmocological
ranitidine NN Pharmocological
at IN Pharmocological
6.25 CD Pharmocological
mg/hr NN Pharmocological
( ( None
n JJ None
= NNP None
9 CD None
) ) None
or CC None
placebo NN Control
( ( None
n JJ None
= NNP None
11 CD None
) ) None
for IN None
a DT None
maximum NN None
of IN None
5 CD None
days NNS None
. . None
ranitidine NN Pharmocological
placebo VB Control
ranitidine NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

cardiac JJ Surgical
transplantation NN Surgical
cardiac JJ Surgical
transplantation NN Surgical
-DOCSTART- -X- N

imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
curettage VB Surgical
electrodesiccation NN Physical
Curettage NNP Surgical
and CC None
electrodesiccation NN Physical
( ( None
C NNP Physical
& CC Physical
D NNP Physical
) ) None
imiquimod NN Pharmocological
C NNP Surgical
& CC Surgical
D NNP Surgical
C NNP Physical
& CC Physical
D NNP Physical
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
or CC None
vehicle NN Pharmocological
cream NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
. . None
imiquimod JJ Pharmocological
vehicle NN Control
imiquimod NN Pharmocological
Imiquimod NNP Pharmocological
C NNP Surgical
& CC Surgical
D NNP Surgical
C NNP Surgical
& CC Surgical
D NNP Surgical
imiquimod JJ Pharmocological
adjunctive JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

enalapril NN Pharmocological
enalapril NN Pharmocological
Enalapril NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

nicardipine NN Pharmocological
propranolol NN Pharmocological
nicardipine JJ Pharmocological
propranolol JJ Pharmocological
nicardipine NN Pharmocological
propranolol NN Pharmocological
nicardipine NN Pharmocological
propranolol NN Pharmocological
nicardipine NN Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
-DOCSTART- -X- N

postoperative JJ Surgical
CEA NNP Surgical
clearance NN Surgical
tumor NN Surgical
resection NN Surgical
postoperative JJ Surgical
pattern NN Surgical
of IN Surgical
CEA NNP Surgical
clearance NN Surgical
-DOCSTART- -X- N

ondansetron NN Pharmocological
droperidol NN Pharmocological
perphenazine NN Pharmocological
metoclopramide RB Pharmocological
ondansetron NN Pharmocological
droperidol NN Pharmocological
perphenazine NN Pharmocological
metoclopramide NN Pharmocological
ondansetron NN Pharmocological
droperidol VBZ Pharmocological
perphenazine VBP Pharmocological
metoclopramide RB Pharmocological
placebo RB Control
metoclopramide NN Pharmocological
-DOCSTART- -X- N

randomized VBN None
to TO None
one CD None
of IN None
two CD None
groups NNS None
: : None
group NN None
1 CD None
, , None
forced VBN Pharmocological
diuresis NN Pharmocological
and CC None
chemotherapy NN Pharmocological
( ( None
10 CD None
patients NNS None
) ) None
, , None
and CC None
group NN None
2 CD None
, , None
forced VBN Pharmocological
diuresis NN Pharmocological
, , None
chemotherapy NN Pharmocological
, , None
and CC None
plasmapheresis NN Physical
( ( None
11 CD None
patients NNS None
) ) None
. . None
-DOCSTART- -X- N

granulocyte-macrophage NN Pharmocological
colony-stimulating NN Pharmocological
factor NN Pharmocological
( ( None
GM-CSF NNP Pharmocological
) ) None
Zidovudine NNP None
was VBD None
discontinued VBN None
in IN None
group NN None
A NNP None
patients NNS None
before IN None
instituting VBG None
GM-CSF NNP Pharmocological
treatment NN Pharmocological
and CC None
was VBD None
restarted VBN None
in IN None
a DT None
graduated JJ None
fashion NN None
over IN None
4 CD None
weeks NNS None
. . None
Group NNP None
B NNP None
patients NNS None
continued VBD None
on IN None
full-dose JJ Pharmocological
( ( Pharmocological
1,200 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
zidovudine NN Pharmocological
therapy NN Pharmocological
while IN Pharmocological
beginning VBG Pharmocological
GM-CSF NNP Pharmocological
therapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Combined VBN Other
delivery NN Other
approach NN Other
bone NN Physical
marrow NN Physical
mononuclear JJ Physical
stem NN Physical
cells NNS Physical
early RB Physical
bone-marrow-derived JJ Physical
stem NN Physical
cell NN Physical
therapy NN Physical
stem NN Physical
cells NNS Physical
cardiac JJ Surgical
stem NN Surgical
cell NN Surgical
delivery NN Surgical
-DOCSTART- -X- N

one-time JJ Educational
e-mail JJ Educational
reminder NN Educational
highlighting VBG Educational
six CD Educational
HF-specific JJ Educational
clinical JJ Educational
recommendations NNS Educational
. . None
initial JJ Educational
e-mail JJ Educational
reminder NN Educational
supplemented VBN Educational
by IN Educational
provider NN Educational
prompts NNS Educational
, , Educational
patient JJ Educational
education NN Educational
material NN Educational
, , Educational
and CC Educational
clinical JJ Educational
nurse NN Educational
specialist NN Educational
outreach NN Educational
. . None
-DOCSTART- -X- N

anesthesia NN Physical
periprostatic JJ Physical
nerve NN Physical
block NN Physical
or CC None
no DT Physical
anesthesia NN Physical
. . None
Patients NNS None
were VBD None
evaluated VBN None
for IN None
the DT None
, , None
and CC None
symptoms NNS Physical
and CC Physical
signs NNS Physical
of IN Physical
anesthesia NN Physical
-DOCSTART- -X- N

Epigastric JJ Physical
impedance NN Physical
epigastric JJ Physical
impedance NN Physical
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone VB Pharmocological
or CC None
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
-DOCSTART- -X- N

Immunotherapy NNP Pharmocological
BCG NNP Pharmocological
chemotherapy NN Control
alone RB Control
chemotherapy JJ None
plus CC None
Bacille NNP None
Calmette-Gu?rin NNP None
vaccine NN None
( ( None
BCG NNP None
) ) None
of IN None
BCG NNP None
-DOCSTART- -X- N

liu NN Pharmocological
wei NN Pharmocological
di NN Pharmocological
huang NN Pharmocological
jin NN Pharmocological
gui NN Pharmocological
shen NN Pharmocological
qi JJ Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
Liu NNP Pharmocological
Wei NNP Pharmocological
Di NNP Pharmocological
Huang NNP Pharmocological
Jin NNP Pharmocological
Gui NNP Pharmocological
Shen NNP Pharmocological
Qi NNP Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Chinese JJ Pharmocological
herb NN Pharmocological
Chinese JJ Pharmocological
Kidney-tonifying NNP Pharmocological
decoction NN Pharmocological
-DOCSTART- -X- N

dopamine NN Pharmocological
dopamine NN Pharmocological
dopamine NN Pharmocological
bumetanide NN Pharmocological
dopamine NN Pharmocological
dopamine NN Pharmocological
-DOCSTART- -X- N

behavioral JJ Psychological
treatment NN Psychological
modified JJ Psychological
behavioral JJ Psychological
treatment NN Psychological
single-session NN Psychological
modified VBD Psychological
behavioral JJ Psychological
treatment NN Psychological
( ( Psychological
SSBT NNP Psychological
) ) Psychological
designed VBN None
to TO None
enhance VB None
sense NN None
of IN None
control NN None
over IN None
or CC None
waiting VBG Educational
list NN Educational
control NN Educational
condition NN Educational
( ( Educational
WL NNP Educational
) ) Educational
. . None
SSBT NNP Pharmocological
behavioral JJ Psychological
treatment NN Psychological
-DOCSTART- -X- N

posterior JJ Physical
tibial JJ Physical
nerve NN Physical
stimulation NN Physical
posterior JJ None
tibial JJ None
nerve NN None
stimulation NN None
posterior JJ None
tibial JJ None
nerve NN None
stimulation NN None
placebo NN None
Posterior NNP None
tibial JJ None
nerve NN None
stimulation NN None
-DOCSTART- -X- N

selamectin NN Pharmocological
selamectin NN Pharmocological
selamectin NN Pharmocological
selamectin VBP Pharmocological
selamectin NN Pharmocological
fenthion NN Pharmocological
pyrethrins NNS Pharmocological
Selamectin NNP Pharmocological
selamectin-treated JJ Pharmocological
Selamectin NNP Pharmocological
selamectin NN None
ivermectin NN Pharmocological
Selamectin NNP None
Selamectin NNP None
selamectin NN None
Selamectin NNP None
-DOCSTART- -X- N

ipsilateral JJ Physical
backward NN Physical
arm NN Physical
swing NN Physical
ipsilateral JJ Physical
arm NN Physical
forward NN Physical
swing NN Physical
. . None
-DOCSTART- -X- N

sclerotherapy NN Surgical
staple JJ Surgical
transection NN Surgical
of IN Surgical
the DT Surgical
esophagus NN Surgical
undergo VB Surgical
either DT Surgical
emergency NN Surgical
sclerotherapy NN Surgical
( ( None
n JJ None
= NNP None
50 CD None
) ) None
or CC None
staple JJ Surgical
transection NN Surgical
of IN Surgical
the DT Surgical
esophagus NN Surgical
( ( None
n JJ None
= NNP None
51 CD None
) ) None
sclerotherapy VB Surgical
sclerotherapy VB Surgical
sclerotherapy VB Surgical
sclerotherapy NN Surgical
sclerotherapy NN Surgical
-DOCSTART- -X- N

cetamolol NN Pharmocological
: : None
placebo-controlled JJ Control
cetamolol JJ Pharmocological
hydrochloride NN Pharmocological
placebo JJ Control
cetamolol JJ Pharmocological
5-10-15 JJ None
mg/d NN None
cetamolol JJ Pharmocological
15-25-50 JJ Pharmocological
mg/d NN Pharmocological
placebo NN Control
low-dose JJ Pharmocological
high-dose JJ Pharmocological
placebo NN Control
cetamolol NN Pharmocological
-DOCSTART- -X- N

atenolol NN Pharmocological
, , None
labetalol NN Pharmocological
, , None
metoprolol NN Pharmocological
and CC None
pindolol NN Pharmocological
. . None
( ( None
atenolol JJ Pharmocological
labetalol VBZ Pharmocological
metoprolol PRP Pharmocological
pindolol VB Pharmocological
. . None
. . None
-DOCSTART- -X- N

Bridge NNP Surgical
plate NN Surgical
osteosynthesis NN Surgical
using VBG None
dynamic JJ Surgical
condylar JJ Surgical
screw NN Surgical
( ( Surgical
DCS NNP Surgical
) ) Surgical
or CC None
retrograde VBN Surgical
intramedullary JJ Surgical
supracondylar JJ Surgical
nail NN Surgical
( ( Surgical
RIMSN NNP Surgical
) ) Surgical
-DOCSTART- -X- N

off-pump JJ Surgical
versus NN None
on-pump JJ Surgical
bypass NN Surgical
surgery NN Surgical
: : None
off-pump JJ Surgical
or CC None
on-pump JJ Surgical
techniques NNS None
off-pump JJ Surgical
on-pump JJ Surgical
off-pump JJ Surgical
on-pump JJ Surgical
off-pump NN Surgical
off-pump NN Surgical
on-pump JJ Surgical
off-pump JJ Surgical
on-pump JJ Surgical
-DOCSTART- -X- N

Befriending NNP Educational
Volunteer NNP Educational
befriending NN Educational
befriending VBG Educational
-DOCSTART- -X- N

glibenclamide NN Pharmocological
6 CD Pharmocological
minutes NNS Pharmocological
after IN Pharmocological
glucagon NN Pharmocological
( ( None
1 CD None
mg NN None
given VBN None
intravenously RB None
) ) None
after IN None
4 CD None
and CC None
6 CD None
months NNS None
of IN None
successive JJ None
periods NNS None
of IN None
treatment NN None
with IN None
insulin NN Pharmocological
and CC Pharmocological
oral JJ Pharmocological
hypoglycaemics NNS Pharmocological
( ( Pharmocological
glibenclamide NN Pharmocological
and CC Pharmocological
metformin NN Pharmocological
) ) Pharmocological
glibenclamide NN Pharmocological
-DOCSTART- -X- N

Antifibrinolytic JJ Pharmocological
therapy NN Pharmocological
antifibrinolytic JJ Pharmocological
drug NN Pharmocological
tranexemic JJ Pharmocological
acid NN Pharmocological
saline NN Pharmocological
tranexemic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

breast NN Educational
self-examination NN Educational
( ( Educational
BSE NNP Educational
) ) Educational
Program NNP Educational
BSE NNP Educational
BSE NNP Educational
-DOCSTART- -X- N

Paracetamol NNP Pharmocological
by IN Surgical
the DT Surgical
transaxillary JJ Surgical
approach NN Surgical
. . None
intravenous JJ Pharmocological
paracetamol NN Pharmocological
robot-assisted JJ Surgical
endoscopic JJ Surgical
thyroidectomy NN Surgical
transaxillary JJ Surgical
approach NN Surgical
. . None
placebo-controlled JJ Control
placebo NNS Control
paracetamol NN Pharmocological
anesthesia NN Pharmocological
paracetamol NN Pharmocological
placebo NN Control
paracetamol NN Pharmocological
placebo NN Control
placebo NN Control
paracetamol NN Pharmocological
intravenous JJ Pharmocological
paracetamol NN Pharmocological
-DOCSTART- -X- N

atorvastatin NN Pharmocological
Atorvastatin NNP Pharmocological
atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
-DOCSTART- -X- N

[ JJ None
Intra-arterial JJ Pharmocological
( ( Pharmocological
5-FU/FA JJ Pharmocological
and CC Physical
FUDR NNP Pharmocological
) ) Physical
versus VBP None
systemic JJ Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
5-FU/FA JJ Pharmocological
) ) Pharmocological
HAI NNP Pharmocological
FUDR NNP Pharmocological
, , Physical
HAI NNP Pharmocological
5-FU/FA CD Pharmocological
, , Physical
and CC Physical
i.v NN Physical
. . Physical
5-FU/FA JJ None
chemotherapy NN None
HAI NNP Pharmocological
HAI NNP Pharmocological
FUDR NNP Pharmocological
HAI NNP Pharmocological
5-FU/FA JJ Pharmocological
. . Pharmocological
5-FU/FA-therapy NN Pharmocological
-DOCSTART- -X- N

surgical JJ Surgical
technique NN Surgical
subtotal JJ Surgical
and CC Surgical
bilateral JJ Surgical
thyroidectomy NN Surgical
surgical JJ Surgical
technique NN Surgical
bilateral JJ Surgical
strumectomies NNS Surgical
surgical JJ Surgical
techniques NNS Surgical
-DOCSTART- -X- N

Oxytocin NNP Pharmocological
infusion NN Pharmocological
oxytocin NN Pharmocological
oxytocin NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

Vitamin NNP Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
vitamin VB Pharmocological
D NNP Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
vitamin NN None
D NNP None
serum JJ Pharmocological
25-hydroxyvitamin JJ Pharmocological
D NNP Pharmocological
placebo-controlled JJ Control
vitamin NN Pharmocological
D NNP Pharmocological
placebo VB Control
) ) None
vitamin NN None
D? NNP None
increasing VBG None
vitamin NN None
D? NNP None
dose NN None
vitamin NN None
D? NNP None
recommendations NNS None
for IN None
vitamin NN None
D NNP None
-DOCSTART- -X- N

Self-management JJ Educational
improvement NN Educational
program NN Educational
combined VBN Educational
with IN Educational
community NN Educational
involvement NN Educational
program NN Educational
that WDT Educational
utilizes VBZ Educational
community NN Educational
involvement NN Educational
self-management JJ Educational
strategies NNS Educational
experimental JJ Educational
group NN Educational
control NN Control
group NN Control
program NN Educational
to TO Educational
improve VB Educational
self-management JJ Educational
methods NNS Educational
based VBN Educational
on IN Educational
social JJ Educational
cognitive JJ Educational
theory NN Educational
( ( Educational
SCT NNP Educational
) ) Educational
. . None
group NN Educational
meetings NNS Educational
home NN Educational
visit NN Educational
monitoring NN Educational
social JJ Educational
cognitive JJ Educational
theory NN Educational
( ( Educational
SCT NNP Educational
) ) Educational
self-management JJ Educational
techniques NNS Educational
-DOCSTART- -X- N

features NNS Educational
and CC Educational
outcomes NNS Educational
of IN Educational
therapy NN Educational
in IN Educational
these DT Educational
children NNS Educational
were VBD Educational
compared VBN Educational
by IN Educational
age NN Educational
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
lornoxicam NN Pharmocological
and CC None
aspirin NN Pharmocological
lornoxicam NN Pharmocological
lornoxicam NN Pharmocological
aspirin JJ Pharmocological
650 CD Pharmocological
placebo NN Control
. . None
Lornoxicam NNP Pharmocological
lornoxicam NN Pharmocological
aspirin VB Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
dactinomycin NN Pharmocological
( ( Pharmocological
Actinomycin NNP Pharmocological
D NNP Pharmocological
[ NNP Pharmocological
AMD NNP Pharmocological
] NNP Pharmocological
vincristine NN Pharmocological
( ( Pharmocological
VCR NNP Pharmocological
) ) Pharmocological
AMD NNP Pharmocological
+ NNP Pharmocological
VCR NNP Pharmocological
+/- JJ Pharmocological
Adriamycin NNP Pharmocological
( ( Pharmocological
ADR NNP Pharmocological
postoperative JJ Physical
radiation NN Physical
therapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
AMD NNP Pharmocological
+ NNP Pharmocological
VCR NNP Pharmocological
+ NNP Pharmocological
ADR NNP Pharmocological
+/- JJ Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
CPM NNP Pharmocological
) ) Pharmocological
. . None
CPM NNP Pharmocological
-DOCSTART- -X- N

Physical JJ Educational
activity NN Educational
physical JJ Educational
activity NN Educational
physical JJ Educational
activity NN Educational
physical JJ Educational
activity NN Educational
increase VB Educational
activity NN Educational
levels NNS Educational
-DOCSTART- -X- N

conventional JJ Pharmocological
therapy NN Pharmocological
with IN Pharmocological
digoxin NN Pharmocological
, , Pharmocological
diuretic JJ Pharmocological
drugs NNS Pharmocological
and CC Pharmocological
a DT Pharmocological
converting VBG Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
-DOCSTART- -X- N

TOM NNP Other
test NN Other
: : None
TOM NNP Other
test NN Other
TOM NNP Other
test NN Other
. . None
TOM NNP Other
test NN Other
-DOCSTART- -X- N

received VBD None
etanercept IN None
with IN None
etanercept-treated JJ None
( ( None
with IN None
and CC None
without IN None
methotrexate NN None
) ) None
patients NNS None
-DOCSTART- -X- N

gemcitabine NN Pharmocological
S-1 NNP Pharmocological
gemcitabine NN None
S-1 NNP None
S-1 NNP Pharmocological
gemcitabine NN Pharmocological
gemcitabine NN Pharmocological
S-1 NNP Pharmocological
-DOCSTART- -X- N

folic JJ Pharmocological
acid-containing JJ Pharmocological
multivitamin NN Pharmocological
supplementation NN Pharmocological
mg NN None
) ) None
-containing VBG Pharmocological
multivitamin JJ Pharmocological
supplementation NN Pharmocological
carbamazepine NN Pharmocological
and CC Pharmocological
a DT Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
mg NN None
) ) None
-containing VBG Pharmocological
multivitamin NN Pharmocological
-DOCSTART- -X- N

trimethoprim-sulfamethoxazole JJ Pharmocological
or CC None
aerosolized JJ Pharmocological
pentamidine NN Pharmocological
treated VBN None
with IN None
zidovudine NN Pharmocological
receive VB None
either RB None
800 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
sulfamethoxazole NN Pharmocological
and CC Pharmocological
160 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
trimethoprim JJ Pharmocological
once JJ None
daily JJ None
or CC None
300 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
aerosolized JJ Pharmocological
pentamidine NN Pharmocological
administered VBN None
every DT None
four CD None
weeks NNS None
by IN None
jet NN Pharmocological
nebulizer NN Pharmocological
. . None
trimethoprim-sulfamethoxazole JJ Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
pentamidine NN Pharmocological
pentamidine NN Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
pentamidine NN Pharmocological
, , None
trimethoprim-sulfamethoxazole JJ Pharmocological
aerosolized JJ Pharmocological
pentamidine NN Pharmocological
-DOCSTART- -X- N

bendrofluazide NN Pharmocological
, , None
bumetanide NN Pharmocological
and CC None
xipamide NNP Pharmocological
. . None
daily JJ None
dose NN None
of IN None
5 CD Pharmocological
mg NNS Pharmocological
bendrofluazide RB Pharmocological
, , None
1 CD Pharmocological
mg NN Pharmocological
bumetanide NN Pharmocological
and CC None
40 CD Pharmocological
mg NN Pharmocological
xipamide NN Pharmocological
. . None
bumetanide NN Pharmocological
. . None
-DOCSTART- -X- N

Dairy NN Other
products NNS Other
dairy NN Pharmocological
calcium NN Pharmocological
dairy NN Pharmocological
calcium NN Pharmocological
control NN Physical
: : Physical
continue NN Physical
established VBD Physical
dietary JJ Physical
intake NN Physical
; : None
medium NN None
dairy NN None
: : None
substitute NN None
dairy NN None
products NNS None
to TO None
achieve VB None
intake NN Pharmocological
of IN Pharmocological
calcium NN Pharmocological
of IN Pharmocological
approximately RB Pharmocological
1000-1100 JJ Pharmocological
mg/d NN Pharmocological
and CC None
maintain VB None
isocaloric JJ Pharmocological
intake NN Pharmocological
; : None
high JJ None
dairy NN None
: : None
substitute NN None
dairy NN None
products NNS None
to TO None
achieve VB None
intake NN Pharmocological
of IN Pharmocological
calcium NN Pharmocological
of IN Pharmocological
1300-1400 JJ Pharmocological
mg/d NN Pharmocological
and CC None
maintain VB None
isocaloric JJ Pharmocological
intake NN Pharmocological
. . None
dairy NN Pharmocological
products NNS Pharmocological
-DOCSTART- -X- N

succinylcholine NN Pharmocological
rocuronium NN Pharmocological
succinylcholine NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
mg RB Pharmocological
kg-1 NN Pharmocological
) ) Pharmocological
and CC Pharmocological
two CD Pharmocological
doses NNS Pharmocological
of IN Pharmocological
rocuronium NN Pharmocological
( ( Pharmocological
0.6 CD Pharmocological
and CC Pharmocological
0.9 CD Pharmocological
mg JJ Pharmocological
kg-1 NN Pharmocological
) ) Pharmocological
electromyography NN Other
( ( Other
EMG NNP Other
) ) Other
and CC Other
acceleromyography NN Other
electromyographic JJ Other
method NN Other
rocuronium NN Pharmocological
rocuronium $ Pharmocological
rocuronium NN Pharmocological
rocuronium NN Pharmocological
succinylcholine NN Pharmocological
-DOCSTART- -X- N

and CC Surgical
blood NN Physical
collected VBN Physical
before IN Physical
anesthesia NN Physical
CPB NNP Surgical
ELISA NNP None
. . None
CPB NNP Surgical
-DOCSTART- -X- N

L-arginine NNP Pharmocological
L-arginine NNP Pharmocological
two CD None
groups NNS None
according VBG None
to TO None
different JJ None
ovarian JJ None
stimulation NN None
protocols NNS None
: : None
( ( None
i NN None
) ) None
flare-up JJ Pharmocological
gonadotrophin-releasing JJ Pharmocological
hormone NN Pharmocological
analogue NN Pharmocological
( ( Pharmocological
GnRHa NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
elevated JJ Pharmocological
pure NN Pharmocological
follicle NN Pharmocological
stimulating VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
pFSH NN Pharmocological
) ) Pharmocological
( ( None
n JJ None
= NNP None
17 CD None
) ) None
; : None
and CC None
( ( None
ii NN None
) ) None
flare-up NN Pharmocological
GnRHa NNP Pharmocological
plus CC Pharmocological
elevated VBN Pharmocological
pFSH JJ Pharmocological
plus CC Pharmocological
oral JJ Pharmocological
L-arginine NNP Pharmocological
( ( None
n JJ None
= NNP None
17 CD None
) ) None
. . None
the DT None
patients NNS None
were VBD None
submitted VBN None
to TO None
hormonal VB None
( ( None
oestradiol NN None
and CC None
growth NN None
hormone NN None
) ) None
, , None
ultrasonographic JJ Physical
( ( None
follicular JJ None
number NN None
and CC None
diameter NN None
, , None
endometrial JJ None
thickness NN None
) ) None
and CC None
Doppler NNP None
( ( None
uterine JJ None
and CC None
perifollicular JJ None
arteries NNS None
) ) None
evaluations NNS None
. . None
L-arginine NNP Pharmocological
L-arginine NNP Pharmocological
L-arginine JJ Pharmocological
-DOCSTART- -X- N

preadmission NN Educational
telephone NN Educational
intervention NN Educational
telephone NN Educational
intervention NN Educational
-DOCSTART- -X- N

cluster NN Educational
randomized VBN Educational
controlled VBN Educational
lifestyle JJ Educational
intervention NN Educational
lifestyle JJ Educational
programme NN Educational
health NN Educational
intervention NN Educational
programme NN Educational
health NN Educational
interventions NNS Educational
-DOCSTART- -X- N

triggered VBN None
and CC None
conventional JJ Physical
fast JJ Physical
rate NN Physical
ventilation NN Physical
conventional JJ None
or CC None
trigger JJ Pharmocological
ventilation NN Pharmocological
with IN None
the DT None
SLE NNP Pharmocological
2000 CD Pharmocological
ventilator NN Pharmocological
. . None
-DOCSTART- -X- N

Placebo-controlled JJ Control
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide IN Pharmocological
whitening VBG Pharmocological
strips NNS Pharmocological
. . None
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide IN Pharmocological
whitening VBG Pharmocological
strips NNS Pharmocological
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide JJ Pharmocological
strips NNS Pharmocological
or CC Pharmocological
placebo VB Pharmocological
strips NNS Pharmocological
. . Pharmocological
6 CD Pharmocological
% NN Pharmocological
strip NN Pharmocological
placebo NN Control
6 CD Pharmocological
% NN Pharmocological
strip NN Pharmocological
placebo NN Control
strip NN Control
6 CD Pharmocological
% NN Pharmocological
strip NN Pharmocological
placebo NN Control
6 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide IN Pharmocological
whitening VBG Pharmocological
strips NNS Pharmocological
placebo JJ Control
strips NNS Control
. . None
-DOCSTART- -X- N

very RB Physical
low JJ Physical
level NN Physical
exercise NN Physical
. . None
supine JJ Physical
exercise NN Physical
-DOCSTART- -X- N

Clozapine NNP Pharmocological
versus NN None
placebo NN Control
clozapine NN Pharmocological
clozapine NN Pharmocological
or CC None
placebo NN Control
Clozapine NNP Pharmocological
Clozapine NNP Pharmocological
Clozapine NNP Pharmocological
clozapine NN Pharmocological
-DOCSTART- -X- N

Transcutaneous JJ None
electrical JJ None
nerve NN None
stimulation NN None
Transcutaneous JJ Control
electrical JJ Control
nerve NN Control
stimulation NN Control
( ( Control
TENS NNP Control
) ) Control
placebo-controlled JJ None
-DOCSTART- -X- N

Clonidine NNP Pharmocological
clonidine NN Pharmocological
clonidine NN Pharmocological
or CC None
flunitrazepam NN Pharmocological
insulin NN Pharmocological
clonidine NN Pharmocological
clonidine JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
porcine NN Pharmocological
secretin NN Pharmocological
secretin JJ Pharmocological
secretin NN Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
placebo-controlled JJ Control
secretin JJ Pharmocological
-DOCSTART- -X- N

corticosteroid NN Pharmocological
methylprednisolone NN Pharmocological
( ( None
30 CD None
-DOCSTART- -X- N

fuzheng NN Pharmocological
yiliu NN Pharmocological
granule NN Pharmocological
Fuzheng NNP Pharmocological
Yiliu NNP Pharmocological
Granule NNP Pharmocological
( ( Pharmocological
FZYLG NNP Pharmocological
) ) Pharmocological
FZYLG NNP Pharmocological
FZYLG NNP Pharmocological
-DOCSTART- -X- N

cefixime NN Pharmocological
ceftriaxone NN Pharmocological
ceftriaxone NN Pharmocological
400 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
800 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
cefixime NN Pharmocological
, , None
administered VBN Educational
orally RB Educational
, , None
and CC None
250 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
ceftriaxone NN Pharmocological
cefixime NN Pharmocological
cefixime NN Pharmocological
ceftriaxone NN Pharmocological
cefixime NN Pharmocological
ceftriaxone NN Pharmocological
-DOCSTART- -X- N

tirofiban VB Pharmocological
or CC None
abciximab VB Pharmocological
. . None
-DOCSTART- -X- N

vancomycin NN Pharmocological
vancomycin NN Pharmocological
vancomycin NN Pharmocological
vancomycin NN Pharmocological
-DOCSTART- -X- N

cytotoxic NN Pharmocological
chemotherapy NN Pharmocological
with IN None
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
and CC Pharmocological
etoposide NN Pharmocological
second JJ Pharmocological
line NN Pharmocological
chemotherapy NN Pharmocological
( ( None
methotrexate NN Pharmocological
and CC Pharmocological
doxorubicin NN Pharmocological
) ) None
or CC None
symptomatic JJ None
treatment NN None
only RB None
. . None
-DOCSTART- -X- N

external JJ Physical
beam NN Physical
radiotherapy NN Physical
cryoablation NN Physical
external JJ Physical
beam NN Physical
radiation NN Physical
therapy NN Physical
( ( Physical
EBRT NNP Physical
) ) Physical
external JJ Physical
beam NN Physical
EBRT NNP Physical
cryoablation NN Physical
or CC None
EBRT NNP Physical
neoadjuvant JJ Pharmocological
antiandrogen NN Pharmocological
EBRT NNP Physical
cryoablation NN Physical
cryoablation NN Physical
cryoablation NN Physical
cryoablation NN Physical
. . None
EBRT NNP Physical
cryoablation NN Physical
. . None
-DOCSTART- -X- N

acetaminophen NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
acetaminophen NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
without IN Educational
nurse JJ Educational
coaching NN Educational
; : None
with IN None
coaching NN Educational
. . None
-DOCSTART- -X- N

Pethidine NNP Pharmocological
versus NN Pharmocological
tramadol NN Pharmocological
tramadol NN Pharmocological
pethidine NN Pharmocological
pethidine VBP Pharmocological
; : Pharmocological
tramadol NN Pharmocological
pethidine NN Pharmocological
tramadol JJ Pharmocological
tramadol NN Pharmocological
Pethidine NNP Pharmocological
tramadol NN Pharmocological
-DOCSTART- -X- N

adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
regimen NNS Pharmocological
of IN Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
no DT Pharmocological
adjuvant JJ Pharmocological
treatment NN Pharmocological
or CC None
intravenous JJ Pharmocological
adriamycin NNS Pharmocological
vincristine VBP Pharmocological
cyclophosphamide RB Pharmocological
methotrexate VB Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
AVCMF NNP Pharmocological
) ) Pharmocological
AVCMF NNP Pharmocological
-DOCSTART- -X- N

field NN Physical
, , Physical
total JJ Physical
lymphoid NN Physical
, , Physical
or CC Physical
whole JJ Physical
body NN Physical
irradiation NN Physical
, , None
single JJ Pharmocological
alkylating VBG Pharmocological
agent NN Pharmocological
chemotherapy NN Pharmocological
, , None
combination NN Pharmocological
chemotherapy NN Pharmocological
with IN Pharmocological
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
CVP NNP Pharmocological
) ) Pharmocological
or CC None
with IN None
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
procarbazine NN Pharmocological
, , Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
( ( Pharmocological
C-MOPP NNP Pharmocological
) ) Pharmocological
, , None
or CC None
various JJ None
combinations NNS None
of IN None
chemotherapy NN Pharmocological
and CC None
irradiation NN Physical
. . None
-DOCSTART- -X- N

exclusive JJ Educational
breastfeeding NN Educational
breastfeeding VBG Educational
24-hour JJ Educational
hotline NN Educational
and CC Educational
postpartum NN Educational
support NN Educational
film NN Educational
multiple JJ None
logistic JJ None
regression NN None
analysis NN None
breastfeeding NN Educational
-DOCSTART- -X- N

efavirenz JJ Pharmocological
ACTG NNP Pharmocological
368 CD Pharmocological
abacavir NN Pharmocological
( ( Pharmocological
ABC NNP Pharmocological
) ) Pharmocological
efavirenz NN None
( ( None
EFV NNP None
) ) None
indinavir NN Pharmocological
( ( Pharmocological
IDV NNP Pharmocological
) ) None
placebo-controlled JJ Control
EFV NNP Pharmocological
plus CC Pharmocological
indinavir NN Pharmocological
( ( Pharmocological
EFV+IDV NNP Pharmocological
) ) Pharmocological
vs. FW Pharmocological
EFV+IDV NNP Pharmocological
plus CC Pharmocological
abacavir NN Pharmocological
( ( Pharmocological
ABC NNP Pharmocological
) ) Pharmocological
EFV-HS NNP Pharmocological
EFV-HS NNP Pharmocological
HIV NNP Pharmocological
-DOCSTART- -X- N

Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
Zostavax NNP Pharmocological
-DOCSTART- -X- N

primary JJ Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

linezolid NNS Pharmocological
linezolid NN Pharmocological
placebo-controlled JJ Control
linezolid VBD Pharmocological
or CC None
placebo VB Control
linezolid JJ Pharmocological
. . Pharmocological
Linezolid NNP Pharmocological
linezolid JJ Pharmocological
linezolid JJ Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

unexpected JJ Physical
forward NN Physical
perturbations NNS Physical
( ( Physical
FP NNP Physical
) ) Physical
FP NNP Physical
FP NNP Physical
. . Physical
-DOCSTART- -X- N

ranitidine NN Pharmocological
ranitidine NN Pharmocological
triazolam NN Pharmocological
0.25-mg JJ Pharmocological
triazolam NN Pharmocological
tablet NN Pharmocological
after IN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
ranitidine NN Pharmocological
; : None
0.25-mg JJ Pharmocological
triazolam NN Pharmocological
tablet NN Pharmocological
, , Pharmocological
with IN Pharmocological
no DT Pharmocological
ranitidine JJ Pharmocological
pretreatment NN Pharmocological
; : None
0.25-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
triazolam NN Pharmocological
after IN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
ranitidine NN Pharmocological
; : None
0.25-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
triazolam NN Pharmocological
, , Pharmocological
with IN Pharmocological
no DT Pharmocological
ranitidine NN Pharmocological
pretreatment NN Pharmocological
. . None
Ranitidine NNP Pharmocological
triazolam NN Pharmocological
ranitidine NN Pharmocological
Ranitidine NNP Pharmocological
Ranitidine JJ Pharmocological
-DOCSTART- -X- N

Lumbar NNP Physical
puncture NN Physical
-DOCSTART- -X- N

Chlorhexidine-based JJ Pharmocological
antiseptic JJ Pharmocological
solution NN Pharmocological
alcohol-based JJ Pharmocological
povidone-iodine NN Pharmocological
chlorhexidine-based JJ Pharmocological
solutions NNS Pharmocological
alcohol-based JJ Pharmocological
povidone-iodine NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
povidone-iodine NN Pharmocological
in IN Pharmocological
70 CD Pharmocological
% NN Pharmocological
ethanol NN Pharmocological
or CC Pharmocological
with IN Pharmocological
a DT Pharmocological
combination NN Pharmocological
of IN Pharmocological
0.25 CD Pharmocological
% NN Pharmocological
chlorhexidine NN Pharmocological
gluconate NN Pharmocological
, , Pharmocological
0.025 CD Pharmocological
% NN Pharmocological
benzalkonium NN Pharmocological
chloride NN Pharmocological
, , Pharmocological
and CC Pharmocological
4 CD Pharmocological
% NN Pharmocological
benzylic JJ Pharmocological
alcohol NN Pharmocological
. . Pharmocological
povidone-iodine NN Pharmocological
chlorhexidine-based JJ Pharmocological
solution NN Pharmocological
povidone-iodine NN Pharmocological
Chlorhexidine-based JJ Pharmocological
solutions NNS Pharmocological
povidone-iodine NN Pharmocological
( ( Pharmocological
including VBG Pharmocological
alcohol-based VBN Pharmocological
) ) Pharmocological
formulations NNS Pharmocological
-DOCSTART- -X- N

limited JJ Surgical
palmar NN Surgical
incision NN Surgical
vs IN None
traditional JJ Physical
open JJ Physical
technique NN Physical
: : None
limited JJ Surgical
palmar NN Surgical
incision NN Surgical
for IN Physical
carpal JJ Surgical
tunnel NN Surgical
release NN Surgical
( ( Surgical
CTR NNP Surgical
) ) Surgical
with IN None
a DT None
traditional JJ Physical
open JJ Physical
technique NN Physical
Limited NNP Surgical
palmar NN Surgical
incision NN Surgical
CTR NNP Surgical
traditional JJ Physical
CTR NNP Physical
technique NN Physical
-DOCSTART- -X- N

Polydioxanone NNP Surgical
sternal JJ Surgical
sutures NNS Surgical
polydioxanone NN Surgical
( ( Surgical
PDS NNP Surgical
) ) Surgical
suture NN Surgical
PDS NNP Surgical
stainless JJ Other
steel NN Other
PDS NNP Surgical
PDS NNP Surgical
PDS NNP Surgical
-DOCSTART- -X- N

intravenous JJ Control
nitroglycerin JJ Control
plus CC Control
placebo JJ Control
nitroglycerin JJ Pharmocological
plus CC Pharmocological
N-acetylcysteine JJ Pharmocological
N-acetylcysteine NN Pharmocological
nitroglycerin NN Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
microgram/kg NN Pharmocological
per IN Pharmocological
min NN Pharmocological
) ) Pharmocological
combined VBN None
with IN None
N-acetylcysteine NNP Pharmocological
placebo NN Control
N-acetylcysteine NNP Pharmocological
and CC Pharmocological
nitroglycerin RB Pharmocological
( ( None
nitroglycerin JJ Pharmocological
plus CC Pharmocological
N-acetylcysteine JJ Pharmocological
nitroglycerin CC Control
plus CC Control
placebo NN Control
N-acetylcysteine NNP Pharmocological
( ( None
nitroglycerin JJ Pharmocological
plus CC Pharmocological
N-acetylcysteine JJ Pharmocological
: : None
nitroglycerin JJ Pharmocological
plus CC Pharmocological
placebo NN Pharmocological
: : None
nitroglycerin JJ Pharmocological
and CC Pharmocological
N-acetylcysteine JJ Pharmocological
N-acetylcysteine NNP Pharmocological
nitroglycerin NN Pharmocological
-DOCSTART- -X- N

choice NN Educational
assessment NN Educational
A DT Educational
choice NN Educational
assessment NN Educational
choice NN Educational
assessment NN Educational
concurrent NN Educational
operants VBZ Educational
paradigm JJ Educational
. . None
choice NN Educational
assessment NN Educational
-DOCSTART- -X- N

Interferon NNP None
treatment NN None
IFN NNP Pharmocological
IFN NNP Pharmocological
IFN NNP Pharmocological
pentostatin NN Pharmocological
) ) Pharmocological
interferon VB Pharmocological
interferon NN Pharmocological
. . None
interferon NN Pharmocological
IFN NNP Pharmocological
pentostatin NN Pharmocological
2-chlorodeoxyadenosine JJ Pharmocological
( ( Pharmocological
2-CdA JJ Pharmocological
) ) Pharmocological
. . Pharmocological
interferon NN Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

resting NN Physical
state NN Physical
fMRI NN Physical
study NN Physical
and CC Physical
were VBD Physical
scanned VBN Physical
during IN Physical
two CD Physical
separate JJ Physical
sessions NNS Physical
while IN Physical
receiving VBG Physical
a DT Physical
placebo NN Control
or CC Physical
nicotine JJ Pharmocological
patch NN Pharmocological
, , Pharmocological
in IN Physical
a DT Physical
randomized JJ Physical
, , Physical
cross-over JJ Physical
design NN Physical
. . None
-DOCSTART- -X- N

propofol NN Pharmocological
propofol NN Pharmocological
Propofol NNP Pharmocological
-DOCSTART- -X- N

liberal JJ None
versus NN None
restrictive JJ None
guidelines NNS None
for IN None
red JJ None
blood NN None
cell NN None
transfusion NN None
restrictive JJ None
guidelines NNS None
for IN None
red JJ None
blood NN None
cell NN None
( ( None
RBC NNP None
) ) None
transfusions NNS None
liberal- NN Physical
or CC Physical
the DT Physical
restrictive-transfusion NN Physical
restrictive-transfusion NN None
restrictive-transfusion NN None
transfusion NN None
restrictive JJ None
RBC-transfusion NNP None
restrictive JJ None
transfusions NNS None
-DOCSTART- -X- N

montelukast NN Pharmocological
montelukast NN Pharmocological
, , Pharmocological
a DT Pharmocological
cysteinyl JJ Pharmocological
leukotriene NN Pharmocological
receptor NN Pharmocological
antagonist NN Pharmocological
placebo- JJ Control
placebo JJ Control
montelukast JJ Pharmocological
loratadine JJ Pharmocological
or CC None
placebo NN Control
Montelukast NNP Pharmocological
placebo NN Control
montelukast NN Pharmocological
Loratadine NNP Pharmocological
montelukast NN Pharmocological
loratadine NN Pharmocological
montelukast NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

lexical JJ Educational
decision NN Educational
target NN Educational
word NN Educational
visual JJ Educational
display NN Educational
on IN Educational
a DT Educational
computer NN Educational
screen NN Educational
while IN Educational
listening VBG Educational
to TO Educational
a DT Educational
concurrent JJ Educational
auditory NN Educational
input NN Educational
. . None
-DOCSTART- -X- N

training NN Educational
live JJ Educational
workshop NN Educational
training NN Educational
video NN Educational
training NN Educational
condition NN Educational
video-trained JJ Educational
Video-trained JJ Educational
-DOCSTART- -X- N

Shouldice NNP None
, , None
Lichtenstein NNP None
transabdominal JJ Surgical
preperitoneal NN Surgical
( ( Surgical
TAPP NNP Surgical
) ) Surgical
hernia NN Surgical
repair NN Surgical
Shouldice NNP None
, , None
tension-free JJ None
Lichtenstein NNP None
or CC None
laparoscopic JJ Surgical
TAPP NNP Surgical
repair NN Surgical
. . None
-DOCSTART- -X- N

Stilboestrol NNP Pharmocological
Cyproterone NNP Pharmocological
acetate NN Pharmocological
Medroxyprogesterone NNP Pharmocological
acetate NN Pharmocological
Stilboestrol NNP Pharmocological
Estracyt NNP Pharmocological
Stilboestrol NNP Pharmocological
Adriamycin NNP Pharmocological
Procarbazine NNP Pharmocological
Procarbazine NNP Pharmocological
-DOCSTART- -X- N

sevelamer NN Pharmocological
hydrochloride NN Pharmocological
and CC Pharmocological
calcium NN Pharmocological
carbonate NN Pharmocological
sevelamer JJ Pharmocological
hydrochloride NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
calcium JJ Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
CC NNP Pharmocological
) ) Pharmocological
CC NNP Pharmocological
to TO Pharmocological
sevelamer VB Pharmocological
group NN Pharmocological
A NNP Pharmocological
, , Pharmocological
sevelamer NN Pharmocological
6.0 CD Pharmocological
g/day NN Pharmocological
; : Pharmocological
group NN Pharmocological
B NNP Pharmocological
, , Pharmocological
sevelamer VBD Pharmocological
3.0 CD Pharmocological
g/day NN Pharmocological
and CC Pharmocological
CC NNP Pharmocological
3.0 CD Pharmocological
g/day NN Pharmocological
; : Pharmocological
group NN Pharmocological
C NNP Pharmocological
, , Pharmocological
CC NNP Pharmocological
3.0 CD Pharmocological
g/day NN Pharmocological
. . Pharmocological
sevelamer VB Pharmocological
. . None
sevelamer JJ Pharmocological
-DOCSTART- -X- N

IFN NNP Pharmocological
alpha-N1 JJ Pharmocological
IFN NNP Pharmocological
i.m NN Pharmocological
. . Pharmocological
alpha-2a JJ Pharmocological
IFN NNP Pharmocological
i.m NN Pharmocological
. . Pharmocological
2 CD Pharmocological
alpha-2a JJ Pharmocological
IFN NNP Pharmocological
courses NNS None
-DOCSTART- -X- N

Magnocellular JJ Other
visual JJ Other
, , None
motion NN Other
processing NN Other
and CC None
visual JJ Other
pathway NN Other
integrity NN Other
. . None
-DOCSTART- -X- N

Diet NNP Physical
data NNS Other
sets NNS Other
of IN Other
the DT Other
DCCT NNP Other
-DOCSTART- -X- N

hypnotherapy NN Psychological
systematic JJ Other
relaxation NN Other
experimental JJ Educational
hypnosis NN Educational
group NN Educational
, , Educational
the DT Physical
comparison NN Other
relaxation NN Other
group NN Other
, , None
and CC None
the DT None
waiting VBG Control
list NN Control
control NN Control
group NN Control
. . None
hypnosis NN Psychological
-DOCSTART- -X- N

nifedipine NN Pharmocological
nifedipine NN Pharmocological
Nifedipine CC Pharmocological
pentagastrin NN Pharmocological
-- : None
that WDT None
pentagastrin JJ Pharmocological
Nifedipine NNP Pharmocological
-DOCSTART- -X- N

amlodipine NN Pharmocological
and CC None
enalapril NN Pharmocological
amlodipine NN Pharmocological
and CC Pharmocological
enalapril NN Pharmocological
placebo-controlled JJ Control
placebo NNS Control
amlodipine VB Pharmocological
or CC Pharmocological
enalapril JJ Pharmocological
placebo NN None
enalapril NN Pharmocological
and CC None
amlodipine NN Pharmocological
. . None
Enalapril NNP Pharmocological
Amlodipine NNP Pharmocological
amlodipine NN Pharmocological
enalapril JJ Pharmocological
amlodipine NN Pharmocological
enalapril JJ Pharmocological
enalapril NN Pharmocological
amlodipine NN Pharmocological
amlodipine VB Pharmocological
-DOCSTART- -X- N

growth NN Pharmocological
hormone NN Pharmocological
releasing VBG Pharmocological
hormone CD Pharmocological
administration NN None
growth NN Pharmocological
hormone NN Pharmocological
GHRH NNP Pharmocological
( ( None
1 CD None
microgram/kg RB None
iv NN None
) ) None
or CC None
TRH NNP Pharmocological
( ( None
400 CD None
microgram RB None
iv NN None
) ) None
GHRH-induced JJ Pharmocological
placebo NN Control
GHRH-stimulated JJ Pharmocological
TRH-stimulated NNP Pharmocological
-DOCSTART- -X- N

haloperidol NN Pharmocological
placebo-controlled JJ Control
haloperidol JJ Pharmocological
Haloperidol NNP Pharmocological
haloperidol NN Pharmocological
placebo NN None
. . None
-DOCSTART- -X- N

augmented JJ Physical
sensorimotor NN Physical
input NN Physical
manually RB Physical
guided VBN Physical
-DOCSTART- -X- N

Adjvant NNP Pharmocological
treatment NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
years NNS Pharmocological
( ( Pharmocological
methotrexate VB Pharmocological
400 CD Pharmocological
mg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
citrovorum NN Pharmocological
factor NN Pharmocological
100 CD Pharmocological
mg NN Pharmocological
+ NNP Pharmocological
bleomycin VBZ Pharmocological
60 CD Pharmocological
mg/week NN Pharmocological
, , Pharmocological
during IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
15 CD Pharmocological
weeks NNS Pharmocological
) ) Pharmocological
, , None
during IN None
2 CD None
years NNS None
, , None
while IN None
the DT None
did VBD Control
not RB Control
receive VB Control
any DT Control
treatment NN Control
. . None
adjuvant JJ Pharmocological
adjuvant JJ Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

, , Educational
newly RB Educational
familiar JJ Educational
faces VBZ Educational
novel JJ Educational
faces VBZ Educational
-DOCSTART- -X- N

heparinized VBN Pharmocological
and CC Pharmocological
nonheparinized JJ Pharmocological
solutions NNS Pharmocological
heparinized VBN Pharmocological
and CC Pharmocological
nonheparinized VBN Pharmocological
infusions NNS Pharmocological
2 CD None
groups NNS None
to TO None
receive VB None
heparinized VBN Pharmocological
( ( None
group NN None
H NNP None
, , None
n JJ None
= NNP None
100 CD None
) ) None
or CC None
nonheparinized VBN Pharmocological
( ( None
group NN None
S NNP None
, , None
n JJ None
= NNP None
100 CD None
) ) None
flush NN Pharmocological
solutions NNS Pharmocological
. . None
were VBD Physical
assessed VBN Physical
using VBG Physical
before IN Physical
, , Physical
just RB Physical
after IN Physical
, , Physical
and CC Physical
24 CD Physical
h NN Physical
after IN Physical
by IN Physical
the DT Physical
same JJ Physical
investigator NN Physical
. . Physical
heparinized VBN Pharmocological
and CC Pharmocological
nonheparinized VBN Pharmocological
flush JJ Pharmocological
solutions NNS Pharmocological
-DOCSTART- -X- N

Intravenous JJ Pharmocological
magnesium NN Pharmocological
sulfate NN Pharmocological
intravenous JJ Pharmocological
Magnesium NNP Pharmocological
sulfate NN Pharmocological
( ( Pharmocological
i.v JJ Pharmocological
. . Pharmocological
MgSO4 NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
MgSO4 NNP Pharmocological
received VBD Pharmocological
0.2 CD Pharmocological
ml/kg NN Pharmocological
of IN Pharmocological
50 CD Pharmocological
% NN Pharmocological
MgSO4 NNP Pharmocological
as IN Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
i.v JJ Pharmocological
. . Pharmocological
) ) Pharmocological
infusion NN Pharmocological
placebo NN Control
normal JJ Pharmocological
saline JJ Pharmocological
infusion NN Pharmocological
MgSO4 NNP Pharmocological
solution NN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
oxygen NN Pharmocological
, , Pharmocological
nebulized JJ Pharmocological
salbutamol NN Pharmocological
, , Pharmocological
i.v NN Pharmocological
. . Pharmocological
aminophylline NN Pharmocological
corticosteroids NNS Pharmocological
. . Pharmocological
MgSO4 NNP Pharmocological
placebo VB Control
MgSO4 NNP Pharmocological
MgSO4 NNP Pharmocological
conventional JJ Physical
therapy NN Physical
-DOCSTART- -X- N

temporal JJ Educational
outcome NN Educational
temporal JJ Psychological
expectation NN Psychological
task NN Psychological
Videos NNP Psychological
representing VBG Psychological
movements NNS Psychological
-DOCSTART- -X- N

Propofol NNP Pharmocological
and CC None
midazolam NNP Pharmocological
i.v NN None
. . None
propofol NN Pharmocological
and CC None
midazolam NN Pharmocological
propofol NN Pharmocological
and CC None
midazolam VB Pharmocological
alone RB None
and CC None
in IN None
combination NN None
. . None
midazolam NN Pharmocological
propofol NN Pharmocological
midazolam NN Pharmocological
-DOCSTART- -X- N

socio-demographic JJ Physical
factors NNS Physical
participation NN Physical
in IN Physical
oral JJ Physical
visual JJ Physical
inspection NN Physical
intervention NN Physical
population-based JJ Physical
oral JJ Physical
screening NN Physical
patient-provider JJ Educational
communication NN Educational
-DOCSTART- -X- N

surgery NN Surgical
: : None
glucose RB Pharmocological
parenteral JJ Pharmocological
nutrition NN Pharmocological
glucose NN Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
glucose JJ Pharmocological
isotope NN Pharmocological
infusion NN Pharmocological
fasting VBG Physical
amino NN Pharmocological
acids NNS Pharmocological
, , None
Travasol NNP None
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
glucose JJ Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
amino JJ None
acids NNS None
and CC None
glucose VB None
amino JJ Pharmocological
acids NNS Pharmocological
and CC None
glucose VB Pharmocological
amino JJ Pharmocological
acids NNS Pharmocological
glucose JJ Pharmocological
glucose NN Pharmocological
amino NN Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

early JJ Educational
intensification NN Educational
: : None
different JJ Physical
central JJ Physical
nervous JJ Physical
system NN Physical
( ( Physical
CNS NNP Physical
) ) Physical
directed VBD Physical
therapies NNS Physical
. . None
-DOCSTART- -X- N

personalized VBN Educational
feedback NN Educational
Web-based JJ Educational
screening NN Educational
and CC None
brief JJ Educational
interventions NNS Educational
laboratory-based JJ Educational
computerized JJ Educational
intervention NN Educational
. . Educational
Intervention NNP None
( ( None
Alcohol NNP None
Feedback NNP None
vs. IN None
Control NNP None
) ) None
?2 FW None
Assessment NNP None
( ( None
Motivational NNP None
Assessment NNP None
vs. IN None
No NNP None
Motivational NNP None
Assessment NNP None
) ) None
between-subjects NNS None
that IN None
a DT None
feedback-based JJ None
computerized JJ None
intervention NN None
that WDT None
-DOCSTART- -X- N

paliperidone NN Pharmocological
paliperidone NN Pharmocological
paliperidone NN Pharmocological
risperidone NN Pharmocological
Paliperidone NNP None
-DOCSTART- -X- N

citalopram NN Pharmocological
citalopram NN Pharmocological
citalopram JJ Pharmocological
-DOCSTART- -X- N

Basics NNS None
computer-assisted JJ Educational
intervention NN Educational
Computer NNP Educational
Assisted NNP Educational
Instruction NNP Educational
( ( Educational
CAI NNP Educational
) ) Educational
CAI NNP Educational
TeachTown NN Educational
: : Educational
Basics NNS Educational
, , Educational
a DT Educational
CAI NNP Educational
program NN Educational
which WDT Educational
also RB Educational
includes VBZ Educational
supplementary JJ Educational
off-computer NN Educational
activities NNS Educational
computer NN Educational
20 CD Educational
minutes NNS Educational
per IN Educational
day NN Educational
in IN Educational
supplementary JJ Educational
TeachTown NN Educational
: : Educational
Basics JJ Educational
activities NNS Educational
. . Educational
CAI NNP Other
CAI NNP Educational
-DOCSTART- -X- N

endotracheal NN Pharmocological
and CC Pharmocological
peripheral JJ Pharmocological
intravenous JJ Pharmocological
adrenaline NN Pharmocological
adrenaline NN Pharmocological
and CC None
noradrenaline NN Pharmocological
. . None
adrenaline NN Pharmocological
adrenaline JJ Pharmocological
-DOCSTART- -X- N

Magnesium NN Pharmocological
sulphate NN Pharmocological
Hypothermia NNP Physical
Magnesium NNP Pharmocological
magnesium NN Pharmocological
control NN Control
magnesium NN Pharmocological
Lactated VBN Pharmocological
Ringer NNP Pharmocological
's POS Pharmocological
solution NN Pharmocological
Magnesium NNP Pharmocological
magnesium NN Pharmocological
Magnesium NNP Pharmocological
-DOCSTART- -X- N

alexithymia NN Other
alexithymia NN Other
-DOCSTART- -X- N

Diamox NNP Pharmocological
Sustets NNP Pharmocological
( ( Pharmocological
acetazolamide RB Pharmocological
) ) Pharmocological
peroperative JJ Pharmocological
intracameral JJ Pharmocological
Miochol NNP Pharmocological
( ( Pharmocological
acetylcholine NN Pharmocological
) ) Pharmocological
treatments NNS Control
combined VBN Control
acetazolamide IN Pharmocological
acetylcholine NN Pharmocological
acetylcholine NN Pharmocological
acetazolamide NN Pharmocological
acetylcholine NN Pharmocological
acetazolamide NN Pharmocological
acetazolamide IN Pharmocological
acetylcholine NN Pharmocological
acetylcholine NN Pharmocological
acetazolamide NN Pharmocological
combined JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

Lansoprazole NNP Pharmocological
, , None
omeprazole JJ Pharmocological
MUPS NNP Pharmocological
and CC None
esomeprazole NN Pharmocological
lansoprazole JJ Pharmocological
mgomeprazole JJ Pharmocological
esomeprazole JJ Pharmocological
. . None
omeprazole NN Pharmocological
lansoprazole JJ Pharmocological
omeprazole NN Pharmocological
. . None
esomeprazole NN Pharmocological
lansoprazole NN Pharmocological
esomeprazole NN Pharmocological
lansoprazole NN Pharmocological
-DOCSTART- -X- N

P-selectin NNP Pharmocological
blocking NN Pharmocological
agent NN Pharmocological
heparin NN Pharmocological
Pentosan NNP Pharmocological
Polysulfate NNP Pharmocological
Sodium NNP Pharmocological
( ( Pharmocological
PPS NNP Pharmocological
) ) Pharmocological
PPS NNP Pharmocological
PPS NNP Pharmocological
-DOCSTART- -X- N

torso NN Physical
weighting VBG Physical
balance-based JJ Physical
torso NN Physical
weighting NN Physical
( ( Physical
BBTW NNP Physical
) ) Physical
BBTW NNP Physical
BBTW NNP Physical
-DOCSTART- -X- N

Calcium NN Pharmocological
and CC Pharmocological
fibre JJ Pharmocological
supplementation NN Pharmocological
calcium NN Pharmocological
fibre JJ Pharmocological
diet JJ Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
calcium NN Pharmocological
and CC Pharmocological
fibre NN Pharmocological
calcium NN Other
gluconolactate NN Other
and CC Other
carbonate NN Other
( ( Other
2 CD Other
g NN Other
elemental JJ Other
calcium NN Other
daily RB Other
) ) Other
, , None
fibre JJ Other
( ( Other
3.5 CD Other
g NN Other
ispaghula NN Other
husk NN Other
) ) Other
, , None
or CC None
placebo NN Control
. . None
calcium NN None
calcium NN None
fibre JJ None
calcium NN None
fibre NN None
-DOCSTART- -X- N

social JJ Educational
treatment NN Educational
manualized VBN Educational
social JJ Educational
intervention NN Educational
treatment NN Educational
wait-list JJ Control
conditions NNS Control
. . Control
Treatment NNP None
instruction NN Educational
and CC Educational
therapeutic JJ Educational
activities NNS Educational
targeting VBG Educational
social JJ Educational
skills NNS Educational
, , Educational
face-emotion NN Educational
recognition NN Educational
, , Educational
interest NN Educational
expansion NN Educational
, , Educational
and CC Educational
interpretation NN Educational
of IN Educational
non-literal JJ Educational
language NN Educational
. . Educational
-DOCSTART- -X- N

DIR/Floortime? NNP None
parent NN None
training NN None
intervention NN None
adding VBG None
home-based JJ None
Developmental NNP None
, , None
Individual-Difference NNP None
, , None
Relationship-Based JJ None
( ( None
DIR NNP None
) ) None
/Floortime? VBZ None
intervention NN None
to TO None
added VBD None
home-based JJ None
DIR/Floortime? NNP None
intervention NN None
at IN None
an DT None
-DOCSTART- -X- N

local JJ Pharmocological
anesthesia NN Pharmocological
and CC Surgical
endometrial JJ Surgical
biopsy NN Surgical
with IN None
paracervical JJ Pharmocological
block NN Pharmocological
by IN Pharmocological
10 CD Pharmocological
mL NNS Pharmocological
of IN Pharmocological
1 CD Pharmocological
% NN Pharmocological
mepivacaine NN Pharmocological
hydrochloride JJ Pharmocological
solution NN Pharmocological
no DT Control
local JJ Control
anesthesia NN Control
Paracervical JJ Physical
anesthesia NN Physical
-DOCSTART- -X- N

Intensive JJ Educational
behavioral JJ Educational
treatment NN Educational
early JJ Educational
intensive JJ Educational
behavioral JJ Educational
treatment NN Educational
developed VBD Educational
at IN Educational
UCLA NNP Educational
, , None
that WDT Educational
received VBD Educational
intensive JJ Educational
hours NNS Educational
but CC Educational
less JJR Educational
supervision NN Educational
by IN Educational
equally RB Educational
well-trained JJ Educational
supervisors NNS Educational
. . None
-DOCSTART- -X- N

percutaneous JJ Surgical
transluminal JJ Surgical
angioplasty NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
angioplasty NN Surgical
( ( Surgical
PTA NNP Surgical
) ) Surgical
vasodilator NN None
, , None
glyceryl JJ Pharmocological
trinitrate NN Pharmocological
( ( Pharmocological
GTN NNP Pharmocological
) ) Pharmocological
balloon NN Physical
dilatation NN Physical
an DT Physical
intra-arterial JJ Physical
bolus NN Physical
of IN None
either CC None
150 CD Pharmocological
micrograms NNS Pharmocological
GTN NNP Pharmocological
, , None
with IN None
or CC None
without IN None
a DT None
10 CD None
mg NN None
GTN NNP Pharmocological
patch NN Pharmocological
for IN None
24 CD None
h NN None
, , None
or CC None
a DT None
saline JJ Control
placebo NN Control
saline JJ Control
GTN NNP Pharmocological
GTN NNP Pharmocological
GTN NNP Pharmocological
-DOCSTART- -X- N

repeat NN Surgical
sextant JJ Surgical
prostate NN Surgical
biopsy NN Surgical
radical JJ Surgical
prostatectomy NN Surgical
with IN None
or CC None
without IN None
neoadjuvant JJ Physical
hormonal JJ Physical
therapy NN Physical
. . None
-DOCSTART- -X- N

heparin NN Pharmocological
. . None
Heparin NNP Pharmocological
placebo-controlled JJ Control
trial NN Control
intravenous JJ Pharmocological
heparin NN Pharmocological
, , None
aspirin NN Pharmocological
, , None
both DT Educational
treatments NNS Educational
, , None
and CC None
neither RB None
heparin NN Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

pegged JJ Physical
trabecular JJ Physical
metal NN Physical
screw-fixed JJ Physical
pegged JJ Physical
porous JJ Physical
titanium NN Physical
fiber NN Physical
mesh NN Physical
: : None
high-porosity NN Surgical
trabecular JJ Surgical
metal NN Surgical
( ( Surgical
TM NNP Surgical
) ) Surgical
tibial JJ Surgical
components NNS Surgical
low-porosity JJ Surgical
titanium NN Surgical
pegged VBD Surgical
porous JJ Surgical
fiber-metal JJ Surgical
( ( Surgical
Ti NNP Surgical
) ) Surgical
polyethylene NN Surgical
metal JJ Surgical
backings NNS Surgical
. . Surgical
cementless JJ Surgical
tibial JJ Surgical
25 CD Surgical
TM NNP Surgical
tibial JJ Surgical
components NNS Surgical
were VBD Surgical
fixed VBN Surgical
press-fit JJ Surgical
by IN Surgical
2 CD None
hexagonal JJ None
pegs NN None
25 CD Surgical
Ti NNP Surgical
tibial JJ Surgical
components NNS Surgical
were VBD Surgical
fixed VBN Surgical
press-fit JJ Surgical
and CC Surgical
by IN Surgical
4 CD Surgical
supplemental JJ Surgical
screws NNS Surgical
Ti NNP Physical
components NNS None
TM NNP Physical
components NNS None
Ti NNP Physical
components NNS None
TM NNP None
tibial JJ None
components NNS None
Ti NNP Physical
tibial JJ None
components NNS None
TM NNP Physical
tibial JJ None
component NN None
. . None
-DOCSTART- -X- N

7-hexanoyltaxol-eluting JJ Surgical
stent NN Surgical
stent-based JJ Surgical
polymer NN Surgical
sleeve NN Surgical
delivering VBG None
7-hexanoyltaxol JJ Pharmocological
. . None
7-hexanoyltaxol JJ Surgical
( ( Surgical
QP2 NNP Surgical
) ) Surgical
-eluting VBG Surgical
stents NNS Surgical
( ( Surgical
qDES NN Surgical
) ) Surgical
with IN Surgical
bare NN Surgical
metal NN Surgical
stents NNS Surgical
( ( Surgical
BMS NNP Surgical
) ) Surgical
qDES NNS Surgical
BMS NNP Surgical
qDES RB Surgical
qDES NN Surgical
qDES NN Surgical
BMS NNP Surgical
. . None
7-hexanoyltaxol NNP Pharmocological
-DOCSTART- -X- N

Capsaicin NNP Pharmocological
jelly RB Pharmocological
Capsaicin NNP Pharmocological
Topical JJ Pharmocological
capsaicin NN Pharmocological
topical JJ Pharmocological
periarterial JJ Pharmocological
capsaicin NN Pharmocological
topical JJ Pharmocological
capsaicin NN Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
vaseline NN Pharmocological
jelly RB Pharmocological
Topical NNP Pharmocological
capsaicin NN Pharmocological
capsaicin NN Pharmocological
vaseline NN Control
. . None
topical JJ Pharmocological
capsaicin NN Pharmocological
capsacinoids NNS Pharmocological
-DOCSTART- -X- N

simvastatin NN Pharmocological
simvastatin NN Pharmocological
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

zengjing VBG None
no DT None
. . None
1 CD None
capsule NN None
Zengjing VBG Pharmocological
Capsule NNP Pharmocological
No NNP Pharmocological
. . Pharmocological
1 CD Pharmocological
( ( Pharmocological
ZJC1 NNP Pharmocological
) ) Pharmocological
ZJC1 NNP Pharmocological
Wuzi NNP Pharmocological
Yanzong NNP Pharmocological
Pill NNP Pharmocological
ZJC1 NNP Pharmocological
-DOCSTART- -X- N

regional JJ Pharmocological
chemotherapy NN Pharmocological
Adjuvant JJ Surgical
portal JJ Surgical
therapy NN Surgical
of IN Surgical
the DT Surgical
liver NN Surgical
with IN Surgical
resection NN Surgical
of IN Surgical
the DT Surgical
colorectal JJ Surgical
primary JJ Surgical
malignancy NN Surgical
curative JJ Surgical
resection NN Surgical
of IN Surgical
palliative JJ Pharmocological
local JJ Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

nifedipine NN Pharmocological
. . None
nifedipine JJ Pharmocological
real-time JJ Pharmocological
ST NNP Pharmocological
segment NN Pharmocological
depression NN Pharmocological
monitor NN Pharmocological
. . None
placebo NN Control
nifedipine NN Pharmocological
therapy NN Pharmocological
nifedipine JJ Pharmocological
Nifedipine NNP Pharmocological
therapy NN Pharmocological
( ( Pharmocological
immediate JJ Pharmocological
release NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

guanethidine JJ Pharmocological
3 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
and CC Pharmocological
adrenaline VB Pharmocological
0.5 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
( ( Pharmocological
Ganda NNP Pharmocological
3.0/0.5 CD Pharmocological
) ) Pharmocological
guanethidine $ Pharmocological
1 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
adrenaline VB Pharmocological
0.2 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
( ( None
Ganda NNP Pharmocological
1.0/0.2 CD Pharmocological
) ) None
Timolol NNP Pharmocological
( ( Pharmocological
Timoptol NNP Pharmocological
) ) Pharmocological
0.25 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
. . None
Ganda NNP Pharmocological
3.0/0.5 CD Pharmocological
Timolol NNP Pharmocological
0.25 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
Ganda NNP Pharmocological
1.0/0.2 CD Pharmocological
Timolol $ Pharmocological
0.25 CD Pharmocological
per IN Pharmocological
cent NN Pharmocological
-DOCSTART- -X- N

heparin NN Pharmocological
the DT None
low-dose JJ None
heparin NN None
group NN None
anticoagulant JJ None
heparin NN None
and CC None
the DT None
low-dose JJ None
heparin NN None
group NN None
the DT None
heparin-free JJ None
group NN None
MARS NNP None
was VBD None
the DT None
heparin-free JJ None
group NN None
the DT None
MARS NNP None
circuit NN None
before IN None
MARS NNP None
. . None
low JJ None
dose JJ None
heparin NN None
in IN None
MARS NNP None
improves VBZ None
while IN None
heparin-free JJ None
during IN None
-DOCSTART- -X- N

Blind NNP Surgical
versus NN Surgical
open JJ Surgical
approach NN Surgical
to TO Surgical
laparoscopic VB Surgical
cholecystectomy NN Surgical
: : Surgical
laparoscopic JJ Surgical
open JJ Surgical
laparoscopic NN Surgical
technique NN Surgical
blind JJ Physical
approach NN Physical
; : None
-DOCSTART- -X- N

Hysteroscopic NNP Surgical
transcervical JJ Surgical
endometrial JJ Surgical
resection NN Surgical
thermal JJ Surgical
destruction NN Surgical
transcervical JJ Surgical
hysteroscopic NN Surgical
endometrial JJ Surgical
resection NN Surgical
thermal JJ Surgical
destruction NN Surgical
transcervical JJ Surgical
hysteroscopic NN Surgical
endometrial JJ Surgical
resection NN Surgical
or CC None
to TO None
thermal JJ Surgical
destruction NN Surgical
of IN Surgical
the DT Surgical
endometrium NN Surgical
. . None
thermal JJ Surgical
destruction NN Surgical
transcervical JJ Surgical
hysteroscopic NN Surgical
endometrial JJ Surgical
resection NN Surgical
Thermal NNP Surgical
destruction NN Surgical
of IN Surgical
the DT Surgical
endometrium NN Surgical
-DOCSTART- -X- N

availability NN Educational
of IN Educational
information NN Educational
( ( Educational
not RB Educational
available JJ Educational
, , Educational
available JJ Educational
upon IN Educational
request NN Educational
, , Educational
available JJ Educational
automatically RB Educational
) ) None
-DOCSTART- -X- N

plafibride NN Pharmocological
N-2- NNP Pharmocological
( ( Pharmocological
p-chlorophenoxy JJ Pharmocological
) ) Pharmocological
-isobutyryl-N'-morpholinomethylurea NN Pharmocological
( ( Pharmocological
plafibride NN Pharmocological
, , Pharmocological
ITA NNP Pharmocological
104 CD Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Routine NNP Pharmocological
antibiotic JJ Pharmocological
use NN Pharmocological
routine JJ Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
routine JJ Pharmocological
antibiotics NNS Pharmocological
control NN Control
group NN Control
( ( None
no DT Pharmocological
antibiotics NNS Pharmocological
unless IN None
clinically RB None
indicated VBN None
) ) None
. . None
antibiotic JJ Pharmocological
-DOCSTART- -X- N

amifostine NN Pharmocological
amifostine NN Pharmocological
Amifostine NNP Pharmocological
radiochemotherapy NN Physical
. . None
Cytoprotection NN Pharmocological
amifostine NN Pharmocological
Amifostine NNP Pharmocological
amifostine NN Pharmocological
Amifostine NNP Pharmocological
-DOCSTART- -X- N

amantadine NN Pharmocological
. . None
Amantadine-sulfate NNP Pharmocological
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
TMS NNP Physical
) ) Physical
amantadine NN Pharmocological
placebo-controlled JJ Control
oral JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
50 CD Pharmocological
and CC Pharmocological
100 CD Pharmocological
mg NNS Pharmocological
amantadine VBP Pharmocological
with IN None
single JJ Pharmocological
and CC Pharmocological
paired JJ Pharmocological
pulse NN Pharmocological
TMS NNP Pharmocological
paradigms NN Pharmocological
. . None
amantadine NN Pharmocological
amantadine JJ Pharmocological
amantadine JJ Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
amantadine NN Pharmocological
-DOCSTART- -X- N

cyclophosphamide NN Pharmocological
low-dose JJ Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
CY NNP Pharmocological
) ) Pharmocological
conventional JJ None
chemotherapy JJ None
CY NNP Pharmocological
CY NNP Pharmocological
-DOCSTART- -X- N

corticosteroids NNS Pharmocological
. . Pharmocological
corticosteroid JJ Pharmocological
corticosteroid VB Pharmocological
corticosteroid JJ Pharmocological
-DOCSTART- -X- N

17 CD Pharmocological
alpha-hydroxyprogesterone JJ Pharmocological
caproate NN Pharmocological
. . None
17 CD Pharmocological
alpha-hydroxyprogesterone NN Pharmocological
caproate NN Pharmocological
, , None
250 CD None
mg NN None
by IN None
intramuscular JJ None
injection NN None
once RB None
a DT None
week NN None
, , None
or CC None
a DT None
placebo NN Control
control NN Control
progesterone NN Pharmocological
caproate NN Pharmocological
-DOCSTART- -X- N

dipeptidyl JJ Pharmocological
peptidase-4 JJ Pharmocological
inhibitor NN Pharmocological
vildagliptin NN Pharmocological
Dipeptidyl NNP Pharmocological
peptidase NN Pharmocological
4 CD Pharmocological
( ( Pharmocological
DPP-4 NNP Pharmocological
) ) Pharmocological
inhibitors NNS Pharmocological
DPP-4 NNP Pharmocological
inhibitors NNS Pharmocological
DPP-4 NNP Pharmocological
inhibitors NNS Pharmocological
placebo-controlled JJ Control
metformin NN Pharmocological
diet NN None
vildagliptin NN Pharmocological
placebo NN Control
metformin NN Pharmocological
diet JJ None
DPP-4 JJ Pharmocological
inhibitor NN Pharmocological
Vildagliptin NNP Pharmocological
-DOCSTART- -X- N

docosahexaenoic NN Pharmocological
acid NN Pharmocological
docosahexaenoic NN Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
DHA NNP Pharmocological
DHA NNP Pharmocological
placebo NN Control
. . None
placebo NN Control
DHA NNP Pharmocological
DHA NNP Pharmocological
-DOCSTART- -X- N

salvinorin NN Pharmocological
A NNP Pharmocological
Salvinorin VB Pharmocological
A DT Pharmocological
placebo NN Control
salvinorin NN Pharmocological
A NNP Pharmocological
salvinorin NN Pharmocological
A NNP Pharmocological
and CC None
4 CD None
intermixed JJ Control
placebo NN Control
Salvinorin CC None
A DT None
conditions NNS None
, , None
salvinorin VBP None
A DT None
-DOCSTART- -X- N

intramedullary JJ Surgical
nailing NN Surgical
of IN Surgical
the DT Surgical
femur NN Surgical
: : Surgical
intramedullary JJ None
nailing NN None
of IN None
the DT None
femur NN None
( ( Surgical
piriformis JJ Surgical
fossa NN Surgical
portal NN Surgical
) ) Surgical
( ( Surgical
trochanteric JJ Surgical
portal NN Surgical
) ) Surgical
intramedullary JJ None
nailing VBG None
intramedullary JJ Educational
nailing NN Educational
-DOCSTART- -X- N

vaccination NN Pharmocological
and CC None
of IN None
DHEA NNP Pharmocological
administration NN Pharmocological
vaccination NN Pharmocological
dehydroepiandrosterone NN Pharmocological
( ( Pharmocological
DHEA NNP Pharmocological
) ) Pharmocological
influenza VB Pharmocological
vaccine NN Pharmocological
DHEA NNP Pharmocological
placebo NN Control
. . Control
DHEA NNP Pharmocological
treatment NN Pharmocological
DHEA NNP Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

Aminocaproic NNP Pharmocological
acid VBZ Pharmocological
prednisone NN Pharmocological
aminocaproic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
Amicar NNP Pharmocological
) ) Pharmocological
systemic JJ Pharmocological
prednisone NN Pharmocological
oral JJ None
dosage NN None
of IN None
50 CD None
mg/kg NN None
of IN None
aminocaproic JJ Pharmocological
acid NN Pharmocological
oral JJ None
dosage NN None
of IN None
40 CD None
mg NN None
of IN None
prednisone JJ Pharmocological
daily JJ None
Placebo NNP Control
-DOCSTART- -X- N

clarithromycin NN Pharmocological
, , None
roxithromycin NN Pharmocological
and CC None
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
, , None
roxithromycin NN Pharmocological
and CC None
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
500 CD Pharmocological
mg NN Pharmocological
12-hourly RB Pharmocological
, , None
30 CD None
with IN None
roxithromycin NN Pharmocological
150 CD None
mg NN None
12-hourly JJ None
, , None
and CC None
27 CD None
with IN None
erythromycin JJ Pharmocological
stearate NN None
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
. . None
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
erythromycin JJ Pharmocological
stearate NN Pharmocological
clarithromycin NN Pharmocological
roxithromycin NN Pharmocological
-DOCSTART- -X- N

artemisinin-based JJ Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
rapid JJ Physical
diagnostic JJ Physical
tests NNS Physical
( ( Physical
RDTs NNP Physical
) ) Physical
microscopy VB Other
RDTs NNP None
-DOCSTART- -X- N

Combined VBN Physical
chemotherapy NN Physical
and CC Physical
radiotherapy NN Physical
radiotherapy NN Physical
alone RB Physical
combined JJ Physical
chemotherapy NN Physical
and CC Physical
radiation NN Physical
therapy NN Physical
fluorouracil NN Pharmocological
( ( Pharmocological
1000 CD Pharmocological
mg NN Pharmocological
per IN Pharmocological
square JJ Pharmocological
meter NN Pharmocological
of IN Pharmocological
body-surface JJ Pharmocological
area NN Pharmocological
daily RB Pharmocological
for IN Pharmocological
four CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
75 CD Pharmocological
mg NN Pharmocological
per IN Pharmocological
square JJ Pharmocological
meter NN Pharmocological
on IN Pharmocological
the DT Pharmocological
first JJ Pharmocological
day NN Pharmocological
) ) Pharmocological
plus CC Pharmocological
5000 CD Physical
cGy NN Physical
of IN Physical
radiation NN Physical
therapy NN Physical
6400 CD Physical
cGy NN Physical
of IN Physical
radiation NN Physical
therapy NN Physical
chemotherapy NN Physical
and CC Physical
radiation NN Physical
therapy NN Physical
. . None
combined VBN Physical
therapy NN Physical
Concurrent NNP Physical
therapy NN Physical
with IN Physical
cisplatin NN Physical
and CC Physical
fluorouracil NN Physical
and CC Physical
radiation NN Physical
radiation VB Physical
therapy NN Physical
-DOCSTART- -X- N

Oxytocin NNP Pharmocological
Oxytocin NNP Pharmocological
oxytocin JJ Pharmocological
Oxytocin NNP Pharmocological
and CC None
placebo NN Control
placebo NN Control
oxytocin NN Pharmocological
oxytocin NN Pharmocological
-DOCSTART- -X- N

chemoradiation NN Physical
therapy NN Physical
curative JJ Pharmocological
radical JJ Pharmocological
chemoradiation NN Pharmocological
therapy NN Pharmocological
. . None
radiation NN Physical
therapy NN Physical
moderate JJ Pharmocological
dose JJ Pharmocological
chemoradiation NN Pharmocological
therapy NN Pharmocological
Gy/20 NNP Pharmocological
weekly JJ Pharmocological
vinorelbine NN Pharmocological
25 CD Pharmocological
mg/m NN Pharmocological
+ NNP Pharmocological
cisplatin VBZ Pharmocological
Gy/15 NNP Pharmocological
weekly JJ Pharmocological
gemcitabine NN Pharmocological
200 CD Pharmocological
mg. NN Pharmocological
radiation NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

gaviscon JJ Pharmocological
preparation NN Pharmocological
Geviskon NNP Pharmocological
aluminum-magnesium JJ Pharmocological
antacids NNS Pharmocological
alginate JJ Pharmocological
product NN Pharmocological
-- : Pharmocological
Geviskon NNP Pharmocological
forte VBP Pharmocological
dose NN Pharmocological
of IN Pharmocological
10 CD Pharmocological
ml NNS Pharmocological
and CC Pharmocological
aluminum-magnesium JJ Pharmocological
antacid JJ Pharmocological
drug NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
1 CD Pharmocological
sachet NN Pharmocological
. . Pharmocological
antacids NNS Pharmocological
Geviskon NNP Pharmocological
-DOCSTART- -X- N

Dader NNP Educational
Method NNP Educational
pharmacist JJ Educational
intervention NN Educational
community NN Educational
pharmacist NN Educational
interventions NNS Educational
Dader NNP Educational
Method NNP Educational
for IN Educational
pharmaceutical JJ Educational
care NN Educational
intervention NN Educational
group NN Educational
that WDT Educational
received VBD Educational
pharmaceutical JJ Educational
care NN Educational
, , Educational
which WDT Educational
was VBD Educational
provided VBN Educational
by IN Educational
specially RB Educational
trained JJ Educational
pharmacists NNS Educational
working VBG Educational
in IN Educational
collaboration NN Educational
with IN Educational
physicians NNS Educational
control NN Educational
group NN Educational
that WDT Educational
received VBD Educational
usual JJ Educational
care NN Educational
( ( Educational
routine JJ Educational
dispensing VBG Educational
counseling NN Educational
) ) Educational
and CC Educational
verbal JJ Educational
and CC Educational
written VBN Educational
counseling VBG Educational
regarding VBG Educational
CVD NNP Educational
prevention NN Educational
. . None
intervention NN None
control NN None
) ) None
usual JJ None
care NN None
plus CC None
written VBN None
education NN None
, , None
pharmaceutical JJ None
care NN None
focused VBN None
on IN None
patient JJ None
evaluation NN None
and CC None
follow-up NN None
in IN None
collaboration NN None
with IN None
physicians NNS None
-DOCSTART- -X- N

Grenz NNP Physical
rays NNS Physical
topical JJ Physical
corticosteroid NN Physical
combined VBN Physical
with IN Physical
Grenz NNP Physical
rays NNS Physical
. . Physical
Grenz NNP Physical
ray NN Physical
therapy NN Physical
Grenz NNP Pharmocological
rays NNS Pharmocological
combined VBN Pharmocological
with IN Pharmocological
a DT Pharmocological
topical JJ Pharmocological
corticosteroid NN Pharmocological
( ( Pharmocological
betamethasone JJ Pharmocological
dipropionate NN Pharmocological
) ) Physical
4 CD None
Grenz NNP Physical
ray NN Physical
treatment NN Physical
plus CC Physical
topical JJ Physical
corticosteroid NN Physical
. . Physical
Grenz NNP Physical
ray NN Physical
Grenz NNP Physical
ray NN Physical
Grenz NNP Physical
ray NN Physical
therapy NN Physical
corticosteroid NN Physical
-DOCSTART- -X- N

Ambulatory NNP Surgical
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
: : None
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
. . None
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
compression NN Physical
sclerotherapy NN Physical
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
compression NN Physical
sclerotherapy NN Physical
therapy NN Physical
. . None
compression NN Physical
sclerotherapy NN Physical
ambulatory JJ Surgical
phlebectomy NN Surgical
-DOCSTART- -X- N

[ JJ None
Stent NNP Surgical
and CC Surgical
surgery NN Surgical
stent-supported JJ Surgical
angioplasty NN Surgical
( ( Surgical
CAS NNP Surgical
) ) Surgical
vs NN None
carotid NN Surgical
endarterectomy NN Surgical
( ( Surgical
CEA NNP Surgical
) ) Surgical
CAS NNP Surgical
CEA NNP Surgical
CAS NNP Surgical
CEA NNP Surgical
CAS NNP Surgical
Stent-supported JJ Surgical
angioplasty NN Surgical
-DOCSTART- -X- N

Supportive-expressive JJ Psychological
group NN Psychological
therapy NN Psychological
manualized JJ Psychological
12-week JJ Psychological
supportive-expressive JJ Psychological
group NN Psychological
therapy NN Psychological
program NN None
brief JJ Educational
supportive-expressive JJ Educational
intervention NN Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
valproate NN Pharmocological
valproate JJ Pharmocological
placebo-controlled JJ Control
valproate NN Pharmocological
( ( Pharmocological
VPA NNP Pharmocological
) ) Pharmocological
placebo NN Control
( ( Pharmocological
PBO NNP Pharmocological
) ) Pharmocological
VPA NNP Pharmocological
PBO NNP Pharmocological
VPA NNP Pharmocological
VPA NNP Pharmocological
PBO NNP Pharmocological
VPA NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

multimodal NN Physical
exercise NN Physical
intervention NN Physical
chemotherapy NN Physical
exercise NN Physical
intervention NN Physical
supervised JJ Physical
multimodal NN Physical
exercise NN Physical
intervention NN Physical
, , None
adjunct JJ Physical
to TO Physical
chemotherapy VB Physical
and CC Physical
standard VB Physical
care NN Physical
intervention NN Educational
group NN Educational
wait-list JJ Control
control NN Control
group NN Control
. . None
Supervised VBD Physical
exercise NN Physical
, , Physical
comprising VBG Physical
high-intensity NN Physical
cardiovascular NN Physical
and CC Physical
heavy JJ Physical
resistance NN Physical
training NN Physical
, , Physical
relaxation- JJ Physical
and CC Physical
body NN Physical
awareness JJ Physical
training NN Physical
and CC Physical
massage NN Physical
supervised JJ Physical
multimodal NN Physical
exercise NN Physical
intervention NN Physical
-DOCSTART- -X- N

dietary JJ None
intervention NN None
gluten NN None
and CC None
casein-free JJ None
diet NN None
controls NNS Control
. . Control
-DOCSTART- -X- N

2-chlorodeoxyadenosine JJ Pharmocological
2-chlorodeoxyadenosine JJ Pharmocological
( ( Pharmocological
Cladribine NNP Pharmocological
, , Pharmocological
CDA NNP Pharmocological
) ) Pharmocological
CDA NNP Pharmocological
( ( None
CDA NNP Pharmocological
( ( None
CDA NNP Pharmocological
CDA NNP Pharmocological
-DOCSTART- -X- N

Butorphanol NNP Pharmocological
and CC None
meperidine NN Pharmocological
butorphanol NN Pharmocological
meperidine NN Pharmocological
butorphanol NN Pharmocological
meperidine NN Pharmocological
butorphanol NN Pharmocological
. . None
butorphanol NN Pharmocological
butorphanol NN Pharmocological
. . None
-DOCSTART- -X- N

placebo NN Control
human JJ Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
. . None
human JJ Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
( ( Pharmocological
HSS NNP Pharmocological
) ) Pharmocological
placebo NN Control
human JJ Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
( ( Pharmocological
HSS NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
saline JJ Pharmocological
placebo/HSS NN Pharmocological
) ) Pharmocological
( ( None
HSS/saline NNP Pharmocological
placebo NN Pharmocological
) ) None
. . None
placebo NN Control
, , None
secretin FW Pharmocological
treatment NN Pharmocological
HSS NNP Pharmocological
placebo NN Control
. . None
HSS NNP Pharmocological
saline JJ Control
placebo NN Control
. . None
human JJ Pharmocological
secretin NN Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

MRI NNP Physical
. . None
MRI NNP Physical
plain NN Physical
radiography NN Physical
MRI NNP Physical
core-decompression NN Physical
group NN None
or CC None
a DT None
conservatively-treated JJ Physical
group NN None
. . None
plain VBP Physical
radiography NN Physical
MRI NNP Physical
-DOCSTART- -X- N

conventional JJ Pharmocological
GIC NNP Pharmocological
( ( Pharmocological
group NN Pharmocological
1 CD Pharmocological
) ) Pharmocological
or CC Pharmocological
GIC NNP Pharmocological
with IN Pharmocological
0.01 CD Pharmocological
% NN Pharmocological
, , Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
1 CD Pharmocological
% NN Pharmocological
collagen NN Pharmocological
( ( Pharmocological
groups NNS Pharmocological
2 CD Pharmocological
, , Pharmocological
3 CD Pharmocological
, , Pharmocological
4 CD Pharmocological
respectively RB Pharmocological
) ) Pharmocological
or CC Pharmocological
, , Pharmocological
10 CD Pharmocological
% NN Pharmocological
, , Pharmocological
30 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
50 CD Pharmocological
% NN Pharmocological
bioactive JJ Pharmocological
glass NN Pharmocological
( ( Pharmocological
groups NNS Pharmocological
5 CD Pharmocological
, , Pharmocological
6 CD Pharmocological
, , Pharmocological
7 CD Pharmocological
respectively RB Pharmocological
) ) Pharmocological
, , Pharmocological
or CC Pharmocological
Mineral NNP Pharmocological
Trioxide NNP Pharmocological
Aggregate NNP Pharmocological
( ( Pharmocological
group NN Pharmocological
8 CD Pharmocological
) ) Pharmocological
. . Pharmocological
-DOCSTART- -X- N

vitamin NN Pharmocological
B6 NNP Pharmocological
supplementation NN Pharmocological
2.5 CD None
, , None
4 CD None
, , None
and CC None
10 CD None
mg NN None
of IN None
pyridoxine JJ Pharmocological
supplementation NN Pharmocological
4 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
pyridoxine JJ Pharmocological
supplementation NN Pharmocological
daily RB Pharmocological
pyridoxine NN Pharmocological
vitamin JJ Pharmocological
B6 NNP Pharmocological
vitamin NN Pharmocological
B6 NNP Pharmocological
-DOCSTART- -X- N

Information NNP Educational
source NN Educational
videotape NN Educational
-DOCSTART- -X- N

anthelmintic JJ Pharmocological
treatment NN Pharmocological
Enzyme-linked JJ Pharmocological
immunosorbent NN Pharmocological
assays NNS Pharmocological
-DOCSTART- -X- N

DFT NNP Physical
determined VBD Physical
using VBG Physical
biphasic JJ Physical
shocks NNS Physical
VF NNP Physical
-DOCSTART- -X- N

rosuvastatin NN None
fenofibrate NN None
?-3 JJ None
fatty JJ None
acids NNS None
rosuvastatin NN None
fenofibrate NN None
?-3 JJ None
fatty JJ None
acids NNS None
rosuvastatin VB None
rosuvastatin $ None
fenofibrate JJ None
?-3 JJ None
fatty JJ None
acids NNS None
RF NNP None
RF NNP None
R NNP None
R? NNP None
-DOCSTART- -X- N

vitamin NN None
C NNP None
, , None
vitamin NN None
E NNP None
, , None
carotenoids NNS None
antioxidants NNS Pharmocological
measured VBN None
blood NN None
levels NNS None
8-oxodeoxyguanosine JJ Pharmocological
lymphocyte NN Pharmocological
DNA NN Pharmocological
12-wk JJ Physical
carotenoid NN Physical
supplementation NN Physical
regime NN Physical
. . Physical
liquid NN Pharmocological
chromatography NN Pharmocological
-DOCSTART- -X- N

Paracetamol NNP Pharmocological
paracetamol NN Pharmocological
( ( Pharmocological
acetaminophen NN Pharmocological
, , Pharmocological
APAP NNP Pharmocological
) ) Pharmocological
intravenous JJ Pharmocological
paracetamol NN Pharmocological
( ( None
APAP NNP None
1 CD None
g NN None
) ) None
or CC None
saline NN Control
( ( None
placebo NN Control
, , None
pl NN None
) ) None
IV NNP Pharmocological
naloxone NN Pharmocological
( ( None
Nal NNP None
8 CD None
mg NN None
) ) None
or CC None
saline NN Control
APAP/pl NNP Pharmocological
APAP/Nal NNP Pharmocological
. . None
APAP/Nal NNP Pharmocological
naloxone RB Pharmocological
paracetamol JJ Pharmocological
-DOCSTART- -X- N

studied VBD Educational
-DOCSTART- -X- N

i.e NN None
. . None
implant JJ None
treatment NN None
and CC None
one CD None
group NN None
receiving VBG None
conventional JJ None
complete JJ None
dentures NNS None
( ( None
CD NN None
) ) None
. . None
implant-supported JJ Physical
mandibular JJ Physical
overdenture NN Physical
transmandibular JJ Physical
implant NN Physical
( ( Physical
TMI NNP Physical
) ) Physical
implant-tissue-supported JJ None
mandibular JJ None
overdenture NN None
IMZ JJ None
implants NNS None
( ( None
IMZ NNP None
) ) None
. . None
TMI NNP None
IMZ NNP None
-DOCSTART- -X- N

Measurements NNS None
of IN None
and CC None
are VBP None
often RB None
followed VBN None
over RP None
time NN None
in IN None
urological JJ Educational
management NN Educational
. . Educational
-DOCSTART- -X- N

Questionnaire NNP Other
. . None
Siriraj NNP Other
Asthma NNP Other
Control NNP Other
Questionnaire NNP Other
Kruskal-Wallis NNP Other
test NN Other
Siriraj NNP Other
Asthma NNP Other
Control NNP Other
Questionnaire NNP Other
-DOCSTART- -X- N

perindopril/indapamide NN Pharmocological
combination NN Pharmocological
low JJ Pharmocological
dose NN Pharmocological
combination NN Pharmocological
perindopril VBD Pharmocological
2 CD Pharmocological
mg/indapamide RB Pharmocological
atenolol $ Pharmocological
Per/Ind NNP Pharmocological
or CC None
Ate NNP Pharmocological
-DOCSTART- -X- N

high JJ Other
and CC Other
low JJ Other
fat NN Other
meals NNS Other
meals NNS Pharmocological
upright JJ Other
and CC Other
recumbent JJ Physical
position NN Physical
. . None
-DOCSTART- -X- N

two CD Pharmocological
theophylline NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
58-55-9 NNP Pharmocological
) ) Pharmocological
sustained VBD Pharmocological
release NN Pharmocological
preparations NNS Pharmocological
( ( None
T NNP Pharmocological
: : Pharmocological
Bronchoretard NNP Pharmocological
Capsules/R NNP Pharmocological
: : Pharmocological
Capsule JJ Pharmocological
formulation NN Pharmocological
from IN Pharmocological
the DT Pharmocological
US NNP Pharmocological
market NN Pharmocological
) ) None
Following VBG Pharmocological
individual JJ Pharmocological
dosing NN Pharmocological
of IN Pharmocological
100-300 JJ Pharmocological
mg NNS Pharmocological
theophylline VB Pharmocological
twice RB Pharmocological
a DT Pharmocological
day NN Pharmocological
, , None
a DT None
pharmacokinetic JJ Pharmocological
profile NN Pharmocological
for IN Pharmocological
24 CD Pharmocological
h NN Pharmocological
was VBD Pharmocological
derived VBN Pharmocological
after IN Pharmocological
seven CD Pharmocological
days NNS Pharmocological
of IN Pharmocological
multiple JJ Pharmocological
dosing NN Pharmocological
. . None
All DT None
and CC None
were VBD None
calculated VBN None
for IN None
both DT None
formulations NNS None
. . None
-DOCSTART- -X- N

Flow NNP Other
cytometry NN Other
colony-stimulating NN Pharmocological
factor NN Pharmocological
[ IN Pharmocological
G-CSF NNP Pharmocological
] NNP Pharmocological
) ) Pharmocological
and CC None
autologous JJ Pharmocological
stem NN Pharmocological
cell NN Pharmocological
support NN Pharmocological
. . None
chemotherapy NN Pharmocological
-DOCSTART- -X- N

phenylbutazone NN Pharmocological
Phenylbutazone NNP Pharmocological
phenylbutazone NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

buspirone NN Pharmocological
serotonin-1A JJ Pharmocological
( ( Pharmocological
5-HT1A JJ Pharmocological
) ) Pharmocological
receptor NN Pharmocological
agonist VBP Pharmocological
buspirone NN Pharmocological
buspirone NN Pharmocological
placebo-controlled JJ Control
buspirone NN Pharmocological
30 CD None
mg JJ None
daily JJ None
or CC None
placebo NN Control
. . None
placebo NN Control
. . None
buspirone NN Pharmocological
and CC None
placebo NN Control
-DOCSTART- -X- N

Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
b NN Pharmocological
vaccines NNS Pharmocological
. . Pharmocological
Hib NNP Pharmocological
vaccines NNS Pharmocological
Hib-specific NNP Pharmocological
capsular JJ Pharmocological
polysaccharide NN Pharmocological
, , Pharmocological
PRP NNP Pharmocological
; : Pharmocological
contained VBN None
PRP NNP Pharmocological
pertussis NN Pharmocological
vaccine NN Pharmocological
, , Pharmocological
PRP-P. NNP Pharmocological
DTP NNP Pharmocological
control NN Control
PRP NNP Pharmocological
PRP-P NNP Pharmocological
PRP-P NNP Pharmocological
-DOCSTART- -X- N

sedation NN Pharmocological
techniques NNS Pharmocological
midazolam NN Pharmocological
and CC None
pethidine NN Pharmocological
combination NN Pharmocological
midazolam NN Pharmocological
and CC None
tramadol JJ Pharmocological
combination NN Pharmocological
. . None
midazolam JJ Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
pethidine NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
intravenously RB Pharmocological
midazolam JJ Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
tramadol NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
pethidine NN Pharmocological
tramadol NN Pharmocological
Midazolam-tramadol NNP Pharmocological
combination NN Pharmocological
midazolam-pethidine JJ Pharmocological
combination NN Pharmocological
-DOCSTART- -X- N

random JJ Physical
single JJ Physical
donor NN Physical
platelet NN Physical
transfusions NNS Physical
: : None
multiple-donor JJ Pharmocological
platelet NN Pharmocological
concentrates NNS Pharmocological
random JJ Physical
single-donor JJ Physical
platelets NNS Physical
random NN Physical
SD NNP Physical
platelet NN Physical
transfusions NNS Physical
-DOCSTART- -X- N

transplantation NN Physical
transplantation NN Physical
marrow NN Physical
blood NN Physical
stem NN Physical
cell NN Physical
blood NN None
stem NN None
cell NN None
-DOCSTART- -X- N

Retroinfusion-supported JJ Surgical
stenting NN Surgical
retroinfusion-supported JJ Surgical
stenting NN Surgical
bypass VB Surgical
surgery NN Surgical
. . None
stent JJ Surgical
implantation NN Surgical
conventional JJ Surgical
bypass NN Surgical
surgery NN Surgical
stent JJ Surgical
implantation NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary JJ Surgical
angioplasty/stent NN Surgical
procedure NN Surgical
bypass NN Surgical
surgery NN Surgical
stent VB Surgical
implantation NN Surgical
selective JJ Surgical
pressure-regulated JJ Surgical
retroinfusion NN Surgical
retroinfusion-supported JJ Surgical
stent NN Surgical
implantation NN Surgical
bypass NN Surgical
surgery NN Surgical
. . None
retroinfusion-supported JJ Surgical
stent NN Surgical
implantation NN Surgical
-DOCSTART- -X- N

First-line JJ Pharmocological
cisplatin NN Pharmocological
with IN Pharmocological
docetaxel NN Pharmocological
or CC None
vinorelbine NN Pharmocological
Docetaxel NNP Pharmocological
( ( Pharmocological
DCT NNP Pharmocological
) ) Pharmocological
and CC None
cisplatin NN Pharmocological
( ( Pharmocological
CDDP NNP Pharmocological
) ) Pharmocological
doublet NN Pharmocological
vinorelbine NN Pharmocological
( ( Pharmocological
VNR NNP Pharmocological
) ) Pharmocological
and CC None
CDDP NNP Pharmocological
VNR/CDDP NNP Physical
CDDP NNP Pharmocological
75 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
plus CC Pharmocological
DCT NNP Pharmocological
75 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
CDDP $ Pharmocological
80 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
on IN Pharmocological
day NN Pharmocological
1 CD Pharmocological
plus CC Pharmocological
VNR NNP Pharmocological
30 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
G-CSF NNP Pharmocological
and/or JJ None
EPO NNP Pharmocological
DCT/CDDP NNP None
VNR/CDDP NNP Pharmocological
DCT/CDDP NNP Pharmocological
VNR/CDDP NNP Pharmocological
DCT/CDDP NNP Pharmocological
VNR/CDDP NNP None
VNR/CDDP NNP Pharmocological
VNR/CDDP NNP Pharmocological
DCT/CDDP NNP Pharmocological
-DOCSTART- -X- N

Decompressive JJ Physical
craniectomy NN Physical
decompressive JJ Physical
craniectomy NN Physical
decompressive JJ Physical
craniectomy NN Physical
-DOCSTART- -X- N

Trunk NNP Physical
exercise NN Physical
combined VBN Physical
with IN Physical
spinal JJ Physical
manipulative NN Physical
or CC None
NSAID NNP Pharmocological
therapy NN Pharmocological
Spinal NNP Physical
manipulative JJ Physical
therapy NN Physical
( ( Physical
SMT NNP Physical
) ) Physical
combined VBD Physical
with IN Physical
trunk NN Physical
strengthening VBG Physical
exercises NNS Physical
( ( Physical
TSE NNP Physical
) ) Physical
vs. FW Physical
SMT NNP Physical
combined VBD Physical
with IN Physical
trunk NN Physical
stretching VBG Physical
exercises NNS Physical
, , Physical
and CC Physical
SMT NNP Physical
combined VBN Physical
with IN Physical
TSE NNP Physical
vs. FW Physical
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drug NN Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
TSE NNP Pharmocological
. . None
SMT NNP Physical
or CC None
NSAID NNP Pharmocological
therapy NN Physical
in IN Physical
combination NN Physical
with IN Physical
supervised JJ Physical
trunk NN Physical
exercise NN Physical
supervised JJ Physical
exercise NN Physical
alone RB Physical
. . Physical
SMT NNP Physical
or CC None
NSAID NNP Pharmocological
therapy NN Pharmocological
( ( Control
placebo NN Control
) ) Control
-DOCSTART- -X- N

ofloxacin NN Pharmocological
cefixime NN Pharmocological
fluoroquinolone NN Pharmocological
antibiotics NNS Pharmocological
Cefixime NNP Pharmocological
cephalosporin NN Pharmocological
ofloxacin NN Pharmocological
ofloxacin NN Pharmocological
cefixime NN Pharmocological
ofloxacin JJ Pharmocological
cefixime NN Pharmocological
ofloxacin NN Pharmocological
cefixime NN Pharmocological
ofloxacin NN Pharmocological
. . None
-DOCSTART- -X- N

action NN Physical
observation NN Physical
treatment NN Physical
( ( Physical
AOT NNP Physical
) ) Physical
or CC None
control NN Control
group NN None
. . None
observe VB Educational
video JJ Educational
clips NNS Educational
showing VBG Educational
daily JJ Educational
actions NNS Educational
and CC Educational
to TO Educational
imitate VB Educational
them PRP Educational
afterward RB Educational
. . Physical
observe VB Educational
video JJ Educational
clips NNS Educational
with IN Educational
no DT Educational
motor NN Educational
content NN Educational
and CC Educational
to TO Educational
execute VB Educational
the DT Educational
same JJ Educational
actions NNS Educational
as IN Educational
patients NNS Educational
in IN Educational
the DT Educational
case NN Educational
group NN Educational
-DOCSTART- -X- N

psychiatric JJ Educational
hospital NN Educational
community NN Educational
treatment NN Educational
standard JJ Educational
hospital NN Educational
care NN Educational
and CC Educational
follow-up NN Educational
back RB Educational
to TO Educational
the DT Educational
community NN Educational
follow-up JJ Educational
treatment NN Educational
-DOCSTART- -X- N

Arm-cranking JJ Physical
exercise NN Physical
arm-cranking JJ Physical
exercise NN Physical
program NN Physical
12-week JJ Physical
arm-cranking JJ Physical
exercise NN Physical
program NN Physical
consisting VBG Educational
of IN Educational
warming-up JJ Educational
( ( Educational
10-15min JJ Educational
) ) Educational
followed VBN Educational
by IN Educational
a DT Educational
main JJ Educational
part NN Educational
in IN Educational
arm-crank JJ Educational
cooling-down JJ Physical
arm-cranking JJ Physical
exercise NN Physical
program NN Physical
-DOCSTART- -X- N

vitamin NN Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
D3 NNP Pharmocological
( ( Pharmocological
cholecalciferol NN Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
supplemental JJ Pharmocological
oral JJ Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
( ( None
placebo NN None
short-term JJ None
exposure NN None
to TO None
vitamin VB None
D NNP None
supplementation NN None
-DOCSTART- -X- N

formoterol NN Pharmocological
, , None
salmeterol NN Pharmocological
or CC None
oxitropium NN Pharmocological
bromide NN Pharmocological
formoterol NN Pharmocological
, , None
oxitropium NN Pharmocological
bromide NN Pharmocological
, , None
or CC None
salmeterol NN Pharmocological
received VBD None
24 CD Pharmocological
microg NNS Pharmocological
formoterol NN Pharmocological
, , None
50 CD Pharmocological
microg NN Pharmocological
salmeterol NN Pharmocological
, , None
200 CD Pharmocological
microg NN Pharmocological
oxitropium NN Pharmocological
bromide NN Pharmocological
, , None
or CC None
placebo VB Control
on IN None
four CD None
non-consecutive JJ None
days NNS None
. . None
Spirometric JJ Physical
testing NN Physical
constructed VBN Pharmocological
using VBG Pharmocological
doses NNS Pharmocological
of IN Pharmocological
100 CD Pharmocological
, , Pharmocological
100 CD Pharmocological
, , Pharmocological
200 CD Pharmocological
microg NN Pharmocological
and CC Pharmocological
400 CD Pharmocological
microg NN Pharmocological
-- : Pharmocological
that WDT Pharmocological
is VBZ Pharmocological
, , Pharmocological
a DT Pharmocological
total JJ Pharmocological
cumulative JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
800 CD Pharmocological
microg NN Pharmocological
. . None
Formoterol NNP Pharmocological
, , None
salmeterol NN Pharmocological
oxitropium NN Pharmocological
bromide RB Pharmocological
placebo NN Control
placebo $ Control
formoterol NN Pharmocological
salmeterol NN Pharmocological
oxitropium NN Pharmocological
bromide IN Pharmocological
placebo NN Control
: : None
formoterol NN Pharmocological
: : None
salmeterol NN Pharmocological
: : None
oxitropium JJ Pharmocological
bromide NN Pharmocological
: : None
formoterol NN Pharmocological
, , None
salmeterol NN Pharmocological
, , None
or CC None
oxitropium NN Pharmocological
bromide NN Pharmocological
placebo NN Control
. . None
formoterol NN Pharmocological
, , None
salmeterol NN Pharmocological
, , None
or CC None
oxitropium JJ Pharmocological
bromide NN Pharmocological
salbutamol NN Pharmocological
-DOCSTART- -X- N

imiquimod JJ Pharmocological
reflectance-mode JJ Physical
confocal JJ Physical
microscopy NN Physical
Mohs NNP Surgical
micrographic JJ Surgical
surgery NN Surgical
Imiquimod NNP Pharmocological
imiquimod JJ Pharmocological
reflectance-mode JJ Physical
confocal JJ Physical
microscopy NN Physical
imiquimod JJ Pharmocological
Confocal NNP Physical
microscopy NN Physical
Mohs NNP Surgical
micrographic JJ Surgical
surgery NN Surgical
. . None
Mohs NNP Surgical
micrographic JJ Surgical
surgery NN Surgical
excision NN Surgical
Confocal JJ Physical
microscopy NN Physical
Imiquimod NNP Pharmocological
-DOCSTART- -X- N

naproxen NN Pharmocological
. . None
naproxen NNS Pharmocological
-DOCSTART- -X- N

3'-azido-2',3'-dideoxythymidine JJ Pharmocological
interferon-? NN None
Human JJ None
interferon-?2a JJ None
( ( None
huIFN-?2a JJ None
) ) None
and CC None
3'-azido-2',3'-dideoxythymidine JJ None
( ( None
AZT NNP None
) ) None
have VBP None
huIFN-?2a NN None
, , None
AZT NNP None
huIFN-?2a NN None
( ( None
10 CD None
( ( None
, , None
AZT NNP None
or CC None
placebo NN None
( ( None
10 CD None
or CC None
AZT NNP None
-DOCSTART- -X- N

Problem-solving JJ Educational
counseling NN Educational
problem-solving JJ Educational
counseling NN Educational
individualized JJ Educational
problem-solving JJ Educational
counseling NN Educational
by IN Educational
nurses NNS Educational
nurse JJ Educational
counseling NN Educational
or CC Educational
not RB Control
. . None
nurse JJ Educational
counseling NN Educational
control NN Control
counseling VBG Educational
counseling NN Educational
control VB Control
nurse RB Educational
counseling VBG Educational
-DOCSTART- -X- N

adjuvant JJ Physical
portal JJ Physical
chemotherapy NN Physical
adjuvant JJ Surgical
portal JJ Surgical
infusion NN Surgical
( ( Surgical
5-Fluorouracil JJ Surgical
, , Surgical
Mitomycin NNP Surgical
C NNP Surgical
) ) Surgical
compared VBN Surgical
to TO Surgical
radical JJ Surgical
surgery NN Surgical
alone RB Surgical
. . None
-DOCSTART- -X- N

aliskiren NN Pharmocological
placebo VB Control
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
( ( None
perindopril NN Pharmocological
) ) None
receive VB None
aliskiren NNS None
( ( None
150 CD None
, , None
aliskiren RB None
( ( None
300 CD None
, , None
perindopril NN None
( ( None
5 CD None
, , None
perindopril NN None
( ( None
10 CD None
placebo NN None
. . None
RESULTS NNP None
Aliskiren NNP None
and CC None
perindopril NN None
aliskiren NNS None
( ( None
150 CD None
) ) None
with IN None
aliskiren NN None
( ( None
300 CD None
mg NN None
with IN None
perindopril NN None
( ( None
5 CD None
mg NN None
) ) None
and CC None
with IN None
perindopril NN None
( ( None
10 CD None
mg NN None
) ) None
, , None
compared VBN None
placebo VB None
aliskiren NNS None
and CC None
perindopril NN None
. . None
CONCLUSIONS NNP None
Aliskiren NNP None
perindopril NN None
, , None
for IN None
equivalent JJ None
The DT None
renin JJ None
inhibitor NN None
-DOCSTART- -X- N

psychotherapy VBN Psychological
increase VB Psychological
the DT Psychological
number NN Psychological
of IN Psychological
self-disclosures NNS Psychological
treatment NN Psychological
refrain NN Psychological
from IN Psychological
making VBG Psychological
self-disclosures NNS Psychological
during IN Psychological
treatment NN Psychological
psychotherapy NN Psychological
therapist NN Psychological
disclosure NN Psychological
-DOCSTART- -X- N

-DOCSTART- -X- N

fenoterol NN Pharmocological
and CC Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
Fenoterol NNP None
( ( None
FNT NNP None
) ) None
, , None
ipratropium JJ Pharmocological
bromide NN Pharmocological
( ( Pharmocological
IB NNP Pharmocological
) ) Pharmocological
, , None
and CC None
placebo NN Control
FNT NNP None
or CC None
IB NNP None
, , None
receiving VBG None
FNT NNP None
and CC None
IB NNP None
which WDT None
placebo NN None
FNT NNP None
than IN None
IB NNP None
of IN None
FNT NNP None
or CC None
IB NNP None
with IN None
FNT NNP None
. . None
-DOCSTART- -X- N

naproxen NN Pharmocological
naproxen JJ Pharmocological
250-mg JJ Pharmocological
naproxen JJ Pharmocological
tablets NNS Pharmocological
naproxen NN Pharmocological
-DOCSTART- -X- N

haloperidol NN Pharmocological
and CC Pharmocological
risperidone NN Pharmocological
. . None
-DOCSTART- -X- N

home-based JJ Physical
task-specific JJ Physical
reach-to-grasp NN Physical
( ( Physical
RTG NNP Physical
) ) Physical
14 CD Physical
training NN Physical
sessions NNS Physical
arm NN Control
therapy NN Control
-DOCSTART- -X- N

Intermittent JJ Physical
theta-burst JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
intermittent JJ Physical
theta-burst JJ Physical
stimulation NN Physical
( ( Physical
iTBS NN Physical
) ) Physical
Repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
rTMS NN Physical
) ) Physical
iTBS NN Physical
rTMS NN Physical
rTMS NN Physical
. . None
iTBS NN Physical
iTBS NN Physical
sham JJ Physical
stimulation NN Physical
. . None
iTBS NN Physical
iTBS NN Physical
iTBS NN Physical
-DOCSTART- -X- N

interferon NN Pharmocological
alpha NN Pharmocological
2b CD Pharmocological
and CC None
ribavirin VB Pharmocological
combination NN Pharmocological
of IN Pharmocological
interferon NN Pharmocological
alpha NN Pharmocological
plus CC Pharmocological
ribavirin NN Pharmocological
. . None
interferon NN Pharmocological
alpha NN Pharmocological
2b CD Pharmocological
oral JJ Pharmocological
ribavirin NN Pharmocological
-DOCSTART- -X- N

ad NN Pharmocological
libitum NN Pharmocological
FMS NNP Pharmocological
. . None
groundnut NNS Pharmocological
cake VBP Pharmocological
with IN None
-DOCSTART- -X- N

sugar-free JJ Pharmocological
gum NN Pharmocological
CPP-ACP NNP Pharmocological
sugar-free JJ Control
gum NN Control
not RB Control
containing VBG Control
CPP-ACP NNP Control
gum NN Pharmocological
containing VBG Pharmocological
CPP-ACP NNP Pharmocological
control NN Control
gum NN Control
sugar-free JJ Pharmocological
gum NN Pharmocological
containing VBG Pharmocological
CPP-ACP NNP Pharmocological
gum NN Control
-DOCSTART- -X- N

vacuum-assisted JJ Physical
closure NN Physical
therapy NN Physical
the DT Physical
Vacuum-Assisted JJ Physical
Closure NNP Physical
( ( Physical
V.A.C NNP Physical
. . Physical
) ) Physical
system NN Physical
standard VB Physical
moist NN Physical
wound IN Physical
therapy NN Physical
( ( Physical
MWT NNP Physical
) ) Physical
. . None
MWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
NPWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
NPWT NNP Physical
MWT NNP Physical
. . None
-DOCSTART- -X- N

Laparoscopically RB Physical
assisted VBN Physical
vaginal JJ Physical
hysterectomy NN Physical
abdominal JJ Physical
hysterectomy NN Physical
laparoscopic JJ Physical
treatment NN Physical
traditional JJ Physical
transabdominal JJ Physical
approach NN Physical
laparoscopic JJ Physical
treatment NN Physical
laparoscopic JJ Physical
procedure NN Physical
-DOCSTART- -X- N

home NN Educational
visiting NN Educational
asthma JJ Educational
education NN Educational
program NN Educational
: : None
nurse JJ Educational
home NN Educational
visiting NN Educational
asthma JJ Educational
education NN Educational
program NN Educational
home-based JJ Educational
asthma NN Educational
education NN Educational
programs NNS Educational
-DOCSTART- -X- N

radiotherapy NN Physical
enucleation NN Physical
-DOCSTART- -X- N

Thermal JJ Surgical
welding VBG Surgical
versus NN None
bipolar JJ Surgical
tonsillectomy NN Surgical
: : None
thermal JJ Physical
welding VBG Physical
tonsillectomy NN Physical
( ( Physical
TWT NNP Physical
) ) Physical
with IN None
bipolar JJ Physical
electrocautery NN Physical
tonsillectomy NN Physical
( ( Physical
BET NNP Physical
) ) Physical
procedure NN Surgical
. . None
TWT NNP Physical
BET NNP Physical
TWT NNP Physical
BET NNP Physical
TWT NNP Physical
BET NNP Physical
TWT NNP Physical
BET NNP Physical
Thermal NNP Surgical
welding VBG Surgical
tonsillectomy JJ Surgical
procedure NN Surgical
-DOCSTART- -X- N

naltrexone NN Pharmocological
naltrexone NN Pharmocological
( ( Pharmocological
NTX NNP Pharmocological
) ) Pharmocological
daily JJ None
oral JJ None
dose NN None
of IN None
0.5 CD None
mg/kg/day NN None
was VBD None
contrasted VBN None
with IN None
placebo NN Control
( ( None
PLC NNP None
) ) None
PLC NNP Pharmocological
NTX NNP Pharmocological
NTX NNP Pharmocological
PLC NNP Pharmocological
. . Pharmocological
NTX NNP Pharmocological
-DOCSTART- -X- N

soy-based JJ Pharmocological
dietary JJ Pharmocological
supplement NN Pharmocological
soy NN Pharmocological
protein NN Pharmocological
, , None
isoflavones NNS Pharmocological
, , None
and CC None
cotyledon VB Pharmocological
fiber NN Pharmocological
( ( Pharmocological
Abalon NNP Pharmocological
) ) Pharmocological
6 CD Pharmocological
weeks NNS Pharmocological
with IN Pharmocological
Abalon NNP Pharmocological
( ( Pharmocological
soy JJ Pharmocological
protein NN Pharmocological
isoflavones NNS Pharmocological
cotyledon VB Pharmocological
fiber NN Pharmocological
placebo NN Control
Abalon NNP Pharmocological
placebo NN Control
Abalon NNP Pharmocological
Abalon NNP Pharmocological
-DOCSTART- -X- N

cefditoren NNS Pharmocological
pivoxil VBP Pharmocological
ceftriaxone NN Pharmocological
cefditoren NNS Pharmocological
pivoxil VBP Pharmocological
IV NNP Pharmocological
ceftriaxone NN Pharmocological
2g CD Pharmocological
IV NNP Pharmocological
ceftriaxone NN Pharmocological
( ( None
IV NNP Pharmocological
ceftriaxone NN Pharmocological
) ) None
( ( None
oral JJ Pharmocological
cefditoren NNS Pharmocological
pivoxil VBP Pharmocological
400mg CD Pharmocological
ceftriaxone NN Pharmocological
cefditoren NNS Pharmocological
pivoxil NN Pharmocological
-DOCSTART- -X- N

laparoscopy NN Physical
open JJ Surgical
appendicectomy NN Surgical
laparoscopy VBN Physical
, , None
followed VBN None
by IN None
open JJ Surgical
appendicectomy NN Surgical
-DOCSTART- -X- N

Concurrent NNP Pharmocological
doxorubicin NN Pharmocological
plus CC Pharmocological
docetaxel NN Pharmocological
concurrent NN Pharmocological
doxorubicin NN Pharmocological
plus CC Pharmocological
cyclophosphamide NN Pharmocological
doxorubicin NN Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
AC NNP Pharmocological
) ) Pharmocological
Doxorubicin NNP Pharmocological
and CC Pharmocological
docetaxel NN Pharmocological
( ( Pharmocological
AT NNP Pharmocological
) ) Pharmocological
doxorubicin NN Pharmocological
plus CC Pharmocological
either DT Pharmocological
cyclophosphamide NN Pharmocological
or CC Pharmocological
docetaxel NN Pharmocological
AC NNP Pharmocological
AT NNP Pharmocological
-DOCSTART- -X- N

propofol NN Pharmocological
propofol NN Pharmocological
placebo-controlled JJ Control
normal JJ Pharmocological
saline NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
3.3 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
3.3 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
1.0 CD Pharmocological
mg/kg NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
3.3 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
2.0 CD Pharmocological
mg/kg NN Pharmocological
at IN Pharmocological
50 CD Pharmocological
mg/sec NN Pharmocological
. . Pharmocological
Rapid NNP Physical
injection NN Physical
lidocaine JJ Pharmocological
slow VB Physical
injection NN Physical
pretreatment NN Pharmocological
with IN Pharmocological
lidocaine JJ Pharmocological
Rapid JJ Physical
injection NN Physical
slow JJ Physical
injection NN Physical
with IN None
lidocaine JJ Pharmocological
slow VB Physical
injection NN Physical
after IN Pharmocological
pretreatment NN Pharmocological
with IN Pharmocological
lidocaine JJ Pharmocological
rapid JJ Physical
administration NN Physical
of IN None
propofol JJ Pharmocological
slow JJ Physical
administration NN Physical
of IN None
propofol NN Pharmocological
. . None
-DOCSTART- -X- N

trandolapril JJ Pharmocological
hydrochlorothiazide VB Pharmocological
single-blind JJ None
placebo NN Control
trandolapril JJ Pharmocological
hydrochlorothiazide RB Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
or CC None
the DT None
combination NN None
-DOCSTART- -X- N

chemotherapy NN Pharmocological
Human NNP Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
receptor NN Pharmocological
2 CD Pharmocological
chemotherapy NN Pharmocological
anti-HER2 JJ Pharmocological
therapy NN Pharmocological
local JJ None
and CC None
central JJ None
evaluation NN None
using VBG None
immunohistochemistry NN Physical
combined VBN None
with IN None
in IN Physical
situ-hybridization NN Physical
evaluation NN None
of IN None
using VBG None
kinetic JJ Physical
RT-PCR JJ Physical
from IN None
formalin-fixed JJ None
, , None
paraffin-embedded JJ None
( ( None
FFPE NNP None
) ) None
tissue NN None
samples NNS None
-DOCSTART- -X- N

carbohydrate-protein JJ Pharmocological
supplement NN Pharmocological
protein NN Pharmocological
to TO Pharmocological
a DT Pharmocological
carbohydrate NN Pharmocological
supplement NN Pharmocological
carbohydrate NN Pharmocological
carbohydrate-protein JJ Pharmocological
supplement NN Pharmocological
Supplements NNS None
( ( None
200 CD None
ml NN None
) ) None
were VBD None
provided VBN None
every DT None
20 CD None
min NN None
and CC None
consisted VBN None
of IN None
placebo NN Control
, , None
a DT None
7.75 CD None
% NN None
carbohydrate JJ Pharmocological
solution NN Pharmocological
, , None
and CC None
a DT None
7.75 CD None
% NN None
carbohydrate/1.94 NN Pharmocological
% NN Pharmocological
protein JJ Pharmocological
solution NN Pharmocological
. . None
carbohydrate NN Pharmocological
carbohydrate-protein JJ Pharmocological
supplementation NN Pharmocological
carbohydrate-protein JJ Pharmocological
carbohydrate NN Pharmocological
supplement NN Pharmocological
-DOCSTART- -X- N

sodium JJ Pharmocological
restriction NN Pharmocological
no DT Control
dietary JJ Control
restriction NN Control
an DT None
energy NN None
reduced VBN None
diet JJ None
sodium NN Pharmocological
intake NN Pharmocological
being VBG Pharmocological
supplemented VBN Pharmocological
and CC None
hence RB None
unchanged JJ None
no DT Control
intervention NN Control
, , None
which WDT None
was VBD None
followed VBN None
by IN None
taking VBG None
a DT None
diet JJ None
restricted VBN None
in IN None
energy NN None
sodium NN Pharmocological
-DOCSTART- -X- N

nicorandil JJ Pharmocological
nicorandil NN Pharmocological
nicorandil NN Pharmocological
or CC None
a DT None
placebo NN Pharmocological
nicorandil JJ Pharmocological
placebo NN Control
nicorandil JJ Pharmocological
placebo NN Control
nicorandil NN Pharmocological
nicorandil NN Pharmocological
placebo NN Control
nicorandil NNS Pharmocological
-DOCSTART- -X- N

INCB13739 NNP Pharmocological
placebo-controlled JJ Control
INCB13739 NNP Pharmocological
doses NNS Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

booster NN Pharmocological
vaccination NN Pharmocological
] NNP None
booster NN Pharmocological
vaccination NN Pharmocological
against IN Pharmocological
diphtheria NN Pharmocological
vaccination NN None
booster NN Pharmocological
booster NN Pharmocological
vaccination NN Pharmocological
-DOCSTART- -X- N

We PRP Educational
identified VBD Educational
independent JJ Educational
predictors NNS Educational
of IN Educational
beta-blocker NN None
use NN None
-DOCSTART- -X- N

novel NN Physical
technique NN Physical
using VBG Physical
a DT Physical
barbed JJ Surgical
suture NN Surgical
. . None
barbed JJ Physical
suture NN Physical
barbed JJ Physical
suture NN Physical
conventional JJ Physical
closure NN Physical
3-0 JJ Pharmocological
polydioxanone NN Pharmocological
suture NN Pharmocological
. . None
conventional JJ Physical
suture NN Physical
-DOCSTART- -X- N

intermittent JJ Physical
mandatory JJ Physical
ventilation NN Physical
synchronized JJ Physical
intermittent NN Physical
mandatory JJ Physical
ventilation NN Physical
pressure NN Physical
support NN Physical
intermittent JJ Physical
mandatory JJ Physical
ventilation NN Physical
( ( Physical
IMV NNP Physical
) ) Physical
synchronized JJ Physical
intermittent JJ Physical
mandatory NN Physical
ventilation NN Physical
plus CC Physical
pressure NN Physical
support NN Physical
( ( Physical
SIMV+PS NNP Physical
) ) Physical
IMV NNP Physical
( ( Physical
IMVG NNP Physical
; : None
SIMV+PS NNP Physical
( ( None
SIMVG NNP Physical
; : None
[ JJ None
IMVG NNP Physical
: : None
SIMVG NNP Physical
: : None
[ JJ None
IMVG NNP Physical
: : None
SIMVG NNP Physical
: : None
IMV NNP Physical
SIMV+PS NNP Physical
-DOCSTART- -X- N

race NN Educational
-DOCSTART- -X- N

Three CD Pharmocological
diets NNS Pharmocological
Diet NNP Pharmocological
A NNP Pharmocological
, , Pharmocological
an DT Physical
average JJ Physical
American JJ Physical
diet NN Physical
, , Pharmocological
was VBD Pharmocological
designed VBN Pharmocological
to TO Pharmocological
provide VB Pharmocological
37 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
fat JJ Pharmocological
, , Pharmocological
16 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
saturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
SFAs NNP Pharmocological
) ) Pharmocological
; : None
diet JJ Pharmocological
B NNP Pharmocological
( ( Pharmocological
step NN Pharmocological
1 CD Pharmocological
diet NN Pharmocological
) ) Pharmocological
was VBD Pharmocological
designed VBN Pharmocological
to TO Pharmocological
provide VB Pharmocological
30 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
fat JJ Pharmocological
, , Pharmocological
9 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
SFA NNP Pharmocological
; : None
diet JJ Pharmocological
C NNP Pharmocological
( ( Pharmocological
low JJ Pharmocological
SFA NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
was VBD Pharmocological
designed VBN Pharmocological
to TO Pharmocological
provide VB Pharmocological
26 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
from IN Pharmocological
fat JJ Pharmocological
, , Pharmocological
5 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
-DOCSTART- -X- N

6 CD Physical
minute NN Physical
walk NN Physical
test NN Physical
( ( Physical
6MWT CD Physical
) ) Physical
6MWT CD Physical
-DOCSTART- -X- N

beta-blocker NN Pharmocological
usage NN Pharmocological
: : None
preoperative JJ None
?-blockers NNS None
preoperative JJ None
?-blocker NN None
use NN None
-DOCSTART- -X- N

probucol NN Pharmocological
probucol NN Pharmocological
control NN Pharmocological
( ( Pharmocological
levamlodipine JJ Pharmocological
besylate NN Pharmocological
plus CC Control
benazepril JJ Control
10 CD Control
or CC Pharmocological
probucol VBN Pharmocological
group NN Pharmocological
( ( Pharmocological
levamlodipine JJ Pharmocological
besylate NN Pharmocological
plus CC Pharmocological
benazepril JJ Pharmocological
plus CC Pharmocological
probucol JJ Pharmocological
-DOCSTART- -X- N

levosimendan NN Pharmocological
dobutamine NN Pharmocological
Levosimendan NNP Pharmocological
levosimendan NNS Pharmocological
dobutamine NN Pharmocological
levosimendan NN Pharmocological
or CC None
dobutamine NN Pharmocological
. . None
levosimendan NN Pharmocological
dobutamine NN Pharmocological
Levosimendan NNP Pharmocological
levosimendan JJ Pharmocological
levosimendan JJ Pharmocological
-DOCSTART- -X- N

Combined VBN Physical
modality NN Physical
therapy NN Physical
ABVD/MOPP NNP Pharmocological
compared VBN Pharmocological
to TO Pharmocological
ABVD/OPP NNP Pharmocological
ABVD/OPP NNP Physical
-DOCSTART- -X- N

Instant JJ None
Recess? NNP None
: : None
policy NN None
implementation NN None
intervention NN None
in-school JJ None
PA NNP None
Instant NNP None
Recess? NNP None
was VBD None
10-minute JJ None
PA NNP None
breaks NNS None
in IN None
classroom-based JJ None
-DOCSTART- -X- N

diuretics NNS Pharmocological
diuretics NNS Pharmocological
placebo NN Control
oral JJ Pharmocological
diuretics NNS Pharmocological
( ( Pharmocological
chlorothiazide NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg/kg/dose NN Pharmocological
and CC Pharmocological
spironolactone NN Pharmocological
, , Pharmocological
1.5 CD Pharmocological
mg/kg/dose NN Pharmocological
) ) Pharmocological
given VBN None
twice RB None
daily RB None
, , None
or CC None
placebo NN Control
. . None
placebo NN Control
. . None
placebo NN Control
. . None
diuretics NNS Pharmocological
-DOCSTART- -X- N

peginterferon NN Pharmocological
alpha NN Pharmocological
2a CD Pharmocological
interferon NN Pharmocological
alpha NN Pharmocological
2b CD Pharmocological
plus CC Pharmocological
ribavirin VB Pharmocological
peginterferon NN Pharmocological
alpha NN Pharmocological
( ( Pharmocological
pegIFNalpha NN Pharmocological
) ) Pharmocological
2a CD None
monotherapy NN Physical
combination NN Pharmocological
of IN Pharmocological
interferon NN Pharmocological
alpha NN Pharmocological
( ( Pharmocological
IFNalpha NNP Pharmocological
) ) Pharmocological
2b CD Pharmocological
plus CC Pharmocological
ribavirin NN Pharmocological
( ( Pharmocological
RBV NNP Pharmocological
) ) Pharmocological
open-label JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
either DT Pharmocological
pegIFNalpha NN Pharmocological
2a CD Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
206 CD Pharmocological
) ) Pharmocological
or CC None
IFNalpha $ Pharmocological
2b/RBV CD Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
206 CD Pharmocological
) ) Pharmocological
. . None
PegIFNalpha $ Pharmocological
2a CD Pharmocological
IFNalpha $ Pharmocological
2b/RBV CD Pharmocological
pegIFNalpha NN Pharmocological
2a CD Pharmocological
IFNalpha NNP Pharmocological
2b/RBV CD Pharmocological
pegIFNalpha VB Pharmocological
2a CD Pharmocological
IFNalpha NNP Pharmocological
2b/RBV CD Pharmocological
. . None
pegIFNalpha JJ Pharmocological
2a CD Pharmocological
IFNalpha NNP Pharmocological
2b/RBV CD Pharmocological
pegIFNalpha VB Pharmocological
2a CD Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
intravenous JJ Pharmocological
immunoglobulin NN Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
intravenously RB Pharmocological
administered VBN Pharmocological
immunoglobulin NN Pharmocological
G. NNP Pharmocological
placebo JJ Control
solution NN Control
or CC None
immunoglobulin NN Pharmocological
Immunomodulatory NNP Pharmocological
treatment NN Pharmocological
immunoglobulin NN Pharmocological
-DOCSTART- -X- N

bedside-precepted JJ Educational
visit NN Educational
with IN Educational
an DT Educational
specialist NN Educational
with IN Educational
pain NN Educational
specialization NN Educational
and CC Educational
a DT Educational
focus NN Educational
group NN Educational
to TO Educational
discuss VB Educational
attitudinal JJ Educational
issues NNS Educational
. . None
-DOCSTART- -X- N

zidovudine NN Pharmocological
didanosine NN Pharmocological
. . None
zidovudine NN Pharmocological
and CC None
didanosine NN Pharmocological
zidovudine NN Pharmocological
didanosine NN Pharmocological
zidovudine NN Pharmocological
didanosine JJ Pharmocological
zidovudine NN Pharmocological
didanosine JJ Pharmocological
zidovudine NN Pharmocological
didanosine JJ Pharmocological
-DOCSTART- -X- N

bupivacaine NN Pharmocological
infiltration NN Pharmocological
0.25 CD Pharmocological
% NN Pharmocological
plain NN Pharmocological
bupivacaine NN Pharmocological
or CC Pharmocological
0.9 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
-DOCSTART- -X- N

LEGO NNP Psychological
therapy NN Psychological
social JJ Educational
use NN Educational
of IN Educational
language NN Educational
programme NN Educational
: : None
LEGO NNP Psychological
therapy NN Psychological
Social NNP Educational
Use NNP Educational
of IN Educational
Language NNP Educational
Programme NNP Educational
( ( Educational
SULP NNP Educational
) ) Educational
social JJ Educational
skills NNS Educational
interventions NNS Educational
LEGO NNP Psychological
SULP NNP Educational
. . None
no-intervention JJ Control
control NN Control
group NN Control
LEGO NNP Psychological
no-intervention JJ Control
-DOCSTART- -X- N

sedation NN Pharmocological
regimens NNS Pharmocological
standard JJ Pharmocological
sedation NN Pharmocological
regimens NNS Pharmocological
Mini-Mental JJ Educational
State NNP Educational
Examination NNP Educational
propofol JJ Pharmocological
plus CC Pharmocological
fentanyl JJ Pharmocological
midazolam NN Pharmocological
plus CC Pharmocological
fentanyl JJ Pharmocological
propofol-alone JJ Pharmocological
propofol NN Pharmocological
fentanyl NN Pharmocological
. . None
-DOCSTART- -X- N

clarithromycin NN Pharmocological
clarithromycin JJ Pharmocological
caffeine NN Pharmocological
tolbutamide RB Pharmocological
dextromethorphan NN Pharmocological
clarithromycin NN Pharmocological
clarithromycin JJ Pharmocological
clarithromycin NN Pharmocological
clarithromycin NN Pharmocological
-DOCSTART- -X- N

elvitegravir/cobicistat/emtricitabine/tenofovir NN Pharmocological
disoproxil NN Pharmocological
fumarate NN Pharmocological
efavirenz/emtricitabine/tenofovir JJ Pharmocological
disoproxil NN Pharmocological
fumarate NN Pharmocological
EVG/COBI/FTC/TDF NNP Pharmocological
EFV/FTC/TDF NNP Pharmocological
EVG/COBI/FTC/TDF NNP Pharmocological
. . None
-DOCSTART- -X- N

device-guided JJ Educational
breathing NN Educational
exercises NNS Educational
device NN Educational
that WDT Educational
helps VBZ Educational
to TO Educational
( ( Educational
Resperate NNP Educational
) ) Educational
listened VBD Educational
to TO Educational
music NN Educational
and CC Educational
used VBN Educational
no DT Educational
other JJ Educational
therapeutic JJ Educational
device NN Educational
. . None
-DOCSTART- -X- N

alfuzosin NN Pharmocological
alfuzosin NN Pharmocological
placebo-controlled JJ Control
alfuzosin NN Pharmocological
or CC Control
matching VBG Control
placebo NN Control
alfuzosin NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

high-dose JJ Pharmocological
rate NN Pharmocological
intracavitary JJ Pharmocological
therapy NN Pharmocological
High-dose JJ Pharmocological
rate NN Pharmocological
( ( Pharmocological
HDR NNP Pharmocological
) ) Pharmocological
remote VBP Pharmocological
afterloading VBG Pharmocological
intracavitary JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Spatial JJ Other
orientation NN Other
adjustments NNS Other
wore VBD Physical
ambient JJ Other
prism NN Other
lenses NNS Other
alterations NNS Other
to TO Other
the DT Other
sensory JJ Other
systems NNS Other
-DOCSTART- -X- N

primary JJ Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
versus NN None
tissue NN Surgical
plasminogen NN Surgical
activator NN Surgical
therapy NN Surgical
. . None
tissue VB Physical
plasminogen NN Physical
activator NN Physical
( ( Physical
tPA NN Physical
) ) Surgical
or CC None
primary JJ Physical
percutaneous JJ Physical
transluminal JJ Physical
coronary NN Physical
angioplasty NN Physical
( ( Physical
PTCA NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

randomized VBN None
to TO None
endoscopic VB None
injection NN None
treatment NN None
with IN None
one CD None
of IN None
the DT None
following JJ None
agents NNS None
: : None
cyanoacrylate NN Pharmocological
; : None
a DT Pharmocological
1:1:1 CD Pharmocological
mixture NN Pharmocological
of IN Pharmocological
sodium NN Pharmocological
tetradecyl NN Pharmocological
sulfate VBP Pharmocological
3 CD Pharmocological
% NN Pharmocological
, , Pharmocological
ethanol RB Pharmocological
98 CD Pharmocological
% NN Pharmocological
, , Pharmocological
and CC Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
; : None
ethanolamine VB Pharmocological
oleate VBP Pharmocological
5 CD Pharmocological
% NN Pharmocological
; : None
sodium NN Pharmocological
morrhuate VBP Pharmocological
5 CD Pharmocological
% NN Pharmocological
; : Pharmocological
sodium NN Pharmocological
tetradecyl NN Pharmocological
sulfate VBP Pharmocological
1.5 CD Pharmocological
% NN Pharmocological
; : Pharmocological
polidocanol CC Pharmocological
1 CD Pharmocological
% NN Pharmocological
; : None
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
with IN Pharmocological
epinephrine JJ Pharmocological
1:10,000 CD Pharmocological
; : None
or CC None
normal JJ Control
saline JJ Control
solution NN Control
( ( Control
control NN Control
) ) Control
. . Control
-DOCSTART- -X- N

chemotherapy NN Pharmocological
whole JJ Pharmocological
abdominal JJ Pharmocological
radiotherapy NN Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
prednisone NN Pharmocological
association NN Pharmocological
. . None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
adriamycin NN Pharmocological
, , None
prednisone NN Pharmocological
. . None
Chemotherapy NNP Pharmocological
-DOCSTART- -X- N

with IN Physical
technetium-99m JJ Physical
methoxyisobutylisonitrile NN Physical
single JJ Physical
photon NN Physical
emission NN Physical
computed VBD Physical
tomography NN Physical
and CC None
computed VBD Physical
tomography NN Physical
: : None
18-fluoro-2-deoxyglucose JJ Physical
positron NN Physical
emission NN Physical
tomography NN Physical
. . Physical
technetium-99m JJ Physical
methoxyisobutylisonitrile NN Physical
( ( Physical
Tc-MIBI NNP Physical
) ) Physical
single JJ Physical
photon NN Physical
emission NN Physical
computed VBN Physical
tomography NN Physical
( ( Physical
SPECT NNP Physical
) ) Physical
and CC None
computed VBN Physical
tomography NN Physical
( ( Physical
CT NNP Physical
) ) Physical
radiotherapy NN Physical
positron NN Physical
emission NN Physical
tomography NN Physical
( ( Physical
PET NNP Physical
) ) Physical
with IN Physical
18-fluoro-2-deoxyglucose JJ Physical
( ( Physical
FDG NNP Physical
) ) Physical
. . None
FDG-PET NNP Physical
FDG-PET NNP Physical
CT NNP Physical
and CC None
Tc-MIBI NNP Physical
SPECT NNP Physical
FDG-PET NNP Physical
. . None
-DOCSTART- -X- N

L-ornithine-L-aspartate NNP Pharmocological
L-Ornithine-L-aspartate NNP Pharmocological
( ( Pharmocological
LOLA NNP Pharmocological
) ) Pharmocological
LOLA NNP Pharmocological
oral JJ Pharmocological
glutamine NN Pharmocological
( ( None
20 CD None
g NN None
) ) None
challenges VBZ None
, , None
receiving VBG None
LOLA NNP Pharmocological
( ( None
5 CD None
g RB None
intravenously RB None
) ) None
placebo NN Control
LOLA NNP Pharmocological
LOLA NNP Pharmocological
placebo NN Control
LOLA NNP Pharmocological
-DOCSTART- -X- N

Netilmicin NNP Pharmocological
versus NN Pharmocological
tobramycin NN Pharmocological
netilmicin-ticarcillin NN Pharmocological
tobramycin-ticarcillin NN Pharmocological
-DOCSTART- -X- N

azithromycin NN Pharmocological
Azithromycin NNP Pharmocological
azithromycin JJ Pharmocological
azithromycin VB Pharmocological
-DOCSTART- -X- N

inactivated JJ Pharmocological
whole-virus JJ Pharmocological
H1N1 NNP Pharmocological
A/California/07/2009 NNP Pharmocological
vaccine NN Pharmocological
. . None
3.75 CD None
or CC None
7.5 CD None
?g JJ None
hemagglutinin NN None
antigen NN None
21 CD None
days NNS None
apart RB None
. . None
-DOCSTART- -X- N

in-hospital JJ Educational
data NNS Educational
post-hospital JJ Educational
data NNS Educational
post-hospital JJ Educational
data NNS Educational
in-hospital JJ Educational
data NNS Educational
in-hospital JJ Educational
data NNS Educational
post-hospital JJ Educational
data NN Educational
. . None
post-hospital JJ Educational
data NNS Educational
. . None
-DOCSTART- -X- N

water NN Pharmocological
, , Pharmocological
lavender NN Pharmocological
, , Pharmocological
or CC Pharmocological
rosemary JJ Pharmocological
scent NN Pharmocological
-DOCSTART- -X- N

nifedipine NN Pharmocological
sustained VBN Pharmocological
release NN Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
nifedipine NN Pharmocological
sustained VBN Pharmocological
release NN Pharmocological
nifedipine JJ Pharmocological
SR NNP Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
nifedipine JJ Pharmocological
SR NNP Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
nifedipine JJ Pharmocological
SR NNP Pharmocological
Ginkgo NNP Pharmocological
biloba NN Pharmocological
extract NN Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
, , Pharmocological
nitroglycerin NN Pharmocological
, , Pharmocological
or CC Pharmocological
sodium NN Pharmocological
nitroprusside RB Pharmocological
. . None
Diltiazem NNP Pharmocological
Nitroglycerin NNP Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

emotional JJ Educational
distress NN Educational
structured JJ Other
questionnaire NN Other
enhanced JJ Educational
intervention NN Educational
conditions NNS Educational
standard JJ Educational
intervention NN Educational
. . None
motivation NN Educational
intervention NN Educational
-DOCSTART- -X- N

paclitaxel NN Control
or CC None
cyclophosphamide JJ Control
combination NN Control
treatment NN None
chemotherapy NN Pharmocological
paclitaxel NN Pharmocological
therapy NN None
. . None
paclitaxel NN Pharmocological
and CC None
cisplatin NN None
or CC None
cyclophosphamide NN Pharmocological
and CC None
cisplatin NN Pharmocological
. . None
paclitaxel/cisplatin NN Pharmocological
therapy NN None
cyclophosphamide/cisplatin JJ Pharmocological
paclitaxel/cisplatin NN Pharmocological
chemotherapy NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
cyclophosphamide NN Pharmocological
cisplatin NN Pharmocological
therapy NN None
paclitaxel/cisplatin JJ Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
hydroxide NN Pharmocological
and CC None
zinc NN Pharmocological
oxide RB Pharmocological
eugenol RB Pharmocological
Calcium NNP Pharmocological
hydroxide NN Pharmocological
calcium NN Pharmocological
hydroxide NN Pharmocological
and CC None
zinc NN Pharmocological
oxide NN Pharmocological
eugenol NN Pharmocological
used VBN None
as IN None
-DOCSTART- -X- N

Survey NNP Educational
thank NN Other
you PRP Other
or CC None
reminder VB Other
postcard NN Other
-DOCSTART- -X- N

Sun NNP Educational
protection NN Educational
behaviors NNS Educational
sun NN Educational
protection NN Educational
behaviors NNS Educational
avoid VBZ Educational
the DT Educational
sun NN Educational
during IN Educational
midday NN Educational
sunscreen JJ Other
) ) None
-DOCSTART- -X- N

RCT NNP None
of IN None
yoga NN Physical
, , None
exercise NN Physical
, , None
and CC None
omega-3 JJ Pharmocological
supplements NNS Pharmocological
. . None
3 CD None
nonhormonal JJ None
therapies NNS None
to TO None
yoga VB Physical
exercise NN None
or CC None
usual JJ Control
activity NN Control
of IN None
omega-3 JJ Pharmocological
177 CD None
) ) None
or CC None
placebo NN Control
1 CD None
) ) None
weekly JJ None
90-minute CD None
yoga NN None
classes NNS None
with IN None
daily JJ None
at-home JJ None
practice NN None
, , None
( ( None
2 CD None
) ) None
individualized VBN None
facility-based JJ None
aerobic JJ None
exercise NN None
training NN None
3 CD None
times/week NN None
, , None
omega-3 JJ Pharmocological
supplement NN Pharmocological
, , None
For IN None
yoga NN None
underwent VBP None
exercise NN Physical
and CC None
omega-3 JJ Pharmocological
therapy NN Pharmocological
yoga NN None
-DOCSTART- -X- N

erythromycin NN Pharmocological
erythromycin JJ Pharmocological
erythromycin JJ Pharmocological
250 CD None
mg RB None
four CD None
times NNS None
daily RB None
for IN None
10 CD None
days NNS None
or CC None
an DT None
identical-appearing JJ None
placebo NN None
. . None
erythromycin NN Pharmocological
placebo-treated JJ Control
erythromycin NN Pharmocological
placebo NN Control
erythromycin VB Pharmocological
Erythromycin NNP Pharmocological
-DOCSTART- -X- N

Ultrasonographic JJ Physical
tissue NN Physical
characterisation NN Physical
three-dimensional JJ Physical
imaging NN Physical
of IN Physical
the DT Physical
Achilles NNP Physical
tendon NN Physical
by IN Physical
ultrasonographic JJ Physical
tissue NN Physical
characterisation NN Physical
( ( Physical
UTC NNP Physical
) ) Physical
Symptomatic NNP None
and CC None
asymptomatic JJ None
tendons NNS None
were VBD None
scanned VBN Physical
using VBG Physical
the DT Physical
One CD None
researcher NN None
performed VBD None
the DT None
data NNS Physical
collection NN Physical
. . None
UTC NNP Physical
UTC NNP Physical
-DOCSTART- -X- N

oestroprogestins NNS None
two CD None
estroprogestins NNS None
( ( None
EPs NNP None
) ) None
, , None
ethinyl-estradiol JJ Pharmocological
( ( None
EE NNP None
) ) None
30 CD None
mcg/drospirenone NN None
( ( None
DRSP NNP None
) ) None
3 CD None
mg NN None
, , None
and CC None
ethinyl-estradiol NN Pharmocological
( ( None
EE NNP None
) ) None
30 CD None
mcg/chlormadinone NN Pharmocological
acetate NN Pharmocological
( ( None
CMA NNP None
) ) None
2 CD None
mg NN None
EE/DRSP NNP None
EE/CMA NNP None
EE/DRSP NNP None
Estroprogestins NNP Pharmocological
EE NNP None
30 CD None
mcg/DRSP NN None
3 CD None
mg NN None
-DOCSTART- -X- N

beta-adrenoceptor NN Pharmocological
pindolol NN Pharmocological
beta-adrenoceptor NN Pharmocological
blocking VBG Pharmocological
agent NN Pharmocological
metoprolol NN Pharmocological
pindolol NN Pharmocological
and CC None
metoprolol NN Pharmocological
metoprolol VB Pharmocological
, , None
pindolol VB Pharmocological
-DOCSTART- -X- N

progestogen NN Pharmocological
plus CC Pharmocological
oestradiol JJ Pharmocological
micronized JJ Pharmocological
oestradiol-17 JJ Pharmocological
beta NN Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
either DT Pharmocological
norethisterone NN Pharmocological
acetate NN Pharmocological
1 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
megestrol VB Pharmocological
acetate JJ Pharmocological
5 CD Pharmocological
mg NN Pharmocological
norethisterone NN Pharmocological
acetate NN Pharmocological
. . None
oestradiol-progestogen JJ Pharmocological
combination NN Pharmocological
progestogen NN Pharmocological
-DOCSTART- -X- N

high-dose JJ Pharmocological
cisplatin NN Pharmocological
paclitaxel NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
Paclitaxel NNP Pharmocological
cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
cisplatin NN Pharmocological
paclitaxel/cisplatin NN Pharmocological
-DOCSTART- -X- N

ozonotherapy NN Pharmocological
and CC None
klimadynon NN Pharmocological
-DOCSTART- -X- N

Dynamic NNP Other
Hip NNP Other
Screw NNP Other
and CC None
the DT Physical
Gamma NNP Other
locking VBG Other
nail NN Other
Gamma NNP Other
nail NN Other
. . None
Gamma NNP Physical
nail NN Physical
-DOCSTART- -X- N

ketoconazole NN Pharmocological
griseofulvin NN Pharmocological
ketoconazole JJ Pharmocological
200 CD Pharmocological
mg JJ Pharmocological
daily JJ Pharmocological
or CC Pharmocological
griseofulvin JJ Pharmocological
1 CD Pharmocological
g JJ Pharmocological
ketoconazole NN Pharmocological
griseofulvin NN Pharmocological
-DOCSTART- -X- N

amnioinfusion NN Pharmocological
amnioinfusion NN Pharmocological
with IN Pharmocological
warmed JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
, , None
room-temperature JJ Pharmocological
saline NN Pharmocological
, , None
or CC None
control NN Control
. . None
amnioinfusion NN Pharmocological
amnioinfusion NN Pharmocological
-DOCSTART- -X- N

serum NN Pharmocological
methotrexate NN Pharmocological
methotrexate NN Pharmocological
6-mercaptopurine JJ Pharmocological
( ( Pharmocological
6-MP JJ Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

compare VB None
pretreatment JJ Physical
plasma JJ Physical
EBV-DNA JJ Physical
quantification NN Physical
with IN None
EBV NNP Physical
by IN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

Denosumab NNP Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
denosumab NN Pharmocological
with IN None
zoledronic JJ None
acid NN None
receive VB None
either RB None
subcutaneous JJ None
denosumab NN None
120 CD None
mg NN None
and CC None
intravenous JJ None
or CC None
intravenous JJ None
zoledronic JJ None
acid NN None
4 CD None
mg NN None
adjusted VBN None
for IN None
creatinine JJ None
clearance NN None
and CC None
subcutaneous JJ None
daily JJ None
calcium NN None
and CC None
vitamin NN None
D NNP None
RESULTS NNP None
Denosumab NNP None
to TO None
zoledronic JJ None
acid NN None
with IN None
denosumab NN None
. . None
denosumab NN None
; : None
zoledronic JJ None
acid NN None
; : None
CONCLUSION NNP None
Denosumab NNP None
to TO None
zoledronic JJ None
acid NN None
denosumab JJ None
-DOCSTART- -X- N

Lactoferrin NNP Pharmocological
supplementation NN Pharmocological
supplemental JJ Pharmocological
lactoferrin NN Pharmocological
lactoferrin NN Pharmocological
lactoferrin JJ Pharmocological
supplements NNS Pharmocological
lactoferrin JJ Pharmocological
supplements NNS Pharmocological
Lactoferrin NNP Pharmocological
supplementation NN Pharmocological
lactoferrin JJ Pharmocological
supplementation NN Pharmocological
lactoferrin NN Pharmocological
-DOCSTART- -X- N

John NNP Pharmocological
's POS Pharmocological
wort NN Pharmocological
( ( Pharmocological
SJW NNP Pharmocological
) ) Pharmocological
SJW NNP Pharmocological
SJW NNP Pharmocological
SJW NNP Pharmocological
300 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
600 CD Pharmocological
mg NN Pharmocological
, , None
or CC None
a DT None
matching JJ None
placebo NN Control
tablet NN None
3 CD None
times NNS None
a DT None
day NN None
combined VBN Educational
with IN Educational
a DT Educational
behavioral JJ Psychological
intervention NN Psychological
for IN Educational
12 CD Educational
weeks NNS Educational
. . Educational
SJW NNP Pharmocological
SJW NNP Pharmocological
. . Pharmocological
SJW NNP Pharmocological
-DOCSTART- -X- N

Misoprostol NNP Pharmocological
( ( None
400 CD None
mcg NN None
) ) None
or CC None
its PRP$ None
matching JJ None
placebo NN Control
misoprostol NN Pharmocological
misoprostol NN Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
placebo-controlled JJ Control
diltiazem NN Pharmocological
placebo VB Control
diltiazem NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

moxifloxacin NN Pharmocological
moxifloxacin NN Pharmocological
400-mg JJ Pharmocological
intravenous JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
moxifloxacin NN Pharmocological
. . None
moxifloxacin JJ Pharmocological
-DOCSTART- -X- N

Tramadol NNP Pharmocological
suppository NN Pharmocological
placebo NN Control
tramodol NN Pharmocological
placebo NN Control
oftramadol VBP Pharmocological
50 CD Pharmocological
mg NNS Pharmocological
or CC None
two CD Control
tablets NNS Control
ofplacebo RB Control
Tramadol NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

Estradiol NNP Pharmocological
and CC None
the DT None
addition NN None
of IN None
progesterone NN Pharmocological
neuroactive JJ Pharmocological
steroid NN Pharmocological
, , Pharmocological
pregnanolone NN Pharmocological
postmenopausal NN Pharmocological
hormone NN Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
HRT NNP Pharmocological
) ) Pharmocological
natural JJ Pharmocological
progesterone NN Pharmocological
. . None
pregnanolone NN Pharmocological
HRT NNP Pharmocological
oral JJ Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
vaginal JJ Pharmocological
progesterone NN Pharmocological
or CC None
placebo NN Control
pregnanolone NN None
pregnanolone NN Pharmocological
( ( Pharmocological
3alpha-hydroxy-5beta-pregnan-20-one CD Pharmocological
) ) Pharmocological
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
alone RB Pharmocological
or CC None
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
+progesterone CD Pharmocological
pregnanolone NN Pharmocological
HRT NNP Pharmocological
. . None
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
alone RB None
, , None
or CC None
E NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
+progesterone NN Pharmocological
, , None
pregnanolone VB Pharmocological
HRT NNP Pharmocological
. . None
-DOCSTART- -X- N

beclomethasone NN Pharmocological
dipropionate NN Pharmocological
intranasal NN Pharmocological
beclomethasone NN Pharmocological
dipropionate NN Pharmocological
( ( Pharmocological
Bdp NNP Pharmocological
) ) Pharmocological
Bdp NNP Pharmocological
Bdp NNP Pharmocological
. . None
-DOCSTART- -X- N

Esmolol NNP Pharmocological
esmolol NN Pharmocological
placebo NN Control
. . Control
Esmolol NNP Pharmocological
anesthesia NN Pharmocological
extubation NN Surgical
. . None
-DOCSTART- -X- N

Needle NNP Surgical
versus NN Surgical
loop NN Surgical
diathermy NN Surgical
excision NN Surgical
needle JJ Surgical
excision NN Surgical
of IN Surgical
the DT Surgical
transformation NN Surgical
zone NN Surgical
( ( Surgical
NETZ NNP Surgical
) ) Surgical
than IN None
with IN None
loop JJ Surgical
excision NN Surgical
( ( Surgical
LLETZ NNP Surgical
) ) Surgical
. . None
LLETZ NNP Surgical
or CC None
NETZ NNP Surgical
. . None
LLETZ NNP Surgical
NETZ NNP Surgical
NETZ NNP Surgical
LLETZ NNP Surgical
. . None
-DOCSTART- -X- N

online NN Educational
continuing VBG Educational
medical JJ Educational
education NN Educational
( ( Educational
CME NNP Educational
) ) Educational
seminars VBZ Educational
seminar NN Educational
about IN Educational
type NN Educational
2 CD Educational
diabetes NNS Educational
or CC None
a DT None
seminar NN Educational
about IN Educational
systolic JJ Educational
heart NN Educational
failure NN Educational
. . None
seminar NN Educational
online JJ Educational
CME NNP Educational
programs NNS Educational
-DOCSTART- -X- N

desvenlafaxine NN Pharmocological
versus NN None
placebo NN Control
. . None
desvenlafaxine NN Pharmocological
desvenlafaxine JJ Pharmocological
succinate NN Pharmocological
) ) Pharmocological
( ( None
n JJ None
= NNP None
285 CD None
) ) None
and CC None
placebo NN None
( ( None
n JJ None
desvenlafaxine NN None
and CC None
placebo NN None
were VBD None
desvenlafaxine NN None
( ( None
n JJ None
= NNP None
208 CD None
) ) None
and CC None
placebo NN None
Desvenlafaxine NNP None
-DOCSTART- -X- N

immunotherapy NN Pharmocological
tablet NN Pharmocological
grass NN Pharmocological
allergy NN Pharmocological
immunotherapy NN Pharmocological
tablet NN Pharmocological
( ( Pharmocological
AIT NNP Pharmocological
) ) Pharmocological
grass NN Pharmocological
AIT NNP Pharmocological
placebo NN Control
placebo VB None
: : None
AIT NNP Pharmocological
placebo VB None
. . None
-DOCSTART- -X- N

Intranasal NNP None
recombinant JJ None
alfa-2b JJ Pharmocological
interferon NN Pharmocological
recombinant JJ Pharmocological
alfa-2b JJ Pharmocological
interferon NN Pharmocological
placebo VB Control
placebo VBN Control
placebo NN Control
nasal JJ Physical
washings NNS Physical
placebo NN Control
interferon NN Pharmocological
Interferon NNP Pharmocological
placebo VB Control
placebo NN Control
recombinant JJ None
alfa-2b JJ Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

high-dose JJ Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
HD-MPA NNP Pharmocological
) ) Pharmocological
placebo NN Control
Combination NNP Physical
therapy NN Physical
, , Physical
( ( Physical
CT NNP Physical
) ) Physical
MPA NNP Pharmocological
CT NNP Physical
+ NNP Physical
MPA NNP Physical
CT NNP Control
+ NNP Control
placebo NN Control
. . None
MPA NNP Physical
-DOCSTART- -X- N

thrombolytic JJ Pharmocological
agents NNS Pharmocological
pre-hospital JJ Pharmocological
early JJ Pharmocological
thrombolytic JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

epidural JJ Pharmocological
tramadol-ropivacaine JJ Pharmocological
and CC None
fentanyl-ropivacaine JJ Pharmocological
tramadol NN Pharmocological
fentanyl NN Pharmocological
ropivacaine NN Pharmocological
tramadol VBD Pharmocological
( ( Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
ropivacaine NN Pharmocological
plus CC Pharmocological
tramadol JJ Pharmocological
5 CD Pharmocological
mg/mL NN Pharmocological
) ) Pharmocological
fentanyl NNP Pharmocological
( ( Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
ropivacaine NN Pharmocological
plus CC Pharmocological
fentanyl JJ Pharmocological
3 CD Pharmocological
ug/mL NN Pharmocological
) ) Pharmocological
fentanyl VBD Pharmocological
tramadol NN Pharmocological
tramadol NN Pharmocological
fentanyl VB Pharmocological
-DOCSTART- -X- N

educational JJ Other
baby NN Other
books NNS Other
an DT None
educational JJ Other
book NN Other
group NN Other
, , None
a DT None
noneducational JJ Other
book NN Other
group NN Other
, , None
or CC None
a DT None
no-book JJ Control
group NN Control
. . None
-DOCSTART- -X- N

Theta NNP Physical
burst JJS Physical
stimulation NN Physical
cortical JJ Physical
stimulation NN Physical
theta JJ Physical
burst JJ Physical
stimulation NN Physical
( ( Physical
TBS NNP Physical
) ) Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
TMS NNP Physical
) ) Physical
sham NN Physical
TBS NNP Physical
. . Control
TBS NNP Physical
TBS NNP Physical
. . None
-DOCSTART- -X- N

tamsulosin NN Pharmocological
and CC None
silodosin NN Pharmocological
the DT None
T-S NNP None
group NN None
( ( None
tamsulosin $ None
0.2 CD None
mg NN None
orally RB None
once RB None
daily JJ None
for IN None
4 CD None
weeks NNS None
then RB None
silodosin VBD None
4 CD None
mg NNS None
orally RB None
twice RB None
daily RB None
for IN None
4 CD None
weeks NNS None
) ) None
or CC None
the DT None
S-T JJ None
group NN None
( ( None
silodosin $ None
4 CD None
mg NN None
orally RB None
twice JJ None
daily RB None
for IN None
4 CD None
weeks NNS None
then RB None
tamsulosin VBD None
0.2 CD None
mg NNS None
orally RB None
once RB None
daily JJ None
for IN None
4 CD None
weeks NNS None
) ) None
. . None
preferred VBD None
tamsulosin NN None
preferred VBD None
silodosin NN None
with IN None
tamsulosin NN None
with IN None
silodosin NN None
that IN None
tamsulosin NN None
-DOCSTART- -X- N

midazolam NN Pharmocological
midazolam NN Pharmocological
or CC None
placebo NN Control
etomidate NN Pharmocological
. . None
midazolam NN Pharmocological
etomidate NN Pharmocological
placebo NN Control
midazolam VBD Pharmocological
-DOCSTART- -X- N

benzodiazepine JJ Pharmocological
Ro NNP Pharmocological
15-1788 JJ Pharmocological
. . None
Ro NNP Pharmocological
15-1788 JJ Pharmocological
Ro NNP Pharmocological
15-1788 JJ Pharmocological
-DOCSTART- -X- N

imipramine NN Pharmocological
, , None
mexiletine NN Pharmocological
, , None
pirmenol NN Pharmocological
, , None
procainamide NN Pharmocological
, , None
propafenone NN Pharmocological
, , None
quinidine NN Pharmocological
, , None
and CC None
sotalol NN Pharmocological
electrophysiologic NN Physical
study NN Physical
or CC Physical
Holter NNP Physical
monitoring VBG Physical
together RB Physical
with IN Physical
exercise NN Physical
testing NN Physical
. . None
-DOCSTART- -X- N

choline NN Pharmocological
choline NN Pharmocological
with IN Pharmocological
0 CD Pharmocological
( ( Pharmocological
control NN Pharmocological
) ) Pharmocological
, , Pharmocological
425 CD Pharmocological
, , Pharmocological
850 CD Pharmocological
, , Pharmocological
1,700 CD Pharmocological
, , Pharmocological
3,400 CD Pharmocological
6,800 CD Pharmocological
mg/kg NN Pharmocological
of IN Pharmocological
corn-soybean JJ Pharmocological
meal-based JJ Pharmocological
diets NNS Pharmocological
corn-soybean JJ Pharmocological
meal-based JJ Pharmocological
diet NN Pharmocological
-DOCSTART- -X- N

phlebotomy NN Control
alone RB Control
myelosuppressive JJ Pharmocological
agents NNS Pharmocological
, , None
32P CD Pharmocological
or CC None
chlorambucil NN Pharmocological
supplemented VBN None
by IN None
phlebotomy NN Physical
single JJ None
optimal JJ None
therapy NN None
-DOCSTART- -X- N

bedtime JJ None
aspirin JJ Pharmocological
administration NN Pharmocological
Aspirin NNP Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
nonpharmacological JJ None
hygienic-dietary JJ None
recommendations NNS None
; : None
the DT None
same JJ None
recommendations NNS None
and CC None
aspirin NN Pharmocological
( ( None
100 CD None
mg/day NN None
) ) None
on IN None
awakening VBG None
; : None
the DT None
same JJ None
recommendations NNS None
and CC None
aspirin NN Pharmocological
at IN None
bedtime NN None
. . None
nonpharmacological JJ Physical
intervention NN Physical
aspirin NN Pharmocological
aspirin NN Pharmocological
aspirin JJ Pharmocological
aspirin NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

irradiated VBN Physical
with IN Physical
7 CD Physical
Gy NNP Physical
single JJ Physical
dose NN Physical
within IN Physical
16-20 JJ Physical
h NN Physical
before IN Physical
operation NN Physical
. . Physical
treated VBN Pharmocological
with IN Pharmocological
nonsteroidal JJ Pharmocological
anti-inflammatory JJ Pharmocological
drugs NNS Pharmocological
( ( Pharmocological
NSAID NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
Voltaren NNP Pharmocological
resinat VBZ Pharmocological
2 CD Pharmocological
x NN Pharmocological
75 CD Pharmocological
mg/day NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
) ) Pharmocological
. . Pharmocological
-DOCSTART- -X- N

reperfusion NN None
primary VB Physical
percutaneous JJ Physical
coronary JJ Physical
intervention NN Physical
streptokinase NN Pharmocological
. . None
Primary NNP Physical
percutaneous JJ Physical
coronary JJ Physical
intervention NN Physical
( ( Physical
PCI NNP Physical
) ) Physical
thrombolytic JJ Pharmocological
therapy NN Pharmocological
PCI NNP Physical
thrombolytic JJ Pharmocological
therapy NN Pharmocological
PCI NNP Physical
SK NNP Pharmocological
-DOCSTART- -X- N

rituximab NN Pharmocological
rituximab NN Pharmocological
( ( Pharmocological
RTX NNP Pharmocological
) ) Pharmocological
placebo VB Control
( ( None
PBO NNP None
) ) None
+ NN Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
; : Pharmocological
PBO-randomized NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
RTX NNP Pharmocological
+ NNP Pharmocological
MTX NNP Pharmocological
( ( Pharmocological
RTX-randomized NNP Pharmocological
) ) Pharmocological
. . None
RTX NNP Pharmocological
RTX NNP Pharmocological
RTX NNP Pharmocological
RTX-randomized JJ Pharmocological
RTX NNP Pharmocological
RTX-randomized NNP Pharmocological
both DT None
PBO-randomized NNP None
( ( None
and CC None
RTX-randomized NNP None
( ( None
PBO-randomized NNP None
versus NN None
RTX-randomized JJ None
patients NNS None
CONCLUSION NNP None
RTX NNP None
re-treatment NN None
over IN None
initiating VBG None
RTX NNP None
treatment NN None
may MD None
-DOCSTART- -X- N

melphalan/prednisone NN Pharmocological
melphalan/ VB Pharmocological
prednisone NN Pharmocological
+ NNP Pharmocological
interferon VBZ Pharmocological
alpha-2b NN Pharmocological
-DOCSTART- -X- N

Symptomatic JJ Physical
treatment NN Physical
combination NN Pharmocological
chemotherapy NN Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
cisplatin NN Pharmocological
etoposide VB Pharmocological
symptomatic JJ Physical
treatment NN Physical
. . None
-DOCSTART- -X- N

pentoxifylline NN Pharmocological
added VBN Pharmocological
to TO Pharmocological
risperidone VB Pharmocological
: : None
pentoxifylline NN Pharmocological
plus CC Pharmocological
risperidone NN Pharmocological
pentoxifylline+risperidone VB Pharmocological
or CC None
placebo+risperidone VB Pharmocological
risperidone NN Pharmocological
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
combination NN Pharmocological
of IN Pharmocological
atypical JJ Pharmocological
antipsychotic JJ Pharmocological
medications NNS Pharmocological
and CC Pharmocological
pentoxifylline NN Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
supplementation NN Pharmocological
calcium NN Pharmocological
supplementation NN Pharmocological
calcium NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
receiving VBG Pharmocological
a DT Pharmocological
1200-mg JJ Pharmocological
calcium NN Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
Caltrate NNP Pharmocological
) ) Pharmocological
supplement NN Pharmocological
. . Pharmocological
Calcium NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

moderate JJ Physical
to TO Physical
aerobic JJ Physical
exercise NN Physical
Exercise NN Physical
exercise NN Physical
exercise NN Physical
randomised VBN None
to TO None
no-exercise NN None
or CC None
to TO None
a DT None
bout NN None
of IN None
treadmill NN None
exercise NN None
at IN None
Sleep VB None
on IN None
no-exercise NN None
and CC None
exercise NN None
nights NNS None
assessed VBN None
by IN None
polysomnography NN None
. . None
Participants NNS None
after IN None
exercise NN None
at IN None
no-exercise JJ None
condition NN None
vigorous JJ None
exercise NN None
did VBD None
level NN None
of IN None
exercise NN None
-DOCSTART- -X- N

oxprenolol JJ Pharmocological
or CC Pharmocological
methyldopa NN Pharmocological
beta-adrenoreceptor NN Pharmocological
blocking VBG Pharmocological
agents NNS Pharmocological
. . None
oxprenolol NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Induction NNP Pharmocological
noninduction NN Pharmocological
antithymocyte NN Pharmocological
globulins NNS Pharmocological
( ( Pharmocological
ATG NNP Pharmocological
) ) Pharmocological
tacrolimus JJ Pharmocological
tacrolimus NN Pharmocological
Steroid JJ Pharmocological
boluses NNS Pharmocological
Azathioprine NNP Pharmocological
ATG NNP Pharmocological
-DOCSTART- -X- N

Continuous JJ Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
. . None
discontinue VB Pharmocological
cytotoxics NNS Pharmocological
after IN Pharmocological
6 CD Pharmocological
months NNS Pharmocological
and CC Pharmocological
move VB Pharmocological
to TO Pharmocological
maintenance VB Pharmocological
hormones NNS Pharmocological
continue VB Pharmocological
chemotherapy NN Pharmocological
Continuous JJ Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

aggressive JJ Pharmocological
cystostatic JJ Pharmocological
aggressiveness NN Pharmocological
of IN Pharmocological
effective JJ Pharmocological
induction NN Pharmocological
treatment NN Pharmocological
maintenance NN None
chemotherapy NN None
. . None
followed VBN Physical
without IN Physical
cytostatics NNS Physical
receiving VBG None
six CD None
courses NNS None
of IN None
melphalan NN None
and CC None
prednisone NN None
( ( None
MP-P NNP None
) ) None
MPH-P NNP None
MPH-P NNP None
and CC None
four CD None
courses NNS None
of IN None
combination NN None
chemotherapy NN None
with IN None
Peptichemio NNP None
, , None
vincristine NN None
and CC None
prednisone NN None
( ( None
PTC-VCR-P NNP None
) ) None
. . None
MPH-P NNP None
MPH-P NNP None
combination NN None
chemotherapy NN None
Combination NNP None
chemotherapy NN None
MPH-P NNP None
MPH-P NNP None
MPH-P NNP None
combination NN None
chemotherapy NN None
. . None
chemotherapy NN None
MPH-P NNP None
PTC NNP None
, , None
VCR NNP None
and CC None
P NNP None
PTC-VCR-P NNP None
MPH-P NNP None
-DOCSTART- -X- N

argon-laser NN Surgical
trabeculoplasty NN Surgical
-DOCSTART- -X- N

whey-predominant JJ Pharmocological
, , Pharmocological
50 CD Pharmocological
% NN Pharmocological
medium NN Pharmocological
chain NN Pharmocological
triglyceride IN Pharmocological
formula NN Pharmocological
with IN Pharmocological
relatively RB Pharmocological
high JJ Pharmocological
concentrations NNS Pharmocological
of IN Pharmocological
zinc NN Pharmocological
and CC None
copper NN Pharmocological
12.5 CD Pharmocological
mg/L NN Pharmocological
of IN Pharmocological
zinc NN Pharmocological
0.9 CD Pharmocological
mg/L NN Pharmocological
or CC Pharmocological
2.1 CD Pharmocological
mg/L NN Pharmocological
of IN Pharmocological
copper NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

resistance NN Physical
versus NN Physical
endurance NN Physical
training NN Physical
resistance NN Physical
and CC Physical
endurance NN Physical
training NN Physical
endurance NN Physical
training NN Physical
group NN Educational
( ( Educational
n=8 NN Educational
) ) Educational
, , Educational
resistance NN Physical
training NN Physical
group NN Educational
( ( Educational
n=8 CC Educational
) ) Educational
and CC Educational
control NN Control
group NN Educational
( ( Educational
n=8 RB Educational
) ) Educational
. . None
were VBD None
taken VBN None
in IN None
fasting VBG None
state NN None
from IN None
all DT None
subjects NNS None
. . None
The DT None
experimental JJ None
groups NNS None
performed VBD None
either CC None
endurance NN Physical
or CC None
resistance NN Physical
training NN Physical
3 CD None
days NNS None
a DT None
week NN None
for IN None
12 CD None
weeks NNS None
. . None
The DT None
endurance NN Physical
training NN Physical
programme NN Physical
included VBD None
continuous JJ None
running VBG None
at IN None
an DT None
intensity NN None
corresponding VBG None
to TO None
75-85 CD None
% NN None
of IN None
maximal JJ None
heart NN None
rate NN None
, , None
while IN None
resistance NN Physical
training NN Physical
consisted VBD None
of IN None
four CD None
sets NNS None
of IN None
circuit NN None
weight NN None
training NN None
for IN None
11 CD None
stations NNS None
and CC None
at IN None
an DT None
intensity NN None
corresponding VBG None
to TO None
50-60 CD None
% NN None
of IN None
one-repetition JJ None
maximum NN None
. . None
-DOCSTART- -X- N

Buprenorphine NNP None
naloxone NN None
naloxone NN Pharmocological
buprenorphine NN Pharmocological
buprenorphine NN None
naloxone NN None
placebo NN Control
. . None
Buprenorphine NNP None
naloxone RB None
buprenorphine NN None
. . None
buprenorphine NN None
buprenorphine VB None
-DOCSTART- -X- N

laquinimod NN Pharmocological
laquinimod JJ Pharmocological
laquinimod NN Pharmocological
placebo VB Control
laquinimod $ Pharmocological
-DOCSTART- -X- N

carbohydrate NN Pharmocological
and CC Pharmocological
fiber NN Pharmocological
increased JJ Pharmocological
carbohydrate NN Pharmocological
and CC Pharmocological
fiber NN Pharmocological
intakes NNS Pharmocological
energy NN Pharmocological
from IN Pharmocological
low-fiber JJ Pharmocological
breakfast NN Pharmocological
cereal NN Pharmocological
( ( Pharmocological
LF NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
, , None
high-fiber JJ Pharmocological
breakfast NN Pharmocological
cereal NN Pharmocological
( ( Pharmocological
HF NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
, , None
or CC None
monounsaturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
MUFA NNP Pharmocological
diet NN Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

calcium NN Pharmocological
and CC None
salmon JJ Pharmocological
calcitonin NN Pharmocological
] NN None
salmon JJ Pharmocological
calcitonin NN Pharmocological
. . None
calcium NN Pharmocological
100 CD None
I.U NNP None
. . None
calcitonin NN Pharmocological
subcutaneously RB None
every DT None
second JJ None
evening NN None
and CC None
group NN None
3 CD None
( ( None
n JJ None
= NNP None
20 CD None
) ) None
received VBD None
the DT None
same JJ None
dose NN None
every DT None
evening NN None
. . None
-DOCSTART- -X- N

tunnelling VBG Physical
tunnelling NN Physical
Tunnelling NN Physical
tunnelled JJ Physical
catheters NNS Physical
non-tunnelled JJ Physical
catheters NNS Physical
tunnelling NN Physical
-DOCSTART- -X- N

Cimetidine NNP Pharmocological
H2-histamine NNP Pharmocological
receptor NN Pharmocological
antagonists NNS Pharmocological
cimetidine NN Pharmocological
Cimetidine NNP Pharmocological
cimetidine NN Pharmocological
. . None
-DOCSTART- -X- N

short-term JJ Other
sprint NN Other
and CC Educational
power NN Other
training NN Other
programs NNS Other
short-term JJ Other
sprint NN Other
and CC Educational
power NN Other
training NN Other
protocols NNS Other
The DT Educational
training NN Educational
intervention NN Educational
6 CD Educational
supervised JJ Educational
training NN Educational
sessions NNS Educational
SPRINT NNP Other
training NN Other
protocol NN Other
CONTRAST NNP Educational
training NN Educational
-DOCSTART- -X- N

Metformin NNP Pharmocological
metformin NN Pharmocological
pretreatment NN Pharmocological
metformin RB Pharmocological
day-1 NN None
) ) None
/placebo NN Control
metformin/placebo VBN Pharmocological
together RB None
with IN None
clomiphene NN Pharmocological
metformin NNS Pharmocological
placebo NN Control
placebo NN Control
metformin NN Pharmocological
placebo NN Control
metformin NNS Pharmocological
placebo NNS Control
Metformin NNP Pharmocological
-DOCSTART- -X- N

inspiratory JJ Physical
impedance NN Physical
threshold JJ Physical
device NN Physical
on IN Physical
a DT Physical
facemask NN Physical
and CC Physical
endotracheal VB Physical
tube NN Physical
inspiratory JJ Physical
impedance NN Physical
threshold NN Physical
device NN Physical
( ( Physical
ITD NNP Physical
) ) Physical
ITD NNP Physical
facemask NN Physical
or CC Physical
ETT NNP Physical
. . None
An DT None
active JJ Physical
and CC Physical
sham JJ Physical
ITD NNP Physical
facemask NN Physical
ETT NNP Physical
A DT None
sham NN Physical
and CC Physical
an DT Physical
active JJ Physical
ITD NNP Physical
facemask NN Physical
ETT NNP Physical
. . None
sham NN Physical
active JJ Physical
ITD NN Physical
facemask NN Physical
and CC Physical
ETT NNP Physical
active JJ Physical
ITD NNP Physical
attached VBD Physical
to TO Physical
a DT Physical
facemask NN Physical
or CC Physical
an DT Physical
ETT NNP Physical
ITD NNP Physical
a DT None
facemask NN Physical
ETT NNP Physical
ITD-facemask JJ Physical
combination NN Physical
-DOCSTART- -X- N

autologous JJ Physical
transplantation NN Physical
of IN Physical
bone-marrow JJ Physical
cells NNS Physical
: : Physical
autologous JJ Physical
implantation NN Physical
of IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
in IN None
injected VBN Physical
with IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
into IN Physical
the DT Physical
gastrocnemius NN Physical
of IN Physical
the DT Physical
ischaemic JJ Physical
limb NN Physical
and CC Physical
with IN Physical
saline NN Physical
into IN Physical
the DT Physical
less JJR Physical
ischaemic JJ Physical
limb NN Physical
. . None
injected VBN Physical
with IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
in IN Physical
one CD Physical
leg NN Physical
and CC Physical
peripheral JJ Physical
blood-mononuclear JJ Physical
cells NNS Physical
in IN Physical
the DT Physical
other JJ Physical
as IN Physical
a DT Physical
control NN Physical
. . None
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
peripheral JJ Physical
blood-mononuclear JJ Physical
cells NNS Physical
Autologous NNP Physical
implantation NN Physical
of IN Physical
bone NN Physical
marrow-mononuclear JJ Physical
cells NNS Physical
-DOCSTART- -X- N

sibutramine NN Pharmocological
sibutramine-induced JJ Pharmocological
sibutramine JJ Pharmocological
placebo NN Control
sibutramine JJ Pharmocological
sibutramine NN Pharmocological
sibutramine JJ Pharmocological
sibutramine NN Pharmocological
sibutramine NN Pharmocological
-DOCSTART- -X- N

Naltrexone NN Pharmocological
naltrexone NN Pharmocological
Naltrexone NNP Pharmocological
, , None
1.0 CD None
mg/kg NN None
, , None
or CC None
placebo NN Control
was VBD None
administered VBN None
daily RB None
for IN None
2 CD None
weeks NNS None
. . None
videotaped JJ Educational
samples NNS Educational
of IN Educational
seminaturalistic JJ Educational
parent-child JJ Educational
interaction NN Educational
. . None
naltrexone NN Pharmocological
placebo NN Control
naltrexone NN Pharmocological
-DOCSTART- -X- N

Clomipramine NNP Pharmocological
versus NN Pharmocological
haloperidol NN Pharmocological
placebo-controlled JJ Control
Clomipramine NNP Pharmocological
, , Pharmocological
haloperidol NN Pharmocological
, , None
and CC None
placebo NN Control
clomipramine NN Pharmocological
haloperidol NN Pharmocological
haloperidol NN Pharmocological
. . Pharmocological
clomipramine NN Pharmocological
haloperidol VB Pharmocological
clomipramine NN Pharmocological
haloperidol NN Pharmocological
haloperidol VBZ Pharmocological
Clomipramine NNP Pharmocological
-DOCSTART- -X- N

refrain VB Educational
from IN Educational
blinking VBG Educational
refrain VB Educational
from IN Educational
blinking VBG Educational
subjects NNS Educational
who WP Educational
are VBP Educational
discouraged VBN Educational
from IN Educational
blinking VBG Educational
-DOCSTART- -X- N

manual JJ Physical
physical JJ Physical
therapy NN Physical
and CC Physical
exercise NN Physical
physical JJ Physical
therapy NN Physical
manual JJ Physical
therapy NN Physical
standardized JJ Physical
knee NN Physical
exercise NN Physical
program NN Physical
subtherapeutic JJ Control
ultrasound NN Control
treatment NN Physical
placebo NN Control
treatment NN Physical
treatment NN Physical
placebo NN Control
treatment NN Physical
placebo NN Control
treatment NN Physical
manual JJ Physical
physical JJ Physical
therapy NN Physical
and CC Physical
supervised VBD Physical
exercise NN Physical
-DOCSTART- -X- N

teicoplanin NN Pharmocological
prophylaxis NN Pharmocological
parenteral JJ Pharmocological
prophylaxis NN Pharmocological
with IN Pharmocological
Teicoplanin NNP Pharmocological
-DOCSTART- -X- N

Bevacizumab NNP Pharmocological
plus CC Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
fluorouracil NN Pharmocological
, , Pharmocological
and CC Pharmocological
leucovorin NN Pharmocological
Bevacizumab NNP Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
bolus JJ Pharmocological
fluorouracil NN Pharmocological
, , Pharmocological
and CC Pharmocological
leucovorin NN Pharmocological
( ( Pharmocological
IFL NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
. . Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
IFL NNP Pharmocological
plus CC Pharmocological
bevacizumab NN Pharmocological
IFL NNP Control
plus CC Control
placebo NN Control
bevacizumab NN Pharmocological
fluorouracil-based JJ Pharmocological
combination NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

randomized VBN None
and CC None
dosed VBN None
with IN None
either DT None
lopinavir/ritonavir JJ None
monotherapy NN None
( ( None
n JJ None
= NNP None
83 CD None
) ) None
or CC None
lopinavir/ritonavir JJ Pharmocological
+ JJ None
zidovudine/lamivudine NN None
( ( None
n JJ None
= NNP None
53 CD None
) ) None
lopinavir/ritonavir VB None
monotherapy NN None
( ( None
n JJ None
First-line JJ None
lopinavir/ritonavir JJ None
monotherapy NN None
can MD None
-DOCSTART- -X- N

colour-coded JJ Other
QC NNP Other
Result NNP Other
Sheet NNP Other
and CC None
QC NNP Other
Action NNP Other
Sheet NNP Other
for IN Physical
on-site JJ Physical
recording NN Physical
and CC Physical
interpreting NN Physical
of IN Physical
their PRP$ Physical
results NNS Physical
. . None
-DOCSTART- -X- N

treatment NN None
with IN None
0.3 CD Pharmocological
% NN Pharmocological
ofloxacin JJ Pharmocological
eyedrops NNS Pharmocological
, , Pharmocological
BID NNP Pharmocological
or CC Pharmocological
QID NNP Pharmocological
, , Pharmocological
for IN Pharmocological
10 CD Pharmocological
days NNS Pharmocological
. . None
-DOCSTART- -X- N

Paricalcitol NNP Pharmocological
capsule NN Pharmocological
paricalcitol NN Pharmocological
paricalcitol NNS Pharmocological
placebo NN Control
. . None
Paricalcitol NNP Pharmocological
-DOCSTART- -X- N

Vigorous JJ Physical
, , Physical
aerobic JJ Physical
exercise NN Physical
versus NN None
general JJ Physical
motor NN Physical
training NN Physical
activities NNS Physical
: : None
antecedent JJ Physical
exercise NN Physical
conditions NNS Physical
exercise NN Physical
non-exercise JJ Physical
conditions NNS None
. . None
aerobic JJ Physical
exercise NN Physical
antecedent JJ Physical
aerobic JJ Physical
exercise NN Physical
aerobic JJ Physical
exercise NN Physical
antecedent JJ Physical
exercise NN Physical
. . None
antecedent NN Physical
aerobic JJ Physical
exercise NN Physical
-DOCSTART- -X- N

n3 JJ Pharmocological
fatty JJ Pharmocological
acid NN Pharmocological
ethyl NN Pharmocological
esters NNS Pharmocological
n3 JJ Pharmocological
fatty RB Pharmocological
acid JJ Pharmocological
ethyl NN Pharmocological
ester NN Pharmocological
( ( Pharmocological
FAEE NNP Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
deficit NN Physical
WL NNP Physical
WL+FAEE NNP Pharmocological
intervention NN Pharmocological
WL+FAEE NNP Pharmocological
WL NNP Physical
n3 JJ Pharmocological
FAEEs NNP Pharmocological
-DOCSTART- -X- N

walking-associated JJ Educational
cognitive JJ Educational
task NN Educational
simultaneously RB Educational
performed VBN Educational
cognitive JJ Educational
task NN Educational
cognitive JJ Educational
task NN Educational
-DOCSTART- -X- N

rofecoxib NN Pharmocological
, , None
celecoxib NN Pharmocological
acetaminophen NN Pharmocological
acetaminophen NN Pharmocological
celecoxib $ Pharmocological
rofecoxib VBZ Pharmocological
rofecoxib VB Pharmocological
[ NNP None
Vioxx NNP Pharmocological
, , None
Acetaminophen NNP Pharmocological
, , None
Celecoxib NNP Pharmocological
acetaminophen NN Pharmocological
, , None
celecoxib NN Pharmocological
, , None
rofecoxib VBZ Pharmocological
rofecoxib VBZ Pharmocological
acetaminophen NN Pharmocological
rofecoxib CC Pharmocological
celecoxib NN Pharmocological
rofecoxib NN Pharmocological
rofecoxib NN Pharmocological
celecoxib NN Pharmocological
Rofecoxib $ Pharmocological
celecoxib NN Pharmocological
rofecoxib NN Pharmocological
celecoxib NN Pharmocological
acetaminophen VB Pharmocological
. . None
celecoxib NN Pharmocological
rofecoxib VB Pharmocological
acetaminophen NN Pharmocological
Rofecoxib NNP Pharmocological
celecoxib NN Pharmocological
acetaminophen VB Pharmocological
. . None
celecoxib $ Pharmocological
Rofecoxib NNP Pharmocological
celecoxib $ Pharmocological
-DOCSTART- -X- N

terazosin NN Pharmocological
enalapril NN Pharmocological
antihypertensive JJ Pharmocological
drug NN Pharmocological
selective JJ Pharmocological
alpha NN Pharmocological
1-adrenergic JJ Pharmocological
blocker NN Pharmocological
terazosin NN Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
enalapril NN Pharmocological
placebo JJ Control
Terazosin NNP Pharmocological
and CC None
enalapril VB Pharmocological
terazosin NN Pharmocological
enalapril NN Pharmocological
placebo NN Control
terazosin NN Pharmocological
enalapril NN Pharmocological
; : None
terazosin NN Pharmocological
enalapril NN Pharmocological
; : None
placebo NN Control
-DOCSTART- -X- N

Leukotriene NNP Pharmocological
antagonist NN Pharmocological
leukotriene JJ Pharmocological
antagonist JJ Pharmocological
ONO-1078 NNP Pharmocological
( ( Pharmocological
pranlukast NN Pharmocological
) ) Pharmocological
corticosteroid NN Pharmocological
orally RB Pharmocological
ONO-1078 NNP Pharmocological
, , Pharmocological
450 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , None
or CC None
placebo NN Control
. . None
placebo NN Control
placebo NN Control
leukotriene JJ Pharmocological
antagonist JJ Pharmocological
ONO-1078 JJ Pharmocological
-DOCSTART- -X- N

Chronic NNP None
kidney NN None
disease NN None
( ( None
CKD NNP None
) ) None
CKD NNP None
multivariable JJ Physical
logistic JJ Physical
regression NN Physical
model NN Physical
patients NNS None
with IN None
and CC None
without IN None
CKD NNP None
. . None
Matched NNP Educational
Cox NNP Educational
regression NN Educational
analyses NNS Educational
CKD NNP None
with IN None
and CC None
without IN None
CKD NNP None
CKD NNP None
-DOCSTART- -X- N

triamcinolone NN Pharmocological
acetonide RB Pharmocological
aqueous JJ Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
of IN Pharmocological
triamcinolone NN Pharmocological
acetonide NN Pharmocological
triamcinolone NN Pharmocological
acetonide RB Pharmocological
aqueous JJ Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
placebo NN Control
triamcinolone NN Pharmocological
acetonide RB Pharmocological
aqueous JJ Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

restricted VBD Other
feeding NN Other
combined VBN Other
stresses NNS Other
( ( Other
thermal JJ Physical
stress NN Physical
and CC Other
restricted VBD Other
feeding VBG Other
) ) Other
control NN Control
) ) Control
thermal JJ Physical
stress NN Physical
) ) Physical
restricted VBN Educational
feeding NN Educational
) ) Educational
combined VBN Educational
stress NN Educational
) ) Educational
with IN Other
a DT Other
diet JJ Other
consisting NN Other
of IN Other
60 CD Other
% NN Other
roughage NN Other
and CC Other
40 CD Other
% NN Other
concentrate NN Other
. . Other
-DOCSTART- -X- N

long-term JJ None
lowering NN None
of IN None
( ( Physical
HbA1 NNP Physical
% NN Physical
) ) Physical
Individual NNP None
( ( None
OP-1 NNP None
, , None
OP-2 NNP None
, , None
OP-3 NNP None
) ) None
and CC None
summed VBN None
( ( None
OP-sum NNP None
) ) None
amplitudes NNS None
of IN None
oscillatory JJ None
potentials NNS None
( ( None
OPs NNP None
) ) None
of IN None
electroretinography NN Physical
were VBD None
recorded VBN None
-DOCSTART- -X- N

Salmeterol NNP Pharmocological
theophylline NN Pharmocological
ketotifen NN Pharmocological
salmeterol NN Pharmocological
theophylline NN Pharmocological
and CC Pharmocological
ketotifen NN Pharmocological
-DOCSTART- -X- N

replicated VBN Physical
and CC Physical
gold-coated JJ Physical
. . None
-DOCSTART- -X- N

( ( None
cryotherapy NN Physical
and CC None
control NN Control
) ) None
-DOCSTART- -X- N

zoledronic JJ Pharmocological
acid NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
Zoledronic JJ Pharmocological
acid NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
placebo NN Control
zoledronic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

educational JJ Educational
intervention NN Educational
view VB Educational
a DT Educational
video NN Educational
of IN Educational
the DT Educational
same JJ Educational
boy NN Educational
in IN Educational
one CD Educational
of IN Educational
three CD Educational
conditions NNS Educational
: : Educational
No DT Educational
Autism NNP Educational
, , Educational
Autism NNP Educational
, , Educational
or CC Educational
Autism/Information NNP Educational
. . Educational
-DOCSTART- -X- N

Preservative-free JJ Pharmocological
ocular JJ Pharmocological
hydrating VBG Pharmocological
agents NNS Pharmocological
saline NN Pharmocological
versus IN None
PVP NNP Pharmocological
solution NN Pharmocological
. . None
preservative-free JJ Pharmocological
hydrating VBG Pharmocological
agents NNS Pharmocological
2 CD Pharmocological
% NN Pharmocological
polyvinylpyrrolidone NN Pharmocological
( ( Pharmocological
PVP NNP Pharmocological
) ) Pharmocological
solution NN Pharmocological
with IN None
a DT None
0.9 CD Pharmocological
% NN Pharmocological
NaCl NNP Pharmocological
solution NN Pharmocological
PVP NNP Pharmocological
NaCl NNP Pharmocological
PVP NNP Pharmocological
NaCl NNP Pharmocological
PVP NNP Pharmocological
NaCl NNP Pharmocological
PVP NNP Pharmocological
-DOCSTART- -X- N

thrombosis JJ Physical
embolic JJ Physical
deterrent NN Physical
stockings NNS Physical
alone RB Physical
or CC None
thrombosis VB Physical
embolic JJ Physical
deterrent NN Physical
stockings NNS Physical
and CC None
pneumatic JJ Physical
compression NN Physical
boots NNS Physical
-DOCSTART- -X- N

1-week JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
omeprazole JJ Pharmocological
, , Pharmocological
amoxicillin NN Pharmocological
, , Pharmocological
and CC Pharmocological
clarithromycin NN Pharmocological
( ( Pharmocological
OAC NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
placebo NN Control
. . Pharmocological
OAC NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
sequential JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
. . None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
2 CD Pharmocological
mg NNS Pharmocological
estradiol RB Pharmocological
-DOCSTART- -X- N

low-dose JJ Pharmocological
bolus JJ Pharmocological
growth NN Pharmocological
hormone-releasing VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH2 NNP Pharmocological
) ) Pharmocological
supramaximal JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
GHRH NNP Pharmocological
radiotherapy NN Physical
. . None
GHRH NNP Pharmocological
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
( ( None
median JJ None
GHRH NNP Pharmocological
( ( Pharmocological
1-29 JJ Pharmocological
) ) Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Desmopressin NNP Pharmocological
desmopressin NN Pharmocological
desmopressin JJ Pharmocological
desmopressin NN Pharmocological
placebo NN Control
. . None
desmopressin NN Pharmocological
placebo NN Pharmocological
desmopressin-treated JJ Control
placebo-treated JJ Control
desmopressin NN Pharmocological
desmopressin NN Pharmocological
placebo NN Pharmocological
; : None
desmopressin NN Pharmocological
placebo NN Pharmocological
; : None
desmopressin NN Pharmocological
placebo NN Pharmocological
desmopressin NN Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

venlafaxine NN Pharmocological
placebo NN Control
placebo NN Control
venlafaxine JJ Pharmocological
XR NNP Pharmocological
75 CD Pharmocological
and CC Pharmocological
150 CD Pharmocological
mg NN Pharmocological
venlafaxine JJ Pharmocological
venlafaxine NN Pharmocological
venlafaxine NN Pharmocological
-DOCSTART- -X- N

Classroom NNP Educational
intervention NN Educational
medical JJ Pharmocological
intervention NN Pharmocological
alone RB Pharmocological
behavioral JJ Educational
plus CC Educational
medical JJ Other
intervention NN Other
medical JJ Other
and CC Educational
behavioral JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

porcine NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
. . None
secretin VB Pharmocological
or CC None
placebo VB None
placebo NN Control
or CC None
porcine NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
. . None
porcine NN Pharmocological
secretin NN Pharmocological
-DOCSTART- -X- N

Cirrhosis NN None
prophylactic JJ Pharmocological
therapy NN Pharmocological
propranolol NN Pharmocological
. . None
endoscopic NN Physical
therapy NN Physical
-DOCSTART- -X- N

General NNP Pharmocological
anaesthesia NN Pharmocological
enflurane NN Pharmocological
halothane NN Pharmocological
. . None
enflurane NN Pharmocological
halothane NN Pharmocological
halothane NN Pharmocological
general JJ Pharmocological
anaesthesia NN Pharmocological
. . None
-DOCSTART- -X- N

altered JJ Educational
pain NN Educational
processing NN Educational
pain NN Educational
modulation NN Educational
response NN Educational
cold VB Educational
pressor NN Educational
task NN Educational
altered JJ Educational
central JJ Educational
processing NN Educational
-DOCSTART- -X- N

Removing VBG Physical
bee JJ Physical
stings NNS Physical
. . None
venom NN Pharmocological
quick JJ Physical
removal NN Physical
-DOCSTART- -X- N

acupuncture NN Physical
early JJ Physical
acupuncture NN Physical
routine JJ None
treatment NN None
of IN None
neurosurgical JJ Control
operation NN Control
and CC Control
drug NN Control
treatment NN Control
( ( Control
Mannitol NNP Pharmocological
, , Control
Citioline NNP Pharmocological
Sodium NNP Pharmocological
, , Control
Cefeazidime NNP Pharmocological
, , Pharmocological
etc. NN Pharmocological
) ) Control
. . None
routine JJ Control
treatment NN Control
and CC None
acupuncture NN Physical
treatment NN Physical
48 CD None
h NN None
( ( None
-1 NNP None
) ) None
week NN None
selected VBN Physical
main JJ Physical
points NNS Physical
were VBD Physical
Neiguan NNP Physical
( ( Physical
PC NNP Physical
6 CD Physical
) ) Physical
, , Physical
Qu-chi NNP Physical
( ( Physical
LI NNP Physical
11 CD Physical
) ) Physical
, , Physical
Waiguan NNP Physical
( ( Physical
TE NNP Physical
5 CD Physical
) ) Physical
, , Physical
Hegu NNP Physical
( ( Physical
LI NNP Physical
4 CD Physical
) ) Physical
, , Physical
Binao NNP Physical
( ( Physical
LI NNP Physical
14 CD Physical
) ) Physical
, , Physical
Jianyu NNP Physical
( ( Physical
LI NNP Physical
15 CD Physical
) ) Physical
, , Physical
Fengshi NNP Physical
( ( Physical
GB NNP Physical
31 CD Physical
) ) Physical
, , Physical
Xuehai NNP Physical
( ( Physical
SP NNP Physical
10 CD Physical
) ) Physical
, , Physical
Yinlingquan NNP Physical
( ( Physical
SP NNP Physical
9 CD Physical
) ) Physical
, , Physical
Sanyinjiao NNP Physical
( ( Physical
SP NNP Physical
6 CD Physical
) ) Physical
, , Physical
Taichong NNP Physical
( ( Physical
LR NNP Physical
3 CD Physical
) ) Physical
, , Physical
etc.. VBZ None
acupuncture NN Physical
-DOCSTART- -X- N

perindopril NN Pharmocological
and CC Pharmocological
hydrochlorothiazide VB Pharmocological
alone RB Pharmocological
and CC Pharmocological
in IN Pharmocological
combination NN Pharmocological
perindopril NN Pharmocological
hydrochlorothiazide NN Pharmocological
alone RB None
in IN None
combination NN None
perindopril NN Pharmocological
perindopril NN Pharmocological
or CC None
hydrochlorothiazide NN Pharmocological
perindopril NN Pharmocological
hydrochlorothiazide NN Pharmocological
. . None
hydrochlorothiazide NN Pharmocological
Perindopril NNP Pharmocological
hydrochlorothiazide NN Pharmocological
perindopril NN Pharmocological
and CC None
hydrochlorothiazide NN Pharmocological
-DOCSTART- -X- N

chestnut NN Pharmocological
tannins NNS Pharmocological
raised VBN None
at IN None
20?C CD None
and CC None
fed VBN None
with IN None
basal NN None
diet NN None
( ( None
N NNP None
) ) None
and CC None
other JJ None
three CD None
groups NNS None
( ( None
33?C CD None
) ) None
were VBD None
fed VBN None
basal JJ None
diet JJ None
with IN None
0 CD None
( ( None
C NNP None
) ) None
, , None
5 CD None
( ( None
CT5 NNP None
) ) None
, , None
and CC None
10 CD None
g NN None
( ( None
CT10 NNP None
) ) None
of IN None
CT/kg NNP None
of IN None
diet NN None
. . None
-DOCSTART- -X- N

Torasemide NN Pharmocological
torasemide NN Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
furosemide JJ Pharmocological
( ( Pharmocological
50 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
low-sodium NN Pharmocological
( ( Pharmocological
40 CD Pharmocological
mmol/day NN Pharmocological
) ) Pharmocological
diet NN Pharmocological
and CC None
the DT None
aldosterone NN Pharmocological
antagonist NN Pharmocological
, , None
potassium NN Pharmocological
canrenoate NN Pharmocological
Torasemide NNP Pharmocological
furosemide NN Pharmocological
. . None
torasemide JJ Pharmocological
torasemide JJ Pharmocological
furosemide JJ Pharmocological
torasemide NN Pharmocological
-DOCSTART- -X- N

camel NN Pharmocological
milk NN Pharmocological
camel NN Pharmocological
milk NN Pharmocological
( ( Pharmocological
CM NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
raw JJ Pharmocological
and CC Pharmocological
boiled VBN Pharmocological
) ) Pharmocological
placebo VB Control
group NN Control
( ( Control
cow JJ Control
milk NN Control
) ) Control
-DOCSTART- -X- N

sublingual JJ Pharmocological
immunotherapy NN Pharmocological
Sublingual NNP Pharmocological
administration NN Pharmocological
of IN Pharmocological
allergens NNS Pharmocological
sublingual JJ Pharmocological
immunotherapy NN Pharmocological
. . None
symptomatic JJ Control
treatments NNS Control
. . None
sublingual JJ Pharmocological
immunotherapy NN Pharmocological
, , None
with IN None
three CD None
different JJ None
induction NN None
protocols NNS None
( ( None
8- CD None
, , None
15- CD None
and CC None
20-day JJ None
, , None
respectively RB None
) ) None
sublingual JJ Pharmocological
immunotherapy NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

PSK NNP Pharmocological
oral JJ Pharmocological
adjuvant JJ Pharmocological
immunochemotherapy NN Pharmocological
with IN None
protein-bound JJ Pharmocological
polysaccharide NN Pharmocological
K NNP Pharmocological
( ( Pharmocological
PSK NNP Pharmocological
) ) Pharmocological
and CC None
tegafur/uracil NN Pharmocological
( ( Pharmocological
UFT NNP Pharmocological
) ) Pharmocological
UFT NNP Pharmocological
alone RB None
. . None
PSK NNP Pharmocological
PSK NNP Pharmocological
PSK NNP Pharmocological
plus CC Pharmocological
300 CD Pharmocological
mg NN Pharmocological
UFT NNP Pharmocological
( ( Pharmocological
PSK NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
UFT NNP Pharmocological
alone RB Pharmocological
PSK NNP Pharmocological
control NN Control
group NN None
PSK NNP Pharmocological
PSK NNP Pharmocological
+ NNP Pharmocological
UFT NNP Pharmocological
PSK NNP Pharmocological
-DOCSTART- -X- N

Osteocalcin NNP Pharmocological
intramuscular JJ Pharmocological
( ( Pharmocological
im NN Pharmocological
) ) Pharmocological
gold NN Pharmocological
with IN Pharmocological
im JJ Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
MTX NNP Pharmocological
) ) Pharmocological
DMARD NNP Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

alkalinized JJ Pharmocological
lidocaine JJ Pharmocological
2 CD Pharmocological
% NN Pharmocological
standard JJ None
general JJ None
anesthesia NN None
by IN None
means NNS None
of IN None
low-flow JJ Physical
rebreathing NN Physical
system NN Physical
low-flow JJ Physical
anesthesia NN Physical
only RB Physical
low-flow JJ Physical
anesthesia NN Physical
with IN Physical
additional JJ Physical
reflective JJ Physical
blankets NNS Physical
low-flow JJ Physical
anesthesia NN Physical
with IN Physical
active JJ Physical
forced-air JJ Physical
warming NN Physical
low-flow JJ Physical
anesthesia NN Physical
alone RB Physical
and CC Physical
in IN Physical
combination NN Physical
with IN Physical
reflective JJ Physical
blankets NNS Physical
-DOCSTART- -X- N

Laser-aided JJ Surgical
external JJ Surgical
subretinal JJ Surgical
fluid NN Surgical
transchoroidally RB Surgical
needle JJ Other
angulated VBN Surgical
endolaser NN Surgical
probe NN Surgical
laser-aided JJ Surgical
drainage NN Surgical
transchoroidal NN Surgical
needle JJ Surgical
drainage NN Surgical
-DOCSTART- -X- N

Ropivacaine-clonidine JJ Pharmocological
combination NN Pharmocological
clonidine NN Pharmocological
weak JJ Pharmocological
ropivacaine JJ Pharmocological
solutions NNS Pharmocological
ropivacaine JJ Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
-clonidine JJ Pharmocological
mixture NN Pharmocological
plain NN Pharmocological
ropivacaine VBP Pharmocological
randomly RB None
allocated VBN None
to TO None
receive VB None
a DT None
caudal JJ None
injection NN None
of IN None
either DT None
plain NN Pharmocological
ropivacaine VBP Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
ml/kg NN Pharmocological
) ) Pharmocological
( ( None
R0.2 NNP None
) ) None
or CC None
a DT None
mixture NN None
of IN None
ropivacaine JJ Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
with IN None
clonidine JJ Pharmocological
2 CD Pharmocological
microg/kg NN Pharmocological
( ( Pharmocological
1 CD Pharmocological
ml/kg NN Pharmocological
) ) Pharmocological
( ( None
R0.1C NNP None
) ) None
were VBD None
used VBN None
to TO None
evaluate VB None
analgesia NN None
during IN None
the DT None
first JJ None
24 CD None
h NN None
postoperatively RB None
. . None
was VBD None
also RB None
assessed VBN None
. . None
clonidine NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
microg/kg NN Pharmocological
) ) Pharmocological
and CC Pharmocological
ropivacaine VB Pharmocological
0.1 CD Pharmocological
% NN Pharmocological
plain VB Pharmocological
0.2 CD Pharmocological
% NN Pharmocological
ropivacaine NN Pharmocological
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

niacin JJ Pharmocological
alone NN Pharmocological
or CC None
with IN None
atorvastatin NN Pharmocological
extended-release JJ Pharmocological
niacin NN Pharmocological
( ( Pharmocological
niacin JJ Pharmocological
ER NNP Pharmocological
) ) Pharmocological
either CC None
alone RB None
or CC None
in IN None
combination NN None
with IN None
atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
niacin NN Pharmocological
ER NNP Pharmocological
niacin NNS Pharmocological
ER NNP Pharmocological
combination NN Control
treatment NN Control
treated VBN None
with IN None
atorvastatin NN Pharmocological
( ( Pharmocological
10 CD Pharmocological
mg/d NN Pharmocological
) ) Pharmocological
plus CC None
niacin JJ Pharmocological
ER NNP Pharmocological
-DOCSTART- -X- N

Tele-Airway NNP Educational
Management NNP Educational
System NNP Educational
Tele-Airway NNP Educational
Management NNP Educational
System NNP Educational
TAMS NNP Educational
TAMS NNP Educational
. . None
( ( None
TAMS NNP Other
OSD NNP Educational
TAMS NNP Educational
OSD NNP Other
TAMS NNP Educational
. . None
OSD NNP Educational
. . None
-DOCSTART- -X- N

growth NN Pharmocological
hormone CD Pharmocological
substitution NN Pharmocological
Growth NNP Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GH NNP Pharmocological
) ) Pharmocological
GH NNP Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
GH NNP Pharmocological
or CC None
placebo NN Control
in IN None
a DT None
dose NN None
of IN None
0.25 CD None
U/kg NNP None
GH NNP Pharmocological
. . None
placebo-controlled JJ Control
GHD NNP None
GHD NNP None
. . None
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

Nateglinide NNP Pharmocological
strict JJ Pharmocological
glycemic NNS Pharmocological
control NN Pharmocological
nateglinide NN Pharmocological
( ( None
270 CD None
mg/dL NN None
) ) None
and CC None
40 CD None
to TO None
control VB Control
group NN Control
( ( Control
no DT Control
treatment NN Control
) ) Control
. . None
untreated JJ Educational
group NN None
strict JJ Pharmocological
glycemic NNS Pharmocological
control NN Pharmocological
by IN Pharmocological
nateglinide JJ Pharmocological
-DOCSTART- -X- N

epoetin NN Pharmocological
zeta NN Pharmocological
to TO None
epoetin VB Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
zeta NN Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
zeta NN Pharmocological
or CC None
epoetin NN Pharmocological
alfa NN Pharmocological
epoetin NN Pharmocological
epoetin NN Pharmocological
epoetin NN Pharmocological
zeta NN Pharmocological
epoetin JJ Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
zeta NN Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
Epoetin NNP Pharmocological
zeta NN Pharmocological
-DOCSTART- -X- N

lapatinib VB Pharmocological
plus JJ Pharmocological
vinorelbine NN Pharmocological
[ NNP None
( ( None
N NNP None
= NNP None
75 CD None
) ) None
1,250 CD None
mg NN None
orally RB None
once RB None
daily JJ None
( ( None
QD NNP None
) ) None
continuously RB None
plus CC None
20 CD None
mg/m NN None
( ( None
2 CD None
) ) None
/day NN None
intravenously RB None
] VBZ None
or CC None
lapatinib JJ Pharmocological
plus CC Pharmocological
capecitabine JJ Pharmocological
[ NNP None
( ( None
N NNP None
= NNP None
37 CD None
) ) None
1,250 CD None
mg NN None
orally RB None
QD NNP None
continuously RB None
plus CC None
2,000 CD None
mg/m NN None
( ( None
2 CD None
) ) None
/day NN None
orally RB None
, , None
2 CD None
doses NNS None
] RB None
. . None
-DOCSTART- -X- N

sphygmomanometrically RB Physical
determined VBN Physical
and CC None
mean JJ None
calcium NN Pharmocological
channel NN Pharmocological
blocking VBG Pharmocological
agent NN Pharmocological
, , None
digoxin NN Pharmocological
diuretic JJ Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
digoxin NN Pharmocological
noninvasive JJ Physical
blood NN Physical
pressure NN Physical
measurement NN Physical
-DOCSTART- -X- N

pretense NN Educational
pretend JJ Educational
play NN Educational
pretense NN Educational
scenarios NNS Educational
lacking VBG Educational
pretend JJ Educational
speech NN Educational
or CC Educational
sound JJ Educational
effects NNS Educational
-DOCSTART- -X- N

L-arginine JJ Pharmocological
S-nitrosoglutathione JJ Pharmocological
L-Arginine JJ Pharmocological
L-arginine NNP Pharmocological
S-nitrosoglutathione NNP Pharmocological
( ( Pharmocological
GSNO NNP Pharmocological
) ) Pharmocological
L-arginine NNP Pharmocological
GSNO NNP Pharmocological
placebo NN Control
placebo NN None
L-arginine JJ Pharmocological
GSNO NNP Pharmocological
L-arginine NNP Pharmocological
GSNO NNP Pharmocological
-DOCSTART- -X- N

face-to-face NN Educational
interviews NNS Educational
Medical JJ Educational
chart NN Educational
data NNS Educational
were VBD Educational
abstracted VBN Educational
Univariate NNP Physical
and CC Physical
multivariate VB Physical
logistic JJ Physical
regression NN Physical
analyses NNS Physical
-DOCSTART- -X- N

adaptive JJ Educational
pacing NN Educational
therapy NN Educational
, , None
cognitive JJ Educational
behaviour NN Educational
therapy NN Educational
, , None
graded VBD Educational
exercise NN Educational
therapy NN Educational
specialist VB Other
medical JJ Other
care NN Other
cognitive JJ None
behaviour NN None
therapy NN None
( ( None
CBT NNP None
) ) None
graded VBN None
exercise NN None
therapy NN None
( ( None
GET NNP None
) ) None
pacing NN None
specialist NN None
health NN None
care NN None
. . None
and CC None
randomly RB None
allocated VBN None
by IN None
computer-generated JJ None
sequence NN None
to TO None
receive VB None
specialist NN None
medical JJ None
care NN None
( ( None
SMC NNP None
) ) None
alone RB None
or CC None
with IN None
adaptive JJ Educational
pacing VBG Educational
therapy NN Educational
( ( Educational
APT NNP Educational
) ) Educational
, , None
CBT NNP None
, , None
or CC None
GET NNP None
. . None
longitudinal JJ None
regression NN None
models NNS None
to TO None
compare VB None
SMC NNP None
alone RB None
with IN None
other JJ None
treatments NNS None
, , None
APT NNP Educational
with IN None
CBT NNP Educational
, , None
and CC None
APT NNP None
with IN None
GET NNP None
. . None
SMC-alone NNP Physical
-DOCSTART- -X- N

ultrasound-guided JJ Surgical
celiac NN Surgical
plexus NN Surgical
neurolysis NN Surgical
bilateral JJ Surgical
paramedian JJ Surgical
unilateral JJ Surgical
paramedian JJ Surgical
needle-insertion NN Surgical
technique NN Surgical
. . None
Percutaneous NNP Surgical
anterior JJ Surgical
abdominal JJ Surgical
ultrasound NN Surgical
guidance NN Surgical
ultrasound-guided JJ Surgical
celiac NN Surgical
plexus NN Surgical
neurolysis NN Surgical
( ( Surgical
USCPN NNP Surgical
) ) Surgical
USCPN NNP Surgical
bilateral JJ Surgical
paramedian NN Surgical
( ( Surgical
double JJ Surgical
needle NN Surgical
) ) Surgical
technique NN Surgical
unilateral JJ Surgical
paramedian NN Surgical
( ( Surgical
single JJ Surgical
needle NN Surgical
) ) Surgical
technique NN Surgical
. . None
ethanol NN Pharmocological
bupivacaine NN Pharmocological
unilaterally RB Physical
or CC None
bilaterally RB None
CONCLUSION NNP None
Ultrasound-guided JJ None
celiac NN None
plexus NN None
neurolysis NN None
using VBG None
unilateral JJ None
paramedian NN None
( ( None
single JJ None
needle NN None
) ) None
needle-insertion NN None
technique NN None
is VBZ None
with IN None
bilateral JJ None
paramedian NN None
( ( None
double JJ None
needle NN None
) ) None
needle-insertion NN None
technique NN None
with IN None
-DOCSTART- -X- N

Providing VBG Educational
Assistance NNP Educational
to TO Educational
Caregivers NNPS Educational
in IN Educational
Transition NNP Educational
( ( Educational
PACT NNP Educational
) ) Educational
program NN Educational
PACT NNP Other
program NN Other
PACT NNP Educational
case NN Educational
management NN Educational
in IN Educational
addition NN Educational
to TO Educational
their PRP$ Educational
usual JJ Educational
medical JJ Educational
and CC Educational
nursing NN Educational
home NN Educational
care NN Educational
. . None
usual JJ Educational
care NN Educational
. . None
PACT-type JJ Educational
intervention NN Educational
-DOCSTART- -X- N

psychotherapy NN Physical
with IN Physical
biofeedback NN Physical
( ( None
hypotensive JJ Psychological
drugs NNS Psychological
+ VBP Psychological
psychotherapy NN Psychological
with IN Psychological
biofeedback NN Psychological
or CC Psychological
hypotensive JJ Psychological
drugs NNS Psychological
only RB Psychological
-- : Pharmocological
45 CD Pharmocological
controls NNS Control
-DOCSTART- -X- N

larger JJR Physical
and CC Physical
small JJ Physical
forceps NNS Physical
bronchoscopy NN Surgical
, , None
placing VBG Surgical
a DT Surgical
non NN Surgical
inflated VBN Surgical
Fogarty NNP Surgical
balloon NN Surgical
and CC None
a DT None
rigid JJ Surgical
aspirator NN Surgical
( ( None
diameter JJ None
4 CD None
mm NN None
) ) None
in IN None
lobar NN None
bronchus NN None
near IN None
the DT None
biopsy NN None
segment NN None
. . None
The DT Surgical
Fogarty NNP Surgical
balloon NN Surgical
has VBZ Surgical
been VBN Surgical
inflated VBN Surgical
in IN Surgical
case NN Surgical
of IN Surgical
bleeding NN Surgical
. . None
-DOCSTART- -X- N

granisetron NNS Pharmocological
perphenazine NN Pharmocological
granisetron NN Pharmocological
perphenazine NN Pharmocological
granisetron NN Pharmocological
perphenazine VB Pharmocological
granisetron NN Pharmocological
perphenazine NN Pharmocological
granisetron NN Pharmocological
perphenazine NN Pharmocological
-DOCSTART- -X- N

nonhandicapped JJ Educational
peers NNS Educational
regular JJ Educational
opportunities NNS Educational
to TO Educational
interact VB Educational
with IN Educational
a DT Educational
normally RB Educational
developing VBG Educational
peer NN Educational
peer-mediated JJ Educational
intervention NN Educational
. . None
-DOCSTART- -X- N

morphine NN Pharmocological
morphine NN Pharmocological
formulation NN Pharmocological
( ( Pharmocological
OAD NNP Pharmocological
morphine NN Pharmocological
) ) Pharmocological
morphine NN Pharmocological
) ) None
CR NNP Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
CR NNP None
morphine NN Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

Low-intensity NNP Physical
exercise NN Physical
low-intensity JJ Physical
exercise NN Physical
program NN Physical
exercise NN Physical
intervention NN Physical
no-intervention JJ Control
control NN Control
. . Control
Exercise NN Physical
exercise NN Physical
sessions NNS Physical
exercise NN Physical
low-intensity JJ Physical
exercise NN Physical
program NN Physical
-DOCSTART- -X- N

Dexamethasone NN Pharmocological
dexamethasone NN Pharmocological
with IN Pharmocological
0.5 CD Pharmocological
mg/kg NNS Pharmocological
placebo NN Control
salbutamol NN Pharmocological
-DOCSTART- -X- N

Accumulated VBN Physical
brisk JJ Physical
walking NN Physical
days/week NN None
) ) None
brisk NN None
walking NN None
current JJ None
physical JJ None
activity NN None
-DOCSTART- -X- N

error NN Educational
training NN Educational
surgical JJ Surgical
technical JJ Surgical
skill NN Surgical
instruction NN Surgical
and CC Surgical
evaluation NN Surgical
. . Surgical
two CD Educational
types NNS Educational
of IN Educational
rater NN Educational
training NN Educational
videotapes NNS Educational
examples NNS Educational
of IN Educational
common JJ Educational
errors NNS Educational
( ( Educational
error NN Educational
) ) Educational
skill NN Educational
being VBG Educational
performed VBN Educational
correctly RB Educational
( ( Educational
correct NN Educational
) ) Educational
error NN Educational
instruction NN Educational
none NN Educational
, , Educational
error NN Educational
only RB Educational
, , Educational
correct VBP Educational
only RB Educational
, , Educational
and CC Educational
error+correct NN Educational
. . Educational
error NN Educational
training NN Educational
testing NN Educational
videotape NN Educational
and CC Educational
interrater NN Educational
reliability NN Educational
error NN Educational
training NN Educational
no DT Control
training NN Control
. . Control
error+correct JJ Educational
correct NN None
only RB None
error VBZ None
only RB None
common JJ None
errors NNS None
surgical JJ Surgical
technical JJ Surgical
skill NN Surgical
instruction NN Surgical
. . Surgical
error NN None
training NN None
-DOCSTART- -X- N

adenosine JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging VBG Physical
adenosine JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging NN Physical
Coronary NNP Physical
angiography NN Physical
was VBD None
conducted VBN None
within IN None
6 CD None
weeks NNS None
of IN None
an DT None
adenosine JJ Physical
thallium-201 JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging VBG Physical
study NN None
. . None
adenosine JJ Physical
thallium-201 JJ Physical
myocardial JJ Physical
perfusion NN Physical
imaging NN Physical
-DOCSTART- -X- N

Parecoxib NNP Pharmocological
placebo-controlled JJ Control
parecoxib NN Pharmocological
40 CD Pharmocological
mg NN Pharmocological
Remifentanil NNP Pharmocological
i.v NN None
. . None
morphine NN Pharmocological
i.m NN None
. . None
morphine VB Pharmocological
5 CD Pharmocological
mg NNS Pharmocological
acetaminophen NN Pharmocological
Morphine NNP Pharmocological
-DOCSTART- -X- N

secretin NN Pharmocological
. . None
secretin NN Pharmocological
placebo NN Control
. . None
synthetic JJ None
human JJ None
secretin NN None
placebo VB Control
( ( Control
saline NN Control
) ) Control
. . None
placebo NN Pharmocological
, , Pharmocological
followed VBD Pharmocological
six CD Pharmocological
weeks NNS Pharmocological
later RB Pharmocological
by IN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
placebo NN Pharmocological
. . None
secretin NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

interferon VB Pharmocological
interferon NN Pharmocological
-DOCSTART- -X- N

placebo NN Control
of IN Pharmocological
metronidazole NN Pharmocological
and CC Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

atropine VBP Pharmocological
neostigmine JJ Pharmocological
atropine JJ Pharmocological
plus CC Physical
neostigmine JJ Pharmocological
0.9 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
atropine NN Pharmocological
control NN Control
1.2 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
atropine NN Pharmocological
. . None
2.5 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
neostigmine JJ Pharmocological
simultaneously RB None
. . None
atropine NN Pharmocological
neostigmine JJ Pharmocological
-DOCSTART- -X- N

ofloxacin NN Pharmocological
amoxycillin/clavulanate NN Pharmocological
ofloxacin NN Pharmocological
amoxycillin/clavulanate NN Pharmocological
. . None
Ofloxacin NNP Pharmocological
ofloxacin NN Pharmocological
ofloxacin NN Pharmocological
ofloxacin NN Pharmocological
-DOCSTART- -X- N

Azelnidipine NNP Pharmocological
amlodipine VB Pharmocological
azelnidipine NN Pharmocological
amlodipine NN Pharmocological
azelnidipine VB Pharmocological
amlodipine VB Pharmocological
-DOCSTART- -X- N

summary JJ Physical
ST-segment JJ Physical
and CC Physical
T-wave JJ Physical
changes NNS Physical
. . None
ST-segment JJ Physical
and CC Physical
T-wave JJ Physical
changes NNS Physical
on IN None
the DT None
initial JJ Surgical
electrocardiogram NN Surgical
( ( Surgical
ECG NNP Surgical
) ) Surgical
-DOCSTART- -X- N

reducing VBG None
dietary JJ None
[ NN None
( ( None
Na+ NNP None
+ NNP None
K+ NNP None
) ) None
- : None
( ( None
Cl- JJ None
+ NNP None
SO4= NNP None
) ) None
] NN None
[ NNP None
( ( None
Na+ NNP None
+ NNP None
K+ NNP None
) ) None
- : None
( ( None
Cl- JJ None
+ NNP None
SO4= NNP None
) ) None
] VBP None
-4 JJ None
meq NN None
( ( None
anion NN None
diet NN None
) ) None
or CC None
+572.5 JJ None
meq NN None
( ( None
cation NN None
diet NN None
) ) None
of IN None
[ NN None
( ( None
Na+ NNP None
+ NNP None
K+ NNP None
) ) None
- : None
( ( None
Cl- JJ None
+ NNP None
SO4= NNP None
) ) None
] VBD None
kg-1 JJ None
dietary JJ None
dry JJ None
matter NN None
( ( None
DM NNP None
) ) None
. . None
grass NN None
hay NN None
and CC None
concentrates NNS None
. . None
KCl NNP None
, , None
K2SO4 NNP None
and CC None
( ( None
NH4 NNP None
) ) None
2SO4 CD None
( ( None
anion NN None
diet NN None
) ) None
or CC None
K2CO3 NNP None
( ( None
cation NN None
diet NN None
) ) None
-DOCSTART- -X- N

Anecortave NNP Pharmocological
acetate NN Pharmocological
treatment NN Pharmocological
anecortave JJ Pharmocological
acetate JJ Pharmocological
treatment NN Pharmocological
anecortave NN Pharmocological
acetate NN Pharmocological
sterile JJ Pharmocological
suspension NN Pharmocological
for IN Pharmocological
juxtascleral JJ Pharmocological
administration NN Pharmocological
. . None
anecortave JJ Pharmocological
acetate NN Pharmocological
anecortave VBP Pharmocological
acetate JJ Pharmocological
-DOCSTART- -X- N

Transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
. . None
randomly RB Physical
allocated VBN Physical
to TO Physical
receive VB Physical
either RB Physical
transcutaneous JJ Physical
electrical JJ Physical
nerve NN Physical
stimulation NN Physical
with IN Physical
intramuscular JJ Physical
papaveretum NN Physical
( ( Physical
20 CD Physical
patients NNS Physical
) ) Physical
or CC None
intramuscular JJ Physical
papaveretum NN Physical
alone RB Physical
( ( Physical
20 CD Physical
patients NNS Physical
) ) Physical
for IN Physical
postoperative JJ Physical
pain NN Physical
relief NN Physical
. . Physical
-DOCSTART- -X- N

dietary JJ Physical
exposure NN Physical
Dietary JJ Physical
factors NNS Physical
daidzein NN Pharmocological
genistein NN Pharmocological
. . None
soy JJ Pharmocological
foods NNS Pharmocological
and CC Pharmocological
fatty JJ Pharmocological
fish NN Pharmocological
-DOCSTART- -X- N

esmolol JJ Pharmocological
electroconvulsive JJ Physical
therapy NN Physical
( ( Physical
ECT NNP Physical
) ) Physical
esmolol JJ Pharmocological
ECT NNP Surgical
with IN Pharmocological
and CC Pharmocological
without IN Pharmocological
esmolol JJ Pharmocological
pretreatment NN Pharmocological
-DOCSTART- -X- N

human JJ Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
: : Pharmocological
intravenous JJ Pharmocological
human JJ Pharmocological
epidermal JJ Pharmocological
growth NN Pharmocological
factor NN Pharmocological
( ( Pharmocological
hEGF NN Pharmocological
) ) Pharmocological
cetraxate VB Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
CH NNP Pharmocological
) ) Pharmocological
EGF NNP Pharmocological
CH NNP Pharmocological
. . Pharmocological
hEGF NN Pharmocological
hydroxypropyl NN Pharmocological
cellulose NN Pharmocological
EGF NNP Pharmocological
EGF NNP Pharmocological
-DOCSTART- -X- N

emotion NN Psychological
recognition NN Psychological
emotion NN Psychological
training NN Psychological
programme NN Psychological
emotion NN Psychological
training NN Psychological
emotion NN Educational
training NN Educational
programme NN Educational
emotion NN Psychological
recognition NN Psychological
skills NNS Psychological
the DT None
Transporters NNPS Educational
Thomas NNP Control
the DT Control
Tank NNP Control
Engine NNP Control
The DT Educational
Transporters NNP Psychological
Transporters NNP Psychological
-DOCSTART- -X- N

corticosteroid NN Pharmocological
( ( Pharmocological
ICS NNP Pharmocological
) ) Pharmocological
triamcinolone NN Pharmocological
acetonide NN Pharmocological
placebo NN Control
ICS NNP Pharmocological
placebo VB None
ICS NNP Pharmocological
placebo NN None
ICS NNP Pharmocological
ICSs NNP None
-DOCSTART- -X- N

Fondaparinux NNP Pharmocological
combined VBD Pharmocological
with IN Pharmocological
intermittent JJ Pharmocological
pneumatic JJ Pharmocological
compression NN Pharmocological
intermittent JJ Physical
pneumatic JJ Physical
compression NN Physical
alone RB Physical
fondaparinux NN Pharmocological
in IN Pharmocological
conjunction NN Pharmocological
with IN Pharmocological
intermittent JJ Pharmocological
pneumatic JJ Pharmocological
compression NN Pharmocological
intermittent JJ Physical
pneumatic JJ Physical
compression NN Physical
alone RB Physical
placebo-controlled JJ Control
fondaparinux JJ Pharmocological
placebo NN Control
intermittent JJ Physical
pneumatic JJ Physical
compression NN Physical
. . Physical
Fondaparinux NNP Pharmocological
fondaparinux-treated JJ Pharmocological
placebo-treated JJ Control
fondaparinux NN Pharmocological
placebo NN Control
, , Pharmocological
fondaparinux VBP Pharmocological
pneumatic JJ Physical
compression NN Physical
alone RB Physical
placebo VB Control
. . None
-DOCSTART- -X- N

progestogen-only JJ Pharmocological
progestogen-only JJ Pharmocological
continuous JJ Pharmocological
progestogens NNS Pharmocological
for IN None
contraception NN None
depot-medroxyprogesterone JJ Pharmocological
acetate NN Pharmocological
( ( Pharmocological
DMPA NNP Pharmocological
) ) Pharmocological
continuous JJ Control
levonorgestrel NN Control
treatment NN Control
with IN Control
subdermal JJ Control
implants NNS Control
depot-medroxy-progesterone JJ Pharmocological
acetate NN Pharmocological
; : None
DMPA NNP Pharmocological
levonorgestrel NN Pharmocological
DMPA NNP Pharmocological
-DOCSTART- -X- N

Fluvoxamine NNP Pharmocological
clomipramine NN Pharmocological
fluvoxamine NN Pharmocological
clomipramine NN Pharmocological
. . Pharmocological
placebo JJ Control
fluvoxamine NN Pharmocological
or CC Pharmocological
clomipramine NN Pharmocological
-DOCSTART- -X- N

dezocine NN Pharmocological
dezocine NN Pharmocological
intravenous JJ Pharmocological
dezocine NN Pharmocological
or CC None
a DT None
matching JJ Control
placebo NN Control
midazolam JJ None
0.1 CD None
mg/kg NN None
, , None
fentanyl VBP None
5 CD None
?g/kg NN None
, , None
propofol JJ None
1-1.5 JJ None
mg/kg NN None
, , None
and CC None
suxamethonium NN None
intravenous JJ None
dezocine NN None
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
( ( Pharmocological
low-dose JJ Pharmocological
: : None
0.125 CD None
mg/day NN None
[ VBD None
20 CD None
to TO None
< VB None
45 CD None
kg NN None
] NN None
, , None
0.175 CD None
mg/day NN None
[ NNP None
> VBZ None
45 CD None
kg NN None
] NN None
or CC None
high-dose NN Pharmocological
: : None
1.25 CD None
mg/day NN None
[ VBD None
20 CD None
to TO None
< VB None
45 CD None
kg NN None
] NN None
, , None
1.75 CD None
mg/day NN None
[ NNP None
> VBZ None
45 CD None
kg NN None
] NN None
) ) None
or CC None
placebo NN Control
-DOCSTART- -X- N

calcineurin NN Pharmocological
inhibitors NNS Pharmocological
and CC None
everolimus JJ Pharmocological
monotherapy NN Pharmocological
early JJ None
withdrawal NN None
of IN None
cyclosporine NN Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
followed VBN None
by IN None
the DT None
initiation NN None
of IN None
everolimus NN Pharmocological
( ( Pharmocological
Evr NNP Pharmocological
) ) Pharmocological
monotherapy NN Pharmocological
CsA NNP Pharmocological
Evr NNP Pharmocological
in IN None
combination NN None
with IN Pharmocological
CsA NNP Pharmocological
Evr NNP Control
monotherapy NN Control
( ( Control
Evr NNP Control
group NN Control
) ) Control
CsA NNP Pharmocological
with/without NN None
mycophenolate NN Pharmocological
mofetil NN Pharmocological
( ( None
CsA NNP None
group NN None
) ) None
( ( None
Evr NNP Pharmocological
CsA NNP Pharmocological
Evr NNP Pharmocological
CsA NNP Pharmocological
Evr NNP Pharmocological
CsA NNP None
withdrawal NN None
of IN None
CsA NNP None
followed VBN None
by IN None
Evr NNP None
-DOCSTART- -X- N

joint JJ Psychological
attention NN Psychological
and CC None
symbolic JJ Psychological
play NN Psychological
. . None
joint JJ Psychological
attention NN Psychological
intervention NN Psychological
, , None
a DT None
symbolic JJ Psychological
play NN Psychological
intervention NN Psychological
, , None
or CC Physical
control NN Control
group NN Control
. . Physical
-DOCSTART- -X- N

Radiographic NNP Physical
views NNS Physical
of IN None
the DT None
TF NNP None
and CC None
PF NNP None
compartments NNS None
, , None
knee VB Physical
extension NN Physical
strength NN Physical
, , None
and CC None
knee VB Physical
range NN Physical
of IN Physical
motion NN Physical
Treatment NNP None
strategies VBZ None
targeting VBG None
the DT None
PF NNP None
joint NN None
may MD None
-DOCSTART- -X- N

Chemotherapy NNP Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN None
using VBG None
5-fluorouracil JJ Pharmocological
, , Pharmocological
doxorubicin JJ Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
FAMTX NNP Pharmocological
) ) Pharmocological
prior RB Pharmocological
to TO Pharmocological
surgery NN Pharmocological
or CC None
to TO None
undergo VB None
surgery NN Surgical
only RB Surgical
. . None
The DT None
response NN None
to TO None
chemotherapy NN Pharmocological
was VBD None
evaluated VBN None
after IN None
two CD None
and CC None
four CD None
courses NNS None
. . None
FAMTX NNP Pharmocological
-DOCSTART- -X- N

omeprazole NN Pharmocological
, , None
clarithromycin NN Pharmocological
tinidazole NN Pharmocological
omeprazole JJ Pharmocological
20 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
clarithromycin VBP Pharmocological
250 CD Pharmocological
mg NN Pharmocological
b.d NN Pharmocological
. . None
and CC Pharmocological
tinidazole JJ Pharmocological
500 CD Pharmocological
mg NN Pharmocological
b.d NN Pharmocological
. . Pharmocological
placebos NN Control
. . None
-DOCSTART- -X- N

vascularized JJ Surgical
bone NN Surgical
grafts NNS Surgical
one-third NN Surgical
of IN Surgical
the DT Surgical
total JJ Surgical
length NN Surgical
of IN Surgical
the DT Surgical
bone NN Surgical
was VBD Surgical
removed VBN Surgical
-DOCSTART- -X- N

tamoxifen NN Pharmocological
and CC None
to TO None
assess VB None
the DT None
of IN None
sequentially RB None
adding VBG None
low-dose JJ Pharmocological
cyclophosphamide-methotrexate-5-fluorouracil NN Pharmocological
( ( Pharmocological
CMF NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
in IN Pharmocological
tamoxifen JJ Pharmocological
responders NNS Pharmocological
. . None
tamoxifen NN Pharmocological
alone RB Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

pain-free JJ Physical
treadmill NN Physical
training VBG Physical
pain-free JJ Physical
treadmill NN Physical
training VBG Physical
treadmill NN Physical
training NN Physical
control NN Control
group NN Control
( ( None
no DT Physical
change NN Physical
in IN Physical
physical JJ Physical
activity NN Physical
) ) None
treadmill JJ Physical
pain-free JJ None
treadmill NN None
training NN None
parallels NNS None
-DOCSTART- -X- N

Endovascular NNP Surgical
aneurysm NN Surgical
repair NN Surgical
( ( Surgical
EVAR NNP Surgical
) ) Surgical
EVAR NNP Surgical
or CC None
no DT Pharmocological
intervention NN Pharmocological
aneurysm JJ Surgical
repair NN Surgical
EVAR NNP Surgical
-DOCSTART- -X- N

interferon NN Pharmocological
IFN-alpha JJ Pharmocological
2b CD Pharmocological
IFN-alpha JJ Pharmocological
2b CD Pharmocological
( ( Pharmocological
HDI NNP Pharmocological
) ) Pharmocological
Obs NNP Pharmocological
HDI NNP Pharmocological
Obs NNP Pharmocological
HDI NNP Pharmocological
Obs NNP Pharmocological
-DOCSTART- -X- N

Thoracoscopic NNP Pharmocological
talc NN Pharmocological
insufflation NN Pharmocological
talc NN Pharmocological
slurry NN Pharmocological
video-assisted JJ Pharmocological
thoracoscopic NN Pharmocological
talc NN Pharmocological
insufflation NN Pharmocological
with IN None
bedside JJ Pharmocological
talc NN Pharmocological
slurry NN Pharmocological
in IN None
video-assisted JJ Pharmocological
thoracoscopic NN Pharmocological
talc NN Pharmocological
insufflation NN Pharmocological
general JJ Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

mechlorethamine NN Physical
, , Physical
Oncovin NNP Physical
, , Physical
procarbazine NN Physical
, , Physical
and CC Physical
prednisone NN Physical
( ( Physical
MOPP NNP Physical
) ) Physical
and CC None
supradiaphragmatic JJ Physical
radiotherapy NN Physical
( ( Physical
40 CD Physical
Gy NNP Physical
) ) Physical
, , None
and CC None
no DT Physical
laparotomy NN Physical
MOPP NNP Pharmocological
CCNU NNP Pharmocological
, , Pharmocological
vinblastine NN Pharmocological
, , Pharmocological
procarbazine NN Pharmocological
prednisone NN Pharmocological
laparotomy NN Surgical
supradiaphragmatic JJ Physical
radiotherapy NN Physical
-DOCSTART- -X- N

acupuncture VB Physical
acupuncture NN Physical
acupuncture NN Physical
acupuncture NN Physical
acupuncture NN Physical
Acupuncture NNP Physical
-DOCSTART- -X- N

calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
supplements NNS Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
and CC None
vitamin NN Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
total JJ Pharmocological
thyroidectomy NN Pharmocological
plus CC Pharmocological
CND NNP Pharmocological
. . None
oral JJ Pharmocological
calcium NN Pharmocological
vitamin JJ Pharmocological
D NNP Pharmocological
calcium NN Pharmocological
alone RB Pharmocological
no DT Pharmocological
supplements NNS Pharmocological
-DOCSTART- -X- N

tested VBN None
with IN None
TRH NNP Pharmocological
( ( None
200 CD None
micrograms NNS None
IV NNP None
bolus NN None
) ) None
in IN None
the DT None
presence NN None
( ( None
experimental JJ None
test NN None
) ) None
and CC None
absence NN None
( ( None
control VB None
test NN None
) ) None
of IN None
the DT None
serotonergic JJ Pharmocological
agonist NN Pharmocological
fenfluramine NN Pharmocological
( ( None
60 CD None
mg NN None
PO NNP None
90 CD None
min NN None
before IN None
TRH NNP None
) ) None
. . None
-DOCSTART- -X- N

prophylactic JJ Pharmocological
amiodarone NN Pharmocological
amiodarone NN Pharmocological
amiodarone NN Pharmocological
group NN Pharmocological
amiodarone NN Pharmocological
control NN None
normal JJ Pharmocological
saline NN Pharmocological
. . None
amiodarone NN Pharmocological
amiodarone NN Pharmocological
-DOCSTART- -X- N

Oxytocin NNP Pharmocological
neuropeptide JJ Pharmocological
oxytocin NN Pharmocological
placebo-controlled JJ Control
intranasal JJ Pharmocological
oxytocin NN Pharmocological
functional JJ Physical
magnetic JJ Physical
resonance NN Physical
imaging NN Physical
oxytocin NN Pharmocological
neurotypical JJ Control
control NN Control
neuropeptide JJ Pharmocological
oxytocin NN Pharmocological
oxytocin NN Pharmocological
-DOCSTART- -X- N

eleutherococcus JJ Educational
senticosus NN Educational
extract NN Educational
placebo-controlled JJ Control
Eleutherococcus NNP Educational
senticosus NN Educational
extract NN Educational
( ( Educational
Eleukokk NNP Educational
) ) Educational
ethanolic JJ Educational
( ( Educational
vincamine JJ Educational
free JJ Educational
) ) Educational
eleutherococcus VBP Educational
senticosus JJ Educational
preparation NN Educational
placebo NN Control
, , Control
the DT Control
eleutherococcus NN Control
extract NN Control
was VBD Control
substituted VBN Control
by IN Control
additional JJ Control
wine NN Control
, , Control
resulting VBG Control
in IN Control
identical JJ Control
final JJ Control
concentrations NNS Control
of IN Control
ethanol NN Control
in IN Control
both DT Control
preparations NNS Control
. . None
-DOCSTART- -X- N

propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
propofol NN Pharmocological
placebo NN Control
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
propofol JJ Pharmocological
droperidol VBZ Pharmocological
metoclopramide RB Pharmocological
placebo NN Control
( ( Control
isotonic JJ Control
saline NN Control
) ) Control
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
placebo NN None
propofol NN Pharmocological
droperidol NN Pharmocological
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide NN Pharmocological
propofol NN Pharmocological
droperidol NN Pharmocological
propofol NN Pharmocological
droperidol NN Pharmocological
metoclopramide JJ Pharmocological
placebo NN Pharmocological
-DOCSTART- -X- N

palatal JJ Surgical
operations NNS Surgical
2 CD Surgical
palatal JJ Surgical
surgical JJ Surgical
procedures NNS Surgical
radiofrequency NN Surgical
ablation NN Surgical
of IN Surgical
the DT Surgical
palate NN Surgical
( ( Surgical
RFAP NNP Surgical
) ) Surgical
for IN Surgical
a DT Surgical
planned JJ Surgical
3-stage JJ Surgical
treatment NN Surgical
or CC None
laser-assisted JJ Surgical
uvulopalatoplasty JJ Surgical
( ( Surgical
LAUP NNP Surgical
) ) Surgical
, , Surgical
also RB Surgical
for IN Surgical
3 CD Surgical
stages NNS Surgical
of IN Surgical
treatment NN Surgical
, , Surgical
using VBG Surgical
a DT Surgical
CO NNP Surgical
( ( Surgical
2 CD Surgical
) ) Surgical
laser NN Surgical
. . Physical
alternative JJ Surgical
surgical JJ Surgical
therapy NN Surgical
for IN Surgical
attempted JJ Surgical
salvage NN Surgical
. . None
RFAP NNP Physical
LAUP NNP Surgical
RFAP NNP Surgical
LAUP NNP Surgical
. . None
LAUP NNP Surgical
nasal JJ Surgical
surgery NN Surgical
. . None
RFA NNP Surgical
. . None
LAUP NNP Surgical
RFAP NNP Surgical
-DOCSTART- -X- N

paroxetine NN Pharmocological
352 CD None
paroxetine NN Pharmocological
paroxetine NN Pharmocological
and CC None
imipramine NN Pharmocological
paroxetine NN Pharmocological
or CC None
imipramine VB Pharmocological
versus NN None
placebo NN Control
. . None
-DOCSTART- -X- N

Propofol NNP Pharmocological
submucosal JJ None
Propofol NNP Pharmocological
-DOCSTART- -X- N

spinal JJ Physical
manipulation NN Physical
therapy NN Physical
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
fixed-point JJ Physical
spin NN Physical
reduction NN Physical
of IN Physical
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
and CC None
dialectical JJ Pharmocological
prescription NN Pharmocological
. . None
spinal JJ Physical
manipulation NN Physical
therapy NN Physical
-DOCSTART- -X- N

intramammary JJ Pharmocological
tilmicosin NN Pharmocological
intramammary JJ Pharmocological
infusion NN Pharmocological
, , Pharmocological
containing VBG Pharmocological
tilmicosin NN Pharmocological
phosphate NN Pharmocological
infusion NN Control
of IN Control
a DT Control
negative JJ Control
control NN Control
intramammary JJ Control
placebo NN Control
intramammary JJ Pharmocological
tilmicosin NNS Pharmocological
intramammary JJ Pharmocological
placebo NN Pharmocological
intramammary JJ Pharmocological
tilmicosin NN Pharmocological
-DOCSTART- -X- N

Fine NNP Surgical
needle JJ Surgical
aspiration NN Surgical
coupled VBN Surgical
with IN Surgical
real-time JJ Physical
PCR NNP Physical
: : None
methodology NN Physical
fine JJ Physical
needle JJ Physical
aspiration NN Physical
technique NN Physical
Multiplex NNP Physical
tandem VBD Physical
RT-PCR NNP Physical
painless JJ Physical
methodology NN Physical
-DOCSTART- -X- N

propofol NN Pharmocological
. . Pharmocological
propofol NN Pharmocological
propofol NN Pharmocological
lignocaine NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
or CC None
normal JJ Control
saline JJ Control
2 CD Pharmocological
ml NN Pharmocological
to TO Pharmocological
the DT Pharmocological
propofol NN Pharmocological
before IN Pharmocological
injection NN Pharmocological
. . None
-DOCSTART- -X- N

cognitive JJ Educational
behavioral JJ Educational
therapy NN Educational
CBT NNP Educational
CBT NNP Educational
randomly RB None
assigned VBN None
to TO None
an DT None
immediate JJ Educational
treatment NN Educational
( ( Educational
IT NNP Educational
; : None
n JJ None
= NNP None
17 CD None
) ) None
or CC None
3-month JJ None
waitlist NN None
( ( None
WL NNP None
; : None
n CC None
= VB None
23 CD None
) ) None
condition NN None
. . None
-DOCSTART- -X- N

incentives VB Educational
use NN Educational
of IN Educational
lottery JJ Educational
tickets NNS Educational
as IN Educational
incentives NNS Educational
three CD None
incentive JJ None
groups NNS None
: : None
( ( None
a DT None
) ) None
no DT Control
incentive NN Control
; : None
( ( None
b NN None
) ) None
a DT None
promised JJ Educational
incentive NN Educational
of IN Educational
one CD Educational
lottery NN Educational
ticket NN Educational
to TO Educational
be VB Educational
received VBN Educational
upon IN Educational
reply NN Educational
; : None
( ( None
c NN None
) ) None
a DT None
promised JJ Educational
incentive NN Educational
of IN Educational
one CD Educational
lottery NN Educational
ticket NN Educational
to TO Educational
be VB Educational
received VBN Educational
upon IN Educational
reply NN Educational
and CC Educational
an DT Educational
additional JJ Educational
lottery NN Educational
ticket NN Educational
upon IN Educational
reply NN Educational
within IN Educational
1 CD Educational
week NN Educational
. . None
no DT Control
incentive NN Control
group NN Control
one CD Educational
plus CC Educational
one CD Educational
lottery NN Educational
ticket NN Educational
group NN Educational
incentive NN Educational
group NN Educational
. . None
lottery JJ Educational
tickets NNS Educational
Incentives NNS Educational
-DOCSTART- -X- N

Active NNP Pharmocological
specific JJ Pharmocological
immunotherapy NN Pharmocological
active JJ Pharmocological
specific JJ Pharmocological
immunotherapy NN Pharmocological
autologous JJ Physical
tumour NN Physical
cells NNS Physical
. . None
ASI NNP Pharmocological
-DOCSTART- -X- N

hormonal JJ Pharmocological
contraceptives NNS Pharmocological
Hormonal NNP Pharmocological
contraceptives NNS Pharmocological
hormonal JJ Pharmocological
contraceptive NN Pharmocological
hormonal JJ Pharmocological
contraceptive NN Pharmocological
hormonal JJ None
contraception NN None
hormonal JJ None
contraception NN None
hormonal JJ None
contraception NN None
hormonal JJ None
contraception NN None
hormonal JJ None
contraceptive NN None
-DOCSTART- -X- N

social-communication-based JJ Educational
approach NN Educational
therapy NN Educational
and CC Educational
coaching VBG Educational
social-interaction NN Educational
and CC Educational
the DT Educational
parent-child JJ Educational
relationship NN Educational
. . None
community NN Control
treatment NN Control
variety NN Other
of IN Other
services NNS Other
averaging VBG Other
3.9 CD Other
hours NNS Other
per IN Other
week NN Other
. . None
-DOCSTART- -X- N

Estrogen NNP Pharmocological
therapy NN Pharmocological
estrogen NN Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
conjugated VBN Pharmocological
estrogen NN Pharmocological
Placebos NNS Control
estrogen-treated JJ Pharmocological
placebo NN Control
estrogen NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

First-intron NNP Physical
polymorphisms NN Physical
polymorphism NN Physical
evaluated VBD Physical
the DT Physical
possible JJ Physical
-DOCSTART- -X- N

Alinidine NNP Pharmocological
alinidine NN Pharmocological
alinidine NN Pharmocological
or CC None
placebo NN Control
Alinidine NNP Pharmocological
upright JJ Physical
bicycle NN Physical
exercise NN Physical
. . None
Alinidine NN Pharmocological
alinidine NN Pharmocological
placebo NN Control
alinidine NN Pharmocological
-DOCSTART- -X- N

Psychiatric NNP Psychological
treatment NN Psychological
dermatological JJ Physical
treatment NN Physical
only RB Physical
same JJ Educational
dermatological JJ Psychological
treatment NN Psychological
plus CC Psychological
psychiatric JJ Psychological
treatment NN Psychological
psychiatric JJ Psychological
treatment NN Psychological
-DOCSTART- -X- N

Insecticide-treated JJ Other
bednets NNS Other
free JJ Educational
Interviews NNS Educational
coverage NN Other
of IN Other
per IN Other
bednet NN Other
owned VBN Other
. . None
bednet NN Other
free JJ Other
bednet NN Other
distribution NN Other
program NN Other
-DOCSTART- -X- N

Paclitaxel NNP Pharmocological
plus CC Pharmocological
carboplatin NN Pharmocological
versus NN None
paclitaxel NN Pharmocological
plus CC Pharmocological
carboplatin NN Pharmocological
paclitaxel NN Pharmocological
and CC None
carboplatin NN Pharmocological
paclitaxel NN Pharmocological
plus CC Pharmocological
carboplatin NN Pharmocological
paclitaxel NN Pharmocological
chemotherapy NN Pharmocological
paclitaxel NN Pharmocological
paclitaxel JJ Pharmocological
paclitaxel NNS Pharmocological
-DOCSTART- -X- N

Nimodipine NNP Pharmocological
placebo-controlled JJ Control
nimodipine NN Pharmocological
nimodipine NN Pharmocological
placebo VB Control
nimodipine NN Pharmocological
nimodipine NN Pharmocological
nimodipine NN Pharmocological
nimodipine NN Pharmocological
-DOCSTART- -X- N

Hyperbaric NNP Physical
oxygen NN Physical
hyperbaric JJ Physical
therapy NN Physical
one-hour JJ Physical
sessions NNS Physical
of IN Physical
either DT Physical
HBOT NNP Physical
at IN Physical
153 CD Physical
kPa NN Physical
sham JJ Physical
air NN Physical
at IN Physical
116 CD Physical
kPa NN Physical
HBOT NNP Physical
-DOCSTART- -X- N

Chinese JJ Pharmocological
herbal JJ Pharmocological
medicine NN Pharmocological
Chinese NNP Pharmocological
herbal JJ Pharmocological
medicine NN Pharmocological
( ( Pharmocological
CHM NNP Pharmocological
) ) Pharmocological
Participants NNS None
were VBD None
initially RB None
randomized VBN None
to TO None
either DT None
wait-list JJ Control
control NN Control
( ( Control
WLC NNP Control
) ) Control
or CC None
treatment NN None
groups NNS None
to TO None
receive VB None
either DT None
individualized JJ Pharmocological
CHM NNP Pharmocological
decoctions NNS Pharmocological
or CC None
a DT None
therapeutically RB Control
inert JJ Control
placebo NN Control
decoction NN Control
. . None
-DOCSTART- -X- N

Nucleotides NNP Pharmocological
nucleotides NNS Pharmocological
soy-based JJ Pharmocological
formula NN Pharmocological
assigned VBN None
randomly RB None
to TO None
soy VB Pharmocological
formula NN Pharmocological
groups NNS None
with IN None
and CC None
without IN None
added VBN None
nucleotides NNS Pharmocological
, , None
was VBD None
Blood NN None
samples NNS None
were VBD None
collected VBN None
at IN None
6 CD None
, , None
7 CD None
, , None
and CC None
12 CD None
months NNS None
. . None
nucleotide-supplemented JJ Pharmocological
nucleotides NNS Pharmocological
. . None
nucleotides NNS Pharmocological
-DOCSTART- -X- N

L-carnitine NNP Pharmocological
L-carnitine NNP Pharmocological
placebo-controlled JJ Control
L-carnitine JJ Pharmocological
L-carnitine NNP Pharmocological
in IN Pharmocological
1500 CD Pharmocological
ml NN Pharmocological
cardioplegia NN Pharmocological
aortic JJ Surgical
cross-clamping NN Surgical
. . None
L-carnitine JJ Pharmocological
therapy NN Pharmocological
L-carnitine NNP Pharmocological
-DOCSTART- -X- N

Pre-bent JJ Physical
instruments NNS Physical
single-port JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
versus IN Surgical
conventional JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
: : Surgical
single-incision NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
SILS NNP Surgical
) ) Surgical
conventional JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
CLS NNP Surgical
) ) Surgical
single-port JJ Surgical
laparoscopic NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

urokinase NN Pharmocological
A NNP None
multicentre JJ None
trial NN None
( ( None
10 CD None
centres NNS None
) ) None
of IN None
urokinase NN Pharmocological
( ( Pharmocological
UK NNP Pharmocological
) ) Pharmocological
two CD Pharmocological
doses NNS Pharmocological
of IN Pharmocological
UK NNP Pharmocological
administered VBD None
via IN None
a DT None
catheter NN None
in IN None
the DT None
pulmonary JJ None
artery NN None
: : None
2000 CD None
IU NNP None
kg-1 JJ None
h-1 NN None
for IN None
24 CD Pharmocological
hours NNS Pharmocological
( ( Pharmocological
UK IN Pharmocological
2000 CD Pharmocological
) ) Pharmocological
in IN Pharmocological
conjunction NN Pharmocological
with IN Pharmocological
heparin NN Pharmocological
versus NN None
4400 CD Pharmocological
IU NNP Pharmocological
kg-1 JJ Pharmocological
h-1 JJ Pharmocological
UK NNP Pharmocological
alone RB Pharmocological
for IN Pharmocological
12 CD Pharmocological
hours NNS Pharmocological
( ( Pharmocological
UK IN Pharmocological
4400 CD Pharmocological
) ) Pharmocological
followed VBN Pharmocological
by IN Pharmocological
heparin NN Pharmocological
. . None
thrombolytic JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

paroxetine NN Pharmocological
Methamphetamine NNP Pharmocological
methamphetamine VBP Pharmocological
's POS Pharmocological
SSRI NNP Pharmocological
paroxetine NN Pharmocological
versus NN None
placebo NN Control
-DOCSTART- -X- N

immune JJ Pharmocological
globulin NN Pharmocological
immune NNS Pharmocological
globulin NN Pharmocological
intravenous JJ Pharmocological
immune JJ Pharmocological
globulin NN Pharmocological
group NN Pharmocological
control NN Control
group NN Control
immune JJ None
globulin NN None
immune JJ Pharmocological
globulin NN Pharmocological
-DOCSTART- -X- N

diclofenac NN Pharmocological
versus NN None
paracetamol NN Pharmocological
and CC None
placebo NN Control
diclofenac-K NN Pharmocological
paracetamol NN Pharmocological
placebo VB Control
placebo-controlled JJ Control
diclofenac-K NN Pharmocological
( ( Pharmocological
12.5 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
tablets VBZ Pharmocological
vs JJ Pharmocological
paracetamol NN Pharmocological
placebo NN Control
diclofenac-K NN Pharmocological
paracetamol NN Pharmocological
placebo JJ Control
diclofenac-K NN Pharmocological
placebo VB Control
paracetamol VB Pharmocological
placebo NN Control
. . None
placebo NN Control
. . None
diclofenac-K NN Pharmocological
paracetamol NN Pharmocological
-DOCSTART- -X- N

computerised JJ Physical
posturography NN Physical
propofol/alfentanil/N2O NN Pharmocological
anaesthesia NN Pharmocological
with IN Pharmocological
thiopentone/halothane/N2O JJ Pharmocological
anaesthesia NN Pharmocological
. . None
propofol/alfentanil/N2O NNS Pharmocological
thiopentone/halothane/N2O RB Pharmocological
. . None
propofol/alfentanil/N2O NN Pharmocological
anaesthesia NN Pharmocological
thiopentone/halothane/N2O VB Pharmocological
anaesthesia NN Pharmocological
otolaryngological JJ Surgical
surgery NN Surgical
. . Surgical
-DOCSTART- -X- N

eicosapentaenoic NN Pharmocological
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
eicosapentaenoic VBZ Pharmocological
acid NNS Pharmocological
( ( Pharmocological
EPA NNP Pharmocological
) ) Pharmocological
and CC None
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
EPA NNP Pharmocological
DHA NNP Pharmocological
olive JJ Control
oil NN Control
as IN Control
placebo NN Control
placebo NN Control
EPA NNP Pharmocological
DHA NNP Pharmocological
EPA NNP Pharmocological
EPA NNP Pharmocological
. . None
EPA NNP Pharmocological
DHA NNP Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

maternal JJ Pharmocological
glucose JJ Pharmocological
infusion NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
dextrose NN Pharmocological
glucose NN Pharmocological
) ) None
or CC None
Ringer NNP Pharmocological
's POS Pharmocological
lactate NN Pharmocological
or CC None
isotonic JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
epidural JJ Physical
anesthesia NN Physical
. . None
-DOCSTART- -X- N

Gefitinib NNP Pharmocological
plus CC None
best JJS Other
supportive JJ Other
care NN Other
placebo-controlled JJ Control
gefitinib NN Pharmocological
gefitinib NN Pharmocological
( ( Pharmocological
250 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
, , None
plus CC Other
best JJS Other
supportive JJ Other
care NN Other
. . None
gefitinib NN Pharmocological
-DOCSTART- -X- N

cuffed NN Physical
and CC Physical
uncuffed JJ Physical
endotracheal NN Physical
tubes NNS Physical
Uncuffed NNP Physical
endotracheal NN Physical
tubes NNS Physical
cuffed NN Physical
versus NN Physical
uncuffed JJ Physical
endotracheal NN Physical
tubes NNS Physical
cuffed NN Physical
tube NN Physical
sized VBN Physical
by IN Physical
a DT Physical
new JJ Physical
formula NN Physical
uncuffed JJ Physical
tube NN Physical
sized VBN Physical
by IN Physical
the DT Physical
modified JJ Physical
Cole NNP Physical
's POS Physical
formula NN Physical
Cuffed NNP Physical
tubes RB Physical
Uncuffed NNP Physical
tubes RB Physical
cuffed JJ Physical
endotracheal JJ Physical
tubes NNS Physical
cuffed NN Physical
endotracheal VBP Physical
tubes NNS Physical
-DOCSTART- -X- N

Long-stay JJ Physical
short-stay JJ Physical
hospital NN Physical
treatment NN Physical
early JJ Other
discharge NN Other
attempted VBD Other
full JJ Other
nutritional JJ Other
rehabilitation NN Other
short-stay NN Physical
( ( Physical
SS NNP Physical
) ) Physical
or CC None
long-stay JJ Physical
( ( Physical
LS NNP Physical
) ) Physical
group NN None
. . None
LS NNP Physical
retained VBD None
in IN None
hospital NN None
for IN None
full JJ None
nutritional JJ None
rehabilitation NN None
SS NNP Physical
discharged VBD None
immediately RB None
for IN None
standard JJ None
Health NNP None
Service NNP None
care NN None
at IN None
home NN None
plus CC None
high-energy JJ None
supplement NN None
LS NNP Physical
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
thrombopoietin NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
thrombopoietin NN Pharmocological
( ( Pharmocological
rhTPO NN Pharmocological
) ) Pharmocological
placebo NN Control
, , Control
placebo NN Control
, , None
rhTPO VBZ Pharmocological
high-dose JJ Pharmocological
chemotherapy NN Pharmocological
and CC Pharmocological
PBPC NNP Pharmocological
transplantation NN Pharmocological
placebo JJ Control
rhTPO NN Pharmocological
rhTPO NN Pharmocological
rhTPO NN Pharmocological
placebo VB Control
rhTPO-treated JJ Physical
rhTPO VB Pharmocological
rhTPO NN Pharmocological
chemotherapy NN Pharmocological
PBPC NNP Pharmocological
transplantation NN Pharmocological
. . None
-DOCSTART- -X- N

laryngeal JJ Physical
tube NN Physical
suction-device NN Physical
( ( Physical
LTS-D NNP Physical
) ) Physical
single-use JJ Physical
laryngeal NN Physical
tube NN Physical
with IN Physical
suction NN Physical
option NN Physical
( ( Physical
LTS-D NNP Physical
) ) Physical
instead RB Surgical
endotracheal JJ Surgical
intubation NN Surgical
( ( Surgical
ET NNP Surgical
) ) Surgical
and CC Surgical
bag-mask-valve JJ Surgical
ventilation NN Surgical
( ( Surgical
BMV NNP Surgical
) ) Surgical
for IN Surgical
emergency NN Surgical
airway NN Surgical
management NN Surgical
could MD Surgical
LTS-D NNP Physical
LTS-D NNP Physical
ET NNP Surgical
BMV NNP Surgical
. . None
LTS-D NNP Physical
ET NNP Surgical
BMV NNP Surgical
LTS-D NNP Physical
ET NNP Surgical
and CC None
BMV NNP Surgical
. . None
LTS-D NNP Physical
ET NNP Surgical
BMV NNP Surgical
ET NNP Surgical
BMV NNP Surgical
. . None
-DOCSTART- -X- N

Gefitinib NNP Pharmocological
or CC None
placebo NN Control
tamoxifen JJ Pharmocological
plus CC None
placebo NN Control
gefitinib NN Pharmocological
( ( None
gefitinib NN Pharmocological
: : Pharmocological
placebo NN Pharmocological
) ) None
with IN None
gefitinib NN None
with IN None
placebo NN None
. . None
with IN None
gefitinib NN None
with IN None
placebo NN None
. . None
with IN None
gefitinib JJ None
plus CC None
tamoxifen JJ None
for IN None
gefitinib NN None
; : None
-DOCSTART- -X- N

Elastic JJ Surgical
stable JJ Surgical
intramedullary JJ Surgical
nailing VBG Surgical
nonoperative JJ Physical
treatment NN Physical
elastic JJ Surgical
stable JJ Surgical
intramedullary JJ Surgical
nailing NN Surgical
( ( Surgical
ESIN NNP Surgical
) ) Surgical
nonoperative JJ Control
treatment NN Control
simple JJ Physical
shoulder NN Physical
sling NN Physical
ESIN NNP Surgical
-DOCSTART- -X- N

( ( None
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
methotrexate NN Pharmocological
, , Pharmocological
prednisone NN Pharmocological
[ NNP Pharmocological
COMP NNP Pharmocological
] NNP Pharmocological
) ) Pharmocological
10-drug JJ Pharmocological
( ( Pharmocological
LSA2-L2 NNP Pharmocological
modified VBN Pharmocological
) ) Pharmocological
central JJ Pharmocological
nervous JJ Pharmocological
system NN Pharmocological
prophylaxis NN Pharmocological
with IN Pharmocological
intrathecal JJ Pharmocological
methotrexate NN Pharmocological
local JJ Physical
or CC Physical
regional JJ Physical
radiation NN Physical
treatment NN Physical
. . None
COMP NNP Pharmocological
LSA2-L2 NNP Pharmocological
LSA2-L2 NNP Pharmocological
COMP NNP Pharmocological
-DOCSTART- -X- N

Percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
underwent VBP None
percutaneous JJ None
coronary JJ None
intervention NN None
only RB None
for IN None
-DOCSTART- -X- N

Social NNP Educational
skills NNS Educational
training VBG Educational
social JJ Educational
skills NNS Educational
interventions NNS Educational
an DT Educational
evidence-based JJ Educational
, , None
caregiver-assisted JJ Educational
social JJ Educational
skills NNS Educational
intervention NN Educational
known VBN Educational
as IN Educational
PEERS NNP Educational
for IN Educational
Young NNP Educational
Adults NNP Educational
caregiver-assisted JJ Educational
, , None
manualized VBN Educational
intervention NN Educational
-DOCSTART- -X- N

Eberconazole JJ Pharmocological
miconazole JJ Pharmocological
Eberconazole NNP Pharmocological
eberconazole JJ Pharmocological
miconazole JJ Pharmocological
eberconazole VB Pharmocological
miconazole VB Pharmocological
-DOCSTART- -X- N

alone RB Educational
or CC Educational
combined VBN Educational
with IN Educational
the DT Educational
commercial JJ Educational
Weight NNP Educational
Watchers NNP Educational
program NN Educational
. . Educational
control NN Control
group NN Control
Weight NNP Educational
Watchers NNP Educational
group NN Educational
comprehensive JJ Educational
group NN Educational
that WDT Educational
used VBD Educational
both DT Educational
individualized JJ Educational
counseling NN Educational
and CC Educational
Weight NNP Educational
Watchers NNP Educational
. . Educational
-DOCSTART- -X- N

rubber NN Educational
hand NN Educational
illusion NN Educational
. . None
rubber JJ Educational
hand NN Educational
illusion NN Educational
. . None
body NN Educational
ownership NN Educational
illusions NNS Educational
rubber NN Educational
hand NN Educational
illusion NN Educational
noxious JJ Physical
heat NN Physical
stimuli NNS Physical
rubber NN None
hand NN None
illusion NN None
or CC None
during IN None
a DT None
control JJ None
condition NN None
. . None
There EX None
rubber NN None
hand NN None
illusion NN None
or CC None
rubber NN None
hand NN None
illusion NN None
does VBZ None
-DOCSTART- -X- N

precision NN Physical
grip NN Physical
tasks NNS Physical
while IN Physical
a DT Physical
constant JJ Physical
extension NN Physical
or CC Physical
flexion NN Physical
moment NN Physical
was VBD Physical
applied VBN Physical
to TO Physical
their PRP$ Physical
elbow NN Physical
joints NNS Physical
surface NN Physical
electromyography NN Physical
( ( Physical
EMG NNP Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
rhesus-human JJ Pharmocological
reassortant JJ Pharmocological
rotavirus NN Pharmocological
vaccine NN Pharmocological
rhesus-human JJ Pharmocological
reassortant JJ Pharmocological
rotavirus NN Pharmocological
tetravalent NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
RRV-TV NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
Placebo NNP Control
or CC None
RRV-TV NNP Pharmocological
placebo NN Control
RRV-TV JJ Pharmocological
placebo NN Control
RRV-TV NNP Pharmocological
RRV-TV NNP Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

6-thioguanine JJ Pharmocological
versus NN None
6-mercaptopurine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
6-thioguanine NN Pharmocological
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
6-thioguanine JJ Pharmocological
( ( None
750 CD None
6-mercaptopurine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
, , None
6-thioguanine JJ Pharmocological
6-mercaptopurine JJ Pharmocological
-DOCSTART- -X- N

inguinal JJ Surgical
herniorrhaphy NN Surgical
. . Surgical
-DOCSTART- -X- N

Multiple NNP Other
risk NN Other
factor NN Other
intervention NN Other
multiple JJ None
risk NN None
factor NN None
intervention NN None
B-mode NNP Physical
ultrasound NN Physical
High NNP Physical
resolution NN Physical
B-mode NNP Physical
ultrasound NN Physical
intervention NN None
group NN None
usual JJ Control
care NN Control
group NN Control
intervention NN Physical
group NN Physical
. . None
multiple NN Physical
risk NN Physical
intervention NN Physical
programme NN Physical
-DOCSTART- -X- N

urea JJ Pharmocological
fertiliser NN Pharmocological
urea JJ Pharmocological
fertiliser NN Pharmocological
urea JJ Pharmocological
fertiliser NN Pharmocological
-DOCSTART- -X- N

health NN Educational
information NN Educational
package NN Educational
experimental JJ None
validated JJ Other
planned JJ Other
educational JJ Other
programme NN Other
with IN Other
visual JJ Other
aids NNS Other
and CC Other
iron NN Other
supplementation NN Other
. . None
iron NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

collaborative JJ Educational
care NN Educational
management NN Educational
of IN Educational
Alleviating NNP Educational
Depression NNP Educational
Among IN Educational
( ( Educational
ADAPt-C NNP Educational
) ) Educational
collaborative NN Educational
care NN Educational
management NN Educational
access NN Educational
for IN Educational
up IN Educational
to TO Educational
12 CD Educational
months NNS Educational
to TO Educational
a DT Educational
depression NN Educational
clinical JJ Educational
specialist NN Educational
( ( Educational
supervised VBN Educational
by IN Educational
a DT Educational
psychiatrist NN Educational
) ) Educational
who WP Educational
offered VBD Educational
education NN Educational
, , None
structured VBD Psychological
psychotherapy NN Psychological
, , None
and CC None
maintenance/relapse NN Educational
prevention NN Educational
support NN Educational
. . None
antidepressant JJ Pharmocological
medications NNS Pharmocological
ADAPt-C NNP Educational
collaborative JJ Educational
care NN Educational
-DOCSTART- -X- N

bladder NN Physical
flap NN Physical
bladder NN Physical
flap NN Physical
abdominal JJ Surgical
surgeries NNS Surgical
cesarean JJ Surgical
deliveries NNS Surgical
omission NN Physical
of IN Physical
the DT Physical
bladder NN Physical
flap NN Physical
-DOCSTART- -X- N

piroxicam NN Pharmocological
piroxicam NN Pharmocological
piroxicam NN Pharmocological
codeine NN Pharmocological
sulfate NN Pharmocological
and CC None
placebo NN Control
. . None
Piroxicam NNP Pharmocological
placebo NN Control
Codeine VB Pharmocological
placebo VB None
Piroxicam NNP Pharmocological
codeine VBP Pharmocological
piroxicam NN Pharmocological
aspirin JJ Pharmocological
placebo NN None
. . None
piroxicam NN Pharmocological
placebo NN None
Piroxicam NNP Pharmocological
aspirin RB Pharmocological
Piroxicam VB Pharmocological
aspirin NN Pharmocological
piroxicam VBD Pharmocological
aspirin NN Pharmocological
placebo NN None
piroxicam NNS Pharmocological
codeine NN Pharmocological
or CC None
aspirin NN Pharmocological
-DOCSTART- -X- N

Risperidone NN Pharmocological
risperidone NN Pharmocological
were VBD Pharmocological
followed VBN Pharmocological
for IN Pharmocological
6 CD Pharmocological
months NNS Pharmocological
-DOCSTART- -X- N

live JJ Other
supervision NN Other
via IN Other
teleconferencing VBG Other
Teleconferencing VBG Other
Supervision NNP Other
Teleconferencing VBG Other
Supervision NN Other
-DOCSTART- -X- N

lidocaine NN Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
placebo VB Control
lidocaine NN Pharmocological
placebo NN Pharmocological
lidocaine NN Pharmocological
Lidocaine NNP Pharmocological
-DOCSTART- -X- N

proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
and CC None
roxithromycin NN Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
roxithromycin NN Pharmocological
omeprazole VBP Pharmocological
20 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
lansoprazole JJ Pharmocological
30 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
roxithromycin VBZ Pharmocological
300 CD Pharmocological
mg NN Pharmocological
b.d. NN Pharmocological
and CC None
the DT None
combination NN None
of IN None
roxithromycin NN Pharmocological
with IN None
either DT None
omeprazole NN Pharmocological
or CC Pharmocological
lansoprazole NN Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
and CC None
roxithromycin NN Pharmocological
roxithromycin VB Pharmocological
proton NN None
pump NN None
inhibitor NN None
Proton NNP Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
roxithromycin VB Pharmocological
proton VBP Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
-DOCSTART- -X- N

diclofenac NN Pharmocological
diclofenac NN Pharmocological
and CC None
ketorolac NN Pharmocological
postoperative VB Pharmocological
diclofenac NN Pharmocological
in IN None
one CD None
eye NN None
and CC None
ketorolac NN Pharmocological
in IN Pharmocological
the DT Pharmocological
other JJ Pharmocological
. . None
-DOCSTART- -X- N

citalopram NN Pharmocological
citalopram NN Pharmocological
Selective NNP Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitors NNS Pharmocological
citalopram JJ Pharmocological
hydrobromide NN Pharmocological
therapy NN Pharmocological
citalopram NN Pharmocological
placebo NN Control
citalopram NN Pharmocological
hydrobromide NN Pharmocological
( ( Pharmocological
10 CD Pharmocological
mg/5 RB Pharmocological
mL NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
citalopram NN Pharmocological
hydrobromide NN Pharmocological
citalopram-treated JJ Pharmocological
placebo NN Control
citalopram-treated JJ Pharmocological
placebo NN Control
Citalopram NNP Pharmocological
citalopram NN Pharmocological
-DOCSTART- -X- N

control VB Control
( ( Control
standard JJ Control
care NN Control
plus CC Control
telephone NN Control
follow-up NN Control
or CC None
intervention NN Educational
post-PCI JJ Educational
-DOCSTART- -X- N

Internet-based JJ Educational
intervention NN Educational
psychotherapeutic JJ Educational
interventions NNS Educational
control VB Control
groups NNS Control
. . None
-DOCSTART- -X- N

PostureJac NNP Physical
PostureJac NNP Physical
PostureJac NNP None
-DOCSTART- -X- N

parent-mediated JJ Psychological
communication-focused JJ Psychological
treatment NN Psychological
-DOCSTART- -X- N

Stress NNP Educational
reduction NN Educational
stress JJ Educational
reduction NN Educational
program NN Educational
group-based JJ Educational
psychosocial JJ Educational
intervention NN Educational
program NN Educational
or CC Educational
usual JJ Educational
care NN Educational
. . Educational
education NN Educational
about IN Educational
risk NN Educational
factors NNS Educational
, , None
relaxation NN Educational
training NN Educational
techniques NNS Educational
, , None
methods NNS Educational
for IN Educational
self-monitoring NN Educational
and CC Educational
cognitive JJ Educational
restructuring NN Educational
, , None
with IN None
an DT None
emphasis NN None
on IN None
coping VBG Educational
with IN Educational
stress JJ Educational
exposure NN Educational
from IN Educational
family NN Educational
and CC Educational
work NN Educational
, , None
and CC None
self-care NN Educational
and CC Educational
compliance NN Educational
with IN Educational
clinical JJ Educational
advice NN Educational
. . None
into IN None
multivariate NN None
models NNS None
group-based JJ Educational
psychosocial JJ Educational
intervention NN Educational
program NN Educational
-DOCSTART- -X- N

duloxetine NN Pharmocological
duloxetine NN Pharmocological
duloxetine NN Pharmocological
placebo NN Control
placebo NN Control
duloxetine NN Pharmocological
duloxetine NN Pharmocological
placebo NN Control
duloxetine NN Pharmocological
placebo JJ Control
duloxetine NN Pharmocological
placebo NN Control
duloxetine NN Pharmocological
placebo NN Control
duloxetine NN Pharmocological
duloxetine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

analysis NN None
all-polyethylene JJ Pharmocological
versus NN Pharmocological
metal-backed JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
. . Pharmocological
all-polyethylene JJ Pharmocological
and CC Pharmocological
metal-backed JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
. . Pharmocological
all-polyethylene JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
metal-backed JJ Pharmocological
tibial JJ Pharmocological
components NNS Pharmocological
. . Pharmocological
all-polyethylene JJ Pharmocological
tibial JJ Pharmocological
component NN Pharmocological
-DOCSTART- -X- N

monoamine NN Pharmocological
oxidase NN Pharmocological
B NNP Pharmocological
inhibitor NN Pharmocological
mofegiline NN Pharmocological
pharmacokinetics NNS None
, , None
and CC None
pharmacodynamics NNS None
of IN None
single JJ None
oral JJ None
doses NNS None
of IN None
up IN None
to TO None
48 CD None
mg NNS None
and CC None
daily JJ None
( ( None
for IN None
28 CD None
days NNS None
) ) None
doses NNS None
of IN None
up IN None
24 CD None
mg NNS None
mofegiline NN Pharmocological
-DOCSTART- -X- N

dietary JJ Pharmocological
glutamine NN Pharmocological
supplementation NN Pharmocological
. . Pharmocological
Dietary JJ Pharmocological
supplementation NN Pharmocological
of IN Pharmocological
glutamine NN Pharmocological
free JJ Pharmocological
access NN Pharmocological
to TO Pharmocological
diets NNS Pharmocological
supplemented VBN Pharmocological
with IN Pharmocological
1 CD Pharmocological
% NN Pharmocological
L-glutamine NNP Pharmocological
( ( Pharmocological
wt NN Pharmocological
: : Pharmocological
wt NN Pharmocological
) ) Pharmocological
or CC Pharmocological
isonitrogenous JJ Pharmocological
L-alanine JJ Pharmocological
( ( Pharmocological
control NN Pharmocological
) ) Pharmocological
. . Pharmocological
Dietary NNP Pharmocological
glutamine JJ Pharmocological
supplementation NN Pharmocological
the DT Pharmocological
glutamine NN Pharmocological
treatment NN Pharmocological
glutamine NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

pioglitazone NN Pharmocological
and CC None
glimepiride NN Pharmocological
Pioglitazone NNP Pharmocological
glimepiride VB Pharmocological
Pioglitazone NN Pharmocological
glimepiride NN Pharmocological
glimepiride NN Pharmocological
or CC None
pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
glimepiride RB Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
pioglitazone NN Pharmocological
glimepirede NN Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
Pioglitazone NN Pharmocological
glimepiride NN Pharmocological
Pioglitazone NNP Pharmocological
glimepiride NN Pharmocological
pioglitazone NN Pharmocological
glimepiride NN Pharmocological
pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
glimepiride VB Pharmocological
pioglitazone NN Pharmocological
-DOCSTART- -X- N

quinapril NN Pharmocological
and CC None
captopril NN Pharmocological
diuretic JJ Physical
therapy NN Physical
quinapril NN Pharmocological
captopril NN Pharmocological
diuretic JJ Pharmocological
therapy NN Pharmocological
quinapril NN Pharmocological
captopril NN Pharmocological
quinapril VB Pharmocological
captopril VB Pharmocological
. . None
quinapril NN Pharmocological
captopril NN Pharmocological
) ) None
quinapril NN Pharmocological
. . None
quinapril NN Pharmocological
captopril NN Pharmocological
-DOCSTART- -X- N

Social NNP Educational
Skills NNP Educational
Training NNP Educational
Group-based JJ Educational
Program NNP Educational
( ( Educational
SST-GP NNP Educational
) ) Educational
Leisure NN Educational
Activities VBZ Educational
Group-based JJ Educational
Program NNP Educational
( ( Educational
LA-GP NNP Educational
) ) Educational
SST NNP Educational
LA NNP Educational
SST NNP Educational
LA NNP Educational
SST NNP Educational
SST NNP Educational
SST-GP NNP Educational
LA-GP NNP Educational
-DOCSTART- -X- N

HMG NNP Pharmocological
CoA NNP Pharmocological
reductase NN Pharmocological
inhibitors NNS Pharmocological
statins NNS Pharmocological
statins VBZ Pharmocological
atorvastatin NN Pharmocological
simvastatin NN Pharmocological
atorvastatin NN Pharmocological
simvastatin NN Pharmocological
statin NN Pharmocological
atorvastatin NN Pharmocological
. . None
statin NN Pharmocological
-DOCSTART- -X- N

Dietary NNP Pharmocological
lignan NN Pharmocological
and CC Pharmocological
proanthocyanidin NN Pharmocological
consumption NN Pharmocological
polyphenols NNS Pharmocological
lignan NN Pharmocological
and CC Pharmocological
proanthocyanidin JJ Pharmocological
intake NN Pharmocological
-DOCSTART- -X- N

Teacher-implemented JJ Educational
joint JJ Educational
attention NN Educational
intervention NN Educational
: : None
( ( Educational
the DT Educational
Joint NNP Educational
Attention NNP Educational
and CC Educational
Symbolic NNP Educational
Play/Engagement NNP Educational
and CC Educational
Regulation NNP Educational
intervention NN Educational
; : Educational
JASP/ER NNP Educational
) ) Educational
JASP/ER NNP Educational
intervention NN Educational
control NN Control
group NN Control
. . Control
JASP/ER NNP Educational
JASP/ER NNP Educational
JASP/ER NNP Educational
JASP/ER NNP Educational
taped VBN Educational
play NN Educational
interaction NN Educational
. . None
-DOCSTART- -X- N

oestradiol JJ Pharmocological
-DOCSTART- -X- N

risperidone NN Pharmocological
Risperidone NNP Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
-DOCSTART- -X- N

CVC NNP Educational
self-care NN Educational
professionally RB None
controlled VBN None
CVC NNP None
care NN None
. . None
CVC NNP Educational
self-care NN Educational
. . None
standard JJ Educational
CVC NNP Educational
procedure NN Educational
provided VBN Educational
by IN Educational
nurses NNS Educational
. . None
Central NNP Physical
venous JJ Physical
catheter NN Physical
Central NNP Educational
venous JJ Educational
catheter NN Educational
self-care NN Educational
CVC NNP Educational
self-management NN Educational
. . None
-DOCSTART- -X- N

Cyclosporine NNP Pharmocological
randomized VBN None
, , None
controlled VBN None
trial NN None
testing VBG None
the DT None
benefit NN None
of IN None
the DT None
Pgp NNP Pharmocological
modulator NN Pharmocological
, , None
cyclosporin VB Pharmocological
A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
. . None
assigned VBN None
to TO None
treatment NN None
with IN None
cytarabine NN Pharmocological
and CC Pharmocological
infusional JJ Pharmocological
daunorubicin NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
intravenous JJ Pharmocological
CsA NNP Pharmocological
. . None
-DOCSTART- -X- N

acupressure NN None
Premedication NNP None
with IN None
sedatives NNS None
acupressure NN Physical
acupressure NN Physical
at IN Physical
the DT Physical
extra JJ Physical
1 CD Physical
point NN Physical
sham NN None
group NN None
acupressure NN Control
at IN Control
a DT Control
sham JJ Control
point NN Control
. . None
electrocardiogram NN None
Acupressure NN Physical
acupressure NN Physical
Acupressure NN Physical
Acupressure NN Physical
acupressure NN Physical
acupressure NN Physical
-DOCSTART- -X- N

sirolimus NN Pharmocological
single JJ Pharmocological
subconjunctival NN Pharmocological
( ( Pharmocological
SCJ NNP Pharmocological
) ) Pharmocological
intravitreal NN Pharmocological
( ( Pharmocological
IVT NNP Pharmocological
) ) Pharmocological
injection NN Pharmocological
sirolimus NN Pharmocological
sirolimus NN None
administered VBN None
administered VBD None
sirolimus NN None
was VBD None
well-tolerated JJ None
-DOCSTART- -X- N

haloperidol NN Pharmocological
haloperidol NN Pharmocological
placebo-controlled JJ Control
haloperidol-placebo-haloperidol JJ Pharmocological
or CC None
placebo-haloperidol-placebo JJ Pharmocological
haloperidol NN Pharmocological
placebo VB Control
haloperidol NN Pharmocological
placebo NNS Control
haloperidol NN Pharmocological
placebo VB Control
. . None
-DOCSTART- -X- N

Botulinum NNP Pharmocological
toxin NN Pharmocological
botulinum NN Pharmocological
toxin NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
BTX-A NNP Pharmocological
) ) Pharmocological
BTX-A NNP Pharmocological
injection NN Pharmocological
BTX-A NNP Pharmocological
BTX-A NNP Pharmocological
-DOCSTART- -X- N

chemo NN Physical
+ NN Physical
radio NN Physical
+ NNP Physical
BCG-therapy NNP Physical
. . None
chemo NN Pharmocological
+ NNP Pharmocological
radiotherapy NN Pharmocological
and CC Pharmocological
thereafter RB Pharmocological
by IN Pharmocological
maintenance NN Pharmocological
BCG NNP Pharmocological
therapy NN Pharmocological
. . None
BCG NNP Physical
. . None
-DOCSTART- -X- N

Chlorthalidone NN Pharmocological
nifedipine NN Pharmocological
nifedipine JJ Pharmocological
+ NNP Pharmocological
chlorthalidone NN Pharmocological
placebo NN Control
nifedipine VB Pharmocological
chlorthalidone NN Pharmocological
placebo NN Control
. . None
nifedipine NN Pharmocological
placebo NN Control
chlorthalidone NN Pharmocological
. . None
nifedipine JJ Pharmocological
+ FW Pharmocological
chlorthalidone NN Pharmocological
nifedipine JJ Pharmocological
dihydropyridine JJ Pharmocological
calcium NN Pharmocological
antagonist NN Pharmocological
+ VBD Pharmocological
a DT Pharmocological
thiazide JJ Pharmocological
diuretic NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
nefazodone NN Pharmocological
placebo-controlled JJ Control
nefazodone NN Pharmocological
placebo NN Control
Nefazodone NNP Pharmocological
and CC None
placebo VB Control
treatment NN None
placebo NN Control
nefazodone RB Pharmocological
placebo NN Control
) ) None
nefazodone-treated JJ Pharmocological
placebo-treated JJ Control
nefazodone NN Pharmocological
placebo-treated JJ Control
nefazodone-treated JJ Pharmocological
placebo-treated JJ Control
Nefazodone NNP Pharmocological
nefazodone NN Pharmocological
-DOCSTART- -X- N

depot NN Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
: : None
mail NN Educational
and CC Educational
telephone NN Educational
reminders NNS Educational
only RB None
a DT None
scheduled JJ Other
appointment NN Other
at IN None
the DT None
time NN None
of IN None
the DT None
previous JJ None
injection NN None
. . None
-DOCSTART- -X- N

marine NN Physical
food NN Physical
products NNS Physical
EPA NNP Pharmocological
DHA NNP Pharmocological
marine NN Pharmocological
food NN Pharmocological
products NNS Pharmocological
and CC None
marine VB None
food NN None
products NNS None
( ( None
minimum JJ None
EPA NNP None
+ NNP None
DHA NNP None
intake NN None
-DOCSTART- -X- N

estradiol NN Pharmocological
and CC None
trimegestone NN Pharmocological
or CC None
dydrogesterone NN Pharmocological
6 CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
either DT Pharmocological
estradiol NN Pharmocological
( ( Pharmocological
2mg CD Pharmocological
) ) Pharmocological
+trimegestone NN Pharmocological
( ( Pharmocological
0.5mg CD Pharmocological
) ) Pharmocological
( ( Pharmocological
T-group NNP Pharmocological
) ) Pharmocological
or CC None
estradiol NN Pharmocological
( ( Pharmocological
2mg CD Pharmocological
) ) Pharmocological
+dydrogesterone NN Pharmocological
( ( Pharmocological
10mg CD Pharmocological
) ) Pharmocological
( ( Pharmocological
DYDR NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
. . None
were VBD None
measured VBN None
before IN None
, , None
after IN None
cycle NN None
1 CD None
, , None
3 CD None
and CC None
6 CD None
and CC None
at IN None
4 CD None
weeks NNS None
post-treatment JJ None
. . None
-DOCSTART- -X- N

Dobutamine NNP Physical
stress NN Physical
echo NN Physical
-DOCSTART- -X- N

placebo-controlled JJ Control
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
placebo-controlled JJ Control
Pentoxifylline NNP Pharmocological
placebo NN Control
. . None
pentoxifylline NN Pharmocological
placebo NN Control
pentoxifylline NN Pharmocological
placebo NN Control
. . None
pentoxifylline NN Pharmocological
placebo NN Control
. . None
pentoxifylline NN Pharmocological
-DOCSTART- -X- N

laparoscopy NN Surgical
laparotomy NN Surgical
. . None
laparoscopy NN Surgical
laparotomy NN Surgical
laparoscopy NN Surgical
laparotomy NN Surgical
operative JJ Surgical
laparoscopy NN Surgical
laparotomy NN Surgical
. . None
-DOCSTART- -X- N

transdermal JJ Pharmocological
nicotine NN Pharmocological
system NN Pharmocological
( ( Pharmocological
Nicoderm NNP Pharmocological
) ) Pharmocological
Transdermal NNP Pharmocological
nicotine NN Pharmocological
therapy NN Pharmocological
active JJ Pharmocological
transdermal JJ Pharmocological
nicotine JJ Pharmocological
systems NNS Pharmocological
. . Pharmocological
active JJ Pharmocological
and CC None
placebo JJ Control
systems NNS Control
concurrently RB Control
. . None
transdermal JJ Pharmocological
nicotine NN Pharmocological
system NN Pharmocological
transdermal JJ Pharmocological
nicotine NN Pharmocological
system NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
oral JJ Pharmocological
human JJ Pharmocological
immunoglobulin NN Pharmocological
placebo-controlled JJ Control
oral JJ Physical
, , Physical
human JJ Pharmocological
immunoglobulin NN Pharmocological
( ( None
IGOH NNP None
IGOH NNP Pharmocological
-DOCSTART- -X- N

Endoscopic NNP Pharmocological
injection NN Pharmocological
sclerotherapy NN Pharmocological
( ( Pharmocological
EIS NNP Pharmocological
) ) Pharmocological
and CC None
endoscopic $ Surgical
variceal JJ Surgical
ligation NN Surgical
( ( Surgical
EVL NNP Surgical
) ) Surgical
EIS NNP Pharmocological
EVL NNP Surgical
. . None
EIS NNP Pharmocological
-DOCSTART- -X- N

thoracic JJ Pharmocological
peridural JJ Pharmocological
analgesia NN Pharmocological
epidural JJ Pharmocological
analgesia NN Pharmocological
( ( Pharmocological
EA NNP Pharmocological
) ) Pharmocological
. . None
halothane NN Pharmocological
anesthesia NN Pharmocological
neuroleptanalgesia NN Pharmocological
( ( Pharmocological
NLA NNP Pharmocological
) ) Pharmocological
thoracic NNS Pharmocological
EA NNP Pharmocological
with IN Pharmocological
bupivacaine NN Pharmocological
( ( Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
) ) Pharmocological
combination NN None
with IN None
a DT None
light JJ None
general JJ Control
anesthesia NN Control
. . None
-DOCSTART- -X- N

Amiprilose NNP Pharmocological
hydrochloride NN Pharmocological
amiprilose JJ Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
HCl NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ None
amiprilose VB Pharmocological
HCl NNP Pharmocological
, , Pharmocological
6 CD Pharmocological
g/d NN Pharmocological
, , None
or CC None
placebo NN None
amiprilose JJ Pharmocological
placebo NN Control
amiprilose JJ Pharmocological
placebo NN Control
amiprilose JJ Pharmocological
placebo NN Control
amiprilose NN Pharmocological
Amiprilose NNP Pharmocological
HCl NNP Pharmocological
-DOCSTART- -X- N

diabetes NN Physical
specific JJ Physical
formula NN Physical
diabetes NN Physical
specific JJ Physical
formula NN Physical
( ( Pharmocological
Diason NNP Physical
low JJ Physical
energy NN Physical
: : Pharmocological
313.8 CD Pharmocological
kJ/100 NNS Pharmocological
ml NN Pharmocological
) ) Pharmocological
, , Pharmocological
compared VBN None
with IN None
a DT None
standard JJ Pharmocological
formula NN Pharmocological
Enteral NNP Physical
formulas NNS Physical
were VBD None
given VBN None
orally RB None
as IN None
the DT None
sole JJ None
source NN None
of IN None
nutrition NN None
to TO None
the DT None
subjects NNS None
for IN None
6 CD None
days NNS None
. . None
diabetes VBZ Physical
specific JJ Physical
formula NN Physical
standard JJ Pharmocological
formula NN Pharmocological
. . None
diabetes NNS Pharmocological
specific JJ Pharmocological
formula NN Pharmocological
diabetes NNS Pharmocological
specific JJ Pharmocological
formula NN Pharmocological
standard JJ Pharmocological
formula NN Pharmocological
nutrition NN Physical
formulas NNS Physical
standard NN Physical
mixed JJ Physical
meal NN Physical
. . None
diabetes NNS Physical
specific JJ Physical
formula NN Physical
disease NN Physical
specific JJ Physical
formula NN Physical
-DOCSTART- -X- N

workplace NN Educational
intervention NN Educational
solar JJ Educational
protection NN Educational
intervention NN Educational
individual JJ Educational
skin NN Educational
screening NN Educational
by IN Educational
a DT Educational
dermatologist NN Educational
and CC Educational
participated VBD Educational
in IN Educational
an DT Educational
education NN Educational
session NN Educational
. . Educational
-DOCSTART- -X- N

placebo- JJ Control
paliperidone NN Pharmocological
Paliperidone NNP Pharmocological
ER NNP Pharmocological
monotherapy NN Pharmocological
paliperidone NN Pharmocological
ER NNP Pharmocological
olanzapine JJ Pharmocological
paliperidone NN Pharmocological
ER NNP Pharmocological
placebo NN Control
olanzapine JJ Pharmocological
( ( None
paliperidone JJ Pharmocological
ER NNP Pharmocological
) ) None
( ( None
placebo NN Control
) ) None
olanzapine NN Pharmocological
paliperidone NN Pharmocological
ER NNP Pharmocological
olanzapine JJ Pharmocological
placebo NN Control
paliperidone NN Pharmocological
ER NNP Pharmocological
Paliperidone NNP Pharmocological
ER NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

norfloxacin NN Pharmocological
norfloxacin NN Pharmocological
and CC None
trimethoprim/sulfamethoxazole NN Pharmocological
Norfloxacin NNP Pharmocological
, , None
trimethoprim/sulfamethoxazole NN Pharmocological
, , None
cytokines NNS Pharmocological
, , None
nitric JJ Pharmocological
oxide NN Pharmocological
Trimethoprim/sulfamethoxazole NNP Pharmocological
Norfloxacin NNP Pharmocological
trimethoprim/sulfamethoxazole JJ Pharmocological
-DOCSTART- -X- N

acarbose NN Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
acarbose NN Pharmocological
placebo-controlled JJ Control
acarbose JJ Pharmocological
placebo NN Control
placebo NN Control
placebo NN Control
acarbose NN Pharmocological
sulphonylurea/insulin VB Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
Acarbose NNP Pharmocological
-DOCSTART- -X- N

Tetrahydrobiopterin NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ Control
tetrahydrobiopterin JJ Pharmocological
placebo NN Control
. . None
tetrahydrobiopterin NN Pharmocological
-DOCSTART- -X- N

catheter-tip JJ Other
transducers NNS Other
catheter-tip JJ Other
transducers NNS Other
catheters NNS None
catheters NNS None
catheters NNS Physical
catheter NN None
Intrauterine NNP Other
catheter-tip JJ Other
transducers NNS Other
-DOCSTART- -X- N

intensive JJ Physical
therapy NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
Intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ Physical
treatment NN Physical
intensive JJ None
treatment NN None
Intensive JJ Physical
treatment NN Physical
-DOCSTART- -X- N

Evidence-based JJ Educational
narratives NNS Educational
evidence-based JJ Educational
narrative JJ Educational
traditional JJ Educational
summary JJ Educational
narrative JJ Educational
summary JJ Educational
read VB Educational
either CC Educational
a DT Educational
summary NN Educational
of IN Educational
the DT Educational
guideline NN Educational
( ( Educational
control NN Educational
) ) Educational
or CC Educational
a DT Educational
narrative JJ Educational
( ( Educational
intervention NN Educational
) ) Educational
. . None
opioid JJ Educational
guidelines NNS Educational
-DOCSTART- -X- N

strict JJ Physical
treatment NN Physical
to TO Physical
maintain VB Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
mild JJ Physical
treatment NN Physical
to TO Physical
maintain VB Physical
systolic JJ Physical
blood NN Physical
pressure NN Physical
strict JJ Physical
treatment NN Physical
( ( None
n=2,212 JJ None
) ) None
or CC None
mild JJ Physical
treatment NN Physical
( ( None
n=2,206 JJ None
) ) None
efonidipine JJ Physical
hydrochloride NN Physical
, , None
a DT None
long-acting JJ None
calcium NN None
antagonist NN None
. . None
-DOCSTART- -X- N

prone NN Physical
position NN Physical
Initial JJ Physical
sleeping VBG Physical
position NN Physical
was VBD Physical
assigned VBN Physical
randomly RB Physical
. . None
1 CD Physical
minute NN Physical
before IN Physical
and CC Physical
after IN Physical
0.4 CD Physical
mL NN Physical
of IN Physical
water NN Physical
was VBD Physical
instilled VBN Physical
into IN Physical
the DT Physical
oropharynx NN Physical
. . None
-DOCSTART- -X- N

short-term JJ Physical
training NN Physical
programs NNS Physical
off-season JJ Physical
, , Physical
short-term JJ Physical
basketball NN Physical
training NN Physical
programs NNS Physical
specialized JJ Physical
basketball NN Physical
training NN Physical
group NN Physical
a DT Physical
mixed JJ Physical
basketball NN Physical
plus CC Physical
conditioning VBG Physical
training NN Physical
group NN Physical
and CC None
a DT None
control NN Control
group NN Control
Training VBG Physical
-DOCSTART- -X- N

intravenous JJ Pharmocological
yohimbine NN Pharmocological
yohimbine NN Pharmocological
or CC None
normal JJ Pharmocological
saline NN Pharmocological
yohimbine JJ Pharmocological
-DOCSTART- -X- N

indomethacin NN Pharmocological
, , None
angiotensin NN Pharmocological
II NNP Pharmocological
and CC None
frusemide VB Pharmocological
indomethacin NN Pharmocological
( ( None
200 CD None
mg NN None
) ) None
, , None
to TO None
infused VBN Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
placebo-controlled JJ Control
placebo NN Control
, , None
angiotensin NN Pharmocological
II NNP Pharmocological
infusion NN Pharmocological
indomethacin JJ Pharmocological
indomethacin JJ Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
infusion NN None
placebo NN Control
) ) None
Frusemide NNP Pharmocological
pre-frusemide JJ Pharmocological
-DOCSTART- -X- N

ketorolac NN Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
ketorolac NNS Pharmocological
-DOCSTART- -X- N

parent-mediated JJ Educational
intervention NN Educational
experimental JJ Physical
intervention NN Physical
( ( Physical
Focused JJ Physical
Playtime NNP Physical
Intervention NNP Physical
, , Physical
FPI NNP Physical
) ) Physical
FPI NNP Physical
FPI NNP Physical
FPI NNP Physical
. . None
-DOCSTART- -X- N

ketoprofen NN Pharmocological
ketoprofen $ Pharmocological
ketoprofen NN Pharmocological
-DOCSTART- -X- N

Standard-dose JJ Pharmocological
lansoprazole NN Pharmocological
high-dose JJ Pharmocological
ranitidine NN Pharmocological
Lansoprazole NNP Pharmocological
standard-dose JJ Pharmocological
lansoprazole NN Pharmocological
high-dose JJ Pharmocological
ranitidine NN Pharmocological
Lansoprazole NNP Pharmocological
ranitidine NN Pharmocological
lansoprazole JJR Pharmocological
ranitidine NN Pharmocological
lansoprazole JJ Pharmocological
. . None
lansoprazole JJ Pharmocological
ranitidine NN Pharmocological
ranitidine NN Pharmocological
lansoprazole NN Pharmocological
. . None
Standard-dose JJ Pharmocological
lansoprazole NN Pharmocological
high-dose JJ Pharmocological
ranitidine NN Pharmocological
-DOCSTART- -X- N

Web-based JJ Educational
and CC Educational
print-delivered JJ Educational
tailored JJ Educational
interventions NNS Educational
Web-based JJ Educational
and CC Educational
a DT Educational
print-delivered JJ Educational
version NN Educational
of IN Educational
the DT Educational
Active NNP Educational
Plus NNP Educational
intervention NN Educational
-DOCSTART- -X- N

18F-FDG JJ None
PET/CT NNP None
neoadjuvant JJ Pharmocological
lapatinib NN Pharmocological
, , None
trastuzumab NN Pharmocological
, , None
and CC None
their PRP$ Pharmocological
combination NN Pharmocological
Neo-ALTTO NNP None
( ( None
Neoadjuvant NNP Pharmocological
Lapatinib NNP Pharmocological
and/or VBZ None
Trastuzumab NNP Pharmocological
neoadjuvant JJ Pharmocological
lapatinib NN Pharmocological
, , None
trastuzumab NN Pharmocological
, , None
and CC None
their PRP$ None
combination NN Pharmocological
. . None
anti-HER2 JJ Pharmocological
therapy NN Pharmocological
paclitaxel NN Pharmocological
. . Pharmocological
anti-HER2 JJ Pharmocological
therapies NNS Pharmocological
anti-HER2 JJ Pharmocological
treatment NN Pharmocological
. . Pharmocological
neoadjuvant JJ Pharmocological
trastuzumab NN Pharmocological
, , None
lapatinib NN Pharmocological
, , None
or CC None
their PRP$ None
combination NN Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

topical JJ Pharmocological
agents NNS Pharmocological
topical JJ Pharmocological
agents NNS Pharmocological
topical JJ Pharmocological
agents NNS Pharmocological
) ) None
or CC None
non-treatment JJ None
( ( None
control NN Control
) ) None
topical JJ Pharmocological
agents NNS Pharmocological
-DOCSTART- -X- N

web-based JJ Educational
patient NN Educational
activation NN Educational
intervention NN Educational
the DT Educational
intervention NN Educational
condition NN Educational
-- : Educational
Web-based JJ Educational
hypertension NN Educational
feedback NN Educational
, , Educational
based VBN Educational
on IN Educational
the DT Educational
individual JJ Educational
patient NN Educational
's POS Educational
self-report NN Educational
of IN Educational
health NN Educational
variables NNS Educational
and CC Educational
previous JJ Educational
BP NNP Educational
measurements NNS Educational
, , Educational
to TO Educational
prompt VB Educational
them PRP Educational
to TO Educational
ask VB Educational
questions NNS Educational
during IN Educational
their PRP$ Educational
next JJ Educational
physician NN Educational
's POS Educational
visit NN Educational
about IN Educational
hypertension NN Educational
care NN Educational
the DT Educational
control NN Educational
condition NN Educational
-- : Educational
Web-based JJ Educational
preventive JJ Educational
health NN Educational
feedback NN Educational
, , Educational
based VBN Educational
on IN Educational
the DT Educational
individual NN Educational
's POS Educational
self-report NN Educational
of IN Educational
receiving VBG Educational
preventive JJ Educational
care NN Educational
( ( None
e.g. UH None
pap JJ None
testing VBG None
) ) None
, , None
to TO Educational
prompt VB Educational
them PRP Educational
to TO Educational
ask VB Educational
questions NNS Educational
during IN Educational
their PRP$ Educational
next JJ Educational
physician NN Educational
's POS Educational
visit NN Educational
about IN Educational
preventive JJ Educational
care NN Educational
. . None
-DOCSTART- -X- N

Extra NNP Pharmocological
virgin NN Pharmocological
olive JJ Pharmocological
oil NN Pharmocological
( ( Pharmocological
EVOO NNP Pharmocological
) ) Pharmocological
EVOO NNP Pharmocological
polyphenol-rich JJ Pharmocological
EVOO NNP Pharmocological
with IN None
high JJ Pharmocological
oleuropein NNS Pharmocological
derivative JJ Pharmocological
contents NNS Pharmocological
. . None
control NN Control
group NN Control
( ( None
CG NNP None
) ) None
maintained VBD Educational
their PRP$ Educational
dietary JJ Other
habits NNS Other
olive JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
OG NNP Pharmocological
) ) Pharmocological
who WP None
consumed VBD None
EVOO NNP Pharmocological
EVOO NNP Physical
EVOO NNP Pharmocological
EVOO NNP Pharmocological
EVOO NNP Pharmocological
-DOCSTART- -X- N

Modulation NN Physical
of IN Physical
oxidant JJ Physical
stress NN Physical
in IN Physical
vivo NN Physical
8-epi-prostaglandin JJ Pharmocological
( ( Pharmocological
PG NNP Pharmocological
) ) Pharmocological
F2 NNP Pharmocological
alpha NN Pharmocological
, , Pharmocological
a DT Pharmocological
stable JJ Pharmocological
product NN Pharmocological
of IN Pharmocological
lipid JJ Pharmocological
peroxidation NN Pharmocological
in IN Pharmocological
vivo NN Pharmocological
modulation NN None
by IN None
aspirin NN Pharmocological
and CC None
antioxidant JJ Pharmocological
vitamins NNS Pharmocological
smoking VBG Educational
cessation NN Educational
( ( None
3 CD None
weeks NNS None
) ) None
and CC None
nicotine JJ Pharmocological
patch NN Pharmocological
supplementation NN Pharmocological
aspirin NN Pharmocological
consumption NN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
vitamin FW Pharmocological
C NNP Pharmocological
( ( None
2 CD None
g NN None
) ) None
Aspirin NNP Pharmocological
treatment NN Pharmocological
Vitamin NNP Pharmocological
C NNP Pharmocological
combination NN Pharmocological
of IN Pharmocological
vitamin JJ Pharmocological
C NNP Pharmocological
and CC Pharmocological
E NNP Pharmocological
vitamin JJ Pharmocological
E NNP Pharmocological
quitting VBG Educational
cigarettes NNS Educational
and CC None
switching VBG Pharmocological
to TO Pharmocological
nicotine VB Pharmocological
patches NNS Pharmocological
antioxidant JJ Pharmocological
vitamin NN Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

telmisartan NN Pharmocological
and CC None
enalapril NN Pharmocological
telmisartan NN Pharmocological
enalapril NN Pharmocological
telmisartan NN Pharmocological
at IN Pharmocological
80 CD Pharmocological
mg NNS Pharmocological
day NN Pharmocological
( ( Pharmocological
-1 NN Pharmocological
) ) Pharmocological
enalapril VBN Pharmocological
at IN Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
day NN Pharmocological
( ( Pharmocological
-1 NN Pharmocological
) ) Pharmocological
telmisartan NN Pharmocological
enalapril NN Pharmocological
telmisartan JJ Pharmocological
enalapril VB Pharmocological
-DOCSTART- -X- N

Memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
memory NN Other
aids NNS Other
-DOCSTART- -X- N

endocrine NN None
treatments NNS None
aromatase NN Pharmocological
inhibitors NNS Pharmocological
tamoxifen NN Pharmocological
exemestane VB Pharmocological
endocrine JJ Pharmocological
treatment NN Pharmocological
tamoxifen NN Pharmocological
exemestane NN Pharmocological
exemestane NN Pharmocological
-DOCSTART- -X- N

amoxicillin NN Pharmocological
erythromycin NN Pharmocological
benzathine-penicillin NN Pharmocological
amoxicillin NN Pharmocological
erythromycin NN Pharmocological
. . Pharmocological
amoxicillin NN Pharmocological
erythromycin $ Pharmocological
; : Pharmocological
-DOCSTART- -X- N

Emergency NNP Educational
Clinical NNP Educational
Pathways NNP Educational
( ( Educational
ECP NNP Educational
) ) Educational
ECP NNP Educational
cluster-RCT NN None
-DOCSTART- -X- N

sponsor JJ Educational
kit NN Educational
of IN Educational
promotional JJ Educational
materials NNS Educational
sponsorship NN Educational
kits NNS Educational
-DOCSTART- -X- N

peridural JJ Pharmocological
morphine NN Pharmocological
sublingual JJ Pharmocological
buprenorphine NN Pharmocological
. . Pharmocological
peridural JJ Pharmocological
morphine NN Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
) ) Pharmocological
sublingual JJ Pharmocological
buprenorphine NN Pharmocological
( ( Pharmocological
0.4 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
buprenorphine NN Pharmocological
-DOCSTART- -X- N

Auditory NNP Educational
integration NN Educational
training NN Educational
Auditory NNP Educational
integration NN Educational
training NN Educational
and CC None
a DT None
control NN Control
treatment NN Control
auditory JJ Educational
integration NN Educational
training NN Educational
. . Educational
-DOCSTART- -X- N

cognitive JJ Educational
behavioural JJ Educational
intervention NN Educational
intervention NN None
wait-list JJ Control
control NN Control
conditions NNS Control
. . None
six CD Educational
2-h JJ Educational
weekly JJ Educational
sessions NNS Educational
-DOCSTART- -X- N

Ultrasonography-guided JJ Physical
bilateral JJ Physical
rectus NN Physical
sheath NN Physical
block NN Physical
vs NN None
local JJ Physical
anesthetic JJ Physical
infiltration NN Physical
Regional NNP Pharmocological
anesthetic JJ Pharmocological
techniques NNS Pharmocological
Ropivacaine NNP Pharmocological
hydrochloride NN Pharmocological
administered VBD None
at IN None
the DT None
conclusion NN None
of IN None
surgery NN Surgical
as IN None
LAI NNP None
by IN None
the DT None
surgeon NN None
as IN None
ultrasonography-guided JJ None
BRSB NNP None
by IN None
the DT None
anesthesiologist NN None
( ( None
n JJ None
-DOCSTART- -X- N

dihydropyridine JJ Pharmocological
calcium NN Pharmocological
antagonists NNS Pharmocological
niguldipine NN Pharmocological
nifedipine JJ Pharmocological
placebo-controlled JJ Control
nifedipine NN Pharmocological
dihydropyridines NNS Pharmocological
nifedipine NN Pharmocological
) ) None
niguldipine NN Pharmocological
) ) None
-DOCSTART- -X- N

total JJ Physical
parenteral JJ Physical
nutrition NN Physical
lipid NN Pharmocological
) ) None
amino JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

High-calcium JJ Pharmocological
milk NN Pharmocological
high-calcium NN Pharmocological
, , Pharmocological
fortified VBN Pharmocological
, , Pharmocological
low-fat JJ Pharmocological
milk NN Pharmocological
drink NN Pharmocological
added JJ Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
low-calcium JJ Control
placebo NN Control
drink NN Control
high-calcium JJ Pharmocological
milk NN Pharmocological
placebo NN Control
drink NN None
. . None
high-calcium NN Pharmocological
fortified VBD Pharmocological
milk NN Pharmocological
-DOCSTART- -X- N

home-based JJ Educational
intervention NN Educational
programme NN Educational
early JJ Educational
childhood NN Educational
intervention NN Educational
Intervention NNP Educational
received VBD Educational
an DT Educational
additional JJ Educational
home-based JJ Educational
programme NN Educational
consisting NN Educational
of IN Educational
40 CD Educational
weekly JJ Educational
visits NNS Educational
. . None
-DOCSTART- -X- N

delayed JJ Surgical
cord NN Surgical
clamping VBG Surgical
immediate JJ Surgical
cord NN Surgical
clamping NN Surgical
cord NN Surgical
clamping VBG Surgical
delayed VBN Surgical
till JJ Surgical
descent NN Surgical
of IN Surgical
placenta NN Surgical
into IN Surgical
vagina NN Surgical
delayed JJ Surgical
clamping NN Surgical
early JJ Surgical
clamping NN Surgical
delayed JJ Surgical
clamping NN Surgical
early JJ Surgical
clamping NN Surgical
delayed JJ Surgical
clamping NN Surgical
delaying VBG Surgical
cord NN Surgical
clamping NN Surgical
-DOCSTART- -X- N

tryptophan NN Pharmocological
depletion NN Pharmocological
low-tryptophan JJ Pharmocological
diet NN Pharmocological
amino NN Pharmocological
acid NN Pharmocological
drink NN Pharmocological
amino NN Pharmocological
acid NN Pharmocological
drink NN Pharmocological
-DOCSTART- -X- N

Hypoxic NNP Educational
exercise NN Educational
training NN Educational
normoxic NN None
( ( None
21 CD None
% NN None
O? NNP None
) ) None
resting NN None
( ( None
N-C NNP None
) ) None
, , None
hypoxic NN None
( ( None
15 CD None
% NN None
O? NNP None
) ) None
resting NN None
( ( None
H-C NNP None
) ) None
, , None
normoxic JJ None
exercise NN None
( ( None
50 CD None
% NN None
W NNP None
( ( None
max NN None
) ) None
under IN None
21 CD None
% NN None
O? NNP None
, , None
N-T NNP None
) ) None
, , None
hypoxic-relative JJ None
exercise NN None
( ( None
50 CD None
% NN None
maximal JJ None
heart NN None
rate NN None
reserve NN None
under IN None
15 CD None
% NN None
O? NNP None
, , None
H-RT NNP None
) ) None
, , None
or CC None
hypoxic-absolute JJ None
exercise NN None
( ( None
50 CD None
% NN None
W NNP None
( ( None
max NN None
) ) None
under IN None
15 CD None
% NN None
O? NNP None
, , None
H-AT NNP None
) ) None
for IN None
Simultaneously RB None
, , None
this DT None
intervention NN None
increased VBD None
the DT None
N-C NNP None
, , None
H-C NNP None
, , None
N-T NNP None
, , None
and CC None
H-RT NNP None
interventions NNS None
. . None
Therefore RB None
, , None
H-AT NNP None
intervention NN None
hypoxic NN None
exercise NN None
regimen NNS None
-DOCSTART- -X- N

The DT None
interstimulus JJ Physical
interval NN Physical
( ( Physical
ISI NNP Physical
) ) Physical
, , None
or CC None
time NN Physical
interval NN Physical
between IN Physical
the DT Physical
go NN Physical
and CC Physical
stop NN Physical
signals NNS Physical
was VBD None
recorded VBN None
from IN None
biceps NNS None
brachii NNS None
and CC None
triceps NNS None
brachii NN None
. . None
-DOCSTART- -X- N

estrogens NNS Pharmocological
. . None
GH NNP Pharmocological
treatment NN Pharmocological
combining VBG Pharmocological
GH NNP Pharmocological
treatment NN Pharmocological
with IN Pharmocological
low JJ Pharmocological
dose NN Pharmocological
estrogens NNS Pharmocological
GH NNP Pharmocological
treatment NN Pharmocological
micronized VBN Pharmocological
17beta-estradiol CD Pharmocological
estrogen NN Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
GH NNP Pharmocological
-DOCSTART- -X- N

flumazenil NN Pharmocological
midazolam NN Pharmocological
craniotomy NN Pharmocological
. . None
midazolam NN Pharmocological
, , None
fentanyl NN Pharmocological
and CC None
nitrous JJ Pharmocological
oxide NN Pharmocological
. . None
Pancuronium NN Pharmocological
flumazenil JJ Pharmocological
flumazenil NN Pharmocological
. . None
Flumazenil NNP Pharmocological
-DOCSTART- -X- N

[ JJ None
Prophylactic NNP Physical
intraaortic JJ Physical
balloon NN Physical
pumping VBG Physical
prophylactic JJ Physical
IABP NNP Physical
insertion NN Physical
postoperative JJ None
IABP NNP None
support NN None
Prophylactic NNP None
preoperative JJ None
IABP NNP None
insertion NN None
in IN None
-DOCSTART- -X- N

( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
-cyanidanol-3 NN Pharmocological
12 CD Pharmocological
months NNS Pharmocological
' POS Pharmocological
treatment NN Pharmocological
with IN Pharmocological
( ( Pharmocological
+ NN Pharmocological
) ) Pharmocological
-cyanidanol-3 NN Pharmocological
was VBD Pharmocological
carried VBN Pharmocological
-DOCSTART- -X- N

Dark-phase NNP Physical
light JJ Physical
contamination NN Physical
photobiologic JJ Physical
light-exposure JJ Physical
chambers NNS Physical
light NN Control
: : Control
dark JJ Control
cycle NN Control
without IN Control
dark-phase JJ Control
light JJ Control
contamination NN Control
low JJ None
level NN None
of IN None
light NN None
constant JJ None
bright JJ None
light NN None
( ( None
constant VB None
bright JJ None
constant VB None
bright JJ None
light NN None
or CC None
-DOCSTART- -X- N

Intravenous JJ Pharmocological
regional JJ Pharmocological
anaesthesia NN Pharmocological
prilocaine NN Pharmocological
prilocaine NN Pharmocological
-DOCSTART- -X- N

Chemotherapy NNP Pharmocological
cisplatin-based JJ Pharmocological
chemotherapy NN Pharmocological
surgery NN Surgical
surgery NN Surgical
cisplatin/vindesine NN Pharmocological
, , Pharmocological
mitomycin/ifosfamide/cisplatin NN Pharmocological
, , Pharmocological
mitomycin/vinblastine/cisplatin NN Pharmocological
or CC Pharmocological
vinorelbine/cisplatin NN Pharmocological
. . Pharmocological
Chemotherapy NNP Pharmocological
surgery NN Surgical
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
no DT None
chemotherapy NN None
chemotherapy NN Pharmocological
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
cisplatin-based JJ Pharmocological
chemotherapy NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

pegylated VBN Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
topotecan JJ Pharmocological
pegylated JJ Pharmocological
liposomal JJ Pharmocological
doxorubicin NN Pharmocological
( ( Pharmocological
PLD NNP Pharmocological
) ) Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
PLD NNP Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
topotecan VB Pharmocological
topotecan JJ Pharmocological
topotecan JJ Pharmocological
PLD NNP Pharmocological
-DOCSTART- -X- N

liquid JJ None
fluoxetine NN None
serotonin-receptive JJ Pharmocological
inhibitor NN Pharmocological
fluvoxamine NN Pharmocological
placebo NN Control
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
liquid JJ Pharmocological
fluoxetine NN Pharmocological
fluoxetine NN Pharmocological
placebo NN None
liquid JJ Pharmocological
fluoxetine NN Pharmocological
placebo VB Control
Liquid NNP Pharmocological
fluoxetine NN Pharmocological
fluoxetine NN Pharmocological
placebo VB None
placebo NN None
Liquid NNP Pharmocological
fluoxetine NN Pharmocological
placebo NN None
-DOCSTART- -X- N

VX-770 NNP Pharmocological
oral JJ Pharmocological
VX-770 NNP Pharmocological
placebo NN None
VX-770 JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

CRP NNP Pharmocological
-DOCSTART- -X- N

Psychological JJ Psychological
adjustment NN Psychological
and CC None
levels NNS None
of IN None
self NN Psychological
esteem NN Psychological
directive JJ Psychological
visual-motor NN Psychological
intervention NN Psychological
( ( Psychological
DVMI NNP Psychological
) ) None
non-directive JJ Psychological
supportive JJ Psychological
intervention NN Psychological
( ( Psychological
NDSI NNP Psychological
) ) Psychological
. . None
NDSI NNP Psychological
DVMI NNP Psychological
. . None
-DOCSTART- -X- N

Alcohol NNP Educational
Dependence NNP Educational
Scale NNP Educational
-DOCSTART- -X- N

lavender NN Pharmocological
aromatherapy NN Pharmocological
aromatherapy NN Pharmocological
, , Pharmocological
lavender JJR Pharmocological
aroma NN Pharmocological
placebos NNS Control
lavender NN Pharmocological
aroma NN Pharmocological
mixed-factorial JJ Control
placebo-controlled JJ Control
exposed VBN Pharmocological
to TO Pharmocological
lavender VB Pharmocological
, , None
placebo NN Control
, , None
or CC None
no DT Other
aroma NN Other
cognitive JJ None
task NN None
. . None
lavender NN Control
aroma NN Control
-DOCSTART- -X- N

Multisensory JJ Physical
temporal JJ Physical
integration NN Physical
DSM-5 NNP Pharmocological
multisensory JJ Physical
temporal JJ Physical
tasks NNS Physical
( ( None
with IN None
both DT None
simple JJ None
and CC None
complex JJ None
stimuli NN None
) ) None
multisensory JJ Educational
temporal JJ Educational
tasks NNS Educational
-DOCSTART- -X- N

Internet-based JJ Educational
multimedia NN Educational
program NN Educational
-DOCSTART- -X- N

Nitroglycerin NNP Pharmocological
, , None
nitroprusside RB Pharmocological
vasodilating NN Pharmocological
cocktails NNS Pharmocological
heparin NN Pharmocological
, , None
lidocaine NN Pharmocological
diltiazem NN Pharmocological
. . None
nitroglycerin JJ Pharmocological
; : None
nitroprusside JJ Pharmocological
nitroglycerin NN Pharmocological
; : None
nitroglycerin NNS Pharmocological
and CC None
nitroprusside RB Pharmocological
. . None
direct JJ None
nitric JJ Pharmocological
oxide NN Pharmocological
donor NN None
nitroglycerin VB Pharmocological
nitroglycerin NN Pharmocological
nitroprusside NN Pharmocological
. . None
-DOCSTART- -X- N

rheopheresis NN Pharmocological
Rheopheresis NNP Pharmocological
placebo-controlled JJ Control
rheopheresis NN Pharmocological
treatment NN None
placebo-control JJ Control
treatment NN None
. . None
rheopheresis NN Pharmocological
or CC None
sham NN Pharmocological
treatment NN Pharmocological
placebo NN Control
placebo NN Control
rheopheresis NN Pharmocological
-DOCSTART- -X- N

Family RB Educational
economic JJ Educational
empowerment NN Educational
family NN Educational
economic JJ Educational
empowerment NN Educational
family NN Educational
economic JJ Educational
empowerment NN Educational
intervention NN Educational
matched JJ Educational
children NNS Educational
savings NNS Educational
accounts NNS Educational
, , Educational
financial JJ Educational
management NN Educational
workshops NNS Educational
and CC Educational
mentorship NN Educational
. . Educational
control NN None
-DOCSTART- -X- N

caregiver-based JJ Educational
intervention NN Educational
program NN Educational
caregiver-based JJ Educational
intervention NN Educational
program NN Educational
parents NNS Educational
and CC Educational
child NN Educational
care NN Educational
workers NNS Educational
received VBD Educational
a DT Educational
12-week JJ Educational
intervention NN Educational
consisting NN Educational
of IN Educational
lectures NNS Educational
and CC Educational
on-site JJ Educational
consultations NNS Educational
to TO Educational
day-care JJ Educational
centers NNS Educational
. . Educational
day NN Control
care VB Control
alone RB Control
. . Educational
-DOCSTART- -X- N

topical JJ Pharmocological
anti-inflammatory JJ Pharmocological
agents NNS Pharmocological
. . Pharmocological
image NN None
analytic JJ None
method NN None
using VBG None
a DT None
videomicroscope NN None
interfaced VBN None
with IN None
a DT None
computer NN None
. . None
corticosteroids NNS Pharmocological
indomethacin NN Pharmocological
topical JJ Pharmocological
anti-inflammatory JJ Pharmocological
agents NNS Pharmocological
-DOCSTART- -X- N

Wheelchair NNP Physical
skills VBZ Physical
training NN Physical
wheelchair NN Physical
skills NNS Physical
training VBG Physical
two CD Physical
1-hour JJ Physical
training NN Physical
sessions NNS Physical
that WDT Physical
followed VBD Physical
the DT Physical
Wheelchair NNP Physical
Skills NNP Physical
Training NNP Physical
Program NNP Physical
( ( Physical
WSTP NNP Physical
) ) Physical
protocol NN Physical
. . None
single JJ Educational
socialization NN Educational
contact NN Educational
. . None
-DOCSTART- -X- N

laparoscopically RB Surgical
assisted VBN Surgical
vaginal JJ Surgical
hysterectomy NN Surgical
( ( Surgical
LAVH NNP Surgical
) ) Surgical
and CC None
total JJ Surgical
abdominal JJ Surgical
hysterectomy NN Surgical
( ( Surgical
TAH NNP Surgical
) ) Surgical
LAVH NNP Surgical
and CC None
TAH NNP Physical
. . None
LAVH NNP Surgical
TAH NNP Physical
LAVH NNP Surgical
TAH NNP Physical
; : None
LAVH NNP Surgical
LAVH NNP Physical
TAH NNP Physical
TAH NNP Physical
, , None
LAVH NNP Surgical
LAVH NNP Surgical
TAH NNP Physical
-DOCSTART- -X- N

abstinent-contingent JJ Educational
housing NN Educational
and CC Educational
work NN Educational
. . None
-DOCSTART- -X- N

donepezil JJ Pharmocological
HCl NNP Pharmocological
and CC Pharmocological
digoxin NN Pharmocological
: : Pharmocological
donepezil NN Pharmocological
HCl NNP Pharmocological
and CC Pharmocological
digoxin NN Pharmocological
separately RB Pharmocological
, , Pharmocological
and CC Pharmocological
in IN Pharmocological
combination NN Pharmocological
donepezil NN Pharmocological
administered VBD Pharmocological
alone RB Pharmocological
donepezil NN Pharmocological
administered VBN Pharmocological
in IN None
combination NN None
with IN None
digoxin NN Pharmocological
. . None
digoxin NN Pharmocological
digoxin NN None
donepezil NN None
. . None
donepezil NN None
HCl NNP None
digoxin NN None
-DOCSTART- -X- N

pirarubicin NN Pharmocological
( ( Pharmocological
THP NNP Pharmocological
) ) Pharmocological
THP NNP Pharmocological
50 CD Pharmocological
ml NNS Pharmocological
saline NN Pharmocological
no DT Control
instillation NN Control
was VBD None
performed VBN None
before IN None
TUR NNP Surgical
. . None
-DOCSTART- -X- N

bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
randomly RB None
assigned VBN None
to TO None
receive VB None
a DT None
local JJ Pharmocological
injection NN Pharmocological
of IN Pharmocological
bupivacaine NN Pharmocological
with IN Pharmocological
1:200,000 CD Pharmocological
epinephrine NN Pharmocological
, , None
an DT None
injection NN Pharmocological
of IN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
, , None
or CC None
no DT Control
injection NN Control
, , Control
just RB Control
superior JJ None
to TO None
each DT None
band NN None
. . None
was VBD None
graded VBN None
by IN None
the DT None
patient NN None
and CC None
by IN None
the DT None
study NN None
nurse NN None
within IN None
30 CD None
minutes NNS None
, , None
and CC None
any DT None
were VBD None
recorded VBN None
. . None
At IN None
intervals NNS None
6 CD None
, , None
24 CD None
, , None
and CC None
48 CD None
hours NNS None
postbanding VBG None
, , None
the DT None
patient NN None
recorded VBD None
bupivacaine NN Pharmocological
normal JJ Control
saline JJ Control
no DT Control
injection NN Control
. . None
bupivacaine NN Pharmocological
bupivacaine NN Pharmocological
Bupivacaine NNP Pharmocological
-DOCSTART- -X- N

tubular VB Physical
airway RP Physical
resistance NN Physical
endotracheal JJ Surgical
tube NN Surgical
a DT None
mouthpiece NN Physical
fitted VBN Physical
in IN Physical
random JJ Physical
order NN Physical
with IN Physical
a DT Physical
5 CD Physical
, , Physical
6 CD Physical
, , Physical
7 CD Physical
, , Physical
8 CD Physical
, , Physical
or CC Physical
15 CD Physical
mm NNS Physical
diameter NN Physical
( ( Physical
17 CD Physical
mm RB Physical
long RB Physical
) ) Physical
resistor NN Physical
. . Physical
-DOCSTART- -X- N

Codeine/acetaminophen NNP Pharmocological
hydrocodone/acetaminophen JJ Pharmocological
combination NN Pharmocological
acetaminophen VBP Pharmocological
. . None
codeine NN Pharmocological
and CC Pharmocological
hydrocodone NN Pharmocological
in IN None
combination NN Pharmocological
with IN Pharmocological
acetaminophen NN Pharmocological
. . None
codeine NN Pharmocological
phosphate NN Pharmocological
versus IN None
hydrocodone NN Pharmocological
bitartrate NN Pharmocological
acetaminophen NN Pharmocological
of IN None
codeine/acetaminophen NN None
( ( None
C/A NNP None
) ) None
or CC None
hydrocodone/acetaminophen NN None
( ( None
H/A NNP None
) ) None
received VBD None
C/A NNP None
received VBD None
H/A NNP None
. . None
received VBD None
C/A NNP None
, , None
with IN None
H/A NNP None
, , None
the DT None
C/A NNP None
and CC None
H/A NNP None
between IN None
C/A NNP None
and CC None
H/A NNP None
-DOCSTART- -X- N

dronedarone NN Pharmocological
dronedarone NN Pharmocological
dronedarone NN Pharmocological
. . None
dronedarone NN Pharmocological
placebo NN Pharmocological
or CC None
dronedarone NN Pharmocological
. . None
Dronedarone NNP Pharmocological
placebo NN Control
) ) None
dronedarone NN Pharmocological
placebo NN Control
) ) None
Dronedarone NNP Pharmocological
dronedarone NN Pharmocological
Dronedarone NNP Pharmocological
-DOCSTART- -X- N

tamsulone-FS JJ Pharmocological
Tamsulone-FS NNP Pharmocological
-- : Pharmocological
a DT None
novel JJ None
Russian JJ None
alpha1A/D-adrenoblocker NN None
( ( None
Farm-Syntez NNP None
) ) None
-- : None
was VBD None
tamsulone-FS JJ Pharmocological
-DOCSTART- -X- N

family NN Educational
practice-based JJ Educational
lifestyle JJ Educational
intervention NN Educational
program NN Educational
multi-component JJ Educational
lifestyle JJ Educational
intervention NN Educational
standard NN Educational
of IN Educational
care NN Educational
lifestyle JJ Educational
intervention NN Educational
behaviourally-based JJ Educational
, , Educational
matched VBD Educational
prescriptive JJ Educational
physical JJ Educational
activity NN Educational
and CC Educational
diet JJ Educational
change NN Educational
program NN Educational
. . None
-DOCSTART- -X- N

treated VBN Pharmocological
topically RB Pharmocological
with IN Pharmocological
Contractubex NNP Pharmocological
gel NN Pharmocological
( ( Pharmocological
Merz NNP Pharmocological
+ NNP Pharmocological
Co. NNP Pharmocological
D-Frankfurt/Main NNP Pharmocological
) ) Pharmocological
, , Pharmocological
containing VBG Pharmocological
10 CD Pharmocological
% NN Pharmocological
onion NN Pharmocological
extract NN Pharmocological
, , Pharmocological
50/U CD Pharmocological
of IN Pharmocological
sodium NN Pharmocological
heparin NN Pharmocological
per IN Pharmocological
one CD Pharmocological
g NN Pharmocological
of IN Pharmocological
gel NN Pharmocological
and CC Pharmocological
1 CD Pharmocological
% NN Pharmocological
allantoin NN Pharmocological
, , None
or CC None
to TO None
a DT None
group NN None
receiving VBG None
no DT None
treatment NN None
. . None
average JJ None
26 CD None
days NNS None
after IN None
the DT None
operation NN None
and CC None
was VBD None
continued VBN None
for IN None
one CD None
year NN None
. . None
-DOCSTART- -X- N

enflurane NN Pharmocological
versus NN None
propofol NN Pharmocological
. . None
Group NNP None
1 CD None
( ( None
control NN None
) ) None
received VBD None
thiopental JJ Pharmocological
sodium NN Pharmocological
4 CD Pharmocological
mg/kg NN Pharmocological
intravenously RB Pharmocological
( ( None
i.v JJ None
. . None
) ) None
, , None
followed VBN None
by IN None
0.5 CD Pharmocological
% NN Pharmocological
to TO Pharmocological
1.5 CD Pharmocological
% NN Pharmocological
enflurane NN Pharmocological
and CC None
67 CD Pharmocological
% NN Pharmocological
N2O NNP Pharmocological
in IN Pharmocological
oxygen NN Pharmocological
( ( Pharmocological
O2 NNP Pharmocological
) ) None
. . None
Group NNP Pharmocological
2 CD Pharmocological
received VBD Pharmocological
propofol JJ Pharmocological
2 CD Pharmocological
mg/kg NN Pharmocological
i.v. NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
to TO Pharmocological
1.5 CD Pharmocological
% NN Pharmocological
enflurane NN Pharmocological
and CC Pharmocological
67 CD Pharmocological
% NN Pharmocological
N2O NNP Pharmocological
in IN Pharmocological
O2 NNP Pharmocological
. . Pharmocological
Group NNP Pharmocological
3 CD Pharmocological
received VBD Pharmocological
propofol JJ Pharmocological
2 CD Pharmocological
mg/kg NN Pharmocological
i.v. NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
propofol NN Pharmocological
50 CD Pharmocological
to TO Pharmocological
160 CD Pharmocological
micrograms/kg/min NN Pharmocological
i.v NN Pharmocological
. . Pharmocological
and CC Pharmocological
67 CD Pharmocological
% NN Pharmocological
N2O NNP Pharmocological
in IN Pharmocological
O2 NNP Pharmocological
. . Pharmocological
succinylcholine JJ Pharmocological
atracurium NN Pharmocological
thiopental-enflurane-N2O JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
1 CD Pharmocological
) ) Pharmocological
propofol-propofol-N2O JJ Pharmocological
group NN Pharmocological
( ( Pharmocological
Group NNP Pharmocological
3 CD Pharmocological
) ) Pharmocological
propofol NN Pharmocological
thiopental JJ Pharmocological
enflurane NN Pharmocological
propofol NN Pharmocological
enflurane NN Pharmocological
propofol NN Pharmocological
thiopental JJ Pharmocological
. . None
enflurane NN Pharmocological
propofol NN Pharmocological
enflurane NN Pharmocological
-DOCSTART- -X- N

nebivolol NN None
in IN None
with IN None
metoprolol NN None
in IN None
receive VB None
5 CD None
mg NN None
of IN None
nebivolol NN None
( ( None
N=65 NNP None
95 CD None
mg NN None
of IN None
metoprolol NN None
( ( None
N=63 NNP None
-DOCSTART- -X- N

laparoscopy $ Surgical
laparoscopic NN Surgical
surgery NN Surgical
minimally RB Surgical
invasive JJ Surgical
techniques NNS Surgical
conventional JJ Physical
instrument NN Physical
laparoscopic JJ Physical
instrument NN Physical
laparoscopic JJ Surgical
instruments NNS Surgical
-DOCSTART- -X- N

nebivolol NN Pharmocological
and CC None
valsartan NN Pharmocological
valsartan NN Pharmocological
nebivolol RB Pharmocological
-DOCSTART- -X- N

mexicor NN Pharmocological
mexicor NN Pharmocological
, , Physical
a DT Physical
Russian JJ Physical
cytoprotector NN Physical
mexidor NN Pharmocological
-DOCSTART- -X- N

Cefprozil NNP Pharmocological
versus NN None
penicillin NN Pharmocological
V NNP Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
V. NNP Pharmocological
cefprozil NNS Pharmocological
penicillin NN Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
penicillin NN Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
therapy NN Pharmocological
cefprozil JJ Pharmocological
cefprozil NN Pharmocological
penicillin NN Pharmocological
) ) None
Cefprozil NNP Pharmocological
-DOCSTART- -X- N

parent NN Educational
education NN Educational
and CC Educational
skills NNS Educational
training VBG Educational
intervention NN Educational
parent NN Educational
education NN Educational
on IN Educational
parent NN Educational
education NN Educational
and CC Educational
counselling VBG Educational
intervention NN Educational
and CC Educational
a DT Educational
parent NN Educational
education NN Educational
and CC Educational
behaviour JJ Educational
management NN Educational
intervention NN Educational
to TO Educational
control VB Educational
for IN Educational
parent NN Educational
skills NNS Educational
training NN Educational
and CC None
a DT None
control NN Educational
sample NN Educational
. . None
parent VB Educational
education NN Educational
and CC Educational
behaviour JJ Educational
management NN Educational
or CC Educational
parent JJ Educational
education NN Educational
and CC Educational
counselling NN Educational
-DOCSTART- -X- N

ACLR NNP Surgical
ACLR NNP Surgical
-DOCSTART- -X- N

ferric NNS Pharmocological
carboxymaltose VBP Pharmocological
injection NN Pharmocological
large-dose JJ Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
IV NNP Pharmocological
) ) Pharmocological
administration NN Pharmocological
of IN Pharmocological
ferric JJ Pharmocological
carboxymaltose NN Pharmocological
oral JJ Pharmocological
iron NN Pharmocological
IV NNP Pharmocological
ferric NN Pharmocological
carboxymaltose NN Pharmocological
of IN Pharmocological
ferrous JJ Pharmocological
sulfate NN Pharmocological
ferrous JJ Pharmocological
sulfate NN Pharmocological
ferric VB Pharmocological
carboxymaltose NN Pharmocological
ferric JJ Pharmocological
carboxymaltose NN Pharmocological
ferrous JJ Pharmocological
sulfate NN Pharmocological
new JJ Pharmocological
iron NN Pharmocological
agent NN Pharmocological
, , Pharmocological
ferric JJ Pharmocological
carboxymaltose NN Pharmocological
oral JJ Pharmocological
iron NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Psychosocial NNP Psychological
interventions NNS Psychological
telephone-delivered JJ Psychological
psychosocial JJ Psychological
interventions NNS Psychological
three CD None
different JJ None
6-week JJ None
programs NNS None
: : None
( ( None
a DT None
) ) None
telephone NN Psychological
interpersonal JJ Psychological
counseling NN Psychological
( ( Educational
TIP-C NNP Educational
) ) Educational
; : None
( ( None
b NN None
) ) None
self-managed JJ Educational
exercise NN Educational
; : None
or CC None
( ( None
c NN None
) ) None
attention NN Educational
control NN Educational
( ( Educational
AC NNP Educational
) ) Educational
. . None
TIP-C NNP Psychological
TIP-C NNP Psychological
-DOCSTART- -X- N

health NN None
care NN None
services NNS None
placebo-controlled JJ Control
sibenadet NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

melatonin NN Pharmocological
, , None
singly RB Psychological
and CC Psychological
combined VBN Psychological
with IN Psychological
cognitive JJ Psychological
behavioural JJ Psychological
therapy NN Psychological
melatonin NN Pharmocological
and CC None
cognitive-behavioural JJ Psychological
therapy NN Psychological
combination NN None
of IN None
controlled-release JJ Pharmocological
melatonin NN Pharmocological
and CC None
cognitive-behavioural JJ Educational
therapy NN Educational
; : None
( ( None
2 CD None
) ) None
controlled-release NN Pharmocological
melatonin NN Pharmocological
; : None
( ( None
3 CD None
) ) None
four CD Educational
sessions NNS Educational
of IN Educational
cognitive-behavioural JJ Educational
therapy NN Educational
; : None
or CC None
( ( None
4 CD None
) ) None
placebo FW Control
drug NN None
treatment NN None
condition NN None
Melatonin NNP Pharmocological
cognitive-behavioural JJ Psychological
therapy NN Psychological
behavioural JJ Educational
intervention NN Educational
melatonin VB Pharmocological
-DOCSTART- -X- N

Granulocyte-macrophage JJ Physical
colony-stimulating JJ Physical
factor NN Physical
( ( Physical
GM-CSF NNP Physical
) ) Physical
CEF NNP Pharmocological
chemotherapy NN Pharmocological
: : None
( ( None
GM-CSF NNP Physical
) ) None
standard-dose JJ Physical
CEF NNP Physical
regimen NNS Physical
chemotherapy JJ Pharmocological
CEF NNP Pharmocological
( ( None
cyclophosphamide VB Pharmocological
600 CD Pharmocological
mg JJ Pharmocological
m-2 NN Pharmocological
, , None
epidoxorubicin VBZ Pharmocological
60 CD Pharmocological
mg NN Pharmocological
m-2 NN Pharmocological
and CC None
fluorouracil NN Pharmocological
600 CD Pharmocological
mg JJ Pharmocological
m-2 NN Pharmocological
) ) None
chemotherapy NN Pharmocological
GM-CSF NNP Physical
CEF NNP Physical
+ NNP Physical
GM-CSF NNP Physical
GM-CSF NNP Physical
CEF NNP Pharmocological
CEF NNP Pharmocological
+ NNP Pharmocological
GM-CSF NNP Pharmocological
GM-CSF NNP Pharmocological
CEF NNP Pharmocological
+ NNP Pharmocological
GM-CSF NNP Pharmocological
-DOCSTART- -X- N

Probiotics NNS Pharmocological
probiotic-supplemented JJ Pharmocological
, , None
Bifidobacterium NNP Pharmocological
lactis VBZ Pharmocological
Bb-12 NNP Pharmocological
or CC None
Lactobacillus NNP Pharmocological
strain VBP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
ATCC NNP Pharmocological
53103 CD Pharmocological
) ) Pharmocological
, , Pharmocological
extensively RB Pharmocological
hydrolysed VBD Pharmocological
whey JJ Pharmocological
formulas NNS Pharmocological
or CC None
to TO None
the DT None
same JJ Control
formula NN Control
without IN Control
probiotics NNS Control
. . None
-DOCSTART- -X- N

ibutilide JJ Pharmocological
procainamide NN Pharmocological
ibutilide NN Pharmocological
procainamide NN Pharmocological
placebo NN Control
ibutilide NN Pharmocological
, , None
procainamide NN Pharmocological
placebo NN Control
. . Control
ibutilide JJ Pharmocological
procainamide JJ Pharmocological
placebo NN Control
. . Control
placebo NN Control
ibutilide RB Pharmocological
procainamide RB Pharmocological
Ibutilide NNP Pharmocological
procainamide RB Pharmocological
placebo NN Control
ibutilide NN Pharmocological
procainamide NN Pharmocological
. . Pharmocological
ibutilide NN Pharmocological
procainamide NN Pharmocological
-DOCSTART- -X- N

single-chamber JJ Surgical
atrial JJ Surgical
pacing NN Surgical
single-chamber JJ Surgical
ventricular JJ Surgical
pacing NN Surgical
single-chamber JJ Surgical
atrial JJ Surgical
pacing NN Surgical
-DOCSTART- -X- N

psychotherapeutic JJ Educational
management NN Educational
. . None
psychotherapy NN Psychological
8 CD None
weeks NNS None
to TO None
one CD None
of IN None
three CD None
types NNS None
of IN None
psychotherapy NN Educational
or CC None
to TO None
an DT None
untreated JJ Control
control NN Control
group NN None
, , None
and CC None
were VBD None
followed VBN None
up RP None
six CD None
months NNS None
later RB None
. . None
psychotherapy NN Psychological
psychotherapy NN Psychological
. . None
-DOCSTART- -X- N

local JJ Pharmocological
immunotherapy NN Pharmocological
powder NN Pharmocological
extract NN Pharmocological
of IN Pharmocological
house NN Pharmocological
dust NN Pharmocological
mite NN Pharmocological
( ( Pharmocological
HDM NNP Pharmocological
) ) Pharmocological
parenteral JJ Pharmocological
immunotherapy NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
placebo NN Control
lactose NN Pharmocological
disodium NN Pharmocological
cromoglycate NN Pharmocological
( ( Pharmocological
DSCG NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

leukocyte NN Physical
reduction NN Physical
filters NNS Physical
leukocyte JJ Physical
reduction NN Physical
filters NNS Physical
blood VBD None
cardioplegia NN None
was VBD None
administered VBN None
using VBG None
leukocyte JJ None
reduction NN None
filters NNS None
leukocyte JJ Physical
reduction NN Physical
filters NNS Physical
were VBD Physical
not RB Physical
used VBN Physical
for IN Physical
blood NN Physical
cardioplegia NN Physical
. . None
leukocyte JJ None
reduction NN None
filters NNS None
, , None
we PRP None
-DOCSTART- -X- N

methylphenidate NN Pharmocological
treatment NN Pharmocological
psychostimulant JJ None
medication NN None
, , None
combining VBG None
extended-release JJ Pharmocological
methylphenidate NN Pharmocological
( ( Pharmocological
MPH NNP Pharmocological
) ) Pharmocological
in IN Pharmocological
the DT Pharmocological
morning NN Pharmocological
with IN None
immediate-release JJ Pharmocological
MPH NNP Pharmocological
in IN Pharmocological
the DT Pharmocological
afternoon NN Pharmocological
. . None
MPH NNP Pharmocological
MPH NNP Pharmocological
-DOCSTART- -X- N

fasting VBG Physical
and CC None
treatment NN Pharmocological
omission NN Pharmocological
omitted VBD None
normal JJ None
dose NN None
of IN None
evening VBG Pharmocological
GH NNP Pharmocological
and/or NN None
morning NN Pharmocological
hydrocortisone NN Pharmocological
. . None
omitted VBN None
. . None
-DOCSTART- -X- N

desipramine NN Pharmocological
150 CD Pharmocological
mg/day NN Pharmocological
, , None
or CC None
a DT Pharmocological
metapramine JJ Pharmocological
450 CD Pharmocological
mg/day JJ Pharmocological
antidepressant JJ Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

LX4211 NNP Pharmocological
LX4211 NNP Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

needle-through-needle JJ Pharmocological
double JJ Physical
segment NN Physical
technique NN Physical
spinal JJ Physical
epidural JJ Physical
anaesthesia NN Physical
the DT Physical
needle-through-needle JJ Physical
technique NN Physical
and CC None
the DT Physical
double JJ Physical
segment NN Physical
technique NN Physical
27G CD Physical
pencil NN Physical
point NN Physical
needle NN Physical
, , Physical
an DT Physical
18G CD Physical
Tuohy NNP Physical
needle NN Physical
, , Physical
and CC Physical
a DT Physical
20G CD Physical
multiport NN Physical
epidural JJ Physical
catheter NN Physical
needle-through-needle JJ Pharmocological
technique NN Pharmocological
needle-through-needle JJ Physical
double JJ Physical
segment NN Physical
needle-through-needle JJ Physical
technique NN Physical
double JJ Pharmocological
segment NN Pharmocological
-DOCSTART- -X- N

norgestimate NN Pharmocological
ethinyl NN Pharmocological
estradiol NN Pharmocological
oral JJ Pharmocological
contraceptives NNS Pharmocological
triphasic JJ Pharmocological
, , Pharmocological
combination NN Pharmocological
OC NNP Pharmocological
( ( Pharmocological
ORTHO NNP Pharmocological
TRI-CYCLEN NNP Pharmocological
[ NNP Pharmocological
Ortho-McNeil NNP Pharmocological
Pharmaceutical NNP Pharmocological
, , Pharmocological
Raritan NNP Pharmocological
, , Pharmocological
N.J. NNP Pharmocological
] NNP Pharmocological
, , Pharmocological
norgestimate/ethinyl RB Pharmocological
estradiol NN Pharmocological
) ) Pharmocological
placebo NN Control
OC NNP Pharmocological
ethinyl JJ Pharmocological
estradiol NN Pharmocological
[ VBD None
0.035 CD None
mg NN None
] NN None
and CC None
increasing VBG None
doses NNS None
of IN None
norgestimate JJ Pharmocological
inactive JJ Pharmocological
drug NN Pharmocological
or CC None
placebo NN Control
ethinyl JJ Pharmocological
estradiol NN Pharmocological
-DOCSTART- -X- N

focused JJ Educational
imitation NN Educational
intervention NN Educational
focused JJ Educational
imitation NN Educational
intervention NN Educational
imitation NN None
-DOCSTART- -X- N

gamma-secretase JJ Pharmocological
inhibitor NN Pharmocological
LY450139 NNP Pharmocological
using VBG Pharmocological
doses NNS Pharmocological
from IN Pharmocological
5 CD Pharmocological
to TO Pharmocological
50 CD Pharmocological
mg/day NN Pharmocological
given VBN Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
. . Pharmocological
and CC Pharmocological
LY450139 NNP Pharmocological
-DOCSTART- -X- N

ibuprofen JJ Pharmocological
arginate NN Pharmocological
versus NN None
dexibuprofen NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
ibuprofen NN Pharmocological
S NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
-ibuprofen VBD Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
dexibuprofen NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
dexibuprofen NN Pharmocological
dexibuprofen NN Pharmocological
, , None
ibuprofen JJ Pharmocological
arginate NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
dexibuprofen NN Pharmocological
. . None
-DOCSTART- -X- N

propranolol NN Pharmocological
Propranolol NNP Pharmocological
propranolol NN Pharmocological
propranolol JJ Pharmocological
propranolol NNS Pharmocological
saline NN Pharmocological
propranolol NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Montelukast NNP Control
treatment NN Control
placebo-controlled JJ Control
placebo-controlled JJ Control
leukotriene JJ Physical
antagonist NN Physical
montelukast NN Physical
. . None
montelukast NN Physical
placebo NN Control
. . None
-DOCSTART- -X- N

verbascoside NN Pharmocological
verbascoside NN Pharmocological
verbascoside NN Pharmocological
with IN None
verbascoside NN None
and CC None
aspirin NN None
( ( None
verbascoside NN None
( ( None
1 CD None
Verbascoside $ None
2 CD None
mg/dL NN None
aspirin-treated JJ None
0.01 CD None
) ) None
. . None
Verbascoside NNP None
in IN None
vitro JJ None
verbascoside NN None
orally RB None
-DOCSTART- -X- N

minimally-invasive JJ Surgical
surgery NN Surgical
plus CC Surgical
rtPA NN Surgical
minimally-invasive JJ Surgical
surgery NN Surgical
plus CC Surgical
recombinant JJ Surgical
tissue NN Surgical
plasminogen NN Surgical
activator NN Surgical
( ( Surgical
rtPA NN Surgical
) ) Surgical
surgical JJ Surgical
intervention NN Surgical
plus CC Surgical
rtPA NN Surgical
and CC None
standard JJ None
medical JJ None
management NN None
for IN None
stereotactic JJ Surgical
catheter NN Surgical
placement NN Surgical
and CC Surgical
clot NN Surgical
aspiration NN Surgical
. . None
Injections NNS Pharmocological
of IN Pharmocological
rtPA NN Pharmocological
sterile JJ Pharmocological
saline NN Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
combined VBN Control
therapy NN Control
. . None
radiotherapy NN Physical
alone RB Physical
radiotherapy NN Physical
( ( None
the DT None
same JJ None
schedule NN None
) ) None
plus CC Control
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
and CC Pharmocological
prednisone NN Pharmocological
) ) Pharmocological
. . None
radiotherapy VB Physical
combined JJ Physical
therapy NN Physical
adjuvant JJ Physical
chemotherapy NN Physical
radiotherapy NN Physical
-DOCSTART- -X- N

imipenem NN Pharmocological
meropenem NN Pharmocological
constant JJ None
30-min JJ None
infusion NN None
of IN None
either CC None
1 CD None
g NN None
of IN None
imipenem JJ Pharmocological
plus CC Pharmocological
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
cilastatin NN Pharmocological
or CC None
1 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
meropenem NN Pharmocological
. . None
determined VBN None
by IN None
two-compartment JJ Physical
model NN Physical
and CC None
a DT None
noncompartmental JJ Physical
technique NN Physical
. . None
-DOCSTART- -X- N

anesthesia NN Physical
positioning VBG Physical
30 CD Physical
degrees NNS Physical
Reverse NNP Physical
Trendelenburg NNP Physical
; : None
Supine-Horizontal NN Physical
; : None
30 CD Physical
degrees NNS Physical
Back VBP Physical
Up RP Physical
Fowler NNP Physical
. . None
Mask NNP Physical
ventilation NN Physical
, , Physical
full JJ Physical
neuromuscular JJ Physical
paralysis NN Physical
and CC Physical
direct JJ Physical
laryngoscopy NN Physical
1 CD Pharmocological
% NN Pharmocological
isoflurane NN Pharmocological
in IN Pharmocological
a DT Pharmocological
mixture NN Pharmocological
of IN Pharmocological
50 CD Pharmocological
% NN Pharmocological
oxygen/50 NN Pharmocological
% NN Pharmocological
air NN Pharmocological
Reverse NNP Physical
Trendelenburg NNP Physical
Back VBP Physical
Up NNP Physical
Fowler NNP Physical
Horizontal-Supine NNP Physical
Reverse NNP Physical
Trendelenburg NNP Physical
-DOCSTART- -X- N

weight NN Physical
training NN Physical
weight JJ Physical
training NN Physical
exercises NNS Physical
risedronate NN Pharmocological
calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
strength/weight JJ Physical
training NN Physical
( ( Physical
ST NNP Physical
) ) Physical
exercises NNS Physical
exercise VB Physical
plus JJ Educational
medication NN Pharmocological
medication NN Pharmocological
calcium NN Pharmocological
vitamin NNP Pharmocological
D NNP Pharmocological
risedronate JJ Pharmocological
exercise NN Physical
ST NNP Physical
exercises NNS Physical
medications NNS Physical
exercising VBG Physical
exercised VBD None
exercise VB None
Strength/weight NNP None
training NN None
exercises NNS None
-DOCSTART- -X- N

atropine NN Pharmocological
and CC None
scopolamine NN Pharmocological
unilateral JJ Physical
or CC Physical
bilateral JJ Physical
otoplasty NN Physical
scopolamine NN Pharmocological
scopolamine NN None
( ( None
TTS-scopolamine NNP None
) ) None
placebo NN Control
atropine JJ Pharmocological
10 CD None
microg NN None
x NN None
kg NN None
( ( None
-1 NNP None
) ) None
intravenously RB None
scopolamine-treated JJ Pharmocological
atropine-treated JJ Pharmocological
TTS-scopolamine NNP Pharmocological
TTS-scopolamine-treated JJ Pharmocological
atropine-treated JJ None
atropine-treated JJ Pharmocological
scopolamine-treated JJ Pharmocological
TTS-scopolamine NNP Pharmocological
TTS-scopolamine JJ Pharmocological
TTS-scopolamine NNP Pharmocological
-DOCSTART- -X- N

game NN Educational
play NN Educational
skills NNS Educational
social JJ Educational
story NN Educational
targeting VBG Educational
the DT Educational
during IN Educational
game NN Educational
play NN Educational
-DOCSTART- -X- N

receptor-? JJ None
pioglitazone NN None
PPAR-? NNP None
) ) None
pioglitazone NN None
could MD None
of IN None
45 CD None
mg JJ None
daily JJ None
pioglitazone NN None
versus NN None
placebo NN None
, , None
with IN None
a DT None
3-month JJ None
duration/arm NN None
and CC None
a DT None
2-month JJ None
washout NN None
treatment NN None
, , None
pioglitazone NN Pharmocological
significantly RB None
placebo NN None
. . None
Further NNP None
, , None
pioglitazone NN Pharmocological
significantly RB None
Addition NNP None
of IN None
pioglitazone NN Pharmocological
to TO None
RA NNP None
-DOCSTART- -X- N

evening VBG None
primrose JJ None
oil NN None
( ( None
gamma NN Pharmocological
linolenic RB Pharmocological
acid NN Pharmocological
) ) None
and CC None
fish JJ None
oil NN None
( ( None
eicosapentaenoic JJ Pharmocological
+ NNP Pharmocological
docahexaenoic NN Pharmocological
acid NN Pharmocological
) ) None
versus NN None
magnesium NN Pharmocological
, , None
and CC None
versus NN None
placebo NN Control
placebo NN Control
combination NN None
of IN None
evening VBG None
primrose JJ None
oil NN None
and CC None
fish JJ None
oil NN None
was VBD None
compared VBN None
to TO None
Magnesium NNP Pharmocological
Oxide NNP Pharmocological
, , None
and CC None
to TO None
a DT None
Placebo NNP Control
Placebo NNP Control
evening VBG Pharmocological
primrose JJ Pharmocological
oil NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
Gamma-linolenic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
GLA NNP Pharmocological
) ) Pharmocological
, , None
Eicosapentaenoic NNP Pharmocological
acid NN Pharmocological
( ( Pharmocological
EPA NNP Pharmocological
) ) Pharmocological
Docosahexaenoic NNP Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
Magnesium NNP Pharmocological
Oxide NNP Pharmocological
Placebo NNP Control
-DOCSTART- -X- N

insulin NN Pharmocological
therapy NN Pharmocological
diet JJ Educational
and CC Educational
diabetes VBZ Educational
education NN Educational
insulin JJ Pharmocological
therapy NN Pharmocological
was VBD None
withdrawn VBN None
. . None
-DOCSTART- -X- N

medication NN Educational
adherence NN Educational
and CC Educational
AA NNP Educational
meeting NN Educational
attendance NN Educational
lithium NN Pharmocological
carbonate NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

anaferon NN Pharmocological
complex JJ Pharmocological
therapy NN Pharmocological
anaferon NN Pharmocological
anaferon NN Pharmocological
complex JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Lanthanum NNP Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
Fosrenol NNP Pharmocological
) ) Pharmocological
Lanthanum NNP Pharmocological
carbonate NN Pharmocological
( ( Pharmocological
Fosrenol NNP Pharmocological
) ) Pharmocological
lanthanum JJ Pharmocological
carbonate NN Pharmocological
treatment NN Pharmocological
placebo NN Control
lanthanum NN Pharmocological
carbonate NN Pharmocological
lanthanum NN Pharmocological
carbonate NN Pharmocological
or CC None
placebo NN Control
lanthanum JJ Pharmocological
carbonate-treated JJ Pharmocological
lanthanum JJ Pharmocological
carbonate NN Pharmocological
lanthanum NN Pharmocological
carbonate NN Pharmocological
Lanthanum NNP Pharmocological
carbonate NN Pharmocological
Lanthanum NNP Pharmocological
carbonate NN Pharmocological
lanthanum NN Pharmocological
carbonate NN Pharmocological
-DOCSTART- -X- N

zotarolimus-eluting JJ Pharmocological
stents NNS Pharmocological
sirolimus-eluting JJ Pharmocological
stents NNS Pharmocological
drug-eluting JJ Pharmocological
stents NNS Pharmocological
zotarolimus-eluting JJ Physical
stent NN Physical
( ( None
ZES NNP None
; : None
Endeavor NNP None
Sprint? NNP None
, , None
sirolimus-eluting JJ Physical
stent NN Physical
( ( None
SES NNP None
; : None
Cypher? NNP None
, , None
-DOCSTART- -X- N

interactive JJ Pharmocological
multimedia NN Pharmocological
learning NN Pharmocological
system NN Pharmocological
learning NN Physical
system NN Physical
-DOCSTART- -X- N

adenosine NN Pharmocological
by IN None
adenosine NN None
intravenous JJ Pharmocological
adenosine NN Pharmocological
, , None
140 CD None
?g?kg NN None
( ( None
-1 NNP None
) ) None
?min NNP None
( ( None
-1 NNP None
) ) None
, , None
during IN None
5 CD None
min NNS None
vs. FW None
placebo NN None
) ) None
. . None
We PRP None
did VBD None
effect NN None
. . None
Adenosine NNP None
Intravenous JJ None
-DOCSTART- -X- N

randomly RB Pharmocological
allocated VBN Pharmocological
to TO Pharmocological
receive VB Pharmocological
a DT Pharmocological
single JJ Pharmocological
oral JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
either DT Pharmocological
one CD Pharmocological
FDC NNP Pharmocological
tablet NN Pharmocological
or CC None
co-administration NN Pharmocological
of IN Pharmocological
two CD Pharmocological
separate JJ Pharmocological
diflunisal NN Pharmocological
and CC Pharmocological
naproxen RB Pharmocological
marketed VBN Pharmocological
tablets NNS Pharmocological
. . None
Plasma NNP None
samples NNS None
were VBD None
obtained VBN None
over IN None
a DT None
72-h JJ None
interval NN None
and CC None
analyzed VBN None
for IN None
by IN None
reversed JJ None
phase NN None
liquid NN None
chromatography NN None
with IN None
UV NNP None
detection NN None
. . None
-DOCSTART- -X- N

losartan NN Pharmocological
and CC Pharmocological
enalapril NN Pharmocological
enalapril NN Pharmocological
( ( Pharmocological
E NNP Pharmocological
) ) Pharmocological
and/or NN Pharmocological
losartan NN Pharmocological
E NNP Pharmocological
L NNP Pharmocological
E NNP Pharmocological
+ NNP Pharmocological
L NNP Pharmocological
E NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
L NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
, , Pharmocological
L NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
E NNP Pharmocological
( ( Pharmocological
+ NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

tetracycline- JJ Pharmocological
clarithromycin-containing JJ Pharmocological
omeprazole NN Pharmocological
, , Pharmocological
20 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , Pharmocological
bismuth NN Pharmocological
, , Pharmocological
120 CD Pharmocological
mg NN Pharmocological
four CD Pharmocological
times NNS Pharmocological
daily RB Pharmocological
, , Pharmocological
metronidazole NN Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
, , None
and CC None
either DT None
tetracycline NN Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
four CD None
times NNS None
daily RB None
, , None
or CC None
clarithromycin NN Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
twice RB None
daily RB None
-DOCSTART- -X- N

dietary JJ Other
folate NN Other
intakes NNS Other
white JJ None
flour NN None
and CC None
select JJ None
cereal NN None
grain NN None
products NNS None
dietary JJ None
folate JJ None
intakes NNS None
folic JJ Pharmocological
acid NN Pharmocological
supplement NN Pharmocological
weighed VBN None
food NN None
records NNS None
folic JJ Pharmocological
acid JJ Pharmocological
supplement NN Pharmocological
-DOCSTART- -X- N

Isoniazid NNP None
isoniazid NN Pharmocological
isoniazid NN Pharmocological
isoniazid JJ Pharmocological
placebo NN Control
isoniazid JJ Pharmocological
-DOCSTART- -X- N

Perioperative JJ None
enteral JJ None
nutrition NN None
perioperative JJ Physical
nutritional JJ Physical
support NN Physical
no DT Physical
preoperative JJ Physical
and CC Physical
standard JJ Physical
postoperative JJ Physical
tube-feeding NN Physical
( ( Physical
group NN Physical
I PRP Physical
) ) Physical
, , Physical
standard JJ Physical
preoperative NN Physical
and CC Physical
postoperative JJ Physical
tube-feeding NN Physical
( ( Physical
group NN Physical
II NNP Physical
) ) Physical
arginine-supplemented JJ Physical
preoperative NN Physical
and CC None
postoperative JJ Physical
tube-feeding NN Physical
preoperatively RB Physical
fed VBN Physical
both DT Physical
pre-fed JJ Physical
groups NNS Physical
. . None
Enteral NNP Physical
nutrition NN Physical
preoperative JJ Physical
enteral JJ Physical
feeding NN Physical
-DOCSTART- -X- N

behavioral JJ Educational
plus CC Educational
nutrition JJ Educational
education NN Educational
intervention NN Educational
with IN None
a DT None
nutrition NN Educational
education NN Educational
intervention NN Educational
alone RB Educational
. . None
-DOCSTART- -X- N

enflurane NN Pharmocological
and CC None
isoflurane NN Pharmocological
enflurane NN Pharmocological
and CC None
isoflurane NN Pharmocological
enflurane NN Pharmocological
and CC None
isoflurane NN Pharmocological
anesthesia NN None
. . None
enflurane NN Pharmocological
or CC None
isoflurane NN Pharmocological
enflurane NN Pharmocological
enflurane NN Pharmocological
; : None
isoflurane VB Pharmocological
. . None
Enflurane NNP Pharmocological
Isoflurane NNP Pharmocological
enflurane VB Pharmocological
. . None
-DOCSTART- -X- N

lamotrigine NN Pharmocological
and CC None
carbamazepine NN Pharmocological
lamotrigine NN Pharmocological
and CC None
carbamazepine NN Pharmocological
oral JJ Pharmocological
lamotrigine NN Pharmocological
100 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
LTG NNP Pharmocological
100 CD Pharmocological
, , Pharmocological
n RB Pharmocological
= VBZ Pharmocological
115 CD Pharmocological
) ) Pharmocological
or CC None
200 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
LTG NNP Pharmocological
200 CD Pharmocological
, , Pharmocological
n RB Pharmocological
= VBZ Pharmocological
111 CD Pharmocological
) ) Pharmocological
or CC None
carbamazepine $ Pharmocological
600 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
CBZ NNP Pharmocological
lamotrigine NN Pharmocological
lamotrigine NN Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
CBZ NNP Pharmocological
CBZ NNP Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
( ( None
LTG NNP Pharmocological
CBZ NNP Pharmocological
lamotrigine NN Pharmocological
LTG NNP Pharmocological
LTG NNP Pharmocological
lamotrigine NN Pharmocological
carbamazepine NN Pharmocological
. . None
-DOCSTART- -X- N

postoperative JJ Physical
radiation NN Physical
therapy NN Physical
versus NN None
adjuvant JJ Physical
chemotherapy NN Physical
adjuvant JJ Physical
chemotherapy NN Physical
postoperative JJ Physical
radiation NN Physical
( ( None
RT NNP None
) ) None
with IN None
adjuvant JJ Physical
CMF-type JJ Physical
chemotherapy NN Physical
( ( None
CT NNP None
) ) None
. . None
RT NNP Pharmocological
CT NNP Pharmocological
-DOCSTART- -X- N

naltrexone NN Pharmocological
hydrochloride NN Pharmocological
placebo-controlled JJ Control
naltrexone JJ Pharmocological
hydrochloride NN Pharmocological
naltrexone JJ Pharmocological
hydrochloride NN Pharmocological
. . Pharmocological
naltrexone NN Pharmocological
hydrochloride NN Pharmocological
Naltrexone CD Pharmocological
naltrexone RB Pharmocological
-DOCSTART- -X- N

were VBD Educational
performed VBN Educational
on IN Educational
baseline NN Educational
and CC Educational
nine-month JJ Educational
follow-up JJ Educational
data NNS Educational
. . None
-DOCSTART- -X- N

aquatics NNS Educational
programme NN Educational
aquatic JJ Educational
exercise NN Educational
programme NN Educational
aquatic JJ Educational
exercise NN Educational
group NN Educational
and CC Educational
eight CD Educational
to TO Educational
a DT Educational
control NN Educational
group NN Educational
. . None
-DOCSTART- -X- N

intranasal NN Surgical
surgery NN Surgical
-- : None
comparison NN None
Mallinckrodt NNP Surgical
Hi-Lo-Evac NNP Surgical
tube NN Surgical
and CC None
Portex NNP Surgical
blue JJ Surgical
line NN Surgical
tube NN Surgical
-DOCSTART- -X- N

Armodafinil NNP Pharmocological
and CC Pharmocological
modafinil NN Pharmocological
Armodafinil NNP Pharmocological
armodafinil NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

cholinomimetic JJ Pharmocological
SDZ NNP Pharmocological
ENS-163 NNP Pharmocological
new JJ Pharmocological
cholinomimetic JJ Pharmocological
SDZ NNP Pharmocological
ENS-163 NNP Pharmocological
. . None
oral JJ Control
placebo/intravenous JJ Control
saline NN Control
, , None
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
SDZ NNP Pharmocological
ENS-163/intravenous JJ Pharmocological
saline NN Pharmocological
, , None
oral JJ Control
placebo/0.4 NN Control
mg NN Control
of IN Control
intravenous JJ Control
scopolamine NN Control
, , None
and CC None
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
SDZ NNP Pharmocological
ENS-163/0.4 NNP Pharmocological
mg NN Pharmocological
of IN Pharmocological
intravenous JJ Pharmocological
scopolamine NN Pharmocological
. . None
-DOCSTART- -X- N

Left NNP None
ventricular JJ None
mass NN None
regression NN None
calcium NN Pharmocological
blocker NN Pharmocological
, , Pharmocological
verapamil NN Pharmocological
, , None
and CC None
the DT None
beta-blocker NN Pharmocological
, , Pharmocological
atenolol NN Pharmocological
2-D JJ Physical
echocardiographic JJ Physical
evaluation NN Physical
verapamil NN Pharmocological
atenolol NN Pharmocological
verapamil NN Pharmocological
atenolol NN Pharmocological
. . None
-DOCSTART- -X- N

self-inflation NN Physical
of IN Physical
the DT Physical
cuff NN Physical
just RB Physical
wearing VBG Physical
the DT Physical
inflated JJ Physical
cuff NN Physical
Inflating VBG Physical
the DT Physical
cuff NN Physical
inflated JJ Physical
cuff NN Physical
cuff NN Physical
inflation NN Physical
-DOCSTART- -X- N

heparin NN Pharmocological
( ( Pharmocological
dalteparin NN Pharmocological
) ) Pharmocological
oral JJ Pharmocological
anticoagulant JJ Pharmocological
therapy NN Pharmocological
receiving VBG None
extended VBN Pharmocological
duration NN Pharmocological
therapy NN Pharmocological
heparin NN Pharmocological
( ( None
dalteparin NN Pharmocological
) ) None
-DOCSTART- -X- N

TISSEEL NNP Pharmocological
VH NNP Pharmocological
S/D NNP Pharmocological
fibrin NN Pharmocological
sealant NN Pharmocological
currently RB Pharmocological
licensed VBN Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
fibrin NN Pharmocological
sealant NN Pharmocological
( ( Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
S/D NNP Pharmocological
) ) Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
S/D NNP Pharmocological
to TO Pharmocological
TISSEEL NNP Pharmocological
VH NNP Pharmocological
-DOCSTART- -X- N

hyperfractionated VBN Physical
radiation NN Physical
therapy NN Physical
concurrent JJ Physical
chemotherapy NN Physical
Gy NNP Pharmocological
hyperfractionated JJ Physical
radiation NN Physical
therapy NN Physical
( ( None
HFX NNP None
RT NNP None
) ) None
Gy NNP Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
CDDP NNP Pharmocological
) ) Pharmocological
50.6 CD Pharmocological
Gy NNP Pharmocological
to TO Pharmocological
HFX NNP Physical
RT NNP Physical
CDDP NNP Pharmocological
. . None
radio-chemotherapy NN Physical
-DOCSTART- -X- N

treated VBN Pharmocological
with IN Pharmocological
either DT Pharmocological
medication NN Pharmocological
or CC Pharmocological
trabeculectomy NN Pharmocological
. . None
treated VBN Physical
aggressively RB Physical
in IN Physical
an DT Physical
effort NN Physical
to TO Physical
to TO Physical
a DT Physical
level NN Physical
at IN Physical
or CC Physical
below IN Physical
a DT Physical
predetermined JJ Physical
, , Physical
eye-specific JJ Physical
target NN Physical
pressure NN Physical
. . Physical
Visual JJ Physical
field NN Physical
progression NN Physical
was VBD Physical
analyzed VBN Physical
using VBG Physical
repeated JJ Physical
measures NNS Physical
models NNS Physical
. . None
Initial JJ Surgical
surgery NN Surgical
initial JJ Pharmocological
medicine NN Pharmocological
-DOCSTART- -X- N

were VBD None
also RB None
measured VBN None
. . None
-DOCSTART- -X- N

Zolmitriptan NNP Pharmocological
( ( Pharmocological
311C90 CD Pharmocological
) ) Pharmocological
fluoxetine NN Pharmocological
Zolmitriptan NNP Pharmocological
( ( Pharmocological
Zomig NNP Pharmocological
, , Pharmocological
formerly RB Pharmocological
311C90 CD Pharmocological
) ) Pharmocological
selective JJ Pharmocological
5-hydroxytryptamine JJ Pharmocological
( ( Pharmocological
5-HT JJ Pharmocological
) ) Pharmocological
1B/1D-receptor JJ Pharmocological
agonist NN Pharmocological
placebo-controlled JJ Control
fluoxetine JJ Pharmocological
fluoxetine JJ Pharmocological
fluoxetine JJ Pharmocological
zolmitriptan NN Pharmocological
fluoxetine NN Pharmocological
. . None
Zolmitriptan NNP Pharmocological
fluoxetine NN Pharmocological
. . None
zolmitriptan NN Pharmocological
zolmitriptan NN Pharmocological
-DOCSTART- -X- N

GH NNP Pharmocological
GH NNP Pharmocological
treatment NN None
GH NNP None
GH NNP Pharmocological
treatment NN None
GH NNP Pharmocological
2 CD None
mg/m NN None
( ( None
2 CD None
) ) None
GnRH NNP None
analog NN None
( ( None
GnRHa NNP None
) ) None
improves VBZ None
combined JJ None
GH/GnRHa NNP None
and CC None
subsequent JJ None
GH NNP None
treatment NN None
until IN None
0.001 CD None
) ) None
. . None
Treatment NN None
with IN None
GH NNP None
2 CD None
received VBD None
GH/GnRHa NNP None
, , None
compared VBN None
received VBD None
GH NNP None
only RB None
( ( None
P NNP None
adolescence NN None
, , None
GH NNP None
treatment NN None
significantly RB None
combined JJ None
GH/GnRHa NNP None
treatment NN None
. . None
-DOCSTART- -X- N

amlodipine JJ Pharmocological
maleate NN Pharmocological
versus NN Pharmocological
amlodipine NN Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
. . None
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
amlodipine VB Pharmocological
maleate NN Pharmocological
or CC Pharmocological
amlodipine NN Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine VB Pharmocological
besylate NN Pharmocological
: : Pharmocological
amlodipine JJ Pharmocological
maleate NN Pharmocological
amlodipine NN Pharmocological
maleate NN Pharmocological
amlodipine JJ Pharmocological
besylate NN Pharmocological
-DOCSTART- -X- N

Ropivacaine NNP Pharmocological
lidocaine NN Pharmocological
Ropivacaine NNP Pharmocological
2.5 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
0.75 CD Pharmocological
% NN Pharmocological
ropivacaine JJ Pharmocological
solution NN Pharmocological
and CC None
2.5 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
% NN Pharmocological
lidocaine JJ Pharmocological
solution NN Pharmocological
. . None
ropivacaine NN Pharmocological
lidocaine NN Pharmocological
Lidocaine NNP Pharmocological
Ropivacaine NNP Pharmocological
lidocaine NN Pharmocological
ropivacaine NN Pharmocological
Ropivacaine NNP Pharmocological
-DOCSTART- -X- N

cognitive-behavioral JJ Educational
treatment NN Educational
. . None
with IN None
cognitive-behavioral JJ None
therapy NN None
( ( None
CBT NNP None
) ) None
. . None
from IN None
family NN None
CBT NNP None
( ( None
FCBT NNP None
) ) None
than IN None
individual JJ None
CBT NNP None
( ( None
ICBT NNP None
; : None
OR NNP None
Study CC None
2 CD None
: : None
CBT JJ None
greater JJR None
in IN None
FCBT NNP None
and CC None
outperformed VBD None
ICBT NNP None
for IN None
involvement NN None
in IN None
FCBT NNP None
. . None
-DOCSTART- -X- N

increase VB Educational
their PRP$ Educational
verbal JJ Educational
responsiveness NN Educational
short-term JJ Educational
language NN Educational
intervention NN Educational
group NN Educational
parent NN Educational
education NN Educational
sessions NNS Educational
individual JJ Educational
and CC Educational
small-group JJ Educational
coaching NN Educational
sessions NNS Educational
of IN Educational
parent-child JJ Educational
play NN Educational
interactions NNS Educational
. . None
parent-mediated JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

plain NN Pharmocological
mepivacaine NN Pharmocological
subarachnoid JJ Pharmocological
lidocaine NN Pharmocological
mepivacaine NN Pharmocological
. . None
preservative-free JJ Pharmocological
plain NN Pharmocological
mepivacaine NN Pharmocological
plain NN Pharmocological
mepivacaine NN Pharmocological
. . None
spinal-epidural JJ Physical
anesthetic JJ Physical
technique NN Physical
. . None
subarachnoid JJ Pharmocological
mepivacaine NN Pharmocological
. . None
mepivacaine NN Pharmocological
-DOCSTART- -X- N

2-min JJ Physical
iCSO NN Physical
. . Physical
at IN Physical
2 CD Physical
min NN Physical
of IN Physical
coronary JJ Physical
artery NN Physical
balloon NN Physical
occlusion NN Physical
. . Physical
-DOCSTART- -X- N

cyclosporin NN Pharmocological
A NNP Pharmocological
placebo VB Control
cyclosporin VB Pharmocological
A NNP Pharmocological
. . None
cyclosporin VBP Pharmocological
A DT Pharmocological
cyclosporin JJ Pharmocological
cyclosporin NN Pharmocological
A NNP Pharmocological
cyclosporin NN Pharmocological
A NNP Pharmocological
placebo NN Control
cyclosporin NN Pharmocological
A NNP Pharmocological
-DOCSTART- -X- N

recombinant JJ Pharmocological
alpha JJ Pharmocological
2b-interferon JJ Pharmocological
with IN None
or CC None
without IN None
indomethacin NNS Pharmocological
alpha-Interferon NN Pharmocological
indomethacin JJ Pharmocological
indomethacin NN Pharmocological
alpha JJ Pharmocological
2b-interferon CD Pharmocological
indomethacin NN Pharmocological
indomethacin NN Pharmocological
Indomethacin NNP Pharmocological
Indomethacin NNP Pharmocological
indomethacin NN Pharmocological
-DOCSTART- -X- N

educational JJ Educational
instrument NN Educational
intervention NN None
intervention NN None
reference NN Educational
education NN Educational
instrument NN Educational
education NN Educational
seminar NN Educational
-DOCSTART- -X- N

GnRH NNP Pharmocological
analogue NN Pharmocological
GnRH NNP Pharmocological
analogue NN Pharmocological
GnRH NNP Pharmocological
analogue NN Pharmocological
-DOCSTART- -X- N

dietary JJ Physical
intervention NN Physical
polyunsaturated/saturated VBN Pharmocological
( ( Pharmocological
P/S NNP Pharmocological
) ) Pharmocological
ratio NN Pharmocological
-DOCSTART- -X- N

7 CD Pharmocological
mg.kg-1 NN Pharmocological
identical JJ Control
placebo NN Control
. . Control
-DOCSTART- -X- N

Cemented VBN Physical
CeraOne NNP Physical
and CC Physical
porcelain NN Physical
fused VBD Physical
to TO Physical
TiAdapt NNP Physical
abutment JJ Physical
restorations NNS Physical
: : None
cemented VBN Physical
noncemented VBN Physical
single-implant JJ Physical
restorations NNS Physical
baked VBN Physical
porcelain NN Physical
to TO Physical
custom-made JJ Physical
TiAdapt NNP Physical
titanium NN Physical
abutments NNS Physical
or CC None
cement JJ None
crowns NNS None
onto IN None
CeraOne NNP None
( ( None
Nobel NNP None
Biocare NNP None
AB NNP None
) ) None
abutments NNS None
( ( None
control NN None
) ) None
the DT None
implants NNS None
the DT None
test NN None
and CC None
control NN None
groups NNS None
the DT None
implants NNS None
was VBD None
) ) None
. . None
Implants NNS None
with IN None
with IN None
implants NNS None
with IN None
the DT None
test NN None
and CC None
control VB None
single-implant JJ None
restorations NNS None
during IN None
some DT None
restorations NNS None
presented VBD None
one-piece JJ None
single-implant JJ None
protocol NN None
( ( None
test NN None
) ) None
allows VBZ None
installed JJ None
single JJ None
implant NN None
crowns NNS None
in IN None
-DOCSTART- -X- N

gabapentin NN Pharmocological
placebo-controlled JJ Control
oral JJ Pharmocological
gabapentin NN Pharmocological
gabapentin NN Pharmocological
placebo NN Control
. . None
gabapentin NN Pharmocological
. . None
-DOCSTART- -X- N

Both DT None
children NNS None
's POS None
eyes NNS None
were VBD None
examined VBN None
an DT Physical
was VBD Physical
taken VBN Physical
from IN Physical
each DT Physical
child NN Physical
's POS Physical
right JJ Physical
eye NN Physical
and CC Physical
processed VBN Physical
by IN Physical
to TO Physical
test VB Physical
for IN Physical
the DT Physical
presence NN Physical
of IN Physical
C. NNP Physical
trachomatis NN None
DNA NNP None
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

platelet-activating JJ Pharmocological
factor NN Pharmocological
intrauterine JJ Physical
insemination NN Physical
exogenous JJ Pharmocological
platelet-activating JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
PAF NNP Pharmocological
) ) Pharmocological
intrauterine JJ Physical
insemination NN Physical
( ( Physical
IUI NNP Physical
) ) Physical
IUI NNP Physical
with IN None
or CC None
without IN None
exogenous JJ Pharmocological
PAF NNP Pharmocological
treatment NN Pharmocological
IUI NNP Physical
sperm JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
PAF NNP Pharmocological
PAF NNP Pharmocological
sperm FW Pharmocological
treatment NN Pharmocological
exogenous JJ Pharmocological
PAF NNP Pharmocological
-DOCSTART- -X- N

clopidogrel NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NNS Pharmocological
extended-release JJ Pharmocological
dipyridamole JJ Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
clopidogrel NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ASA NNP Pharmocological
) ) Pharmocological
dipyridamole+ASA NN Pharmocological
. . None
dual JJ Pharmocological
antiplatelet NN Pharmocological
regimens NNS Pharmocological
clopidogrel JJ Pharmocological
75 CD Pharmocological
mg NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
extended-release JJ Pharmocological
dipyridamole NN Pharmocological
200 CD Pharmocological
mg NN Pharmocological
plus CC Pharmocological
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
clopidogrel JJ Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
extended-release JJ Pharmocological
dipyridamole JJ Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
Clopidogrel NNP Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
extended-release JJ Pharmocological
dipyridamole JJ Pharmocological
plus CC None
acetylsalicylic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Interferential JJ Physical
therapy NN Physical
electrode NN Physical
placement NN Physical
technique NN Physical
interferential JJ Physical
therapy NN Physical
( ( Physical
IFT NNP Physical
) ) Physical
electrode VBP Physical
placement NN Physical
technique NN Physical
control NN Control
treatment NN Control
IFT NNP Pharmocological
painful JJ Pharmocological
area NN Pharmocological
and CC Pharmocological
The DT Pharmocological
Back NNP Pharmocological
Book NNP Pharmocological
IFT NNP Physical
spinal JJ Physical
nerve NN Physical
and CC Pharmocological
The DT Physical
Back NNP Physical
Book NNP Physical
Control NN Control
, , Control
The DT Control
Back NNP Control
Book NNP Control
IFT NNP Pharmocological
IFT NNP Physical
electrode FW Physical
placement NN Physical
technique NN Physical
-DOCSTART- -X- N

fosamprenavir NN Pharmocological
( ( Pharmocological
FPV NNP Pharmocological
) ) Pharmocological
and CC None
ritonavir NN Pharmocological
( ( Pharmocological
RTV NNP Pharmocological
) ) Pharmocological
FPV NNP Pharmocological
RTV $ Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
FPV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
FPV NNP Pharmocological
RTV NNP Pharmocological
-DOCSTART- -X- N

chemotherapy NN Pharmocological
with IN None
chemohormonal JJ Pharmocological
therapy NN Pharmocological
chemotherapy NN Pharmocological
simultaneous JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
chemotherapy NN None
( ( None
cyclophosphamide NN None
, , None
doxorubicin NN None
, , None
and CC None
fluorouracil RB None
?CAF NNP None
) ) None
or CC None
chemohormonal JJ None
therapy NN None
( ( None
CAF NNP None
plus CC None
tamoxifen NN None
and CC None
Halotestin NNP None
?fluoxymesterone NN None
; : None
Pharmacia-Upjohn NNP None
, , None
Kalamazoo NNP None
, , None
MI NNP None
?CAFTH NNP None
) ) None
as IN None
front-line JJ None
therapy NN None
for IN None
cancer NN None
, , None
chemohormonal JJ None
therapy NN None
prolongs NNS None
-DOCSTART- -X- N

creatine JJ Pharmocological
supplementation NN Pharmocological
creatine NN Pharmocological
monohydrate NN Pharmocological
( ( Pharmocological
Cr NNP Pharmocological
) ) Pharmocological
maltodextrin JJ Pharmocological
placebo NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
Cr NNP Pharmocological
-DOCSTART- -X- N

oxitropium NN Pharmocological
bromide NN Pharmocological
. . None
placebo NN Control
( ( None
drug NN Pharmocological
placebo NN Control
) ) Control
placebo NN Control
oxitropium NN Pharmocological
oxitropium JJ Pharmocological
bromide NN Pharmocological
treatment NN None
placebo NN Control
-DOCSTART- -X- N

dihydropyridine JJ Pharmocological
calcium NN Pharmocological
channel NN Pharmocological
blocker NN Pharmocological
nitrendipine NN Pharmocological
placebo VB Control
nitrendipine VB Pharmocological
Nitrendipine NNP Pharmocological
placebo VB Control
nitrendipine JJ Pharmocological
nitrendipine NN Pharmocological
nitrendipine JJ Pharmocological
-DOCSTART- -X- N

non-nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitors NNS Pharmocological
, , Pharmocological
protease NN Pharmocological
inhibitors NNS Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
in IN Pharmocological
the DT Pharmocological
presence NN Pharmocological
of IN Pharmocological
nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitors NNS Pharmocological
protease NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
non-nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
NNRTI NNP Pharmocological
) ) Pharmocological
, , Pharmocological
or CC Pharmocological
both DT Pharmocological
are VBP Pharmocological
lacking VBG Pharmocological
. . Pharmocological
protease NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
strategy NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
plus CC Pharmocological
nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitor NN Pharmocological
[ NNP Pharmocological
NRTI NNP Pharmocological
] NNP Pharmocological
; : Pharmocological
a DT Pharmocological
non-nucleoside JJ Pharmocological
reverse NN Pharmocological
transcriptase NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
NNRTI NNP Pharmocological
) ) Pharmocological
strategy NN Pharmocological
( ( Pharmocological
NNRTI NNP Pharmocological
plus CC Pharmocological
NRTI NNP Pharmocological
; : Pharmocological
or CC Pharmocological
a DT Pharmocological
three-class JJ Pharmocological
strategy NN Pharmocological
( ( Pharmocological
PI NNP Pharmocological
plus CC Pharmocological
NNRTI NNP Pharmocological
plus CC Pharmocological
NRTI NNP Pharmocological
; : Pharmocological
NNRTI-based JJ Pharmocological
regimen NNS Pharmocological
PI-based JJ Pharmocological
regimen NN Pharmocological
-DOCSTART- -X- N

Co-administration NN None
of IN None
pethidine NN Pharmocological
and CC None
clonidine NN Pharmocological
: : None
pethidine NN Pharmocological
0.75 CD None
mg NN None
kg-1 NN None
and CC None
clonidine NN Pharmocological
75 CD None
micrograms NNS None
0.5 CD Pharmocological
% NN Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
. . Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
isobaric JJ Pharmocological
bupivacaine NN Pharmocological
with IN None
morphine JJ Pharmocological
( ( None
pethidine-clonidine JJ Pharmocological
: : None
bupivacaine NN Pharmocological
: : None
bupivacaine JJ Pharmocological
alone NN Pharmocological
bupivacaine NN Pharmocological
and CC None
morphine NN Pharmocological
-DOCSTART- -X- N

Pemetrexed NNP Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
cisplatin JJ Pharmocological
versus NN Pharmocological
cisplatin NN Pharmocological
monotherapy NN Pharmocological
placebo-controlled JJ Control
Platinum-based JJ Pharmocological
chemotherapy NN Pharmocological
Pemetrexed NNP Pharmocological
pemetrexed-cisplatin NN Pharmocological
pemetrexed-cisplatin JJ Pharmocological
placebo-cisplatin JJ Control
( ( Pharmocological
pemetrexed-cisplatin NN Pharmocological
placebo-cisplatin NN None
pemetrexed-cisplatin NN Pharmocological
placebo-cisplatin NN None
pemetrexed-cisplatin NN Pharmocological
placebo-cisplatin NN None
Pemetrexed-cisplatin NNP Pharmocological
pemetrexed-cisplatin NN Pharmocological
-DOCSTART- -X- N

computer-based JJ Educational
intervention NN Educational
. . None
FaceSay NNP Educational
, , Educational
a DT Educational
computer-based JJ Educational
training VBG Educational
program NN Educational
-DOCSTART- -X- N

ACE NNP Pharmocological
inhibitors NNS Pharmocological
or CC None
AT-1 JJ Pharmocological
antagonists NNS Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
Type NNP Pharmocological
1 CD Pharmocological
antagonist NN Pharmocological
losartan NN Pharmocological
captonpril NN Pharmocological
losartan JJ Pharmocological
captopril NN Pharmocological
losartan NN Pharmocological
and CC None
captopril NN Pharmocological
captopril NN Pharmocological
Losartan NNP Pharmocological
captopril NN Pharmocological
losartan NN Pharmocological
captopril NN Pharmocological
captopril NN Pharmocological
-DOCSTART- -X- N

Orlistat NNP Pharmocological
orlistat-assisted JJ Pharmocological
diet NN Pharmocological
. . None
Orlistat NNP Educational
and CC Educational
diet JJ Educational
counseling NN Educational
were VBD Educational
compared VBN Educational
with IN Educational
diet JJ Educational
counseling VBG Educational
alone RB Educational
. . None
Orlistat CC Pharmocological
Orlistat NNP Pharmocological
-DOCSTART- -X- N

oxandrolone NN Pharmocological
anabolic JJ None
treatment NN None
placebo NN Control
or CC None
oxandrolone NN Pharmocological
-DOCSTART- -X- N

tobramycin JJ Pharmocological
aerosols NNS Pharmocological
tobramycin NN Pharmocological
intravenous JJ Pharmocological
betalactam NNS Pharmocological
and CC None
tobramycin NNS Pharmocological
were VBD None
randomly RB None
allocated VBN None
to TO None
receive VB None
aerosolized VBN Pharmocological
tobramycin NN Pharmocological
( ( None
6 CD None
mg/kg/day NN None
, , None
n JJ None
= NNP None
21 CD None
) ) None
or CC None
placebo NN None
( ( None
n JJ None
= NNP None
17 CD None
) ) None
. . None
The DT None
aerosol NN Pharmocological
was VBD None
administered VBN None
via IN None
a DT None
pneumatic JJ None
nebulizer NN None
once RB None
a DT None
day NN None
for IN None
5 CD None
days NNS None
. . None
-DOCSTART- -X- N

selumetinib NN Pharmocological
chemotherapy NN Pharmocological
selumetinib NN Pharmocological
selumetinib JJ Pharmocological
chemotherapy NN Physical
selumetinib NN Pharmocological
chemotherapy NN None
( ( None
temozolomide JJ Pharmocological
, , None
150 CD None
dacarbazine NN None
, , None
1000 CD None
in IN None
the DT None
chemotherapy NN None
group NN None
could MD None
selumetinib NN None
at IN None
the DT None
randomized VBN None
to TO None
chemotherapy VB None
was VBD None
7 CD None
weeks NNS None
randomized VBN None
to TO None
selumetinib VB Pharmocological
was VBD None
15.9 CD None
selumetinib NN Pharmocological
with IN None
chemotherapy NN None
. . None
Forty-nine JJ None
with IN None
selumetinib NN Pharmocological
compared VBN None
with IN None
chemotherapy NN None
resulted VBN None
-DOCSTART- -X- N

zoledronic JJ Pharmocological
acid NN Pharmocological
bisphosphonates NNS Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
4 CD Pharmocological
mg NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
intravenously RB Pharmocological
every DT Pharmocological
no DT Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
four CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
neoadjuvant JJ Pharmocological
epirubicin NN Pharmocological
plus CC None
docetaxel JJ Pharmocological
and CC Pharmocological
two CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
adjuvant JJ Pharmocological
epirubicin JJ Pharmocological
plus CC Pharmocological
docetaxel JJ Pharmocological
. . None
zoledronic JJ Pharmocological
acid NN Pharmocological
Zoledronic NNP Pharmocological
acid NN Pharmocological
zoledronic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Arthroscopic NNP Surgical
rotator NN Surgical
cuff NN Surgical
repair NN Surgical
with IN Surgical
and CC None
without IN Physical
acromioplasty NN Physical
arthroscopic VBN Surgical
cuff JJ Surgical
repair NN Surgical
with IN Surgical
or CC None
without IN Physical
acromioplasty JJ Physical
-DOCSTART- -X- N

Topical NNP Pharmocological
retapamulin NN Pharmocological
ointment NN Pharmocological
cephalexin NN Pharmocological
topical JJ Pharmocological
retapamulin NN Pharmocological
ointment VBD Pharmocological
cephalexin NN Pharmocological
retapamulin VB Pharmocological
ointment JJ Pharmocological
oral JJ Pharmocological
cephalexin NN Pharmocological
Retapamulin NNP Pharmocological
cephalexin NN Pharmocological
retapamulin NN Pharmocological
cephalexin NN Pharmocological
. . None
Retapamulin NNP Pharmocological
oral JJ Pharmocological
drug NN Pharmocological
. . None
retapamulin NN Pharmocological
cephalexin NN Pharmocological
) ) None
retapamulin NN Pharmocological
cephalexin NN Pharmocological
. . None
Retapamulin NNP Pharmocological
ointment VBD Pharmocological
cephalexin NN Pharmocological
-DOCSTART- -X- N

Simvastatin NNP Pharmocological
polyunsaturated JJ Pharmocological
phospholipids NNS Pharmocological
Simvastatin NNP Pharmocological
-DOCSTART- -X- N

lithium NN Pharmocological
carbonate NN Pharmocological
and CC Pharmocological
haloperidol NN Pharmocological
lithium NN Pharmocological
carbonate NN Pharmocological
and CC Pharmocological
haloperidol NN Pharmocological
placebo-controlled JJ Control
Haloperidol NNP Pharmocological
Lithium JJ Pharmocological
carbonate NN Pharmocological
-DOCSTART- -X- N

multifaceted VBN Educational
, , Educational
community-wide JJ Educational
intervention NN Educational
on IN Educational
overall JJ Educational
antibiotic JJ Educational
use NN Educational
physician JJ Educational
behavior-change NN Educational
strategy NN Educational
that WDT Educational
included VBD Educational
guideline JJ Educational
dissemination NN Educational
, , Educational
small-group JJ Educational
education NN Educational
, , Educational
frequent JJ Educational
updates NNS Educational
and CC Educational
educational JJ Educational
materials NNS Educational
, , Educational
and CC Educational
prescribing VBG Educational
feedback NN Educational
. . None
Parents NNS None
received VBD None
educational JJ Educational
materials NNS Educational
by IN Educational
mail NN Educational
and CC Educational
in IN Educational
primary JJ Educational
care NN Educational
practices NNS Educational
, , Educational
pharmacies NNS Educational
, , Educational
and CC Educational
child NN Educational
care NN Educational
settings NNS Educational
. . None
health-plan JJ None
data NNS None
-DOCSTART- -X- N

Liposome-encapsulated JJ Pharmocological
doxorubicin NNS Pharmocological
conventional JJ Pharmocological
doxorubicin NN Pharmocological
liposome-encapsulated JJ Pharmocological
doxorubicin NN Pharmocological
, , None
TLC NNP Pharmocological
D-99 NNP Pharmocological
( ( Pharmocological
Myocet NNP Pharmocological
, , Pharmocological
Elan NNP Pharmocological
Pharmaceuticals NNP Pharmocological
, , Pharmocological
Princeton NNP Pharmocological
, , Pharmocological
NJ NNP Pharmocological
) ) Pharmocological
conventional JJ Pharmocological
doxorubicin NN Pharmocological
TLC NNP Pharmocological
D-99 NNP Pharmocological
( ( Pharmocological
75 CD Pharmocological
mg/m NN Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
or CC None
doxorubicin NN Pharmocological
multiple-gated JJ Pharmocological
radionuclide NN Pharmocological
cardioangiography NN Pharmocological
scan JJ Pharmocological
doxorubicin-treated JJ Pharmocological
doxorubicin NN Pharmocological
TLC NNP Pharmocological
D-99 NNP Pharmocological
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
. . None
doxorubicin NN Pharmocological
doxorubicin NN Pharmocological
. . None
TLC NNP Pharmocological
D-99 NNP Pharmocological
doxorubicin NNS Pharmocological
-DOCSTART- -X- N

soy NN Pharmocological
protein NN Pharmocological
containing VBG Pharmocological
isoflavones NNS Pharmocological
Dietary NNP Pharmocological
intake NN Pharmocological
of IN Pharmocological
soy JJ Pharmocological
protein NN Pharmocological
with IN Pharmocological
isoflavones NNS Pharmocological
water-washed JJ Pharmocological
soy NN Pharmocological
protein NN Pharmocological
concentrate NN Pharmocological
milk-protein JJ Pharmocological
based VBN Pharmocological
control NN Pharmocological
milk NN Pharmocological
protein-based JJ Pharmocological
supplement NN Pharmocological
( ( None
continued VBN Pharmocological
milk NN Pharmocological
protein NN Pharmocological
) ) None
( ( None
soy JJ Pharmocological
protein NN Pharmocological
) ) None
soy NN Pharmocological
protein NN Pharmocological
protein NN Pharmocological
supplement NN Pharmocological
. . None
-DOCSTART- -X- N

Shenyanning NNP Pharmocological
] NNP None
Shenyanning NNP Pharmocological
( ( Pharmocological
SYN NNP Pharmocological
) ) Pharmocological
SYN NNP Pharmocological
Decoction NNP Pharmocological
Losartan NNP Pharmocological
SYN NNP Pharmocological
-DOCSTART- -X- N

Enalapril NNP Pharmocological
enalapril NN Pharmocological
placebo NNS Control
enalapril NNS Pharmocological
. . None
Enalapril NNP Pharmocological
-DOCSTART- -X- N

ranitidine NN Pharmocological
amoxicillin NN Pharmocological
clarithromycin NN Pharmocological
placebo NN None
placebo-treated JJ None
-DOCSTART- -X- N

local JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

Computer-delivered JJ Educational
tailored VBN Educational
intervention NN Educational
computer-delivered JJ Educational
tailored JJ Educational
intervention NN Educational
-DOCSTART- -X- N

enzymatically RB Pharmocological
depolymerized VBN Pharmocological
low JJ Pharmocological
molecular JJ Pharmocological
weight NN Pharmocological
heparin NN Pharmocological
( ( Pharmocological
LMW-heparin NNP Pharmocological
; : Pharmocological
Logiparin NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

observing VBG Educational
-DOCSTART- -X- N

granisetron NN Pharmocological
and CC Pharmocological
methylprednisolone NN Pharmocological
granisetron NN Pharmocological
alone RB Pharmocological
and CC None
granisetron JJ Pharmocological
plus CC Pharmocological
methylprednisolone JJ Pharmocological
] NN None
Granisetron NNP Pharmocological
40 CD Pharmocological
micrograms/kg NN Pharmocological
during IN Pharmocological
chemotherapy NN Pharmocological
, , Pharmocological
and CC Pharmocological
methylprednisolone NN Pharmocological
Granisetron NNP Pharmocological
granisetron NN Pharmocological
and CC Pharmocological
methylprednisolone NN Pharmocological
-DOCSTART- -X- N

melphalan NN Pharmocological
and CC Pharmocological
cis-platinum JJ Pharmocological
hexamethylmelamine NN Pharmocological
, , Pharmocological
adriamycin NN Pharmocological
, , Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
hexamethylmelamine NN Pharmocological
, , Pharmocological
Adriamycin NNP Pharmocological
, , Pharmocological
and CC Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
HAC NNP Pharmocological
) ) Pharmocological
to TO None
a DT None
combination NN Pharmocological
of IN Pharmocological
melphalan NN Pharmocological
and CC Pharmocological
cis-platinum NN Pharmocological
. . None
HAC NNP Pharmocological
melphalan-platinum JJ Pharmocological
( ( None
HAC NNP Pharmocological
melphalan-platinum JJ Pharmocological
melphalan-platinum JJ Pharmocological
-DOCSTART- -X- N

serum NN Pharmocological
prostate NN Pharmocological
specific JJ Pharmocological
antigen NN Pharmocological
5alpha-reductase JJ Pharmocological
inhibitors NNS Pharmocological
dutasteride JJ Pharmocological
placebo NN Control
dutasteride RB Pharmocological
dutasteride JJ Pharmocological
dutasteride NN Pharmocological
vs NN None
placebo NN Control
dutasteride NN Pharmocological
dutasteride NN Pharmocological
. . None
dutasteride NN Pharmocological
-DOCSTART- -X- N

individualized JJ Psychological
breast NN Psychological
cancer NN Psychological
risk NN Psychological
counseling NN Psychological
individualized JJ Psychological
breast NN Psychological
cancer NN Psychological
risk NN Psychological
counseling VBG Psychological
individualized VBN Psychological
breast NN Psychological
cancer NN Psychological
risk NN Psychological
counseling VBG Psychological
general JJ Control
health NN Control
counseling NN Control
( ( Control
control NN Control
) ) Control
risk NN Educational
counseling NN Educational
risk NN Psychological
counseling VBG Psychological
risk-counseling JJ Educational
programs NNS Educational
-DOCSTART- -X- N

graded JJ Physical
exercise NN Physical
graded JJ Physical
aerobic JJ Physical
exercise NN Physical
programme NN Physical
graded VBN Physical
aerobic NN Physical
exercise NN Physical
flexibility NN Physical
exercises NNS Physical
and CC None
relaxation NN Physical
therapy NN Physical
. . None
flexibility NN Physical
programme NN Physical
exercise NN Physical
programme NN Physical
exercise NN Physical
flexibility NN Control
treatment NN Control
exercise NN Physical
treatment NN Physical
flexibility NN Control
treatment NN Control
. . None
exercise NN Physical
flexibility NN Control
treatment NN Control
. . None
exercise VB Physical
exercise NN Physical
treatment NN Physical
supervised JJ Physical
exercise NN Physical
treatment NN Physical
. . None
graded VBN Physical
aerobic JJ Physical
exercise NN Physical
-DOCSTART- -X- N

MF101 NNP Pharmocological
, , Pharmocological
a DT Pharmocological
selective JJ Pharmocological
estrogen NN Pharmocological
receptor NN Pharmocological
estrogen NN Pharmocological
receptor NN Pharmocological
beta NN Pharmocological
selective JJ Pharmocological
Chinese NNP Pharmocological
herbal NN Pharmocological
extract NN Pharmocological
, , None
menopausal JJ Pharmocological
formula NN Pharmocological
101 CD Pharmocological
placebo NN Control
. . None
placebo NN Control
MF101 NNP Pharmocological
-DOCSTART- -X- N

allopurinol NN Pharmocological
Allopurinol NNP Pharmocological
Allopurinol NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
g NN Pharmocological
) ) Pharmocological
were VBD None
measured VBN None
before IN None
anesthesia NN None
in IN None
arterial JJ None
blood NN None
, , None
before IN None
cross-clamping JJ None
and CC None
1 CD None
and CC None
10 CD None
min NN None
after IN None
reperfusion NN None
in IN None
arterial JJ None
and CC None
coronary JJ None
sinus NN None
blood NN None
. . None
Levels NNS Educational
were VBD Educational
measured VBN Educational
as IN Educational
relative JJ Educational
concentrations NNS Educational
by IN Educational
the DT Educational
electron NN Educational
spin NN Educational
resonance NN Educational
method NN Educational
. . None
-DOCSTART- -X- N

mitral JJ Surgical
valve NN Surgical
surgery NN Surgical
Mitral JJ Surgical
surgery NN Surgical
Group NNP None
I PRP None
contained VBD None
, , None
and CC None
Group NNP None
II NNP None
contained VBD None
-DOCSTART- -X- N

Oral JJ None
ganciclovir NN None
oral JJ None
formulation NN None
of IN None
ganciclovir NN None
( ( None
GCV NNP None
) ) None
GCV NNP Pharmocological
GCV NNP Pharmocological
was VBD Pharmocological
taken VBN Pharmocological
within IN Pharmocological
30 CD Pharmocological
min NNS Pharmocological
after IN Pharmocological
a DT Pharmocological
meal NN Pharmocological
. . None
oral JJ Pharmocological
GCV NNP Pharmocological
oral JJ Pharmocological
GCV NNP Pharmocological
-DOCSTART- -X- N

Dexamethasone NNP Pharmocological
placebo-controlled JJ Pharmocological
placebo NN Control
normal JJ Control
saline JJ Control
dexamethasone RB Pharmocological
-DOCSTART- -X- N

leukotriene NN Pharmocological
D4 NNP Pharmocological
methacholine VB Pharmocological
cysteinyl JJ Pharmocological
leukotriene NN Pharmocological
LTE4 NNP Pharmocological
LTD4 NNP Pharmocological
LTD4 NNP Pharmocological
methacholine NN Pharmocological
( ( Pharmocological
PBS/ethanol NNP Pharmocological
-DOCSTART- -X- N

budesonide JJ Pharmocological
Turbuhaler NNP Pharmocological
budesonide JJ Pharmocological
aqua NN Pharmocological
budesonide NN Pharmocological
Turbuhaler NNP Pharmocological
budesonide JJ Pharmocological
aqua NN Pharmocological
budesonide NN Pharmocological
Turbuhaler NNP Pharmocological
Turbuhaler NNP Pharmocological
aqua NN Pharmocological
spray NN Pharmocological
budesonide NN Pharmocological
aqua NN Pharmocological
budesonide NN Pharmocological
Turbuhaler NNP Pharmocological
budesonide NN Pharmocological
powder NN Pharmocological
Turbuhaler NNP Pharmocological
aqua JJ Pharmocological
-DOCSTART- -X- N

post-Resources NNS Other
for IN Other
Enhancing VBG Other
Alzheimer NNP Other
's POS Other
Caregiver NNP Other
Health NNP Other
( ( Other
REACH NNP Other
) ) Other
intervention NN Other
REACH NNP Control
intervention NN Control
or CC None
a DT None
no-treatment JJ Control
control NN Control
group NN Control
. . None
REACH NNP None
intervention NN None
through IN None
in-home JJ None
telephone NN Educational
sessions NNS Educational
check-in JJ Control
telephone NN Control
calls VBZ Control
-DOCSTART- -X- N

improvisational JJ Educational
music NN Educational
therapy NN Educational
. . None
musical JJ Educational
interaction NN Educational
improvisational JJ Other
music NN Other
therapy NN Other
improvisational JJ Educational
music NN Educational
therapy NN Educational
and CC Educational
toy NN Educational
play NN Educational
sessions NNS Educational
, , Educational
and CC Educational
DVD NNP Educational
analysis NN Educational
of IN Educational
sessions NNS Educational
. . None
Improvisational JJ Other
music NN Other
therapy NN Other
toy NN Educational
play NN Educational
sessions NNS Educational
. . None
music NN Other
therapy NN Other
. . None
music NN Educational
therapy NN Educational
-DOCSTART- -X- N

theophylline NN Pharmocological
: : Pharmocological
theophylline NN Pharmocological
theophylline NN None
theophylline NN Pharmocological
theophylline NN Pharmocological
theophylline NN Pharmocological
-DOCSTART- -X- N

family NN Educational
intervention NN Educational
program NN Educational
control NN Control
group NN Control
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
histamine-free JJ Pharmocological
diet NN Pharmocological
-DOCSTART- -X- N

vincristine/corticosteroid NNS Physical
chemotherapy NN Physical
intensive JJ Physical
chemotherapy NN Physical
protocols NNS Physical
that WDT Physical
contain VBP Physical
vincristine JJ Physical
and CC Physical
corticosteroids NNS Physical
. . None
chemotherapy NN Physical
vincristine NN Pharmocological
bolus NN Pharmocological
vincristine NN Pharmocological
Cronassial NNP Pharmocological
, , Pharmocological
a DT Pharmocological
mixture NN Pharmocological
of IN Pharmocological
four CD Pharmocological
naturally RB Pharmocological
occurring VBG Pharmocological
gangliosides NNS Pharmocological
vincristine-induced JJ Pharmocological
dexamethasone NN Pharmocological
Cronassial NNP Pharmocological
Vincristine NNP Pharmocological
corticosteroids NNS Pharmocological
vincristine/corticosteroid-based JJ Physical
treatment NN Physical
vincristine VB Pharmocological
or CC Pharmocological
corticosteroids NNS Pharmocological
-DOCSTART- -X- N

Zinc NNP Pharmocological
supplementation NN Pharmocological
zinc NN Pharmocological
sulfate NN Pharmocological
and CC None
a DT None
placebo NN Control
zinc NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

vitamin NN Pharmocological
E NNP Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
twice RB Pharmocological
daily JJ Pharmocological
dosing NN Pharmocological
of IN Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
( ( Pharmocological
400 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
/placebo NN Control
. . None
( ( None
34 CD None
% NN None
-vitamin NNP Pharmocological
E NNP Pharmocological
Vitamin NNP None
E NNP None
did VBD None
-DOCSTART- -X- N

saline JJ Educational
solution NN Educational
load NN Educational
test NN Educational
. . None
saline JJ Educational
solution NN Educational
load NN Educational
test NN Educational
saline NN Pharmocological
solution NN Pharmocological
A DT None
standard JJ None
inferolateral JJ None
arthroscopic NN None
portal NN None
was VBD None
made VBN None
with IN None
a DT None
single JJ Physical
stab NN Physical
incision NN Physical
with IN Physical
use NN Physical
of IN Physical
a DT Physical
number-11 JJ Physical
blade NN Physical
. . None
injection NN Pharmocological
of IN Pharmocological
normal JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
at IN Pharmocological
a DT Pharmocological
rate NN Pharmocological
of IN Pharmocological
5 CD Pharmocological
mL/sec NNS Pharmocological
through IN Pharmocological
an DT Pharmocological
18-gauge JJ Pharmocological
needle NN Pharmocological
-DOCSTART- -X- N

diamorphine NN Pharmocological
pethidine NN Pharmocological
pethidine NN Pharmocological
pethidine NN Pharmocological
pethidine NN Pharmocological
diamorphine NN Pharmocological
diamorphine NN Pharmocological
pethidine NN Pharmocological
Diamorphine NNP Pharmocological
Pethidine NNP Pharmocological
diamorphine NN Pharmocological
pethidine NN Pharmocological
diamorphine NN Pharmocological
diamorphine NN Pharmocological
opioid NN Pharmocological
-DOCSTART- -X- N

docosahexaenoic NN Pharmocological
acid NN Pharmocological
placebo NN Control
30 CD None
mg/kg/d NNS None
DHA NNP None
or CC None
placebo VB None
plus CC None
-DOCSTART- -X- N

plastic NN Other
curettes NNS Other
conventional JJ Other
steel NN Other
curettes NNS Other
conventional JJ Other
steel NN Other
curettes NNS Other
plastic NN Other
curettes NNS Other
non-root JJ Other
substance NN Other
removing VBG Other
curettes NNS Other
-DOCSTART- -X- N

percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
percutaneous JJ Surgical
coronary JJ Surgical
intervention NN Surgical
-DOCSTART- -X- N

Combined-modality NNP Pharmocological
treatment NN Pharmocological
positron NN Physical
emission NN Physical
tomography NN Physical
( ( Physical
PET NNP Physical
) ) Physical
involved-node JJ Physical
radiotherapy NN Physical
( ( Physical
IN-RT NNP Physical
) ) Physical
( ( Pharmocological
doxorubicin NN Pharmocological
, , Pharmocological
bleomycin NN Pharmocological
, , Pharmocological
vinblastine NN Pharmocological
, , Pharmocological
and CC Pharmocological
dacarbazine NN Pharmocological
) ) Pharmocological
combined-modality NN Pharmocological
treatment NN Pharmocological
. . None
PET JJ Physical
scan JJ Physical
PET JJ Physical
scan JJ Physical
PET-negative JJ Physical
-DOCSTART- -X- N

haloperidol NN Pharmocological
, , None
risperidone NN Pharmocological
and CC None
olanzapine NN Pharmocological
. . None
haloperidol NN Pharmocological
, , None
risperidone NN Pharmocological
and CC None
olanzapine NN Pharmocological
haloperidol NN Pharmocological
, , None
risperidone NN Pharmocological
, , None
and CC None
olanzapine NN Pharmocological
-DOCSTART- -X- N

Mediterranean NNP Other
diet NN Other
and CC None
high JJ Other
dietary JJ Other
acid NN Other
load NN Other
mixed JJ Other
nuts NNS Other
: : None
recommended JJ Control
low-fat JJ Other
diet NN Other
( ( Control
control VB Control
diet JJ Control
group NN Control
) ) Control
, , None
a DT None
Mediterranean NNP Other
diet NN Other
supplemented VBD Other
with IN Other
virgin JJ Other
olive JJ Other
oil NN Other
, , Physical
or CC None
a DT None
Mediterranean NNP None
diet NN None
supplemented VBD None
with IN None
mixed JJ None
nuts NNS None
. . None
Mediterranean NNP Other
diet NN Other
with IN Other
mixed JJ Other
nuts NNS Other
Mediterranean NNP Other
diet NN Other
with IN Other
nuts NNS Other
Mediterranean NNP Educational
dietary JJ Educational
pattern NN Educational
Mediterranean NNP Other
diet NN Other
without IN Other
mixed JJ Other
nuts NNS Other
or CC None
a DT None
control NN Control
diet NN Control
-DOCSTART- -X- N

prednisone NN Pharmocological
prednisone NN Pharmocological
10 CD Pharmocological
or CC Pharmocological
25 CD Pharmocological
mg NNS Pharmocological
prednisone JJ Pharmocological
two-step JJ Pharmocological
hyperinsulinemic JJ Pharmocological
euglycemic JJ Pharmocological
glucose NN Pharmocological
clamp NN Pharmocological
: : None
insulin NN None
infusion NN None
= VBD None
80 CD None
mU/m?/min NN None
) ) None
in IN None
prednisone NN None
compared VBN None
placebo VB None
. . None
prednisone NN None
compared VBN None
placebo VB None
; : None
prednisone NN None
, , None
-DOCSTART- -X- N

levobunolol NN Pharmocological
placebo NN Control
or CC None
levobunolol NN Pharmocological
levobunolol NN Pharmocological
-DOCSTART- -X- N

dexamethasone JJ Pharmocological
dexamethasone NN None
dexamethasone NN None
placebo NN None
dexamethasone NN None
placebo NN None
granisetron NN None
dexamethasone NN None
granisetron NN None
fluorouracil/epirubicin/cyclophosphamide NN None
doxorubicin/cyclophosphamide NN None
placebo NN None
dexamethasone NN None
dexamethasone NN None
dexamethasone NN None
placebo NN None
-DOCSTART- -X- N

haloperidol NN Pharmocological
placebo-controlled JJ Control
haloperidol NN Pharmocological
with IN None
placebo NN Control
-DOCSTART- -X- N

Comprehensive NNP Psychological
cognitive-behavioural JJ Psychological
therapy NN Psychological
atypical JJ Pharmocological
neuroleptic JJ Pharmocological
amisulpride NN Pharmocological
-DOCSTART- -X- N

gastric JJ Physical
electrical JJ Physical
stimulation NN Physical
gastric JJ Surgical
electrical JJ Surgical
stimulation NN Surgical
( ( Surgical
GES NNP Surgical
) ) Surgical
GES NNP Surgical
gastric JJ Surgical
electrical JJ Surgical
stimulator NN Surgical
butylscopolamine NN Pharmocological
. . None
GES-induced NNP Surgical
GES NNP Surgical
GES NNP Surgical
. . None
-DOCSTART- -X- N

tracheostomy NN Physical
electrocautery JJ Surgical
division NN Surgical
of IN Surgical
the DT Surgical
isthmus NN Surgical
electrocautery DT Physical
division NN Physical
of IN Physical
the DT Physical
-DOCSTART- -X- N

ibuprofen JJ Pharmocological
arginate NN Pharmocological
ibuprofen NN Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
standard JJ Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
200 CD Pharmocological
or CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
ibuprofen JJ Pharmocological
200 CD Pharmocological
or CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
or CC None
placebo NN Control
ibuprofen JJ Pharmocological
arginate NN Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
placebo NN Control
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
ibuprofen JJ Pharmocological
arginate NN Pharmocological
Ibuprofen NNP Pharmocological
arginate NN Pharmocological
-DOCSTART- -X- N

intra- JJ Physical
and CC Physical
extracapsular JJ Physical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
implantation NN Physical
ECCE NNP Physical
and CC Physical
PCL NNP Physical
. . Physical
ICCE NNP Physical
and CC Physical
ACL NNP Physical
implantation NN Physical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
. . None
ECCE NNP Physical
with IN Physical
PCL NNP Physical
. . None
ECCE NNP Physical
and CC Physical
PCL NNP Physical
YAG-laser NNP Surgical
capsulotomy NN Surgical
. . None
YAG-laser NNP Surgical
capsulotomy NN Surgical
ICCE NNP Physical
with IN Physical
ACL NNP Physical
ECCE VB Surgical
with IN Surgical
PCL NNP Surgical
ACL-implantation NN Surgical
-DOCSTART- -X- N

autologous JJ Pharmocological
fibroblasts NNS Pharmocological
: : None
autologous JJ Pharmocological
fibroblasts NNS Pharmocological
( ( Pharmocological
human JJ Pharmocological
dermal NN Pharmocological
) ) Pharmocological
injections NNS Pharmocological
placebo JJ Control
autologous JJ Pharmocological
fibroblast JJ Pharmocological
placebo-controlled JJ Control
2 CD Pharmocological
mL NNS Pharmocological
of IN Pharmocological
autologous JJ Pharmocological
fibroblast JJ Pharmocological
suspension NN Pharmocological
vehicle NN Control
control NN Control
Autologous JJ Pharmocological
fibroblast JJ Pharmocological
treatment NN Pharmocological
Autologous JJ Pharmocological
fibroblast JJ Pharmocological
injections NNS Pharmocological
Autologous NNP Pharmocological
fibroblast VBD Pharmocological
injections NNS Pharmocological
-DOCSTART- -X- N

[ JJ None
Rilmenidine NNP Pharmocological
rilmenidine NN Pharmocological
placebo NN Control
( ( None
rilmenidine VB Pharmocological
1 CD Pharmocological
mg JJ Pharmocological
bid NN Pharmocological
, , None
placebo NN Control
) ) None
placebo NN Control
-DOCSTART- -X- N

mefloquine NN Pharmocological
chloroquine VB Pharmocological
mefloquine VB Pharmocological
-DOCSTART- -X- N

first JJ None
postoperative JJ None
tacrolimus NN None
dose NN None
was VBD None
upon IN None
tacrolimus JJ None
trough IN None
pre-transplant JJ None
tacrolimus NN None
C NNP None
( ( None
2 CD None
) ) None
does VBZ None
pre-transplant JJ None
tacrolimus NN None
C NNP None
( ( None
2 CD None
) ) None
does VBZ None
-DOCSTART- -X- N

bibrocathol NN None
( ( None
Posiformin? NNP None
2 CD None
% NN None
) ) None
. . None
BACKGROUND NNP None
Bibrocathol NNP None
well-established JJ None
antiseptic JJ None
drug NN None
of IN None
bibrocathol $ None
2 CD None
% NN None
of IN None
bibrocathol NN None
( ( None
Posiformin? NNP None
2 CD None
double-masked JJ None
, , None
placebo-controlled JJ None
parallel-group NN None
bibrocathol JJ None
2 CD None
% NN None
eye NN None
ointment NN None
was VBD None
receiving VBG None
bibrocathol RB None
2 CD None
% NN None
the DT None
placebo NN None
bibrocathol NN None
. . None
Patients NNS None
bibrocathol NN None
over IN None
placebo NN None
the DT None
antiseptic JJ None
bibrocathol NN None
2 CD None
% NN None
in IN None
this DT None
-DOCSTART- -X- N

ketorolac NN Pharmocological
Ketorolac NNP Pharmocological
NSAIDs NNP Pharmocological
placebo-controlled JJ Control
normal JJ Pharmocological
saline NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
30 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
ketorolac NN Pharmocological
placebo NN Control
ketorolac NN Pharmocological
ketorolac NN Pharmocological
-DOCSTART- -X- N

mitomycin NN Pharmocological
C NNP Pharmocological
adjunctive JJ Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
randomly RB None
assigned VBN None
to TO None
receive VB None
either DT None
no DT Control
adjunctive JJ Control
mitomycin NN Control
C NNP Control
( ( Control
101 CD Control
eyes NNS Control
of IN Control
101 CD Control
patients NNS Control
) ) Control
or CC None
to TO None
receive VB Pharmocological
adjunctive JJ Pharmocological
subconjunctival NN Pharmocological
mitomycin NN Pharmocological
C NNP Pharmocological
( ( Pharmocological
96 CD Pharmocological
eyes NNS Pharmocological
of IN Pharmocological
96 CD Pharmocological
patients NNS Pharmocological
) ) Pharmocological
during IN Pharmocological
the DT Pharmocological
primary JJ Pharmocological
glaucoma NN Pharmocological
triple JJ Pharmocological
procedure NN Pharmocological
. . None
control NN None
mitomycin NN None
C NNP None
Adjunctive NNP None
mitomycin NN None
C NNP None
adjunctive JJ None
mitomycin NN None
C NNP None
mitomycin NN None
C NNP None
-DOCSTART- -X- N

indomethacin NN None
indomethacin NN None
placebo NN Control
, , None
indomethacin NN None
indomethacin NN None
placebo NN Control
indomethacin JJ Pharmocological
indomethacin JJ None
placebo NN None
. . None
indomethacin NN None
. . None
-DOCSTART- -X- N

anti-cancer JJ Pharmocological
drugs NNS Pharmocological
Adriamycin NNP Control
Adriamycin NNP Pharmocological
Nocardia NNP Pharmocological
rubra NN Pharmocological
cell NN Pharmocological
wall NN Pharmocological
skeleton NN Pharmocological
tube NN Surgical
thoracostomy NN Surgical
N-CWS NNP Pharmocological
group NN Pharmocological
N-CWS NNP Pharmocological
group NN Pharmocological
. . None
anti-cancer JJ Pharmocological
agent NN Pharmocological
and CC Pharmocological
immunopotentiator NN Pharmocological
anti-cancer JJ Pharmocological
drugs NNS Pharmocological
Carbazilquinone NNP Pharmocological
, , Pharmocological
Mitomycin-C NNP Pharmocological
ACNU NNP Pharmocological
pericardial JJ None
drainage NN None
. . None
anti-cancer JJ Pharmocological
drug NN Pharmocological
anti-cancer JJ Pharmocological
agents NNS Pharmocological
pericardial JJ None
drainage NN None
-DOCSTART- -X- N

simvastatin NN Pharmocological
and CC None
fenofibrate NN Pharmocological
simvastatin NN Pharmocological
fenofibrate NN Pharmocological
-DOCSTART- -X- N

aflibercept NN Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
5-fluorouracil JJ Pharmocological
and CC Pharmocological
leucovorin JJ Pharmocological
aflibercept $ Pharmocological
irinotecan JJ Pharmocological
, , Pharmocological
5-fluorouracil JJ Pharmocological
and CC Pharmocological
leucovorin JJ Pharmocological
( ( Pharmocological
LV5FU2 NNP Pharmocological
) ) Pharmocological
. . None
placebo VB Control
or CC None
aflibercept VB Pharmocological
irinotecan-LV5FU2 NN Pharmocological
aflibercept JJ Pharmocological
irinotecan-LV5FU2 JJ Pharmocological
placebo NN Control
aflibercept NN Pharmocological
aflibercept JJ Pharmocological
CONCLUSION NNP None
Aflibercept IN None
4 CD None
plus CC None
irinotecan-LV5FU2 JJ None
every DT None
-DOCSTART- -X- N

diltiazem NN Pharmocological
sustained-release JJ Pharmocological
diltiazem NN Pharmocological
placebo NN Control
. . Control
diltiazem NN Pharmocological
. . Pharmocological
Diltiazem NNP Pharmocological
diltiazem JJ Pharmocological
Diltiazem NNP Pharmocological
-DOCSTART- -X- N

somatostatin NN Pharmocological
analogue NN Pharmocological
octreotide NN Pharmocological
. . None
octreotide NN Pharmocological
placebo NN Control
octreotide-induced JJ Pharmocological
placebo NN Control
placebo NN Control
. . None
( ( None
octreotide IN Pharmocological
: : None
placebo NN Control
: : None
octreotide IN Pharmocological
placebo NN None
Octreotide NNP Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

[ JJ None
Aortofemoral NNP Surgical
bifurcation NN Surgical
bypass NN Surgical
. . None
( ( None
NLA NNP Physical
, , Physical
thoracic RB Physical
continuous JJ Physical
catheter NN Physical
peridural JJ Physical
anesthesia NN Physical
) ) None
Ringer NNP Pharmocological
lactate JJ Pharmocological
solution NN Pharmocological
-DOCSTART- -X- N

anticoagulant NN None
treatment NN None
warfarin NN Pharmocological
placebo-controlled JJ Control
warfarin JJ Pharmocological
placebo NN Control
warfarin NN Pharmocological
warfarin-treated JJ Pharmocological
warfarin NN Pharmocological
placebo NN Control
warfarin NN Pharmocological
anticoagulant JJ None
therapy NN None
-DOCSTART- -X- N

hydrofluoroalkane-134a NN Pharmocological
( ( Pharmocological
HFA NNP Pharmocological
) ) Pharmocological
albuterol NN Pharmocological
. . Pharmocological
Hydrofluoroalkane-134a NNP Pharmocological
( ( Pharmocological
HFA NNP Pharmocological
) ) Pharmocological
switched VBN Pharmocological
from IN Pharmocological
CFC NNP Pharmocological
albuterol NN Pharmocological
to TO Pharmocological
HFA NNP Pharmocological
albuterol NN Pharmocological
. . None
either DT Physical
continue NN Physical
receiving VBG Physical
CFC NNP Pharmocological
albuterol NN Pharmocological
or CC None
to TO Physical
be VB Physical
switched VBN Physical
to TO Physical
receive VB Physical
HFA NNP Pharmocological
albuterol NN Pharmocological
in IN Physical
a DT Physical
yearlong JJ Physical
safety NN Physical
and CC Physical
efficacy NN Physical
trial NN Physical
. . None
HFA NNP Physical
albuterol NN Physical
HFA NNP Physical
albuterol NN Physical
-DOCSTART- -X- N

( ( None
diflunisal NN Pharmocological
) ) None
( ( Pharmocological
bupivacaine NN Pharmocological
) ) Pharmocological
( ( Pharmocological
paracetamol NN Pharmocological
with IN Pharmocological
codeine NN Pharmocological
) ) Pharmocological
lignocaine NN Pharmocological
diflunisal/bupivacaine NN Pharmocological
treatment NN Pharmocological
diflunisal NN Pharmocological
-DOCSTART- -X- N

Combination NN Pharmocological
peel NN Pharmocological
with IN Pharmocological
incorporated JJ Pharmocological
fractional JJ Pharmocological
prickle NN Pharmocological
coral JJ Pharmocological
calcium NN Pharmocological
fractional JJ None
prickle JJ None
coral JJ None
calcium NN None
( ( None
FCR? NNP None
) ) None
in IN None
-DOCSTART- -X- N

induction NN Physical
chemotherapy NN Physical
followed VBN None
by IN None
either DT None
standard JJ Physical
thoracic NN Physical
radiotherapy NN Physical
or CC None
hyperfractionated VBN Physical
accelerated JJ Physical
radiotherapy NN Physical
once-daily JJ Physical
radiation NN Physical
therapy NN Physical
( ( Physical
qdRT NN Physical
) ) Physical
hyperfractionated VBN Physical
accelerated JJ Physical
radiation NN Physical
therapy NN Physical
( ( Physical
HART NNP Physical
) ) Physical
induction NN Physical
chemotherapy NN Physical
. . None
Induction NNP Physical
chemotherapy NN Physical
carboplatin JJ Pharmocological
paclitaxel JJ Pharmocological
qdRT NN Physical
HART NNP Physical
; : None
qdRT VB Physical
HART NNP Physical
HART NNP Pharmocological
qdRT NN Physical
HART NNP Physical
qdRT NN Pharmocological
HART NNP Pharmocological
qdRT NN Pharmocological
HART NNP Pharmocological
qdRT NN Pharmocological
HART NNP Pharmocological
induction NN Physical
chemotherapy NN Physical
carboplatin-paclitaxel NN Pharmocological
, , Pharmocological
HART NNP Pharmocological
HART NNP Pharmocological
-DOCSTART- -X- N

SI NNP Pharmocological
vaccines NNS Pharmocological
commercial JJ Pharmocological
inactivated JJ Pharmocological
bivalent NN Pharmocological
( ( Pharmocological
H1N1/H3N2 NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
field NN Pharmocological
SI NNP Pharmocological
variant NN Pharmocological
. . None
Vaccination NN Pharmocological
-DOCSTART- -X- N

doxycycline NN Pharmocological
doxycycline NN Pharmocological
doxycycline NN Pharmocological
-DOCSTART- -X- N

topical JJ Pharmocological
and CC Pharmocological
systemic JJ Pharmocological
folic JJ Pharmocological
acid NN Pharmocological
systemic JJ Educational
and CC Educational
topical JJ Educational
folate NN Educational
placebo JJ Control
mouthwash NN Control
and CC Control
tablets NNS Control
; : Pharmocological
placebo NN Pharmocological
mouthwash NN Pharmocological
and CC Pharmocological
5 CD Pharmocological
mg NN Pharmocological
folate JJ Pharmocological
tablets NNS Pharmocological
; : Pharmocological
folate NN Pharmocological
mouthwash NN Pharmocological
and CC Pharmocological
placebo NN Pharmocological
tablets NNS Pharmocological
. . Pharmocological
-DOCSTART- -X- N

Virtual JJ Educational
reality NN Educational
intervention NN Educational
virtual JJ Educational
reality NN Educational
distraction NN Educational
intervention NN Educational
virtual JJ Educational
reality NN Educational
a DT None
head-mounted JJ None
display NN None
( ( None
Sony NNP None
PC NNP None
Glasstron NNP None
PLM NNP None
- : None
S700 NN None
) ) None
was VBD None
used VBN None
to TO None
display VB None
encompassing VBG None
images NNS None
and CC None
block NN None
competing VBG None
stimuli NNS None
during IN None
chemotherapy JJ None
infusions NNS None
. . None
were VBD None
used VBN None
to TO None
measure VB None
symptom JJ None
distress NN None
. . None
VR NNP Educational
distraction NN Educational
intervention NN Educational
during IN Educational
one CD Educational
chemotherapy NN Psychological
treatment NN Educational
and CC None
received VBD None
no DT Control
distraction NN Control
intervention NN Control
( ( Control
control VB Control
condition NN Control
) ) Control
during IN None
an DT None
alternate JJ None
chemotherapy NN None
treatment NN None
. . None
-DOCSTART- -X- N

Aortic JJ Physical
valve NN Physical
replacement NN Physical
. . None
Bj?rk-Shiley NNP None
and CC None
Lillehei-Kaster NNP None
disc NN None
valves NNS None
. . None
Cine-aortography NN None
was VBD None
small JJ None
L-K JJ None
valves NNS None
( ( None
the DT None
B-S NNP None
than IN None
the DT None
L-K NNP None
valves NNS None
the DT None
L-K NNP None
the DT None
L-K NNP None
valves NNS None
-DOCSTART- -X- N

minoxidil NN Pharmocological
lignocaine NN Pharmocological
: : Pharmocological
minoxidil NN Pharmocological
lignocaine NN Pharmocological
local JJ Pharmocological
applications NNS Pharmocological
of IN Pharmocological
ointments NNS Pharmocological
containing VBG Pharmocological
5 CD Pharmocological
% NN Pharmocological
lignocaine NN Pharmocological
( ( Pharmocological
n=28 JJ Pharmocological
) ) Pharmocological
, , Pharmocological
0.5 CD Pharmocological
% NN Pharmocological
minoxidil NN Pharmocological
or CC None
both DT Pharmocological
( ( None
lignocaine VB Pharmocological
minoxidil VBD Pharmocological
minoxidil NN Pharmocological
lignocaine JJ Pharmocological
lignocaine JJ Pharmocological
minoxidil NN Pharmocological
lignocaine NN Pharmocological
-DOCSTART- -X- N

chosen VBN None
randomly RB None
and CC None
for IN None
180 CD None
days NNS None
, , None
500 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
propionyl-L-carnitine NN Pharmocological
was VBD None
orally RB None
administered VBN None
, , None
3 CD None
times NNS None
a DT None
day NN None
in IN None
addition NN None
to TO None
their PRP$ None
usual JJ None
treatment NN None
. . None
At IN None
basal JJ None
conditions NNS None
and CC None
after IN None
30 CD None
, , None
90 CD None
and CC None
180 CD None
days NNS None
the DT None
performed VBD None
on IN None
an DT None
ergometer NN None
bicycle NN None
and CC None
the DT None
was VBD None
tested VBN None
by IN None
means NNS None
of IN None
-DOCSTART- -X- N

collaborative JJ Educational
care NN Educational
including VBG Educational
PST NNP Educational
and CC None
an DT None
antidepressant JJ Pharmocological
treatment NN Pharmocological
algorithm NN Pharmocological
collaborative JJ Educational
care NN Educational
approach NN Educational
with IN Educational
and CC None
an DT None
antidepressant JJ Pharmocological
treatment NN Pharmocological
algorithm NN Pharmocological
Problem NNP Educational
Solving VBG Educational
Treatment NNP Educational
. . None
adapted JJ None
collaborative NN None
care NN None
framework NN None
, , None
including VBG None
contracting NN None
and CC None
adherence-improving JJ None
strategies NNS None
, , None
combined VBN None
with IN None
Problem NNP None
Solving NNP None
Treatment NNP None
and CC None
antidepressant JJ None
medication NN None
according VBG None
to TO None
a DT None
treatment NN None
algorithm NN None
. . None
randomised VBN None
to TO None
either CC None
the DT None
intervention NN None
group NN None
or CC None
the DT None
control NN None
group NN None
. . None
Patients NNS None
in IN None
the DT None
intervention NN None
group NN None
will MD None
receive VB None
treatment NN None
based VBN None
on IN None
the DT None
collaborative JJ None
care NN None
approach NN None
, , None
and CC None
patients NNS None
in IN None
the DT None
control NN None
group NN None
will MD None
receive VB None
care NN None
as IN None
usual JJ None
. . None
Baseline NN None
measurements NNS None
and CC None
follow VB None
up RP None
measures NNS None
( ( None
3 CD None
, , None
6 CD None
, , None
9 CD None
and CC None
12 CD None
months NNS None
) ) None
are VBP None
assessed VBN None
using VBG None
questionnaires NNS Educational
and CC None
an DT None
interview NN Educational
. . None
collaborative JJ Educational
care NN Educational
model NN Educational
-DOCSTART- -X- N

bisphosphonate NN Pharmocological
therapy NN Pharmocological
risedronate NN Pharmocological
placebo-controlled JJ Control
risedronate NN Pharmocological
placebo NN Control
. . None
risedronate NN Pharmocological
Risedronate NNP Pharmocological
Risedronate NNP Pharmocological
-DOCSTART- -X- N

Disopyramide-pyridostigmine JJ Pharmocological
placebo FW Control
cholinesterase NN Pharmocological
inhibitor NN Pharmocological
-- : Pharmocological
slow-release JJ Pharmocological
pyridostigmine NN Pharmocological
disopyramide NN Pharmocological
. . None
disopyramide JJ Pharmocological
Disopyramide NNP Pharmocological
disopyramide NN Pharmocological
. . None
disopyramide NN Pharmocological
pyridostigmine NN Pharmocological
pyridostigmine NN Pharmocological
: : None
pyridostigmine NN Pharmocological
placebo NN Control
: : None
-DOCSTART- -X- N

repeated JJ Educational
high-single-dose JJ Educational
allergen NN Educational
challenge NN Educational
. . None
repetitive JJ Educational
high-dose JJ Educational
allergen NN Educational
challenges NNS Educational
with IN Educational
household NN Educational
dust NN Educational
mites NNS Educational
for IN Educational
four CD Educational
consecutive JJ Educational
days NNS Educational
. . None
requiring VBG None
prednisolone NN None
-DOCSTART- -X- N

-DOCSTART- -X- N

infusion NN Pharmocological
of IN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
1-3 JJ Pharmocological
g/kg/day NN Pharmocological
of IN Pharmocological
fat JJ Pharmocological
emulsion NN Pharmocological
into IN Pharmocological
either CC Pharmocological
the DT Pharmocological
ecmo NN Pharmocological
circuit NN Pharmocological
or CC Pharmocological
separate JJ Pharmocological
intravenous JJ Pharmocological
access NN Pharmocological
. . None
fat JJ Pharmocological
emulsion NN Pharmocological
Fat NNP Pharmocological
emulsion NN Pharmocological
-DOCSTART- -X- N

Thai NNP Educational
Traditional NNP Educational
Massage NNP Educational
( ( Educational
TTM NNP Educational
) ) Educational
Standard NNP Educational
sensory JJ Educational
integration NN Educational
therapy NN Educational
( ( Educational
SI NNP Educational
) ) Educational
TTM NNP Educational
-DOCSTART- -X- N

three CD Pharmocological
dosage-prediction NN Pharmocological
Three CD Pharmocological
dosage-prediction NN Pharmocological
methods NNS Pharmocological
warfarin JJ Pharmocological
therapy NN Pharmocological
warfarin NN Pharmocological
warfarin NNS Pharmocological
analog NN Physical
computer NN Physical
linear JJ Physical
regression NN Physical
empiric JJ Physical
dosing NN Physical
by IN Physical
the DT Physical
physician NN Physical
-DOCSTART- -X- N

auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
auditory JJ Educational
integrative JJ Educational
training NN Educational
( ( Educational
AIT NNP Educational
) ) Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
iatrogenic JJ Physical
hookworm NN Physical
infection NN Physical
hookworm NN Physical
infection NN Physical
-DOCSTART- -X- N

Intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
glucose NN Pharmocological
control NN Pharmocological
protocol NN Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
. . None
intensive JJ Pharmocological
glucose NNS Pharmocological
control NN Pharmocological
group NN Pharmocological
continuous JJ Pharmocological
insulin NN Pharmocological
infusion NN Pharmocological
conventional JJ Pharmocological
treatment NN Pharmocological
group NN Pharmocological
insulin NN Pharmocological
insulin JJ Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
conventional JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ Pharmocological
insulin NN Pharmocological
control NN None
group NN None
conventional JJ Pharmocological
therapy NN Pharmocological
group NN None
conventional JJ Pharmocological
and CC None
intensive JJ Pharmocological
therapy NN Pharmocological
groups NNS None
conventional JJ Pharmocological
and CC None
intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
intensive JJ None
insulin NN None
therapy NN None
conventional JJ Pharmocological
therapy NN Pharmocological
Intensive JJ Pharmocological
insulin NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

clomipramine VB Pharmocological
haloperidol VB Pharmocological
clomipramine NN Pharmocological
placebo NN Control
haloperidol NN Pharmocological
placebo NN Control
clomipramine NN Pharmocological
-DOCSTART- -X- N

Interactive NNP Educational
voice NN Educational
response NN Educational
( ( Educational
IVR NNP Educational
) ) Educational
technology NN Educational
Quitline NNP Educational
treatment NN Educational
-- : Educational
a DT Educational
interactive JJ Educational
voice NN Educational
response NN Educational
( ( Educational
IVR NNP Educational
) ) Educational
IVR NNP Control
screening NN Control
for IN Control
current JJ Control
smoking NN Control
( ( Control
control VB Control
group NN Control
) ) Control
IVR NNP Educational
screening VBG Educational
plus CC Educational
an DT Educational
IVR NNP Educational
intervention NN Educational
. . Educational
IVR NNP Educational
intervention NN Educational
IVR NNP Educational
system NN Educational
IVR NNP Educational
system NN Educational
IVR NNP Educational
messages NNS Educational
Proactive NNP Educational
IVR NNP Educational
outreach NN Educational
IVR NNP Educational
-DOCSTART- -X- N

home NN Educational
TEACCHing NNP Educational
program NN Educational
training NN Psychological
intervention NN Psychological
waitlist NN Control
-DOCSTART- -X- N

cardiac JJ Physical
contractility NN Physical
modulation NN Physical
electrical JJ Physical
signals NNS Physical
electrical JJ Physical
signals NNS Physical
cardiac NN Physical
contractility NN Physical
modulating NN Physical
( ( Physical
CCM NNP Physical
) ) Physical
electrical JJ Physical
signals NNS Physical
CCM NNP Physical
signals NNS Physical
CCM NNP Physical
therapy NN Physical
. . None
CCM NNP Physical
therapy NN Physical
CCM NNP Physical
therapy NN Physical
CCM NNP Physical
therapy NN Physical
CCM NNP Physical
therapy NN Physical
-DOCSTART- -X- N

Short-term NNP Pharmocological
intravenous JJ Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
short-term JJ Physical
long-term JJ Physical
intravenous JJ Pharmocological
antibiotics NNS Pharmocological
surgical JJ Surgical
drainage NN Surgical
. . None
antibiotic JJ Pharmocological
-DOCSTART- -X- N

lithium NN Pharmocological
disilicate NN Pharmocological
glass NN Pharmocological
ceramic NN Pharmocological
-DOCSTART- -X- N

Oral JJ Pharmocological
6-mercaptopurine JJ Pharmocological
oral JJ Pharmocological
6-thioguanine JJ Pharmocological
substitution NN Pharmocological
of IN Pharmocological
oral JJ Pharmocological
6-thioguanine JJ Pharmocological
( ( Pharmocological
TG NNP Pharmocological
) ) Pharmocological
for IN Pharmocological
6-mercaptopurine JJ Pharmocological
( ( Pharmocological
MP NNP Pharmocological
) ) Pharmocological
and CC None
triple JJ Pharmocological
intrathecal JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
ITT NNP Pharmocological
) ) Pharmocological
for IN Pharmocological
intrathecal JJ Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
IT-MTX NNP Pharmocological
) ) Pharmocological
MP NNP Pharmocological
or CC None
TG NNP Pharmocological
and CC None
IT-MTX NNP Pharmocological
or CC None
ITT NNP Pharmocological
-DOCSTART- -X- N

Immunoenhanced NNP Pharmocological
enteral JJ Pharmocological
nutrition NN Pharmocological
formulas NNS Pharmocological
immunoenhanced VBD Pharmocological
enteral JJ Pharmocological
nutritions NNS Pharmocological
arginine-enhanced JJ Pharmocological
formula NN Pharmocological
standard JJ None
polymeric NN None
formula NN None
arginine NN Pharmocological
, , Pharmocological
RNA NNP Pharmocological
and CC Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
enhanced VBD Pharmocological
formula NN Pharmocological
Immunoenhanced NNP None
enteral JJ None
nutrition NN None
formulas NNS None
-DOCSTART- -X- N

active JJ Other
placebo NN Control
-DOCSTART- -X- N

web-based JJ Educational
approach NN Educational
Web-based JJ Educational
health NN Educational
and CC Educational
leadership NN Educational
development NN Educational
program NN Educational
-- : Educational
designed VBN Educational
6-month JJ Educational
Internet-based JJ Educational
program NN Educational
or CC Educational
a DT Educational
control JJ Control
condition NN Control
. . None
intervention NN Educational
-DOCSTART- -X- N

social JJ Educational
phobia NN Educational
social JJ Psychological
phobics NNS Psychological
. . None
participants NNS Psychological
heard VBP Psychological
their PRP$ Psychological
heart NN Psychological
sounds VBZ Psychological
first JJ Psychological
via IN Psychological
headphones NNS Psychological
and CC None
then RB None
via IN None
loudspeakers NNS None
which WDT None
were VBD None
also RB None
audible JJ None
to TO None
observers NNS None
. . None
controls NNS Control
-DOCSTART- -X- N

radial JJ Educational
artery NN Educational
internal JJ Educational
thoracic NN Educational
artery NN Educational
saphenous JJ Educational
vein NNS Educational
Protocol-directed JJ Physical
angiography NN Physical
-DOCSTART- -X- N

dietary JJ Pharmocological
selenium NN Pharmocological
( ( Pharmocological
Se-enriched NNP Pharmocological
yeast NN Pharmocological
) ) Pharmocological
selenium NN Pharmocological
experimental JJ Pharmocological
diet JJ Pharmocological
with IN Pharmocological
different JJ Pharmocological
Se NNP Pharmocological
levels NNS Pharmocological
real-time JJ None
PCR NNP None
and CC None
-DOCSTART- -X- N

thumb NN Physical
be VB Physical
immobilised VBN Physical
Immobilisation NN Physical
of IN Physical
the DT Physical
thumb NN Physical
forearm JJ Physical
gauntlet NN Physical
( ( Physical
Colles NNP Physical
' POS Physical
) ) Physical
cast NN Physical
conventional JJ Physical
'scaphoid NN Physical
' '' Physical
plaster NN Physical
incorporating VBG Physical
the DT Physical
thumb NN Physical
as RB Physical
far RB Physical
as IN Physical
its PRP$ Physical
interphalangeal NN Physical
joint NN Physical
. . None
-DOCSTART- -X- N

Pregabalin NNP Pharmocological
naltrexone NN Pharmocological
Pregabalin NNP Pharmocological
( ( Pharmocological
PRE NNP Pharmocological
) ) Pharmocological
naltrexone NN Pharmocological
( ( Pharmocological
NAL NNP Pharmocological
) ) Pharmocological
receiving VBG Pharmocological
50 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
NAL NNP Pharmocological
or CC Pharmocological
150-450 JJ Pharmocological
mg NN Pharmocological
of IN Pharmocological
PRE NNP Pharmocological
. . Pharmocological
NAL NNP Pharmocological
, , Pharmocological
PRE NNP Pharmocological
PRE NNP None
NAL NNP Pharmocological
. . Pharmocological
PRE NNP Pharmocological
-DOCSTART- -X- N

[ JJ Pharmocological
Mitomycin NNP Pharmocological
C NNP Pharmocological
plus CC Pharmocological
HCFU NNP Pharmocological
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
mitomycin JJ Pharmocological
C NNP Pharmocological
( ( Pharmocological
MMC NNP Pharmocological
) ) Pharmocological
and CC None
carmofur NN Pharmocological
( ( Pharmocological
HCFU NNP Pharmocological
) ) Pharmocological
MMC NNP Pharmocological
MMC NNP Pharmocological
+ NNP Pharmocological
HCFU NNP Pharmocological
group NN Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
+ NNP Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
only RB Pharmocological
MMC NNP Pharmocological
+ NNP Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
HCFU NNP Pharmocological
MMC NNP Pharmocological
HCFU NNP Pharmocological
-DOCSTART- -X- N

exercise NN Physical
training NN Physical
: : None
cardiorespiratory JJ Physical
exercise NN Physical
training NN Physical
exercise NN Physical
training NN Physical
. . None
exercise NN Physical
training NN Physical
exercise NN Physical
training NN Physical
exercise NN Physical
intervention NN Physical
Moderate NNP Physical
intensity NN Physical
exercise NN Physical
training NN Physical
exercise NN Physical
-DOCSTART- -X- N

metronidazole NN Pharmocological
erythromycin-neomycin JJ Pharmocological
and CC None
metronidazole-neomycin JJ Pharmocological
-DOCSTART- -X- N

evidence-based JJ Educational
prescription NN Educational
label NN Educational
enhanced JJ Educational
label NN Educational
label NN Educational
-DOCSTART- -X- N

Lithium NN Pharmocological
lithium NN Pharmocological
( ( None
lithium JJ Control
plus CC Control
early JJ Control
morning NN Control
sleep NN Control
deprivation NN Control
, , None
lithium NN Control
plus CC Control
a DT Control
control NN Control
sleep JJ Control
deprivation NN Control
procedure NN Control
, , None
and CC None
desipramine NN Control
with IN Control
either DT Control
of IN Control
the DT Control
two CD Control
sleep JJ Control
manipulations NNS Control
) ) None
Lithium NNP None
plus CC None
early JJ None
morning NN None
sleep JJ None
deprivation NN None
desipramine/sleep JJ Pharmocological
deprivation NN Pharmocological
sleep/pharmacologic JJ Physical
intervention NN Physical
-DOCSTART- -X- N

prethrombolytic JJ Pharmocological
cyclosporine-A JJ Pharmocological
injection NN Pharmocological
Cyclosporine-A NNP Pharmocological
( ( Pharmocological
CsA NNP Pharmocological
) ) Pharmocological
Patients NNS None
in IN None
the DT None
treatment NN None
group NN None
received VBD None
an DT None
intravenous JJ None
bolus NN None
injection NN None
of IN None
2.5 CD None
mg/kg NN None
of IN None
CsA NNP Pharmocological
immediately RB None
before IN None
TLT NNP None
. . None
The DT None
patients NNS None
in IN None
the DT None
control NN None
group NN None
received VBD None
an DT None
equivalent JJ None
volume NN None
of IN None
normal JJ Control
saline NN Control
. . None
-DOCSTART- -X- N

clozapine NN None
conventional JJ None
antipsychotic JJ None
medication NN None
clozapine NN Pharmocological
Clozapine NNP Pharmocological
clozapine NN Pharmocological
Clozapine NNP Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

amorphous JJ Pharmocological
cream NN Pharmocological
phosphate NN Pharmocological
complexes NNS Pharmocological
casein JJ Pharmocological
phosphoprotein-amorphous JJ Pharmocological
calcium NN Pharmocological
phosphate NN Pharmocological
fluoride JJ Pharmocological
bracket NN Surgical
removal NN Surgical
, , None
professional JJ Physical
tooth NN Physical
cleaning NN Physical
and CC Physical
drying NN Physical
, , None
a DT Physical
visual JJ Physical
scoring NN Physical
( ( Physical
0-4 JJ Physical
) ) Physical
and CC Physical
laser JJR Physical
fluorescence NN Physical
( ( Physical
LF NNP Physical
) ) Physical
readings NNS Physical
daily RB Pharmocological
topical JJ Pharmocological
applications NNS Pharmocological
of IN Pharmocological
a DT Pharmocological
dental JJ Pharmocological
cream NN Pharmocological
containing VBG Pharmocological
CPP-ACP NNP Pharmocological
( ( Pharmocological
Topacal NNP Pharmocological
) ) Pharmocological
for IN Pharmocological
3 CD Pharmocological
months NNS Pharmocological
followed VBN Physical
by IN Physical
a DT Physical
3-month JJ Physical
period NN Physical
of IN Physical
daily JJ Physical
toothbrushing VBG Physical
with IN Physical
fluoridated JJ Physical
dentifrice NN Physical
, , Physical
or CC Physical
B NNP Physical
) ) Physical
daily RB Control
0.05 CD Control
% NN Control
sodium NN Control
fluoride NN Control
mouthwash NN Control
combined VBN Control
with IN Control
fluoridated JJ Control
dentifrice NN Control
for IN Control
6 CD Control
months NNS Control
. . None
amorphous JJ Pharmocological
calcium NN Pharmocological
phosphate NN Pharmocological
treatments NNS Pharmocological
-DOCSTART- -X- N

contrast NN Physical
echocardiography NN Physical
wall JJ Physical
motion NN Physical
and CC Physical
technetium-99m JJ Physical
sestamibi NN Physical
single-photon JJ Physical
emission NN Physical
computed VBD Physical
tomography NN Physical
. . Physical
myocardial JJ Physical
contrast NN Physical
echocardiography NN Physical
( ( Physical
MCE NNP Physical
) ) Physical
Myocardial NNP Physical
contrast NN Physical
echocardiography NN Physical
perfusion NN Physical
scintigraphy NN Physical
perfluorocarbon-filled JJ Pharmocological
contrast NN Pharmocological
agent NN Pharmocological
( ( Pharmocological
NC100100 NNP Pharmocological
) ) Pharmocological
. . Physical
single-photon JJ Physical
emission NN Physical
computed VBN Physical
tomography NN Physical
( ( Physical
SPECT NNP Physical
) ) Physical
after IN None
the DT None
injection NN None
of IN None
technetium-99m JJ None
( ( None
Tc-99m NNP None
) ) None
sestamibi NN None
at IN None
rest NN None
. . None
Quantitative NNP None
and CC None
semiquantitative JJ None
SPECT NNP Physical
MCE NNP Physical
-DOCSTART- -X- N

Circulating VBG Physical
blood NN Physical
B NNP Physical
cells NNS Physical
flow JJ Physical
cytometry NN Physical
. . None
PCR NNP Physical
-DOCSTART- -X- N

low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
, , None
enoxaparin JJ Pharmocological
sodium NN Pharmocological
enoxaparin NN Pharmocological
unfractionated JJ Pharmocological
heparin NN Pharmocological
( ( Pharmocological
UFH NNP Pharmocological
) ) Pharmocological
enoxaparin NN Pharmocological
UFH NNP Pharmocological
. . None
UFH NNP Pharmocological
enoxaparin NN Pharmocological
Enoxaparin NNP Pharmocological
UFH NNP Pharmocological
enoxaparin NN Pharmocological
low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

remifentanil NN Pharmocological
fentanyl NN Pharmocological
midazolam NN Pharmocological
, , Pharmocological
propofol NN Pharmocological
remifentanil NN Pharmocological
midazolam JJ Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
fentanyl VBP Pharmocological
1 CD Pharmocological
microg/kg NN Pharmocological
, , Pharmocological
and CC Pharmocological
propofol VB Pharmocological
initially RB Pharmocological
at IN Pharmocological
140 CD Pharmocological
microg/kg/min NN Pharmocological
. . Pharmocological
midazolam RB Pharmocological
0.03 CD Pharmocological
mg/kg NN Pharmocological
, , Pharmocological
remifentanil NN Pharmocological
: : Pharmocological
propofol NN Pharmocological
( ( Pharmocological
1:500 CD Pharmocological
) ) Pharmocological
given VBN Pharmocological
at IN Pharmocological
an DT Pharmocological
initial JJ Pharmocological
propofol JJ Pharmocological
infusion NN Pharmocological
rate NN Pharmocological
of IN Pharmocological
40 CD Pharmocological
microg/kg/min NN Pharmocological
. . Pharmocological
propofol NN Pharmocological
propofol JJ Pharmocological
fentanyl JJ Pharmocological
-DOCSTART- -X- N

Diazoxide NNP Pharmocological
and CC None
labetalol NN Pharmocological
peripheral JJ Pharmocological
vasodilator NN Pharmocological
diazoxide NN Pharmocological
diazoxide JJ Pharmocological
150 CD Pharmocological
mg NN Pharmocological
or CC None
labetalol $ Pharmocological
50 CD Pharmocological
mg NN Pharmocological
diazoxide JJ Pharmocological
diazoxide NN Pharmocological
. . None
labetalol-treated JJ Pharmocological
labetalol $ Pharmocological
labetalol VBD Pharmocological
labetalol NN Pharmocological
. . None
diazoxide NN Pharmocological
-DOCSTART- -X- N

Nicotinic JJ Pharmocological
acid NN Pharmocological
nicotinic JJ Pharmocological
acid NN Pharmocological
nicotinic JJ Pharmocological
acid NN Pharmocological
no DT Control
therapy NN Control
nicotinic JJ Pharmocological
acid NN Pharmocological
nicotinic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

Ambient JJ None
temperature NN None
and CC None
biomarkers NNS None
12 CD Educational
weeks NNS Educational
of IN Educational
tai NN Educational
chi NN Educational
classes NNS Educational
or CC Educational
to TO Educational
time-matched JJ Control
education NN Control
control NN Control
. . Educational
-DOCSTART- -X- N

40 CD None
% NN None
maximal JJ None
voluntary JJ None
contraction NN None
handgrip NN None
for IN None
3 CD None
min NN None
of IN None
postexercise NN None
circulatory NN None
occlusion NN None
( ( None
PECO NNP None
) ) None
to TO None
breathed JJ None
room NN None
air NN None
-DOCSTART- -X- N

vitamin NN Pharmocological
K2 NNP Pharmocological
Vitamin NNP Pharmocological
K2 NNP Pharmocological
( ( Pharmocological
VK2 NNP Pharmocological
) ) Pharmocological
VK2 NNP Pharmocological
control VB Control
Glakay NNP Pharmocological
dynamic JJ Physical
CT NNP Physical
abdominal JJ Physical
angiography NN Physical
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
etoricoxib $ Pharmocological
ibuprofen NN Pharmocological
etoricoxib $ Pharmocological
placebo VB Control
ibuprofen VB Pharmocological
placebo- JJ Control
placebo NN Control
, , None
etoricoxib VBZ Pharmocological
ibuprofen VB Pharmocological
etoricoxib NN Pharmocological
's POS Pharmocological
placebo NN Control
ibuprofen VB Pharmocological
etoricoxib JJ Pharmocological
ibuprofen NN Pharmocological
etoricoxib JJ Pharmocological
ibuprofen JJ Pharmocological
etoricoxib NN Pharmocological
ibuprofen NN Pharmocological
placebo VB Control
etoricoxib $ Pharmocological
ibuprofen VB Pharmocological
etoricoxib JJ Pharmocological
placebo NN Control
ibuprofen NN Pharmocological
-DOCSTART- -X- N

magnesium NN Pharmocological
sulphate NN Pharmocological
infusion NN Pharmocological
Magnesium NNP Pharmocological
sulphate NN Pharmocological
magnesium NN Pharmocological
Spinal NNP Surgical
anaesthesia NN Surgical
was VBD Surgical
performed VBN Surgical
at IN Surgical
L3-4 NNP Surgical
or CC Surgical
L4-5 NNP Surgical
interspace NN Surgical
with IN Surgical
12.5 CD Surgical
mg NNS Surgical
0.5 CD Surgical
% NN Surgical
heavy JJ Surgical
bupivacaine NN Surgical
, , Surgical
using VBG Surgical
a DT Surgical
25 CD Surgical
G NNP Surgical
Quincke NNP Surgical
needle NN Surgical
. . None
Patients NNS None
received VBD None
a DT None
5 CD Pharmocological
mg NN Pharmocological
kg NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
bolus NN Pharmocological
of IN Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
a DT Pharmocological
500 CD Pharmocological
mg NN Pharmocological
h NN Pharmocological
( ( Pharmocological
-1 NNP Pharmocological
) ) Pharmocological
infusion NN Pharmocological
or CC Pharmocological
saline NN Pharmocological
Magnesium NNP Pharmocological
sulphate JJ Pharmocological
-DOCSTART- -X- N

enhanced VBD Educational
milieu NNS Educational
teaching VBG Educational
enhanced JJ Educational
milieu NN Educational
teaching NN Educational
( ( Educational
EMT NNP Educational
) ) Educational
parent NN Educational
+ NNP Educational
therapist NN Educational
EMT NNP Educational
therapist-only RB Educational
EMT NNP Educational
-DOCSTART- -X- N

shearing VBG Physical
shearing VBG Physical
. . None
a DT Control
control NN Control
group NN Control
already RB Physical
shorn VBN Physical
, , None
and CC None
a DT None
treatment NN None
group NN None
left VBN Control
unshorn JJ Control
-DOCSTART- -X- N

ciclesonide NN Pharmocological
Ciclesonide NNP Pharmocological
ciclesonide JJ Pharmocological
placebo NN Control
ciclesonide NN Pharmocological
placebo NN Control
ciclesonide NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

nocturnal JJ Physical
continuous JJ Physical
positive JJ Physical
airway NN Physical
pressure NN Physical
. . None
continuous JJ Physical
positive JJ Physical
airway NN Physical
pressure NN Physical
( ( Physical
CPAP NNP Physical
) ) Physical
of IN None
were VBD None
recorded VBN None
on IN None
the DT None
morning NN None
after IN None
overnight JJ None
polysomnography NN None
, , None
and CC None
again RB None
one CD None
month NN None
after IN None
patients NNS None
were VBD None
randomly RB None
allocated VBN None
nocturnal JJ Physical
CPAP NNP Physical
treatment NN Physical
or CC None
no DT None
CPAP NNP None
( ( None
control NN None
) ) None
nocturnal JJ Physical
CPAP NNP Physical
-DOCSTART- -X- N

galacto-oligosaccharides NNS Pharmocological
and CC None
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
LGG NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
galacto-oligosaccharides NNS Pharmocological
( ( Pharmocological
GOS NNP Pharmocological
) ) Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
+ NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
LGG NNP Pharmocological
GOS NNP Pharmocological
GOS NNP Pharmocological
-DOCSTART- -X- N

tobramycin NN Pharmocological
] NN None
-DOCSTART- -X- N

dietary JJ Educational
intake NN Educational
-DOCSTART- -X- N

Non-pharmacological JJ Educational
treatment NN Educational
( ( Educational
NPT NNP Educational
) ) Educational
NPT NNP Educational
six CD Educational
self-management JJ Educational
group NN Educational
sessions NNS Educational
provided VBN Educational
by IN Educational
a DT Educational
multi-disciplinary JJ Educational
team NN Educational
two CD Control
group NN Control
sessions NNS Control
and CC Control
four CD Control
sessions NNS Control
by IN Control
telephone NN Control
non-pharmacological JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

Vilazodone NN Pharmocological
Vilazodone NNP Pharmocological
vilazodone NN Pharmocological
placebo- JJ Control
placebo NN Control
; : None
moxifloxacin CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
; : None
or CC None
vilazodone NN Pharmocological
Placebo-corrected JJ Control
vilazodone NN Pharmocological
vilazodone NN Pharmocological
vilazodone NN Pharmocological
Vilazodone NNP Pharmocological
vilazodone NN Pharmocological
vilazodone NN Pharmocological
moxifloxacin NN Pharmocological
placebo NN Control
Vilazodone NNP Pharmocological
-DOCSTART- -X- N

leisure NN Educational
programme NN Educational
1-year JJ Educational
group NN Educational
leisure NN Educational
programme NN Educational
interaction NN Educational
with IN Educational
media NNS Educational
, , None
engagement NN Educational
in IN Educational
exercise NN Educational
, , None
playing VBG Educational
games NNS Educational
and CC Educational
doing VBG Educational
crafts NNS Educational
, , None
attending VBG Educational
events NNS Educational
, , None
and CC None
participating VBG Educational
in IN Educational
other JJ Educational
recreation NN Educational
activities NNS Educational
-DOCSTART- -X- N

corifollitropin NN Pharmocological
alfa NN Pharmocological
versus NN None
recombinant JJ Pharmocological
FSH NNP Pharmocological
corifollitropin NN Pharmocological
alfa NN Pharmocological
recombinant JJ Pharmocological
FSH NNP Pharmocological
( ( Pharmocological
rFSH NN Pharmocological
) ) Pharmocological
150?g CD None
corifollitropin NN None
alfa NN None
versus IN None
daily JJ None
200IU CD None
rFSH NN None
after IN None
corifollitropin NN None
alfa NN None
compared VBN None
corifollitropin NN None
alfa NN None
and CC None
rFSH NN None
are VBP None
corifollitropin NN None
alfa NN None
can MD None
recombinant JJ None
FSH NNP None
( ( None
rFSH NN None
) ) None
using VBG None
corifollitropin NN None
alfa JJ None
versus JJ None
daily JJ None
rFSH NN None
. . None
A DT None
150?g CD None
corifollitropin NN None
alfa NN None
or CC None
200IU CD None
rFSH NN None
for IN None
corifollitropin NN None
alfa NN None
compared VBN None
daily JJ None
rFSH NN None
regimen NNS None
reached VBN None
. . None
Corifollitropin NNP None
alfa JJ None
treatment NN None
pharmacokinetics NNS None
of IN None
corifollitropin NN Pharmocological
alfa NN Pharmocological
and CC None
rFSH NN Pharmocological
are VBP None
-DOCSTART- -X- N

isoprenaline NN Pharmocological
isoprenaline JJ Pharmocological
sulphate NN Pharmocological
isoprenaline JJ Pharmocological
sulphate NN Pharmocological
. . None
Practolol NNP Pharmocological
Practolol CC Pharmocological
Propranolol NNP Pharmocological
Practolol NNP Pharmocological
propranolol NN Pharmocological
propranolol NN Pharmocological
practolol NN Pharmocological
-DOCSTART- -X- N

ropivacaine NN Pharmocological
, , None
bupivacaine NN Pharmocological
etidocaine NN Pharmocological
] NN None
Ropivacaine NNP Pharmocological
( ( None
bupivacaine VB Pharmocological
ropivacaine VB Pharmocological
etidocaine VB Pharmocological
ropivacaine JJ Pharmocological
bupivacaine VB Pharmocological
etidocaine VB Pharmocological
. . None
bupivacaine VBP Pharmocological
ropivacaine VB Pharmocological
etidocaine VBP Pharmocological
Injections NNS Pharmocological
of IN Pharmocological
3 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
the DT Pharmocological
local JJ Pharmocological
anesthetic NN Pharmocological
followed VBN Pharmocological
by IN Pharmocological
the DT Pharmocological
remainder NN Pharmocological
of IN Pharmocological
the DT Pharmocological
local JJ Pharmocological
anesthetic NN Pharmocological
at IN Pharmocological
10 CD Pharmocological
ml/min NN Pharmocological
1 CD Pharmocological
min NN Pharmocological
later RB Pharmocological
. . None
bupivacaine NN Pharmocological
ropivacaine JJ Pharmocological
etidocaine JJ Pharmocological
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
) ) None
bupivacaine NN Pharmocological
, , None
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
bupivacaine NN Pharmocological
, , None
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
. . None
bupivacaine NN Pharmocological
ropivacaine NN Pharmocological
etidocaine NN Pharmocological
ropivacaine NN Pharmocological
bupivacaine NN Pharmocological
etidocaine NN Pharmocological
Bupivacaine NNP Pharmocological
ropivacaine NN Pharmocological
etidocaine VB Pharmocological
ropivacaine NN Pharmocological
bupivacaine NN Pharmocological
etidocaine NN Pharmocological
... : None
-DOCSTART- -X- N

trivalent NN Pharmocological
poliovirus NN Pharmocological
vaccines NNS Pharmocological
. . None
oral JJ Pharmocological
trivalent NN Pharmocological
poliovirus NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
OPV NNP Pharmocological
) ) Pharmocological
injectable JJ Pharmocological
( ( Pharmocological
inactivated VBN Pharmocological
) ) Pharmocological
trivalent NN Pharmocological
poliovirus NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
IPV NNP Pharmocological
) ) Pharmocological
IPV NNP Pharmocological
-DOCSTART- -X- N

testosterone NN Pharmocological
topical JJ Pharmocological
hormones NNS Pharmocological
local JJ Pharmocological
testosterone NN Pharmocological
received VBD Pharmocological
local JJ Pharmocological
estrogen NN Pharmocological
cream NN Pharmocological
; : None
study CC None
group NN None
2 CD None
received VBD None
local JJ Pharmocological
estrogen NN Pharmocological
and CC Pharmocological
testosterone NN Pharmocological
cream NN Pharmocological
; : Pharmocological
the DT None
control NN None
group NN None
received VBD None
nonhormonal JJ Control
lubricant JJ Control
KY NNP Control
gel NN Control
for IN Control
12 CD Control
weeks NNS Control
. . None
Local NNP Pharmocological
estrogen NN Pharmocological
-DOCSTART- -X- N

hexaminolevulinate NN Physical
enabled VBN Physical
fluorescence NN Physical
cystoscopy NN Physical
. . None
hexaminolevulinate NN Physical
fluorescence NN Physical
cystoscopic NN Physical
detection NN Physical
white JJ Physical
light NN Physical
fluorescence NN Physical
white JJ Physical
light NN Physical
fluorescence NN Physical
Cystectomy NNP Physical
white JJ Physical
light NN Physical
fluorescence NN Physical
Hexaminolevulinate NNP Physical
fluorescence NN Physical
cystoscopy NN Physical
-DOCSTART- -X- N

Combination NNP Pharmocological
chemotherapy NN Pharmocological
ALVAC-CEA/B7.1 NNP Pharmocological
vaccine NN Pharmocological
vaccines NNS Pharmocological
chemotherapy NN Pharmocological
fluorouracil NN Pharmocological
, , None
leucovorin NN Pharmocological
, , None
and CC None
irinotecan JJ Pharmocological
ALVAC-CEA/B7.1 NNP Pharmocological
vaccine NN Pharmocological
with IN None
or CC None
without IN None
tetanus JJ Pharmocological
toxoid NN Pharmocological
adjuvant NN Pharmocological
. . None
ALVAC NNP Pharmocological
followed VBN None
by IN None
chemotherapy NN Pharmocological
and CC None
booster NN Pharmocological
vaccination NN Pharmocological
( ( None
group NN None
1 CD None
) ) None
, , None
ALVAC NNP Pharmocological
and CC None
tetanus NN Pharmocological
toxoid NN Pharmocological
followed VBN None
by IN None
chemotherapy NN Pharmocological
( ( None
group NN None
2 CD None
) ) None
, , None
or CC None
chemotherapy VB Pharmocological
alone RB None
followed VBN None
by IN None
ALVAC NNP Pharmocological
in IN None
( ( None
group NN None
ELISA NNP Physical
assay NN Physical
IFN-gamma NNP Physical
enzyme-linked JJ Physical
immunospot NN Physical
assay NN Physical
. . None
ALVAC NNP Pharmocological
chemotherapy NN Pharmocological
ALVAC NNP Pharmocological
tetanus NN Pharmocological
adjuvant NN Pharmocological
chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
ALVAC NNP Pharmocological
ALVAC-CEA/B7.1 NNP Pharmocological
vaccine NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
10 CD None
mmol NN None
of IN None
potassium NN Pharmocological
and CC None
10 CD None
mmol NN None
of IN None
calcium NN Pharmocological
mixed VBN None
in IN None
their PRP$ None
table JJ None
salt JJ None
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
supplementation NN Pharmocological
supplement NN Pharmocological
of IN Pharmocological
potassium NN Pharmocological
and CC None
calcium NN Pharmocological
-DOCSTART- -X- N

rituximab NN Pharmocological
( ( Pharmocological
R NNP Pharmocological
) ) Pharmocological
to TO Pharmocological
fludarabine VB Pharmocological
and CC Pharmocological
cyclophosphamide VB Pharmocological
from IN None
R-FC NNP None
from IN None
R-FC NNP None
, , None
with IN None
R-FC NNP None
vs NN None
FC NNP None
. . None
-DOCSTART- -X- N

Amonafide NN Pharmocological
Amonafide NNP Pharmocological
Amonafide NNP Pharmocological
cyclophosphamide-doxorubicin-5-fluorouracil NN Pharmocological
cyclophosphamide-doxorubicin-5-fluorouracil NN Physical
amonafide RB Pharmocological
cyclophosphamide-doxorubicin-5-fluorouracil JJ Pharmocological
Amonafide NNP Pharmocological
amonafide NN Pharmocological
-DOCSTART- -X- N

sildenafil NN Pharmocological
sildenafil NN Pharmocological
placebo-controlled JJ Control
sildenafil VB Pharmocological
placebo NN Control
Sildenafil NNP Pharmocological
sildenafil-treated JJ Pharmocological
sildenafil-treated JJ Pharmocological
-DOCSTART- -X- N

lumiracoxib JJ Pharmocological
celecoxib NN Pharmocological
lumiracoxib NN Pharmocological
lumiracoxib NN Pharmocological
at IN Pharmocological
doses NNS Pharmocological
of IN Pharmocological
100 CD Pharmocological
mg NNS Pharmocological
once RB Pharmocological
daily JJ Pharmocological
( ( Pharmocological
o.d JJ Pharmocological
. . Pharmocological
) ) Pharmocological
and CC Pharmocological
100 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
celecoxib JJ Pharmocological
200 CD Pharmocological
mg NN Pharmocological
o.d NN Pharmocological
. . Pharmocological
lumiracoxib VB Pharmocological
lumiracoxib $ Pharmocological
celecoxib $ Pharmocological
celecoxib NN Pharmocological
lumiracoxib NN Pharmocological
lumiracoxib VBZ Pharmocological
celecoxib JJ Pharmocological
lumiracoxib JJ Pharmocological
celecoxib NN Pharmocological
-DOCSTART- -X- N

dietary JJ Pharmocological
pyridoxine NN Pharmocological
dietary JJ Pharmocological
pyridoxine NN Pharmocological
( ( Pharmocological
PN NNP Pharmocological
) ) Pharmocological
into IN None
six CD None
treatments NNS None
in IN None
triplicates NNS None
( ( None
Five CD None
iso-nitrogenous JJ None
( ( None
356.3 CD None
? . None
2.7 CD None
g/kg JJ None
crude NN None
protein NN None
) ) None
purified VBD None
diets NNS None
were VBD None
PN NNP None
supplementation NN None
increased VBD None
mg JJ None
PN/kg NNP None
diet-fed NN None
group NN None
their PRP$ None
non-PN-fed JJ None
counterpart NN None
dietary JJ None
PN NNP None
supplementation NN None
at IN None
-DOCSTART- -X- N

pyridoxine JJ Pharmocological
administration NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
oral JJ Control
dosing VBG Control
with IN Control
placebo NN Control
or CC None
fluoxetine NN Pharmocological
, , Pharmocological
40 CD Pharmocological
mg NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
. . None
[ NNP None
( ( Physical
11 CD Physical
) ) Physical
C NNP Physical
] NNP Physical
SB207145 NNP Physical
-DOCSTART- -X- N

given VBN None
nicotine JJ Pharmocological
or CC None
placebo JJ Control
solution NN None
on IN None
two CD None
separate JJ None
occasions NNS None
in IN None
a DT None
randomized JJ None
sequence NN None
. . None
water-perfused JJ None
manometry NN None
catheter NN None
, , None
with IN None
openings NNS None
at IN None
5 CD None
, , None
10 CD None
and CC None
15 CD None
cm NN None
from IN None
the DT None
tip NN None
, , None
was VBD None
placed VBN None
by IN None
rigid JJ None
sigmoidoscopy NN None
in IN None
the DT None
recto-sigmoid JJ None
region NN None
. . None
were VBD None
measured VBN None
for IN None
15 CD None
min NNS None
prior RB None
to TO None
instillation NN None
of IN None
20 CD None
ml NN None
of IN None
saline JJ None
alone NN None
or CC None
with IN None
nicotine JJ None
, , None
1.2 CD None
mg NN None
, , None
at IN None
pH JJ None
4.5 CD None
. . None
-DOCSTART- -X- N

BRAF NNP Pharmocological
inhibition NN Pharmocological
vemurafenib NN Pharmocological
-DOCSTART- -X- N

gabapentin NN Pharmocological
( ( Pharmocological
1200 CD Pharmocological
mg FW Pharmocological
daily RB Pharmocological
) ) Pharmocological
or CC Pharmocological
vigabatrin NN Pharmocological
( ( Pharmocological
2000 CD Pharmocological
mg FW Pharmocological
daily RB Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

stanol NN Pharmocological
ester NN Pharmocological
stanol NN Pharmocological
esters NNS Pharmocological
stanol JJ Pharmocological
ester NN Pharmocological
or CC None
placebo NN Physical
stanol NN Pharmocological
( ( Pharmocological
ester JJ Pharmocological
form NN Pharmocological
) ) Pharmocological
stanol NN Pharmocological
( ( Pharmocological
ester JJ Pharmocological
form NN Pharmocological
) ) Pharmocological
stanol NN Pharmocological
placebo VB Control
stanol JJ Pharmocological
esters NNS Pharmocological
placebo NN Control
. . None
Stanol NNP Pharmocological
esters NNS Pharmocological
-DOCSTART- -X- N

growth NN Pharmocological
hormone-secretagogues NNS Pharmocological
thyrotropin-releasing JJ Pharmocological
hormone NN Pharmocological
. . Pharmocological
TRH NN Pharmocological
( ( Educational
one CD Educational
day NN Educational
) ) Educational
and CC None
placebo NN Control
Peptide NNP None
infusions NNS None
placebo NN Control
TRH NNP Pharmocological
GH-secretagogue NNP Pharmocological
-DOCSTART- -X- N

controlled VBN Physical
heated VBN Physical
breathing VBG Physical
tube NN Physical
humidifier NN Physical
heated VBN Physical
humidifier NN Physical
continuous JJ Physical
positive JJ Physical
airway NN Physical
pressure NN Physical
( ( Physical
CPAP NNP Physical
) ) Physical
therapy NN Physical
conventional JJ Physical
heated JJ Physical
humidification NN Physical
added VBD Physical
to TO Physical
CPAP NNP Physical
controlled VBN Physical
heated VBN Physical
breathing VBG Physical
tube NN Physical
humidifier NN Physical
( ( Physical
ThermoSmart NNP Physical
( ( Physical
R NNP Physical
) ) Physical
; : Physical
controlled VBN Physical
heated VBD Physical
breathing VBG Physical
tube NN Physical
humidifier NN Physical
controlled VBN Physical
heated VBN Physical
breathing VBG Physical
tube JJ Physical
humidification NN Physical
technology NN Physical
-DOCSTART- -X- N

xylometazoline NNP Pharmocological
dexpanthenol JJ Pharmocological
Xylometazoline NN Pharmocological
Dexpanthenol NNP Pharmocological
( ( Pharmocological
Nasic NNP Pharmocological
) ) Pharmocological
Xylometazoline NNP Pharmocological
alone RB None
verum NN Pharmocological
placebo NN Control
Xylometazoline-Dexpanthenol JJ Pharmocological
Xylometazoline NNP Pharmocological
Xylometazoline-Dexpanthenol NNP Pharmocological
Xylometazoline NNP Pharmocological
-DOCSTART- -X- N

cardiotocography NN Physical
cardiotocography NN Physical
Cardiotocography NNP Physical
-DOCSTART- -X- N

fennel NN Pharmocological
extract NN Pharmocological
mefenamic JJ Pharmocological
acid NN Pharmocological
fennel NN Pharmocological
mefenamic JJ Pharmocological
acid NN Pharmocological
fennel NN Pharmocological
mefenamic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

granulocyte/colony-stimulating JJ Physical
factor NN Physical
granulocyte/colony-stimulating JJ Physical
factor NN Physical
( ( Physical
G-CSF NNP Physical
) ) Physical
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
G-CSF NNP Pharmocological
-DOCSTART- -X- N

Autism-Spectrum JJ Other
Quotient-Japanese JJ Other
Japanese JJ Other
version NN Other
of IN Other
the DT Other
Autism NNP Other
Spectrum NNP Other
Quotient NNP Other
( ( Other
AQ NNP Other
) ) Other
, , Other
AQ-J NNP Other
AQ-J NNP Other
AQ-J NNP Other
AQ-J NNP Other
. . Other
AQ-J JJ Other
-DOCSTART- -X- N

fluticasone NN Pharmocological
placebo-controlled JJ Control
fluticasone NN Pharmocological
fluticasone NN Pharmocological
placebo NN Control
fluticasone NN Pharmocological
fluticasone NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

nicotine VB Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
: : None
nicotine JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
NRT NNP Pharmocological
) ) Pharmocological
NRT NNP Pharmocological
-DOCSTART- -X- N

tension-free JJ Surgical
hernioplasty NN Surgical
tension-free JJ Surgical
hernioplasty NN Surgical
tension-free JJ Physical
repairs NNS Physical
Cooper NNP Surgical
ligament NN Surgical
or CC Surgical
abdominal JJ Surgical
ring NN Surgical
repair NN Surgical
tension-free JJ Surgical
repair NN Surgical
; : None
abdominal JJ Surgical
ring NN Surgical
repair NN Surgical
Cooper NNP Surgical
ligament NN Surgical
repair NN Surgical
conventionel NN Surgical
herniotomies NNS Surgical
-DOCSTART- -X- N

Bevacizumab-augmented JJ Pharmocological
retinal JJ Physical
laser NN Physical
photocoagulation NN Physical
intravitreal NN Pharmocological
bevacizumab NN Pharmocological
injection NN Pharmocological
standard JJ Physical
laser NN Physical
treatment NN Physical
laser NN Physical
treatment NN Physical
1.25 CD Pharmocological
mg NNS Pharmocological
intravitreal JJ Pharmocological
bevacizumab NN Pharmocological
Fluorescein NNP Physical
angiography NN Physical
Avastin-treated JJ Pharmocological
bevacizumab NN Pharmocological
Avastin NNP Pharmocological
-DOCSTART- -X- N

3 CD Pharmocological
% NN Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
and CC None
5 CD Pharmocological
% NN Pharmocological
5-fluorouracil JJ Pharmocological
. . None
Diclofenac NNP Pharmocological
sodium NN Pharmocological
and CC None
5-Fluorouracil JJ Pharmocological
3 CD Pharmocological
% NN Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
hyaluronic JJ Pharmocological
acid NN Pharmocological
and CC None
of IN None
5 CD Pharmocological
% NN Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
or CC None
5-Fluorouracil JJ Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac NN Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac NN Pharmocological
5-Fluorouracil JJ Pharmocological
diclofenac NN Pharmocological
sodium NN Pharmocological
5-Fluorouracil JJ Pharmocological
5-Fluorouracil NN Pharmocological
diclofenac JJ Pharmocological
sodium NN Pharmocological
. . None
-DOCSTART- -X- N

preventive JJ Psychological
intervention NN Psychological
( ( Psychological
CBT NNP Psychological
) ) Psychological
based VBN Psychological
intervention NN Psychological
program NN Psychological
, , Psychological
FRIENDS NNP Psychological
the DT None
story-reading NN None
or CC None
FRIENDS JJ None
-DOCSTART- -X- N

melatonin NN Pharmocological
melatonin NN Pharmocological
placebo NN Control
melatonin NN Pharmocological
placebo NN Control
melatonin NN Pharmocological
-DOCSTART- -X- N

Benzodiazepine NNP Pharmocological
opioid JJ Pharmocological
sedation NN Pharmocological
beta-adrenergic JJ Pharmocological
anatagonist NN Pharmocological
labetalol $ Pharmocological
10mg CD Pharmocological
iv NN Pharmocological
given VBN Pharmocological
with IN Pharmocological
midazolam-alfentanil JJ Pharmocological
sedation NN Pharmocological
. . None
labetalol NN Pharmocological
midazolam-alfentanil JJ Pharmocological
sedation NN Pharmocological
labetalol NN Pharmocological
-DOCSTART- -X- N

Risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Control
placebo-controlled JJ Control
risperidone NN Pharmocological
placebo NN Control
. . None
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
Risperidone NN Pharmocological
Risperidone NN Pharmocological
-DOCSTART- -X- N

conventional JJ Pharmocological
hypofractionated VBD Physical
three-dimensional JJ Physical
conformal JJ Physical
radiotherapy NN Physical
hypofractionation NN Pharmocological
vs. FW None
conventional JJ Pharmocological
fractionation NN Pharmocological
hypofractionated VBN Physical
or CC None
conventionally RB Pharmocological
fractionated VBN Pharmocological
three-dimensional JJ Pharmocological
conformal JJ Pharmocological
radiotherapy NN Pharmocological
hypofractionation NN Physical
-DOCSTART- -X- N

DNAemia NNP Physical
cut-off NN Physical
qualitative JJ Pharmocological
pp65 NN Pharmocological
antigenemia NN Pharmocological
. . None
quantitative JJ Pharmocological
DNAemia NNP Pharmocological
versus NN None
positive JJ Pharmocological
antigenemia NN Pharmocological
DNAemia NNP Pharmocological
antiviral JJ Pharmocological
therapy NN Pharmocological
DNAemia NNP Physical
cut-off NN Physical
positive JJ Pharmocological
antigenemia NN Pharmocological
. . None
DNAemia NNP Physical
DNAemia NNP Pharmocological
cut-off NN Pharmocological
antiviral JJ Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

cyclosporin NN Pharmocological
cyclosporin NN Pharmocological
-DOCSTART- -X- N

hyperinsulinemic-euglycemic JJ Physical
clamps NNS Physical
-DOCSTART- -X- N

beta-adrenoceptor NN Physical
blocker NN Physical
and CC None
diuretic JJ Physical
combination NN Physical
products NNS Physical
pindolol NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
5 CD Pharmocological
mg NNS Pharmocological
clopamide NN Pharmocological
metoprolol NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
12.5 CD Pharmocological
mg NNS Pharmocological
hydrochlorothiazide RB Pharmocological
pindolol/clopamide JJ Pharmocological
combination NN None
products NNS None
-DOCSTART- -X- N

esmolol NN Pharmocological
isoflurane NN Pharmocological
and CC None
sodium NN Pharmocological
nitroprusside RB Pharmocological
. . None
isoflurane NN Pharmocological
and CC Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
isoflurane NN Pharmocological
sodium JJ Pharmocological
nitroprusside NN Pharmocological
esmolol NN Pharmocological
Esmolol NNP Pharmocological
sodium JJ Pharmocological
nitroprusside NN Pharmocological
isoflurane NN Pharmocological
sodium NN Pharmocological
nitroprusside NN Pharmocological
isoflurane NN Pharmocological
. . None
sodium NN Pharmocological
nitroprusside NN Pharmocological
esmolol NN Pharmocological
. . None
esmolol NN Pharmocological
-DOCSTART- -X- N

Acupuncture NNP Physical
with IN Physical
sham JJ Physical
device NN Physical
twice RB Physical
a DT Physical
week NN Physical
for IN Physical
six CD Physical
weeks NNS Physical
or CC Physical
placebo NN Control
pill NN Control
once RB Control
a DT Control
day NN Control
for IN Control
eight CD Control
weeks NNS Control
. . None
-DOCSTART- -X- N

Dalteparin NNP Pharmocological
heparin NN Pharmocological
dalteparin NN Pharmocological
standard JJ Pharmocological
chemotherapy NN Pharmocological
( ( Pharmocological
CT NNP Pharmocological
) ) Pharmocological
dalteparin NN Pharmocological
CONCLUSION NNP None
Dalteparin NNP None
is VBZ None
dalteparin NN None
. . None
-DOCSTART- -X- N

Psychosocial JJ Psychological
nursing NN Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
psychosocial JJ Psychological
therapy NN Psychological
cognitive JJ Psychological
behavioral JJ Psychological
therapy NN Psychological
control NN Control
Psychosocial NNP Psychological
therapy NN Psychological
-DOCSTART- -X- N

Double-pulse JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
dpTMS NN Physical
) ) Physical
was VBD Physical
used VBN Physical
to TO Physical
examine VB Physical
inhibition NN Physical
by IN Physical
means NNS Physical
of IN Physical
short-interval JJ Physical
intracortical JJ Physical
inhibition NN Physical
( ( Physical
SICI NNP Physical
) ) Physical
of IN Physical
the DT Physical
contralateral JJ Physical
primary JJ Physical
motor NN Physical
cortex NN Physical
-DOCSTART- -X- N

Ciprofloxacin NNP Pharmocological
and CC Pharmocological
rifampicin VB Pharmocological
versus NN None
doxycycline NN Pharmocological
and CC Pharmocological
rifampicin NN Pharmocological
rifampicin NN Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
and CC Pharmocological
doxycycline VB Pharmocological
200 CD Pharmocological
mg/day NN Pharmocological
rifampicin VBZ Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
and CC Pharmocological
ciprofloxacin NN Pharmocological
1 CD Pharmocological
g/day NN Pharmocological
for IN Pharmocological
30 CD Pharmocological
days NNS Pharmocological
Ciprofloxacin NNP Pharmocological
and CC Pharmocological
rifampicin VB Pharmocological
doxycycline NN Pharmocological
and CC Pharmocological
rifampicin NN Pharmocological
-DOCSTART- -X- N

parent NN Educational
training NN Educational
intervention NN Educational
parent NN Educational
training NN Educational
intervention NN Educational
CHAT NNP None
screen NN None
and CC None
randomised VBD None
to TO None
the DT None
parent NN Educational
training VBG Educational
group NN None
or CC None
to TO None
local JJ Control
services NNS Control
only RB Control
. . None
home-based JJ Educational
behavioural JJ Educational
intervention NN Educational
-DOCSTART- -X- N

CBT NNP Pharmocological
CBT NNP None
CBT-group NNP Pharmocological
participated VBN Educational
in IN Educational
psychoeducation NN Educational
. . None
Children NNP Control
were VBD Control
randomly RB Control
assigned VBN Control
to TO Control
an DT Control
experimental JJ Control
or CC Control
delayed-treatment JJ Control
control NN Control
group NN Control
. . None
CBT NNP Pharmocological
-DOCSTART- -X- N

random NN Psychological
interval JJ Psychological
repetition NN Psychological
task NN Psychological
. . None
task NN Psychological
task NN Psychological
task NN Educational
task NN Educational
. . None
single-task JJ Psychological
random-interval JJ Psychological
dual-task JJ Psychological
single-task NN Psychological
dual-task JJ Psychological
-DOCSTART- -X- N

Selenium NNP Pharmocological
supplementation NN Pharmocological
prevention NN Educational
selenium NN Pharmocological
as IN Pharmocological
selenized VBN Pharmocological
yeast NN Pharmocological
selenium JJ Pharmocological
supplementation NN Pharmocological
selenium JJ Pharmocological
supplementation NN Pharmocological
selenium NN Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

halothane NN Pharmocological
isoflurane NN Pharmocological
Halothane NNP Pharmocological
or CC None
isoflurane NN Pharmocological
halothane NN Pharmocological
group NN Pharmocological
isoflurane JJ Physical
group NN Physical
anesthesia NN None
midazolam NN Pharmocological
, , None
fentanyl NN Pharmocological
, , None
and CC None
pancuronium NN Pharmocological
. . None
Anesthesia NNP None
fentanyl NN Pharmocological
and CC None
halothane NN Pharmocological
or CC None
isoflurane NN Pharmocological
in IN Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
and CC Pharmocological
oxygen NN Pharmocological
isoflurane NN Pharmocological
isoflurane-anesthetized JJ None
halothane-anesthetized JJ Pharmocological
anesthesia NN Pharmocological
halothane NN Pharmocological
-DOCSTART- -X- N

transcranial JJ Physical
electrostimulation NN Physical
traditional JJ Pharmocological
treatment NN Pharmocological
transcranial JJ Physical
electrotherapy NN Physical
( ( Pharmocological
traditional JJ Pharmocological
therapy NN Pharmocological
plus CC Pharmocological
electrostimulation NN Physical
-DOCSTART- -X- N

CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
, , None
5-fluorouracil JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
topical JJ Pharmocological
application NN Pharmocological
and CC None
Interferon NNP Pharmocological
alpha-2a NN Pharmocological
( ( Pharmocological
IFA NNP Pharmocological
alpha-2a NN Pharmocological
) ) Pharmocological
5-FU JJ Pharmocological
plus JJ Pharmocological
IFN NNP Pharmocological
alpha-2a NN Pharmocological
CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
plus CC Pharmocological
5-FU JJ Pharmocological
plus JJ Pharmocological
IFN NNP Pharmocological
alpha-2a NN Pharmocological
( ( Pharmocological
high JJ Pharmocological
dose NN Pharmocological
) ) Pharmocological
( ( Pharmocological
93.93 CD Pharmocological
% NN Pharmocological
) ) Pharmocological
combination NN Pharmocological
of IN Pharmocological
CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
plus CC Pharmocological
5-FU JJ Pharmocological
IFN NNP Pharmocological
alpha-2a NN Pharmocological
CO2 NNP Pharmocological
laser NN Pharmocological
vaporization NN Pharmocological
or/plus IN Pharmocological
5-FU JJ Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
aripiprazole NN Pharmocological
aripiprazole NN Pharmocological
aripiprazole VB Pharmocological
( ( Pharmocological
5 CD Pharmocological
, , Pharmocological
10 CD Pharmocological
, , Pharmocological
or CC Pharmocological
15 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
aripiprazole JJ Pharmocological
aripiprazole JJ Pharmocological
placebo NN Control
aripiprazole JJ Pharmocological
placebo NN Control
. . None
Aripiprazole NNP Pharmocological
-DOCSTART- -X- N

therapy NN Pharmocological
: : None
frontotemporal JJ Pharmocological
nitroglycerin JJ Pharmocological
test NN Pharmocological
. . None
nitroglycerin JJ Pharmocological
ointment NN Pharmocological
-DOCSTART- -X- N

immunomodulating VBG Pharmocological
treatment NN Pharmocological
immunomodulatory NN Pharmocological
drugs NNS Pharmocological
thymostimulin NN Pharmocological
drug NN Pharmocological
therapy NN Pharmocological
thymostimulin NN Pharmocological
-DOCSTART- -X- N

zoster NN Pharmocological
vaccine NN Pharmocological
zoster NN None
vaccine NN None
( ( None
ZV NNP None
) ) None
ZV NNP None
ZV NNP None
ZV NNP None
placebo NN None
ZV NNP None
ZV NNP None
placebo NN None
ZV NNP None
ZV NNP None
-DOCSTART- -X- N

inhibitor NN Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blocker NN Pharmocological
valsartan NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
and CC Pharmocological
the DT Pharmocological
same JJ Pharmocological
diet NN Pharmocological
supplemented VBN Pharmocological
by IN Pharmocological
100 CD Pharmocological
mEq NNS Pharmocological
Na+ NNP Pharmocological
for IN Pharmocological
4 CD Pharmocological
weeks NNS Pharmocological
. . None
randomized VBN Pharmocological
to TO Pharmocological
valsartan VB Pharmocological
320 CD Pharmocological
mg/day NN Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
28 CD Pharmocological
) ) Pharmocological
, , None
or CC None
the DT None
addition NN Pharmocological
of IN Pharmocological
hydrochlorothiazide NN Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
12.5 CD Pharmocological
mg/day NN Pharmocological
( ( Pharmocological
n JJ Pharmocological
= NNP Pharmocological
30 CD Pharmocological
) ) Pharmocological
, , None
or CC None
benazepril VB Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
to TO Pharmocological
the DT Pharmocological
valsartan NN Pharmocological
160 CD Pharmocological
mg/day NN Pharmocological
for IN Pharmocological
an DT Pharmocological
additional JJ Pharmocological
6 CD Pharmocological
weeks NNS Pharmocological
. . None
-DOCSTART- -X- N

infusion NN Pharmocological
of IN Pharmocological
GHRH NNP Pharmocological
antagonist NN Pharmocological
( ( Pharmocological
( ( Pharmocological
N-Ac-Tyr NNP Pharmocological
( ( Pharmocological
1 CD Pharmocological
) ) Pharmocological
, , Pharmocological
D-Arg NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
GHRH-29 NNP Pharmocological
( ( Pharmocological
NH NNP Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
) ) Pharmocological
) ) Pharmocological
or CC None
saline NN Control
for IN Control
a DT Control
12-h JJ Control
period NN Control
GHRH NNP Pharmocological
-DOCSTART- -X- N

manual JJ Physical
external JJ Physical
defibrillation NN Physical
external JJ Physical
defibrillation NN Physical
. . None
defibrillator NN Physical
paddles NNS Physical
Transverse NNP Physical
paddle JJ Physical
orientation NN Physical
-DOCSTART- -X- N

propranolol NN Pharmocological
with IN Pharmocological
placebo NN Control
propranolol NN Pharmocological
-DOCSTART- -X- N

CNS NNP Physical
irradiation NN Physical
. . None
-DOCSTART- -X- N

prophylactic JJ Pharmocological
chemotherapy NN Pharmocological
prophylactic JJ Pharmocological
chemotherapy NN Pharmocological
post-operative JJ Pharmocological
prophylactic JJ Pharmocological
chemotherapy NN Pharmocological
cyclophosphamide NN Pharmocological
( ( Pharmocological
Endoxan NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
radiotherapy NN Physical
-DOCSTART- -X- N

Salbutamol NNP Pharmocological
mist NN Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
saline NN Control
saline NN Control
mist NN Pharmocological
oxygen NN Pharmocological
Salbutamol NNP Pharmocological
-DOCSTART- -X- N

risperidone VB Pharmocological
risperidone NN Pharmocological
versus NN None
placebo NN Control
risperidone NN Pharmocological
placebo NN Control
Risperidone NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
( ( Pharmocological
20 CD Pharmocological
mg/day NN Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

retention NN Physical
of IN Physical
needles NNS Physical
on IN Physical
head NN Physical
] NN Physical
behavior JJ Educational
training NN Educational
with IN Educational
head NN Educational
needling VBG Educational
retention NN Educational
and CC Educational
behavior NN Educational
training NN Educational
after IN Educational
acupuncture NN Educational
head NN Educational
needling VBG Educational
retention NN Educational
and CC Educational
behavior JJ Educational
training NN Educational
group NN Educational
behavior JJ Educational
training NN Educational
after IN Educational
acupuncture NN Educational
treatment NN Educational
group NN Educational
Retention NNP Physical
needles NNS Physical
behavior JJ Educational
training NN Educational
. . Educational
behavior JJ Educational
training NN Educational
behavior JJ Educational
training NN Educational
behavior JJ None
training NN None
after IN None
acupuncture NN None
-DOCSTART- -X- N

chlorhexidine NN Pharmocological
gluconate NN Pharmocological
chlorhexidine JJ Pharmocological
gluconate NN Pharmocological
( ( Pharmocological
CHG NNP Pharmocological
) ) Pharmocological
chlorhexidine NN Pharmocological
nonmedicated JJ Physical
skin NN Physical
cleanser NN Physical
. . None
-DOCSTART- -X- N

Reichert NNP Pharmocological
AT550 NNP Pharmocological
Reichert NNP Pharmocological
AT550 NNP Pharmocological
Reichert NNP Physical
Xpert NNP Physical
Plus NNP Physical
Goldmann NNP Other
applanation NN Other
tonometer NN Other
Perkins NNP Other
tonometer NN Other
AT550 NNP Physical
NCT NNP Physical
Goldmann NNP Pharmocological
tonometer NN Pharmocological
AT550 NNP Physical
NCT NNP Physical
Goldmann NNP Pharmocological
tonometry NN Pharmocological
-DOCSTART- -X- N

computer-assisted JJ Educational
practice NN Educational
computer-assisted JJ Educational
practice NN Educational
on IN Educational
reading NN Educational
and CC Educational
spelling NN Educational
in IN Educational
reading NN Educational
spelling NN Educational
computer-based JJ Educational
reading NN Educational
and CC Educational
spelling NN Educational
practice NN Educational
1 CD Educational
) ) Educational
Copy NNPS Educational
the DT Educational
target NN Educational
word NN Educational
from IN Educational
the DT Educational
computer NN Educational
screen NN Educational
( ( Educational
n=22 NN Educational
) ) Educational
, , Educational
2 CD Educational
) ) Educational
Memorize VB Educational
the DT Educational
target NN Educational
word NN Educational
and CC Educational
write VB Educational
it PRP Educational
from IN Educational
memory NN Educational
( ( Educational
n=21 JJ Educational
) ) Educational
, , Educational
3 CD Educational
) ) Educational
Word NNP Educational
reading NN Educational
( ( Educational
n=21 JJ Educational
) ) Educational
, , Educational
and CC Educational
4 CD Educational
) ) Educational
the DT Educational
untrained JJ Educational
control NN Educational
group NN Educational
-DOCSTART- -X- N

Primary JJ Physical
stenting NN Physical
Primary NNP Surgical
intracoronary JJ Surgical
stent NN Surgical
placement NN Surgical
conventional JJ Physical
balloon NN Physical
angioplasty NN Physical
. . Physical
stent JJ Surgical
implantation NN Surgical
conventional JJ Physical
stented VBN Surgical
stented VBN Surgical
conventional JJ Pharmocological
stenting VBG Surgical
balloon VB Physical
angioplasty JJ Physical
alone RB Physical
-DOCSTART- -X- N

Periotest NNP Physical
Osstell NNP Physical
( ( None
Osstell NNP Physical
) ) None
( ( None
Periotest NNP Physical
) ) None
; : None
-DOCSTART- -X- N

Pazopanib NNP Pharmocological
Pazopanib NNP Pharmocological
oral JJ Pharmocological
angiogenesis NN Pharmocological
inhibitor NN Pharmocological
placebo-controlled JJ Control
pazopanib JJ Pharmocological
monotherapy NN Pharmocological
receive VB None
oral JJ Pharmocological
pazopanib NN Pharmocological
or CC None
placebo NN Control
. . None
pazopanib NNS Pharmocological
placebo NN Control
treatment-naive JJ None
pazopanib NN Pharmocological
placebo NN Control
pazopanib JJ Pharmocological
versus NN None
placebo NN Control
. . None
Pazopanib NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

therapeutic JJ Physical
targets NNS Physical
-DOCSTART- -X- N

protein NN Pharmocological
ingestion NN Pharmocological
50 CD Pharmocological
g NN Pharmocological
protein NN Pharmocological
in IN Pharmocological
the DT Pharmocological
form NN Pharmocological
of IN Pharmocological
very RB Pharmocological
lean JJ Pharmocological
beef NN Pharmocological
or CC None
only RB Control
water NN Control
at IN None
0800 CD None
h NN None
and CC None
studied VBN None
over IN None
the DT None
subsequent JJ None
8 CD None
h. NN None
Protein NNP Pharmocological
-DOCSTART- -X- N

radiation NN Physical
therapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
with IN None
or CC None
without IN None
short-term JJ Pharmocological
androgen NN Pharmocological
deprivation NN Pharmocological
( ( Pharmocological
STAD NNP Pharmocological
) ) Pharmocological
. . None
-DOCSTART- -X- N

second-line JJ Physical
chemotherapy NN Physical
platinum-based JJ Pharmocological
regimen NN Pharmocological
mono NN Pharmocological
chemotherapy NN Pharmocological
docetaxel NN Pharmocological
docetaxel NN Pharmocological
cisplatin NN Pharmocological
doublet NN Pharmocological
. . Pharmocological
docetaxel NN Pharmocological
cisplatin NN Pharmocological
docetaxel NN Pharmocological
alone RB Pharmocological
-DOCSTART- -X- N

selamectin NN Pharmocological
, , Pharmocological
imidacloprid JJ Pharmocological
, , Pharmocological
and CC Pharmocological
fipronil- NN Pharmocological
( ( Pharmocological
S NNP Pharmocological
) ) Pharmocological
-methoprene VBD Pharmocological
selamectin NN Pharmocological
, , Pharmocological
imidacloprid JJ Pharmocological
, , Pharmocological
and CC Pharmocological
fipronil- NN Pharmocological
( ( Pharmocological
S NNP Pharmocological
) ) Pharmocological
-methoprene NN Pharmocological
imidacloprid JJ Pharmocological
selamectin NN Pharmocological
, , Pharmocological
fipronil- JJ Pharmocological
( ( Pharmocological
S NNP Pharmocological
) ) Pharmocological
-methoprene NN Pharmocological
, , Pharmocological
and CC Pharmocological
imidacloprid VB Pharmocological
-DOCSTART- -X- N

cuff NN Other
pressure NN Other
release NN Other
valve NN Other
. . None
release NN Other
valve NN Other
( ( None
with IN Other
and CC None
without IN Physical
CPRV NNP Other
) ) None
-DOCSTART- -X- N

B-type JJ Other
natriuretic JJ Other
peptide NN Other
diagnostic JJ Other
strategy NN Other
including VBG Other
point-of-care JJ Other
measurement NN Other
of IN Other
BNP NNP Other
standard JJ Control
assessment NN Control
without IN Control
BNP NNP Control
BNP NNP Other
levels NNS Other
-DOCSTART- -X- N

Albumin-glutaraldehyde JJ Pharmocological
bioadhesive NN Pharmocological
( ( Pharmocological
Bioglue NNP Pharmocological
) ) Pharmocological
biological JJ Pharmocological
albumin-glutaraldehyde JJ Pharmocological
glue NN Pharmocological
Bioglue NNP Pharmocological
Bioglue NNP Pharmocological
in IN Pharmocological
the DT Pharmocological
mucosa NN Pharmocological
anastomosis NN Pharmocological
area NN Pharmocological
. . None
standardized JJ Pharmocological
postoperative JJ Pharmocological
analgesic NN Pharmocological
, , Pharmocological
laxative JJ Pharmocological
and CC Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
. . None
-DOCSTART- -X- N

treatment NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
a DT Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitor NN Pharmocological
azithromycin JJ Pharmocological
500 CD Pharmocological
mg JJ Pharmocological
daily JJ Pharmocological
and CC Pharmocological
tinidazole JJ Pharmocological
500 CD Pharmocological
mg NN Pharmocological
two CD Pharmocological
tablets NNS Pharmocological
daily RB Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
lansoprasole JJ Pharmocological
30 CD Pharmocological
mg JJ Pharmocological
daily RB Pharmocological
for IN Pharmocological
6 CD Pharmocological
days NNS Pharmocological
( ( Pharmocological
ATL-group NNP Pharmocological
) ) Pharmocological
or CC None
with IN None
placebo NN Pharmocological
( ( Pharmocological
ATP-group NNP Pharmocological
) ) Pharmocological
. . None
was VBD None
performed VBN None
at IN None
inclusion NN None
and CC None
after IN None
a DT None
minimum NN None
of IN None
6 CD None
weeks NNS None
after IN None
end NN None
of IN None
therapy NN None
. . None
-DOCSTART- -X- N

active-learning JJ Psychological
strategies NNS Psychological
motivational JJ Educational
interviewing NN Educational
lecture NN Educational
practice NN Psychological
activities NNS Psychological
( ( Psychological
written VBN Psychological
dialogue NN Psychological
, , Psychological
peer VB Psychological
role-play NN Psychological
, , Psychological
or CC Psychological
mock-patient JJ Psychological
counseling NN Psychological
activities NNS Psychological
) ) Psychological
mock-patient JJ Educational
counseling NN Educational
-DOCSTART- -X- N

Supplemental JJ Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
Supplemental NNP Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
supplemental JJ Pharmocological
oxygen NN Pharmocological
30 CD Pharmocological
% NN Pharmocological
or CC Pharmocological
80 CD Pharmocological
% NN Pharmocological
fraction NN Pharmocological
of IN Pharmocological
inspired JJ Pharmocological
oxygen NN Pharmocological
30 CD Pharmocological
% NN Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
80 CD Pharmocological
% NN Pharmocological
perioperative JJ Pharmocological
oxygen NN Pharmocological
. . None
80 CD Pharmocological
% NN Pharmocological
FIO2 NNP Pharmocological
30 CD Pharmocological
% NN Pharmocological
FIO2 NNP Pharmocological
supplemental JJ Pharmocological
inspired JJ Pharmocological
oxygen NN Pharmocological
Supplemental JJ Pharmocological
oxygen NN Pharmocological
-DOCSTART- -X- N

Anastrozole NNP Pharmocological
anastrozole NN Pharmocological
clomiphene NN Pharmocological
citrate NN Pharmocological
( ( Pharmocological
CC NNP Pharmocological
) ) Pharmocological
Single-dose JJ Pharmocological
anastrozole NN Pharmocological
5-day JJ Pharmocological
course NN Pharmocological
of IN Pharmocological
CC NNP Pharmocological
anastrozole NN None
at IN None
the DT None
anastrozole JJ None
5 CD None
single-dose JJ None
anastrozole NN None
at IN None
-DOCSTART- -X- N

N NNP Pharmocological
, , Pharmocological
N-dimethylglycine NNP Pharmocological
receive VB None
either DT None
placebo NN Control
or CC None
dimethylglycine NN Pharmocological
for IN None
4 CD None
weeks NNS None
. . None
two CD Educational
behavioral JJ Educational
measures NNS Educational
, , Educational
the DT Educational
-DOCSTART- -X- N

shengxuening VBG Pharmocological
] NNP None
shengxuening VBG Pharmocological
( ( Pharmocological
SXN NNP Pharmocological
) ) Pharmocological
SXN NNP Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
g NN Pharmocological
, , Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
) ) Pharmocological
and CC None
ferrous JJ Pharmocological
gluconate NN Pharmocological
( ( Pharmocological
0.1 CD Pharmocological
g NN Pharmocological
, , Pharmocological
three CD Pharmocological
times NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
) ) Pharmocological
respectively RB None
, , None
for IN None
30 CD None
days NNS None
. . None
SXN NNP Pharmocological
-DOCSTART- -X- N

atorvastatin JJ Pharmocological
simvastatin NN Pharmocological
, , None
pravastatin NN Pharmocological
, , None
lovastatin NN Pharmocological
, , None
and CC None
fluvastatin NN Pharmocological
3-hydroxy-3-methylglutaryl JJ Pharmocological
coenzyme NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
HMG-CoA NNP Pharmocological
) ) Pharmocological
reductase NN Pharmocological
inhibitor NN Pharmocological
atorvastatin VBD Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
, , Pharmocological
40 CD Pharmocological
, , Pharmocological
and CC Pharmocological
80 CD Pharmocological
mg NNS Pharmocological
compared VBN None
with IN None
simvastatin NN Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
, , Pharmocological
and CC Pharmocological
40 CD Pharmocological
mg NN Pharmocological
, , None
pravastatin NN Pharmocological
10 CD Pharmocological
, , Pharmocological
20 CD Pharmocological
, , Pharmocological
and CC Pharmocological
40 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
lovastatin VBZ Pharmocological
20 CD Pharmocological
, , Pharmocological
40 CD Pharmocological
, , Pharmocological
and CC Pharmocological
80 CD Pharmocological
mg NN Pharmocological
, , None
and CC None
fluvastatin $ Pharmocological
20 CD Pharmocological
and CC Pharmocological
40 CD Pharmocological
mg. NN Pharmocological
Atorvastatin $ Pharmocological
simvastatin NN Pharmocological
, , None
pravastatin NN Pharmocological
, , None
lovastatin NN Pharmocological
fluvastatin NN Pharmocological
. . None
Atorvastatin $ Pharmocological
simvastatin NN Pharmocological
pravastatin NN Pharmocological
lovastatin CC Pharmocological
fluvastatin $ Pharmocological
Atorvastatin NNP Pharmocological
simvastatin NN Pharmocological
, , None
pravastatin NN Pharmocological
, , None
lovastatin NN Pharmocological
fluvastatin NN Pharmocological
. . None
-DOCSTART- -X- N

randomly RB None
assigned VBN None
to TO None
ASC NNP Pharmocological
alone RB None
( ( None
treatment NN None
could MD None
include VB None
steroids NNS Pharmocological
, , Pharmocological
analgesic JJ Pharmocological
drugs NNS Pharmocological
, , Pharmocological
bronchodilators NNS Pharmocological
, , Pharmocological
palliative JJ Pharmocological
radiotherapy NN Pharmocological
[ NNP None
n=136 RB None
] NNP None
) ) None
; : None
to TO None
ASC NNP Pharmocological
plus CC Pharmocological
MVP NNP Pharmocological
( ( None
four CD Pharmocological
cycles NNS Pharmocological
of IN Pharmocological
mitomycin NN Pharmocological
6 CD Pharmocological
mg/m2 NN Pharmocological
, , Pharmocological
vinblastine VBP Pharmocological
6 CD Pharmocological
mg/m2 NN Pharmocological
, , Pharmocological
and CC Pharmocological
cisplatin VBZ Pharmocological
50 CD None
mg/m2 NN None
every DT None
3 CD None
weeks NNS None
[ JJ None
n=137 RB None
] NNP None
) ) None
; : None
or CC None
to TO None
ASC NNP Pharmocological
plus CC Pharmocological
vinorelbine NN Pharmocological
( ( Pharmocological
one CD Pharmocological
injection NN Pharmocological
of IN Pharmocological
vinorelbine NN Pharmocological
30 CD Pharmocological
mg/m2 NN Pharmocological
every DT Pharmocological
week NN Pharmocological
for IN Pharmocological
12 CD Pharmocological
weeks NNS Pharmocological
[ JJ None
n=136 RB None
] NN None
) ) None
Follow-up NN None
was VBD None
every DT None
3 CD None
weeks NNS None
to TO None
21 CD None
weeks NNS None
after IN None
randomisation NN None
, , None
and CC None
every DT None
8 CD None
weeks NNS None
thereafter RB None
. . None
-DOCSTART- -X- N

progesterone NN Pharmocological
progesterone NN Pharmocological
were VBD None
assigned VBN None
to TO None
be VB None
untreated JJ None
, , None
control NN None
animals NNS None
( ( None
C NNP None
) ) None
, , None
or CC None
to TO None
receive VB None
PGF NNP None
( ( None
2? CD None
) ) None
on IN None
d0 NN None
( ( None
PG NNP None
) ) None
, , None
or CC None
receive VB None
two CD None
injections NNS None
of IN None
progesterone NN None
( ( None
200mg CD None
, , None
i.m NN None
. . None
each DT None
) ) None
on IN None
D NNP None
-5 NNP None
and CC None
on IN None
D NNP None
-2.5 NNP None
, , None
prior RB None
to TO None
PGF NNP None
( ( None
2? CD None
) ) None
, , None
on IN None
D NNP None
0 CD None
( ( None
2PPG CD None
) ) None
. . None
Treatment NN None
-DOCSTART- -X- N

A-V NNP Physical
Impulse NNP Physical
System NNP Physical
A-V NNP Physical
Impulse NNP Physical
System NNP Physical
Doppler NNP Physical
ultrasonography NN Physical
-DOCSTART- -X- N

arzoxifene NN Pharmocological
( ( Pharmocological
LY353381 NNP Pharmocological
) ) Pharmocological
selective JJ Pharmocological
estrogen NN Pharmocological
receptor NN Pharmocological
modulator NN Pharmocological
arzoxifene NN Pharmocological
arzoxifene NN Pharmocological
was VBD None
assessed VBN None
using VBG None
World NNP Physical
Health NNP Physical
Organization NNP Physical
criteria NNS Physical
. . None
were VBD None
graded VBN None
according VBG None
to TO None
the DT None
National NNP Physical
Cancer NNP Physical
Institute NNP Physical
Common NNP Physical
Toxicity NNP Physical
Criteria NNP Physical
( ( Physical
NCI-CTC NNP Physical
) ) Physical
system NN Physical
. . None
Arzoxifene NNP Pharmocological
arzoxifene NN Pharmocological
arzoxifene NN Pharmocological
. . None
arzoxifene VBZ Pharmocological
-DOCSTART- -X- N

transperitoneal JJ Surgical
versus NN None
retroperitoneal NN Surgical
laparoscopic JJ Surgical
adrenalectomy NN Surgical
. . None
transperitoneal JJ Surgical
laparoscopic JJ Surgical
adrenalectomy NN Surgical
( ( Surgical
TLA NNP Surgical
) ) Surgical
vs FW None
retroperitoneal JJ Surgical
laparoscopic NN Surgical
adrenalectomy NN Surgical
( ( Surgical
RLA NNP Surgical
) ) Surgical
prospectively RB None
randomized VBN None
to TO None
undergo VB None
TLA NNP Surgical
( ( None
25 CD None
) ) None
or CC None
RLA NNP Surgical
( ( None
32 CD None
) ) None
. . None
laparoscopic NN Surgical
adrenalectomy NN Surgical
-DOCSTART- -X- N

hybrid NN Physical
technique NN Physical
using VBG None
bipolar JJ Surgical
energy NN Surgical
in IN Surgical
transurethral JJ Surgical
resection NN Surgical
and CC None
vaporization NN Surgical
with IN Surgical
bipolar JJ Surgical
PlasmaKinetic NNP Surgical
energy NN Surgical
. . None
PlasmaKinetic NNP Surgical
surgery NN Surgical
or CC None
standard JJ Surgical
transurethral JJ Surgical
prostate NN Surgical
resection NN Surgical
( ( Surgical
TURP NNP Surgical
) ) Surgical
. . None
-DOCSTART- -X- N

meropenem NN Pharmocological
imipenem NN Pharmocological
. . None
meropenem NN Pharmocological
new JJ Pharmocological
carbapenem NN Pharmocological
antibiotic JJ Pharmocological
imipenem NN Pharmocological
prophylactic JJ Control
treatment NN Control
prophylactic JJ Control
treatment NN Control
0.5 CD Pharmocological
g NNS Pharmocological
meropenem JJ Pharmocological
t.i.d NN Pharmocological
. . None
intravenously RB None
or CC None
0.5 CD None
g NNS None
imipenem JJ Pharmocological
q.i.d NN None
. . None
intravenously RB None
. . None
Meropenem NNP Pharmocological
imipenem NN Pharmocological
-DOCSTART- -X- N

pre- NN Surgical
and CC Surgical
intraoperative JJ Surgical
positioning NN Surgical
of IN Surgical
the DT Surgical
condyle NN Surgical
positioning NN Surgical
of IN Surgical
the DT Surgical
condylar JJ Surgical
process NN Surgical
condyles NNS Surgical
were VBD Surgical
placed VBN Surgical
in IN Surgical
the DT Surgical
centre NN Surgical
of IN Surgical
the DT Surgical
articular JJ Surgical
fossa NN Surgical
before IN Surgical
and CC Surgical
during IN Surgical
the DT Surgical
operation NN Surgical
, , Surgical
and CC Surgical
in IN Surgical
the DT Surgical
other JJ Surgical
group NN Surgical
they PRP Surgical
were VBD Surgical
not RB Surgical
. . None
Fixing VBG Physical
the DT Physical
condylar JJ Physical
process NN Physical
in IN Physical
the DT Physical
centre NN Physical
of IN Physical
the DT Physical
articular JJ Physical
fossa NN Physical
intraoperatively RB Physical
-DOCSTART- -X- N

personalized JJ Educational
EHR-generated JJ Educational
informed JJ Educational
consent NN Educational
SmartConsents NNS Educational
standard JJ Educational
consent NN Educational
SmartConsent NNP Educational
. . None
-DOCSTART- -X- N

weighted JJ Physical
vests NNS Physical
. . None
weighted JJ Physical
vest NN Physical
intervention NN Physical
control NN Control
with IN Other
and CC Other
without IN Other
a DT Other
vest NN Other
. . None
intervention NN Physical
control NN None
nonweighted JJ Other
vest NN Other
. . None
weighted JJ Physical
vests NNS Physical
-DOCSTART- -X- N

trans NNS Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
Consumption NN None
of IN None
industrial JJ Pharmocological
trans NNS Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
iTFA NN Pharmocological
) ) Pharmocological
iTFA NN Pharmocological
conjugated VBD Pharmocological
linoleic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
CLA NNP Pharmocological
) ) Pharmocological
oleic JJ Control
acid NN Control
( ( Control
control VB Control
diet NN Control
) ) Control
, , None
iTFA JJ Pharmocological
, , None
or CC None
CLA NNP Pharmocological
. . None
of IN None
iTFA NN None
iTFA NN None
and CC None
CLA NNP None
did VBD None
which WDT None
iTFA JJ None
increase NN None
-DOCSTART- -X- N

intensive JJ Physical
diabetes NNS Physical
management NN Physical
with IN Physical
implantable JJ Physical
pumps NNS Physical
multiple JJ Pharmocological
subcutaneous JJ Pharmocological
injections NNS Pharmocological
intraperitoneal JJ Physical
( ( Physical
IP NNP Physical
) ) Physical
insulin NN Physical
infusion NN Physical
via IN Physical
programmable JJ Physical
implantable JJ Physical
pumps NNS Physical
subcutaneous JJ Pharmocological
( ( Pharmocological
SC NNP Pharmocological
) ) Pharmocological
insulin NN Pharmocological
via IN Pharmocological
multiple JJ Pharmocological
injections NNS Pharmocological
. . None
pump NN Physical
implantable JJ Physical
pump NN Physical
multiple JJ Pharmocological
injections NNS Pharmocological
-DOCSTART- -X- N

azithromycin NN Pharmocological
, , None
doxycycline NN Pharmocological
and CC None
phenoxymethylpenicillin NN Pharmocological
. . None
Azithromycin NNP Pharmocological
, , None
doxycycline NN Pharmocological
and CC None
phenoxymethylpenicillin NN Pharmocological
oral JJ Pharmocological
azithromycin NN Pharmocological
phenoxymethylpenicillin $ Pharmocological
doxycycline NN Pharmocological
penicillin NN Pharmocological
doxycycline NN Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
. . None
phenoxymethylpenicillin NN Pharmocological
doxycycline VBP Pharmocological
azithromycin RB Pharmocological
. . None
azithromycin NN Pharmocological
-DOCSTART- -X- N

imatinib NN Pharmocological
mesylate NN Pharmocological
imatinib JJ Pharmocological
mesylate NN Pharmocological
imatinib VB Pharmocological
800 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
400 CD Pharmocological
mg NN Pharmocological
imatinib VB Pharmocological
imatinib NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
placebo-controlled JJ Control
MEDI-545 NNP Pharmocological
( ( None
0.3-30.0 JJ None
mg/kg NN None
) ) None
or CC None
placebo NN Control
. . None
MEDI-545 NNP Pharmocological
and CC None
placebo NN Control
. . None
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
MEDI-545 NNP Pharmocological
-DOCSTART- -X- N

preoperative JJ Pharmocological
xeloda NN Pharmocological
and CC None
radiotherapy NN Pharmocological
combined JJ Pharmocological
preoperative JJ Pharmocological
xeloda NN Pharmocological
and CC Pharmocological
pelvic JJ Pharmocological
radiotherapy NN Pharmocological
operation NN Surgical
alone RB Surgical
xeloda NNP Pharmocological
and CC Pharmocological
radiotherapy NN Pharmocological
before IN Pharmocological
operation NN Pharmocological
. . None
Combined VBD Pharmocological
preoperative JJ Pharmocological
xeloda NN Pharmocological
and CC Pharmocological
radiotherapy NN Pharmocological
-DOCSTART- -X- N

afferent JJ Physical
stimulation NN Physical
and CC None
mirror NN Physical
therapy NN Physical
Mirror NNP Physical
therapy NN Physical
( ( Physical
MT NNP Physical
) ) Physical
and CC None
mesh JJ Physical
glove NN Physical
( ( Physical
MG NNP Physical
) ) Physical
afferent NN Physical
stimulation NN Physical
MT NNP Physical
combined VBD Physical
with IN Physical
MG NNP Physical
( ( Physical
MT NNP Physical
+ NNP Physical
MG NNP Physical
) ) Physical
MG NNP Physical
+ NNP Physical
MT NNP Physical
, , Physical
MT NNP Physical
control NN Control
treatment NN Control
( ( Control
CT NNP Control
) ) Control
MT NNP Physical
+ NNP Physical
MG NNP Physical
, , None
MT NNP Physical
CT NNP Control
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
CT NNP Control
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
. . None
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
+ NNP Physical
MG NNP Physical
MT NNP Physical
CT. NNP Control
MG NNP Physical
+ NNP Physical
MT NNP Physical
-DOCSTART- -X- N

Hypericum NNP Pharmocological
treatment NN Pharmocological
placebo-controlled JJ Control
hypericum JJ Pharmocological
extract JJ Pharmocological
LI NNP Pharmocological
160 CD Pharmocological
. . Pharmocological
-DOCSTART- -X- N

ethanol NN Pharmocological
diazepam NN Pharmocological
. . None
ethanol NN Pharmocological
and CC None
diazepam NN Pharmocological
vs. FW None
placebo NN Control
Ethanol NNP Pharmocological
Ethanol JJ Pharmocological
Diazepam NNP Pharmocological
Diazepam NNP Pharmocological
-DOCSTART- -X- N

ibuprofen NN Pharmocological
acetaminophen NN Pharmocological
analgesics NNS Pharmocological
acetaminophen NN Pharmocological
or CC None
ibuprofen NN Pharmocological
. . None
acetaminophen NN Pharmocological
( ( Pharmocological
paracetamol NN Pharmocological
) ) None
15 CD None
mg.kg-1 JJ None
, , None
ibuprofen JJ Pharmocological
10 CD None
mg.kg-1 NN None
, , None
or CC None
placebo NN Control
. . None
ibuprofen NN Pharmocological
acetaminophen VB Pharmocological
-DOCSTART- -X- N

sizofiran NN Pharmocological
Adjuvant NNP Pharmocological
immunochemotherapy NN Pharmocological
using VBG Pharmocological
the DT Pharmocological
antitumour JJ Pharmocological
polysaccharide NN Pharmocological
sizofiran NN Pharmocological
( ( Pharmocological
SPG NNP Pharmocological
) ) Pharmocological
sizofiran NN Pharmocological
-DOCSTART- -X- N

Rye NNP Pharmocological
bran NN Pharmocological
bread NN Pharmocological
intake VB Pharmocological
Rye NNP Pharmocological
bread NN Pharmocological
rye NN Pharmocological
bran NN Pharmocological
breads NNS Pharmocological
control NN Control
breads VBZ Control
Rye NNP Educational
bran NN Educational
intervention NN Educational
-DOCSTART- -X- N

antiretroviral JJ Physical
therapy NN Physical
( ( Physical
ART NNP Physical
) ) Physical
dual-energy JJ Physical
absorptiometry NN Physical
( ( Physical
DXA NNP Physical
) ) Physical
and CC None
abdominal JJ Physical
computed VBN Physical
tomography NN Physical
for IN Physical
body NN Physical
composition NN Physical
. . None
to TO None
ATV/r NNP Pharmocological
( ( None
vs. FW None
EFV NNP None
) ) None
TDF/FTC NNP None
did VBD None
-DOCSTART- -X- N

propranolol NN Pharmocological
( ( Pharmocological
a DT Pharmocological
beta NN Pharmocological
adrenergic JJ Pharmocological
antagonist NN Pharmocological
) ) Pharmocological
and CC None
following VBG None
placebo NN Control
propranolol NN Pharmocological
-DOCSTART- -X- N

traditional JJ Physical
implant NN Physical
or CC Physical
one CD Physical
which WDT Physical
incorporated VBD Physical
new JJ Physical
design NN Physical
features NNS Physical
. . None
new JJ Physical
design NN Physical
implant JJ Physical
traditional JJ Physical
implant NN Physical
knee NN Physical
implant NN Physical
of IN Physical
a DT Physical
modern JJ Physical
design NN Physical
traditional JJ Physical
implant NN Physical
-DOCSTART- -X- N

non-depolarizing JJ Pharmocological
neuromuscular JJ Pharmocological
blockers NNS Pharmocological
neuromuscular JJ Pharmocological
blockers NNS Pharmocological
fentanyl NN Pharmocological
pancuronium NN Pharmocological
0.12 CD Pharmocological
mg.kg-1 NN Pharmocological
, , Pharmocological
( ( Pharmocological
2 CD Pharmocological
) ) Pharmocological
vecuronium NN Pharmocological
0.12 CD Pharmocological
mg.kg-1 NN Pharmocological
, , None
( ( Pharmocological
3 CD Pharmocological
) ) Pharmocological
atracurium NN Pharmocological
0.4 CD Pharmocological
mg.kg-1 NN Pharmocological
, , None
or CC None
( ( Pharmocological
4 CD Pharmocological
) ) Pharmocological
pancuronium-metocurine NN Pharmocological
mixture NN Pharmocological
Neuromuscular JJ Pharmocological
blockers NNS Pharmocological
fentanyl NN Pharmocological
; : None
pancuronium NN Pharmocological
vecuronium NN Pharmocological
atracurium NN Pharmocological
; : None
pancuronium-metocurine JJ Pharmocological
mixture NN Pharmocological
vecuronium NN Pharmocological
. . None
pancuronium-metocurine JJ Pharmocological
Vecuronium NNP Pharmocological
vecuronium NN Pharmocological
, , None
pancuronium NN Pharmocological
pancuronium-metocurine JJ Pharmocological
mixture NN Pharmocological
; : None
vecuronium NN Pharmocological
. . None
Atracurium NNP Pharmocological
vecuronium VB Pharmocological
atracurium NN Pharmocological
-DOCSTART- -X- N

yoga NNP Physical
versus NN Physical
stretching VBG Physical
complementary JJ Physical
and CC Physical
alternative JJ Physical
medicine NN Physical
( ( Physical
CAM NNP Physical
) ) Physical
therapies NNS Physical
. . None
Yoga NNP Physical
yoga NN Physical
self PRP Educational
care NN Educational
and CC None
exercise NN Physical
12 CD Physical
weekly JJ Physical
yoga NN Physical
classes NNS Physical
, , Physical
12 CD Physical
weekly JJ Physical
conventional JJ Physical
therapeutic JJ Physical
exercise NN Physical
classes NNS Physical
of IN Physical
comparable JJ Physical
physical JJ Physical
exertion NN Physical
, , Physical
or CC Physical
a DT Physical
self-care JJ Other
book NN Other
. . None
yoga NN Physical
yoga NN Physical
yoga NN Physical
yoga NN Physical
-DOCSTART- -X- N

-DOCSTART- -X- N

motor NN Other
imagery NN Other
program NN Other
imagined JJ Physical
movements NNS Physical
mirror NN Physical
movements NNS Physical
hand NN Physical
laterality NN Physical
recognition NN Physical
, , Physical
imagined VBD Physical
movements NNS Physical
, , Physical
mirror NN Physical
movements NNS Physical
( ( Physical
RecImMir NNP Physical
, , Physical
MIP NNP Physical
) ) Physical
; : Physical
imagined VBN Physical
movements NNS Physical
, , Physical
recognition NN Physical
, , Physical
imagined VBD Physical
movements NNS Physical
( ( Physical
ImRecIm NNP Physical
) ) Physical
; : Physical
recognition NN Physical
, , Physical
mirror NN Physical
movements NNS Physical
, , Physical
recognition NN Physical
( ( Physical
RecMirRec NNP Physical
) ) Physical
. . Physical
-DOCSTART- -X- N

diltiazem NNS Pharmocological
Diltiazem NNP Pharmocological
intravenous JJ Pharmocological
diltiazem NNS Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

insufficient JJ Physical
sleep NN Physical
24-h JJ Physical
monitoring NN Physical
sleep JJ Physical
deprivation NN Physical
full JJ Physical
night NN Physical
's POS Physical
sleep NN Physical
sleep-deprivation JJ Physical
sleep JJ Physical
deprivation NN Physical
sleep-insufficient JJ Physical
-DOCSTART- -X- N

alcohol NN Educational
intervention NN Educational
-DOCSTART- -X- N

Intensive JJ Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
intensive JJ Pharmocological
induction NN Pharmocological
chemotherapy NN Pharmocological
high-dose JJ None
or CC None
standard-dose JJ None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
and CC None
semustine NN Pharmocological
-DOCSTART- -X- N

receive VB None
raltegravir NN None
400 CD None
mg NN None
daily RB None
or CC None
placebo VB None
for IN None
CONCLUSIONS NNP None
Raltegravir NNP None
intensification NN None
-DOCSTART- -X- N

continuous JJ Physical
passive JJ Physical
movement NN Physical
continuous JJ Physical
passive JJ Physical
movement NN Physical
at IN Physical
home NN Physical
continuous JJ Physical
passive JJ Physical
movement NN Physical
-DOCSTART- -X- N

filgrastim NN Pharmocological
( ( None
r-metHuG-CSF JJ Pharmocological
) ) None
filgrastim NN Pharmocological
( ( None
recombinant JJ Pharmocological
methionyl NN Pharmocological
human JJ Pharmocological
granulocyte NN Pharmocological
colony-stimulating NN Pharmocological
factor NN Pharmocological
, , None
r-metHuG-CSF NN Pharmocological
) ) None
CAE NNP Pharmocological
chemotherapy NN Pharmocological
( ( None
cyclophosphamide NN Pharmocological
, , None
doxorubicin NN Pharmocological
, , None
and CC None
etoposide RB Pharmocological
) ) None
and CC None
placebo NN Control
or CC None
filgrastim NN None
. . None
-DOCSTART- -X- N

CBT NNP Educational
intervention NN Educational
brief JJ Educational
CBT NNP Educational
intervention NN Educational
for IN Educational
anxiety NN Educational
intervention NN Educational
for IN Educational
child NN Educational
only RB Educational
, , Educational
intervention NN Educational
for IN Educational
child NN Educational
and CC Educational
parent NN Educational
, , Educational
wait-list JJ Educational
control NN Educational
. . Educational
-DOCSTART- -X- N

Epirubicin-based JJ Pharmocological
chemotherapy NN Pharmocological
epirubicin JJ Pharmocological
fluorouracil NN Pharmocological
epirubicin $ Pharmocological
cyclophosphamide RB Pharmocological
( ( None
FEC NNP Pharmocological
FEC NNP Pharmocological
100 CD Pharmocological
epirubicin JJ Pharmocological
FEC NNP Pharmocological
50 CD Pharmocological
( ( Pharmocological
epirubicin JJ Pharmocological
FEC NNP Pharmocological
100 CD Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
FEC NNP Pharmocological
-DOCSTART- -X- N

4'-epi-doxorubicin JJ Pharmocological
cyclophosphamide NN Pharmocological
4'-epi-doxorubicin JJ Pharmocological
+ NN None
cisplatin NN Pharmocological
high-dose JJ Pharmocological
epirubicin NN Pharmocological
cyclophosphamide NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

lag NN Psychological
trials NNS Educational
practice NN Educational
testing VBG Educational
after IN Educational
a DT Educational
delay NN Educational
alphabet JJ Educational
subtraction NN Educational
items NNS Educational
in IN Educational
short JJ Educational
lag NN Educational
and CC Educational
long JJ Educational
lag NN Educational
conditions NNS Educational
. . Educational
immediately RB Educational
tested VBN Educational
tested VBN Educational
after IN Educational
a DT Educational
7-day JJ Educational
delay NN Educational
. . Educational
-DOCSTART- -X- N

Moderate-intensity NNP Physical
exercise NN Physical
training NN Physical
moderate-intensity JJ Physical
step NN Physical
aerobics NNS Physical
training NN Physical
moderate-intensity NN Physical
( ( Physical
50 CD Physical
% NN Physical
of IN Physical
peak NN Physical
oxygen NN Physical
uptake NN Physical
) ) Physical
12-week JJ Physical
training NN Physical
program NN Physical
, , None
progressing VBG Physical
to TO Physical
100 CD Physical
minutes NNS Physical
per IN Physical
week NN Physical
of IN Physical
step NN Physical
aerobics NNS Physical
and CC Physical
50 CD Physical
minutes NNS Physical
per IN Physical
week NN Physical
of IN Physical
cycling NN Physical
. . None
perform VB Physical
a DT Physical
training NN Physical
program NN Physical
. . None
-DOCSTART- -X- N

corticosteroids NNS Pharmocological
Tocolysis NN Pharmocological
, , Pharmocological
prophylactic JJ Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

prophylactic JJ Educational
management NN Educational
and CC Educational
therapeutics NNS Educational
antihypertensive JJ Pharmocological
agents NNS Pharmocological
: : Pharmocological
placebo NN Pharmocological
, , Pharmocological
hydralazine NN Pharmocological
, , Pharmocological
or CC Pharmocological
methyldopa NN Pharmocological
. . None
-DOCSTART- -X- N

desflurane NN Pharmocological
isoflurane NN Pharmocological
desflurane NN Pharmocological
desflurane NN Pharmocological
. . None
desflurane NN Pharmocological
isoflurane NN Pharmocological
propofol NN Pharmocological
. . None
desflurane NN Pharmocological
isoflurane NN Pharmocological
. . None
desflurane NN Pharmocological
isoflurane NN Pharmocological
. . None
-DOCSTART- -X- N

zoledronic JJ Pharmocological
acid NNS Pharmocological
risedronate NN Pharmocological
zoledronic JJ Pharmocological
acid JJ Pharmocological
Zoledronic JJ Pharmocological
acid NN Pharmocological
risedronate NN Pharmocological
zoledronic NN Pharmocological
acid NN Pharmocological
risedronate NN Pharmocological
. . None
zoledronic JJ Pharmocological
acid NN Pharmocological
risedronate NN Pharmocological
glucocorticoids NNS Pharmocological
, , None
zoledronic JJ None
acid NN None
significantly RB None
risedronate NN None
in IN None
zoledronic JJ None
acid NN None
significantly RB None
versus NN None
risedronate NN None
in IN None
subpopulations NNS None
, , None
zoledronic JJ Pharmocological
acid NN Pharmocological
significantly RB None
versus NN None
risedronate NN Pharmocological
at IN None
zoledronic JJ None
acid NNS None
versus NN None
risedronate NN None
at IN None
zoledronic JJ None
acid NN None
is VBZ None
risedronate NN None
in IN None
-DOCSTART- -X- N

tamsulosin NN Pharmocological
placebo-controlled JJ Control
tamsulosin NN Pharmocological
tamsulosin JJ Pharmocological
placebo NN Control
tamsulosin NN Pharmocological
Tamsulosin NNP Pharmocological
-DOCSTART- -X- N

nitric JJ Pharmocological
oxide NN Pharmocological
nitric JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
NO NNP Pharmocological
) ) Pharmocological
NO NNP Pharmocological
. . None
for IN None
conventional JJ Control
therapy NN Control
( ( Control
control NN Control
) ) Control
or CC None
continuous JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
10 CD Pharmocological
parts NNS Pharmocological
per IN Pharmocological
million CD Pharmocological
( ( Pharmocological
ppm NN Pharmocological
) ) Pharmocological
inhaled VBD Pharmocological
NO NNP Pharmocological
until IN None
weaning VBG None
was VBD None
initiated VBN None
. . None
NO-treated JJ Pharmocological
-DOCSTART- -X- N

temporal JJ Physical
repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
rTMS NN Physical
) ) Physical
temporal JJ Physical
low-frequency NN Physical
rTMS NN Physical
rTMS JJ Physical
1 CD None
Hz NNP None
rTMS NN None
over IN None
the DT None
left JJ None
temporal JJ None
cortex NN None
. . None
rTMS JJ Physical
rTMS NN Physical
rTMS VB Physical
-DOCSTART- -X- N

fish JJ Pharmocological
oil NN Pharmocological
supplementation NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
long-chain NN Pharmocological
polyunsaturated VBD Pharmocological
fatty JJ Pharmocological
acid/day NN Pharmocological
) ) Pharmocological
or CC None
vegetable JJ Pharmocological
oil NN Pharmocological
( ( None
control NN None
) ) None
fish JJ Pharmocological
oil NN Pharmocological
( ( Pharmocological
FO NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
control NN Control
FO NNP Pharmocological
control NN Control
group NN None
Fish NNP Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

isotonic JJ Pharmocological
and CC None
hypertonic JJ Pharmocological
saline NN Pharmocological
solutions NNS Pharmocological
isotonic JJ Pharmocological
or CC None
hypertonic JJ Pharmocological
sodium NN Pharmocological
chloride JJ Pharmocological
solution NN Pharmocological
application NN Pharmocological
of IN Pharmocological
intranasal NN Pharmocological
isotonic NN Pharmocological
or CC None
hypertonic JJ Pharmocological
saline NN Pharmocological
. . None
saline JJ Pharmocological
solutions NNS Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
isotonic JJ Pharmocological
saline NN Pharmocological
isotonic JJ Pharmocological
or CC None
hypertonic JJ Pharmocological
saline NN Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
irrigation NN Pharmocological
-DOCSTART- -X- N

Esomeprazole NNP Pharmocological
esomeprazole NN Pharmocological
esomeprazole JJ Pharmocological
esomeprazole JJ Pharmocological
placebo NN None
esomeprazole JJ Pharmocological
placebo NN None
Esomeprazole NNP Pharmocological
placebo NN None
esomeprazole NN Pharmocological
placebo NN None
. . None
Esomeprazole NNP Pharmocological
-DOCSTART- -X- N

anterior JJ Physical
rhinomanometry NN Physical
impulse-oscillometric JJ Physical
rhinometry NN Physical
anterior JJ Physical
rhinomanometry NN Physical
( ( Physical
aR NN Physical
) ) Physical
, , Physical
the DT Physical
impulse-oscillometric JJ Physical
rhinometry NN Physical
( ( Physical
IOS NNP Physical
) ) Physical
aR NN Pharmocological
and CC Pharmocological
IOS NNP Pharmocological
. . Pharmocological
IOS NNP None
-DOCSTART- -X- N

oral JJ Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
Lactobacillus NNP Pharmocological
GG NNP Pharmocological
( ( Pharmocological
LGG NNP Pharmocological
) ) Pharmocological
LGG NNP Pharmocological
antibiotics NNS Pharmocological
-DOCSTART- -X- N

secretin NN Pharmocological
intravenous JJ Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

PEERS NNPS Educational
intervention NN Educational
: : Educational
Program NNP Educational
for IN Educational
the DT Educational
Education NNP Educational
and CC Educational
Enrichment NNP Educational
of IN Educational
Relational NNP Educational
Skills NNP Educational
( ( Educational
PEERS NNS Educational
: : Educational
PEERS CC Educational
immediate JJ Educational
treatment NN Educational
or CC None
waitlist NN Control
comparison NN Control
group NN Control
. . None
waitlist NN Educational
experimental JJ Educational
treatment NN Educational
PEERS NNP Educational
intervention NN Educational
-DOCSTART- -X- N

ischemia NN Physical
postconditioning VBG Physical
ischemia NN Physical
postconditioning VBG Physical
without IN Control
any DT Control
intervention NN Control
after IN Control
PTCA NNP Control
with IN Physical
ischemia NN Physical
postconditioning VBG Physical
angioplasty JJ Surgical
balloon NN Surgical
. . None
CONCLUSIONS NNP None
Ischemia NNP None
postconditioning NN None
can MD None
significantly RB None
-DOCSTART- -X- N

clindamycin JJ Pharmocological
phosphate JJ Pharmocological
1.2 CD Pharmocological
% NN Pharmocological
-benzoyl NNP Pharmocological
peroxide RB Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
aqueous JJ Pharmocological
gel NN Pharmocological
clindamycin NN Pharmocological
phosphate VBP Pharmocological
1.2 CD Pharmocological
% NN Pharmocological
-benzoyl NNP Pharmocological
peroxide RB Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
( ( Pharmocological
clindamycin-BPO JJ Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
) ) Pharmocological
gel NN Pharmocological
clindamycin-BPO JJ Pharmocological
clindamycin-BPO JJ Pharmocological
-DOCSTART- -X- N

[ JJ Pharmocological
Afala NNP Pharmocological
placebo-controlled JJ Control
afala NN Pharmocological
afala NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
2 CD Pharmocological
tablets NNS Pharmocological
4 CD Pharmocological
times NNS Pharmocological
a DT Pharmocological
day NN Pharmocological
placebo VB Control
-DOCSTART- -X- N

Physician-pharmacist JJ Educational
cooperation NN Educational
program NN Educational
cooperation NN Educational
between IN Educational
physician NN Educational
and CC Educational
pharmacist NN Educational
physician-pharmacist JJ Educational
intervention NN Educational
group NN Educational
control NN Control
group NN Control
-DOCSTART- -X- N

vitreous JJ Surgical
needle JJ Surgical
aspiration NN Surgical
mechanized VBN Surgical
vitreous JJ Surgical
biopsy NN Surgical
vitreous JJ Surgical
needle JJ Surgical
tap NN Surgical
vitreous JJ Physical
biopsy NN Physical
20-gauge JJ Physical
vitrectomy NN Physical
-DOCSTART- -X- N

Mode NNP Physical
of IN Physical
ventilation NN Physical
during IN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
modes NNS Physical
of IN Physical
ventilation NN Physical
during IN Physical
cardiopulmonary JJ Surgical
bypass NN Surgical
( ( Surgical
CPB NNP Surgical
) ) Surgical
one CD Physical
of IN Physical
5 CD Physical
modes NNS Physical
of IN Physical
ventilation NN Physical
during IN Physical
bypass NN Surgical
. . None
high-frequency/low-volume JJ Surgical
ventilation NN Surgical
with IN Surgical
100 CD Surgical
% NN Surgical
21 CD Other
% NN Other
oxygen NN Other
continuous JJ Surgical
positive JJ Surgical
airway NN Surgical
pressure NN Surgical
of IN Surgical
5 CD Surgical
cm NN Surgical
H NNP Surgical
( ( Surgical
2 CD Surgical
) ) Surgical
O NN Surgical
with IN Surgical
100 CD Surgical
% NN Surgical
21 CD Other
% NN Other
oxygen NN Other
each DT Surgical
patient NN Surgical
's POS Surgical
airway NN Surgical
was VBD Surgical
disconnected VBN Surgical
from IN Surgical
the DT Surgical
ventilator NN Surgical
( ( Surgical
passive JJ Surgical
deflation NN Surgical
) ) Surgical
Mode NNP Physical
of IN Physical
ventilation NN Surgical
-DOCSTART- -X- N

adaptive JJ None
low-pass NN None
filtered VBD None
speech JJ None
test NN None
low-pass NN Physical
filtered VBD Physical
speech JJ Physical
test NN Physical
LPFST NNP Physical
The DT Educational
University NNP Educational
of IN Educational
Canterbury NNP Educational
Adaptive NNP Educational
Speech NNP Educational
Test NNP Educational
( ( Educational
UCAST NNP Educational
) ) Educational
platform NN Educational
was VBD Educational
used VBN Educational
to TO Educational
administer VB Educational
a DT Educational
four-alternative JJ Educational
forced-choice JJ Educational
adaptive JJ Educational
test NN Educational
that WDT Educational
altered VBD Educational
a DT Educational
low-pass JJ Educational
filter NN Educational
( ( Educational
LPF NNP Educational
) ) Educational
to TO Educational
track VB Educational
the DT Educational
corner NN Educational
frequency NN Educational
at IN Educational
which WDT Educational
participants NNS Educational
correctly RB Educational
identified VBN Educational
a DT Educational
certain JJ Educational
percentage NN Educational
of IN Educational
the DT Educational
word NN Educational
stimuli NN Educational
. . Educational
UCAST-FW JJ None
-DOCSTART- -X- N

droperidol NN Pharmocological
. . Pharmocological
morphine NN Pharmocological
droperidol NN Pharmocological
. . Pharmocological
droperidol NN Pharmocological
or CC None
morphine NN Pharmocological
epidural JJ Pharmocological
anesthesia NN Pharmocological
with IN None
0.5 CD None
% NN None
bupivacaine NN Pharmocological
containing VBG None
1:200,000 CD None
epinephrine NN Pharmocological
, , None
to TO None
which WDT None
2 CD None
mg NN None
morphine NN Pharmocological
sulfate NN Pharmocological
droperidol NN Pharmocological
droperidol NN Pharmocological
) ) Pharmocological
droperidol NN Pharmocological
morphine NN Pharmocological
morphine NN Pharmocological
. . Pharmocological
morphine NN Pharmocological
droperidol NN Pharmocological
. . Pharmocological
morphine NN None
droperidol RB Pharmocological
-DOCSTART- -X- N

acebutolol NN Pharmocological
acebutolol NN Pharmocological
acebutolol NN Pharmocological
placebo-controlled JJ Control
acebutolol NN Pharmocological
Acebutolol NNP Pharmocological
acebutolol NN Pharmocological
acebutolol NN Pharmocological
-DOCSTART- -X- N

nimodipine JJ None
placebo NNS Control
nimodipine JJ Pharmocological
( ( Pharmocological
Nimotop NNP Pharmocological
) ) Pharmocological
10-min JJ Physical
EEG NN Physical
nimodipine VBP None
nimodipine VBP None
nimodipine JJ None
nimodipine VBP Pharmocological
-DOCSTART- -X- N

Social NNP Educational
Communication NNP Educational
Assessment NNP Educational
for IN Educational
Toddlers NNP Educational
with IN Educational
Autism NNP Educational
( ( Educational
SCATA NNP Educational
) ) Educational
: : None
Social NNP Educational
Communication NNP Educational
Assessment NNP Educational
for IN Educational
Toddlers NNP Educational
with IN Educational
Autism NNP Educational
( ( Educational
SCATA NNP Educational
) ) Educational
SCATA NNP Educational
-DOCSTART- -X- N

sodium NN Pharmocological
oxybate NN Pharmocological
placebo-controlled JJ Control
sodium NN Pharmocological
oxybate NN Pharmocological
( ( Pharmocological
SXB NNP Pharmocological
) ) Pharmocological
withdrawn VBN Pharmocological
from IN Pharmocological
antidepressants NNS Pharmocological
and CC Pharmocological
sedative/hypnotics NNS Pharmocological
placebo VB Control
placebo NN Control
-DOCSTART- -X- N

rh-TGF-beta JJ Pharmocological
1 CD Pharmocological
growth NN Pharmocological
factor-beta JJ Pharmocological
1 CD Pharmocological
no DT Control
treatment NN Control
( ( None
control NN None
) ) None
, , None
carrier NN Pharmocological
( ( Pharmocological
Methyl NNP Pharmocological
Cellulose NNP Pharmocological
gel NN Pharmocological
) ) Pharmocological
, , None
50 CD Pharmocological
ng/wound IN Pharmocological
rhTGF-beta JJ Pharmocological
1 CD Pharmocological
in IN Pharmocological
carrier NN Pharmocological
, , Pharmocological
and CC None
500 CD Pharmocological
ng/wound JJ Pharmocological
rhTGF-beta JJ Pharmocological
1 CD Pharmocological
in IN Pharmocological
carrier NN Pharmocological
. . None
TGF-beta NNP Pharmocological
1 CD Pharmocological
-DOCSTART- -X- N

aspirin-treated JJ Pharmocological
aspirin NN Pharmocological
placebo NN Pharmocological
placebo-treated JJ Control
aspirin NN Pharmocological
aspirin-treated JJ Pharmocological
aspirin-treated JJ Pharmocological
-DOCSTART- -X- N

Large JJ Physical
volume NN Physical
, , Physical
low JJ Physical
pressure NN Physical
endotracheal NN Physical
tube NN Physical
cuffs NNS Physical
large JJ Physical
volume NN Physical
cuffed VBD Physical
endotracheal JJ Physical
tubes NNS Physical
Portex NNP Physical
Profile NNP Physical
, , None
Searle NNP Physical
Sensiv NNP Physical
, , None
Mallinkrodt NNP Physical
Hi-Lo NNP Physical
Lanz NNP Physical
. . None
endoscopic JJ None
photographic JJ None
technique NN None
while IN None
varying VBG None
the DT None
cuff NN Physical
inflation NN Physical
pressure NN Physical
. . None
-DOCSTART- -X- N

Physiological JJ Other
pacing VBG Other
physiological JJ Other
pacing NN Other
atrioventricular JJ Physical
synchronous JJ Physical
and CC Physical
ventricular JJ Physical
pacing NN Physical
. . Physical
atrioventricular JJ Physical
synchronous JJ Physical
ventricular JJ Physical
pacing NN Physical
-DOCSTART- -X- N

gluten- JJ Other
and CC Other
casein-free JJ Other
dietary JJ Other
intervention NN Other
gluten- JJ Other
and CC Other
casein-free JJ Other
diets NNS Other
dietary JJ Other
intervention NN Other
placebo NN Control
-DOCSTART- -X- N

Dopamine NNP Pharmocological
transporter NN Pharmocological
gene NN Pharmocological
dopamine NN Pharmocological
transporter NN Pharmocological
gene NN Pharmocological
( ( Pharmocological
SCL6A3/DAT1 NNP Pharmocological
) ) Pharmocological
behavioral JJ Educational
parent NN Educational
training NN Educational
( ( Educational
BPT NNP Educational
) ) Educational
. . Educational
the DT None
dopamine NN None
system NN None
in IN None
BPT NNP None
. . None
-DOCSTART- -X- N

exercise NN Other
training NN Other
and CC Physical
dietary JJ Educational
macronutrient NN Educational
composition NN Educational
exercise NN Other
intervention NN Other
very RB Other
low JJ Other
energy NN Other
diet NN Other
( ( Other
VLED NNP Other
) ) Pharmocological
high-fat NN Other
( ( Other
Hi.F NNP Other
) ) Other
diet NN Other
( ( Pharmocological
60 CD Pharmocological
% NN Pharmocological
of IN Pharmocological
energy NN Pharmocological
( ( Pharmocological
En NNP Pharmocological
% NN Pharmocological
) ) Pharmocological
fat NN Pharmocological
) ) Pharmocological
or CC Pharmocological
a DT Pharmocological
reduced-fat JJ Other
( ( Other
Red.F NNP Other
) ) Other
diet NN Other
( ( Pharmocological
30 CD Pharmocological
En NNP Pharmocological
% NN Pharmocological
fat NN Pharmocological
) ) None
. . None
-DOCSTART- -X- N

capecitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
concurrent NN Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
5-flurouracil JJ Pharmocological
capecitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
concurrent JJ Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
5-flurouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
concurrent NN Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
cisplatin NN Pharmocological
capecitabine NN Pharmocological
capecitabine NN Pharmocological
and CC Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

percutaneous JJ Surgical
laser NN Surgical
radiofrequency NN Surgical
ablation NN Surgical
percutaneous JJ Surgical
laser NN Surgical
ablation NN Surgical
( ( Surgical
PLA NNP Surgical
) ) Surgical
radiofrequency NN Surgical
thermoablation NN Surgical
( ( Surgical
RFA NNP Surgical
) ) Surgical
using VBG None
a DT None
multifibre NN None
system NN None
connected VBN None
to TO None
a DT None
neodymium JJ None
yttrium-aluminium-garnet NN None
laser NN None
, , None
using VBG None
an DT None
expandable JJ None
needle JJ None
compared VBN None
to TO None
PLA NNP None
-DOCSTART- -X- N

Synemol NNP Pharmocological
cream NN Pharmocological
Diprosone NNP Pharmocological
cream NN Pharmocological
Aristocort-A NNP Pharmocological
cream NN Pharmocological
Valisone NNP Pharmocological
cream NN Pharmocological
-DOCSTART- -X- N

arteriovenous JJ Physical
extracorporeal NN Physical
lung NN Physical
assist NN Physical
and CC None
high-frequency NN Physical
oscillatory NN Physical
ventilation NN Physical
arteriovenous JJ Physical
extracorporeal NN Physical
lung NN Physical
assist NN Physical
( ( Physical
AV-ECLA NNP Physical
) ) Physical
and CC None
high-frequency JJ Physical
oscillatory NN Physical
ventilation NN Physical
( ( Physical
HFOV NNP Physical
) ) Physical
Saline NNP Physical
lung NN Physical
lavage NN Physical
pressure-controlled JJ Physical
ventilation NN Physical
( ( Physical
PCV NNP Physical
) ) Physical
PCV NNP Physical
AV-ECLA NNP Physical
; : Surgical
HFOV NNP Physical
; : None
HFOV NNP Physical
and CC Physical
AV-ECLA NNP Physical
. . None
AV-ECLA NNP Physical
AV-ECLA-treated JJ Physical
AV-ECLA NNP Physical
AV-ECLA NNP Physical
and CC None
HFOV NNP Physical
-DOCSTART- -X- N

values-affirmation NN Other
exercise NN Other
or CC None
a DT None
control NN Control
exercise NN Control
values-affirmation NN Other
exercise NN Other
-DOCSTART- -X- N

topotecan JJ Pharmocological
paclitaxel NN Pharmocological
topotecan JJ Pharmocological
paclitaxel NN Pharmocological
topotecan VB Pharmocological
paclitaxel NN Pharmocological
topotecan JJ Pharmocological
paclitaxel NN Pharmocological
topotecan JJ Pharmocological
paclitaxel NN Pharmocological
Topotecan NNP Pharmocological
paclitaxel VB Pharmocological
topotecan JJ Pharmocological
-DOCSTART- -X- N

benzodiazepine NN Pharmocological
( ( Pharmocological
temazepam NN Pharmocological
) ) Pharmocological
a DT Pharmocological
non-benzodiazepine JJ Pharmocological
hypnotic NN Pharmocological
( ( Pharmocological
zolpidem NN Pharmocological
) ) Pharmocological
] NN None
oral JJ Pharmocological
temazepam NN Pharmocological
medium NN Pharmocological
half-life JJ Pharmocological
benzodiazepine NN Pharmocological
vs IN None
oral JJ Pharmocological
zolpidem NN Pharmocological
, , None
a DT Pharmocological
short JJ Pharmocological
half-life JJ Pharmocological
non-benzodiazepine JJ Pharmocological
drug NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

ascorbic JJ Pharmocological
acid NN Pharmocological
placebo-controlled JJ Control
ascorbic JJ Pharmocological
acid NN Pharmocological
ascorbate-ascorbate-placebo JJ Pharmocological
treatment NN Pharmocological
order NN Pharmocological
group NN Pharmocological
or CC None
ascorbate-placebo-ascorbate JJ Pharmocological
treatment NN Pharmocological
order NN None
ascorbic JJ Pharmocological
acid NN Pharmocological
treatment NN Pharmocological
. . None
ascorbic JJ Pharmocological
acid NN Pharmocological
. . None
-DOCSTART- -X- N

lithium JJ Pharmocological
carbonate NN Pharmocological
. . Pharmocological
lithium JJ Pharmocological
carbonate NN Pharmocological
or CC None
placebo NN Control
Lithium NNP Pharmocological
placebo NN Control
. . Control
-DOCSTART- -X- N

sensory JJ Physical
level-high JJ Physical
volt NN Physical
pulsed VBD Physical
electrical JJ Physical
current JJ Physical
( ( Physical
HVPC NNP Physical
) ) Physical
experimental JJ Physical
condition NN Physical
( ( Physical
HVPC NNP Physical
) ) Physical
placebo JJ Control
HVPC NNP Physical
placebo NN Control
( ( None
HVPC NNP Physical
or CC None
placebo NN Control
) ) None
HVPC NNP Physical
placebo NN Control
-DOCSTART- -X- N

ebrotidine NN Pharmocological
placebo NN Control
The DT None
patients NNS None
were VBD None
assigned VBN None
to TO None
5 CD None
groups NNS None
: : None
placebo NN Pharmocological
, , None
200 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
400 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
600 CD Pharmocological
mg NN Pharmocological
and CC Pharmocological
800 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
ebrotidine JJ Pharmocological
once IN None
daily JJ None
. . None
Controls NNS None
were VBD None
performed VBN None
at IN None
baseline NN None
and CC None
every DT None
two CD None
weeks NNS None
at IN None
four CD None
follow-up JJ None
visits NNS None
unless IN None
ulcer NN None
healed VBN None
before RB None
. . None
were VBD None
used VBN None
to TO None
establish VB None
safety NN None
. . None
-DOCSTART- -X- N

allocated VBN None
to TO None
12 CD None
consecutive JJ None
cycles NNS None
of IN None
treatment NN None
with IN None
monophasic JJ Pharmocological
combinations NNS Pharmocological
of IN Pharmocological
: : Pharmocological
20 CD Pharmocological
micrograms NNS Pharmocological
ethinyl VBP Pharmocological
estradiol NN Pharmocological
and CC None
150 CD Pharmocological
micrograms NNS Pharmocological
desogestrel NN Pharmocological
( ( None
n JJ None
= NNP None
15 CD None
) ) None
or CC None
30 CD Pharmocological
micrograms NNS Pharmocological
ethinyl VBP Pharmocological
estradiol NN Pharmocological
and CC None
75 CD Pharmocological
micrograms NNS Pharmocological
gestodene NN Pharmocological
( ( None
n JJ None
= NNP None
19 CD None
) ) None
-DOCSTART- -X- N

novel JJ Pharmocological
antibiotic JJ Pharmocological
regimens NNS Pharmocological
including VBG Educational
concomitant NN Educational
, , Educational
sequential JJ Educational
hybrid JJ Physical
therapies NNS Physical
. . None
concomitant NN Physical
therapy NN Physical
: : Physical
omeprazole JJ Physical
amoxicillin RB Pharmocological
clarithromycin VBD Pharmocological
tinidazole JJ Pharmocological
sequential JJ Physical
therapy NN Physical
: : Physical
omeprazole JJ Physical
amoxicillin $ Pharmocological
omeprazole JJ Pharmocological
clarithromycin VBD Pharmocological
tinidazole JJ Pharmocological
hybrid JJ Physical
therapy NN Physical
: : Physical
omeprazole JJ Physical
amoxicillin VBZ Pharmocological
omeprazole JJ Pharmocological
amoxicillin RB Pharmocological
clarithromycin VBD Pharmocological
tinidazole JJ Pharmocological
( ( Physical
13 CD Physical
) ) Physical
C-urea NNP Physical
breath NN Physical
test NN Physical
. . None
second-line JJ Physical
therapy NN Physical
omeprazole JJ Pharmocological
levofloxacin VBD Pharmocological
amoxicillin RB Pharmocological
concomitant JJ Pharmocological
regimen NNS Pharmocological
sequential JJ Physical
therapy NN Physical
hybrid JJ Pharmocological
regimen NNS Pharmocological
. . None
second-line JJ Pharmocological
regimen NNS Pharmocological
. . None
concomitant NN Pharmocological
sequential JJ None
therapy NN None
hybrid JJ None
therapy NN None
levofloxacin-based JJ None
triple NN None
therapy NN None
-DOCSTART- -X- N

Etanercept NNP Pharmocological
etanercept FW Pharmocological
etanercept NN Pharmocological
etanercept JJ Pharmocological
-DOCSTART- -X- N

Melatonin NNP Pharmocological
versus NN None
placebo NN Control
placebo NN Control
melatonin NN Pharmocological
Melatonin NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

PCI NNP Surgical
. . None
PCI NNP Surgical
. . None
-DOCSTART- -X- N

enrolled VBN Physical
and CC Physical
randomly RB Physical
assigned VBN Physical
to TO Physical
either VB Physical
a DT Physical
postconditioning NN Physical
group NN Physical
( ( None
three CD Surgical
cycles NNS Surgical
of IN Surgical
30 CD Surgical
seconds NNS Surgical
of IN Surgical
ischemia NN Surgical
and CC Surgical
30 CD Surgical
seconds NNS Surgical
of IN Surgical
reperfusion NN Surgical
using VBG Surgical
re-clamping JJ Surgical
and CC None
de-clamping JJ Surgical
starting VBG Surgical
30 CD Surgical
seconds NNS Surgical
after IN Surgical
the DT Surgical
initial JJ Surgical
de-clamping NN Surgical
of IN Surgical
the DT Surgical
aorta NN Surgical
, , Surgical
n JJ Surgical
= NNP Surgical
41 CD Surgical
) ) None
or CC None
a DT None
control NN Control
group NN Control
( ( None
n JJ None
= NNP None
39 CD None
) ) None
. . None
( ( None
cTnI NN None
) ) None
was VBD None
assayed VBN None
preoperatively RB None
, , None
and CC None
then RB None
4 CD None
hours NNS None
, , None
8 CD None
hours NNS None
, , None
12 CD None
hours NNS None
, , None
20 CD None
hours NNS None
, , None
and CC None
48 CD None
hours NNS None
after IN Educational
persistent JJ Educational
reperfusion NN Educational
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
methylphenidate NN Pharmocological
methylphenidate NN Pharmocological
( ( Pharmocological
MPH NNP Pharmocological
) ) Pharmocological
MPH NNP Pharmocological
titration NN Pharmocological
placebo NN Control
optimal JJ Pharmocological
dose NN Pharmocological
MPH NNP Pharmocological
MPH NNP Pharmocological
MPH NNP Pharmocological
-DOCSTART- -X- N

Weighted VBN Other
blankets NNS Other
weighted-blanket JJ Other
intervention NN Other
commercially RB Other
available JJ Other
weighted JJ Other
blanket NN Other
or CC Other
otherwise RB Other
identical JJ Other
usual JJ Other
weight NN Other
blanket NN Other
weighted JJ Other
blanket NN Other
control NN Control
blanket NN Control
weighted JJ Other
blanket NN Other
. . None
weighted JJ Other
blanket NN Other
weighted JJ Other
blanket NN Other
-DOCSTART- -X- N

DRE NNP Physical
PSA NNP Pharmocological
. . None
DRE NNP Physical
PSA NNP Pharmocological
PSA+ NNP Pharmocological
-DOCSTART- -X- N

Insulin NNP Pharmocological
pump NN Pharmocological
insulin JJ None
pump NN None
insulin NN None
MDI NNP None
insulin NN None
therapy NN None
pump JJ None
therapy NN None
pump NN None
therapy NN None
insulin JJ None
insulin NN None
pump NN None
therapy NN None
-DOCSTART- -X- N

Cross-sectional JJ Educational
study NN Educational
1-day JJ None
activity NN None
diary NN None
. . None
questionnaire NN None
. . None
the DT None
Children NNP None
's POS None
Depression NNP None
Inventory NNP None
( ( None
CDI NNP None
) ) None
. . None
the DT None
Childhood NNP None
Health NNP None
Assessment NNP None
Questionnaire NNP None
-DOCSTART- -X- N

dose-escalated JJ Pharmocological
and CC Pharmocological
accelerated JJ Pharmocological
regimen NNS Pharmocological
COPP/ABVD NNP Pharmocological
standard JJ Pharmocological
polychemotherapy NN Pharmocological
novel JJ Pharmocological
bleomycin NN Pharmocological
, , None
etoposide RB Pharmocological
, , Pharmocological
doxorubicin NN Pharmocological
, , None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
procarbazine NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( None
BEACOPP NNP None
) ) None
scheme NN None
( ( None
standard JJ None
and CC None
escalated VBD None
dose NN None
) ) None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
procarbazine NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( Pharmocological
COPP NNP Pharmocological
) ) Pharmocological
/doxorubicin NN Pharmocological
, , None
bleomycin NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
and CC None
dacarbazine NN Pharmocological
( ( Pharmocological
ABVD NNP Pharmocological
) ) Pharmocological
. . None
COPP/ABVD NNP Pharmocological
cyclophosphamide NN Pharmocological
, , None
doxorubicin NN Pharmocological
, , None
and CC None
etoposide RB Pharmocological
with IN Pharmocological
granulocyte JJ Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
G-CSF NNP Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
COPP/ABVD NNP Pharmocological
BEACOPP NNP Pharmocological
BEACOPP NNP Pharmocological
BEACOPP NNP Pharmocological
COPP/ABVD NNP Pharmocological
; : None
BEACOPP NNP Pharmocological
BEACOPP NNP Pharmocological
COPP/ABVD NNP Pharmocological
-DOCSTART- -X- N

Heparin NNP Pharmocological
therapy NN Pharmocological
intermittent NN Pharmocological
or CC Pharmocological
continuous JJ Pharmocological
intravenous JJ Pharmocological
heparin NN Pharmocological
therapy NN Pharmocological
. . None
continuous JJ Pharmocological
heparin NN Pharmocological
therapy NN Pharmocological
. . None
administration NN Pharmocological
of IN Pharmocological
heparin NN Pharmocological
conventional JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ None
conducted VBN None
in IN None
a DT None
normobaric JJ None
hypoxic NN None
chamber NN None
, , None
chronic JJ None
high-altitude NN None
exposure NN None
-DOCSTART- -X- N

ranolazine NN Pharmocological
concurrent JJ Pharmocological
antidiabetic JJ Pharmocological
therapy NN Pharmocological
Ranolazine NNP Pharmocological
glycemic NN None
and CC None
antidiabetes VBZ Pharmocological
drug NN Pharmocological
usage NN None
data NNS None
ranolazine NN Pharmocological
ranolazine NN Pharmocological
placebo NN Control
ranolazine NN Pharmocological
Ranolazine NNP Pharmocological
-DOCSTART- -X- N

board NN Educational
game NN Educational
. . None
effectiveness NN Educational
of IN Educational
a DT Educational
board NN Educational
game NN Educational
as IN Educational
a DT Educational
primary JJ Educational
prevention NN Educational
teaching VBG Educational
strategy NN Educational
-DOCSTART- -X- N

placebo-controlled JJ Control
tetrahydrobiopterin NN Pharmocological
( ( Pharmocological
BH4 NNP Pharmocological
) ) Pharmocological
20 CD None
mg/kg/day JJ None
BH4 NNP None
or CC None
placebo NN None
for IN None
placebo VB None
with IN None
and CC None
placebo NN None
. . None
-DOCSTART- -X- N

tirasemtiv NN Pharmocological
Abstract NNP Pharmocological
Tirasemtiv NNP Pharmocological
tirasemtiv NN Pharmocological
Tirasemtiv NNP Pharmocological
-DOCSTART- -X- N

spiritually RB Educational
based VBN Educational
and CC Educational
non-spiritually RB Educational
based VBN Educational
educational JJ Educational
intervention NN Educational
Health NNP Educational
communication NN Educational
interventions NNS Educational
spiritually RB Educational
based VBN Educational
or CC Educational
the DT Educational
non-spiritual JJ Educational
intervention NN Educational
. . None
educational JJ Educational
session NN Educational
distributed VBD Educational
educational JJ Educational
print NN Educational
materials NNS Educational
. . Educational
-DOCSTART- -X- N

hormonal JJ Pharmocological
contraceptives NNS Pharmocological
contraceptive JJ Pharmocological
pills NNS Pharmocological
ethynylestradiol NN Pharmocological
( ( Pharmocological
EE NNP Pharmocological
) ) Pharmocological
30 CD Pharmocological
mcg NN Pharmocological
and CC Pharmocological
levonorgestrel NN Pharmocological
( ( Pharmocological
LNG NNP Pharmocological
) ) Pharmocological
150 CD Pharmocological
mcg NN Pharmocological
or CC Pharmocological
EE NNP Pharmocological
20 CD Pharmocological
mcg NN Pharmocological
and CC Pharmocological
LNG NNP Pharmocological
100 CD Pharmocological
mcg NN Pharmocological
EE30/LNG150 NNP Pharmocological
EE20/LNG100 NNP Pharmocological
EE20/LNG100 NNP Pharmocological
EE30/LNG150 NNP Pharmocological
EE20/LNG100 NNP Pharmocological
-DOCSTART- -X- N

FSH NNP Pharmocological
priming NN Pharmocological
FSH NNP Pharmocological
no DT Physical
stimulation NN Physical
recombinant JJ Pharmocological
FSH NNP Pharmocological
-DOCSTART- -X- N

complementary JJ None
radiotherapy NN Physical
combination NN None
chemotherapy NN Physical
modern JJ Physical
combination NN Physical
cycles NNS None
of IN None
alternating VBG None
cyclophosphamide NN Pharmocological
, , None
vincristine NN Pharmocological
, , None
procarbazine NN Pharmocological
, , None
and CC None
prednisone NN Pharmocological
( ( Pharmocological
COPP NNP Pharmocological
) ) Pharmocological
plus CC Pharmocological
doxorubicin JJ Pharmocological
, , None
bleomycin NN Pharmocological
, , None
vinblastine NN Pharmocological
, , None
and CC None
dacarbazine NN Pharmocological
( ( Pharmocological
ABVD NNP Pharmocological
) ) Pharmocological
followed VBN None
by IN None
EF NNP Physical
irradiation NN Physical
radiation NN Physical
. . None
polychemotherapy NN Physical
. . None
-DOCSTART- -X- N

Secretin NNP Pharmocological
secretin JJ Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
vs. FW Pharmocological
saline NN Control
infusions NNS Control
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
vs. FW None
saline NN Control
infusions NNS Control
secretin NN Pharmocological
, , Pharmocological
porcine NN Pharmocological
or CC Pharmocological
synthetic JJ Pharmocological
-DOCSTART- -X- N

Rosiglitazone NN Pharmocological
Peroxisome VB None
proliferator-activated JJ None
receptor-? NN None
( ( None
PPAR-? NNP None
) ) None
agonists VBZ None
receive VB None
rosiglitazone NN None
( ( None
4mg/day CD None
) ) None
or CC None
placebo NN None
. . None
A DT None
study NN None
, , None
rosiglitazone NN None
had VBD None
rosiglitazone NN None
in IN None
-DOCSTART- -X- N

botulinum RB Pharmocological
toxin NN Pharmocological
saline JJ Control
injections NNS Control
. . Control
surgical JJ Pharmocological
deactivation NN Pharmocological
deactivation NN Educational
-DOCSTART- -X- N

fixed VBN None
dose JJ None
combination NN None
lamivudine NN Pharmocological
+ NNP Pharmocological
stavudine NN Pharmocological
lamivudine JJ Pharmocological
stavudine NN Pharmocological
lamivudine NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
134678-17-4 CD Pharmocological
) ) Pharmocological
and CC None
stavudine NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
3056-17-5 CD Pharmocological
) ) Pharmocological
lamivudine JJ Pharmocological
tablet NN Pharmocological
and CC None
stavudine NN Pharmocological
capsule NN Pharmocological
lamivudine VBP Pharmocological
stavudine VBP Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
pravastatin NN Pharmocological
-DOCSTART- -X- N

antiangiogenesis NN Pharmocological
therapy NN Pharmocological
anti-neoplastic JJ None
treatment NN None
antiangiogenic JJ Physical
therapy NN Physical
. . None
chemotherapy NN Physical
chemotherapy NN Physical
plus CC Physical
Endostar NNP Physical
) ) None
chemotherapy NN Physical
chemotherapy NN Physical
with IN Physical
Endotatar NNP Physical
) ) None
chemotherapy NN Physical
chemotherapy NN Physical
with IN Physical
Endostar NNP Physical
antiangiogenic JJ Physical
therapy NN Physical
-DOCSTART- -X- N

postpartum JJ Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
regimen NNS Pharmocological
Magnesium NN Pharmocological
sulphate NN Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
standard JJ Pharmocological
Pritchard NNP Pharmocological
regimen NN Pharmocological
of IN Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
shortened JJ None
postpartum NN None
course NN None
intramuscular JJ Pharmocological
magnesium NN Pharmocological
sulphate NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

primary JJ Physical
closure NN Physical
exteriorization NN Physical
-DOCSTART- -X- N

thyroidectomy NN Physical
local/regional JJ Pharmocological
anesthesia NN Pharmocological
and CC Pharmocological
IV NNP Pharmocological
sedation NN Pharmocological
. . None
mini-incision NN Physical
thyroidectomy NN Physical
local/regional JJ Pharmocological
anesthesia NN Pharmocological
and CC Pharmocological
intravenous JJ Pharmocological
sedation NN Pharmocological
. . None
nerve JJ Physical
monitoring NN Physical
of IN Physical
the DT Physical
EBSLN NNP Physical
or CC Physical
no DT Physical
nerve NN Physical
monitoring NN Physical
mini-incision JJ Surgical
thyroidectomy NN Surgical
local/regional JJ Pharmocological
anesthesia NN Pharmocological
-DOCSTART- -X- N

one CD Educational
of IN Educational
which WDT Educational
was VBD Educational
given VBN Educational
treatment NN Educational
for IN Educational
8 CD Educational
days NNS Educational
and CC Educational
the DT Educational
other JJ Educational
for IN Educational
15 CD Educational
days NNS Educational
. . None
early RB Educational
discharge VBP Educational
-DOCSTART- -X- N

fomivirsen NN Pharmocological
fomivirsen NN Pharmocological
-DOCSTART- -X- N

transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Shenmen NNP Physical
point NN Physical
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Shenmen NNP Physical
point NN Physical
group NN Physical
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
auricular JJ Physical
Eye NNP Physical
point NN Physical
group NN Physical
control NN Control
group NN Control
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
pressurization NN None
and CC None
connected VBN None
line NN None
were VBD None
the DT None
same JJ None
with IN None
group NN None
A NNP None
, , None
but CC None
without IN None
electrical JJ Control
stimulation NN Control
. . None
-DOCSTART- -X- N

postoperative JJ None
rhythm NNS None
versus JJ None
rate NN None
control NN None
and CC None
anticoagulation NN None
for IN None
by IN None
and CC None
warfarin NN Pharmocological
-DOCSTART- -X- N

Acipimox NNP Pharmocological
acipimox JJ Pharmocological
placebo NN Control
. . Control
acipimox NNS Pharmocological
placebo VB Control
acipimox NN Pharmocological
placebo VB None
Acipimox NNP Pharmocological
-DOCSTART- -X- N

Sodium-potassium JJ Pharmocological
pump NN Pharmocological
activity NN Pharmocological
sodium-potassium JJ Pharmocological
pump NN Pharmocological
pump NN Physical
activity NN Physical
-DOCSTART- -X- N

15-day JJ None
study NN None
periods NNS None
during IN None
which WDT None
250 CD Pharmocological
mg NN Pharmocological
theophylline NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
or CC None
matching VBG Control
placebo NN Control
was VBD None
used VBN None
. . None
On IN None
the DT None
final JJ None
day NN None
of IN None
each DT None
period NN None
, , None
hyperinsulinemic JJ None
( ( None
360 CD None
pmol NN None
x NNP None
m NN None
( ( None
-2 NNP None
) ) None
x VBP None
min NN None
( ( None
-1 NNP None
) ) None
) ) None
hypoglycemic NN None
( ( None
5.0 CD None
, , None
3.5 CD None
, , None
2.5 CD None
mmol NN None
x NN None
L NNP None
( ( None
-1 NNP None
) ) None
) ) None
glucose VBP None
clamps NNS None
were VBD None
used VBN None
to TO None
assess VB None
-DOCSTART- -X- N

Omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
placebo-controlled JJ None
1.5 CD Pharmocological
g/d NN Pharmocological
of IN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
( ( Pharmocological
.84 JJ Pharmocological
g/d NN Pharmocological
eicosapentaenoic NN Pharmocological
acid NN Pharmocological
, , Pharmocological
.7 NNP Pharmocological
g/d NN Pharmocological
docosahexaenoic NN Pharmocological
acid NN Pharmocological
) ) Pharmocological
supplementation NN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
placebo NN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

aripiprazole NN Pharmocological
aripiprazole JJ Pharmocological
placebo NN Control
placebo-controlled JJ Control
aripiprazole NN Pharmocological
continue VB None
aripiprazole NN None
or CC None
switch VB None
to TO None
placebo VB None
. . None
aripiprazole NN None
and CC None
placebo NN None
was VBD None
for IN None
placebo NN None
( ( None
between IN None
aripiprazole NN None
and CC None
placebo NN None
in IN None
-DOCSTART- -X- N

Intervention NN Educational
comprehensive JJ Educational
intervention NN Educational
Interpersonal NNP Educational
Synchrony NNP Educational
Non-Interpersonal JJ Educational
Synchrony NNP Educational
. . Educational
-DOCSTART- -X- N

Somatostatin NNP Pharmocological
and CC Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
vs. FW Pharmocological
ranitidine NN Pharmocological
somatostatin-UCB NN Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
ranitidine NN Pharmocological
somatostatin NN Pharmocological
Somatostatin NNP Pharmocological
Somatostatin NNP Pharmocological
-DOCSTART- -X- N

docetaxel JJ Pharmocological
plus CC Pharmocological
fluorouracil JJ Pharmocological
and CC None
cisplatin NNS Pharmocological
cisplatin NN Pharmocological
and CC None
fluorouracil NN Pharmocological
docetaxel JJ Pharmocological
plus CC Pharmocological
cisplatin JJ Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
DCF NNP Pharmocological
) ) Pharmocological
cisplatin NN Pharmocological
and CC Pharmocological
fluorouracil NN Pharmocological
( ( Pharmocological
CF NNP Pharmocological
) ) Pharmocological
. . Pharmocological
CF NNP Pharmocological
DCF NNP Pharmocological
protocol-specific JJ Physical
chemotherapy NN Physical
. . None
D NNP Pharmocological
CF NNP Pharmocological
CF NNP Pharmocological
. . None
-DOCSTART- -X- N

timolol/pilocarpine JJ Pharmocological
timolol NN Pharmocological
pilocarpine NN Pharmocological
timolol JJ Pharmocological
maleate NN Pharmocological
pilocarpine NN Pharmocological
HCl NNP Pharmocological
-DOCSTART- -X- N

antioxidants NNS Pharmocological
, , None
zinc NN Pharmocological
, , None
and CC None
copper NN Pharmocological
antioxidants NNS Pharmocological
( ( Pharmocological
vitamin JJ Pharmocological
C NNP Pharmocological
, , Pharmocological
500 CD Pharmocological
mg NN Pharmocological
; : Pharmocological
vitamin CC Pharmocological
E NNP Pharmocological
, , Pharmocological
400 CD Pharmocological
IU NNP Pharmocological
; : Pharmocological
beta NN Pharmocological
carotene NN Pharmocological
, , Pharmocological
15 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
, , Pharmocological
zinc NN Pharmocological
and CC Pharmocological
copper NN Pharmocological
( ( Pharmocological
zinc NN Pharmocological
, , Pharmocological
80 CD Pharmocological
mg NN Pharmocological
; : Pharmocological
cupric JJ Pharmocological
oxide NN Pharmocological
, , Pharmocological
2 CD Pharmocological
mg NN Pharmocological
) ) Pharmocological
, , Pharmocological
antioxidants NNS Pharmocological
plus CC Pharmocological
zinc NN Pharmocological
and CC Pharmocological
copper NN Pharmocological
, , None
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

value-congruence NN None
model NN None
made-in-the-U.S. JJ Other
scenario NN Educational
made-in-Japan JJ Other
scenario NN Educational
daily RB Educational
event NN Educational
sampling VBG Educational
study NN Educational
) ) None
-DOCSTART- -X- N

Plasmakinetic JJ Surgical
prostate NN Surgical
resection NN Surgical
plasmakinetic JJ Surgical
resection NN Surgical
of IN Surgical
prostate NN Surgical
( ( Surgical
PKRP NNP Surgical
) ) Surgical
transurethral JJ Surgical
resection NN Surgical
of IN Surgical
prostate NN Surgical
TURP NNP Surgical
PKRP NNP Surgical
. . None
PKRP NNP Surgical
PKRP NNP Surgical
-DOCSTART- -X- N

placebo-controlled JJ Control
testosterone NN Pharmocological
undecanoate NN Pharmocological
with IN Pharmocological
injectable JJ Pharmocological
norethisterone JJ Pharmocological
enanthate NN Pharmocological
: : Pharmocological
plus CC Pharmocological
norethisterone JJ Pharmocological
enanthate NN Pharmocological
TU NNP Pharmocological
plus CC Pharmocological
placebo JJ Pharmocological
placebo NN Control
-DOCSTART- -X- N

intensive JJ None
therapy NN None
program NN None
intensive JJ Psychological
therapy NN Psychological
program NN Psychological
-DOCSTART- -X- N

bitolterol NN Pharmocological
mesylate NN Pharmocological
and CC None
isoproterenol NN Pharmocological
. . None
Nebulized VBN Pharmocological
bitolterol NN Pharmocological
solution NN Pharmocological
and CC None
isoproterenol JJ Pharmocological
solution NN Pharmocological
Bitolterol NNP Pharmocological
-DOCSTART- -X- N

Metoprolol NNP Pharmocological
CR/XL NNP Pharmocological
metoprolol NN Pharmocological
controlled VBN Pharmocological
release/extended VBD Pharmocological
release NN Pharmocological
( ( Pharmocological
CR/XL NNP Pharmocological
) ) Pharmocological
Metoprolol NNP Pharmocological
CR/XL NNP Pharmocological
metoprolol NN Pharmocological
CR/XL NNP Pharmocological
placebo NN Control
Metoprolol NNP Pharmocological
CR/XL NNP Pharmocological
-DOCSTART- -X- N

Relaxing VBG Physical
retinotomy NN Physical
with IN Physical
silicone JJ Physical
oil NN Physical
or CC Physical
long-acting NN Physical
gas NN Physical
vitrectomy NN Pharmocological
relaxing VBG Physical
retinotomy NN Physical
treatment NN Pharmocological
with IN Pharmocological
long-acting JJ Pharmocological
gas NN Pharmocological
or CC Pharmocological
silicone NN Pharmocological
oil NN Pharmocological
. . None
perflouropropane NN Pharmocological
-DOCSTART- -X- N

ebrotidine NN Pharmocological
and CC None
ranitidine NN Pharmocological
combined VBN None
with IN None
amoxicillin NN Pharmocological
and CC None
metronidazole NN Pharmocological
ebrotidine NN Pharmocological
( ( Pharmocological
N- JJ Pharmocological
[ NN Pharmocological
( ( Pharmocological
E NNP Pharmocological
) ) Pharmocological
- : Pharmocological
[ JJ Pharmocological
[ JJ Pharmocological
2- JJ Pharmocological
[ NN Pharmocological
[ NNP Pharmocological
[ NNP Pharmocological
2- JJ Pharmocological
[ NNP Pharmocological
( ( Pharmocological
diaminomethylene NN Pharmocological
) ) Pharmocological
amino NN Pharmocological
] JJ Pharmocological
-4-thiazolyl NNP Pharmocological
] NNP Pharmocological
methyl NN Pharmocological
] NNP Pharmocological
thio NN Pharmocological
] NNP Pharmocological
ethyl VBZ Pharmocological
] NNP Pharmocological
amino NN Pharmocological
] NNP Pharmocological
methylene NN Pharmocological
] NNP Pharmocological
-4-bromo-benzenesulfonamide NNP Pharmocological
, , Pharmocological
CAS NNP Pharmocological
100981-43-9 CD Pharmocological
, , Pharmocological
FI-3542 NNP Pharmocological
) ) Pharmocological
400 CD Pharmocological
mg NN Pharmocological
and CC None
ranitidine VB Pharmocological
300 CD Pharmocological
mg NN Pharmocological
combined VBN None
with IN None
amoxicillin JJ Pharmocological
metronidazole $ Pharmocological
-DOCSTART- -X- N

maprotiline NN Pharmocological
( ( Educational
MMS NNP Educational
) ) Educational
( ( Educational
GDS NNP Educational
) ) Educational
placebo-controlled JJ Control
maprotiline NN Pharmocological
-DOCSTART- -X- N

Parent-mediated JJ Educational
communication-focused JJ Educational
treatment NN Educational
( ( Educational
Preschool NNP Educational
Autism NNP Educational
Communication NNP Educational
Trial NNP Educational
[ NNP Educational
PACT NNP Educational
] NNP Educational
) ) Educational
intervention NN Educational
treatment NN Control
as IN Control
usual JJ Control
PACT NNP Educational
intervention NN Educational
-DOCSTART- -X- N

night NN Physical
splint NN Physical
to TO None
eccentric VB Physical
exercises NNS Physical
use NN None
of IN None
a DT None
night NN Physical
splint NN Physical
eccentric JJ Physical
exercises NNS Physical
with IN Physical
a DT Physical
night NN Physical
splint NN Physical
eccentric JJ Physical
exercises NNS Physical
only RB Physical
heavy-load NN Physical
eccentric JJ Physical
training NN Physical
programme NN Physical
. . Physical
night NN Physical
splint NN Physical
in IN None
addition NN None
to TO None
eccentric JJ Physical
exercises NNS Physical
. . None
night NN Physical
splint NN Physical
night NN Physical
splint NN Physical
-DOCSTART- -X- N

saccadic JJ Educational
eye NN Educational
movements NNS Educational
3 CD Educational
saccadic JJ Educational
eye NN Educational
movement NN Educational
tasks NNS Educational
of IN None
increasing VBG None
difficulty NN None
. . None
-DOCSTART- -X- N

placebo-controlled JJ Control
fluoxetine NN Pharmocological
selective JJ Pharmocological
serotonin NN Pharmocological
reuptake NN Pharmocological
inhibitor NN Pharmocological
placebo-controlled JJ Control
fluoxetine NN Pharmocological
fluoxetine VB Pharmocological
( ( None
n JJ None
= NNP None
16 CD None
) ) None
or CC None
a DT None
placebo NN Control
( ( None
n JJ None
= NNP None
19 CD None
) ) None
fluoxetine NN Pharmocological
placebo NN Control
fluoxetine NN Pharmocological
fluoxetine NN Pharmocological
-DOCSTART- -X- N

streptokinase-mediated JJ Pharmocological
fibrinolysis NN Pharmocological
; : None
intravenous JJ Pharmocological
heparin NNS Pharmocological
by IN Pharmocological
infusion NN Pharmocological
. . Pharmocological
heparin NN Pharmocological
Heparin NNP Pharmocological
-DOCSTART- -X- N

Yinxing VBG Pharmocological
Damo NNP Pharmocological
combined VBN Pharmocological
with IN Pharmocological
betahistine JJ Pharmocological
hydrochloride NN Pharmocological
Yinxing VBG Pharmocological
Damo NNP Pharmocological
( ( Pharmocological
YXDM NNP Pharmocological
) ) Pharmocological
combined VBD Pharmocological
with IN Pharmocological
Betahistine NNP Pharmocological
Hydrochloride NNP Pharmocological
Injection NNP Pharmocological
YXDM NNP Pharmocological
BHI NNP Pharmocological
-DOCSTART- -X- N

loop NN Surgical
vs. FW None
holder NN Surgical
techniques NNS Surgical
. . None
holder NN Surgical
versus IN Surgical
the DT Surgical
paper NN Surgical
loop NN Surgical
technique NN Surgical
. . None
bitewing NN None
holder NN Surgical
and CC Surgical
paper NN Surgical
loop NN Surgical
techniques NNS Surgical
. . None
bitewing NN Surgical
technique NN Surgical
loop NN Surgical
technique NN Surgical
holder NN Surgical
technique NN Surgical
. . Surgical
loop NN Surgical
technique NN Surgical
holder NN Surgical
technique NN Surgical
. . Surgical
loop NN Surgical
and CC Surgical
holder NN Surgical
techniques NNS Surgical
-DOCSTART- -X- N

Online NNP Other
conductivity NN Other
monitoring NN Other
: : None
reduced JJ Other
dialysate NN Other
conductivity NN Other
. . None
Relatively RB Other
low JJ Other
dialysate NN Other
conductivity NN Other
( ( Other
Cndi NNP Other
) ) Other
controlled JJ None
reduction NN Other
of IN Other
Cndi NNP Other
. . Other
reduction NN Other
of IN Other
Cndi NNP Other
Reduction NN Other
in IN Other
Cndi NNP Other
-DOCSTART- -X- N

vaccination NN Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
or CC Pharmocological
an DT Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
pneumococcal JJ Pharmocological
vaccine NN Pharmocological
Influenza NNP Pharmocological
vaccination NN Pharmocological
pneumococcal JJ Pharmocological
vaccine NN Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
influenza NN Pharmocological
and CC Pharmocological
pneumococcal JJ Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

Midazolam NNP Pharmocological
vs NN None
ondansetron NN Pharmocological
midazolam NN Pharmocological
ondansetron NN Pharmocological
Midazolam NNP Pharmocological
2 CD Pharmocological
mg NN Pharmocological
or CC None
ondansetron $ Pharmocological
4 CD Pharmocological
mg NN Pharmocological
ondansetron NN Pharmocological
midazolam VB Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

alpha JJ Pharmocological
1-blocker NN Pharmocological
, , Pharmocological
YM617 NNP Pharmocological
alpha JJ Pharmocological
1-blocker CD Pharmocological
, , Pharmocological
( ( Pharmocological
R NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
- : Pharmocological
) ) Pharmocological
-5- VBP Pharmocological
[ JJ Pharmocological
2- JJ Pharmocological
[ NN Pharmocological
[ CD Pharmocological
2- JJ Pharmocological
( ( Pharmocological
o-ethoxyphenoxy JJ Pharmocological
) ) Pharmocological
ethyl FW Pharmocological
] NNP Pharmocological
amino NN Pharmocological
] NNP Pharmocological
propyl NN Pharmocological
] NNP Pharmocological
-2- NNP Pharmocological
methoxybenzenesulfonamide NN Pharmocological
hydrochloride NN Pharmocological
( ( Pharmocological
YM617 NNP Pharmocological
) ) Pharmocological
placebo IN Control
P NNP Control
-- : Control
placebo NN Control
YM617 NNP Pharmocological
. . Pharmocological
placebo NN Control
alpha JJ None
1-blocker NN None
, , None
YM617 NNP None
. . None
-DOCSTART- -X- N

supplementary JJ Pharmocological
antioxidant JJ Pharmocological
vitamin NNS Pharmocological
anti-oxidant JJ Pharmocological
vitamin NNS Pharmocological
antioxidant NN Pharmocological
vitamin NNS Pharmocological
colestipol/niacin VB Pharmocological
plus JJ None
diet JJ None
placebo JJ Control
plus CC Control
diet JJ Control
. . Control
vitamin NN Pharmocological
E NNP Pharmocological
vitamin NN Pharmocological
C NNP Pharmocological
placebo NN Control
vitamin NN Pharmocological
E NNP Pharmocological
vitamin NNS Pharmocological
E NN Pharmocological
E NNP Pharmocological
vitamin NN Pharmocological
C NNP Pharmocological
placebo NN Control
Supplementary NNP Pharmocological
vitamin NN Pharmocological
E NNP Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
recombinant JJ Pharmocological
hypoallergenic JJ Pharmocological
Bet NNP Pharmocological
v NN Pharmocological
1 CD Pharmocological
recombinant JJ Pharmocological
Bet NNP Pharmocological
v NN Pharmocological
1 CD Pharmocological
( ( Pharmocological
rBet JJ Pharmocological
v IN Pharmocological
1-FV JJ Pharmocological
) ) Pharmocological
of IN None
rBet JJ None
v JJ None
1-FV JJ None
one CD None
placebo NN None
placebo NN None
( ( None
n JJ None
= NNP None
placebo NN None
( ( None
-18.8 CD None
of IN None
rBet JJ None
v JJ None
1-FV JJ None
appears VBZ None
-DOCSTART- -X- N

biopsy NN None
sheathed JJ Physical
needle NN Physical
suction NN Physical
biopsy NN Physical
needle NN Physical
( ( Physical
Menghini NNP Physical
) ) Physical
routine JJ Physical
percutaneous JJ Physical
liver NN Physical
biopsy NN Physical
. . None
suction NN Physical
needle NN Physical
sheathed JJ Other
needle NN Other
. . None
Menghini NNP Physical
technique NN Physical
. . Physical
suction NN Other
needle NN Other
sheathed JJ Other
needle NN Other
-DOCSTART- -X- N

Methotrexate NNP Pharmocological
placebo-controlled JJ Control
placebo NN Control
methotrexate NN Pharmocological
placebo NN Control
therapy NN Control
. . Control
MTX NNP Pharmocological
placebo NN Control
. . Control
placebo-treatment JJ Control
MTX NNP Pharmocological
. . None
MTX NNP Pharmocological
MTX NNP Pharmocological
MTX NNP Pharmocological
-DOCSTART- -X- N

early JJ Physical
rehabilitation NN Physical
protocol NN Physical
-DOCSTART- -X- N

dihydroergotamine NN Pharmocological
( ( Pharmocological
DHE NNP Pharmocological
) ) Pharmocological
heparin NN Pharmocological
DHE NNP Pharmocological
heparin JJ Pharmocological
DHE NNP Pharmocological
heparin JJ Pharmocological
heparin NN Pharmocological
DHE NNP Pharmocological
placebo NN Control
DHE/Hep NNP Pharmocological
placebo VB Control
-DOCSTART- -X- N

a DT Educational
nurse JJ Educational
assessment NN Educational
visit NN Educational
and CC Educational
follow-up JJ Educational
interventions NNS Educational
targeting VBG Educational
risk NN Educational
factors NNS Educational
for IN Educational
disability NN Educational
and CC Educational
falls NNS Educational
a DT None
general JJ Educational
health NN Educational
promotion NN Educational
nurse JJ Educational
visit NN Educational
usual JJ Control
care NN Control
-DOCSTART- -X- N

valsartan/hydrochlorothiazide NN Pharmocological
valsartan/hydrochlorothiazide NN Pharmocological
( ( Pharmocological
HCTZ NNP Pharmocological
) ) Pharmocological
valsartan VB Pharmocological
80 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
V-low NNP Pharmocological
) ) Pharmocological
, , None
valsartan $ Pharmocological
160 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
V-high NNP Pharmocological
) ) Pharmocological
or CC None
valsartan/HCTZ $ Pharmocological
160/12.5 CD Pharmocological
mg NN Pharmocological
( ( Pharmocological
V/HCTZ NNP Pharmocological
) ) Pharmocological
, , None
and CC None
electively RB None
titrated VBN None
after IN None
weeks NNS None
2 CD None
and CC None
4 CD None
to TO None
the DT None
next JJ None
dosage NN None
level NN None
( ( None
maximum JJ Pharmocological
dose NN Pharmocological
valsartan/HCTZ NN Pharmocological
160/25 CD Pharmocological
mg NN Pharmocological
) ) None
if IN None
BP NNP Pharmocological
remained VBD Pharmocological
> JJ Pharmocological
140/90 CD Pharmocological
mm NN Pharmocological
Hg NNP Pharmocological
. . None
V/HCTZ NNP Pharmocological
V/HCTZ NNP Pharmocological
valsartan NN Pharmocological
HCTZ NNP Pharmocological
valsartan NN Pharmocological
-DOCSTART- -X- N

arginine NN Pharmocological
arginine NN Pharmocological
19.6 CD Pharmocological
g NN Pharmocological
of IN Pharmocological
arginine/d NN Pharmocological
placebo NN Control
arginine-supplemented JJ Pharmocological
arginine NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

epoetin JJ Pharmocological
alfa NN Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
alfa NN Pharmocological
six CD Pharmocological
dosing VBG Pharmocological
epoetin NN Pharmocological
alfa NN Pharmocological
regimens VBZ Pharmocological
40,000 CD Pharmocological
IU NNP Pharmocological
once RB Pharmocological
weekly RB Pharmocological
15,000 CD Pharmocological
IU NNP Pharmocological
every DT Pharmocological
other JJ Pharmocological
day NN Pharmocological
, , Pharmocological
subcutaneously RB Pharmocological
40,000 CD Pharmocological
IU NNP Pharmocological
day NN Pharmocological
subcutaneously RB Pharmocological
subcutaneous JJ Pharmocological
dosing NN Pharmocological
. . Pharmocological
dosing NN Pharmocological
dosing VBG None
epoetin JJ Pharmocological
alfa NN Pharmocological
epoetin JJ Pharmocological
alfa NN Pharmocological
-DOCSTART- -X- N

Resistance NNP Physical
training NN Physical
strength NN Physical
training NN Physical
program NN Physical
randomly RB None
assigned VBN None
to TO None
either CC None
a DT None
whole JJ Physical
body NN Physical
strength NN Physical
training VBG Physical
who WP None
underwent VBD None
three CD None
supervised VBN None
resistance NN Physical
training NN Physical
sessions NNS None
per IN None
week NN None
for IN None
13 CD None
wk NN None
or CC None
who WP None
participated VBD None
in IN None
a DT None
supervised JJ None
stretching NN None
program NN None
. . None
strength NN Physical
training VBG Physical
group NN Physical
strength NN Physical
training NN Physical
short-term JJ Physical
strength NN Physical
training NN Physical
-DOCSTART- -X- N

two CD Physical
consecutive JJ Physical
overnight JJ Physical
polysomnographies NNS Physical
, , None
one CD None
with IN None
a DT None
chinstrap NN Physical
, , None
in IN None
random JJ None
order NN None
. . None
with IN Physical
and CC Physical
without IN Physical
a DT Physical
chinstrap NN Physical
-DOCSTART- -X- N

Tacrolimus/sirolimus NNP Pharmocological
vs NN Pharmocological
tacrolimus/methotrexate NN Pharmocological
tacrolimus NN Pharmocological
and CC Pharmocological
sirolimus NN Pharmocological
( ( Pharmocological
Tac/Sir NNP Pharmocological
) ) Pharmocological
tacrolimus NN Pharmocological
and CC Pharmocological
methotrexate NN Pharmocological
( ( Pharmocological
Tac/Mtx NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

3,4-Methylenedioxymethamphetamine CD Pharmocological
( ( Pharmocological
MDMA NNP Pharmocological
or CC Pharmocological
ecstasy NN Pharmocological
) ) Pharmocological
MDMA NNP Pharmocological
placebo-controlled JJ Control
dexfenfluramine NN Pharmocological
. . None
dexfenfluramine JJ Pharmocological
-DOCSTART- -X- N

placebo NN Control
empiric JJ Pharmocological
antibiotic JJ Pharmocological
treatment NN Pharmocological
placebo NN Control
placebo NN Control
placebo NN Control
-DOCSTART- -X- N

-DOCSTART- -X- N

lanreotide NN Pharmocological
lanreotide NN Pharmocological
transsphenoidal VB Surgical
surgery NN Surgical
lanreotide NN Pharmocological
-DOCSTART- -X- N

Docosahexaenoic NNP Pharmocological
acid-rich JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
placebo-controlled JJ Control
docosahexaenoic JJ Pharmocological
acid-rich JJ Pharmocological
fish JJ Pharmocological
oil NN Pharmocological
or CC Control
placebo NN Control
( ( Control
olive JJ Control
oil NN Control
) ) Control
. . Control
-DOCSTART- -X- N

confession NN Educational
decisions NNS Educational
. . Educational
-DOCSTART- -X- N

vaccine NN Pharmocological
vaccine NN Pharmocological
vaccine NN Pharmocological
vaccine NN Pharmocological
vaccine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

lipid JJ Pharmocological
therapy NN Pharmocological
lipid JJ Pharmocological
emulsions NNS Pharmocological
medium-chain JJ Pharmocological
triglycerides/short-chain JJ Pharmocological
triglycerides NNS Pharmocological
( ( Pharmocological
MCT/LCT NNP Pharmocological
) ) Pharmocological
physical JJ Pharmocological
mixture NN Pharmocological
with IN Pharmocological
a DT Pharmocological
four-component JJ Pharmocological
intravenous JJ Pharmocological
( ( Pharmocological
i.v JJ Pharmocological
. . Pharmocological
) ) Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
( ( Pharmocological
LCT NNP Pharmocological
, , Pharmocological
MCT NNP Pharmocological
, , Pharmocological
Olive-oil NNP Pharmocological
and CC Pharmocological
Fish-oil NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
with IN Pharmocological
the DT Pharmocological
lipid JJ Pharmocological
emulsions NNS Pharmocological
lipid JJ Pharmocological
emulsions NNS Pharmocological
TPN NNP Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

Sinemet NNP Pharmocological
CR NNP Pharmocological
carbidopa/levodopa NN Pharmocological
preparation NN Pharmocological
carbidopa/levodopa NN Pharmocological
placebo-controlled JJ Control
-DOCSTART- -X- N

secretin NN Pharmocological
: : Pharmocological
Secretin NNP Pharmocological
synthetic JJ Pharmocological
human JJ Pharmocological
secretin NN Pharmocological
placebo NN Control
secretin VB Pharmocological
secretin NN Pharmocological
-DOCSTART- -X- N

Phenobarbital JJ Pharmocological
phenytoin NN Pharmocological
phenobarbital NN Pharmocological
phenytoin NN Pharmocological
phenobarbital NN Pharmocological
phenytoin NN Pharmocological
Phenobarbital NNP Pharmocological
phenytoin NN Pharmocological
-DOCSTART- -X- N

eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
, , Pharmocological
gamma-linolenic JJ Pharmocological
acid NN Pharmocological
, , None
and CC None
antioxidants NNS Pharmocological
enteral JJ None
diet NN None
containing VBG None
eicosapentaenoic JJ Pharmocological
acid NN Pharmocological
and CC None
gamma-linolenic JJ Pharmocological
acid NN Pharmocological
and CC None
elevated JJ None
antioxidants NNS Pharmocological
( ( None
EPA+GLA NNP None
; : None
Oxepa NNP None
) ) None
EPA+GLA NNP None
or CC None
an DT None
isonitrogenous JJ Pharmocological
, , None
isocaloric JJ None
standard NN None
diet NN None
EPA+GLA NNP Pharmocological
-DOCSTART- -X- N

received VBD None
progressive JJ None
exercise NN None
training NN None
. . None
either RB None
4 CD None
mg NNS None
perindopril NN None
or CC None
matching VBG None
placebo JJ None
daily JJ None
-DOCSTART- -X- N

grammatical JJ Educational
uninterpretable JJ Educational
extra JJ Educational
argument NN Educational
legitimate JJ Educational
arguments NNS Educational
. . None
grammatical JJ Educational
-DOCSTART- -X- N

Teaching VBG Educational
to TO Educational
seek VB Educational
information NN Educational
: : Educational
A DT Educational
time NN Educational
delay NN Educational
procedure NN Educational
was VBD Educational
used VBN Educational
to TO Educational
teach VB Educational
to TO Educational
ask VB Educational
the DT Educational
question NN Educational
What WP Educational
's VBZ Educational
that DT Educational
? . Educational
when WRB Educational
novel JJ Educational
stimuli NNS Educational
were VBD Educational
presented VBN Educational
during IN Educational
an DT Educational
instructional JJ Educational
task NN Educational
. . Educational
-DOCSTART- -X- N

Yohimbine NN Pharmocological
clonidine NN Pharmocological
( ( Pharmocological
CLO NNP Pharmocological
) ) Pharmocological
or CC None
yohimbine NN Pharmocological
CLO NNP Pharmocological
YHO NNP Pharmocological
CLO NNP Pharmocological
-DOCSTART- -X- N

salbutamol NN Pharmocological
4 CD Pharmocological
mg JJ Pharmocological
oral JJ Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
. . None
underwent VBD Pharmocological
the DT Pharmocological
same JJ Pharmocological
procedure NN Pharmocological
at IN Pharmocological
random NN Pharmocological
without IN Pharmocological
salbutamol NN Pharmocological
. . None
salbutamol NN Pharmocological
Salbutamol NNP Pharmocological
salbutamol NN Pharmocological
salbutamol NN Pharmocological
beta-sympathomimetic JJ Pharmocological
drugs NNS Pharmocological
-DOCSTART- -X- N

brief JJ Psychological
Early JJ Psychological
Start NNP Psychological
Denver NNP Psychological
model NN Psychological
( ( Psychological
ESDM NNP Psychological
) ) Psychological
-based VBD Psychological
intervention NN Psychological
on IN Psychological
low-intensity JJ Psychological
( ( Psychological
1-hour/wk CD Psychological
of IN Psychological
therapist JJ Psychological
contact NN Psychological
) ) Psychological
, , Psychological
parent-delivered JJ Psychological
intervention NN Psychological
for IN Psychological
Early JJ Educational
Start NNP Educational
Denver NNP Educational
model NN Educational
( ( Educational
P-ESDM NNP Educational
) ) Educational
compared VBN Control
to TO Control
community NN Control
treatment NN Control
as IN Control
usual JJ Control
. . Control
Parents NNS None
receiving VBG None
P-ESDM NNP None
P-ESDM NNP None
Parent-implemented JJ None
intervention NN None
studies NNS None
-DOCSTART- -X- N

enoxaparin VBZ Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
enoxaparin NN Pharmocological
-DOCSTART- -X- N

thiopental NN Pharmocological
Propofol NNP Pharmocological
thiopental JJ Pharmocological
lidocaine NN Pharmocological
normal JJ Pharmocological
saline NN Pharmocological
lidocaine JJ Pharmocological
thiopental JJ Pharmocological
manual JJ Physical
venous JJ Physical
occlusion NN Physical
Propofol NNP Pharmocological
lidocaine JJ Pharmocological
thiopental JJ Pharmocological
thiopental JJ Pharmocological
Thiopental JJ Pharmocological
thiopental JJ Pharmocological
thiopental JJ Pharmocological
Thiopental JJ Pharmocological
-DOCSTART- -X- N

imiquimod NN Pharmocological
imiquimod JJ Pharmocological
8 CD Pharmocological
weeks NNS Pharmocological
of IN Pharmocological
treatment NN Pharmocological
with IN Pharmocological
once-daily JJ Pharmocological
dosing VBG Pharmocological
for IN Pharmocological
alternate JJ Pharmocological
weeks NNS Pharmocological
( ( Pharmocological
R1 NNP Pharmocological
) ) Pharmocological
and CC None
5 CD None
weeks NNS None
of IN None
once-daily JJ None
dosing NN None
with IN None
a DT None
1-week JJ None
interval NN None
in IN None
the DT None
middle NN None
of IN None
the DT None
course NN None
imiquimod JJ Pharmocological
-DOCSTART- -X- N

calculus NN Pharmocological
scaling VBG Pharmocological
gel NN Pharmocological
. . None
calculus NN Pharmocological
scaling VBG Pharmocological
gel NN Pharmocological
( ( Pharmocological
SofScale NNP Pharmocological
) ) Pharmocological
gel NN Pharmocological
was VBD None
applied VBN None
directly RB None
to TO None
the DT None
calculus NN None
and CC None
subgingivally RB None
to TO None
the DT None
area NN None
to TO None
be VB None
scaled VBN None
. . None
Pre- JJ None
and CC None
post-treatment JJ None
gingival NN None
and CC None
stain NN None
indices NNS None
were VBD None
taken VBN None
. . None
SofScale NNP Pharmocological
placebo NN Control
-DOCSTART- -X- N

Low JJ Physical
intensity NN Physical
physical JJ Physical
training NN Physical
low JJ Physical
intensity NN Physical
general JJ Physical
training NN Physical
program NN Physical
low JJ Physical
intensity NN Physical
training NN Physical
. . None
two CD Physical
treadmill NN Physical
tests NNS Physical
-DOCSTART- -X- N

placebo NN Control
omeprazole JJ Pharmocological
2 CD Pharmocological
X NN Pharmocological
20mg CD Pharmocological
, , None
clarithromycin VBD Pharmocological
2 CD Pharmocological
X NNP Pharmocological
500mg CD Pharmocological
, , None
and CC None
amoxicillin RB Pharmocological
2 CD Pharmocological
X NNS Pharmocological
1g CD Pharmocological
for IN None
7 CD None
days NNS None
, , None
or CC None
omeprazole JJ Control
2 CD Control
X NN Control
20mg CD Control
plus CC None
placebo NN Control
. . None
-DOCSTART- -X- N

titanoreine NN Pharmocological
titanoreine NN Pharmocological
titanoreine VB Pharmocological
control VB Control
group NN Control
without IN Control
titanoreine NN Control
titanoreine NN Pharmocological
titanoreine NN Pharmocological
Titanoreine NNP Pharmocological
-DOCSTART- -X- N

docosahexaenoic JJ Pharmocological
acid NN Pharmocological
docosahexaenoic JJ Pharmocological
acid NNS Pharmocological
docosahexaenoic NN Pharmocological
acid NN Pharmocological
plus CC Pharmocological
15 CD Pharmocological
000 CD Pharmocological
IU/d NNP Pharmocological
of IN Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
given VBN Pharmocological
as IN Pharmocological
retinyl NN Pharmocological
palmitate NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
+ VBZ Pharmocological
A NNP Pharmocological
group NN Pharmocological
) ) Pharmocological
or CC None
control VB Control
fatty JJ Control
acid JJ Control
plus CC Control
15 CD Control
000 CD Control
IU/d NNP Control
of IN Control
vitamin NN Control
A NNP Control
( ( Control
control NN Control
+ VBZ Control
A NNP Control
group NN Control
) ) Control
DHA NNP Pharmocological
+ VBZ Pharmocological
A NNP Pharmocological
control NN Pharmocological
+ VBZ Pharmocological
A DT Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
not RB Educational
taking VBG Educational
vitamin RP Educational
A DT Educational
DHA NNP Pharmocological
+ NNP Pharmocological
A NNP Pharmocological
control NN Pharmocological
+ VBZ Pharmocological
A NNP Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
docosahexaenoic NN Pharmocological
acid IN Pharmocological
not RB Pharmocological
on IN Pharmocological
vitamin NN Pharmocological
A NNP Pharmocological
control NN None
+ VBZ None
A NNP None
dietary JJ Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acid NNS Pharmocological
vitamin IN Physical
A NNP Physical
therapy NN Physical
docosahexaenoic NN Pharmocological
acid NN Pharmocological
omega-3 JJ Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
-DOCSTART- -X- N

ablation NN Surgical
surgery NN Surgical
ablation NN Surgical
surgery NN Surgical
( ( Surgical
AS IN Surgical
) ) Surgical
cardiac JJ Surgical
surgery NN Surgical
randomly RB Surgical
assigned VBN Surgical
to TO Surgical
undergo VB Surgical
cardiac JJ Surgical
surgery NN Surgical
with IN Surgical
or CC Surgical
without IN Surgical
AS NNP Surgical
. . None
AS NNP Surgical
probability NN None
of IN None
AS NNP None
being VBG None
concomitant NN None
AS IN None
in IN None
AF NNP None
-DOCSTART- -X- N

diazepam NN Pharmocological
and CC Pharmocological
midazolam NN Pharmocological
diazepam NN Pharmocological
and CC Pharmocological
midazolam NN Pharmocological
nitrous JJ Pharmocological
oxide/oxygen NN Pharmocological
inhalation NN Pharmocological
oral JJ Pharmocological
administration NN Pharmocological
of IN Pharmocological
either DT Pharmocological
diazepam NN Pharmocological
0.3 CD Pharmocological
mg/kg NN Pharmocological
or CC Pharmocological
midazolam VB Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
-DOCSTART- -X- N

Antioxidant JJ Pharmocological
supplementation NN None
antipyrine NN None
antioxidant JJ Pharmocological
supplementation NN Pharmocological
dl-alpha-tocopheryl JJ Pharmocological
acetate NN Pharmocological
ascorbic JJ Pharmocological
acid NN Pharmocological
beta-carotene NN Pharmocological
placebo NN Control
Antipyrine NNP Pharmocological
antioxidant JJ Pharmocological
supplementation NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
amantadine JJ Pharmocological
hydrochloride NN Pharmocological
amantadine JJ Pharmocological
single JJ None
daily JJ None
dose NN None
of IN None
amantadine NN Pharmocological
( ( None
2.5 CD None
mg/kg NNS None
per IN None
day NN None
) ) None
or CC None
placebo NN Control
for IN None
the DT None
next JJ None
week NN None
, , None
and CC None
then RB None
bid VB None
dosing VBG None
( ( None
5.0 CD None
mg/kg NNS None
per IN None
day NN None
) ) None
for IN None
the DT None
subsequent JJ None
3 CD None
weeks NNS None
. . None
amantadine-treated JJ Pharmocological
Amantadine NNP Pharmocological
amantadine JJ Pharmocological
-DOCSTART- -X- N

pyrimethamine NN Pharmocological
Pyrimethamine NNP Pharmocological
Leucovorin NNP Pharmocological
pyrimethamine NN Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
trimethoprim-sulfamethoxazole JJ Pharmocological
-DOCSTART- -X- N

botulinum JJ Pharmocological
toxin-A NN Pharmocological
: : Pharmocological
Botulinum NNP Pharmocological
toxin NN Pharmocological
A NNP Pharmocological
( ( Pharmocological
BTX-A NNP Pharmocological
) ) Pharmocological
BTX-A NNP Pharmocological
placebo NN Control
100 CD Pharmocological
units NNS Pharmocological
BTX-A NNP Pharmocological
, , Pharmocological
diluted VBD Pharmocological
in IN Pharmocological
1 CD Pharmocological
ml NNS Pharmocological
saline NN Pharmocological
, , None
while IN None
the DT None
other JJ Control
half NN Control
received VBD Control
just RB Control
saline NN Control
BTX-A NNP Pharmocological
-DOCSTART- -X- N

Valsartan NNP Pharmocological
selective JJ Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blocker NN Pharmocological
( ( Pharmocological
ARB NNP Pharmocological
) ) Pharmocological
ARB NNP Pharmocological
valsartan NN Pharmocological
placebo NN Control
ARB NNP None
ARB NNP None
placebo NN None
ARB NNP None
-DOCSTART- -X- N

desflurane NN Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
ondansetron NNS Pharmocological
compared VBN None
with IN None
propofol NN Pharmocological
prophylactic JJ Pharmocological
ondansetron NN Pharmocological
to TO None
desflurane-based JJ Pharmocological
anesthesia NN Pharmocological
desflurane NN Control
anesthetic NN Control
( ( Control
placebo NN Control
) ) Control
or CC None
a DT None
propofol-infusion-based JJ Pharmocological
( ( Pharmocological
active JJ Pharmocological
control NN Pharmocological
) ) Pharmocological
anesthetic NN Pharmocological
. . None
ondansetron NN Pharmocological
) ) None
ondansetron NN Pharmocological
desflurane NN Pharmocological
desflurane-only JJ Pharmocological
desflurane NN Pharmocological
propofol NN Pharmocological
desflurane-only JJ Pharmocological
desflurane NN Pharmocological
-DOCSTART- -X- N

ultrasound IN Physical
dating VBG Physical
scan JJ Physical
ultrasound JJ Physical
dating NN Physical
scan NN Physical
between IN None
8 CD None
and CC None
12 CD None
weeks NNS None
, , None
measuring VBG None
crown-rump JJ None
length NN None
. . None
ultrasound IN Physical
dating VBG Physical
scan JJ Physical
-DOCSTART- -X- N

stent JJ Surgical
implantation NN Surgical
Lunar NNP Surgical
stent NN Surgical
from IN Surgical
Inflow NNP Surgical
Dynamics NNP Surgical
iridium NN Pharmocological
oxide IN Pharmocological
implantation NN Surgical
of IN Surgical
Lunar NNP Surgical
stents NNS Surgical
. . None
iridium-oxide JJ Pharmocological
coated VBN Surgical
Lunar NNP Surgical
stents NNS Surgical
. . None
Lunar NNP Surgical
stent NN Surgical
-DOCSTART- -X- N

Sodium NN Pharmocological
bicarbonate NN Pharmocological
, , None
N-acetylcysteine NNP Pharmocological
, , None
and CC None
saline NN Control
sodium NN Pharmocological
bicarbonate NN Pharmocological
combination NN None
of IN None
N-acetylcysteine NNP Surgical
( ( Surgical
NAC NNP Surgical
) ) Surgical
plus CC None
sodium JJ Pharmocological
chloride NN Pharmocological
and CC None
sodium NN Pharmocological
chloride NN Pharmocological
alone RB None
infusion NN None
of IN None
sodium NN Pharmocological
bicarbonate NN Pharmocological
, , None
sodium NN Pharmocological
chloride NN Pharmocological
, , None
sodium NN Pharmocological
chloride NN Pharmocological
plus CC None
oral JJ None
NAC NNP Pharmocological
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
alone RB None
combination NN None
sodium NN Pharmocological
bicarbonate NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
sodium JJ Pharmocological
bicarbonate NN Pharmocological
sodium NN Pharmocological
chloride JJ Pharmocological
infusion NN Pharmocological
Combination NNP None
therapy NN None
of IN None
NAC NNP Pharmocological
plus CC Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
sodium JJ Pharmocological
chloride NN Pharmocological
alone RB None
. . None
-DOCSTART- -X- N

ginseng NN Pharmocological
extract JJ Pharmocological
supplementation NN Pharmocological
ginseng NN Pharmocological
extract NN Pharmocological
streptozotocin NN Pharmocological
Standardized VBN Pharmocological
ginseng NN Pharmocological
extract NN Pharmocological
ginseng JJ Pharmocological
extract NN Pharmocological
Ginseng NNP Pharmocological
extract NN Pharmocological
-DOCSTART- -X- N

IMZ NNP None
or CC None
ITI NNP None
implants NNS None
: : None
IMZ NNP None
implant NN None
the DT None
Br?nemark NNP None
implant NN None
system NN None
the DT None
ITI NNP None
implant NN None
system NN None
-DOCSTART- -X- N

Desmopressin NNP Pharmocological
desmopressin NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
desmopressin NN Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
desmopressin NN Pharmocological
desmopressin NN Pharmocological
and CC None
placebo NN Control
groups NNS None
-DOCSTART- -X- N

reporting VBG Physical
the DT Physical
presence NN Physical
of IN Physical
MBD NNP Physical
in IN Physical
the DT Physical
screening NN Physical
mammography NN Physical
results NNS Physical
letter NN Physical
that WDT Physical
was VBD Physical
sent VBN Physical
along IN Physical
with IN Physical
an DT Physical
information NN Physical
pamphlet NN Physical
. . None
controls NNS Control
annual JJ Physical
clinical JJ Physical
breast NN Physical
examination NN Physical
-DOCSTART- -X- N

Continuous JJ None
low-level JJ None
heatwrap NN None
therapy NN None
continuous JJ Physical
low-level JJ Physical
heatwrap NN Physical
therapy NN Physical
placebo-controlled JJ Control
( ( None
heatwrap NN Physical
, , Physical
n=95 RB Physical
; : Physical
oral JJ Physical
placebo NN Physical
, , Physical
n=96 NN Physical
) ) Physical
and CC None
blinding VBG Control
( ( Control
oral JJ Control
ibuprofen NN Control
, , Control
n=12 RB Control
; : Control
unheated VBN Control
back RB Control
, , Control
wrap NN Control
n=16 NN Control
) ) Control
. . None
Heatwrap NNP Physical
therapy NN Physical
placebo NN Control
heatwrap NN Physical
placebo NN Control
. . None
heatwrap NN Physical
heatwrap NN Physical
therapy NN Physical
-DOCSTART- -X- N

Naltrexone NN Pharmocological
naltrexone NN Pharmocological
naltrexone CD Pharmocological
or CC None
placebo NN Control
and CC None
received VBD None
daily JJ None
doses NNS None
over IN None
a DT None
period NN None
of IN None
21 CD None
days NNS None
. . None
Naltrexone NN Pharmocological
placebo VB Control
naltrexone NN Pharmocological
Naltrexone NN Pharmocological
-DOCSTART- -X- N

Topical JJ Pharmocological
treatment NN Pharmocological
dinitrochlorobenzene NN Pharmocological
( ( Pharmocological
DNCB NNP Pharmocological
) ) Pharmocological
contact NN Pharmocological
allergens NNS Pharmocological
. . None
croton NN Pharmocological
oil NN Pharmocological
DNCB NNP Pharmocological
. . None
DNCB NNP Pharmocological
-DOCSTART- -X- N

Placebo-controlled JJ Control
naltrexone NN Pharmocological
placebo-controlled JJ Control
naltrexone NN Pharmocological
. . None
Naltrexone CD Pharmocological
naltrexone NN Pharmocological
-DOCSTART- -X- N

5-fluorouracil JJ Pharmocological
( ( Pharmocological
FU NNP Pharmocological
) ) Pharmocological
-based VBD Pharmocological
5-FU/folinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
FA NNP Pharmocological
, , Pharmocological
FUFA NNP Pharmocological
) ) Pharmocological
alone RB Pharmocological
or CC Pharmocological
in IN Pharmocological
combination NN Pharmocological
with IN Pharmocological
irinotecan JJ Pharmocological
5-fluorouracil/folinic JJ Pharmocological
acid NN Pharmocological
and CC Pharmocological
irinotecan JJ Pharmocological
( ( Pharmocological
FOLFIRI NNP Pharmocological
) ) Pharmocological
stratified VBN Pharmocological
by IN Pharmocological
TS NNP Pharmocological
( ( Pharmocological
low JJ Pharmocological
versus RB Pharmocological
high JJ Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

laryngeal JJ Other
LMA NNP None
Unique? NNP None
in IN None
the DT None
self-pressurised JJ None
air-Q? JJ None
intubating NN None
laryngeal NN None
airway RB None
( ( None
air-Q JJ None
SP NNP None
) ) None
with IN None
the DT None
-DOCSTART- -X- N

dexketoprofen NN Pharmocological
dexketoprofen NNS Pharmocological
trometamol VBP Pharmocological
ilioinguinal JJ Pharmocological
iliohypogastric JJ Pharmocological
block NN Pharmocological
saline NN Pharmocological
DB NNP Pharmocological
levobupivacaine NN Pharmocological
) ) None
dexketoprofen RB Pharmocological
. . None
morphine JJ Pharmocological
analgesia NN Pharmocological
IV NNP None
dexketoprofen NN None
increases NNS None
-DOCSTART- -X- N

active JJ Physical
physical JJ Physical
training NN Physical
active JJ Physical
training NN Physical
programme NN Physical
( ( Physical
AT NNP Physical
) ) Physical
with IN None
a DT None
physiotherapy NN Physical
treatment NN Physical
without IN Physical
active JJ Physical
training NN Physical
( ( Physical
PT NNP Physical
) ) Physical
-DOCSTART- -X- N

peroxide JJ Pharmocological
gel NN Pharmocological
scaling NN Surgical
and CC Physical
root NN Surgical
planing NN Surgical
Scaling NNP Surgical
and CC Surgical
root NN Surgical
planing NN Surgical
( ( Surgical
SRP NNP Surgical
) ) Surgical
SRP NNP Surgical
hydrogen NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
SRP VB Surgical
SRP NNP Surgical
combined VBN Physical
1.7 CD Pharmocological
% NN Pharmocological
hydrogen NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
( ( Pharmocological
Perio NNP Pharmocological
Gel NNP Pharmocological
) ) Pharmocological
brushed VBN Physical
twice RB Physical
daily RB Physical
with IN Physical
a DT Physical
regular JJ Physical
dentifrice NN Physical
and CC Physical
toothbrush NN Physical
SRP NNP Surgical
peroxide JJ Pharmocological
gel NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
SRP NNP Surgical
SRP NNP Surgical
SRP NNP Surgical
peroxide NN Pharmocological
gel NN Pharmocological
SRP NNP Surgical
SRP NNP Surgical
SRP NNP Surgical
SRP NNP Surgical
hydrogen NN Pharmocological
peroxide NN Pharmocological
gel NN Pharmocological
-DOCSTART- -X- N

chemical NN Surgical
or CC Surgical
surgical JJ Surgical
castration NN Surgical
alone RB Surgical
. . None
Anandron NNP Pharmocological
surgical JJ Surgical
castration NN Surgical
MAB NNP Pharmocological
using VBG Pharmocological
Anandron NNP Pharmocological
-DOCSTART- -X- N

computerized JJ Educational
touch NN Educational
screen NN Educational
version NN Educational
. . None
The DT None
computerized JJ Educational
version NN Educational
-DOCSTART- -X- N

treatment NN None
group NN None
( ( None
pricking VBG Physical
therapy NN Physical
group NN None
) ) None
and CC None
a DT None
control NN None
group NN None
( ( None
medication NN Surgical
group NN None
) ) None
. . None
pricking VBG Physical
thyroid JJ Physical
gland NN Physical
high JJ Physical
point NN Physical
or CC Pharmocological
oral JJ Control
administration NN Control
of IN Control
tapazole NN Control
. . Pharmocological
-DOCSTART- -X- N

methylprednisolone NN Pharmocological
Medrol NNP Pharmocological
methylprednisolone NN Pharmocological
methylprednisolone NN Pharmocological
Solu-Medrol NNP Pharmocological
. . None
methylprednisolone NN Pharmocological
. . None
methylprednisolone NN Pharmocological
-DOCSTART- -X- N

placebo NN Control
. . None
placebo NN Control
highly RB Educational
aversive JJ Educational
bitter NN Educational
taste NN Educational
. . None
fMRI NN None
design NN None
misleading NN Educational
cue NN Educational
-DOCSTART- -X- N

teniposide NN Pharmocological
teniposide NN Pharmocological
with IN Physical
whole-brain JJ Physical
radiotherapy NN Physical
-- : None
a DT None
Whole-brain JJ Physical
radiotherapy NN Physical
( ( Physical
WBRT NNP Physical
) ) Physical
WBRT NNP Physical
teniposide NN Pharmocological
WBRT NNP Physical
. . None
Teniposide NNP Pharmocological
WBRT NNP Physical
chemotherapy NN Pharmocological
. . None
teniposide-alone JJ Pharmocological
teniposide-alone JJ Pharmocological
WBRT NNP Physical
teniposide RB Pharmocological
-DOCSTART- -X- N

Sulfadoxine/pyrimethamine NNP Pharmocological
alone RB Pharmocological
or CC Pharmocological
with IN Pharmocological
amodiaquine JJ Pharmocological
or CC Pharmocological
artesunate NN Pharmocological
25 CD Pharmocological
mg/kg JJ Pharmocological
sulfadoxine NN Pharmocological
and CC Pharmocological
1.25 CD Pharmocological
mg/kg NN Pharmocological
pyrimethamine NN Pharmocological
plus CC Pharmocological
either DT Pharmocological
placebo NN Pharmocological
, , Pharmocological
25 CD Pharmocological
mg/kg NN Pharmocological
amodiaquine NN Pharmocological
, , Pharmocological
or CC Pharmocological
12 CD Pharmocological
mg/kg JJ Pharmocological
artesunate NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

cisplatin JJ Pharmocological
carboplatin NN Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
carboplatin JJ Pharmocological
standard NN Pharmocological
concurrent NN Pharmocological
chemoradiotherapy NN Pharmocological
with IN Pharmocological
cisplatin NN Pharmocological
Planned VBD Pharmocological
radiotherapy NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

Fulvestrant NNP Pharmocological
anastrozole NN Pharmocological
Fulvestrant NNP Pharmocological
fulvestrant NN Pharmocological
( ( None
250 CD None
mg NN None
monthly RB None
; : None
n CC None
= VB None
428 CD None
) ) None
with IN None
anastrozole NN Pharmocological
( ( None
1 CD None
mg NNS None
daily RB None
; : None
fulvestrant JJ Pharmocological
anastrozole-treated JJ Pharmocological
fulvestrant NN Pharmocological
-DOCSTART- -X- N

intravenously RB Pharmocological
administered VBN Pharmocological
histamine NN Pharmocological
Placebo NNP Pharmocological
or CC None
histamine NN Pharmocological
histamine NN Pharmocological
administration NN None
of IN None
histamine NN Pharmocological
Intravenous NNP Pharmocological
histamine NN Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

intravenous JJ Pharmocological
and CC Pharmocological
intramuscular JJ Pharmocological
morphine NN Pharmocological
opioids NNS Pharmocological
morphine NN Pharmocological
given VBN Pharmocological
IM NNP Pharmocological
or CC Pharmocological
IV NNP Pharmocological
IM NNP Pharmocological
or CC Pharmocological
IV NNP Pharmocological
morphine VBP Pharmocological
morphine JJ Pharmocological
surgery NN Surgical
morphine VBD Pharmocological
morphine NN Pharmocological
-DOCSTART- -X- N

nitazoxanide NN Pharmocological
nitazoxanide-a JJ Physical
new JJ None
broad-spectrum JJ None
antiparasitic JJ None
drug-on JJ None
-DOCSTART- -X- N

nutritional JJ None
counselling NN None
hypocaloric NN Pharmocological
diet NN Pharmocological
Optisource NNP Pharmocological
diet JJ Pharmocological
I PRP Pharmocological
with IN Pharmocological
lunch NN Pharmocological
and CC Pharmocological
dinner NN Pharmocological
substituted VBN Pharmocological
by IN Pharmocological
two CD Pharmocological
Optisource NNP Pharmocological
II NNP None
with IN None
nutritional JJ None
counselling VBG None
with IN None
a DT None
decrease NN None
of IN None
500 CD None
cal/day NN None
from IN None
the DT None
previous JJ None
dietary JJ None
intake NN None
. . None
commercial JJ Other
hypocaloric NN Other
formula NN Other
dietary JJ Pharmocological
counselling NN Pharmocological
-DOCSTART- -X- N

arachidonic JJ None
acid NN None
docosahexaenoic VB None
acid NN None
placebo-controlled JJ Control
Polyunsaturated VBN Pharmocological
fatty JJ Pharmocological
acids NNS Pharmocological
arachidonic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
ARA NNP Pharmocological
) ) Pharmocological
docosahexaenoic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DHA NNP Pharmocological
) ) Pharmocological
ARA NNP Pharmocological
ARA NNP Pharmocological
doses VBZ Pharmocological
added VBN Pharmocological
to TO Pharmocological
DHA NNP Pharmocological
placebo-controlled JJ Control
placebo NN Control
placebo NN Control
placebo NN Control
ARA NNP Pharmocological
doses VBZ Pharmocological
added VBN Pharmocological
to TO Pharmocological
DHA NNP Pharmocological
-DOCSTART- -X- N

Systematic JJ Physical
approach NN Physical
canalith NN Physical
repositioning VBG Physical
maneuver NN Physical
( ( Physical
CRM NNP Physical
) ) Physical
and CC Physical
vestibular JJ Physical
rehabilitation NN Physical
( ( Physical
VR NNP Physical
) ) Physical
the DT None
CRM NNP Control
and CC Control
avoidance NN Control
( ( Control
no DT Control
treatment NN Control
) ) Control
. . None
an DT None
individualized JJ Physical
combination NN Physical
of IN Physical
CRM NNP Physical
and CC Physical
VR NNP Physical
-DOCSTART- -X- N

pioglitazone NN Pharmocological
( ( None
thiazolidinediones NNS Pharmocological
[ NNP Pharmocological
TZDs NNP Pharmocological
] NNP None
) ) None
pioglitazone NN Pharmocological
pioglitazone NN Pharmocological
or CC None
placebo NN None
in IN None
addition NN None
to TO None
optimal VB None
medical JJ None
therapy NN None
. . None
TZD NNP Pharmocological
TZD NNP Pharmocological
placebo VB None
TZD NNP Pharmocological
TZD NNP Pharmocological
pioglitazone NN Pharmocological
-DOCSTART- -X- N

bexarotene NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
psoralen-ultraviolet NN Physical
A NNP Physical
( ( Pharmocological
PUVA NNP Pharmocological
) ) Pharmocological
compared VBN None
with IN None
PUVA NNP Physical
treatment NN Physical
alone RB Physical
Psoralen NNP Physical
plus CC Physical
ultraviolet VB Physical
A NNP Physical
( ( Physical
PUVA NNP Physical
) ) Physical
combined VBN None
bexarotene NN None
( ( None
Targretin NNP None
( ( None
? . None
) ) None
) ) None
and CC None
PUVA NNP None
vs. FW None
PUVA NNP None
alone RB None
PUVA NNP None
arm NN None
the DT None
PUVA-alone JJ None
arm NN None
. . None
for IN None
PUVA NNP None
alone RB None
for IN None
PUVA NNP None
vs. FW None
received VBD None
PUVA NNP None
alone RB None
received VBN None
fewer JJR None
PUVA NNP None
with IN None
the DT None
PUVA NNP None
arm NN None
UVA NNP None
the DT None
PUVA NNP None
( ( None
PUVA NNP None
+ NNP None
bexarotene NN None
) ) None
but CC None
-DOCSTART- -X- N

synthetic JJ Physical
human JJ Physical
secretin NN Physical
Secretin NNP Physical
secretin NN Physical
secretin JJ Physical
injections NNS Physical
. . None
placebo-controlled JJ Control
synthetic JJ Physical
human JJ Physical
secretin NN Physical
synthetic JJ None
human JJ None
secretin NN None
saline JJ Control
placebo NN Control
. . Control
secretin NN Physical
placebo NN Control
, , None
secretin FW Physical
secretin NN Physical
placebo NN Control
secretin NN Physical
placebo NN None
secretin NN Physical
human JJ Physical
secretin NN Physical
-DOCSTART- -X- N

text JJ Educational
processing NN Educational
strategies NNS Educational
-DOCSTART- -X- N

CT NNP Physical
and CC None
MRI NNP Physical
CT NNP Physical
MRI NNP Physical
-DOCSTART- -X- N

propofol NN Pharmocological
in IN Pharmocological
general JJ Pharmocological
anesthesia NN Pharmocological
( ( None
propofol NN Pharmocological
, , None
halothane NN Pharmocological
and CC None
midazolam/fentanyl NN Pharmocological
) ) None
in IN None
combination NN None
with IN None
catheter JJ None
epidural JJ None
anesthesia NN None
] NN None
. . None
epidural JJ Surgical
anaesthesia NN Surgical
bupivacaine NN Pharmocological
( ( Pharmocological
halothane NN Pharmocological
) ) Pharmocological
, , Pharmocological
light JJ Pharmocological
general JJ Pharmocological
anaesthesia NN Pharmocological
thiopental JJ Pharmocological
3-5 JJ Pharmocological
mg/kg NN Pharmocological
and CC Pharmocological
maintained VBD Pharmocological
with IN Pharmocological
halothane NN Pharmocological
. . None
propofol NN Pharmocological
midazolam FW Pharmocological
and CC Pharmocological
fentanyl NNS Pharmocological
intubated VBN Physical
non-depolarising JJ Pharmocological
muscle NN Pharmocological
relaxants NNS Pharmocological
manually RB Pharmocological
ventilated VBN Pharmocological
with IN Pharmocological
nitrous JJ Pharmocological
oxide-oxygen NN Pharmocological
morphine NN Pharmocological
epidurally RB Pharmocological
midazolam/fentanyl NN Pharmocological
propofol NN Pharmocological
midazolam/fentanyl NN Pharmocological
halothane NN Pharmocological
propofol NN Pharmocological
halothane NN Pharmocological
midazolam/fentanyl NN Pharmocological
Propofol NNP Pharmocological
midazolam/fentanyl NN Pharmocological
halothane NN Pharmocological
-DOCSTART- -X- N

randomly RB Educational
allocated VBN Educational
to TO Educational
three CD Educational
groups NNS Educational
: : Educational
intraoperative JJ Educational
music NN Educational
, , Educational
postoperative JJ Educational
music NN Educational
and CC Educational
silence NN Control
( ( Educational
control VB Educational
group NN Educational
) ) Educational
. . None
Anaesthesia NNP Physical
and CC Physical
postoperative JJ Physical
analgesia NN Physical
were VBD Physical
standardized VBN Physical
and CC None
the DT None
same JJ None
surgeon NN Surgical
performed VBD Surgical
all PDT Surgical
the DT Surgical
operations NNS Surgical
. . None
was VBD None
assessed VBN None
during IN None
and CC None
after IN None
surgery NN None
by IN None
determining VBG None
the DT None
was VBD None
evaluated VBN None
by IN None
studying VBG None
-DOCSTART- -X- N

heparin/hydrocortisone NN Pharmocological
i.v NN Pharmocological
. . None
catheters NNS Pharmocological
heparin JJ Pharmocological
hydrocortisone NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
porcine NN Pharmocological
secretin NN Pharmocological
porcine NN Pharmocological
secretin NN Pharmocological
placebo-controlled JJ Control
secretin NN Pharmocological
or CC None
placebo NN Control
infusion NN Control
placebo NN Control
secretin JJ Pharmocological
secretin NN Pharmocological
placebo NN Control
. . None
-DOCSTART- -X- N

endocervical JJ Physical
sampling VBG Physical
endocervical JJ Physical
sampling NN Physical
endocervical JJ Physical
sampling NN Physical
. . None
endocervical JJ Physical
sampling VBG Physical
with IN Physical
the DT Physical
Kevorkian NNP Physical
curette NN Physical
sampling VBG Physical
with IN Physical
the DT Physical
Medscand NNP Physical
endocervical JJ Physical
brush NN Physical
. . None
Endocervical NNP Physical
sampling VBG Physical
-DOCSTART- -X- N

Pentoxifylline NNP Pharmocological
pentoxifylline NN Pharmocological
pentoxifylline NN Pharmocological
at IN Pharmocological
a DT Pharmocological
dose NN Pharmocological
of IN Pharmocological
800 CD Pharmocological
mg JJ Pharmocological
thrice JJ Pharmocological
daily RB Pharmocological
6 CD Pharmocological
week NN Pharmocological
treatment NN Pharmocological
period NN Pharmocological
and CC None
a DT None
6 CD Control
week NN Control
control NN Control
period NN Control
. . None
-DOCSTART- -X- N

overt JJ Educational
aggression NN Educational
scale NN Educational
for IN None
rating NN None
aggression NN None
-DOCSTART- -X- N

donepezil NN Pharmocological
cognitive JJ Pharmocological
enhancing VBG Pharmocological
drugs NNS Pharmocological
cholinesterase NN Physical
inhibitors NNS Physical
placebo-controlled JJ Control
donepezil NN Pharmocological
( ( None
doses NNS None
of IN None
5 CD None
and CC None
10 CD None
mg NN None
) ) None
, , None
followed VBN None
by IN None
a DT None
10-week JJ None
open JJ None
label NN None
trial NN None
for IN None
placebo NN None
nonresponders NNS None
. . None
donepezil NN None
treatment NN None
-DOCSTART- -X- N

nutrition NN Physical
intervention NN Physical
nutrition NN Physical
intervention NN Physical
nutritious JJ Pharmocological
supplement NN Pharmocological
( ( Pharmocological
atole JJ Pharmocological
) ) Pharmocological
for IN Pharmocological
all DT Pharmocological
children NNS Pharmocological
and CC None
two CD Pharmocological
villages NNS Pharmocological
a DT Pharmocological
less RBR Pharmocological
nutritious JJ Pharmocological
one CD Pharmocological
( ( Pharmocological
fresco NN Pharmocological
) ) Pharmocological
. . None
atole VB Pharmocological
fresco VB Pharmocological
atole VB Pharmocological
atole VB Pharmocological
-DOCSTART- -X- N

investigation NN Physical
of IN Physical
the DT Physical
KeraVision NNP Physical
Intacs NNP Physical
. . None
KeraVision NNP Physical
Intacs NNP Physical
-DOCSTART- -X- N

erythromycin NN Pharmocological
and CC None
gentamicin NN Pharmocological
erythromycin JJ Pharmocological
control NN Control
, , None
2 CD None
mL NN None
of IN None
0.9 CD None
% NN None
NaCl NNP None
; : None
erythromycin NN Pharmocological
, , None
8.8 CD None
mg/kg NN None
; : None
low-dose JJ Pharmocological
gentamicin NN Pharmocological
, , None
4.4 CD None
mg/kg NN None
; : None
high-dose JJ Pharmocological
gentamicin NN Pharmocological
, , None
6.6 CD None
mg/kg NN None
. . None
acetaminophen NN Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
radiotherapy NN Physical
-DOCSTART- -X- N

Early RB Pharmocological
versus NN None
late JJ Physical
replacement NN Physical
of IN None
autotransfused JJ Pharmocological
blood NN Pharmocological
autologous JJ Pharmocological
blood NN Pharmocological
autologous JJ Pharmocological
autologous JJ Pharmocological
blood NN Pharmocological
reinfusion NN Pharmocological
in IN None
elective JJ None
spinal JJ Surgical
surgery NN Surgical
. . None
early JJ Pharmocological
versus NN None
delayed VBN Physical
reinfusion NN Physical
groups NNS Physical
early JJ Pharmocological
and CC None
delayed JJ Physical
reinfusion NN Physical
groups NNS None
. . None
early JJ Pharmocological
reinfusion NN Pharmocological
group NN Pharmocological
early JJ Pharmocological
versus NN None
delayed VBN Physical
reinfusion NN Physical
early JJ Pharmocological
reinfusion NN Pharmocological
-DOCSTART- -X- N

adriamycin NN Pharmocological
adriamycin JJ Pharmocological
Adriamycin NNP Pharmocological
adriamycin JJ Pharmocological
-DOCSTART- -X- N

Vaginal JJ Physical
electrical JJ Physical
stimulation NN Physical
of IN Physical
the DT Physical
pelvic JJ Physical
floor NN Physical
: : Physical
intravaginal JJ Physical
electrical JJ Physical
stimulation NN Physical
( ( Physical
ES NNP Physical
) ) Physical
ES NNP Physical
of IN Physical
the DT Physical
pelvic JJ Physical
floor NN Physical
ES NNP Physical
of IN Physical
the DT Physical
pelvic JJ Physical
floor NN Physical
, , None
or CC None
a DT None
daily JJ Physical
Kegel NNP Physical
exercise NN Physical
( ( Physical
KE NNP Physical
) ) Physical
program NN None
. . None
ES NNP None
KE NNP None
ES NNP None
ES NNP None
. . None
-DOCSTART- -X- N

short JJ Educational
theory NN Educational
of IN Educational
mind NN Educational
intervention NN Educational
theory NN Educational
of IN Educational
mind NN Educational
skills NNS Educational
short JJ Educational
theory NN Educational
of IN Educational
mind NN Educational
intervention NN Educational
intervention NN None
or CC None
a DT None
waiting JJ None
list NN None
control NN Control
group NN None
. . None
intervention NN None
mind NN Educational
intervention NN Educational
-DOCSTART- -X- N

polyvinylpyrrolidone-iodine NN Pharmocological
polyvinylpyrrolidone-iodine JJ Pharmocological
( ( Pharmocological
PVP-I NNP Pharmocological
) ) Pharmocological
procedure NN Educational
Terramycin NNP Pharmocological
cum NN Pharmocological
polymyxin NN Pharmocological
B NNP Pharmocological
cream NN Pharmocological
PVP-I NNP Pharmocological
PVP-I NNP Pharmocological
. . None
PVP-I NNP Pharmocological
PVP-I NNP Pharmocological
-DOCSTART- -X- N

diltiazem NNS Pharmocological
diltiazem NNS Pharmocological
nitroglycerin NN Pharmocological
diltiazem VB Pharmocological
or CC None
nitroglycerin VB Pharmocological
diltiazem NN Pharmocological
nitroglycerin NN Pharmocological
nitroglycerin NN Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
diltiazem NN Pharmocological
-DOCSTART- -X- N

Piperacillin/tazobactam NNP Pharmocological
plus CC None
tobramycin JJ Pharmocological
versus NN None
ceftazidime NN Pharmocological
plus CC Pharmocological
tobramycin NN Pharmocological
piperacillin NN Pharmocological
and CC Pharmocological
tazobactam NN Pharmocological
ceftazidime RB Pharmocological
tobramycin $ Pharmocological
piperacillin VB Pharmocological
tazobactam JJ Pharmocological
tobramycin $ Pharmocological
Vancomycin NNP Pharmocological
ceftazidime NN Pharmocological
piperacillin/tazobactam NN Pharmocological
antibacterial JJ Pharmocological
therapy NN Pharmocological
piperacillin/tazobactam NN Pharmocological
ceftazidime NN Pharmocological
piperacillin/ JJ Pharmocological
tazobactam JJ Pharmocological
ceftazidime NN Pharmocological
piperacillin/tazobactam NN Pharmocological
piperacillin/tazobactam NN Pharmocological
-DOCSTART- -X- N

population-based JJ Other
crosssectional JJ Other
survey NN Other
-DOCSTART- -X- N

estrogens NNS Pharmocological
at IN None
different JJ None
times NNS None
of IN None
the DT None
day NN None
conjugated VBN Pharmocological
equine JJ Pharmocological
estrogens NNS Pharmocological
conjugated JJ Pharmocological
equine NN Pharmocological
estrogens NNS Pharmocological
-DOCSTART- -X- N

laser NN Physical
photocoagulation NN Physical
solid-state NN Physical
green JJ Physical
laser NN Physical
( ( Physical
GLX NNP Physical
) ) Physical
multispot NN Physical
532-nm JJ Physical
pattern JJ Physical
scan JJ Physical
laser NN Physical
one CD Physical
eye NN Physical
with IN Physical
GLX NNP Physical
PASCAL NNP Physical
-DOCSTART- -X- N

750 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
stored JJ Pharmocological
plasma NN Pharmocological
, , None
750 CD Pharmocological
ml NN Pharmocological
of IN Pharmocological
fresh JJ Pharmocological
frozen JJ Pharmocological
plasma NN Pharmocological
, , None
and CC None
then RB None
an DT None
infusion NN Pharmocological
of IN Pharmocological
angiotensin NN Pharmocological
II NNP Pharmocological
Infusion NN Pharmocological
of IN Pharmocological
fresh JJ Pharmocological
frozen JJ Pharmocological
plasma NN Pharmocological
Angiotensin NNP Pharmocological
II NNP Pharmocological
infusion NN Pharmocological
1,000 CD Pharmocological
ml NNS Pharmocological
of IN Pharmocological
fresh JJ Pharmocological
frozen JJ Pharmocological
plasma NN Pharmocological
-DOCSTART- -X- N

insulin NN Pharmocological
continuous JJ Pharmocological
subcutaneous JJ Pharmocological
insulin NN Pharmocological
infusion NN Pharmocological
followed VBN None
by IN None
16 CD None
weeks NNS None
intensive JJ Pharmocological
injection NN Pharmocological
therapy NN Pharmocological
or CC None
the DT None
reverse JJ Pharmocological
order NN Pharmocological
. . None
insulin NN Pharmocological
insulin NN Pharmocological
-DOCSTART- -X- N

moderate-intensity NN Physical
exercise NN Physical
therapy NN None
. . None
brisk JJ Physical
walking VBG Physical
program NN Physical
exercise NN Physical
usual JJ Educational
care NN Educational
usual JJ Physical
care NN Physical
plus CC Physical
exercise NN Physical
. . None
exercise NN Physical
standardized JJ None
, , None
self-administered JJ None
, , None
home-based JJ Physical
brisk NN Physical
walking VBG Physical
intervention NN Physical
exercise NN Physical
programs NNS Physical
. . None
structured JJ Physical
exercise NN Physical
program NN Physical
-DOCSTART- -X- N

fluke NNS Pharmocological
and CC Pharmocological
worm VB Pharmocological
combination NN Pharmocological
products NNS Pharmocological
ivermectin NN Pharmocological
+ NNP None
clorsulon NN Pharmocological
injection NN Pharmocological
, , None
ivermectin JJ Pharmocological
+ JJ None
closantel NN Pharmocological
injection NN Pharmocological
, , None
or CC None
levamisole JJ Pharmocological
+ JJ None
triclabendazole JJ Pharmocological
oral JJ None
drench NN None
. . None
ivermectin JJ Pharmocological
+ NN None
clorsulon NN Pharmocological
( ( None
single JJ None
injection NN None
) ) None
ivermectin JJ Pharmocological
+ JJ None
closantel NN Pharmocological
levamisole JJ Pharmocological
+ JJ None
triclabendazole NN Pharmocological
-DOCSTART- -X- N

gabapentin NN Pharmocological
Gabapentin NNP Pharmocological
placebo-controlled JJ Control
single JJ Educational
and CC Educational
repeated VBD Educational
cutaneous JJ Educational
and CC Educational
intramuscular JJ Physical
electrical JJ Physical
stimulation NN Physical
( ( Educational
temporal JJ Physical
summation NN Physical
to TO Physical
5 CD Physical
stimuli NNS Physical
delivered VBN Educational
at IN Educational
2 CD Educational
Hz NNP Educational
) ) Educational
; : None
stimulus-response NN None
function NN None
relating VBG None
to TO None
increasing VBG None
current JJ None
intensities NNS None
for IN None
electrical JJ None
skin NN None
and CC None
muscle NN None
stimuli NNS None
( ( None
single JJ None
and CC None
repeated VBD None
, , None
determined VBD None
at IN None
baseline NN None
) ) None
; : None
of IN Pharmocological
hypertonic JJ Pharmocological
saline NN Pharmocological
. . Pharmocological
gabapentin NN Pharmocological
: : None
placebo NN None
Gabapentin NNP Pharmocological
-DOCSTART- -X- N

Activator NNP Pharmocological
protein-1 NN Pharmocological
( ( Pharmocological
AP-1 NNP Pharmocological
) ) Pharmocological
AP-1 NNP Pharmocological
( ( Pharmocological
activator IN Pharmocological
protein-1 NN Pharmocological
) ) Pharmocological
AP-1 NNP Pharmocological
activation NN Pharmocological
AP-1 NNP Pharmocological
inhibition NN Pharmocological
AP-1 JJ Pharmocological
activation NN Pharmocological
28 CD None
days NNS None
doxycycline NN None
or CC None
placebo NN None
the DT None
doxycycline NN None
intervention NN None
characterize VB None
AP-1 NNP None
as IN None
-DOCSTART- -X- N

low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
placebo NN Control
low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
with IN None
a DT None
placebo NN Control
. . None
placebo NN Control
Low-molecular-weight JJ Pharmocological
heparin NN Pharmocological
-DOCSTART- -X- N

Noninfiltrative JJ Pharmocological
anesthesia NN Pharmocological
lidocaine-prilocaine JJ Pharmocological
cream NN Pharmocological
lidocaine-ketorolac JJ Pharmocological
gel NN Pharmocological
. . None
anesthesia NN Pharmocological
Noninfiltrative NNP Pharmocological
anesthesia NN Pharmocological
perianal-intrarectal JJ Pharmocological
( ( Pharmocological
PI NNP Pharmocological
) ) Pharmocological
lidocaine NN Pharmocological
gel NN Pharmocological
, , None
lidocaine-ketorolac JJ Pharmocological
gel NN Pharmocological
lidocaine-prilocaine JJ Pharmocological
cream NN Pharmocological
PI NNP None
lidocaine JJ Pharmocological
gel NN Pharmocological
5 CD Pharmocological
g JJ Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
lidocaine JJ Pharmocological
gel NN Pharmocological
and CC Pharmocological
0.3 CD Pharmocological
% NN Pharmocological
ketorolac NN Pharmocological
tromethamine JJ Pharmocological
solution NN Pharmocological
1 CD None
hour NN None
before IN None
TPB NNP None
5 CD Pharmocological
g JJ Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
lidocaine NN Pharmocological
and CC Pharmocological
2.5 CD Pharmocological
% NN Pharmocological
prilocaine NN Pharmocological
cream NN Pharmocological
20 CD None
minutes NNS None
before IN None
TPB NNP None
ketorolac NN Pharmocological
prilocaine NN Pharmocological
to TO None
lidocaine VB Pharmocological
lidocaine-prilocaine JJ Pharmocological
, , None
lidocaine-ketorolac JJ Pharmocological
CONCLUSIONS NNP None
Lidocaine-prilocaine JJ None
cream NN None
whereas IN None
lidocaine-ketorolac JJ None
gel NN None
was VBD None
-DOCSTART- -X- N

DMSA NNP Pharmocological
therapy NN Pharmocological
oral JJ Pharmocological
dimercapto NN Pharmocological
succinic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
DMSA NNP Pharmocological
) ) Pharmocological
therapy NN Pharmocological
DMSA NNP Pharmocological
DMSA NNP Pharmocological
-DOCSTART- -X- N

application NN None
of IN None
C-reactive JJ Physical
protein NN Physical
High-sensitivity NNP Pharmocological
C-reactive JJ Pharmocological
protein NN Pharmocological
( ( Pharmocological
hsCRP NN Pharmocological
) ) Pharmocological
hsCRP NN Pharmocological
hsCRP NN Pharmocological
hsCRP NN Pharmocological
hsCRP NN Pharmocological
hsCRP JJ Pharmocological
hsCRP JJ Pharmocological
-DOCSTART- -X- N

versus NN Pharmocological
intravenous JJ Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
. . None
Fluconazole NNP Pharmocological
( ( Pharmocological
FLU NNP Pharmocological
) ) Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
AMB NNP Pharmocological
) ) Pharmocological
receive VB None
antifungal JJ Pharmocological
prophylaxis NN Pharmocological
with IN Pharmocological
AMB NNP Pharmocological
( ( Pharmocological
0.5 CD Pharmocological
mg/kg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
weekly JJ Pharmocological
) ) None
or CC None
FLU NNP Pharmocological
( ( None
400 CD None
mg NNS None
daily RB None
) ) None
. . None
Trimethoprim-sulfamethoxazole NN Pharmocological
was VBD None
administered VBN None
as IN None
an DT None
antibacterial JJ None
prophylaxis NN None
. . None
Prophylaxis NNP None
was VBD None
continued VBN None
until IN None
the DT None
patient NN None
achieved VBD None
complete JJ None
remission NN None
or CC None
was VBD None
treated VBN None
for IN None
8 CD None
weeks NNS None
without IN None
antileukemic JJ None
response NN None
. . None
AMB NNP Pharmocological
FLU NNP Pharmocological
AMB NNP Pharmocological
FLU NNP Pharmocological
-DOCSTART- -X- N

Gum NNP Physical
elastic JJ Physical
bougie-guided JJ Physical
insertion NN Physical
gum VBZ Physical
elastic-bougie-guided JJ Physical
insertion NN Physical
second JJ Surgical
insertion NN Surgical
attempt NN Surgical
using VBG Surgical
either CC Surgical
the DT Surgical
gum JJ Surgical
elastic JJ Surgical
bougie-guided JJ Surgical
or CC Surgical
introducer JJ Surgical
tool NN Surgical
techniques NNS Surgical
. . Surgical
bougie-guided JJ Physical
technique NN Physical
introducer JJ Physical
tool NN Physical
technique NN Physical
gum JJ Physical
elastic JJ Physical
bougie-guided JJ Physical
insertion NN Physical
tool NN None
insertion NN None
technique NN None
-DOCSTART- -X- N

Digestive JJ Pharmocological
enzyme NN Pharmocological
supplementation NN Pharmocological
digestive JJ Pharmocological
enzyme NN Pharmocological
supplement NN Pharmocological
placebo-controlled JJ Control
placebo NN Control
enzyme NN Pharmocological
-DOCSTART- -X- N

dalcetrapib NN Pharmocological
novel JJ Surgical
non-invasive JJ Surgical
multimodality NN Surgical
imaging NN Surgical
( ( Surgical
dal-PLAQUE JJ Surgical
) ) Physical
: : None
Dalcetrapib NNP Pharmocological
dalcetrapib VB Pharmocological
600 CD Pharmocological
mg/day NN Pharmocological
or CC None
placebo NN Control
for IN None
24 CD None
months NNS None
. . None
dalcetrapib NN Pharmocological
dalcetrapib NNS Pharmocological
placebo VB Control
dalcetrapib NN None
group NN None
placebo NN None
group NN None
. . None
Dalcetrapib NNP None
did VBD None
not RB None
INTERPRETATION NNP None
Dalcetrapib NNP None
showed VBD None
of IN None
dalcetrapib NN None
, , None
including VBG None
-DOCSTART- -X- N

Recombinant JJ Pharmocological
human JJ Pharmocological
granulocyte NN Pharmocological
and CC Pharmocological
granulocyte-macrophage JJ Pharmocological
colony-stimulating JJ Pharmocological
factor NN Pharmocological
( ( Pharmocological
G-CSF NNP Pharmocological
and CC Pharmocological
GM-CSF NNP Pharmocological
) ) Pharmocological
cytotoxic NN Pharmocological
chemotherapy NNS Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
G-CSF NNP Pharmocological
GM-CSF NNP Pharmocological
post-chemotherapy NN Pharmocological
. . None
dexamethasone RB Pharmocological
24 CD Pharmocological
mg JJ Pharmocological
days NNS Pharmocological
1-7 CD Pharmocological
, , Pharmocological
melphalan FW Pharmocological
30 CD Pharmocological
mg/m2 NNS Pharmocological
day NN Pharmocological
3 CD Pharmocological
, , Pharmocological
BCNU NNP Pharmocological
60 CD Pharmocological
mg/m2 NN Pharmocological
day NN Pharmocological
3 CD Pharmocological
, , Pharmocological
etoposide RB Pharmocological
75 CD Pharmocological
mg/m2 JJ Pharmocological
days NNS Pharmocological
4-7 CD Pharmocological
, , Pharmocological
Ara-C NNP Pharmocological
100 CD Pharmocological
mg/m2 NN Pharmocological
twice RB Pharmocological
daily JJ Pharmocological
days NNS Pharmocological
4-7 JJ Pharmocological
( ( Pharmocological
Dexa-BEAM NNP Pharmocological
) ) Pharmocological
receive VB Pharmocological
5/microg/kg/day CD Pharmocological
G-CSF NNP Pharmocological
5 CD Pharmocological
microg/kg/day JJ Pharmocological
GM-CSF NNP Pharmocological
Dexa-BEAM NNP Pharmocological
. . None
cyclophosphamide NN Pharmocological
BCNU NNP Pharmocological
etoposide RB Pharmocological
-DOCSTART- -X- N

rituximab NN Pharmocological
etoposide JJ Pharmocological
and CC Pharmocological
G-CSF JJ Pharmocological
with IN Pharmocological
or CC Pharmocological
without IN Pharmocological
rituximab NN Pharmocological
etoposide JJ Pharmocological
etoposide NN Pharmocological
, , Pharmocological
G-CSF NNP Pharmocological
and CC Pharmocological
rituximab NN Pharmocological
. . None
-DOCSTART- -X- N

facial JJ Educational
sensory JJ Educational
re-training NN Educational
standard JJ Educational
opening NN Educational
exercises VBZ Educational
re-training JJ Educational
-DOCSTART- -X- N

laryngeal NN Physical
methylene NN Pharmocological
blue JJ Pharmocological
capsule NN Pharmocological
-DOCSTART- -X- N

L-arginine NNP Pharmocological
or CC None
L-citrulline JJ Pharmocological
oral JJ Pharmocological
supplementation NN Pharmocological
L-arginine NNP Pharmocological
and CC None
L-citrulline NNP Pharmocological
L-arginine NNP Pharmocological
the DT None
citrulline NN None
( ( None
Administration NNP None
of IN None
L-arginine NNP None
and CC None
-DOCSTART- -X- N

home-visit JJ Educational
invitation NN Educational
in-home JJ Educational
education NN Educational
and CC Educational
invitation NN Educational
intervention NN Educational
intervention NN Educational
control VB Control
zone NN Control
. . Control
visited VBN Educational
in IN Educational
their PRP$ Educational
homes NNS Educational
by IN Educational
one CD Educational
of IN Educational
the DT Educational
researchers NNS Educational
, , Educational
who WP Educational
provided VBD Educational
culturally-sensitive JJ Educational
health NN Educational
education NN Educational
that WDT Educational
emphasized VBD Educational
the DT Educational
need NN Educational
for IN Educational
screening VBG Educational
. . Educational
screening-coverage JJ Educational
interviews NNS Educational
home NN Educational
visit NN Educational
education NN Educational
and CC Educational
invitation NN Educational
intervention NN Educational
-DOCSTART- -X- N

resources NNS None
used VBN None
for IN None
intensive JJ Physical
and CC Physical
conventional JJ Physical
therapy NN Physical
and CC None
to TO None
deal VB None
with IN None
the DT None
side NN None
effects NNS None
of IN None
therapy NN None
were VBD None
assessed VBN None
at IN None
each DT None
of IN None
the DT None
and CC None
summarized VBN None
. . None
Unit NN None
costs NNS None
were VBD None
derived VBN None
from IN None
the DT None
DCCT NNP None
, , None
manufacturers NNS None
, , None
and CC None
Medicare NNP None
DCCT NNP None
DCCT NNP None
DCCT NNP None
intensive JJ None
therapy NN None
-DOCSTART- -X- N

Similac NNP Pharmocological
With IN Pharmocological
Iron NNP Pharmocological
. . None
-DOCSTART- -X- N

treatment NN None
-DOCSTART- -X- N

( ( None
control NN Physical
, , None
desensitizer NN Physical
, , None
disinfectant NN Physical
, , None
saliva NN Physical
, , None
blood NN Physical
, , None
and CC None
hydrogen VB Pharmocological
peroxide NN Pharmocological
) ) None
( ( None
scanning VBG Physical
electron RB Physical
microscopy NN Physical
) ) None
-DOCSTART- -X- N

simvastatin NN Pharmocological
simvastatin NN Pharmocological
( ( Pharmocological
MK NNP Pharmocological
733 CD Pharmocological
) ) None
HMG NNP None
CoA NNP None
reductase NN None
, , None
alone RB None
and CC None
in IN None
combination NN None
with IN None
a DT None
bile JJ Pharmocological
acid NN Pharmocological
sequestrant NN Pharmocological
, , Pharmocological
cholestyramine NN Pharmocological
simvastatin JJ Pharmocological
treatment NN Pharmocological
cholestyramine NN Pharmocological
cholestyramine JJ Pharmocological
treatment NN Pharmocological
simvastatin NN Pharmocological
simvastatin-cholestyramine JJ Pharmocological
regimen NNS Pharmocological
-DOCSTART- -X- N

influenza NN Pharmocological
vaccine NN Pharmocological
, , Pharmocological
trivalent NN Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
2 CD Pharmocological
doses NNS Pharmocological
of IN Pharmocological
influenza JJ Pharmocological
vaccine NN Pharmocological
, , None
or CC None
placebo VB Control
influenza JJ Pharmocological
vaccine NN Pharmocological
placebo NN Control
influenza JJ Pharmocological
vaccine NN Pharmocological
placebo NN Control
. . Control
placebo NN Control
influenza NN Pharmocological
vaccine NN Pharmocological
influenza NN Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

administration NN Pharmocological
of IN Pharmocological
exogenous JJ Pharmocological
growth NN Pharmocological
hormone NN Pharmocological
placebo-controlled JJ Control
recombinant JJ Pharmocological
human JJ Pharmocological
growth NN Pharmocological
hormone NN Pharmocological
( ( Pharmocological
rhGH NN Pharmocological
) ) Pharmocological
placebo JJ Control
bicycle NN Physical
exercise NN Physical
test NN Physical
-DOCSTART- -X- N

chemotherapy NN Pharmocological
chemotherapy NN Pharmocological
vincristine NN Pharmocological
cyclophosphamide NN Pharmocological
5-fluoro-uracil JJ Pharmocological
doxorubicine NN Pharmocological
methotrexate NN Pharmocological
doxorubicine NN Pharmocological
chemotherapy NN Pharmocological
-DOCSTART- -X- N

endoscopic NNS Physical
resection NN Physical
techniques NNS Physical
endoscopic JJ Physical
resection NN Physical
techniques NNS Physical
Fifty NNP Physical
endoscopic JJ Physical
resections NNS Physical
suck-and-ligate JJ Physical
device NN Physical
without IN Physical
prior JJ Physical
submucosa NN Physical
injection NN Physical
and CC Physical
the DT Pharmocological
cap NN Pharmocological
technique NN Pharmocological
with IN Pharmocological
prior JJ Pharmocological
submucosa JJ Pharmocological
injection NN Pharmocological
of IN Pharmocological
a DT Pharmocological
dilute JJ Pharmocological
saline JJ Pharmocological
solution NN Pharmocological
of IN Pharmocological
epinephrine NN Pharmocological
. . None
endoscopic NN None
therapy NN None
cap NN Educational
technique NN Educational
ligation NN Educational
technique NN Educational
-DOCSTART- -X- N

Standard NNP Physical
red VBD Physical
cell NN Physical
serological JJ Physical
techniques NNS Physical
-DOCSTART- -X- N

pre- NN Physical
and CC Physical
postoperative JJ Physical
radiation NN Physical
( ( Physical
45 CD Physical
Gy NNP Physical
) ) Physical
surgery NN Surgical
only RB Surgical
. . None
preoperative JJ Physical
irradiation NN Physical
irradiated JJ Physical
postoperative JJ Physical
preoperatively RB Physical
irradiated JJ Physical
surgery NN Surgical
postoperatively RB Physical
irradiated JJ Physical
surgery NN Surgical
preoperatively RB Physical
treated JJ Physical
postoperative JJ Physical
-DOCSTART- -X- N

iodine NN Pharmocological
iodine NN Pharmocological
dose NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
iodine NN Pharmocological
-DOCSTART- -X- N

Rioprostil NNP Pharmocological
Rioprostil NNP Pharmocological
ranitidine NN Pharmocological
, , Pharmocological
150 CD Pharmocological
mg JJ Pharmocological
once-daily RB Pharmocological
orally RB Pharmocological
. . None
rioprostil NN Pharmocological
ranitidine NN Pharmocological
. . None
rioprostil NN Pharmocological
ranitidine NN Pharmocological
. . None
Rioprostil NNP Pharmocological
ranitidine NN Pharmocological
-DOCSTART- -X- N

two CD Other
oscillating/rotating/pulsating VBG Other
toothbrushes NNS Other
( ( None
Oral-B NNP Other
ProfessionalCare NNP Other
7000 CD Other
[ NNP Other
PC NN Other
7000 CD Other
] NN None
and CC None
Oral-B JJ Other
3D CD Other
Excel NNP Other
[ VBD Other
3DE CD Other
] NN None
) ) None
and CC None
a DT None
high-frequency NN None
toothbrush NN None
( ( None
Sonicare NNP None
Advance NNP None
, , None
Philips NNP None
Oral NNP None
Healthcare NNP None
; : None
SA NNP None
) ) None
-DOCSTART- -X- N

distinctive JJ Educational
information NN Educational
studying VBG Educational
pictures NNS Educational
retrieval NN Educational
strategy NN Educational
. . Educational
picture NN Educational
encoding VBG Educational
word NN Educational
encoding NN Educational
. . Educational
test NN Educational
-DOCSTART- -X- N

phenytoin NN Pharmocological
phenytoin NN Pharmocological
-DOCSTART- -X- N

subconjunctival JJ Pharmocological
5-FU JJ Pharmocological
no DT Control
antimetabolite JJ Control
treatment NN Control
-DOCSTART- -X- N

salmeterol NN Pharmocological
, , None
salmeterol NN Pharmocological
+ NNP None
ipratropium NN Pharmocological
bromide NN Pharmocological
, , None
or CC None
placebo NN Control
. . None
-DOCSTART- -X- N

stapled VBN Surgical
technique NN Surgical
with IN Surgical
the DT Surgical
well-accepted JJ Surgical
conventional JJ Surgical
Stapled NNP Surgical
hemorrhoidectomy NN Surgical
-DOCSTART- -X- N

tocilizumab NN Pharmocological
tocilizumab NN Pharmocological
tocilizumab JJ Pharmocological
tocilizumab NN Pharmocological
placebo NN Control
tocilizumab-treated JJ Pharmocological
patients NNS None
infliximab JJ None
tocilizumab JJ None
treatment NN None
lower JJR None
. . None
Tocilizumab-treated JJ None
patients NNS None
reduced VBN None
by IN None
tocilizumab NN Pharmocological
treatment NN None
tocilizumab NNS None
were VBD None
-DOCSTART- -X- N

vitamin NN Pharmocological
A NNP Pharmocological
or CC Pharmocological
beta NN Pharmocological
carotene JJ Pharmocological
supplementation NN Pharmocological
vitamin NN Pharmocological
A DT Pharmocological
beta NN Pharmocological
carotene NN Pharmocological
placebo-controlled JJ Control
7000 CD None
?g NN None
of IN None
retinol NN None
equivalents NNS None
as IN None
retinyl NN None
palmitate NN None
, , None
42 CD None
mg NN None
of IN None
all-trans NNS None
beta JJ None
carotene NN None
, , None
or CC None
placebo NN None
. . None
the DT None
placebo NN None
the DT None
vitamin NN None
A NNP None
and CC None
beta NN None
carotene NN None
the DT None
placebo NN None
, , None
vitamin FW None
A NNP None
, , None
and CC None
beta NN None
carotene NN None
weekly JJ None
vitamin NN None
A DT None
or CC None
beta NN None
-DOCSTART- -X- N

radiotherapy NN Surgical
conventional JJ Physical
roentgen NN Physical
unit NN Physical
60Co CD Physical
unit NN Physical
60Co CD Physical
radiation NN Physical
60Co CD Physical
radiation NN Physical
-DOCSTART- -X- N

ovarian JJ Physical
cancer NN Physical
algorithm NN Physical
( ( Physical
ROCA NNP Physical
) ) Physical
screening NN None
with IN None
CA-125 NNP None
and CC None
transvaginal JJ None
ultrasound NN None
( ( None
TVU NNP None
) ) None
. . None
ovarian JJ Physical
cancer NN Physical
algorithm NN Physical
( ( Physical
ROCA NNP Physical
) ) Physical
ROCA NNP Physical
in IN Physical
PLCO NNP Physical
ROCA NNP Physical
ROCA NNP Physical
ROCA NNP Physical
ROCA NNP Physical
-DOCSTART- -X- N

intra-arterial JJ Physical
PO2 NNP Physical
sensor NN Physical
-DOCSTART- -X- N

1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo JJ Pharmocological
( ( Pharmocological
b NN Pharmocological
, , Pharmocological
f NN Pharmocological
) ) Pharmocological
pyrazino- NN Pharmocological
( ( Pharmocological
1,2 CD Pharmocological
-- : Pharmocological
d NN Pharmocological
) ) Pharmocological
- : Pharmocological
( ( Pharmocological
1,4 CD Pharmocological
) ) Pharmocological
-oxazepine NN Pharmocological
hydrogen NN Pharmocological
maleate NN Pharmocological
( ( Pharmocological
Org NNP Pharmocological
GC NNP Pharmocological
94 CD Pharmocological
) ) Pharmocological
. . Pharmocological
1,3,4,14b-Tetrahydro-2,7-dimethyl-2H-dibenzo JJ Pharmocological
( ( Pharmocological
b NN Pharmocological
, , Pharmocological
f NN Pharmocological
) ) Pharmocological
pyrazino- NN Pharmocological
( ( Pharmocological
1,2-d CD Pharmocological
) ) Pharmocological
- : Pharmocological
( ( Pharmocological
1,4 CD Pharmocological
) ) Pharmocological
-oxazepine NN Pharmocological
hydrogen NN Pharmocological
maleate NN Pharmocological
( ( Pharmocological
Org NNP Pharmocological
GC NNP Pharmocological
94 CD Pharmocological
) ) Pharmocological
Org NNP Pharmocological
GC NNP Pharmocological
94 CD Pharmocological
-DOCSTART- -X- N

amiloride NN Pharmocological
carbenoxolone NN Pharmocological
carbenoxolone NN Pharmocological
sodium NN Pharmocological
as IN Pharmocological
Biogastrone NNP Pharmocological
tablets VBZ Pharmocological
100 CD Pharmocological
mg NN Pharmocological
three CD Pharmocological
times NNS Pharmocological
a DT Pharmocological
day NN Pharmocological
dummy NN Control
tablets NNS Control
amiloride NN Pharmocological
amiloride NN Pharmocological
amiloride NN Pharmocological
spironolactone NN Pharmocological
-DOCSTART- -X- N

Single NNP Pharmocological
nucleotide JJ Pharmocological
polymorphism NN Pharmocological
single JJ Pharmocological
nucleotide NN Pharmocological
polymorphism NN Pharmocological
( ( Pharmocological
SNP NNP Pharmocological
) ) Pharmocological
C1772T NNP Pharmocological
polymorphism NN Pharmocological
HIF-1alpha NNP Pharmocological
activation NN Pharmocological
control NN Control
-DOCSTART- -X- N

Parent-based JJ Educational
sleep JJ Educational
education NN Educational
sleep JJ Educational
education NN Educational
to TO Educational
individual NN Educational
group NN Educational
format NN Educational
-DOCSTART- -X- N

fenbendazole JJ Pharmocological
ivermectin JJ Pharmocological
fenbendazole JJ Pharmocological
oral JJ Pharmocological
drench NN Pharmocological
in IN None
addition NN None
to TO None
an DT None
ivermectin JJ Pharmocological
pour-on NN Pharmocological
( ( Pharmocological
SG+IVPO NNP Pharmocological
) ) None
ivermectin JJ Pharmocological
pour-on NN Pharmocological
( ( Pharmocological
IVPO NNP Pharmocological
) ) Pharmocological
doramectin NN Pharmocological
injectable JJ Pharmocological
( ( Pharmocological
DMX NNP Pharmocological
) ) Pharmocological
alone RB Pharmocological
SG+IVPO-treated JJ Pharmocological
-DOCSTART- -X- N

Sunlight JJ Control
exposure NN Control
or CC None
vitamin NN Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
Vitamin NNP Pharmocological
D NNP Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
advised JJ Physical
sunlight NN Physical
exposure NN Physical
. . None
Vitamin NNP Pharmocological
D NNP Pharmocological
supplementation NN Pharmocological
advised JJ Control
sunlight JJ Control
exposure NN Control
vitamin NN None
D NNP None
supplementation NN None
or CC None
sunlight JJ None
exposure NN None
. . None
METHODS NNP None
effect NN None
of IN None
vitamin NN None
D NNP None
( ( None
3 CD None
) ) None
supplementation NN None
( ( None
daily JJ None
800 CD None
IU NNP None
or CC None
100,000 CD None
IU/3 NNP None
months NNS None
) ) None
or CC None
sunlight JJ None
exposure NN None
advice NN None
is VBZ None
supplementation NN None
( ( None
daily JJ None
800 CD None
or CC None
advice NN None
for IN None
sunlight JJ None
exposure NN None
for IN None
advised JJ None
sunlight NN None
exposure NN None
( ( None
supplementation NN None
vs FW None
sunshine NN None
p NN None
< NNP None
supplementation NN None
groups NNS None
than IN None
in IN None
the DT None
advised JJ None
sunlight NN None
CONCLUSION NNP None
Vitamin NNP None
D NNP None
supplementation NN None
is VBZ None
more RBR None
effective JJ None
than IN None
advised JJ None
sunlight JJ None
exposure NN None
for IN None
treating VBG None
-DOCSTART- -X- N

Propofol NNP Pharmocological
and CC None
isoflurane NN Pharmocological
propofol NN Pharmocological
isoflurane NN Pharmocological
. . None
randomised VBN None
crossover NN None
study NN None
to TO None
monitor VB None
-DOCSTART- -X- N

Epidural JJ Pharmocological
fentanyl-bupivacaine JJ Pharmocological
clonidine-bupivacaine NN Pharmocological
clonidine NN Pharmocological
50 CD Pharmocological
microg NNS Pharmocological
fentanyl NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
0.125 CD Pharmocological
% NN Pharmocological
bupivacaine NN Pharmocological
bupivacaine-clonidine JJ Pharmocological
bupivacaine-fentanyl JJ Pharmocological
fentanyl-bupivacaine JJ Pharmocological
clonidine-bupivacaine JJ Pharmocological
bupivacaine NN Pharmocological
clonidine NN Pharmocological
bupivacaine-fentanyl NN Pharmocological
. . None
-DOCSTART- -X- N

AnacEtrapib NNP Pharmocological
. . None
Anacetrapib NNP Pharmocological
anacetrapib NN Pharmocological
AnacEtrapib NNP Pharmocological
placebo-controlled JJ Control
anacetrapib NN Pharmocological
anacetrapib NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

satraplatin NN Pharmocological
platinum NN Pharmocological
plus CC Pharmocological
prednisone NN Pharmocological
vs. FW None
prednisone NN Pharmocological
alone RB Pharmocological
Satraplatin NNP Pharmocological
platinum NN Pharmocological
cisplatin-resistant JJ Pharmocological
narcotic JJ Pharmocological
analgesics NNS Pharmocological
. . None
satraplatin NN Pharmocological
prednisone JJ Pharmocological
prednisone VB Pharmocological
satraplatin NN Pharmocological
prednisone NN Pharmocological
prednisone NN Pharmocological
satraplatin NN Pharmocological
plus CC Pharmocological
prednisone NN Pharmocological
prednisone NN Pharmocological
satraplatin NN Pharmocological
prednisone NN Pharmocological
prednisone NN Pharmocological
satraplatin NN Pharmocological
and CC None
prednisone NN Pharmocological
-DOCSTART- -X- N

tamoxifen NN Pharmocological
tamoxifen NN Pharmocological
and CC None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
] NNP None
. . None
tamoxifen NN Pharmocological
( ( Pharmocological
TAM NNP Pharmocological
) ) None
TAM NNP Pharmocological
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
-DOCSTART- -X- N

Clonidine NNP Pharmocological
placebo-controlled JJ Control
clonidine NN Pharmocological
. . Pharmocological
clonidine NN Pharmocological
placebo NN Control
. . None
clonidine JJ Pharmocological
clonidine NN Pharmocological
placebo NN Control
. . None
Clonidine NNP Pharmocological
-DOCSTART- -X- N

resistance VB Physical
training NN Physical
resistance NN Physical
training NN Physical
11weeks CD Physical
of IN Physical
resistance NN Physical
exercise NN Physical
training NN Physical
either DT None
resistance NN None
exercise NN None
( ( None
n=19 JJ None
inactive JJ None
control NN None
group NN None
( ( None
n=18 RB None
randomised VBN None
to TO None
resistance VB None
training NN None
, , None
compared VBN None
to TO None
non-exercising JJ None
controls NNS None
-DOCSTART- -X- N

upright/inverted JJ Psychological
faces VBZ Psychological
with IN Psychological
direct/averted VBN Psychological
gaze NN Psychological
-DOCSTART- -X- N

Risperidone NNP Pharmocological
Risperidone NNP Pharmocological
risperidone NN Pharmocological
placebo-substitution JJ Control
risperidone NN Pharmocological
risperidone NN Pharmocological
risperidone NN Pharmocological
; : Pharmocological
Risperidone NNP Pharmocological
-DOCSTART- -X- N

enterostatin JJ Pharmocological
intake NN Pharmocological
Enterostatin NNP Pharmocological
( ( Pharmocological
ENT NNP Pharmocological
) ) Pharmocological
ENT NNP Pharmocological
ENT NNP Pharmocological
placebo-controlled JJ Control
( ( None
ENT NNP Pharmocological
PLA NNP Control
( ( None
ENT NNP Pharmocological
PLA NNP Control
( ( None
ENT $ Pharmocological
PLA NNP Control
( ( None
ENT NNP Pharmocological
PLA NNP Control
ENT NNP Pharmocological
-DOCSTART- -X- N

local JJ Physical
anaesthetics NNS Physical
EMLA NNP Pharmocological
cream NN Pharmocological
Ametop NNP Pharmocological
gel NN Pharmocological
Ametop NNP Pharmocological
gel NN Pharmocological
-DOCSTART- -X- N

Cyproheptadine NN Pharmocological
placebo-controlled JJ Control
cyproheptadine NN Pharmocological
, , None
a DT None
5-HT2 JJ Pharmocological
antagonist NN Pharmocological
placebo-controlled JJ Control
cyproheptadine NN Pharmocological
plus CC Pharmocological
haloperidol NN Pharmocological
cyproheptadine VB Pharmocological
+ NNP Pharmocological
haloperidol NN Pharmocological
haloperidol JJ Physical
+ JJ Control
placebo NN Control
haloperidol NN Pharmocological
and CC Pharmocological
cyproheptadine NN Pharmocological
cyproheptadine NN Pharmocological
. . None
cyproheptadine NN Pharmocological
with IN None
a DT None
conventional JJ Pharmocological
antipsychotic JJ Pharmocological
conventional JJ Control
antipsychotic JJ Control
alone NN Control
-DOCSTART- -X- N

risedronate NN Pharmocological
risedronate NN Pharmocological
risedronate NN Pharmocological
oral JJ Pharmocological
risedronate NN Pharmocological
calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
oral JJ Pharmocological
calcium NN Pharmocological
vitamin $ Pharmocological
D NNP Pharmocological
-DOCSTART- -X- N

indomethacin NN Pharmocological
anesthetized VBN Pharmocological
with IN Pharmocological
thiopental JJ Pharmocological
, , Pharmocological
fentanyl JJ Pharmocological
, , Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
, , Pharmocological
and CC Pharmocological
isoflurane NN Pharmocological
. . Pharmocological
intravenous JJ Pharmocological
indomethacin JJ Pharmocological
50 CD Pharmocological
mg NN Pharmocological
or CC None
placebo NN Pharmocological
administrated VBN Pharmocological
after IN Pharmocological
exposure NN Pharmocological
of IN Pharmocological
the DT Pharmocological
dura NN Pharmocological
. . None
was VBD Physical
measured VBN Physical
continuously RB Physical
subdurally RB Physical
with IN Physical
a DT Physical
22-gauge JJ Physical
canula NN Physical
connected VBN Physical
to TO Physical
a DT Physical
transducer NN Physical
. . None
indomethacin/placebo JJ None
indomethacin NN Pharmocological
-DOCSTART- -X- N

ten JJ Physical
different JJ Physical
restorative NN Physical
techniques NNS Physical
. . None
deionized JJ None
water NN None
for IN None
7d CD None
prior JJ None
to TO None
longitudinal JJ None
sectioning NN None
in IN None
a DT None
mesio-distal JJ None
plane NN None
. . None
polished VBN None
using VBG None
600-grit JJ Physical
SiC NNP Physical
abrasive JJ Physical
paper NN Physical
and CC None
etched VBD None
for IN None
10 CD None
s NN None
with IN None
50 CD None
% NN None
phosphoric JJ None
acid NN None
addition-cure JJ Physical
vinyl NN Physical
polysiloxane NN Physical
impression NN Physical
material NN Physical
and CC None
an DT None
epoxy JJ Physical
resin NN Physical
. . None
sputter-coated JJ Physical
with IN Physical
gold NN Physical
glass NN Physical
ionomer-based JJ Physical
restorations NNS Physical
resin-based JJ Physical
bonding NN Physical
-DOCSTART- -X- N

Stepping VBG Educational
Stones JJ Educational
Triple NNP Educational
P NNP Educational
group NN Educational
parenting VBG Educational
training NN Educational
-DOCSTART- -X- N

Small-diameter JJ Physical
hysteroscopy NN Physical
with IN Physical
Versapoint NNP Physical
resectoscopy NN Physical
with IN Physical
a DT Physical
unipolar JJ Physical
knife NN Physical
resectoscopy NN Physical
with IN Physical
monopolar JJ Physical
knife NNS Physical
small-diameter JJ Physical
hysteroscopy NN Physical
fitted VBN Physical
with IN Physical
a DT Physical
Versapoint NNP Physical
device NN Physical
. . None
Hysteroscopic NNP Physical
26F CD Physical
resectoscope NN Physical
with IN Physical
unipolar JJ Physical
knife NN Physical
5-mm JJ Physical
diameter NN Physical
hysteroscope NN Physical
with IN Physical
Versapoint NNP Physical
device NN Physical
hysteroscopy NN Physical
resectoscopy NN Physical
-DOCSTART- -X- N

Naltrexone NN Pharmocological
opiate JJ Pharmocological
antagonist NN Pharmocological
naltrexone NN Pharmocological
placebo NN Control
Naltrexone CC Pharmocological
placebo NN Control
-DOCSTART- -X- N

central JJ Physical
venous JJ Physical
catheters NNS Physical
. . None
tunnelled JJ Physical
and CC Physical
non-tunnelled JJ Physical
central JJ Physical
venous JJ Physical
catheters NNS Physical
tunnelled JJ Physical
catheters NNS Physical
conventional JJ Physical
catheters NNS Physical
cuffed NN Physical
, , Physical
tunnelled JJ Physical
central JJ Physical
venous JJ Physical
catheters NNS Physical
traditional JJ Physical
percutaneous JJ Physical
central JJ Physical
venous JJ Physical
catheters NNS Physical
-DOCSTART- -X- N

postmenopausal JJ Physical
hormonal JJ Physical
replacement NN Physical
therapy NN Physical
Mammograms NNP Physical
-DOCSTART- -X- N

adult NN None
confederate NN None
and CC None
an DT None
interaction NN None
partner NN None
, , None
) ) None
another DT None
adult NN None
human NN None
, , None
( ( None
2 CD None
) ) None
a DT None
touchscreen JJ None
computer NN None
game NN None
, , None
and CC None
( ( None
3 CD None
) ) None
a DT None
social JJ None
dinosaur NN None
robot NN None
. . None
-DOCSTART- -X- N

essential JJ Pharmocological
oils NNS Pharmocological
of IN Pharmocological
garlic NN Pharmocological
and CC Pharmocological
onion NN Pharmocological
garlic NN Pharmocological
and CC Pharmocological
onion NN Pharmocological
garlic NN Pharmocological
or CC Pharmocological
onion NN Pharmocological
essential JJ Pharmocological
oils NNS Pharmocological
Garlic NNP Pharmocological
and CC Pharmocological
onion NN Pharmocological
garlic NN Pharmocological
onion NN Pharmocological
garlic JJ Pharmocological
and CC Pharmocological
onion NN Pharmocological
-DOCSTART- -X- N

an DT None
ultrasound JJ Physical
Doppler NNP Physical
device NN Physical
in IN Physical
group NN Physical
II NNP Physical
and CC Physical
a DT Physical
real-time JJ Physical
ultrasonograph NN Physical
in IN Physical
group NN Physical
III NNP Physical
. . None
Central NNP Surgical
venous JJ Surgical
catheters NNS Surgical
were VBD Surgical
placed VBN Surgical
into IN Surgical
the DT Surgical
right JJ Surgical
IJV NNP Surgical
by IN Surgical
the DT Surgical
Seldinger NNP Surgical
technique NN Surgical
. . None
-DOCSTART- -X- N

Dronabinol NNP Pharmocological
versus NN None
megestrol NN Pharmocological
acetate VBP Pharmocological
versus NN Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
dronabinol NN Pharmocological
megestrol JJ Pharmocological
acetate NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
megestrol NN Pharmocological
acetate NN Pharmocological
dronabinol NN Pharmocological
-DOCSTART- -X- N

Beta NNP Physical
radiation NN Physical
intraoperative JJ Physical
beta NN Physical
radiation NN Physical
beta NN Physical
radiation NN Physical
. . None
-DOCSTART- -X- N

angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
inhibitor NN Pharmocological
calcium NN Pharmocological
antagonist NN Pharmocological
. . Pharmocological
angiotensin-converting JJ Pharmocological
enzyme NN Pharmocological
lisinopril NN Pharmocological
calcium NN Pharmocological
antagonist NN Pharmocological
nifedipine NN Pharmocological
lisinopril JJ Pharmocological
and CC Pharmocological
slow-release JJ Pharmocological
nifedipine NN Pharmocological
lisinopril NN Pharmocological
nifedipine JJ Pharmocological
lisinopril NN Pharmocological
nifedipine NN Pharmocological
lisinopril RB Pharmocological
nifedipine NN Pharmocological
lisinopril FW Pharmocological
nifedipine NN Pharmocological
-DOCSTART- -X- N

anesthetics NNS Pharmocological
halothane NN Pharmocological
, , None
enflurane NN Pharmocological
, , None
isoflurane NN Pharmocological
, , None
or CC None
balanced VBD Pharmocological
anesthesia NNS Pharmocological
with IN Pharmocological
enflurane/alfentanil NN Pharmocological
. . None
enflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
. . None
halothane NN Pharmocological
isoflurane NN Pharmocological
. . None
enflurane VB Pharmocological
alfentanil NN Pharmocological
isoflurane NN Pharmocological
Balanced NNP Pharmocological
anesthesia NN Pharmocological
with IN Pharmocological
enflurane/alfentanil NN Pharmocological
-DOCSTART- -X- N

( ( Physical
CAA NNP Physical
) ) Physical
colon-j-pouch JJ Physical
( ( Physical
CPA NNP Physical
) ) Physical
constructed VBD Physical
. . None
-DOCSTART- -X- N

pre-operative JJ Pharmocological
and CC Pharmocological
post-operative JJ Pharmocological
anastrozole NN Pharmocological
or CC Pharmocological
tamoxifen NN Pharmocological
. . None
following VBG None
pre-operative JJ Pharmocological
( ( Pharmocological
3 CD Pharmocological
months NNS Pharmocological
) ) Pharmocological
and CC Pharmocological
post-operative JJ Pharmocological
( ( Pharmocological
5 CD Pharmocological
years NNS Pharmocological
) ) Pharmocological
adjuvant VBP Pharmocological
treatment NN Pharmocological
with IN None
either DT None
anastrozole NN Pharmocological
or CC None
tamoxifen NN Pharmocological
. . None
receive VB None
anastrozole NN Pharmocological
( ( None
1 CD None
mg/day NN None
) ) None
plus CC None
tamoxifen JJ Control
placebo NN Control
or CC None
tamoxifen NN Pharmocological
( ( None
20 CD None
mg/day NN None
) ) None
plus CC None
anastrozole JJ Control
placebo NN Control
pre-operatively RB None
. . None
patients NNS None
continued VBD None
on IN None
the DT None
same JJ None
study NN None
medication NN None
as IN None
adjuvant JJ Pharmocological
therapy NN Pharmocological
for IN None
up IN None
to TO None
5 CD None
years NNS None
or CC None
until IN None
recurrence NN None
, , None
intolerable JJ None
toxicity NN None
or CC None
withdrawal NN None
of IN None
patient JJ None
consent NN None
. . None
anastrozole NN Pharmocological
tamoxifen NN Pharmocological
anastrozole NN Pharmocological
anastrozole JJ Pharmocological
and CC None
tamoxifen NN Pharmocological
anastrozole JJ Pharmocological
tamoxifen NN Pharmocological
. . None
-DOCSTART- -X- N

secretin NN Pharmocological
secretin NN Pharmocological
secretin NN Pharmocological
. . None
Human NNP Pharmocological
synthetic JJ Pharmocological
secretin NN Pharmocological
, , None
mean VBP None
dose JJ None
3.4 CD None
clinical JJ None
units NNS None
, , None
and CC None
placebo NN Control
were VBD None
administered VBN None
intravenously RB None
in IN None
randomized JJ None
order NN None
every DT None
4th CD None
wk NN None
, , None
on IN None
three CD None
occasions NNS None
each DT None
. . None
secretin NN Pharmocological
-DOCSTART- -X- N

Beta-carotene NNP Pharmocological
beta-Carotene NN Pharmocological
beta-carotene JJ Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
beta-carotene NN Pharmocological
beta-carotene NN Pharmocological
, , Pharmocological
180 CD Pharmocological
mg/day NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

oxidized VBN Pharmocological
regenerated VBN Pharmocological
cellulose NN Pharmocological
packed VBN Pharmocological
with IN Pharmocological
ORC NNP Pharmocological
gauze VBP Physical
soaked VBN Physical
in IN Physical
iodine NN Physical
ORC NNP Pharmocological
-DOCSTART- -X- N

imiquimod NN Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
vehicle NN Control
cream NN Control
imiquimod JJ Pharmocological
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
topically RB Pharmocological
imiquimod-treated JJ Pharmocological
vehicle-treated JJ Control
imiquimod-treated JJ Pharmocological
imiquimod NN Pharmocological
vehicle NN Control
5 CD Pharmocological
% NN Pharmocological
cream NN Pharmocological
vehicle NN Control
cream NN None
-DOCSTART- -X- N

eprinomectin JJ Pharmocological
versus NN None
ivermectin NN Pharmocological
eprinomectin NN Pharmocological
eprinomectin JJ Pharmocological
ivermectin NN Pharmocological
eprinomectin NN Pharmocological
eprinomectin NN Pharmocological
ivermectin NN Pharmocological
eprinomectin NN Pharmocological
-DOCSTART- -X- N

[ JJ None
Plasma NNP Pharmocological
separation NN Pharmocological
CVVHF NNP Pharmocological
plasmapheresis NN Physical
in IN Physical
combination NN Physical
with IN Physical
continuous JJ Physical
venovenous JJ Physical
hemofiltration NN Physical
( ( Physical
CVVHF NNP Physical
) ) Physical
-DOCSTART- -X- N

TGMD-2 NNP Educational
Test NNP Psychological
of IN Psychological
Gross NNP Psychological
Motor NNP Psychological
Development NNP Psychological
( ( Psychological
TGMD-2 NNP Psychological
) ) Psychological
TGMD-2 NNP Educational
( ( None
traditional JJ Other
protocol NN Other
, , None
picture NN Other
task NN Other
card NN Other
protocol NN Other
, , None
and CC None
picture NN Other
activity NN Other
schedule NN Other
protocol NN Other
) ) None
TGMD-2 NNP Educational
-DOCSTART- -X- N

coriander NN Pharmocological
oil NN Pharmocological
in IN None
coriander NN Pharmocological
oil NN Pharmocological
6 CD Pharmocological
% NN Pharmocological
coriander NN Pharmocological
oil NN Pharmocological
placebo NN Control
coriander NN Pharmocological
oil NN Pharmocological
Coriander NNP Pharmocological
oil NN Pharmocological
-DOCSTART- -X- N

interferon NN Pharmocological
. . None
interferon JJ Pharmocological
alpha-2a NN Pharmocological
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
cryotherapy NN Pharmocological
placebo-controlled JJ Control
cryotherapy NN Pharmocological
plus CC Pharmocological
subcutaneously RB Pharmocological
administered VBN Pharmocological
interferon NN Pharmocological
alpha-2a NN Pharmocological
cryotherapy NN Control
plus CC Control
placebo NN Control
. . None
adjuvant JJ Pharmocological
chemotherapy NN Pharmocological
placebo NN Control
interferon NN Pharmocological
placebo NN Control
interferon NN Pharmocological
therapy NN Pharmocological
interferon NN Pharmocological
placebo NN Control
Interferon NNP Pharmocological
alpha-2a NN Pharmocological
chemotherapeutic JJ Pharmocological
adjuvant NN Pharmocological
to TO Pharmocological
cryotherapy VB Pharmocological
-DOCSTART- -X- N

external JJ Physical
flow NN Physical
resistive NN Physical
( ( Physical
R NNP Physical
) ) Physical
and CC Physical
elastic JJ Physical
( ( Physical
E NNP Physical
) ) Physical
mechanical JJ Physical
loads NNS Physical
imperceptible JJ Educational
just RB Educational
perceptible JJ Educational
large JJ Educational
-DOCSTART- -X- N

terbinafine NN Pharmocological
. . None
terbinafine NN Pharmocological
( ( Pharmocological
CAS NNP Pharmocological
78628-80-5 NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

aripiprazole NN Pharmocological
aripiprazole NN Pharmocological
dosed VBN Pharmocological
flexibly RB Pharmocological
placebo NN Control
aripiprazole JJ Pharmocological
versus NN None
placebo NN Control
Aripiprazole NNP Pharmocological
-DOCSTART- -X- N

acyclovir NN Pharmocological
and CC None
vidarabine NN Pharmocological
. . None
intravenous JJ Pharmocological
acyclovir NNS Pharmocological
and CC None
vidarabine NN Pharmocological
acyclovir NN Pharmocological
vidarabine NN Pharmocological
Acyclovir NNP Pharmocological
acyclovir NN Pharmocological
acyclovir NN Pharmocological
vidarabine NN Pharmocological
-DOCSTART- -X- N

netilmicin-cefoxitin JJ Pharmocological
gentamicin-cefoxitin JJ Pharmocological
gentamicin NN Pharmocological
netilmicin NN Pharmocological
cefoxitin NN Pharmocological
gentamicin-cefoxitin JJ Pharmocological
netilmicin-cefoxitin JJ Pharmocological
-DOCSTART- -X- N

Ipratropium NNP Pharmocological
bromide NN Pharmocological
nasal NN Pharmocological
spray NN Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
( ( Pharmocological
IB NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
saline NN Control
nasal NN Control
spray NN Control
IB NNP Pharmocological
or CC None
saline NN Control
IB NNP Pharmocological
saline NN Control
IB NNP Pharmocological
or CC None
saline NN Control
) ) None
-DOCSTART- -X- N

prasugrel NN Pharmocological
prasugrel NN Pharmocological
prasugrel NN Pharmocological
. . None
of IN None
prasugrel NN Pharmocological
-DOCSTART- -X- N

atenolol NN Pharmocological
, , None
propranolol NN Pharmocological
, , None
oxprenolol NN Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
. . None
beta-blockade JJ Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
propranolol NN Pharmocological
, , Pharmocological
atenolol NN Pharmocological
, , None
or CC None
placebo NN Control
atenolol NN Pharmocological
propranolol NN Pharmocological
oxprenolol NN Pharmocological
, , Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
, , None
or CC None
placebo NN Pharmocological
. . None
disopyramide JJ Pharmocological
phosphate NN Pharmocological
. . None
three CD Pharmocological
beta-blockers NNS Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
disopyramide JJ Pharmocological
phosphate NN Pharmocological
-DOCSTART- -X- N

somatostatin NN None
infusion NN None
test NN None
bezafibrate JJ Pharmocological
medication NN Pharmocological
] NN None
infusion NN Pharmocological
test NN Pharmocological
of IN Pharmocological
bezafibrate NN Pharmocological
bezafibrate NN Pharmocological
bezafibrate NN Pharmocological
infusion NN Pharmocological
test NN Pharmocological
of IN Pharmocological
somatostatin NN Pharmocological
-DOCSTART- -X- N

oral JJ Pharmocological
, , Pharmocological
inactivated JJ Pharmocological
, , Pharmocological
whole-cell JJ Pharmocological
vaccine NN Pharmocological
for IN Pharmocological
vaccines NNS Pharmocological
whole-cell JJ Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
SsWC NNP Pharmocological
) ) Pharmocological
SsWC NNP Pharmocological
vaccine NN Pharmocological
placebo-controlled JJ Control
SsWC NNP Pharmocological
SsWC NNP Pharmocological
or CC None
placebo VB Control
SsWC NNP Pharmocological
SsWC NNP Pharmocological
SsWC NNP Pharmocological
-DOCSTART- -X- N

diltiazem NN Pharmocological
and CC Pharmocological
propranolol NN Pharmocological
diltiazem NN Pharmocological
( ( Pharmocological
D NNP Pharmocological
) ) Pharmocological
propranolol NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
D NNP Pharmocological
P NNP Pharmocological
D NNP Pharmocological
P NNP Pharmocological
D. NNP Pharmocological
P NNP Pharmocological
D NNP Pharmocological
P NNP Pharmocological
P NNP Pharmocological
D. NNP Pharmocological
D NNP Pharmocological
P VB Pharmocological
-DOCSTART- -X- N

treatment NN Pharmocological
. . None
short-term JJ Pharmocological
treatment NN Pharmocological
with IN Pharmocological
alprazolam NN Pharmocological
or CC None
imipramine NN Pharmocological
. . None
-DOCSTART- -X- N

low-dose JJ Physical
hormone NN Physical
therapy NN Physical
Chinese JJ Pharmocological
formulated VBN Pharmocological
herbs NN Pharmocological
products NNS Pharmocological
] NNP None
low-dose JJ Physical
hormone NN Physical
therapy NN Physical
( ( Physical
HT NNP Physical
) ) Physical
Chinese JJ Pharmocological
formulated VBN Pharmocological
herbs NN Pharmocological
products NNS Pharmocological
. . None
estradiol NN Pharmocological
valerate NN Pharmocological
( ( Pharmocological
E2 NNP Pharmocological
V NNP Pharmocological
) ) Pharmocological
1 CD Pharmocological
mg/d NN Pharmocological
+ NNP None
medroxyprogesterone NN Pharmocological
acetate NN Pharmocological
( ( Pharmocological
MPA NNP Pharmocological
) ) Pharmocological
2 CD Pharmocological
mg/d NN Pharmocological
; : None
group NN None
B NNP None
: : None
conjugated JJ Pharmocological
equine NN Pharmocological
estrogen NN Pharmocological
0.45 CD Pharmocological
mg/d NN Pharmocological
+ NNP None
MPA NNP Pharmocological
2 CD Pharmocological
group NN None
C NNP None
: : None
tibolone NN Pharmocological
group NN None
D NNP None
: : None
a DT Pharmocological
Chinese JJ Pharmocological
formulated VBN Pharmocological
herbs JJ Pharmocological
product NN Pharmocological
( ( Pharmocological
Kuntai NNP Pharmocological
) ) Pharmocological
calcium NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
low-dose JJ Pharmocological
HT NNP Pharmocological
-DOCSTART- -X- N

captopril NN Pharmocological
and CC None
propranolol NN Pharmocological
captopril NN Pharmocological
and CC None
of IN None
propranolol NNS Pharmocological
captopril NN Pharmocological
propranolol NN Pharmocological
. . None
captopril VB Pharmocological
Captopril NNP Pharmocological
-DOCSTART- -X- N

transporters NNS Other
DVD NNP Other
learning NN Educational
tool NN Educational
home NN Educational
based VBN Educational
DVD NNP Educational
intervention NN Educational
The DT Other
Transporters NNPS Other
DVD NNP Other
. . None
DVD NNP Other
alternate NN Other
DVD NNP Other
Transporters NNP Other
DVD NNP Other
-DOCSTART- -X- N

three CD Psychological
performed VBD Psychological
supportive-expressive JJ Psychological
psychotherapy NN Psychological
; : Psychological
three CD Psychological
, , Psychological
cognitive-behavioral JJ Psychological
psychotherapy NN Psychological
; : Psychological
and CC Psychological
three CD Psychological
, , Psychological
drug NN Psychological
counseling NN Psychological
. . Psychological
-DOCSTART- -X- N

magnesium NN Pharmocological
supplementation NN Pharmocological
magnesium NN Pharmocological
magnesium NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

recombinant JJ Educational
human JJ Educational
nerve NN Educational
growth NN Educational
factor NN Educational
Recombinant JJ Educational
human JJ Educational
nerve NN Educational
growth NN Educational
factor NN Educational
( ( Educational
rhNGF NN Educational
) ) Educational
placebo-controlled JJ Control
rhNGF NN Pharmocological
placebo NN Control
rhNGF NN Educational
placebo NN Control
. . None
rhNGF NN Pharmocological
rhNGF NN Pharmocological
. . None
rhNGF NN Pharmocological
-DOCSTART- -X- N

hydrocodone/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
oral JJ Pharmocological
hydrocodone/acetaminophen NN Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg/500 RB Pharmocological
mg NN Pharmocological
) ) Pharmocological
to TO Pharmocological
oral JJ Pharmocological
codeine/acetaminophen NN Pharmocological
( ( Pharmocological
30 CD Pharmocological
mg/300 RB Pharmocological
mg NN Pharmocological
) ) Pharmocological
. . None
hydrocodone/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
codeine/acetaminophen NN Pharmocological
-DOCSTART- -X- N

two-stage JJ Physical
restoration NN Physical
immediate JJ None
restoration NN None
groups NNS None
Restoring VBG Physical
-DOCSTART- -X- N

Beverage NNP Physical
vs. FW Educational
solid JJ Physical
fruits NNS Physical
and CC Physical
vegetables NNS Physical
: : Educational
Energy-matched JJ Physical
beverage NN Physical
or CC Educational
solid JJ Physical
forms NNS Physical
of IN Physical
fruits NNS Physical
and CC Physical
vegetables NNS Physical
-DOCSTART- -X- N

donor NN Educational
recruitment NN Educational
brochure NN Educational
. . None
blood NN Educational
donor NN Educational
recruitment NN Educational
materials NNS Educational
brochures NNS Educational
: : None
a DT Educational
new JJ Educational
brochure NN Educational
addressing VBG Educational
common JJ Educational
donor NN Educational
concerns NNS Educational
and CC Educational
suggesting VBG Educational
specific JJ Educational
coping VBG Educational
strategies NNS Educational
, , None
2 CD None
) ) None
a DT None
standard JJ Educational
blood NN Educational
center NN Educational
brochure NN Educational
a DT Control
control JJ Educational
brochure NN Educational
on IN Educational
healthy JJ Educational
eating NN Educational
and CC Educational
exercise NN Educational
. . None
-DOCSTART- -X- N

Face NNP Other
composite JJ Other
composite JJ Educational
paradigm NN Educational
. . None
-DOCSTART- -X- N

JobTIPS NN None
: : None
JobTIPS NNP None
employment NN None
program NN None
-DOCSTART- -X- N

cangrelor NN Pharmocological
cangrelor NN Pharmocological
cangrelor NN Pharmocological
cangrelor NN Pharmocological
placebo NN Control
cangrelor NN Pharmocological
cangrelor NN Pharmocological
ADP NNP Pharmocological
blockade NN Pharmocological
with IN Pharmocological
cangrelor NN Pharmocological
-DOCSTART- -X- N

Infrared NNP Physical
LED NNP Physical
irradiation NN Physical
LED NNP Physical
irradiation NN Physical
( ( None
1 CD None
) ) None
the DT None
LED NNP None
group NN None
( ( None
treadmill IN None
training VBG None
associated VBN None
with IN None
phototherapy NN None
, , None
n JJ None
= NNP None
10 CD None
) ) None
, , None
( ( None
2 CD None
) ) None
the DT None
exercise NN None
group NN None
( ( None
treadmill IN None
training NN None
, , None
n JJ None
= NNP None
10 CD None
) ) None
, , None
and CC None
( ( None
3 CD None
) ) None
the DT None
sedentary JJ None
group NN None
( ( None
neither DT None
physical JJ None
training NN None
nor CC None
phototherapy NN None
, , None
n JJ None
= NNP None
10 CD None
) ) None
. . None
The DT None
training NN None
the DT None
LED NNP None
exercise NN None
Therefore RB None
, , None
the DT None
infrared JJ None
LED NNP None
irradiation NN None
-DOCSTART- -X- N

Ganitumab NNP Pharmocological
exemestane NN Pharmocological
fulvestrant NN Pharmocological
Ganitumab NNP Pharmocological
intravenous JJ Pharmocological
ganitumab NNS Pharmocological
12 CD None
mg NNS None
per IN None
kg NN None
bodyweight NN None
or CC None
placebo NN Control
in IN None
combination NN None
with IN None
open-label JJ Physical
intramuscular JJ Physical
fulvestrant NN Pharmocological
( ( None
500 CD None
mg NN None
on IN None
day NN None
1 CD None
, , None
then RB None
250 CD None
mg NNS None
on IN None
days NNS None
15 CD None
, , None
29 CD None
, , None
and CC None
every DT None
28 CD None
days NNS None
) ) None
or CC None
oral JJ None
exemestane NN Pharmocological
( ( None
25 CD None
mg NN None
once RB None
daily RB None
) ) None
on IN None
a DT None
28-day JJ None
cycle NN None
. . None
Response NNP None
was VBD None
assessed VBN None
every DT None
8 CD None
weeks NNS None
. . None
ganitumab NN Pharmocological
ganitumab NN None
the DT None
ganitumab NN None
Addition NNP None
of IN None
ganitumab NN None
-DOCSTART- -X- N

ramipril NN Pharmocological
's POS Pharmocological
placebo VB Control
Ramipril NNP Pharmocological
Ramipril JJ Pharmocological
-DOCSTART- -X- N

test VB Educational
alternative JJ Educational
explanations NNS Educational
donate VB Educational
adults NNS None
donated VBD None
significantly RB None
-DOCSTART- -X- N

hyperbaric JJ Physical
oxygen NN Physical
treatment NN Physical
: : None
hyperbaric JJ Physical
oxygen NN Physical
treatment NN Physical
( ( Physical
HBOT NNP Physical
) ) Physical
HBOT NNP Physical
Doppler NNP Physical
imaging NN Physical
Early JJ None
HBOT NNP None
had VBD None
study NN None
. . None
HBOT NNP None
may MD None
-DOCSTART- -X- N

simvastatin NN Pharmocological
simvastatin JJ Pharmocological
simvastatin NN Pharmocological
placebo NN Control
Simvastatin NNP Pharmocological
placebo VB Control
statin NN None
-DOCSTART- -X- N

youdujing VBG Pharmocological
preparation NN Pharmocological
Youdujing NNP Pharmocological
( ( Pharmocological
YDJ NNP Pharmocological
) ) Pharmocological
preparation NN Pharmocological
treatment NN Control
control NN Control
YDJ NNP Control
external JJ Control
lotion NN Control
and CC Control
YDJ NNP Control
cream NN Control
normal JJ None
saline NN None
control NN Control
YDJ NNP Pharmocological
-DOCSTART- -X- N

hyaluronic JJ Pharmocological
acid NN Pharmocological
triamcinolone NN Pharmocological
hexacetonide NN Pharmocological
intra-articular JJ Pharmocological
( ( Pharmocological
i/a NN Pharmocological
) ) Pharmocological
triamcinolone NN Pharmocological
. . Pharmocological
hexacetonide NN Pharmocological
( ( Pharmocological
TH NNP Pharmocological
) ) Pharmocological
and CC Pharmocological
i/a JJ Pharmocological
hyaluronic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
HA NNP Pharmocological
) ) Pharmocological
five CD None
HA NNP Pharmocological
injections NNS Pharmocological
at IN None
weekly JJ None
intervals NNS None
; : None
or CC None
20 CD Control
mg NN Control
TH NNP Pharmocological
followed VBN None
by IN None
four CD None
placebo NN Control
( ( Control
saline NN Control
) ) Control
injections NNS Control
. . None
HA NNP Pharmocological
HA NNP Pharmocological
HA NNP Pharmocological
. . None
HA NNP Pharmocological
-DOCSTART- -X- N

Synthetic JJ Pharmocological
serum NN Pharmocological
substitute NN Pharmocological
( ( Pharmocological
SSS NNP Pharmocological
) ) Pharmocological
: : None
Plasmatein NNP Pharmocological
Plasmanate NNP Pharmocological
divided VBN None
and CC None
cultured VBN None
in IN None
human JJ Pharmocological
tubal JJ Pharmocological
fluid NN Pharmocological
medium NN Pharmocological
( ( Pharmocological
HTF NNP Pharmocological
) ) Pharmocological
supplemented VBD None
with IN None
either DT None
HSA NNP Pharmocological
( ( Pharmocological
5 CD Pharmocological
mg/mL NN Pharmocological
) ) Pharmocological
or CC None
Plasmatein NNP Other
( ( Pharmocological
10 CD Pharmocological
% NN Pharmocological
, , Pharmocological
v/v NN Pharmocological
; : Pharmocological
5 CD Pharmocological
mg/ml NN Pharmocological
) ) Pharmocological
as IN None
a DT None
means NN None
of IN None
indirectly RB None
assessing VBG None
the DT None
effect NN None
alpha- JJ None
and CC None
beta-globulins NNS None
have VBP None
on IN None
embryonic JJ None
development NN None
. . None
Plasmatein NNP Pharmocological
Plasmatein NNP Pharmocological
HSA NNP Pharmocological
Plasmatein NNP Pharmocological
SSS NNP Pharmocological
SSS NNP Pharmocological
Plasmatein NNP Pharmocological
Plasmatein NNP Pharmocological
SSS NNP Pharmocological
Synthetic NNP Pharmocological
serum NN Pharmocological
substitute NN Pharmocological
-DOCSTART- -X- N

neodymium-doped JJ Surgical
yttrium NN Surgical
aluminum NN Surgical
garnet NN Surgical
laser NN Surgical
treatment NN Surgical
cold JJ Surgical
knife NN Surgical
endoscopic NN Surgical
incision NN Surgical
visual JJ Surgical
laser NN Surgical
ablation NN Surgical
treatment NN Surgical
with IN Surgical
neodymium-doped JJ Surgical
yttrium NN Surgical
aluminum NN Surgical
garnet NN Surgical
( ( Surgical
Nd NNP Surgical
: : Surgical
YAG NN Surgical
) ) Surgical
visual JJ Surgical
laser NN Surgical
ablation NN Surgical
of IN Surgical
urethral JJ Surgical
strictures NNS Surgical
( ( Surgical
VLASU NNP Surgical
) ) Surgical
with IN Surgical
Nd NNP Surgical
: : Surgical
YAGlaser NN Surgical
correction NN None
of IN None
urethral JJ None
strictures NNS None
using VBG None
Sachse NNP Surgical
's POS Surgical
optical JJ Surgical
urethrotomy NN Surgical
. . None
optical JJ Surgical
urethrotomy NN Surgical
VLASU NNP Surgical
VLASU NNP Surgical
VLASU NNP Surgical
-DOCSTART- -X- N

Simplified NNP Psychological
subjective JJ Psychological
workload NN Psychological
assessment NN Psychological
technique NN Psychological
. . Educational
( ( Educational
SWAT NNP Educational
) ) Educational
five CD Psychological
variations NNS Psychological
of IN Psychological
SWAT NNP Psychological
continuous JJ Psychological
SWAT NNP Psychological
subscales NNS Psychological
discrete JJ Psychological
SWAT NNP Psychological
subscale NN Psychological
. . Educational
SWAT NNP Educational
original JJ Educational
SWAT NNP Educational
scale NN Educational
. . Educational
conventional JJ Educational
pretask JJ Educational
procedure NN Educational
-DOCSTART- -X- N

ophthalmic JJ Pharmocological
timolol NN Pharmocological
ophthalmic JJ Pharmocological
timolol NN Pharmocological
timolol NN Pharmocological
placebo NN Control
Timolol NNP Pharmocological
timolol-induced JJ Pharmocological
ophthalmic JJ Pharmocological
timolol NN Pharmocological
-DOCSTART- -X- N

Bovine NNP Pharmocological
pericardium NN Pharmocological
vs NN None
dacron NN Pharmocological
Bovine NNP Pharmocological
pericardium NN Pharmocological
( ( Pharmocological
BP NNP Pharmocological
) ) Pharmocological
Dacron NNP Pharmocological
carotid JJ Surgical
endarterectomy NN Surgical
. . None
BP NNP Pharmocological
and CC None
Dacron NNP Surgical
patch NN Surgical
angioplasty NN Surgical
BP NNP Pharmocological
Dacron NNP Surgical
. . None
carotid JJ Surgical
cross-clamp JJ Surgical
removal NN Surgical
BP NNP Pharmocological
Dacron NNP Surgical
BP NNP Pharmocological
Dacron NNP Surgical
BP NNP Pharmocological
Dacron NNP Surgical
BP NNP Pharmocological
Bovine NNP Pharmocological
pericardium NN Pharmocological
Dacron NNP Surgical
. . None
BP NNP Pharmocological
. . None
BP NNP Pharmocological
Dacron NNP Surgical
-DOCSTART- -X- N

recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
enzyme JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
( ( None
P NNP None
9808 CD None
) ) None
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
enzyme JJ Pharmocological
preparation NN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
porphobilinogen NN Pharmocological
deaminase NN Pharmocological
-DOCSTART- -X- N

radiotherapy NN Physical
cisplatin NN Pharmocological
paclitaxel NN Pharmocological
cisplatin NN Pharmocological
paclitaxel NN Pharmocological
standard JJ Physical
radiotherapy NN Physical
40 CD None
mg/m? NN None
Cisplatin NNP None
( ( None
group NN None
I PRP None
; : None
16 CD None
patients NNS None
) ) None
or CC None
50 CD None
mg/m? NNS None
paclitaxel NN None
( ( None
group NN None
II NNP None
; : None
15 CD None
patients NNS None
) ) None
concurrently RB None
with IN None
radiotherapy NN None
. . None
weekly VBP None
paclitaxel NN None
does VBZ None
weekly JJ None
cisplatin NN None
for IN None
concurrent JJ None
chemoradiation NN None
-DOCSTART- -X- N

radiotherapy NN Physical
vs. IN Surgical
trans-oral JJ Surgical
robotic JJ Surgical
surgery NN Surgical
( ( Surgical
ORATOR NNP Surgical
) ) Surgical
-- : Surgical
study NN Surgical
Primary JJ Physical
radiotherapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
concurrent NN Physical
chemotherapy NN Physical
Transoral NNP Surgical
robotic JJ Surgical
surgery NN Surgical
( ( Surgical
TORS NNP Surgical
) ) Surgical
TORS NNP Surgical
RT NNP Physical
primary JJ None
RT NNP None
( ( None
? . None
chemotherapy NN None
) ) None
TORS NNP None
( ( None
? . None
adjuvant NN None
[ NN None
chemo NN None
] NNP None
RT NNP None
) ) None
in IN None
1 CD None
( ( None
RT NNP None
? . None
chemotherapy NN None
) ) None
and CC None
( ( None
TORS NNP None
? . None
adjuvant JJ None
[ NN None
chemo NN None
] NNP None
RT NNP None
) ) None
. . None
In IN None
Arm NNP None
receive VB None
RT NNP None
alone RB None
, , None
receive VB None
concurrent JJ None
chemoradiation NN None
. . None
In IN None
Arm NNP None
2 CD None
undergo VB None
TORS NNP None
along IN None
with IN None
selective JJ None
neck NN None
dissections NNS None
, , None
which WDT None
may MD None
requirement NN None
for IN None
adjuvant JJ None
radiotherapy NN None
+/- JJ None
chemotherapy NN None
. . None
The DT None
primary JJ None
-DOCSTART- -X- N

Minimal NNP None
clinically RB None
important JJ None
change NN None
MCIC NNP None
MCIC NNP None
MCIC NNP None
MCIC NNP None
MCIC NNP None
-DOCSTART- -X- N

Anticholinergic NNP Pharmocological
drugs NNS Pharmocological
: : None
anticholinergic JJ Pharmocological
drugs NNS Pharmocological
atropine NN Pharmocological
glycopyrrolate NN Pharmocological
scopolamine NN Pharmocological
and CC None
placebo NN Control
Atropine NNP Pharmocological
glycopyrrolate NN Pharmocological
Scopolamine NNP Pharmocological
glycopyrrolate NN Pharmocological
Atropine NNP Pharmocological
atropine NN Pharmocological
, , None
glycopyrrolate NN Pharmocological
scopolamine NN Pharmocological
-DOCSTART- -X- N

timolol NN Pharmocological
latanoprost VB Pharmocological
latanoprost NN Pharmocological
timolol VB Pharmocological
timolol NN Pharmocological
timolol NN Pharmocological
timolol NN Pharmocological
latanoprost VB Pharmocological
latanoprost RB Pharmocological
timolol VB Pharmocological
-DOCSTART- -X- N

condition NN Educational
involving VBG Educational
negative JJ Educational
evaluation NN Educational
based VBN Educational
on IN Educational
( ( Educational
negative JJ Educational
evaluation/academic NN Educational
) ) Educational
, , Educational
or CC Educational
a DT Educational
condition NN Educational
involving VBG Educational
negative JJ Educational
evaluation NN Educational
based VBN Educational
on IN Educational
as RB Educational
well RB Educational
as IN Educational
negative JJ Other
evaluation/social JJ Other
rejection NN Other
stressor NN Other
negative JJ Other
evaluation/academic JJ Other
( ( Other
writing VBG Other
) ) Other
stressor NN Other
. . None
negative JJ Educational
evaluation/social JJ Educational
rejection NN Educational
stressor NN Educational
negative JJ Other
evaluation/academic JJ Other
stressor NN Other
. . None
social JJ Educational
rejection NN Educational
stressor NN Educational
negative JJ Other
evaluation NN Other
stressor NN Other
-DOCSTART- -X- N

partial JJ Physical
stepwise NN Physical
partial JJ Physical
caries NNS Physical
removal NN Physical
( ( Physical
PCR NNP Physical
) ) Physical
and CC Physical
stepwise JJ Physical
excavation NN Physical
( ( Physical
SW NNP Physical
) ) Physical
-DOCSTART- -X- N

sodium NN Pharmocological
cromoglycate NN Pharmocological
Sodium NN Pharmocological
cromoglycate NN Pharmocological
placebo NN Control
Sodium NNP Pharmocological
cromoglycate NN Pharmocological
placebo VB Control
sodium NN Pharmocological
cromoglycate NN Pharmocological
sodium NN Pharmocological
cromoglycate NN Pharmocological
placebo VB Control
sodium NN Pharmocological
cromoglycate NN Pharmocological
placebo VB Control
-DOCSTART- -X- N

risperidone NN Pharmocological
risperidone NN Pharmocological
placebo-controlled JJ Control
risperidone NN Pharmocological
risperidone NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

three CD None
kinds NNS None
of IN None
resin NN None
core NN None
material NN None
] NNP None
FRC NNP Physical
( ( Physical
Fiber NNP Physical
Reinforced NNP Physical
Composite NNP Physical
) ) Physical
posts NNS Physical
three CD Physical
kinds NNS Physical
of IN Physical
resin NN Physical
core NN Physical
material NN Physical
. . None
prefabricated JJ Physical
glass-fiber JJ Physical
posts NNS Physical
and CC Physical
Artglass NNP Physical
polymer NN Physical
core NN Physical
; : None
prefabricated JJ Physical
glass-fiber JJ Physical
posts NNS Physical
and CC Physical
Charisma NNP Physical
composite JJ Physical
resin NN Physical
core NN Physical
; : None
prefabricated JJ Physical
glass-fiber JJ Physical
posts NNS Physical
and CC Physical
AB NNP Physical
composite JJ Physical
resin NN Physical
core NN Physical
. . None
FRC NNP Physical
posts NNS Physical
combined VBD Physical
with IN Physical
resin NN Physical
core NN Physical
and CC Physical
resin VB Physical
crown NN Physical
hot-press JJ Physical
methods NNS Physical
. . None
-DOCSTART- -X- N

chemotherapy NN Physical
doxorubicin NN Pharmocological
and CC None
lomustine NN Pharmocological
cyclophosphamide NN Pharmocological
and CC Pharmocological
5-FU JJ Pharmocological
( ( Pharmocological
CF NNP Pharmocological
) ) Pharmocological
. . None
CF NNP Pharmocological
. . None
DC NNP Pharmocological
-DOCSTART- -X- N

fluoxetine NN Pharmocological
monotherapy NN Pharmocological
open-label JJ Pharmocological
fluoxetine NN Pharmocological
20 CD Pharmocological
mg NN Pharmocological
every DT Educational
day NN Educational
for IN Educational
up IN Educational
to TO Educational
8 CD Educational
weeks NNS Educational
. . None
fluoxetine NN Pharmocological
Fluoxetine NNP Pharmocological
Fluoxetine NNP Pharmocological
fluoxetine JJ Pharmocological
monotherapy NN Pharmocological
-DOCSTART- -X- N

light-cured JJ Physical
sealant NN Physical
( ( Physical
HFLCS NNP Physical
) ) Physical
37 CD Physical
% NN Physical
phosphoric JJ Physical
acid NN Physical
for IN Physical
20 CD Physical
seconds NNS Physical
, , None
and CC None
RMGIC NNP Physical
( ( Physical
Fuji NNP Physical
Ortho NNP Physical
LC NNP Physical
, , Physical
GC NNP Physical
Europe NNP Physical
, , Physical
Leuven NNP Physical
, , Physical
Belgium NNP Physical
) ) Physical
HFLCS NNP Physical
( ( Physical
Pro NNP Physical
Seal NNP Physical
, , Physical
Reliance NNP Physical
Orthodontic NNP Physical
Products NNP Physical
, , Physical
Itasca NNP Physical
, , Physical
Ill NNP Physical
) ) Physical
. . None
metal JJ Physical
brackets NNS Physical
ceramic JJ Physical
brackets NNS Physical
. . None
-DOCSTART- -X- N

Ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
Bile NNP Pharmocological
acid JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
exogenous JJ Pharmocological
bile NN Pharmocological
acid NN Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
ursodeoxycholic JJ Pharmocological
acid NN Pharmocological
-DOCSTART- -X- N

fluvoxamine NN Pharmocological
placebo-controlled JJ Control
fluvoxamine NN Pharmocological
maleate NN Pharmocological
fluvoxamine-treated JJ Pharmocological
placebo NN Control
Fluvoxamine NNP Pharmocological
placebo VB Control
fluvoxamine NN Pharmocological
Fluvoxamine NNP Pharmocological
placebo NN Control
fluvoxamine NN Pharmocological
-DOCSTART- -X- N

total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
radical JJ Surgical
prostatectomy NN Surgical
( ( Surgical
RP NNP Surgical
) ) Surgical
neoadjuvant JJ Pharmocological
hormonal JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
NHT NNP Pharmocological
) ) Pharmocological
. . None
total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
NHT NNP Pharmocological
) ) None
total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
neoadjuvant JJ Pharmocological
therapy NN Pharmocological
immediate JJ Pharmocological
surgery NN Pharmocological
alone RB Pharmocological
total JJ Pharmocological
androgen NN Pharmocological
ablation NN Pharmocological
before IN None
RP NNP Surgical
NHT NNP Pharmocological
-DOCSTART- -X- N

tumor-infiltrating JJ Physical
lymphocytes NNS Physical
tumor-infiltrating JJ Physical
lymphocytes NNS Physical
( ( Physical
TIL NNP Physical
) ) Physical
TIL NNP Physical
plus CC Physical
interleukin-2 JJ Physical
( ( Physical
IL-2 NNP Physical
) ) Physical
IL-2 NNP Pharmocological
only RB None
. . None
TIL+IL-2 NNP Pharmocological
IL-2 NNP Pharmocological
TIL NNP Pharmocological
-DOCSTART- -X- N

local JJ Pharmocological
anaesthesia NN Pharmocological
Lidoca?ne NNP None
gel NN None
with IN None
Lidoca?ne NNP None
periprostatic JJ None
infiltration NN None
prior RB None
15 CD None
ml VBD None
2 CD None
% NN None
Lidoca?ne NNP None
gel NN None
was VBD None
administered VBN None
1 CD None
% NN None
Lidoca?ne NNP None
in IN None
two CD None
p?riprostatique JJ None
equivalent JJ None
injections NNS None
, , None
4 CD None
minutes NNS None
administration NN None
of IN None
Lidoca?ne NNP None
gel NN None
and CC None
infiltration NN None
of IN None
Lidoca?ne NNP None
lead NN None
to TO None
, , None
the DT None
Lidoca?ne NNP None
gel NN None
, , None
being VBG None
-DOCSTART- -X- N

improvisational JJ Psychological
music NN Psychological
therapy NN Psychological
's POS Psychological
music NN Psychological
therapy NN Psychological
improvisational JJ Educational
music NN Educational
therapy NN Educational
music NN Educational
therapy NN Educational
three CD Educational
sessions NNS Educational
of IN Educational
parent NN Educational
counselling NN Educational
individual JJ Psychological
, , Psychological
improvisational JJ Psychological
music NN Psychological
therapy NN Psychological
music NN Educational
therapy NN Educational
music NN Educational
therapy NN Educational
-DOCSTART- -X- N

continuous JJ Physical
femoral JJ Physical
nerve NN Physical
block NN Physical
( ( Physical
CFNB NNP Physical
) ) Physical
continuous JJ Physical
epidural JJ Physical
infusion NN Physical
( ( Physical
CEI NNP Physical
) ) Physical
femoral JJ Physical
nerve NN Physical
block NN Physical
( ( Physical
FNB NNP Physical
) ) Physical
continuous JJ Physical
epidural JJ Physical
infusion NN Physical
( ( Physical
CEI NNP Physical
) ) Physical
continuous JJ Physical
femoral JJ Physical
nerve NN Physical
block NN Physical
( ( Physical
CFNB NNP Physical
) ) Physical
CEI NNP Physical
levobupivacaine NN Pharmocological
morphine JJ Pharmocological
CFNB NNP Physical
levobupivacaine NN Pharmocological
CFNB NNP Physical
CEI NNP Physical
CEI NNP Physical
CFNB NNP Physical
CFNB NNP Physical
CFNB NNP Physical
-DOCSTART- -X- N

Lactate NNP Physical
Minimum NNP Physical
Test NNP Physical
( ( Physical
LMT NNP Physical
) ) Physical
-DOCSTART- -X- N

upper JJ Physical
lip NN Physical
bite JJ Physical
test NN Physical
( ( Physical
a DT Physical
simple JJ Physical
new JJ Physical
technique NN Physical
) ) Physical
with IN Physical
modified VBN Physical
Mallampati NNP Physical
classification NN Physical
oropharyngeal NN Physical
class NN Physical
according VBG Physical
to TO Physical
the DT Physical
modified VBN Physical
Mallampati NNP Physical
criteria NNS Physical
; : Physical
the DT Physical
new JJ Physical
, , Physical
upper JJ Physical
lip NN Physical
bite IN Physical
criteria-class NN Physical
I PRP Physical
= VBP Physical
lower JJR Physical
incisors NNS Physical
can MD Physical
bite VB Physical
the DT Physical
upper JJ Physical
lip NN Physical
above IN Physical
the DT Physical
vermilion NN Physical
line NN Physical
, , Physical
class NN Physical
II NNP Physical
= NNP Physical
lower JJR Physical
incisors NNS Physical
can MD Physical
bite VB Physical
the DT Physical
upper JJ Physical
lip NN Physical
below IN Physical
the DT Physical
vermilion NN Physical
line NN Physical
, , Physical
and CC Physical
class NN Physical
III NNP Physical
= NNP Physical
lower JJR Physical
incisors NNS Physical
can MD Physical
not RB Physical
bite VB Physical
the DT Physical
upper JJ Physical
lip NN Physical
; : Physical
and CC Physical
laryngeal NN Physical
view NN Physical
grading VBG Physical
according VBG Physical
to TO Physical
The DT Physical
modified JJ Physical
-DOCSTART- -X- N

Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
B NNP Pharmocological
conjugate NN Pharmocological
Haemophilus NNP Pharmocological
influenzae NN Pharmocological
type NN Pharmocological
b NN Pharmocological
( ( Pharmocological
Hib NNP Pharmocological
) ) Pharmocological
capsular VBD Pharmocological
polysaccharide-protein JJ Pharmocological
conjugate NN Pharmocological
vaccine NN Pharmocological
( ( Pharmocological
PRP-OMP NNP Pharmocological
, , Pharmocological
PRP-T NNP Pharmocological
, , Pharmocological
and CC Pharmocological
HbOC NNP Pharmocological
) ) Pharmocological
Hib NNP Pharmocological
vaccines NNS Pharmocological
( ( Pharmocological
Hib NNP Pharmocological
groups NNS Pharmocological
) ) Pharmocological
or CC None
into IN None
a DT None
control NN Control
group NN Control
. . None
Hib NNP Pharmocological
conjugate NN Pharmocological
vaccines NNS Pharmocological
( ( None
PRP-T NNP Pharmocological
, , None
HbOC NNP Pharmocological
PRP-OMP NNP Pharmocological
) ) None
-DOCSTART- -X- N

placebo NN Control
N-Acetylcysteine NNP Pharmocological
added VBD None
to TO None
risperidone VB Pharmocological
N-acetylcysteine NNP Pharmocological
( ( Pharmocological
NAC NNP Pharmocological
) ) Pharmocological
NAC NNP None
( ( None
1200 CD None
mg/day NN None
) ) None
+risperidone NN None
or CC None
placebo+risperidone NN None
. . None
NAC NNP None
and CC None
placebo NN None
were VBD None
the DT None
NAC+risperidone NNP None
and CC None
placebo+risperidone NN Control
groups NNS None
the DT None
NAC+risperidone NNP None
group NN None
CONCLUSIONS NNP None
Risperidone NNP None
plus CC None
NAC NNP None
more JJR None
and CC None
NAC NNP None
was VBD None
-DOCSTART- -X- N

Cardiopulmonary JJ Physical
exercise NN Physical
cardiopulmonary JJ Physical
exercise NN Physical
( ( Physical
CPX NNP Physical
) ) Physical
CPX NNP Physical
CPX NNP Physical
echocardiography NN None
standardized JJ Physical
CPX NNP Physical
test NN Physical
-DOCSTART- -X- N

two-month JJ Educational
vocal JJ Educational
exercising NN Educational
spectral JJ Educational
biofeedback NN Educational
voice NN Educational
training VBG Educational
traditional JJ Other
way NN Other
-DOCSTART- -X- N

Intensive JJ Educational
case NN Educational
management NN Educational
comprehensive JJ Physical
pre-release JJ Physical
discharge NN Physical
planning NN Physical
antiretroviral JJ Physical
therapy NN Physical
motivational JJ Educational
Strengths NNP Educational
Model NNP Educational
bridging VBG Educational
case NN Educational
management NN Educational
intervention NN Educational
( ( Educational
BCM NNP Educational
) ) Educational
standard NN None
of IN None
care NN None
prison-administered JJ None
discharge NN None
planning VBG None
program NN None
( ( None
SOC NNP None
) ) None
SOC NNP None
assigned VBD None
the DT None
BCM NNP None
case NN None
management NN None
intervention NN None
bridging VBG None
incarceration NN None
and CC None
pre-release JJ None
discharge NN None
planning VBG None
program NN None
in IN None
supporting VBG None
-DOCSTART- -X- N

Group NNP Educational
cognitive JJ Educational
behavior NN Educational
therapy NN Educational
Cognitive JJ Educational
behavioral JJ Educational
therapies NNS Educational
( ( Educational
CBT NNP Educational
) ) Educational
CBT NNP Educational
CBT NNP Educational
treatment-as-usual JJ Educational
( ( Educational
TAU NNP Educational
) ) Educational
CBT NNP Educational
TAU NNP Educational
CBT NNP Educational
CBT NNP None
TAU NNP None
CBT NNP None
-DOCSTART- -X- N

creatine JJ Pharmocological
supplementation NN Pharmocological
. . None
Cr NNP Pharmocological
supplementation NN Pharmocological
( ( Pharmocological
CrS NNP Pharmocological
) ) Pharmocological
Cr NNP Pharmocological
or CC None
placebo NN Control
supplements NNS Control
alternative JJ None
treatment NN None
. . None
Muscle NNP Physical
sampling VBG Physical
Cr NNP Pharmocological
Cr NNP Pharmocological
CrS NNP Pharmocological
. . None
-DOCSTART- -X- N

diets NNS Physical
with IN Physical
low JJ Physical
and CC Physical
high JJ Physical
protein NN Physical
: : Physical
carbohydrate JJ Physical
high JJ Physical
( ( Physical
HP NNP Physical
, , Physical
30 CD Physical
% NN Physical
) ) Physical
, , Physical
low JJ Physical
( ( Physical
LP NNP Physical
, , Physical
6.5 CD Physical
% NN Physical
) ) Physical
, , Physical
or CC Physical
adequate NN Physical
( ( Physical
AP NNP Physical
, , Physical
12.1 CD Physical
% NN Physical
) ) Physical
protein NN Physical
diets NNS Physical
maternal JJ Physical
diets NNS Physical
with IN Physical
during IN Physical
gestation NN Physical
-DOCSTART- -X- N

psychosocial JJ Psychological
interventions NNS Psychological
psychosocial JJ Educational
interventions NNS Educational
-DOCSTART- -X- N

granulocyte-macrophage JJ Physical
colony-stimulating JJ Physical
factor NN Physical
erythropoietin NN Pharmocological
combination NN Pharmocological
of IN Pharmocological
recombinant JJ Pharmocological
human JJ Pharmocological
granulocyte-macrophage NN Pharmocological
colony-stimulating NN Pharmocological
factor NN Pharmocological
( ( Pharmocological
rhGM-CSF NN Pharmocological
) ) Pharmocological
and CC None
recombinant JJ Pharmocological
human JJ Pharmocological
erythropoietin NN Pharmocological
( ( Pharmocological
rHuEPO NN Pharmocological
) ) Pharmocological
autologous JJ Physical
BMT NNP Physical
treated VBN None
with IN None
rhGM-CSF JJ Pharmocological
alone NN None
. . None
-DOCSTART- -X- N

oral JJ Pharmocological
poliomyelitis NN Pharmocological
attenuated VBD Pharmocological
live JJ Pharmocological
vaccine NN Pharmocological
Poliomyelitis NNP Pharmocological
vaccine NN Pharmocological
OPV NNP Pharmocological
( ( Pharmocological
HDC NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
OPV NNP Pharmocological
( ( Pharmocological
HDC NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
OPV NNP Pharmocological
( ( Pharmocological
HDC NNP Pharmocological
) ) Pharmocological
vaccine NN Pharmocological
-DOCSTART- -X- N

Maternal NNP Educational
dietary JJ Educational
counseling NN Educational
to TO None
intervention NN None
and CC None
control NN None
and CC None
dietary JJ None
counseling NN None
who WP None
counseled VBD None
that IN None
dietary JJ None
counseling NN None
-DOCSTART- -X- N

cellulose JJ Pharmocological
sulfate NN Pharmocological
cellulose JJ Pharmocological
sulfate NN Pharmocological
( ( Pharmocological
CS NNP Pharmocological
) ) Pharmocological
placebo-controlled JJ Control
CS NNP Pharmocological
to TO None
placebo VB Control
gel NNS Control
placebo VB Control
CS NNP Pharmocological
vaginal JJ Pharmocological
gel NN Pharmocological
-DOCSTART- -X- N

cavitron NN Surgical
ultrasonic JJ Surgical
surgical JJ Surgical
aspirator NN Surgical
with IN Surgical
bipolar JJ Surgical
cautery NN Surgical
cavitron NN Surgical
ultrasonic JJ Surgical
surgical JJ Surgical
aspirator NN Surgical
with IN Surgical
radiofrequency NN Surgical
coagulator-A JJ Surgical
Cavitron NNP Surgical
ultrasonic JJ Surgical
surgical JJ Surgical
aspirator NN Surgical
( ( Surgical
CUSA NNP Surgical
) ) Surgical
with IN Surgical
bipolar JJ Surgical
cautery NN Surgical
( ( Surgical
BP NNP Surgical
) ) Surgical
to TO Surgical
CUSA NNP Surgical
with IN Surgical
a DT Surgical
radiofrequency NN Surgical
coagulator NN Surgical
CUSA NNP Surgical
with IN Surgical
BP NNP Surgical
CUSA NNP Surgical
with IN Surgical
TL NNP Surgical
. . None
-DOCSTART- -X- N

ondansetron NN Pharmocological
placebo-controlled JJ Control
ondansetron RB Pharmocological
1 CD Pharmocological
, , Pharmocological
8 CD Pharmocological
and CC Pharmocological
16 CD Pharmocological
mg NN Pharmocological
placebo VB Control
8 CD Pharmocological
mg JJ Pharmocological
ondansetron NN Pharmocological
to TO None
placebo VB Control
. . None
8 CD Pharmocological
and CC Pharmocological
16 CD Pharmocological
mg NN Pharmocological
ondansetron NN Pharmocological
groups NNS Pharmocological
placebo NN Control
Ondansetron NNP Pharmocological
ondansetron VBP Pharmocological
-DOCSTART- -X- N

selenium NN Pharmocological
chemotherapy NN Pharmocological
radiotherapy NN Physical
. . None
chemotherapy NN Pharmocological
radiotherapy JJ Physical
-DOCSTART- -X- N

amoxycillin NN Pharmocological
and CC Pharmocological
omeprazole NN Pharmocological
metronidazole NN Pharmocological
of IN None
amoxycillin NN Pharmocological
and CC Pharmocological
omeprazole NN Pharmocological
metronidazole NN Pharmocological
, , Pharmocological
amoxycillin NN Pharmocological
and CC Pharmocological
omeprazole NN Pharmocological
amoxycillin NN Pharmocological
omeprazole JJ Pharmocological
metronidazole NN Pharmocological
plus CC None
amoxycillin JJ Pharmocological
and CC Pharmocological
omeprazole JJ Pharmocological
-DOCSTART- -X- N

Gonadotropin-releasing VBG Pharmocological
hormone NN Pharmocological
Gonadotropin-releasing VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GnRH NNP Pharmocological
) ) Pharmocological
agonists NNS Pharmocological
GnRH NNP Pharmocological
agonist NN Pharmocological
3.75 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
depot NN Pharmocological
leuprolide NN Pharmocological
or CC None
a DT None
placebo NN Control
leuprolide JJ Pharmocological
leuprolide NN Pharmocological
leuprolide JJ Pharmocological
leuprolide JJ Pharmocological
Leuprolide NNP Pharmocological
Leuprolide NNP Pharmocological
-DOCSTART- -X- N

single- JJ Physical
and CC Physical
dual-coil JJ Physical
active JJ Physical
pectoral JJ Physical
defibrillation NN Physical
lead NN Physical
systems NNS Physical
. . Physical
single JJ Physical
dual JJ Physical
transvenous JJ Physical
coils NNS Physical
. . None
lead JJ Physical
configurations NNS Physical
( ( None
single JJ Physical
coil NN Physical
) ) None
( ( None
dual JJ Physical
coil NN None
) ) None
single-coil JJ Physical
dual-coil JJ Physical
dual-coil NN Physical
dual-coil NN Physical
single-coil NN Physical
-DOCSTART- -X- N

Exposure NN None
to TO None
the DT None
self-face NN Physical
facilitates VBZ Physical
self-face NN Physical
( ( None
self-face JJ Physical
prime NN Physical
) ) Physical
or CC Physical
faces VBZ Physical
of IN Physical
others NNS Physical
( ( Physical
nonself-face JJ Physical
prime NN Physical
) ) None
-DOCSTART- -X- N

Ventilator-delivered JJ Physical
mask NN Physical
ventilation NN Physical
compared VBN None
with IN None
three CD None
standard JJ None
methods NNS None
of IN None
mask NN None
ventilation NN None
bag NN Other
and CC Other
mask NN Other
resuscitation NN Other
ventilator-delivered JJ Physical
mask NN Physical
ventilation NN Physical
( ( Physical
VDMV NNP Physical
) ) Physical
. . None
VDMV NNP Physical
hand-delivered JJ None
methods NNS None
of IN None
bag NN None
and CC None
mask NN None
ventilation NN None
: : None
Laerdal JJ Other
self-inflating JJ Other
bag NN Other
( ( Other
SIB NNP Other
) ) Other
; : None
anaesthetic JJ Other
bag NN Other
and CC None
T-piece NNP Other
Neopuff NNP Other
. . None
mask NN Other
ventilation NN Other
. . None
mask NN Other
ventilation NN Other
mask NN None
ventilation NN None
VDMV NNP Physical
VDMV NNP Physical
Neopuff NNP Other
. . None
VDMV NNP Physical
-DOCSTART- -X- N

hemi-body JJ Physical
irradiation NN Physical
recombinant NN Pharmocological
alpha VBD Pharmocological
2b CD Pharmocological
interferon NN Pharmocological
alpha-2b JJ Pharmocological
interferon NN Pharmocological
maintenance NN Pharmocological
. . None
single JJ Physical
hemi-body JJ Physical
irradiation NN Physical
alone RB Physical
persistent JJ None
cytopoenias NN None
interferon NN Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

Laser NNP Physical
therapy NN Physical
combined VBN Physical
with IN Physical
brachytherapy NN Physical
Laser NNP Physical
therapy NN Physical
laser JJR Physical
therapy NN Physical
endoscopic NN Physical
Nd NN Physical
: : Physical
YAG NNP Physical
laser NN Physical
therapy NN Physical
laser NN Physical
brachytherapy NN Physical
. . None
brachytherapy NN Physical
brachytherapy NN Physical
-DOCSTART- -X- N

Norasept NNP Pharmocological
II NNP Pharmocological
-DOCSTART- -X- N

Ropinirole NNP Pharmocological
levodopa NN Pharmocological
sustained VBD Pharmocological
release NN Pharmocological
. . None
ropinirole NN Pharmocological
vs. FW None
levodopa NN Pharmocological
sustained VBN Pharmocological
release NN Pharmocological
( ( Pharmocological
SR NNP Pharmocological
) ) Pharmocological
levodopa JJ Pharmocological
SR NNP Pharmocological
or CC None
ropinirole VB Pharmocological
then RB None
the DT None
alternate NN Pharmocological
treatment NN Pharmocological
Ropinirole NNP Pharmocological
levodopa VB Pharmocological
SR NNP Pharmocological
-DOCSTART- -X- N

androgen NN Pharmocological
therapy NN Pharmocological
control NN Control
group NN Control
or CC Physical
to TO Physical
nandrolone CD Pharmocological
decanoate NN Pharmocological
therapy NN Physical
. . None
androgen NN Pharmocological
therapy NN Pharmocological
androgen-treated JJ Pharmocological
-DOCSTART- -X- N

denopamine NN Pharmocological
denopamine NN Pharmocological
ergometer NN Physical
20 CD Pharmocological
mg NN Pharmocological
denopamine NN Pharmocological
or CC None
placebo NN Control
. . None
placebo NN Control
denopamine NN Pharmocological
Denopamine NNP Pharmocological
denopamine NN Pharmocological
-DOCSTART- -X- N

mixed JJ Physical
kinesio JJ Physical
taping-compression NN Physical
technique NN Physical
Kinesio NNP Physical
taping NN Physical
) ) None
an DT None
experimental JJ None
group NN None
to TO None
receive VB None
a DT None
mixed JJ None
KT-compression NNP None
treatment NN None
following VBG None
KT NNP None
recommendations NNS None
for IN None
gastrocnemius JJ None
muscle NN None
enhancement NN None
and CC None
functional JJ None
correction NN None
of IN None
the DT None
ankle NN None
, , None
and CC None
adding VBG None
2 CD None
tapes NNS None
to TO None
simulate VB None
traditional JJ None
compression NN None
bandages NNS None
( ( None
no DT None
KT NNP None
guidelines NNS None
) ) None
; : None
or CC None
( ( None
2 CD None
) ) None
a DT None
placebo NN None
control NN None
group NN None
for IN None
sham NN None
KT NNP None
. . None
after IN None
mixed JJ None
KT-compression NNP None
therapy NN None
. . None
placebo NN None
effect NN None
-DOCSTART- -X- N

remifentanil NN Pharmocological
lidocaine NN Pharmocological
with IN Pharmocological
esmolol NN Pharmocological
. . None
remifentanil NN Pharmocological
lidocaine-esmolol JJ Pharmocological
0.9 CD Pharmocological
% NN Pharmocological
saline NN Pharmocological
10 CD Pharmocological
ml NN Pharmocological
and CC Pharmocological
remifentanil VB Pharmocological
1 CD Pharmocological
microg/kg NN Pharmocological
. . Pharmocological
lidocaine JJ Pharmocological
1.5 CD Pharmocological
mg/kg NN Pharmocological
and CC Pharmocological
esmolol $ Pharmocological
1.0 CD Pharmocological
mg/kg NN Pharmocological
. . None
thiopental JJ Pharmocological
sodium NN Pharmocological
rocuronium NN Pharmocological
remifentanil VBZ Pharmocological
lidocaine JJ Pharmocological
esmolol $ Pharmocological
-DOCSTART- -X- N

Amphotericin NNP Pharmocological
B NNP Pharmocological
amphotericin NN Pharmocological
B NNP Pharmocological
administered VBN Pharmocological
in IN Pharmocological
dextrose JJ Pharmocological
versus NN None
lipid JJ Pharmocological
emulsion NN Pharmocological
. . None
amphotericin NN Pharmocological
B NNP Pharmocological
( ( Pharmocological
AmB NNP Pharmocological
) ) Pharmocological
dextrose NN Pharmocological
AmB NNP Pharmocological
infused VBD Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
dextrose NN Pharmocological
AmB NNP Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
AmB NNP Pharmocological
infused VBD None
in IN None
dextrose NN Pharmocological
AmB NNP Pharmocological
infused VBD Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
in IN None
dextrose NN Pharmocological
AmB NNP Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
. . None
AmB NNP Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
in IN Pharmocological
lipid JJ Pharmocological
emulsion NN Pharmocological
AmB NNP Pharmocological
in IN None
lipid JJ None
emulsion NN None
dextrose NN Pharmocological
-DOCSTART- -X- N

coumarin NN Pharmocological
coumarin NN Pharmocological
( ( Pharmocological
1,2-benzopyrone CD Pharmocological
) ) Pharmocological
and CC None
warfarin $ Pharmocological
( ( Pharmocological
4-hydroxycoumarin JJ Pharmocological
) ) Pharmocological
coumarin NN Pharmocological
-DOCSTART- -X- N

shuxuening VBG Pharmocological
injection NN Pharmocological
Shuxuening VBG Pharmocological
Injection NNP Pharmocological
( ( Pharmocological
SI NNP Pharmocological
) ) Pharmocological
Routine JJ Control
therapies NNS Control
for IN Control
COPD NNP Control
while IN None
15 CD Pharmocological
mL NNS Pharmocological
SI NNP Pharmocological
was VBD None
given VBN None
to TO None
those DT None
in IN None
the DT None
treatment NN None
group NN None
by IN None
intravenous JJ None
dripping NN None
, , None
twice RB None
daily RB None
for IN None
total JJ None
14 CD None
days NNS None
. . None
and CC None
were VBD None
detected VBN None
by IN None
Spirometer NNP Physical
. . None
SI NNP Pharmocological
-DOCSTART- -X- N

technique NN Physical
-DOCSTART- -X- N

treadmill NN Physical
interventions NNS Physical
treadmill NN Physical
interventions NNS Physical
lower-intensity-generalized JJ Physical
( ( Physical
LG NNP Physical
) ) Physical
training VBG Physical
group NN Physical
, , None
or CC None
a DT None
higher-intensity-individualized JJ Physical
( ( Physical
HI NNP Physical
) ) Physical
training VBG Physical
group NN Physical
. . None
-DOCSTART- -X- N

Ribavirin JJ Pharmocological
peginterferon VB Pharmocological
alpha-2a JJ Pharmocological
180 CD Pharmocological
-DOCSTART- -X- N

Trimetazidine NN Pharmocological
: : None
propranolol NN Pharmocological
Trimetazidine NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
trimetazidine NN Pharmocological
propranolol NN Pharmocological
. . None
-DOCSTART- -X- N

bacille JJ None
Calmette-Gu?rin NNP None
( ( None
BCG NNP None
) ) None
of IN None
BCG NNP None
when WRB None
BCG NNP None
given VBN None
BCG NNP None
-DOCSTART- -X- N

home-based JJ Other
intervention NN Other
HBI NNP Other
HBI NNP Other
HBI NNP Other
HBI NNP Other
HBI NNP Other
-DOCSTART- -X- N

opioids NNS Pharmocological
placebo-controlled JJ Control
1 CD Pharmocological
mg/kg JJ Pharmocological
meperidine NN Pharmocological
or CC None
0.9 CD Control
% NN Control
saline NN Control
tracheal JJ Physical
suction NN Physical
or CC None
routine JJ Physical
nursing NN Physical
care NN Physical
. . None
opioid JJ Pharmocological
analgesia NN Pharmocological
-DOCSTART- -X- N

Expectant JJ Physical
management NN Physical
hormonal JJ Pharmocological
therapy NN Pharmocological
. . None
oral JJ Pharmocological
contraceptives NNS Pharmocological
low-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
a DT None
high-dose JJ Pharmocological
monophasic NN Pharmocological
pill NN Pharmocological
, , None
a DT None
multiphasic JJ Pharmocological
pill NN Pharmocological
or CC None
no DT Control
therapy NN Control
. . None
oral JJ Pharmocological
contraceptive JJ Pharmocological
oral JJ Pharmocological
contraceptive JJ Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

oxibendazole JJ Pharmocological
] NN None
for IN None
comparison NN None
and CC None
as IN None
control NN None
under IN None
double-blind JJ None
observations NNS None
. . None
-DOCSTART- -X- N

After IN None
pre-screening NN None
and CC None
a DT None
washout JJ None
period NN None
of IN None
at IN None
least JJS None
14 CD None
days NNS None
, , None
eligible JJ None
volunteers NNS None
received VBD None
ASA NNP Pharmocological
81 CD Pharmocological
mg NN Pharmocological
with IN None
or CC None
without IN None
esomeprazole JJ Pharmocological
20 CD Pharmocological
mg NN Pharmocological
once RB None
daily JJ None
for IN None
5 CD None
days NNS None
in IN None
randomized JJ None
order NN None
, , None
with IN None
a DT None
14-day JJ None
washout NN None
between IN None
treatments NNS None
. . None
-DOCSTART- -X- N

Intraperitoneal NNP Pharmocological
cisplatin NN Pharmocological
First-line NNP Physical
intravenous JJ Physical
chemotherapy NN Physical
four CD Pharmocological
courses NNS Pharmocological
of IN Pharmocological
intraperitoneal NN Pharmocological
cisplatin NN Pharmocological
( ( Pharmocological
P NNP Pharmocological
) ) Pharmocological
( ( Pharmocological
90 CD Pharmocological
mg/m2 NN Pharmocological
every DT Pharmocological
3 CD Pharmocological
weeks NNS Pharmocological
) ) Pharmocological
or CC None
observation NN Control
. . None
Intraperitoneal NNP Pharmocological
CT NNP Pharmocological
intraperitoneal NN Pharmocological
cisplatin NN Pharmocological
intraperitoneal JJ Pharmocological
CT NNP Pharmocological
-DOCSTART- -X- N

parecoxib NN Pharmocological
placebo-controlled JJ Control
parecoxib NN Pharmocological
parecoxib NN Pharmocological
sodium NN Pharmocological
and CC None
placebo NN None
group NN None
receiving VBG None
normal JJ None
saline JJ None
2 CD None
in IN None
placebo NN None
group NN None
administration NN None
of IN None
parecoxib NN None
after IN None
primary JJ None
-DOCSTART- -X- N

Esmolol NNP Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
verapamil NN Pharmocological
esmolol-treated JJ Pharmocological
verapamil RB Pharmocological
Esmolol NNP Pharmocological
verapamil NN Pharmocological
esmolol NN Pharmocological
. . None
-DOCSTART- -X- N

Prizidilol NNP Pharmocological
hydrochloride NN Pharmocological
Isoprenaline JJ Pharmocological
prizidilol NN Pharmocological
prizidilol NN Pharmocological
propranolol NN Pharmocological
prizidilol NN Pharmocological
-DOCSTART- -X- N

sublingual JJ Pharmocological
fentanyl NN Pharmocological
orally RB Pharmocological
disintegrating VBG Pharmocological
tablet NN Pharmocological
fast-acting JJ Pharmocological
opioid NN Pharmocological
fentanyl NN Pharmocological
sublingual JJ Pharmocological
fentanyl NN Pharmocological
citrate NN Pharmocological
orally RB Pharmocological
disintegrating VBG Pharmocological
tablet NN Pharmocological
( ( Pharmocological
sublingual JJ Pharmocological
fentanyl NN Pharmocological
ODT NNP Pharmocological
) ) Pharmocological
or CC None
placebo NN Control
fentanyl NN Pharmocological
ODT NNP Pharmocological
-DOCSTART- -X- N

Hanen NNP Educational
's POS Educational
'More JJR Educational
Than NNP Educational
Words NNP Educational
' POS Educational
Hanen NNP Educational
's POS Educational
'More JJR Educational
than IN Educational
Words NNS Educational
' POS Educational
( ( Educational
HMTW NNP Educational
) ) Educational
, , Educational
a DT Educational
parent-implemented JJ Educational
intervention NN Educational
'business NN Control
as IN Control
usual JJ Control
' POS Control
control NN Control
HMTW NNP Educational
intervention NN Educational
prior RB None
to TO None
randomization NN None
( ( None
Time NNP None
1 CD None
) ) None
and CC None
at IN None
5 CD None
and CC None
9 CD None
months NNS None
post VBN None
enrollment NN None
( ( None
Times NNP None
2 CD None
and CC None
3 CD None
) ) None
. . None
were VBD None
measured VBN None
at IN None
each DT None
time NN None
point NN None
. . None
, , None
was VBD None
measured VBN None
at IN None
Time NNP None
1 CD None
. . None
HMTW NNP None
The DT None
HMTW NNP None
HMTW NNP None
the DT None
HMTW NNP None
the DT None
HMTW NNP None
-DOCSTART- -X- N

trichloroacetic JJ Pharmocological
acid NN Pharmocological
( ( Pharmocological
TCA NNP Pharmocological
) ) Pharmocological
TCA NNP Pharmocological
TCA NNP Pharmocological
TCA NNP Pharmocological
TCA NNP Pharmocological
-DOCSTART- -X- N

mebendazole NN Pharmocological
mebendazole NN Pharmocological
( ( Pharmocological
Phardazone NNP Pharmocological
) ) Pharmocological
mebendazole NN Pharmocological
placebo-controlled JJ Control
mebendazole NN Pharmocological
placebo NN Control
placebo VB Control
mebendazole NN Pharmocological
albendazole NN Pharmocological
albendazole NN Pharmocological
placebo NN Control
placebo VB Control
mebendazole NN Pharmocological
albendazole NN Pharmocological
albendazole NN Pharmocological
. . None
albendazole NN Pharmocological
. . None
anti-helminth JJ Pharmocological
therapies NNS Pharmocological
-DOCSTART- -X- N

High-dose JJ Pharmocological
pyridoxine NN Pharmocological
and CC Pharmocological
magnesium NN Pharmocological
administration NN Pharmocological
pyridoxine NN Pharmocological
and CC Pharmocological
magnesium NN Pharmocological
( ( Pharmocological
HDPM NNP Pharmocological
) ) Pharmocological
HDPM NNP Pharmocological
HDPM NNP Pharmocological
pyridoxine NN Pharmocological
magnesium NN Pharmocological
oxide NN Pharmocological
HDPM NNP Pharmocological
HDPM NNP Pharmocological
-DOCSTART- -X- N

plasma NN Pharmocological
vitamin NN Pharmocological
D NNP Pharmocological
metabolites VBZ Pharmocological
, , None
vitamin FW None
D NNP None
receptor NN None
polymorphisms NN None
25-hydroxyvitamin JJ Pharmocological
D3 NNP None
( ( None
25 CD None
[ NNP None
OH NNP None
] NNP None
D NNP None
) ) None
25 CD Pharmocological
( ( Pharmocological
OH NNP Pharmocological
) ) Pharmocological
D NNP Pharmocological
1,25 CD Pharmocological
( ( Pharmocological
OH NNP Pharmocological
) ) Pharmocological
2D CD Pharmocological
vitamin NN None
D NNP None
status NN None
VDR NNP None
FokI NNP None
polymorphism NN None
-DOCSTART- -X- N

web- JJ Educational
and CC Educational
a DT Educational
print-based JJ Educational
decision NN Educational
aid NN Educational
booklet NN Educational
interactive JJ Educational
website NN Educational
randomized VBN Educational
controlled JJ Educational
trials NNS Educational
( ( Educational
RCTs NNP Educational
) ) Educational
website NN Educational
-DOCSTART- -X- N

halothane NN Pharmocological
isoflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
. . None
halothane NN Pharmocological
isoflurane NN Pharmocological
halothane NN Pharmocological
isoflurane NN Pharmocological
-DOCSTART- -X- N

7-day JJ Pharmocological
and CC Pharmocological
14-day JJ Pharmocological
proton NN Pharmocological
pump IN Pharmocological
inhibitor-containing JJ Pharmocological
triple JJ Pharmocological
therapy NN Pharmocological
triple JJ Pharmocological
combination NN Pharmocological
therapy NN Pharmocological
a DT None
proton NN Pharmocological
pump NN Pharmocological
inhibitor NN Pharmocological
( ( Pharmocological
PPI NNP Pharmocological
) ) Pharmocological
two CD Pharmocological
antibiotics NNS Pharmocological
7-day JJ Pharmocological
and CC Pharmocological
14-day JJ Pharmocological
PPI-containing JJ Pharmocological
triple NN Pharmocological
therapy NN Pharmocological
. . None
PAC7 NNP Pharmocological
( ( None
omeprazole JJ Pharmocological
20 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
equivalent JJ Pharmocological
dose NN Pharmocological
of IN Pharmocological
other JJ Pharmocological
PPIs NNP Pharmocological
, , Pharmocological
amoxicillin NN Pharmocological
1000 CD Pharmocological
mg NN Pharmocological
, , Pharmocological
and CC Pharmocological
clarithromycin VBZ Pharmocological
500 CD Pharmocological
mg NN Pharmocological
twice RB Pharmocological
daily RB Pharmocological
for IN Pharmocological
7 CD Pharmocological
days NNS Pharmocological
) ) Pharmocological
PAC14 NNP Pharmocological
( ( None
the DT Pharmocological
same JJ Pharmocological
regimen NN Pharmocological
as IN Pharmocological
the DT Pharmocological
PAC7 NNP Pharmocological
group NN Pharmocological
but CC Pharmocological
for IN Pharmocological
14 CD Pharmocological
days NNS Pharmocological
) ) None
PAC7 NNP Pharmocological
PAC14 NNP Pharmocological
PAC7 NNP Pharmocological
PAC14 NNP Pharmocological
7-day JJ None
PPI-containing JJ None
triple JJ None
anti-H. JJ None
pylori NN None
therapy NN None
14-day JJ Other
-DOCSTART- -X- N

CT NNP Other
versus NNP None
digital JJ Other
subtraction NN Other
angiography NN Other
multi-detector JJ Other
row NN Other
computed VBN Other
tomographic JJ Other
( ( Other
CT NNP Other
) ) Other
angiography NN Other
and CC None
digital JJ Other
subtraction NN Other
angiography NN Other
( ( Other
DSA NNP Other
) ) Other
revascularization NN Surgical
CT NNP Other
and CC None
DSA NNP Other
CT NNP Other
DSA NNP Other
CT NNP Other
DSA NNP Other
CT NNP Other
DSA NNP Other
. . None
CT NNP Other
DSA NNP Other
CT NNP Other
angiography NN Other
CT NNP Other
DSA NNP Other
CT NNP Other
DSA NNP Other
-DOCSTART- -X- N

Oat NNP Other
ingestion NN Other
soluble JJ Other
fiber-rich JJ Other
whole JJ Other
oat NN Other
cereals NNS Other
oat NN Pharmocological
cereal NN Pharmocological
group NN Pharmocological
( ( Pharmocological
standardized VBN Pharmocological
to TO Pharmocological
5.52 CD Pharmocological
g/day JJ Pharmocological
beta-glucan JJ Pharmocological
) ) Pharmocological
to TO None
a DT Pharmocological
low-fiber JJ Pharmocological
cereal NN Pharmocological
control NN Pharmocological
group NN Pharmocological
( ( Pharmocological
less JJR Pharmocological
than IN Pharmocological
1.0 CD Pharmocological
g/day JJ Pharmocological
total JJ Pharmocological
fiber NN Pharmocological
) ) Pharmocological
over IN None
6 CD None
weeks NNS None
. . None
oat NN Pharmocological
cereals NNS Pharmocological
Soluble JJ Pharmocological
fiber-rich JJ Pharmocological
whole JJ Pharmocological
oats NNS Pharmocological
-DOCSTART- -X- N

Corticosteroids NNP Pharmocological
plus CC Pharmocological
pulse JJ Pharmocological
cyclophosphamide NN Pharmocological
and CC Pharmocological
plasma NN Pharmocological
exchanges NNS Pharmocological
corticosteroids NNS Pharmocological
plus CC Pharmocological
pulse JJ Pharmocological
cyclophosphamide NN Pharmocological
alone RB Pharmocological
prednisone NN Pharmocological
, , Pharmocological
cyclophosphamide NN Pharmocological
plasma NN Pharmocological
exchanges NNS Pharmocological
prednisone NN Pharmocological
cyclophosphamide VB Pharmocological
-DOCSTART- -X- N

methotrexate NN Pharmocological
placebo NN Control
methotrexate NN Pharmocological
methotrexate NN Pharmocological
placebo NN None
methotrexate NN Pharmocological
methotrexate NN Pharmocological
-DOCSTART- -X- N

Mindfulness-based JJ Psychological
therapy NN Psychological
Mindfulness-based JJ Psychological
therapy NN Psychological
( ( Psychological
MBT NNP Psychological
) ) Psychological
modified JJ Psychological
MBT NNP Psychological
protocol NN Psychological
( ( Psychological
MBT-AS NNP Psychological
) ) Psychological
MBT-AS JJ Educational
training NN Educational
wait-list JJ Control
control NN Control
group NN Physical
. . None
MBT-AS NNP Psychological
. . Psychological
-DOCSTART- -X- N

magnesium NN Pharmocological
levobupivacaine VB Pharmocological
magnesium NN Pharmocological
0.25 CD None
% NN None
levobupivacaine NN Pharmocological
and CC None
1 CD None
ml NN None
of IN None
15 CD None
% NN None
magnesium NN Pharmocological
sulphate NN Pharmocological
Group NNP None
L NNP None
was VBD None
administered VBN None
20 CD None
ml NN None
of IN None
0.25 CD Pharmocological
% NN Pharmocological
levobupivacaine NN Pharmocological
magnesium NN Pharmocological
-DOCSTART- -X- N

interleukin-10 JJ Pharmocological
lentivirus NN None
delivering VBG None
human JJ None
IL-10 NNP None
( ( None
LV/hIL-10 NNP None
) ) None
was VBD None
Group NNP None
CCI?Normal NNP None
Saline NNP None
( ( None
NS NNP None
) ) None
, , None
Group NNP None
CCI?LV/hIL-10 NNP None
( ( None
LV/hIL-10 NNP None
) ) None
, , None
and CC None
Group NNP None
CCI?LV/control NNP None
( ( None
NS NNP None
, , None
LV/control NNP None
, , None
or CC None
recombinant JJ None
vector NN None
LV/hIL-10 NNP None
in IN None
a DT None
that DT None
intrathecal JJ None
LV/hIL-10 NNP None
reverses NNS None
of IN None
IL-10 NNP None
-DOCSTART- -X- N

atorvastatin NN Pharmocological
atorvastatin NN Pharmocological
colestimide NN Pharmocological
atorvastatin NN Pharmocological
colestimide NN Pharmocological
atorvastatin NN Pharmocological
. . None
after IN None
20 CD Pharmocological
mg/day JJ Pharmocological
atorvastatin RB Pharmocological
failed VBD None
to TO None
achieve VB None
their PRP$ None
target NN None
level NN None
. . None
atorvastatin NN Pharmocological
colestimide NN Pharmocological
atorvastatin NN Pharmocological
. . None
-DOCSTART- -X- N

Continuous JJ Physical
epidural JJ Pharmocological
block NN Pharmocological
was VBD None
instituted VBN None
prior RB None
to TO None
the DT None
induction NN None
of IN None
anesthesia NN None
and CC None
maintained VBD None
throughout IN None
the DT None
surgery NN Physical
in IN None
8 CD None
of IN None
16 CD None
patients NNS None
( ( None
Group NNP None
1 CD None
) ) None
while IN None
it PRP None
was VBD None
instituted VBN None
upon IN None
the DT None
peritoneal JJ None
closure NN None
and CC None
maintained VBD None
thereafter RB None
in IN None
the DT None
remaining VBG None
8 CD None
patients NNS None
( ( None
Group NNP None
2 CD None
) ) None
respiratory NN Physical
inductance NN Physical
plethysmography NN Physical
( ( Physical
Respisomnography NNP Physical
, , Physical
Chest NNP Physical
MI NNP Physical
) ) Physical
. . None
-DOCSTART- -X- N

disease JJ Other
management NN Other
program NN Other
with IN Other
repetitive JJ Other
education NN Other
and CC None
telephone NN Other
monitoring NN Other
Education NNP Other
and CC Other
Monitoring NNP Other
control NN Control
. . Control
-DOCSTART- -X- N

low-fat JJ Physical
, , Physical
high-fiber JJ Physical
diet NN Physical
an DT None
intervention NN None
group NN None
given VBN None
intensive JJ None
counseling NN None
and CC None
assigned VBD None
to TO None
follow VB None
a DT None
diet NN Educational
that WDT Educational
was VBD Educational
low JJ Educational
in IN Educational
fat NN Educational
( ( None
20 CD None
percent NN None
of IN None
total JJ None
calories NNS None
) ) None
and CC None
high JJ Educational
in IN Educational
fiber NN Educational
( ( Educational
18 CD Educational
g NN Educational
of IN Educational
dietary JJ Educational
fiber NN Educational
per IN Educational
1000 CD Educational
kcal NN Educational
) ) Educational
and CC None
fruits NNS Educational
and CC Educational
vegetables NNS Educational
( ( None
3.5 CD None
servings NNS None
per IN None
1000 CD None
kcal NN None
) ) None
, , None
and CC None
a DT None
control NN None
group NN None
given VBN None
a DT None
standard JJ None
brochure NN None
on IN None
healthy JJ None
eating NN None
and CC None
assigned VBD None
to TO None
follow VB None
their PRP$ None
usual JJ None
diet NN None
. . None
-DOCSTART- -X- N

psychosocial JJ Educational
intervention NN Educational
-DOCSTART- -X- N

diltiazem NN Pharmocological
and CC None
propranolol NN Pharmocological
] NN None
diltiazem NN Pharmocological
and CC None
propranolol NN Pharmocological
diltiazem NN Pharmocological
or CC None
propranolol NN Pharmocological
coronary JJ Physical
arteriography NN Physical
propranolol NN Pharmocological
-DOCSTART- -X- N

aromatherapy JJ Physical
massage NN Physical
aromatherapy JJ Physical
massage NN Physical
aromatherapy JJ Physical
massage NN Physical
or CC None
usual JJ Control
supportive JJ Control
care NN Control
alone RB Control
. . None
aromatherapy JJ Physical
massage NN Physical
aromatherapy JJ Physical
massage NN Physical
Aromatherapy NNP Physical
massage NN Physical
-DOCSTART- -X- N

Eltrombopag NNP Pharmocological
Eltrombopag NNP Pharmocological
eltrombopag NNS Pharmocological
placebo NN Control
eltrombopag NN None
placebo JJ None
eltrombopag VB None
placebo NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
placebo NN None
eltrombopag NN None
placebo NN None
placebo NN None
eltrombopag-treated JJ None
placebo VB None
placebo NN None
eltrombopag NN None
Eltrombopag NNP None
eltrombopag JJ None
-DOCSTART- -X- N

treprostinil NN Pharmocological
prostanoid NN Pharmocological
therapy NN Pharmocological
prostacyclin NN Pharmocological
treprostinil NN Pharmocological
treprostinil NN Pharmocological
inhaled JJ None
treprostinil NN None
on IN None
inhaled VBN None
treprostinil NN None
4 CD None
receiving VBG None
background NN None
PAH NNP None
therapy NN None
; : None
12 CD None
Inhaled VBD None
treprostinil NN None
was VBD None
treprostinil NN None
appears VBZ None
-DOCSTART- -X- N

RAB-plate JJ Surgical
sliding VBG Surgical
hip NN Surgical
screw NN Surgical
sliding VBG Surgical
hip NN Surgical
screw NN Surgical
120 CD Surgical
degrees NNS Surgical
fixed VBN Surgical
angle JJ Surgical
blade-plate NN Surgical
with IN Surgical
a DT Surgical
buttress NN Surgical
rod NN Surgical
sliding VBG Surgical
hip NN Surgical
screw NN Surgical
RAB-plate NNP Surgical
-DOCSTART- -X- N

interferon VB Pharmocological
. . None
alpha-interferon NN Pharmocological
-DOCSTART- -X- N

dexamethasone NN Pharmocological
( ( None
DEX NNP None
) ) None
DEX NNP Pharmocological
DEX NNP Pharmocological
DEX NNP Pharmocological
glucocorticoids NNS Pharmocological
. . None
-DOCSTART- -X- N

intraoral JJ Physical
fluoride NN Physical
releasing VBG Physical
system NN Physical
intraoral JJ None
fluoride-releasing NN None
system NN None
( ( None
IFRS NNP None
) ) None
containing VBG None
a DT None
sodium NN None
fluoride NN None
core NN None
fluoride-gel-containing JJ Physical
tray NN Physical
IFRS NNP None
IFRS NNP None
retainers NNS None
1100-ppm JJ Physical
fluoride JJ Physical
conventional JJ Physical
sodium NN Physical
fluoride NN Physical
dentifrice NN Physical
twice RB Physical
daily RB Physical
. . None
sodium NN Pharmocological
fluoride NN Pharmocological
-DOCSTART- -X- N

antazoline NN Pharmocological
class NN Pharmocological
IA NNP Pharmocological
, , Pharmocological
IC NNP Pharmocological
and CC Pharmocological
III NNP Pharmocological
antiarrhythmic JJ Pharmocological
drugs NNS Pharmocological
or CC None
vernakalant JJ Pharmocological
hydrochloride NN Pharmocological
. . None
Antazoline NNP Pharmocological
antazoline JJ Pharmocological
placebo-controlled JJ Control
antazoline NN Pharmocological
antazoline NN Pharmocological
placebo NN Control
placebo JJ Control
antazoline JJ Pharmocological
-DOCSTART- -X- N

Moisture-vapour-permeable JJ Physical
film NN Physical
moisture-vapour-permeable JJ Physical
film NN Physical
( ( Physical
MVPF NNP Physical
) ) Physical
silver NN Pharmocological
sulphadiazine NN Pharmocological
MVPF NNP Physical
silver JJ Pharmocological
sulphadiazine NN Pharmocological
MVPF NNP Physical
MVPF NNP Physical
silver VB Pharmocological
sulphadiazine NN Pharmocological
. . None
-DOCSTART- -X- N

logMAR NN Physical
Kay NNP Physical
picture NN Physical
test NN Physical
logMAR JJ Physical
acuity NN Physical
test NN Physical
: : None
crowded JJ Physical
and CC Physical
uncrowded JJ Physical
versions NNS Physical
logMAR JJ Physical
acuity NN Physical
test NN Physical
Kay NNP Physical
picture NN Physical
test NN Physical
logMAR NN Physical
crowded VBD Physical
Kay NNP Physical
picture NN Physical
test NN Physical
crowded VBN Physical
logMAR NN Physical
acuity NN Physical
test NN Physical
uncrowded JJ Physical
test NN Physical
test NN Physical
The DT None
logMAR NN Physical
crowded VBD Physical
Kay NNP Physical
picture NN Physical
test NN Physical
crowded VBD Physical
logMAR JJ Physical
acuity NN Physical
test NN Physical
-DOCSTART- -X- N

creatine NN Pharmocological
phosphate NN Pharmocological
creatine NN Pharmocological
phosphate NN Pharmocological
plain VB Control
cardioplegic JJ Control
solutions NNS Control
( ( None
creatine VB Pharmocological
phosphate NN Pharmocological
) ) None
( ( None
control NN Control
) ) None
-DOCSTART- -X- N

guided VBN Physical
tissue NN Physical
regeneration NN Physical
( ( Physical
GTR NNP Physical
) ) Physical
radiographs NN Physical
GTR NNP Physical
-DOCSTART- -X- N

alcohol NN Educational
dependence NN Educational
Concurrent NNP Educational
alcohol NN Educational
dependence NN Educational
( ( Educational
AD NNP Educational
) ) Educational
contingency JJ Educational
management NN Educational
( ( Educational
CM NNP Educational
) ) Educational
AD NNP Educational
, , Educational
randomized VBN Educational
to TO Educational
standard VB Educational
care NN Educational
( ( Educational
SC NNP Educational
) ) Educational
with IN Educational
or CC Educational
without IN Educational
CM NNP Educational
. . Educational
AD NNP Educational
AD NN Educational
non-AD JJ Educational
CM NNP Educational
SC NNP Educational
AD NNP Educational
AD NNP Educational
non-AD JJ Educational
-DOCSTART- -X- N

fluid NN Physical
resuscitation NN Physical
Phlebotomy NNP Physical
fluid JJ Physical
resuscitation NN Physical
5 CD Pharmocological
mL/kg NN Pharmocological
intravenous JJ Pharmocological
bolus NN Pharmocological
of IN Pharmocological
crystalloids NNS Pharmocological
, , None
hetastarch NN Pharmocological
( ( Pharmocological
HES NNP Pharmocological
) ) Pharmocological
, , None
or CC None
a DT None
hemoglobin-based JJ Pharmocological
oxygen-carrying JJ Pharmocological
solution NN Pharmocological
( ( Pharmocological
HBOCS NNP Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Clarithromycin NNP Pharmocological
placebo-controlled JJ Control
semisynthetic JJ Pharmocological
macrolide NN Pharmocological
antibiotic JJ Pharmocological
, , None
clarithromycin NN Pharmocological
methacholine VB Pharmocological
clarithromycin VBZ Pharmocological
placebo NN Pharmocological
dextrose JJ Pharmocological
clarithromycin NNS Pharmocological
clarithromycin NN Pharmocological
-DOCSTART- -X- N

micronutrient JJ Pharmocological
supplementation NN Pharmocological
micronutrient NN Pharmocological
supplementation NN Pharmocological
placebo-controlled JJ Control
supplementation NN Pharmocological
with IN Pharmocological
beta-carotene NN Pharmocological
, , Pharmocological
vitamins VBZ Pharmocological
C NNP Pharmocological
and CC Pharmocological
E NNP Pharmocological
, , Pharmocological
zinc NN Pharmocological
, , Pharmocological
and CC Pharmocological
selenium NN Pharmocological
surgery NN Surgical
Perioperative NNP Pharmocological
supplementation NN Pharmocological
with IN Pharmocological
micronutrients NNS Pharmocological
-DOCSTART- -X- N

Iron NNP Pharmocological
intake NN Pharmocological
and CC Pharmocological
iron NN Pharmocological
nutritional JJ Pharmocological
status NN Pharmocological
Fe-fortified JJ Pharmocological
formula NN Pharmocological
and CC Other
the DT Other
other JJ Other
a DT Other
nonfortified JJ Control
formula NN Control
. . None
Fe NNP Pharmocological
intake NN Pharmocological
Fe NNP Pharmocological
mainly RB Pharmocological
from IN Pharmocological
fortification NN Pharmocological
Fe NNP Pharmocological
with IN Pharmocological
beikost NN Pharmocological
Fe-fortified NNP Pharmocological
formula NN Pharmocological
commercially RB Pharmocological
prepared JJ Pharmocological
Fe-fortified JJ Pharmocological
beikost NN Pharmocological
with IN Pharmocological
meat NN Pharmocological
-DOCSTART- -X- N

metronidazole JJ Pharmocological
metronidazole JJ Pharmocological
dental JJ Pharmocological
gel NN Pharmocological
scaling NN Physical
and CC Physical
root NN Physical
planing NN Physical
( ( Physical
SRP NNP Physical
) ) Physical
SRP NNP Physical
metronidazole JJ Pharmocological
gel NN Pharmocological
SRP NNP Control
only RB Control
. . None
-DOCSTART- -X- N

concurrent NN Physical
cisplatin NN Physical
and CC None
preoperative NN Physical
or CC Physical
definitive JJ Physical
radiation NN Physical
. . None
concurrent NN Physical
cisplatin NN Physical
to TO Physical
preoperative VB Physical
or CC None
definitive JJ None
radiation NN None
therapy NN None
radiotherapy NN Physical
or CC None
precystectomy JJ Physical
radiotherapy NN Physical
; : None
intravenous JJ Pharmocological
cisplatin NNS Pharmocological
concurrent VBP Physical
with IN Physical
pelvic JJ Physical
radiation NN Physical
receive VB Physical
radiation NN Physical
without IN Physical
chemotherapy NN Physical
. . None
cisplatin-treated JJ Pharmocological
concurrent NN Pharmocological
cisplatin NN Pharmocological
cisplatin NN Pharmocological
Concurrent NNP Pharmocological
cisplatin NN Pharmocological
preoperative JJ Physical
or CC Physical
definitive JJ Physical
radiation NN Physical
concurrent NN Pharmocological
cisplatin NN Pharmocological
-DOCSTART- -X- N

YM17E NNP Pharmocological
, , Pharmocological
an DT Pharmocological
inhibitor NN Pharmocological
of IN Pharmocological
acyl NN Pharmocological
coenzyme NN Pharmocological
dose NN Pharmocological
study NN Pharmocological
of IN Pharmocological
YM17E NNP Pharmocological
YM17E NNP Pharmocological
was VBD Pharmocological
administered VBN Pharmocological
after IN Pharmocological
a DT Pharmocological
meal NN Pharmocological
to TO Pharmocological
YM17E NNP Pharmocological
YM17E NNP Pharmocological
. . Pharmocological
150 CD Pharmocological
mg NNS Pharmocological
YM17E VBN Pharmocological
test JJ Pharmocological
drug NN Pharmocological
at IN Pharmocological
150 CD Pharmocological
mg NN Pharmocological
or CC Pharmocological
300 CD Pharmocological
mg NN Pharmocological
placebo NN Control
( ( Control
n JJ Control
= NNP Control
3 CD Control
) ) Control
twice RB Control
a DT Control
day NN Control
YM17E NNP Pharmocological
once RB Pharmocological
a DT Pharmocological
day NN Pharmocological
-DOCSTART- -X- N

antibiotics NNS Pharmocological
randomly RB None
assigned VBN None
to TO None
either DT None
receive JJ None
systemic JJ Pharmocological
metronidazole NN Pharmocological
plus CC Pharmocological
amoxicillin NN Pharmocological
( ( Pharmocological
AP+AB NNP Pharmocological
) ) Pharmocological
or CC None
were VBD None
treated VBN Pharmocological
mechanically RB Pharmocological
alone RB Pharmocological
( ( Pharmocological
AP NNP Pharmocological
) ) Pharmocological
. . None
identified VBN None
with IN None
before IN None
and CC None
at IN None
days NNS None
2 CD None
, , None
3 CD None
, , None
4 CD None
, , None
7 CD None
, , None
10 CD None
, , None
and CC None
21 CD None
of IN None
healing VBG None
. . None
placebo JJ Control
tablets NNS Control
. . Control
-DOCSTART- -X- N

RelyX NNP Physical
Unicem NNP Physical
with IN Physical
or CC Physical
without IN Physical
selective JJ Physical
enamel NN Physical
etching VBG Physical
. . None
either CC None
with IN Physical
( ( Physical
RXU+E NNP Physical
) ) Physical
or CC Physical
without IN Physical
( ( Physical
RXU NNP Physical
) ) Physical
selective VBP Physical
enamel JJ Physical
etching NN Physical
. . None
PCC NNP Physical
RXU NNP Physical
PCC NNP Physical
RXU+E NNP Physical
. . None
Cerec NNP Physical
3 CD Physical
system NN Physical
. . None
RXU NN Physical
: : None
RXU+E NN Physical
: : None
( ( None
RXU NNP Physical
) ) None
( ( None
RXU+E NNP Physical
) ) None
RXU NNP Physical
and CC None
RXU+E NNP Physical
RXU NNP Physical
-DOCSTART- -X- N

Assisted VBN Physical
exercise NN Physical
exercise NN Physical
assisted JJ Physical
exercise NN Physical
control NN Control
daily JJ Physical
passive JJ Physical
extension NN Physical
and CC Physical
flexion NN Physical
range-of-motion NN Physical
exercise NN Physical
exercise NN Physical
-DOCSTART- -X- N

Minocycline NNP Pharmocological
Minocycline NNP Pharmocological
placebo-controlled JJ Control
minocycline NN Pharmocological
minocycline NN Pharmocological
at IN Pharmocological
100 CD Pharmocological
and CC Pharmocological
200 CD Pharmocological
mg/day NN Pharmocological
-DOCSTART- -X- N

detection NN Physical
of IN Physical
in IN Physical
novel NN Other
red JJ Other
lesion NN Other
detection NN Other
method NN Other
red JJ Other
lesion NN Other
candidate NN Other
detection NN Other
system NN Other
-DOCSTART- -X- N

Denver NNP Physical
Model NNP Physical
and CC None
PROMPT NNP Physical
interventions NNS None
. . None
Denver NNP Physical
Model NNP Physical
( ( None
which WDT None
merges VBZ None
behavioral JJ Educational
, , None
developmental JJ Educational
, , None
and CC None
relationship-oriented JJ Psychological
intervention NN None
) ) None
, , None
and CC None
PROMPT NNP Physical
( ( None
a DT None
neuro-developmental JJ Psychological
approach NN Psychological
for IN None
speech JJ None
production NN None
disorders NNS None
) ) None
. . None
-DOCSTART- -X- N

liquid NN Pharmocological
antacid NN Pharmocological
and CC None
placebo NN Control
antacids NNS Pharmocological
placebo-controlled JJ None
liquid JJ Pharmocological
antacid NN Pharmocological
vs NN None
placebo NN Control
antacid NN Pharmocological
( ( Pharmocological
Maalox NNP Pharmocological
Therapeutic NNP Pharmocological
Concentration NNP Pharmocological
placebo VB Control
active JJ Pharmocological
drug NN Pharmocological
placebo NN None
therapy NN None
. . None
antacid NN Pharmocological
placebo NN None
antacid NN Pharmocological
placebo NN None
. . None
antacid NN Pharmocological
placebo NN None
-DOCSTART- -X- N

abciximab NN Pharmocological
primary JJ Surgical
angioplasty NN Surgical
abciximab NN Pharmocological
( ( Pharmocological
ReoPro NNP Pharmocological
) ) Pharmocological
percutaneous JJ Surgical
coronary JJ Surgical
angioplasty NN Surgical
( ( Surgical
pPCI NN Surgical
) ) Surgical
. . None
abciximab NN Pharmocological
-DOCSTART- -X- N

gonadotropin-releasing JJ Pharmocological
hormone-agonist JJ Pharmocological
leuprolide NN Pharmocological
acetate NN Pharmocological
. . None
leuprolide JJ Pharmocological
acetate NN Pharmocological
( ( Pharmocological
LA NNP Pharmocological
) ) Pharmocological
LA NNP Pharmocological
according VBG None
to TO None
short JJ None
or CC None
ultrashort JJ None
protocols NNS None
. . None
LA NNP Pharmocological
LA NNP Pharmocological
LA NNP Pharmocological
LA NNP Pharmocological
-DOCSTART- -X- N

extracorporeal JJ Surgical
circulation NN Surgical
cardiopulmonary JJ Surgical
bypass NN Surgical
Minimal NNP Physical
extracorporeal NN Physical
circulation NN Physical
( ( Physical
MECC NNP Physical
) ) Physical
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
graft NN Surgical
( ( Surgical
CABG NNP Surgical
) ) Surgical
surgery NN Surgical
MECC NNP Surgical
conventional JJ Physical
extracorporeal JJ Physical
circulation NN Physical
( ( Physical
CECC NNP Physical
) ) Physical
MECC NNP Surgical
or CC None
CECC NNP Surgical
. . None
-DOCSTART- -X- N

surgical JJ Surgical
staging NN Surgical
-DOCSTART- -X- N

intervention NN Educational
community NN Educational
caregiver RB Educational
training NN Educational
interventions NNS Educational
CMM NNP Educational
CMM NNP Educational
-DOCSTART- -X- N

telephone-delivered JJ Educational
intervention NN Educational
for IN Educational
Telephone NNP Educational
Counselling NNP Educational
intervention NN Educational
to TO None
improve VB None
physical JJ None
activity NN None
and CC None
diet NN None
Telephone NNP None
Counselling NNP None
with IN None
a DT None
Usual NNP None
Care NNP None
( ( None
brief JJ None
intervention NN None
) ) None
, , Physical
Usual NNP Physical
Care NNP Physical
and CC Physical
an DT Physical
existing VBG Control
practice NN Control
( ( Control
Real NNP Control
Control NNP Control
) ) Control
Telephone CD Educational
Counselling VBG Educational
Usual NNP Physical
Care NNP Physical
Usual NNP Physical
Care NNP Physical
Telephone CD Educational
Counselling VBG Educational
existing VBG None
practice NN None
( ( None
Real NNP None
Control NNP None
) ) None
Usual JJ Other
Care NNP Other
( ( Other
brief JJ Other
intervention NN Other
) ) Other
existing VBG Control
practice NN Control
( ( Control
Real NNP Control
Control NNP Control
) ) Control
Telephone CD None
Counselling VBG None
existing VBG None
practice NN None
( ( None
Real NNP None
Control NNP None
) ) None
'Usual JJ Physical
Care NNP Physical
' POS Physical
brief NN Physical
intervention NN Physical
existing VBG None
practice NN None
( ( None
Real NNP None
Control NNP None
) ) None
-DOCSTART- -X- N

Immunotherapy NNP Pharmocological
CROP NNP Pharmocological
( ( Pharmocological
cytosine JJ Pharmocological
arabinoside NN Pharmocological
, , Pharmocological
daunorubicin NN Pharmocological
, , Pharmocological
vincristine NN Pharmocological
, , Pharmocological
prednisolone NN Pharmocological
) ) Pharmocological
( ( Pharmocological
cytosine NN Pharmocological
arabinoside RB Pharmocological
, , Pharmocological
daunorubicin NN Pharmocological
) ) Pharmocological
plus CC Pharmocological
hydroxyurea NN Pharmocological
maintenance NN Pharmocological
therapy NN Pharmocological
chemo-immunotherapy NN Pharmocological
( ( None
BCG NNP Pharmocological
plus CC None
intradermal JJ Pharmocological
leukaemic JJ Pharmocological
blast NN Pharmocological
cells NNS Pharmocological
) ) None
or CC None
chemotherapy VB Pharmocological
alone RB None
. . None
chemotherapy NN Pharmocological
chemo-immunotherapy JJ Pharmocological
immunotherapy NN Pharmocological
. . None
-DOCSTART- -X- N

oral JJ Pharmocological
anticoagulant JJ Pharmocological
therapy NN Pharmocological
oral JJ Physical
anticoagulant JJ Physical
therapy NN Physical
warfarin NN Pharmocological
plus CC Pharmocological
aspirin JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
WASA NNP Pharmocological
) ) Pharmocological
versus NN None
aspirin JJ Pharmocological
therapy NN Pharmocological
alone RB Pharmocological
( ( Pharmocological
ASA NNP Pharmocological
) ) Pharmocological
ASA NNP Physical
WASA NNP Physical
ASA NNP Physical
WASA NNP Physical
ASA NNP Physical
WASA NNP Pharmocological
ASA NNP Pharmocological
WASA NNP Pharmocological
warfarin JJ Pharmocological
therapy NN Pharmocological
-DOCSTART- -X- N

placebo-controlled JJ Control
aprindine NN Pharmocological
and CC None
digoxin NN Pharmocological
placebo-controlled JJ Control
aprindine NN Pharmocological
and CC None
digoxin NN Pharmocological
placebo NN Control
aprindine NN Pharmocological
digoxin NN Pharmocological
or CC None
placebo NN Pharmocological
aprindine NN Pharmocological
, , None
digoxin NN Pharmocological
placebo NN Control
placebo NN Control
digoxin NN Pharmocological
aprindine NN Pharmocological
placebo NN Control
digoxin NN Pharmocological
. . None
-DOCSTART- -X- N

spinal JJ Physical
versus NN Physical
general JJ Physical
anesthesia NN Physical
spinal JJ Physical
versus NN Physical
general JJ Physical
anesthesia NN Physical
hyperbaric JJ Pharmocological
tetracaine NN Pharmocological
General NNP Physical
Anesthesia NNP Physical
( ( Physical
GA NNP Physical
) ) Physical
fentanyl RB Pharmocological
intravenous JJ Pharmocological
anesthesia NN Physical
. . None
anesthesia NN Pharmocological
isoflurane NN Pharmocological
nitrous JJ Pharmocological
oxide NN Pharmocological
( ( Pharmocological
N2O NNP Pharmocological
) ) Pharmocological
in IN Pharmocological
oxygen NN Pharmocological
. . None
anesthesia NN Physical
spinal JJ Physical
and CC Physical
general JJ Physical
anesthesia NN Physical
spinal JJ Physical
anesthesia NN Physical
-DOCSTART- -X- N

clomipramine NN Pharmocological
, , None
desipramine NN Pharmocological
, , None
and CC None
placebo NN Control
clomipramine NN Pharmocological
hydrochloride NN Pharmocological
placebo NN Control
noradrenergic JJ Pharmocological
tricyclic JJ Pharmocological
antidepressant NN Pharmocological
agent NN Pharmocological
, , None
desipramine JJ Pharmocological
hydrochloride NN Pharmocological
. . None
placebo NN Control
clomipramine NN Pharmocological
and CC None
placebo NN Control
clomipramine NN Pharmocological
desipramine NN Pharmocological
. . None
Clomipramine NNP Pharmocological
desipramine NN Pharmocological
placebo NN Control
. . None
Clomipramine NNP Pharmocological
desipramine VB Pharmocological
-DOCSTART- -X- N

health-promotion NN Educational
programme NN Educational
health-promotion JJ Educational
programme NN Educational
individual JJ Educational
programme NN Educational
( ( Educational
individual JJ Control
intervention NN Control
health-promotion NN Educational
programme NN Educational
health-promotion NN Educational
group NN Educational
individual JJ Educational
intervention NN Educational
health-promotion NN Educational
group NN Educational
health-promotion NN Physical
health-promotion NN None
programme NN None
-DOCSTART- -X- N

coronary JJ Surgical
angioplasty NN Surgical
and CC None
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
percutaneous JJ Surgical
transluminal JJ Surgical
coronary NN Surgical
angioplasty NN Surgical
and CC None
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
surgery NN Surgical
. . None
coronary JJ Surgical
angioplasty NN Surgical
or CC None
coronary JJ Surgical
artery NN Surgical
bypass NN Surgical
surgery NN Surgical
-DOCSTART- -X- N

control NN Control
in IN Physical
addition NN Physical
to TO Physical
, , Control
including VBG Control
, , Control
and CC Control
-DOCSTART- -X- N

sodium NN Pharmocological
ferric JJ Pharmocological
gluconate NN Pharmocological
complex NN Pharmocological
( ( Pharmocological
SFGC NNP Pharmocological
) ) Pharmocological
IV NNP Pharmocological
SFGC NNP Pharmocological
in IN Pharmocological
sucrose JJ Pharmocological
Ferrlecit NNP None
? . None
Injection NNP None
-DOCSTART- -X- N

albumin NN Pharmocological
intravenously RB Pharmocological
1 CD Pharmocological
gm/kg NN Pharmocological
of IN Pharmocological
salt-poor JJ Pharmocological
human JJ Pharmocological
serum NN Pharmocological
albumin IN Pharmocological
-DOCSTART- -X- N

angiotensin NN Pharmocological
II NNP Pharmocological
receptor NN Pharmocological
blockade NN Pharmocological
DASH NNP Pharmocological
diet NN Pharmocological
angiotensin JJ Pharmocological
receptor NN Pharmocological
blockers NNS Pharmocological
( ( Pharmocological
ARB NNP Pharmocological
) ) Pharmocological
DASH NNP Pharmocological
( ( Pharmocological
Dietary NNP Pharmocological
Approaches NNP Pharmocological
to TO Pharmocological
Stop NNP Pharmocological
Hypertension NNP Pharmocological
) ) Pharmocological
diet VBP Pharmocological
control NN Other
diet NN Other
DASH NNP Pharmocological
diet NN Pharmocological
. . None
losartan NN Pharmocological
placebo NN Control
diet NN Other
-DOCSTART- -X- N

Thyroid NNP Pharmocological
stimulating VBG Pharmocological
antibodies NNS Pharmocological
: : None
thyroid JJ Pharmocological
stimulating VBG Pharmocological
antibody NN Pharmocological
( ( Pharmocological
TSAb NNP Pharmocological
) ) Pharmocological
post-antithyroid JJ Pharmocological
drug NN Pharmocological
treatment NN Pharmocological
-DOCSTART- -X- N

standard JJ Control
outpatient NN Control
clinic JJ Control
treatment NN Control
-DOCSTART- -X- N

( ( None
5-fluorouracil JJ Pharmocological
interferon NN Pharmocological
) ) None
laser NN Surgical
surgery NN Surgical
interferon NN Pharmocological
5-fluorouracil JJ Pharmocological
interferon NN Pharmocological
5-fluorouracil JJ Pharmocological
laser NN Surgical
alone RB Surgical
5-fluorouracil JJ Pharmocological
interferon NN Pharmocological
surgical JJ Surgical
deleulking NN Surgical
-DOCSTART- -X- N

oxytocin MD Pharmocological
24 CD None
or CC None
12 CD None
international JJ None
units NNS None
( ( None
depending VBG None
on IN None
weight NN None
) ) None
intranasal NN Control
placebo NN Control
or CC None
oxytocin JJ Pharmocological
-DOCSTART- -X- N

peer NN Educational
, , Educational
nurse JJ Educational
case-managed JJ Educational
, , Educational
and CC Educational
standard JJ Other
HIV NNP Other
risk-reduction NN Other
programs NNS Other
cognitive-behavioral JJ Educational
HIV NNP Educational
risk-reduction NN Educational
programs NNS Educational
program NN Control
. . None
peer-mentored JJ Educational
and CC Educational
nurse JJ Educational
case-managed JJ Educational
standard JJ Control
group NN Control
-DOCSTART- -X- N

penicillin NN Pharmocological
placebo NN Control
penicillin NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

fentanyl NN Pharmocological
remifentanil NN Pharmocological
fentanyl NN Pharmocological
and CC None
remifentanil NN Pharmocological
isoflurane NN Pharmocological
in IN Pharmocological
oxygen NN Pharmocological
Fentanyl NNP Pharmocological
remifentanil NN Pharmocological
Fentanyl NNP Pharmocological
remifentanil NN Pharmocological
remifentanil NN Pharmocological
remifentanil NN Pharmocological
remifentanil NN Pharmocological
fentanyl VB Pharmocological
-DOCSTART- -X- N

Endoscopic NNP Surgical
ligation NN Surgical
sclerotherapy NN Pharmocological
Endoscopic NNP Pharmocological
sclerotherapy NN Pharmocological
Endoscopic NNP Surgical
ligation NN Surgical
variceal JJ Surgical
band NN Surgical
ligation NN Surgical
-DOCSTART- -X- N

carvedilol NN Pharmocological
14C-labeled JJ Pharmocological
drug NN Pharmocological
. . Pharmocological
-DOCSTART- -X- N

antioxidant JJ Pharmocological
supplementation NN Pharmocological
antioxidants NNS Pharmocological
diet JJ Pharmocological
low JJ Pharmocological
in IN Pharmocological
ascorbate NN Pharmocological
filtered VB Physical
air NN Physical
for IN Physical
2 CD Physical
h NNS Physical
while IN Physical
exercising VBG Physical
( ( Physical
20 CD Physical
L/min/m NNP Physical
( ( Physical
2 CD Physical
) ) Physical
) ) Physical
, , None
and CC None
then RB None
underwent JJ None
bronchoalveolar JJ Physical
lavage NN Physical
( ( Physical
BAL NNP Physical
) ) Physical
and CC None
were VBD None
randomly RB None
assigned VBN None
to TO None
receive VB None
either CC None
a DT None
placebo NN Control
or CC None
250 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
vitamin NN Pharmocological
C NNP Pharmocological
, , None
50 CD Pharmocological
IU NNP Pharmocological
of IN Pharmocological
alpha-tocopherol NN Pharmocological
, , None
and CC None
12 CD None
oz NN None
of IN None
vegetable JJ Pharmocological
cocktail JJ Pharmocological
daily NN Pharmocological
for IN Pharmocological
2 CD Pharmocological
wk NN Pharmocological
. . None
exposed VBN None
to TO None
0.4 CD None
ppm NNS None
O NNP None
( ( None
3 CD None
) ) None
for IN None
2 CD None
h NN None
and CC None
underwent NN None
a DT None
second JJ None
BAL NNP Physical
. . None
placebo NN None
dietary JJ Pharmocological
antioxidants NNS Pharmocological
-DOCSTART- -X- N

status NN None
of IN None
BRAF NNP None
c.1799T NN None
> VBZ None
A NNP None
( ( None
p.V600E NN None
) ) None
mutation NN None
and CC None
MSI NNP None
[ NNP None
5-fluorouracil CD None
and CC None
leucovorin NN None
( ( None
FU/LV NNP None
) ) None
vs. FW None
irinotecan JJ Pharmocological
( ( Pharmocological
CPT11 NNP Pharmocological
) ) Pharmocological
, , Pharmocological
FU NNP Pharmocological
and CC Pharmocological
LV NNP Pharmocological
( ( Pharmocological
IFL NNP Pharmocological
) ) Pharmocological
; : Pharmocological
chemotherapy NN Pharmocological
IFL NNP Pharmocological
FU/LV NNP Pharmocological
IFL NNP Pharmocological
FU/LV NNP Pharmocological
irinotecan-based JJ Pharmocological
therapy NN Pharmocological
. . None
-DOCSTART- -X- N

Etanercept NNP Pharmocological
plus CC Pharmocological
standard JJ Pharmocological
therapy NN Pharmocological
placebo-controlled JJ Control
etanercept NN Pharmocological
etanercept VB Pharmocological
placebo VB Control
standard JJ Pharmocological
therapy NN Pharmocological
( ( Pharmocological
glucocorticoids JJ Pharmocological
plus CC Pharmocological
cyclophosphamide JJ Pharmocological
or CC Pharmocological
methotrexate NN Pharmocological
) ) Pharmocological
. . Pharmocological
standard JJ Pharmocological
medications NNS Pharmocological
etanercept NN Pharmocological
etanercept NN Pharmocological
control NN Control
group NN Control
etanercept NN Pharmocological
etanercept NN Pharmocological
etanercept NN Pharmocological
Etanercept NNP Pharmocological
-DOCSTART- -X- N

propranolol NN Pharmocological
?-adrenergic JJ None
antagonist NN None
propranolol NN None
. . None
suggested VBD None
propranolol NN None
of IN None
propranolol NN None
mg NNS None
propranolol JJ None
after IN None
placebo NN None
, , None
Propranolol NNP None
of IN None
propranolol NN None
-DOCSTART- -X- N

develop VB Other
the DT Other
formulas NN Educational
validate VB Other
the DT Other
prediction NN Educational
algorithms NN Educational
-DOCSTART- -X- N

sensory JJ Physical
stimulation NN Physical
( ( Physical
acupuncture NN Physical
) ) Physical
sensory JJ Physical
stimulation NN Physical
( ( Physical
acupuncture NN Physical
) ) Physical
needle JJ Physical
sensation NN Physical
short JJ Physical
acupuncture NN Physical
needle NN Physical
acupuncture NN Physical
needle NN Physical
acupuncture NN Physical
needle NN Physical
sensory JJ Physical
stimulation NN Physical
( ( Physical
acupunctura NN Physical
) ) Physical
-DOCSTART- -X- N

Diode NNP Physical
laser NN Physical
photocoagulation NN Physical
peripheral JJ Physical
cryotherapy NN Physical
Argon NNP Physical
laser NN Physical
indirect JJ Physical
ophthalmoscope NN Physical
photocoagulation NN Physical
cryotherapy VB Physical
diode NN Physical
lasers NNS Physical
argon NN Physical
laser NN Physical
ablative JJ Physical
therapy NN Physical
. . None
diode NN Physical
laser NN Physical
cryotherapy NN Physical
. . None
diode NN Physical
laser NN Physical
cryotherapy NN Physical
cryotherapy NN Physical
diode NN Physical
laser NN Physical
cryotherapy-treated JJ Physical
cryotherapy-treated JJ Physical
laser-treated JJ Physical
cryotherapy NN Physical
diode NN Physical
laser NN Physical
diode VB Physical
laser RBR Physical
peripheral JJ Physical
retinal JJ Physical
ablation NN Physical
cryotherapy NN Physical
-DOCSTART- -X- N

ad NN Physical
libitum NN Physical
access NN Physical
to TO Physical
high-concentrate JJ Physical
diets NNS Physical
( ( Pharmocological
13 CD Pharmocological
% NN Pharmocological
CP NNP Pharmocological
) ) Pharmocological
containing VBG None
71 CD None
% NN None
whole JJ None
shelled VBN None
corn NN None
, , None
10 CD None
% NN None
corn NN None
silage NN None
, , None
4 CD None
% NN None
condensed JJ None
distillers NNS None
solubles NNS None
, , None
and CC None
15 CD None
% NN None
protein NN None
supplements NNS None
( ( None
DM NNP None
basis NN None
) ) None
. . None
-DOCSTART- -X- N

social JJ Educational
support NN Educational
and CC Educational
education NN Educational
A DT Educational
Roy NNP Educational
adaptation NN Educational
model-based JJ Educational
support NN Educational
and CC Educational
education NN Educational
intervention NN Educational
combined JJ Educational
individual JJ Educational
telephone NN Educational
and CC Educational
in-person NN Educational
group NN Educational
support NN Educational
and CC Educational
education NN Educational
telephone-only JJ Educational
individual JJ Educational
support NN Educational
and CC Educational
education NN Educational
one-time RB Educational
mailed JJ Educational
educational JJ Educational
information NN Educational
. . Educational
-DOCSTART- -X- N

Metronidazole NNP Pharmocological
periodontitis NN Pharmocological
Metronidazole NNP Pharmocological
Metronidazole NNP Pharmocological
metronidazole JJ Pharmocological
metronidazole NNS Pharmocological
metronidazole NN Pharmocological
metronidazole NN Pharmocological
metronidazole NN Pharmocological
. . None
metronidazole NN Pharmocological
. . None
-DOCSTART- -X- N

non-invasive JJ Physical
methods NNS Physical
haemodynamic JJ Physical
laser NN Physical
interferometry NN Physical
of IN Physical
ocular JJ Physical
fundus NN Physical
pulsations NNS Physical
and CC None
of IN None
non-invasive JJ Physical
methods NNS Physical
intravenous JJ Pharmocological
doses NNS Pharmocological
of IN Pharmocological
phenylephrine NN Pharmocological
, , None
isoprenaline NN Pharmocological
, , None
sodium NN Pharmocological
nitroprusside NN Pharmocological
and CC None
of IN None
placebo NN Control
. . None
Laser NNP Physical
interferometry NN Physical
-DOCSTART- -X- N

Stepping NNP Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
: : None
Stepping VBG Educational
Stones JJ Educational
Triple NNP Educational
P NNP Educational
( ( Educational
SSTP NNP Educational
) ) Educational
Group NNP Educational
Stepping NNP Educational
Stones NNP Educational
Triple NNP Educational
P NNP Educational
( ( Educational
GSSTP NNP Educational
) ) Educational
GSSTP NNP Educational
-DOCSTART- -X- N

Profile NNP Educational
of IN Educational
Mood NNP Educational
States NNPS Educational
( ( Educational
POMS NNP Educational
) ) Educational
questionnaire NN Educational
. . None
-DOCSTART- -X- N

-DOCSTART- -X- N

levobupivacaine JJ Pharmocological
ropivacaine VB Pharmocological
bupivacaine VB Pharmocological
racemic JJ Pharmocological
bupivacaine NN Pharmocological
s-enantiomers NNS Pharmocological
levobupivacaine NN Pharmocological
ropivacaine NN Pharmocological
levobupivacaine JJ Pharmocological
ropivacaine VB Pharmocological
bupivacaine JJ Pharmocological
bupivacaine JJ Pharmocological
ropivacaine VB Pharmocological
levobupivacaine VB Pharmocological
-DOCSTART- -X- N

weight-bearing JJ Physical
versus NN None
nonweight-bearing JJ Physical
exercise NN Physical
weight-bearing NN Physical
( ( Physical
WB NNP Physical
) ) Physical
exercise NN Physical
nonweight-bearing JJ Physical
( ( Physical
NWB NNP Physical
) ) Physical
exercise NN Physical
WB NNP Physical
exercise NN Physical
, , None
NWB NNP Physical
exercise NN Physical
control NN Control
group NN Control
( ( Control
no DT Control
exercise NN Control
) ) Control
. . None
WB NNP Physical
exercise NN Physical
and CC None
NWB NNP Physical
exercise NN Physical
groups NNS Physical
underwent VBD None
8-week JJ Physical
knee NN Physical
extension-flexion NN Physical
exercise NN Physical
program NN Physical
. . None
WB NNP Physical
exercise NN Physical
( ( Physical
WB NNP Physical
NWB NNP Physical
) ) None
NWB NNP Physical
exercise NN Physical
WB NNP Physical
exercise NN Physical
-DOCSTART- -X- N

new JJ Pharmocological
capsule-type JJ Pharmocological
colon NN Pharmocological
specific JJ Pharmocological
drug NN Pharmocological
delivery NN Pharmocological
system NN Pharmocological
Colonic JJ Physical
drug NN Physical
delivery NN Physical
novel JJ Physical
capsule-type JJ Physical
colonic NN Physical
delivery NN Physical
system NN Physical
( ( Physical
Colon-Targeted JJ Physical
Delivery NNP Physical
Capsule NNP Physical
) ) Physical
-DOCSTART- -X- N

prostamol NN Pharmocological
uno JJ Pharmocological
Prostamol NNP Pharmocological
Uno NNP Pharmocological
( ( Pharmocological
PU NNP Pharmocological
) ) Pharmocological
PU NNP Pharmocological
PU NNP Pharmocological
-DOCSTART- -X- N

Lamotrigine NNP Pharmocological
therapy NN Pharmocological
lamotrigine NN Pharmocological
lamotrigine NN Pharmocological
, , Pharmocological
the DT Pharmocological
drug NN Pharmocological
was VBD Pharmocological
titrated VBN Pharmocological
upward RB Pharmocological
over IN Pharmocological
8 CD Pharmocological
weeks NNS Pharmocological
to TO Pharmocological
reach VB Pharmocological
a DT Pharmocological
mean JJ Pharmocological
maintenance NN Pharmocological
dose NN Pharmocological
of IN Pharmocological
5.0 CD Pharmocological
mg/kg NNS Pharmocological
per IN Pharmocological
day NN Pharmocological
. . None
This DT Pharmocological
dose NN Pharmocological
was VBD Pharmocological
then RB Pharmocological
maintained VBN Pharmocological
for IN Pharmocological
4 CD Pharmocological
weeks NNS Pharmocological
. . None
Following VBG Pharmocological
maintenance NN Pharmocological
evaluations NNS Pharmocological
, , Pharmocological
the DT Pharmocological
drug NN Pharmocological
was VBD Pharmocological
tapered VBN Pharmocological
down RB Pharmocological
over RB Pharmocological
2 CD Pharmocological
weeks NNS Pharmocological
. . None
The DT Physical
trial NN Physical
ended VBD Physical
with IN Physical
a DT Physical
4-week JJ Physical
drug-free JJ Physical
period NN Physical
. . None
lamotrigine NN Pharmocological
or CC None
placebo NN Control
-DOCSTART- -X- N

nursing NN Psychological
intervention NN Psychological
utilizing VBG Psychological
problem-solving JJ Psychological
approaches NNS Psychological
to TO Psychological
symptom VB Psychological
management NN Psychological
and CC Psychological
improving VBG Psychological
intervention NN Educational
Behavioral NNP Educational
interventions NNS Educational
nursing VBG Educational
care NN Educational
nursing NN Educational
interventions NNS Educational
-DOCSTART- -X- N

exercise NN Physical
Androgen NNP Pharmocological
deprivation NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
ADT NNP Pharmocological
) ) Pharmocological
exercise NN Physical
exercise NN Physical
program NN Physical
resistance/impact NN Physical
loading VBG Physical
exercise NN Physical
, , Physical
( ( Physical
2 CD Physical
) ) Physical
resistance/cardiovascular NN Physical
exercise NN Physical
groups NNS Physical
and CC Physical
( ( Physical
3 CD Physical
) ) Physical
usual JJ Physical
care/delayed VBN Physical
exercise NN Physical
. . Physical
progressive JJ Physical
training NN Physical
exercise NN Physical
-DOCSTART- -X- N

tamoxifen NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
epirubicin NN Pharmocological
tamoxifen NN Pharmocological
to TO Pharmocological
epirubicin VB Pharmocological
versus NN Pharmocological
epirubicin FW Pharmocological
alone RB Pharmocological
tamoxifen NN Pharmocological
to TO Pharmocological
epirubicin VB Pharmocological
epirubicin JJ Pharmocological
plus CC Pharmocological
tamoxifen JJ Pharmocological
tamoxifen JJ Pharmocological
plus CC Pharmocological
epirubicin JJ Pharmocological
. . None
addition NN Pharmocological
of IN Pharmocological
tamoxifen NN Pharmocological
to TO Pharmocological
epirubicin VB Pharmocological
-DOCSTART- -X- N

cardiovascular JJ Other
risk NN Other
assessment NN Other
-DOCSTART- -X- N

placebo-controlled JJ Control
valacyclovir NN Pharmocological
alone RB Pharmocological
aspirin NN Pharmocological
valacyclovir NN Pharmocological
alone RB Pharmocological
aspirin NN Pharmocological
placebo NN Control
500 CD Pharmocological
mg NNS Pharmocological
valacyclovir JJ Pharmocological
once RB Pharmocological
daily JJ Pharmocological
500 CD Pharmocological
mg NNS Pharmocological
valacyclovir JJ Pharmocological
once RB Pharmocological
daily JJ Pharmocological
and CC None
350 CD Pharmocological
mg NN Pharmocological
aspirin JJ Pharmocological
treatment NN None
valacyclovir NNS Pharmocological
valacyclovir NN Pharmocological
with IN Pharmocological
aspirin JJ Pharmocological
valacyclovir JJ Pharmocological
valacyclovir NN Pharmocological
aspirin NN Pharmocological
-DOCSTART- -X- N

ketorolac NN Pharmocological
, , Pharmocological
topical JJ Pharmocological
bupivacaine NN Pharmocological
placebo NN Control
intramuscular JJ Pharmocological
ketorolac NN Pharmocological
and CC Pharmocological
topical JJ Control
placebo NN Control
intramuscular JJ Control
placebo NN Control
and CC Control
topical JJ Pharmocological
bupivacaine NN Pharmocological
intramuscular JJ Control
placebo NN Control
and CC Control
topical JJ Control
placebo NN Control
. . None
placebo NN Control
ketorolac NNS Pharmocological
placebo NN Control
. . None
bupivacaine NN Pharmocological
placebo NN Control
-DOCSTART- -X- N

nuclear JJ Other
magnetic JJ Other
resonance NN Other
imaging NN Other
. . Other
nuclear JJ Other
magnetic JJ Other
resonance NN Other
( ( Other
NMR NNP Other
) ) Other
imaging NN Other
NMR NNP Other
images NNS Other
-DOCSTART- -X- N

intravenous JJ Pharmocological
fructose-1,6-diphosphate NN Pharmocological
fructose-1,6-diphosphate NN Pharmocological
intravenous JJ Pharmocological
fructose-1,6-diphosphate JJ Pharmocological
125 CD Pharmocological
mg/kg NN Pharmocological
or CC None
normal JJ Pharmocological
saline JJ Pharmocological
radionuclide NN Physical
ventriculography NN Physical
Fructose-1,6-diphosphate NNP Pharmocological
fructose-1,6-diphosphate JJ Pharmocological
placebo NN Control
. . None
Fructose-1,6-diphosphate NNP Pharmocological
-DOCSTART- -X- N

ViviScal NNP Pharmocological
, , Pharmocological
with IN Pharmocological
fish JJ Pharmocological
extract NN Pharmocological
ViviScal NNP Pharmocological
( ( Pharmocological
a DT Pharmocological
new JJ Pharmocological
food NN Pharmocological
supplement NN Pharmocological
incorporating VBG Pharmocological
special JJ Pharmocological
marine JJ Pharmocological
extracts NNS Pharmocological
and CC Pharmocological
a DT Pharmocological
silica JJ Pharmocological
compound NN Pharmocological
) ) Pharmocological
with IN None
those DT None
of IN None
a DT None
fish JJ Surgical
extract NN Surgical
fish JJ Pharmocological
extract NN Pharmocological
ViviScal NNP Pharmocological
fish JJ Pharmocological
extract NN Pharmocological
ViviScal NNP Pharmocological
ViviScal JJ Pharmocological
-DOCSTART- -X- N

5-fluorouracil JJ Pharmocological
human JJ Pharmocological
interferon-beta NN Pharmocological
5-fluorouracil JJ Pharmocological
( ( Pharmocological
5-FU JJ Pharmocological
) ) Pharmocological
monotherapy NN Pharmocological
5-FU JJ Pharmocological
combined VBN Pharmocological
with IN Pharmocological
natural JJ Pharmocological
human JJ Pharmocological
interferon-beta NN Pharmocological
( ( Pharmocological
IFN-beta NNP Pharmocological
) ) Pharmocological
IFN-beta NNP Pharmocological
IFN-3 NNP Pharmocological
to TO Pharmocological
5-FU CD Pharmocological
5-FU JJ Pharmocological
IFN-beta NNP Pharmocological
. . None
-DOCSTART- -X- N

Allogeneic NNP Surgical
hematopoietic JJ Surgical
stem-cell NN Surgical
transplantation NN Surgical
data NNS Educational
from IN Educational
a DT Educational
-DOCSTART- -X- N

clinician-guided JJ Physical
Internet-delivered JJ Physical
clinician-guided JJ Physical
Internet-delivered JJ Physical
cognitive JJ Physical
behaviour NN Physical
therapy NN Physical
( ( Physical
iCBT JJ Physical
) ) Physical
program NN Physical
Pain NNP Educational
Course NNP Educational
Treatment NNP Control
Group NNP Control
or CC Control
waitlist VB Control
Control NNP Control
Group NNP Control
. . None
5 CD Educational
iCBT-based JJ Educational
lessons NNS Educational
, , None
homework NN Pharmocological
tasks NNS Pharmocological
, , None
additional JJ Educational
resources NNS Educational
, , None
weekly JJ None
e-mail NN Educational
or CC Educational
telephone NN Educational
contact NN Educational
from IN Educational
a DT Educational
Clinical JJ Educational
Psychologist NN Educational
, , None
and CC None
automated VBD Educational
e-mails NNS Educational
. . None
5 CD None
lessons NNS None
Treatment NNP Physical
Group NNP Physical
Control NNP Control
Group NNP Control
iCBT NN None
clinician-guided JJ Physical
iCBT NN Physical
-DOCSTART- -X- N

CMF- NNP Pharmocological
( ( Pharmocological
cyclophosphamide NN Pharmocological
, , Pharmocological
methotrexate NN Pharmocological
and CC Pharmocological
5-fluorouracil NN Pharmocological
) ) Pharmocological
chemotherapy NN Pharmocological
in IN None
addition NN None
to TO None
endocrine VB Pharmocological
therapy NN Pharmocological
. . None
goserelin NN Pharmocological
, , Pharmocological
goserelin NN Pharmocological
plus CC Pharmocological
tamoxifen NN Pharmocological
, , Pharmocological
tamoxifen VB Pharmocological
alone RB Pharmocological
or CC None
no DT Control
endocrine JJ Control
treatment NN Control
. . None
-DOCSTART- -X- N

Rizatriptan NNP Pharmocological
placebo-controlled JJ Control
rizatriptan JJ Pharmocological
Rizatriptan NNP Pharmocological
rizatriptan NNS Pharmocological
rizatriptan JJ Pharmocological
placebo NN Control
rizatriptan NN Pharmocological
placebo NN Control
, , None
rizatriptan VBP Pharmocological
-DOCSTART- -X- N

153Gd CD Physical
transmission NN Physical
computed VBN Physical
tomography NN Physical
99mTc-ethyl JJ Physical
cysteinate NN Physical
dimer NN Physical
( ( Physical
ECD NNP Physical
) ) Physical
images NNS Physical
ECD NNP Physical
TCT NNP Physical
ECD NNP Physical
ECD-based JJ Physical
TCT-based JJ Physical
ECD/CD NNP Physical
, , None
ECD/NMI NNP Physical
TCT/CD NNP Physical
ECD NNP Physical
CD NN Physical
NMI NNP Physical
TCT NNP Physical
TCT NNP Physical
-DOCSTART- -X- N

Different NNP Pharmocological
aprotinin NN Pharmocological
applications NNS Pharmocological
aprotinin NN Pharmocological
applications NNS Pharmocological
aprotinin RB Pharmocological
bolus NN Pharmocological
of IN Pharmocological
0.5 CD Pharmocological
Mill NNP Pharmocological
. . None
continuous JJ Pharmocological
aprotinin JJ Pharmocological
infusion NN Pharmocological
of IN Pharmocological
0.1-0.4 JJ Pharmocological
Mill NNP Pharmocological
. . Pharmocological
aprotinin NN Pharmocological
-DOCSTART- -X- N

lidocaine NN Pharmocological
lidocaine JJ Pharmocological
solutions NNS None
-DOCSTART- -X- N

maximum JJ Physical
cycle NN Physical
ergometry NN Physical
: : Physical
maximum VB Physical
ramp-incremental JJ Physical
cycle NN Physical
ergometry NN Physical
-DOCSTART- -X- N

gonadotropin-releasing JJ Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
gonadotropin-releasing JJ Pharmocological
hormone NN Pharmocological
agonist NN Pharmocological
( ( Pharmocological
GnRH-a NNP Pharmocological
) ) None
GnRH-a NNP Pharmocological
-DOCSTART- -X- N

triple JJ Pharmocological
dye NN Pharmocological
application NN Pharmocological
Povidone-iodine NN Pharmocological
-DOCSTART- -X- N

physiotherapy JJ Physical
management NN Physical
placebo NN Control
multimodal JJ Physical
physiotherapy NN Physical
programme NN Physical
including VBG None
taping VBG Physical
, , None
exercises NNS Physical
, , None
and CC None
massage NN Physical
placebo NN Control
Physiotherapy NNP Physical
and CC None
placebo JJ Control
Physiotherapy NNP Physical
included VBD Physical
exercise NN Physical
, , None
massage NN Physical
, , None
taping VBG Physical
, , None
and CC None
mobilisation NN Physical
, , None
followed VBN None
by IN None
12 CD None
weeks NNS None
of IN None
self JJ None
management NN None
. . None
Placebo NNP Control
sham VBN Control
ultrasound JJ Control
and CC Control
light JJ Control
application NN Control
of IN Control
a DT Control
non-therapeutic JJ Control
gel NN Control
, , Control
followed VBN Control
by IN Control
no DT Control
treatment NN Control
. . None
physiotherapy NN Physical
programme NN Physical
-DOCSTART- -X- N

Slotted VBN Surgical
versus IN Surgical
non-slotted JJ Surgical
locked JJ Surgical
intramedullary JJ Surgical
nailing NN Surgical
two CD Surgical
slotted VBD Surgical
nails NNS Surgical
, , None
the DT Surgical
Grosse-Kempf NNP Surgical
nail NN Surgical
and CC None
the DT None
AO/ASIF NNP Surgical
universal JJ Surgical
femoral JJ Surgical
nail NN Surgical
non-slotted JJ Physical
Grosse-Kempf NNP Physical
nail NN Physical
and CC None
control NN Physical
bone NN Physical
slotted JJ Surgical
nails NNS Surgical
-DOCSTART- -X- N

were VBD None
monitored VBN None
throughout IN None
the DT None
procedure NN None
by IN None
means NNS None
of IN None
( ( Physical
SpO2 NNP Physical
) ) Physical
. . None
measured VBN None
at IN None
six CD None
points NNS None
before IN None
, , None
during IN None
and CC None
after IN None
endoscopy NN Surgical
from IN None
automated VBN None
cardiac NN None
flow NN None
measurement NN None
by IN None
color NN Physical
Doppler NNP Physical
echocardiography NN Physical
. . Physical
midazolam NN Pharmocological
-DOCSTART- -X- N

TENS NNP Physical
placebo-controlled JJ Control
transcutaneous JJ Physical
electrical JJ Physical
stimulation NN Physical
( ( Physical
TENS NNP Physical
) ) Physical
and CC None
placebo JJ Control
TENS NNP Physical
-DOCSTART- -X- N

Growth NNP Physical
hormone NN Physical
( ( Physical
GH NNP Physical
) ) Physical
treatment NN Physical
to TO None
GH NNP None
or CC None
no DT None
treatment NN None
for IN None
-DOCSTART- -X- N

Low-frequency NNP Physical
repetitive JJ Physical
transcranial JJ Physical
magnetic JJ Physical
stimulation NN Physical
( ( Physical
rTMS NN Physical
) ) Physical
low-frequency NN Physical
, , Physical
repetitive JJ Physical
Transcranial NNP Physical
Magnetic NNP Physical
Stimulation NNP Physical
( ( Physical
rTMS NN Physical
) ) Physical
low-frequency NN Physical
rTMS NN Physical
-DOCSTART- -X- N

GnRH NNP Pharmocological
agonist NN Pharmocological
treatment NN None
gonadotropin-releasing VBG Pharmocological
hormone NN Pharmocological
( ( Pharmocological
GnRH NNP Pharmocological
) ) Pharmocological
agonists VBZ Pharmocological
Total NNP Surgical
laparoscopic NN Surgical
hysterectomy NN Surgical
for IN Surgical
benign JJ Surgical
pathology NN Surgical
. . None
triptorelin NN Pharmocological
depot NN Pharmocological
GnRH NNP Pharmocological
-DOCSTART- -X- N

-DOCSTART- -X- N

Mind NNP Educational
training NN Educational
Theory NN Educational
of IN Educational
Mind NNP Educational
( ( Educational
ToM NNP Educational
) ) Educational
treatments NNS Educational
. . None
ToM NNP Educational
treatment NN Educational
-DOCSTART- -X- N

nebulized JJ Pharmocological
flunisolide NN Pharmocological
combined VBN Pharmocological
with IN Pharmocological
salbutamol NN Pharmocological
and CC Pharmocological
ipratropium NN Pharmocological
bromide NN Pharmocological
corticosteroids NNS Pharmocological
nebulized JJ Pharmocological
flunisolide NN Pharmocological
+ VBZ Pharmocological
salbutamol/ipratropium JJ Pharmocological
bromide NN Pharmocological
placebo NN Control
+ NNP None
salbutamol/ipratropium NN Control
bromide NN Control
. . None
flunisolide NN Pharmocological
placebo NN Control
flunisolide NN Pharmocological
placebo NN Control
flunisolide JJ Pharmocological
flunisolide NN Pharmocological
flunisolide RB Pharmocological
placebo NN Control
Nebulized NNP Pharmocological
flunisolide NN Pharmocological
nebulized JJ Pharmocological
salbutamol/ipratropium NN Pharmocological
bromide NN Pharmocological
-DOCSTART- -X- N

Pulsed VBN Pharmocological
azithromycin JJ Pharmocological
treatment NN Pharmocological
2-week-longer JJ Pharmocological
daily JJ Pharmocological
doxycycline NN Pharmocological
treatment NN Pharmocological
azithromycin NN Pharmocological
and CC Pharmocological
doxycycline NN Pharmocological
azithromycin NNS Pharmocological
and CC None
doxycycline NN Pharmocological
treatments NNS None
azithromycin NN Pharmocological
doxycycline NN Pharmocological
azithromycin NN Pharmocological
doxycycline NN Pharmocological
. . None
-DOCSTART- -X- N

phosphodiesterase-4 JJ Pharmocological
inhibitor NN Pharmocological
cilomilast NN Pharmocological
( ( Pharmocological
Ariflo NNP Pharmocological
) ) Pharmocological
Cilomilast NNP Pharmocological
( ( Pharmocological
Ariflo NNP Pharmocological
) ) Pharmocological
oral JJ Pharmocological
phosphodiesterase-4 JJ Pharmocological
selective JJ Pharmocological
inhibitor NN Pharmocological
cilomilast NN Pharmocological
placebo NN Control
placebo NN None
cilomilast NN Pharmocological
cilomilast NN Pharmocological
Phosphodiesterase-4 JJ Pharmocological
inhibitors NNS Pharmocological
-DOCSTART- -X- N

remifentanil NN Pharmocological
and CC None
alfentanil NN Pharmocological
remifentanil NNS Pharmocological
remifentanil NN Pharmocological
placebo-controlled JJ Control
saline NN Pharmocological
, , None
remifentanil NN Pharmocological
, , None
or CC None
alfentanil NN Pharmocological
for IN None
120 CD None
min NN None
. . None
age- JJ None
and CC None
weight-adjusted JJ None
infusions NNS None
( ( None
determined VBN None
with IN None
STANPUMP NNP Pharmocological
, , None
a DT None
computer NN Pharmocological
modeling VBG Pharmocological
software NN Pharmocological
package NN Pharmocological
) ) None
40 CD None
min NNS None
each DT None
of IN None
remifentanil NN Pharmocological
( ( None
0.75 CD None
, , None
1.5 CD None
, , None
and CC None
3 CD None
ng/ml NN None
) ) None
and CC None
alfentanil NN None
( ( None
16 CD None
, , None
32 CD None
, , None
and CC None
64 CD None
ng/ml NN None
) ) None
. . None
Remifentanil NNP Pharmocological
remifentanil NN Pharmocological
-DOCSTART- -X- N

LV5FU2-irinotecan JJ Pharmocological
and CC None
LV5FU2 NNP Pharmocological
alone RB Pharmocological
or CC None
LV5FU2-cisplatin NNP Pharmocological
LV5FU2-cisplatin JJ Pharmocological
LV5FU2-irinotecan JJ Pharmocological
LV5FU2-irinotecan JJ Pharmocological
-DOCSTART- -X- N

azithromycin NN Pharmocological
Azithromycin NNP Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
plus CC None
warm JJ Pharmocological
compresses NNS Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
azithromycin NN Pharmocological
Azithromycin NNP Pharmocological
-DOCSTART- -X- N

acupuncture NN Physical
oral JJ Physical
care NN Physical
sessions NNS Physical
acupuncture NN Physical
oral JJ Educational
care NN Educational
education NN Educational
acupuncture NN Physical
using VBG Physical
standardised VBN Physical
methods NNS Physical
. . None
Acupuncture NNP Physical
acupuncture NN Other
-DOCSTART- -X- N

mild JJ Physical
physical JJ Physical
exercise NN Physical
physical JJ Physical
exercise NN Physical
regular JJ Physical
physical JJ Physical
exercise NN Physical
exercise NN Physical
exercise NN Physical
mild JJ Physical
regular JJ Physical
physical JJ Physical
exercise NN Physical
-DOCSTART- -X- N

Dexamethasone NNP Pharmocological
therapy NN Pharmocological
Glucocorticoids NNS Pharmocological
radioimmunoassay NN None
. . None
dexamethasone NN Pharmocological
glucocorticoids NNS Pharmocological
cortisol NN Pharmocological
. . None
-DOCSTART- -X- N

syndrome NN Educational
: : Educational
differential JJ Educational
attributions NNS Educational
. . None
Nurses NNS None
and CC None
physician JJ None
assistants NNS None
( ( None
PAs NNP None
) ) None
were VBD None
presented VBN None
a DT None
case NN Psychological
study NN Psychological
of IN Psychological
a DT Psychological
( ( Educational
CNDS NNP Educational
) ) Educational
-DOCSTART- -X- N

( ( Psychological
CYBOCS NNP Psychological
) ) Psychological
modified VBD Psychological
for IN Psychological
pervasive JJ Psychological
developmental NN Psychological
disorders NNS Psychological
( ( Psychological
PDDs NNP Psychological
) ) Psychological
. . None
( ( Psychological
CYBOCS-PDD NNP Psychological
) ) Psychological
five CD Educational
Compulsion NNP Educational
severity NN Educational
items NNS Educational
-DOCSTART- -X- N

sedative JJ Pharmocological
drugs NNS Pharmocological
dexmedetomidine NN Pharmocological
and CC None
midazolam+fentanyl JJ Pharmocological
sedation NN Pharmocological
dexmedetomidine NN Pharmocological
and CC None
topical JJ Pharmocological
anesthesia NN Pharmocological
, , None
dexmedetomidine NN Pharmocological
and CC None
peribulbar NN Pharmocological
anesthesia NN Pharmocological
, , None
midazolam+fentanyl NN Pharmocological
and CC None
topical JJ Pharmocological
anesthesia NN Pharmocological
midazolam+fentanyl NN Pharmocological
and CC None
peribulbar NN Pharmocological
anesthesia NN Pharmocological
. . None
midazolam+fentanyl NN Pharmocological
midazolam+fentanyl NN Pharmocological
combination NN Pharmocological
-DOCSTART- -X- N

Self-Care JJ Educational
Rehabilitation NNP Educational
Program NNP Educational
Self-Care JJ Educational
Rehabilitation NNP Educational
six CD Educational
1-hour JJ Educational
classes NNS Educational
scheduled VBN Educational
twice RB Educational
a DT Educational
week NN Educational
for IN Educational
3 CD Educational
weeks NNS Educational
. . None
eight CD Educational
90-minute JJ Educational
classes NNS Educational
for IN Educational
both DT Educational
scheduled VBN Educational
SCRPA NNP Educational
-DOCSTART- -X- N

single-incision NN Surgical
laparoscopic NN Surgical
vs JJ None
conventional JJ Surgical
3-port JJ Surgical
laparoscopic NN Surgical
appendectomy NN Surgical
single-incision NN Surgical
laparoscopic NN Surgical
surgery NN Surgical
( ( Surgical
SILS NNP Surgical
) ) Surgical
multiport NN Surgical
laparoscopy NN Surgical
. . None
SILS NNP Surgical
3-port JJ Surgical
laparoscopic NN Surgical
appendectomy NN Surgical
. . None
SILS NNP Surgical
or CC None
3-port JJ Surgical
laparoscopic NN Surgical
appendectomy NN Surgical
. . None
SILS NNP None
averaged VBD None
converted VBN None
to TO None
3-port JJ None
. . None
There EX None
However RB None
, , None
3-port JJ None
patients NNS None
and CC None
SILS NNP None
patients NNS None
Single-incision NNP None
laparoscopic NN None
surgery NN None
appendectomy NN None
resulted VBD None
in IN None
-DOCSTART- -X- N

spinal JJ Pharmocological
anesthesia NN Pharmocological
light NN Other
deep JJ Other
sedation NN Pharmocological
light NN Pharmocological
deep JJ Pharmocological
sedation NN Pharmocological
spinal JJ Pharmocological
anesthesia NN Pharmocological
. . None
-DOCSTART- -X- N

crystalloids NNS Pharmocological
colloids NNS Pharmocological
no DT None
prehydration NN None
crystalloid NN Pharmocological
colloid JJ Pharmocological
solution NN Pharmocological
no DT None
prehydration NN None
crystalloid NN Pharmocological
colloid JJ Pharmocological
prehydration NN Pharmocological
crystalloid JJ Pharmocological
solution NN Pharmocological
colloid NN Pharmocological
Haemaccel NNP Pharmocological
no DT Control
prehydration NN Control
colloid NN None
crystalloid NN None
colloid JJ None
prehydration NN None
-DOCSTART- -X- N

practice NN Physical
, , Physical
no-practice JJ Physical
, , Physical
or CC Physical
control NN Control
groups NNS Control
. . None
-DOCSTART- -X- N

fluticasone NN Pharmocological
propionate/salmeterol NN Pharmocological
tiotropium VB Pharmocological
fluticasone/salmeterol NN Pharmocological
( ( Pharmocological
FSC NNP Pharmocological
) ) Pharmocological
to TO None
tiotropium VB Pharmocological
daily RB None
) ) None
( ( None
TIO NNP None
18 CD None
mcg NN None
FSC NNP None
to TO None
-DOCSTART- -X- N

blood NN Physical
conservation NN Physical
device NN Physical
blood NN Physical
conservation NN Physical
device NN Physical
incorporated VBN Physical
into IN Physical
the DT Physical
arterial JJ Physical
pressure NN Physical
monitoring NN Physical
system NN Physical
control NN Control
group NN Control
received VBD Control
a DT Control
conventional JJ Control
arterial JJ Control
pressure NN Control
monitoring NN Control
system NN Control
. . Control
blood NN Physical
conservation NN Physical
system NN Physical
-DOCSTART- -X- N

combination NN Pharmocological
of IN Pharmocological
valsartan NN Pharmocological
and CC None
benazepril NN Pharmocological
Valsartan NNP Pharmocological
combination NN Pharmocological
of IN Pharmocological
valsartan NN Pharmocological
and CC None
benazepril NN Pharmocological
. . None
valsartan JJ Pharmocological
160 CD Pharmocological
mg NN Pharmocological
valsartan JJ Pharmocological
80 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
plus CC None
benazepril JJ Pharmocological
5 CD Pharmocological
or CC Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
once RB Pharmocological
daily JJ Pharmocological
valsartan JJ Pharmocological
160 CD Pharmocological
mg NN Pharmocological
plus CC None
benazepril JJ Pharmocological
5 CD Pharmocological
or CC Pharmocological
10 CD Pharmocological
mg NNS Pharmocological
-DOCSTART- -X- N

intraocular JJ None
pressure NN None
( ( None
IOP NNP None
) ) None
for IN None
central JJ None
corneal NN None
thickness NN None
( ( None
CCT NNP None
) ) None
. . None
baseline NN Physical
prediction NN Physical
model NN Physical
prediction NN Physical
model NN None
-DOCSTART- -X- N

RU NNP Pharmocological
486 CD Pharmocological
RU NNP Pharmocological
486 CD Pharmocological
and CC None
three CD None
of IN None
its PRP$ None
metabolites NNS None
( ( None
RU NNP Pharmocological
42633-monodemethyl CD Pharmocological
, , Pharmocological
RU NNP Pharmocological
42848-didemethyl CD Pharmocological
, , None
and CC None
RU NNP Pharmocological
42698-hydroxymetabolite JJ Pharmocological
) ) None
RU NNP Pharmocological
486 CD Pharmocological
dose NN None
RU NNP Pharmocological
486 CD Pharmocological
-DOCSTART- -X- N

Uvulopalatopharyngoplasty NNP Surgical
laser NN Physical
assisted VBD Physical
uvulopalatoplasty JJ Physical
conventional JJ Physical
uvulopalatopharyngoplasty JJ Physical
( ( Physical
UPPP NNP Physical
) ) Physical
laser $ Physical
assisted VBN Physical
uvulopalatoplasty JJ Physical
( ( Physical
LAUP NNP Physical
) ) Physical
LAUP NNP Physical
UPPP NNP Physical
. . None
LAUP NNP Physical
UPPP NNP Physical
-DOCSTART- -X- N

Prophylactic JJ Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
vs NN None
placebo NN Control
. . None
Lidocaine NNP Pharmocological
lidocaine NN Pharmocological
lidocaine NN Pharmocological
. . None
lidocaine JJ Pharmocological
-DOCSTART- -X- N

Couple-responsible JJ Psychological
therapy NN Psychological
process NN Psychological
: : Psychological
couple-responsible JJ Psychological
and CC Psychological
therapist-responsible JJ Psychological
process NN Psychological
couple NN Psychological
therapy NN Psychological
Couple-responsible JJ Psychological
process NN Psychological
consists VBZ Psychological
of IN Psychological
enactments NNS Psychological
, , Psychological
accommodation NN Psychological
, , Psychological
and CC Psychological
inductive JJ Psychological
process NN Psychological
. . Psychological
Therapist-responsible JJ Psychological
process NN Psychological
consists VBZ Psychological
of IN Psychological
primary JJ Psychological
therapist-couple JJ Psychological
interaction NN Psychological
, , Psychological
therapist JJ Psychological
interpretation NN Psychological
, , Psychological
and CC Psychological
direct JJ Psychological
instruction NN Psychological
. . Psychological
couple-responsible JJ Psychological
and CC Psychological
therapist-responsible JJ Psychological
episodes NNS Psychological
couple-responsible JJ Psychological
episodes NNS Psychological
. . Psychological
therapist NN Physical
process NN Physical
couple-responsible JJ Psychological
episodes NNS Psychological
therapist-responsible JJ Psychological
episodes NNS Psychological
couple-responsible JJ Psychological
episodes NNS Psychological
therapist-responsible JJ Physical
episodes NNS Physical
-DOCSTART- -X- N

an DT Other
environment NN Other
of IN Other
recorded VBN Other
helicopter NN Other
noise NN Other
from IN Other
a DT Other
Speech NNP Other
audiometry NN Other
was VBD Other
performed VBN Other
under IN Other
four CD Other
different JJ Other
conditions NNS Other
: : Other
headset NN Physical
only RB Physical
, , Other
and CC Other
three CD Physical
different JJ Physical
ear NN Physical
plugs NNS Physical
worn VBN Physical
under IN Physical
the DT Physical
headset NN Physical
. . None
Fitting NN Other
of IN Other
the DT Other
ear JJ Physical
plugs NN Physical
was VBD Other
performed VBN Other
by IN Other
an DT Other
ear NN Other
, , Other
nose JJ Other
and CC Other
throat JJ Other
specialist NN Other
to TO Other
ensure VB Other
similar JJ Other
conditions NNS Other
. . None
-DOCSTART- -X- N

interactive JJ Educational
expert NN Educational
system NN Educational
intervention NN Educational
the DT Educational
interactive JJ Educational
expert NN Educational
system NN Educational
intervention NN Educational
; : None
expert NN Educational
system NN Educational
intervention NN Educational
plus CC Educational
counselor NN Educational
calls VBZ Educational
; : None
the DT None
expert NN Educational
system NN Educational
intervention NN Educational
plus CC Educational
the DT Educational
stimulus NN Educational
control NN Educational
computer NN Educational
; : None
assessment NN Educational
only RB Educational
condition NN Educational
. . None
interactive JJ Educational
expert NN Educational
system NN Educational
-DOCSTART- -X- N

primary JJ Educational
care NN Educational
primary JJ Educational
care NN Educational
intervention NN Educational
provided VBD Educational
assistance NN Educational
to TO Educational
practices NNS Educational
in IN Educational
establishing VBG Educational
an DT Educational
office NN Educational
system NN Educational
that WDT Educational
promoted VBD Educational
sun JJ Educational
protection NN Educational
advice NN Educational
to TO Educational
children NNS Educational
and CC Educational
their PRP$ Educational
parents NNS Educational
during IN Educational
office NN Educational
visits NNS Educational
. . Educational
-DOCSTART- -X- N

proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
proton NN Pharmocological
pump NN Pharmocological
inhibitors NNS Pharmocological
. . None
lansoprazole NN Pharmocological
. . Pharmocological
placebo-controlled JJ Control
lansoprazole JJ Pharmocological
60 CD Pharmocological
mg NN Pharmocological
once RB Pharmocological
daily JJ Pharmocological
or CC None
placebo NN Control
placebo JJ Control
lansoprazole VBZ Pharmocological
placebo JJ Control
lansoprazole JJ Pharmocological
-DOCSTART- -X- N

mitral JJ Surgical
valve FW Surgical
replacement NN Surgical
of IN None
the DT None
chordae NN None
tendineae NN None
and CC None
papillary JJ None
muscles NNS None
during IN None
mitral JJ Surgical
valve FW Surgical
replacement NN Surgical
. . None
Rest NNP Physical
and CC Physical
exercise NN Physical
nuclear JJ Physical
ventriculograms NNS Physical
-DOCSTART- -X- N

mifepristone NN Pharmocological
mifepristone NN Pharmocological
receive VB Pharmocological
either RB Pharmocological
5 CD Pharmocological
or CC Pharmocological
10 CD Pharmocological
mg NN Pharmocological
of IN Pharmocological
mifepristone JJ Pharmocological
daily JJ Pharmocological
for IN Pharmocological
6 CD Pharmocological
months NNS Pharmocological
in IN Pharmocological
an DT Pharmocological
open-label JJ Pharmocological
study NN Pharmocological
. . Pharmocological
Mifepristone NNP Pharmocological
mifepristone NN Pharmocological
. . None
-DOCSTART- -X- N

formoterol NN Pharmocological
salmeterol NN Pharmocological
regularly RB Pharmocological
treated VBN Pharmocological
with IN Pharmocological
salbutamol JJ Pharmocological
200 CD Pharmocological
micrograms NNS Pharmocological
twice RB Pharmocological
daily RB Pharmocological
during IN Pharmocological
the DT Pharmocological
study NN Pharmocological
period NN Pharmocological
, , Pharmocological
to TO Pharmocological
avoid VB Pharmocological
variability NN Pharmocological
in IN Pharmocological
were VBD Physical
followed VBN Physical
as IN Physical
measures NNS Physical
of IN Physical
systemic JJ Physical
effects NNS Physical
. . None
Formoterol NNP Pharmocological
methacholine NN Pharmocological
responsiveness NN Pharmocological
( ( Pharmocological
4.6 CD Pharmocological
doubling VBG Pharmocological
doses NNS Pharmocological
after IN Pharmocological
120 CD Pharmocological
micrograms NNS Pharmocological
) ) Pharmocological
-DOCSTART- -X- N

Prophylactic JJ None
cranial JJ None
irradiation NN None
Prophylactic NNP Physical
cranial JJ Physical
irradiation NN Physical
prophylactic JJ Physical
cranial JJ Physical
irradiation NN Physical
prophylactic JJ Physical
cranial JJ Physical
irradiation NN Physical
no DT Physical
prophylactic JJ Physical
cranial JJ Physical
irradiation NN Physical
( ( Physical
control VB Physical
group NN Physical
) ) Physical
. . None
Prophylactic NNP Physical
cranial JJ Physical
irradiation NN Physical
-DOCSTART- -X- N

stretching VBG Physical
durations NNS Physical
Static JJ Physical
stretching NN Physical
stretching VBG Physical
different JJ Physical
stretching VBG Physical
durations NNS Physical
static JJ Physical
stretching NN Physical
. . None
stretching JJ Physical
stretching VBG Physical
20-second JJ Physical
stretching NN Physical
180- JJ Physical
and CC Physical
300-second JJ Physical
stretching NN Physical
20-second JJ Physical
stretching NN Physical
stretching JJ Physical
300-second JJ Physical
stretching NN Physical
20-second JJ Physical
stretching NN Physical
300-second CD Physical
stretching VBG Physical
60-second JJ Physical
stretching NN Physical
stretching JJ Physical
durations NNS Physical
stretching NN Physical
180 CD Physical
seconds NNS Physical
of IN Physical
stretching VBG Physical
stretching VBG Physical
duration NN Physical
. . None
stretching VBG Physical
-DOCSTART- -X- N

carbenicillin NN Pharmocological
ampicillin NN Pharmocological
carbenicillin NN Pharmocological
( ( Pharmocological
CB NNP Pharmocological
) ) Pharmocological
or CC Pharmocological
ampicillin NN Pharmocological
( ( Pharmocological
AMP NNP Pharmocological
) ) Pharmocological
AMP JJ Pharmocological
CB NNP Pharmocological
CB NNP Pharmocological
AMP NNP Pharmocological
CB NNP Pharmocological
-DOCSTART- -X- N

betamethasone NN Pharmocological
valerate NN Pharmocological
active JJ Pharmocological
corticosteroid NN Pharmocological
preparation NN Pharmocological
( ( Pharmocological
Betamethasone NNP Pharmocological
valerate NN Pharmocological
) ) Pharmocological
basal NN Control
formulation NN Control
only RB Control
( ( Control
placebo NN Control
) ) Control
. . Control
-DOCSTART- -X- N

rTMS JJ Surgical
( ( None
rTMS NN Surgical
) ) None
rTMS NN Surgical
randomly RB None
assigned VBN None
to TO None
either DT None
active JJ Physical
rTMS NN Physical
treatment NN Physical
or CC None
wait-list NN Educational
( ( Educational
WTL NNP Educational
) ) Educational
groups NNS Educational
. . None
was VBD Physical
collected VBN Physical
using VBG Physical
128 CD Physical
channel NNS Physical
EEG NNP Physical
system NN Physical
. . Physical
-DOCSTART- -X- N

20 CD Pharmocological
microg NNS Pharmocological
( ( Pharmocological
low-dose JJ Pharmocological
) ) Pharmocological
teriparatide NN Pharmocological
per IN None
day NN None
, , None
but CC None
not RB Control
with IN Control
40 CD Control
microg NNS Control
( ( Control
high-dose JJ Control
) ) Control
teriparatide RB None
-DOCSTART- -X- N

bepotastine NN Pharmocological
besilate NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
placebo-controlled JJ Control
Bepotastine NNP Pharmocological
besilate NN Pharmocological
ophthalmic JJ Pharmocological
solution NN Pharmocological
( ( Pharmocological
BBOS NNP Pharmocological
) ) Pharmocological
dual-acting JJ Pharmocological
histamine NN Pharmocological
placebo-controlled JJ Control
BBOS NNP Pharmocological
or CC None
placebo NN Control
eyedrops NNS Control
-DOCSTART- -X- N

life-style JJ None
changes NNS None
. . None
study NN None
, , None
consisting VBG None
of IN None
dietary JJ None
treatment NN None
and/or JJ None
increase NN None
of IN None
physical JJ None
activity NN None
or CC None
training NN None
with IN None
annual JJ None
check-ups NNS None
, , None
-DOCSTART- -X- N

Direct JJ Physical
microscopy NN Physical
of IN Physical
the DT Physical
bile NN Physical
antibiotic JJ Pharmocological
group NN Pharmocological
control NN Control
group NN Control
. . None
cholecystectomy VB Surgical
-DOCSTART- -X- N

nicotine JJ Pharmocological
replacement NN Pharmocological
therapy NN Pharmocological
( ( Pharmocological
NRT NNP Pharmocological
) ) Pharmocological
NRT NNP Pharmocological
NRT NNP Pharmocological
. . None
NRT NNP Pharmocological
. . None
NRT NNP Pharmocological
NRT NNP Pharmocological
. . None
NRT NNP Pharmocological
-DOCSTART- -X- N

induction NN Pharmocological
chemotherapy NN Pharmocological
Induction NNP Pharmocological
chemotherapy NN Pharmocological
radiation NN Physical
therapy NN Physical
( ( Physical
RT NNP Physical
) ) Physical
-DOCSTART- -X- N

halothane NN Pharmocological
lidocaine NN Pharmocological
ornipressin NN Pharmocological
fentanyl NN Pharmocological
lidocaine NN Pharmocological
ornipressin NN Pharmocological
fentanyl NN Pharmocological
lidocaine NN Pharmocological
epinephrine NN Pharmocological
prilocaine NN Pharmocological
epinephrine NN Pharmocological
-DOCSTART- -X- N

Green JJ Pharmocological
banana-supplemented JJ Pharmocological
diet NN Pharmocological
green JJ Pharmocological
banana NN Pharmocological
standard JJ None
care NN None
group NN None
or CC None
a DT None
standard JJ None
care NN None
plus CC None
green JJ None
banana NN None
group NN None
where WRB None
add VB None
cooked JJ None
green JJ None
banana NN None
to TO None
receiving VBG None
green JJ None
banana NN None
had VBD None
green JJ None
banana-supplemented JJ None
